graph [
  directed 1
  node [
    id 0
    label "Title 21"
  ]
  node [
    id 1
    label "CHAPTER 1 &#8212; ADULTERATED OR MISBRANDED FOODS OR DRUGS"
  ]
  node [
    id 2
    label "SUBCHAPTER I &#8212; FEDERAL FOOD AND DRUGS ACT OF 1906"
  ]
  node [
    id 3
    label "SUBCHAPTER II &#8212; MISCELLANEOUS PROVISIONS"
  ]
  node [
    id 4
    label "CHAPTER 2 &#8212; TEAS"
  ]
  node [
    id 5
    label "CHAPTER 3 &#8212; FILLED MILK"
  ]
  node [
    id 6
    label "CHAPTER 4 &#8212; ANIMALS, MEATS, AND MEAT AND DAIRY PRODUCTS"
  ]
  node [
    id 7
    label "SUBCHAPTER I &#8212; EXAMINATION OF ANIMALS, MEATS, AND MEAT AND DAIRY PRODUCTS"
  ]
  node [
    id 8
    label "SUBCHAPTER II &#8212; IMPORTATION OF CATTLE AND QUARANTINE"
  ]
  node [
    id 9
    label "SUBCHAPTER III &#8212; PREVENTION OF INTRODUCTION AND SPREAD OF CONTAGION"
  ]
  node [
    id 10
    label "SUBCHAPTER IV &#8212; IMPORTATION OF MILK AND CREAM"
  ]
  node [
    id 11
    label "CHAPTER 5 &#8212; VIRUSES, SERUMS, TOXINS, ANTITOXINS, AND ANALOGOUS PRODUCTS"
  ]
  node [
    id 12
    label "CHAPTER 5A &#8212; BUREAU OF NARCOTICS"
  ]
  node [
    id 13
    label "CHAPTER 6 &#8212; NARCOTIC DRUGS"
  ]
  node [
    id 14
    label "CHAPTER 7 &#8212; PRACTICE OF PHARMACY AND SALE OF POISONS IN CONSULAR DISTRICTS IN CHINA"
  ]
  node [
    id 15
    label "CHAPTER 8 &#8212; NARCOTIC FARMS"
  ]
  node [
    id 16
    label "CHAPTER 9 &#8212; FEDERAL FOOD, DRUG, AND COSMETIC ACT"
  ]
  node [
    id 17
    label "SUBCHAPTER I &#8212; SHORT TITLE"
  ]
  node [
    id 18
    label "SUBCHAPTER II &#8212; DEFINITIONS"
  ]
  node [
    id 19
    label "SUBCHAPTER III &#8212; PROHIBITED ACTS AND PENALTIES"
  ]
  node [
    id 20
    label "SUBCHAPTER IV &#8212; FOOD"
  ]
  node [
    id 21
    label "SUBCHAPTER V &#8212; DRUGS AND DEVICES"
  ]
  node [
    id 22
    label "SUBCHAPTER VI &#8212; COSMETICS"
  ]
  node [
    id 23
    label "SUBCHAPTER VII &#8212; GENERAL AUTHORITY"
  ]
  node [
    id 24
    label "SUBCHAPTER VIII &#8212; IMPORTS AND EXPORTS"
  ]
  node [
    id 25
    label "SUBCHAPTER IX &#8212; MISCELLANEOUS"
  ]
  node [
    id 26
    label "CHAPTER 10 &#8212; POULTRY AND POULTRY PRODUCTS INSPECTION"
  ]
  node [
    id 27
    label "CHAPTER 11 &#8212; MANUFACTURE OF NARCOTIC DRUGS"
  ]
  node [
    id 28
    label "CHAPTER 12 &#8212; MEAT INSPECTION"
  ]
  node [
    id 29
    label "SUBCHAPTER I &#8212; INSPECTION REQUIREMENTS; ADULTERATION AND MISBRANDING"
  ]
  node [
    id 30
    label "SUBCHAPTER II &#8212; MEAT PROCESSORS AND RELATED INDUSTRIES"
  ]
  node [
    id 31
    label "SUBCHAPTER III &#8212; FEDERAL AND STATE COOPERATION"
  ]
  node [
    id 32
    label "SUBCHAPTER IV &#8212; AUXILIARY PROVISIONS"
  ]
  node [
    id 33
    label "SUBCHAPTER V &#8212; MISCELLANEOUS PROVISIONS"
  ]
  node [
    id 34
    label "CHAPTER 13 &#8212; DRUG ABUSE PREVENTION AND CONTROL"
  ]
  node [
    id 35
    label "SUBCHAPTER I &#8212; CONTROL AND ENFORCEMENT"
  ]
  node [
    id 36
    label "SUBCHAPTER II &#8212; IMPORT AND EXPORT"
  ]
  node [
    id 37
    label "CHAPTER 14 &#8212; ALCOHOL AND DRUG ABUSE EDUCATIONAL PROGRAMS AND ACTIVITIES"
  ]
  node [
    id 38
    label "CHAPTER 15 &#8212; EGG PRODUCTS INSPECTION"
  ]
  node [
    id 39
    label "CHAPTER 16 &#8212; DRUG ABUSE PREVENTION, TREATMENT, AND REHABILITATION"
  ]
  node [
    id 40
    label "SUBCHAPTER I &#8212; GENERAL PROVISIONS"
  ]
  node [
    id 41
    label "SUBCHAPTER II &#8212; DRUG ABUSE POLICY COORDINATION"
  ]
  node [
    id 42
    label "SUBCHAPTER III &#8212; NATIONAL DRUG ABUSE STRATEGY"
  ]
  node [
    id 43
    label "SUBCHAPTER IV &#8212; OTHER FEDERAL PROGRAMS"
  ]
  node [
    id 44
    label "SUBCHAPTER V &#8212; NATIONAL INSTITUTE ON DRUG ABUSE"
  ]
  node [
    id 45
    label "CHAPTER 17 &#8212; NATIONAL DRUG ENFORCEMENT POLICY"
  ]
  node [
    id 46
    label "CHAPTER 18 &#8212; PRESIDENT'S MEDIA COMMISSION ON ALCOHOL AND DRUG ABUSE PREVENTION"
  ]
  node [
    id 47
    label "CHAPTER 19 &#8212; PESTICIDE MONITORING IMPROVEMENTS"
  ]
  node [
    id 48
    label "CHAPTER 20 &#8212; NATIONAL DRUG CONTROL PROGRAM"
  ]
  node [
    id 49
    label "section_6"
  ]
  node [
    id 50
    label "section_14a"
    class_name "section"
    text "&#167;14a. Transferred"
  ]
  node [
    id 51
    label "section_16"
  ]
  node [
    id 52
    label "section_17"
  ]
  node [
    id 53
    label "section_18"
  ]
  node [
    id 54
    label "section_20"
  ]
  node [
    id 55
    label "section_21"
  ]
  node [
    id 56
    label "section_22"
  ]
  node [
    id 57
    label "section_23"
  ]
  node [
    id 58
    label "section_25"
  ]
  node [
    id 59
    label "section_41"
  ]
  node [
    id 60
    label "section_42"
  ]
  node [
    id 61
    label "section_43"
  ]
  node [
    id 62
    label "section_44"
  ]
  node [
    id 63
    label "section_45"
  ]
  node [
    id 64
    label "section_46"
  ]
  node [
    id 65
    label "section_46a"
    class_name "section"
    text "&#167;46a. Deposit of fee before examination of tea"
  ]
  node [
    id 66
    label "section_47"
  ]
  node [
    id 67
    label "section_48"
  ]
  node [
    id 68
    label "section_49"
  ]
  node [
    id 69
    label "section_50"
  ]
  node [
    id 70
    label "section_61"
    class_name "section"
    text "&#167;61. Definitions"
  ]
  node [
    id 71
    label "section_62"
  ]
  node [
    id 72
    label "section_63"
  ]
  node [
    id 73
    label "section_64"
  ]
  node [
    id 74
    label "section_98"
  ]
  node [
    id 75
    label "section_101"
  ]
  node [
    id 76
    label "section_102"
  ]
  node [
    id 77
    label "section_103"
  ]
  node [
    id 78
    label "section_104"
    class_name "section"
    text "&#167;104. Importation of animals"
  ]
  node [
    id 79
    label "section_105"
  ]
  node [
    id 80
    label "section_111"
  ]
  node [
    id 81
    label "section_112"
  ]
  node [
    id 82
    label "section_113"
  ]
  node [
    id 83
    label "section_113a"
  ]
  node [
    id 84
    label "section_114"
  ]
  node [
    id 85
    label "section_114a"
  ]
  node [
    id 86
    label "section_114a&#8211;1"
  ]
  node [
    id 87
    label "section_114b"
  ]
  node [
    id 88
    label "section_114c"
  ]
  node [
    id 89
    label "section_114d"
    class_name "section"
    text "&#167;114d. Sale of sterile screwworms"
  ]
  node [
    id 90
    label "section_114d&#8211;1"
  ]
  node [
    id 91
    label "section_114e"
  ]
  node [
    id 92
    label "section_114f"
  ]
  node [
    id 93
    label "section_114g"
    class_name "section"
    text "&#167;114g. Hog cholera eradication program"
  ]
  node [
    id 94
    label "section_114h"
    class_name "section"
    text "&#167;114h. Advisory committee"
  ]
  node [
    id 95
    label "section_114i"
    class_name "section"
    text "&#167;114i. Pseudorabies eradication"
  ]
  node [
    id 96
    label "section_115"
  ]
  node [
    id 97
    label "section_116"
  ]
  node [
    id 98
    label "section_117"
    class_name "section"
    text "&#167;117. Penalties for transportation of diseased livestock or live poultry"
  ]
  node [
    id 99
    label "section_118"
  ]
  node [
    id 100
    label "section_119"
  ]
  node [
    id 101
    label "section_120"
  ]
  node [
    id 102
    label "section_121"
  ]
  node [
    id 103
    label "section_122"
  ]
  node [
    id 104
    label "section_123"
  ]
  node [
    id 105
    label "section_124"
  ]
  node [
    id 106
    label "section_125"
  ]
  node [
    id 107
    label "section_126"
  ]
  node [
    id 108
    label "section_127"
  ]
  node [
    id 109
    label "section_128"
  ]
  node [
    id 110
    label "section_129"
  ]
  node [
    id 111
    label "section_130"
  ]
  node [
    id 112
    label "section_131"
  ]
  node [
    id 113
    label "section_132"
  ]
  node [
    id 114
    label "section_134"
    class_name "section"
    text "&#167;134. Definitions"
  ]
  node [
    id 115
    label "section_134a"
    class_name "section"
    text "&#167;134a. Seizure, quarantine, and disposal of livestock or poultry to guard against introduction or dissemination of communicable disease"
  ]
  node [
    id 116
    label "section_134b"
  ]
  node [
    id 117
    label "section_134c"
  ]
  node [
    id 118
    label "section_134d"
    class_name "section"
    text "&#167;134d. Inspections and seizures; issuance of warrants"
  ]
  node [
    id 119
    label "section_134e"
    class_name "section"
    text "&#167;134e. Enforcement provisions"
  ]
  node [
    id 120
    label "section_134f"
  ]
  node [
    id 121
    label "section_134g"
  ]
  node [
    id 122
    label "section_134h"
  ]
  node [
    id 123
    label "section_135"
  ]
  node [
    id 124
    label "section_135a"
    class_name "section"
    text "&#167;135a. Smuggling penalties"
  ]
  node [
    id 125
    label "section_135b"
  ]
  node [
    id 126
    label "section_136"
  ]
  node [
    id 127
    label "section_136a"
    class_name "section"
    text "&#167;136a. Collection of fees for inspection services"
  ]
  node [
    id 128
    label "section_141"
  ]
  node [
    id 129
    label "section_142"
    class_name "section"
    text "&#167;142. Milk or cream when unfit for importation"
  ]
  node [
    id 130
    label "section_143"
  ]
  node [
    id 131
    label "section_144"
  ]
  node [
    id 132
    label "section_145"
  ]
  node [
    id 133
    label "section_146"
  ]
  node [
    id 134
    label "section_147"
  ]
  node [
    id 135
    label "section_148"
  ]
  node [
    id 136
    label "section_149"
    class_name "section"
    text "&#167;149. Definitions"
  ]
  node [
    id 137
    label "section_151"
  ]
  node [
    id 138
    label "section_152"
    class_name "section"
    text "&#167;152. Importation regulated and prohibited"
  ]
  node [
    id 139
    label "section_153"
  ]
  node [
    id 140
    label "section_154"
  ]
  node [
    id 141
    label "section_154a"
    class_name "section"
    text "&#167;154a. Special licenses for special circumstances; expedited procedure; conditions; exemptions; criteria"
  ]
  node [
    id 142
    label "section_155"
  ]
  node [
    id 143
    label "section_156"
  ]
  node [
    id 144
    label "section_157"
  ]
  node [
    id 145
    label "section_158"
  ]
  node [
    id 146
    label "section_159"
    class_name "section"
    text "&#167;159. Enforcement; penalties applicable; Congressional findings"
  ]
  node [
    id 147
    label "section_201"
  ]
  node [
    id 148
    label "section_202"
  ]
  node [
    id 149
    label "section_203"
  ]
  node [
    id 150
    label "section_204"
  ]
  node [
    id 151
    label "section_205"
  ]
  node [
    id 152
    label "section_206"
  ]
  node [
    id 153
    label "section_207"
  ]
  node [
    id 154
    label "section_208"
  ]
  node [
    id 155
    label "section_209"
  ]
  node [
    id 156
    label "section_210"
  ]
  node [
    id 157
    label "section_211"
  ]
  node [
    id 158
    label "section_212"
  ]
  node [
    id 159
    label "section_213"
  ]
  node [
    id 160
    label "section_214"
  ]
  node [
    id 161
    label "section_215"
  ]
  node [
    id 162
    label "section_301"
  ]
  node [
    id 163
    label "section_321"
    class_name "section"
    text "&#167;321. Definitions; generally"
  ]
  node [
    id 164
    label "section_321a"
  ]
  node [
    id 165
    label "section_321b"
  ]
  node [
    id 166
    label "section_321c"
  ]
  node [
    id 167
    label "section_331"
    class_name "section"
    text "&#167;331. Prohibited acts"
  ]
  node [
    id 168
    label "section_332"
    class_name "section"
    text "&#167;332. Injunction proceedings"
  ]
  node [
    id 169
    label "section_333"
    class_name "section"
    text "&#167;333. Penalties"
  ]
  node [
    id 170
    label "section_334"
    class_name "section"
    text "&#167;334. Seizure"
  ]
  node [
    id 171
    label "section_335"
  ]
  node [
    id 172
    label "section_335a"
    class_name "section"
    text "&#167;335a. Debarment, temporary denial of approval, and suspension"
  ]
  node [
    id 173
    label "section_335b"
    class_name "section"
    text "&#167;335b. Civil penalties"
  ]
  node [
    id 174
    label "section_335c"
    class_name "section"
    text "&#167;335c. Authority to withdraw approval of abbreviated drug applications"
  ]
  node [
    id 175
    label "section_336"
  ]
  node [
    id 176
    label "section_337"
    class_name "section"
    text "&#167;337. Proceedings in name of United States; provision as to subpoenas"
  ]
  node [
    id 177
    label "section_341"
  ]
  node [
    id 178
    label "section_342"
    class_name "section"
    text "&#167;342. Adulterated food"
  ]
  node [
    id 179
    label "section_343"
    class_name "section"
    text "&#167;343. Misbranded food"
  ]
  node [
    id 180
    label "section_343&#8211;1"
    class_name "section"
    text "&#167;343&#8211;1. National uniform nutrition labeling"
  ]
  node [
    id 181
    label "section_343&#8211;2"
    class_name "section"
    text "&#167;343&#8211;2. Dietary supplement labeling exemptions"
  ]
  node [
    id 182
    label "section_343a"
    class_name "section"
    text "&#167;343a. Health risks presented by use of saccharin"
  ]
  node [
    id 183
    label "section_344"
    class_name "section"
    text "&#167;344. Emergency permit control"
  ]
  node [
    id 184
    label "section_345"
    class_name "section"
    text "&#167;345. Regulations making exemptions"
  ]
  node [
    id 185
    label "section_346"
    class_name "section"
    text "&#167;346. Tolerances for poisonous or deleterious substances in food; regulations"
  ]
  node [
    id 186
    label "section_346a"
    class_name "section"
    text "&#167;346a. Tolerances for pesticide chemicals in or on raw agricultural commodities"
  ]
  node [
    id 187
    label "section_346b"
    class_name "section"
    text "&#167;346b. Authorization of appropriations"
  ]
  node [
    id 188
    label "section_347"
    class_name "section"
    text "&#167;347. Intrastate sales of colored oleomargarine"
  ]
  node [
    id 189
    label "section_347a"
  ]
  node [
    id 190
    label "section_347b"
  ]
  node [
    id 191
    label "section_348"
    class_name "section"
    text "&#167;348. Food additives"
  ]
  node [
    id 192
    label "section_349"
  ]
  node [
    id 193
    label "section_350"
    class_name "section"
    text "&#167;350. Vitamins and minerals"
  ]
  node [
    id 194
    label "section_350a"
    class_name "section"
    text "&#167;350a. Infant formulas"
  ]
  node [
    id 195
    label "section_350b"
    class_name "section"
    text "&#167;350b. New dietary ingredients"
  ]
  node [
    id 196
    label "section_351"
    class_name "section"
    text "&#167;351. Adulterated drugs and devices"
  ]
  node [
    id 197
    label "section_352"
    class_name "section"
    text "&#167;352. Misbranded drugs and devices"
  ]
  node [
    id 198
    label "section_353"
    class_name "section"
    text "&#167;353. Exemptions and consideration for certain drugs, devices, and biological products"
  ]
  node [
    id 199
    label "section_355"
    class_name "section"
    text "&#167;355. New drugs"
  ]
  node [
    id 200
    label "section_356"
    class_name "section"
    text "&#167;356. Certification of drugs containing insulin"
  ]
  node [
    id 201
    label "section_357"
    class_name "section"
    text "&#167;357. Certification of drugs containing penicillin, streptomycin, chlortetracycline, chloramphenicol, bacitracin, or any other antibiotic drug"
  ]
  node [
    id 202
    label "section_358"
    class_name "section"
    text "&#167;358. Authority to designate official names"
  ]
  node [
    id 203
    label "section_359"
  ]
  node [
    id 204
    label "section_360"
    class_name "section"
    text "&#167;360. Registration of producers of drugs or devices"
  ]
  node [
    id 205
    label "section_360b"
    class_name "section"
    text "&#167;360b. New animal drugs"
  ]
  node [
    id 206
    label "section_360c"
    class_name "section"
    text "&#167;360c. Classification of devices intended for human use"
  ]
  node [
    id 207
    label "section_360d"
    class_name "section"
    text "&#167;360d. Performance standards"
  ]
  node [
    id 208
    label "section_360e"
    class_name "section"
    text "&#167;360e. Premarket approval"
  ]
  node [
    id 209
    label "section_360f"
    class_name "section"
    text "&#167;360f. Banned devices"
  ]
  node [
    id 210
    label "section_360g"
    class_name "section"
    text "&#167;360g. Judicial review"
  ]
  node [
    id 211
    label "section_360h"
    class_name "section"
    text "&#167;360h. Notification and other remedies"
  ]
  node [
    id 212
    label "section_360i"
    class_name "section"
    text "&#167;360i. Records and reports on devices"
  ]
  node [
    id 213
    label "section_360j"
    class_name "section"
    text "&#167;360j. General provisions respecting control of devices intended for human use"
  ]
  node [
    id 214
    label "section_360k"
    class_name "section"
    text "&#167;360k. State and local requirements respecting devices"
  ]
  node [
    id 215
    label "section_360l"
    class_name "section"
    text "&#167;360l. Postmarket surveillance"
  ]
  node [
    id 216
    label "section_361"
    class_name "section"
    text "&#167;361. Adulterated cosmetics"
  ]
  node [
    id 217
    label "section_362"
    class_name "section"
    text "&#167;362. Misbranded cosmetics"
  ]
  node [
    id 218
    label "section_363"
  ]
  node [
    id 219
    label "section_371"
    class_name "section"
    text "&#167;371. Regulations and hearings"
  ]
  node [
    id 220
    label "section_372"
    class_name "section"
    text "&#167;372. Examinations and investigations"
  ]
  node [
    id 221
    label "section_372a"
    class_name "section"
    text "&#167;372a. Transferred"
  ]
  node [
    id 222
    label "section_373"
  ]
  node [
    id 223
    label "section_374"
    class_name "section"
    text "&#167;374. Inspection"
  ]
  node [
    id 224
    label "section_375"
    class_name "section"
    text "&#167;375. Publicity"
  ]
  node [
    id 225
    label "section_376"
  ]
  node [
    id 226
    label "section_377"
  ]
  node [
    id 227
    label "section_378"
    class_name "section"
    text "&#167;378. Advertising of foods"
  ]
  node [
    id 228
    label "section_379"
    class_name "section"
    text "&#167;379. Confidential information"
  ]
  node [
    id 229
    label "section_379a"
  ]
  node [
    id 230
    label "section_379b"
    class_name "section"
    text "&#167;379b. Consolidated administrative and laboratory facility"
  ]
  node [
    id 231
    label "section_379c"
    class_name "section"
    text "&#167;379c. Transferred"
  ]
  node [
    id 232
    label "section_379d"
    class_name "section"
    text "&#167;379d. Automation of Food and Drug Administration"
  ]
  node [
    id 233
    label "section_379e"
    class_name "section"
    text "&#167;379e. Listing and certification of color additives for foods, drugs, devices, and cosmetics"
  ]
  node [
    id 234
    label "section_379f"
    class_name "section"
    text "&#167;379f. Recovery and retention of fees for freedom of information requests"
  ]
  node [
    id 235
    label "section_379g"
    class_name "section"
    text "&#167;379g. Definitions"
  ]
  node [
    id 236
    label "section_379h"
    class_name "section"
    text "&#167;379h. Authority to assess and use drug fees"
  ]
  node [
    id 237
    label "section_381"
    class_name "section"
    text "&#167;381. Imports and exports"
  ]
  node [
    id 238
    label "section_382"
    class_name "section"
    text "&#167;382. Exports of certain unapproved products"
  ]
  node [
    id 239
    label "section_383"
    class_name "section"
    text "&#167;383. Office of International Relations"
  ]
  node [
    id 240
    label "section_391"
  ]
  node [
    id 241
    label "section_392"
    class_name "section"
    text "&#167;392. Exemption of meats and meat food products"
  ]
  node [
    id 242
    label "section_393"
    class_name "section"
    text "&#167;393. Food and Drug Administration"
  ]
  node [
    id 243
    label "section_394"
    class_name "section"
    text "&#167;394. Scientific review groups"
  ]
  node [
    id 244
    label "section_395"
    class_name "section"
    text "&#167;395. Loan repayment program"
  ]
  node [
    id 245
    label "section_451"
  ]
  node [
    id 246
    label "section_452"
  ]
  node [
    id 247
    label "section_453"
    class_name "section"
    text "&#167;453. Definitions"
  ]
  node [
    id 248
    label "section_454"
    class_name "section"
    text "&#167;454. Federal and State cooperation in development and administration of State poultry product inspection programs"
  ]
  node [
    id 249
    label "section_455"
    class_name "section"
    text "&#167;455. Inspection in official establishments"
  ]
  node [
    id 250
    label "section_456"
    class_name "section"
    text "&#167;456. Operation of premises, facilities and equipment"
  ]
  node [
    id 251
    label "section_457"
    class_name "section"
    text "&#167;457. Labeling and container standards"
  ]
  node [
    id 252
    label "section_458"
    class_name "section"
    text "&#167;458. Prohibited acts"
  ]
  node [
    id 253
    label "section_459"
  ]
  node [
    id 254
    label "section_460"
    class_name "section"
    text "&#167;460. Miscellaneous activities subject to regulation"
  ]
  node [
    id 255
    label "section_461"
    class_name "section"
    text "&#167;461. Offenses and punishment"
  ]
  node [
    id 256
    label "section_462"
  ]
  node [
    id 257
    label "section_463"
    class_name "section"
    text "&#167;463. Rules and regulations"
  ]
  node [
    id 258
    label "section_464"
    class_name "section"
    text "&#167;464. Exemptions"
  ]
  node [
    id 259
    label "section_465"
  ]
  node [
    id 260
    label "section_466"
    class_name "section"
    text "&#167;466. Imports"
  ]
  node [
    id 261
    label "section_467"
    class_name "section"
    text "&#167;467. Inspection services"
  ]
  node [
    id 262
    label "section_467a"
  ]
  node [
    id 263
    label "section_467b"
    class_name "section"
    text "&#167;467b. Seizure and condemnation"
  ]
  node [
    id 264
    label "section_467c"
  ]
  node [
    id 265
    label "section_467d"
  ]
  node [
    id 266
    label "section_467e"
  ]
  node [
    id 267
    label "section_467f"
    class_name "section"
    text "&#167;467f. Federal Food, Drug, and Cosmetic Act applications"
  ]
  node [
    id 268
    label "section_468"
  ]
  node [
    id 269
    label "section_469"
  ]
  node [
    id 270
    label "section_470"
  ]
  node [
    id 271
    label "section_601"
    class_name "section"
    text "&#167;601. Definitions"
  ]
  node [
    id 272
    label "section_602"
  ]
  node [
    id 273
    label "section_603"
    class_name "section"
    text "&#167;603. Inspection of meat and meat food products"
  ]
  node [
    id 274
    label "section_604"
  ]
  node [
    id 275
    label "section_605"
  ]
  node [
    id 276
    label "section_606"
  ]
  node [
    id 277
    label "section_607"
    class_name "section"
    text "&#167;607. Labeling, marking, and container requirements"
  ]
  node [
    id 278
    label "section_608"
  ]
  node [
    id 279
    label "section_609"
  ]
  node [
    id 280
    label "section_610"
    class_name "section"
    text "&#167;610. Prohibited acts"
  ]
  node [
    id 281
    label "section_611"
    class_name "section"
    text "&#167;611. Devices, marks, labels, and certificates; simulations"
  ]
  node [
    id 282
    label "section_612"
  ]
  node [
    id 283
    label "section_613"
  ]
  node [
    id 284
    label "section_614"
  ]
  node [
    id 285
    label "section_615"
  ]
  node [
    id 286
    label "section_616"
  ]
  node [
    id 287
    label "section_617"
  ]
  node [
    id 288
    label "section_618"
  ]
  node [
    id 289
    label "section_619"
  ]
  node [
    id 290
    label "section_620"
    class_name "section"
    text "&#167;620. Imports"
  ]
  node [
    id 291
    label "section_621"
  ]
  node [
    id 292
    label "section_622"
  ]
  node [
    id 293
    label "section_623"
    class_name "section"
    text "&#167;623. Exemptions from inspection requirements"
  ]
  node [
    id 294
    label "section_624"
  ]
  node [
    id 295
    label "section_641"
  ]
  node [
    id 296
    label "section_642"
    class_name "section"
    text "&#167;642. Recordkeeping requirements"
  ]
  node [
    id 297
    label "section_643"
  ]
  node [
    id 298
    label "section_644"
  ]
  node [
    id 299
    label "section_645"
  ]
  node [
    id 300
    label "section_661"
    class_name "section"
    text "&#167;661. Federal and State cooperation"
  ]
  node [
    id 301
    label "section_671"
    class_name "section"
    text "&#167;671. Inspection services; refusal or withdrawal; hearing; business unfitness based upon certain convictions; other provisions for withdrawal of services unaffected; responsible connection with business; finality of Secretary's actions; judicial review; record"
  ]
  node [
    id 302
    label "section_672"
  ]
  node [
    id 303
    label "section_673"
    class_name "section"
    text "&#167;673. Seizure and condemnation"
  ]
  node [
    id 304
    label "section_674"
  ]
  node [
    id 305
    label "section_675"
  ]
  node [
    id 306
    label "section_676"
    class_name "section"
    text "&#167;676. Violations"
  ]
  node [
    id 307
    label "section_677"
  ]
  node [
    id 308
    label "section_678"
  ]
  node [
    id 309
    label "section_679"
    class_name "section"
    text "&#167;679. Application of Federal Food, Drug, and Cosmetic Act"
  ]
  node [
    id 310
    label "section_680"
  ]
  node [
    id 311
    label "section_691"
  ]
  node [
    id 312
    label "section_692"
  ]
  node [
    id 313
    label "section_693"
  ]
  node [
    id 314
    label "section_694"
  ]
  node [
    id 315
    label "section_695"
  ]
  node [
    id 316
    label "section_801"
    class_name "section"
    text "&#167;801. Congressional findings and declarations: controlled substances"
  ]
  node [
    id 317
    label "section_801a"
    class_name "section"
    text "&#167;801a. Congressional findings and declarations: psychotropic substances"
  ]
  node [
    id 318
    label "section_802"
    class_name "section"
    text "&#167;802. Definitions"
  ]
  node [
    id 319
    label "section_811"
    class_name "section"
    text "&#167;811. Authority and criteria for classification of substances"
  ]
  node [
    id 320
    label "section_812"
    class_name "section"
    text "&#167;812. Schedules of controlled substances"
  ]
  node [
    id 321
    label "section_813"
  ]
  node [
    id 322
    label "section_814"
    class_name "section"
    text "&#167;814. Removal of exemption of certain drugs"
  ]
  node [
    id 323
    label "section_821"
  ]
  node [
    id 324
    label "section_822"
    class_name "section"
    text "&#167;822. Persons required to register"
  ]
  node [
    id 325
    label "section_823"
    class_name "section"
    text "&#167;823. Registration requirements"
  ]
  node [
    id 326
    label "section_824"
    class_name "section"
    text "&#167;824. Denial, revocation, or suspension of registration"
  ]
  node [
    id 327
    label "section_825"
    class_name "section"
    text "&#167;825. Labeling and packaging"
  ]
  node [
    id 328
    label "section_826"
    class_name "section"
    text "&#167;826. Production quotas for controlled substances"
  ]
  node [
    id 329
    label "section_827"
    class_name "section"
    text "&#167;827. Records and reports of registrants"
  ]
  node [
    id 330
    label "section_828"
    class_name "section"
    text "&#167;828. Order forms"
  ]
  node [
    id 331
    label "section_829"
    class_name "section"
    text "&#167;829. Prescriptions"
  ]
  node [
    id 332
    label "section_830"
    class_name "section"
    text "&#167;830. Regulation of listed chemicals and certain machines"
  ]
  node [
    id 333
    label "section_841"
    class_name "section"
    text "&#167;841. Prohibited acts A"
  ]
  node [
    id 334
    label "section_842"
    class_name "section"
    text "&#167;842. Prohibited acts B"
  ]
  node [
    id 335
    label "section_843"
    class_name "section"
    text "&#167;843. Prohibited acts C"
  ]
  node [
    id 336
    label "section_844"
    class_name "section"
    text "&#167;844. Penalties for simple possession"
  ]
  node [
    id 337
    label "section_844a"
    class_name "section"
    text "&#167;844a. Civil penalty for possession of small amounts of certain controlled substances"
  ]
  node [
    id 338
    label "section_846"
  ]
  node [
    id 339
    label "section_847"
  ]
  node [
    id 340
    label "section_848"
    class_name "section"
    text "&#167;848. Continuing criminal enterprise"
  ]
  node [
    id 341
    label "section_849"
    class_name "section"
    text "&#167;849. Transportation safety offenses"
  ]
  node [
    id 342
    label "section_850"
  ]
  node [
    id 343
    label "section_851"
    class_name "section"
    text "&#167;851. Proceedings to establish prior convictions"
  ]
  node [
    id 344
    label "section_852"
  ]
  node [
    id 345
    label "section_853"
    class_name "section"
    text "&#167;853. Criminal forfeitures"
  ]
  node [
    id 346
    label "section_853a"
    class_name "section"
    text "&#167;853a. Transferred"
  ]
  node [
    id 347
    label "section_854"
    class_name "section"
    text "&#167;854. Investment of illicit drug profits"
  ]
  node [
    id 348
    label "section_855"
  ]
  node [
    id 349
    label "section_856"
    class_name "section"
    text "&#167;856. Establishment of manufacturing operations"
  ]
  node [
    id 350
    label "section_858"
  ]
  node [
    id 351
    label "section_859"
    class_name "section"
    text "&#167;859. Distribution to persons under age twenty-one"
  ]
  node [
    id 352
    label "section_860"
    class_name "section"
    text "&#167;860. Distribution or manufacturing in or near schools and colleges"
  ]
  node [
    id 353
    label "section_861"
    class_name "section"
    text "&#167;861. Employment or use of persons under 18 years of age in drug operations"
  ]
  node [
    id 354
    label "section_862"
    class_name "section"
    text "&#167;862. Denial of Federal benefits to drug traffickers and possessors"
  ]
  node [
    id 355
    label "section_863"
    class_name "section"
    text "&#167;863. Drug paraphernalia"
  ]
  node [
    id 356
    label "section_871"
    class_name "section"
    text "&#167;871. Attorney General"
  ]
  node [
    id 357
    label "section_872"
    class_name "section"
    text "&#167;872. Education and research programs of Attorney General"
  ]
  node [
    id 358
    label "section_873"
    class_name "section"
    text "&#167;873. Cooperative arrangements"
  ]
  node [
    id 359
    label "section_874"
  ]
  node [
    id 360
    label "section_875"
    class_name "section"
    text "&#167;875. Administrative hearings"
  ]
  node [
    id 361
    label "section_876"
    class_name "section"
    text "&#167;876. Subpenas"
  ]
  node [
    id 362
    label "section_877"
  ]
  node [
    id 363
    label "section_878"
    class_name "section"
    text "&#167;878. Powers of enforcement personnel"
  ]
  node [
    id 364
    label "section_879"
  ]
  node [
    id 365
    label "section_880"
    class_name "section"
    text "&#167;880. Administrative inspections and warrants"
  ]
  node [
    id 366
    label "section_881"
    class_name "section"
    text "&#167;881. Forfeitures"
  ]
  node [
    id 367
    label "section_882"
    class_name "section"
    text "&#167;882. Injunctions"
  ]
  node [
    id 368
    label "section_883"
  ]
  node [
    id 369
    label "section_884"
    class_name "section"
    text "&#167;884. Immunity and privilege"
  ]
  node [
    id 370
    label "section_885"
    class_name "section"
    text "&#167;885. Burden of proof; liabilities"
  ]
  node [
    id 371
    label "section_886"
    class_name "section"
    text "&#167;886. Payments and advances"
  ]
  node [
    id 372
    label "section_886a"
    class_name "section"
    text "&#167;886a. Diversion Control Fee Account"
  ]
  node [
    id 373
    label "section_887"
  ]
  node [
    id 374
    label "section_888"
    class_name "section"
    text "&#167;888. Expedited procedures for seized conveyances"
  ]
  node [
    id 375
    label "section_889"
    class_name "section"
    text "&#167;889. Production control of controlled substances"
  ]
  node [
    id 376
    label "section_901"
  ]
  node [
    id 377
    label "section_902"
  ]
  node [
    id 378
    label "section_903"
  ]
  node [
    id 379
    label "section_904"
  ]
  node [
    id 380
    label "section_951"
    class_name "section"
    text "&#167;951. Definitions"
  ]
  node [
    id 381
    label "section_952"
    class_name "section"
    text "&#167;952. Importation of controlled substances"
  ]
  node [
    id 382
    label "section_953"
    class_name "section"
    text "&#167;953. Exportation of controlled substances"
  ]
  node [
    id 383
    label "section_954"
    class_name "section"
    text "&#167;954. Transshipment and in-transit shipment of controlled substances"
  ]
  node [
    id 384
    label "section_955"
  ]
  node [
    id 385
    label "section_956"
    class_name "section"
    text "&#167;956. Exemption authority"
  ]
  node [
    id 386
    label "section_957"
    class_name "section"
    text "&#167;957. Persons required to register"
  ]
  node [
    id 387
    label "section_958"
    class_name "section"
    text "&#167;958. Registration requirements"
  ]
  node [
    id 388
    label "section_959"
    class_name "section"
    text "&#167;959. Possession, manufacture, or distribution of controlled substance"
  ]
  node [
    id 389
    label "section_960"
    class_name "section"
    text "&#167;960. Prohibited acts A"
  ]
  node [
    id 390
    label "section_961"
    class_name "section"
    text "&#167;961. Prohibited acts B"
  ]
  node [
    id 391
    label "section_962"
    class_name "section"
    text "&#167;962. Second or subsequent offenses"
  ]
  node [
    id 392
    label "section_963"
  ]
  node [
    id 393
    label "section_964"
  ]
  node [
    id 394
    label "section_965"
    class_name "section"
    text "&#167;965. Applicability of part E of subchapter I"
  ]
  node [
    id 395
    label "section_966"
  ]
  node [
    id 396
    label "section_967"
  ]
  node [
    id 397
    label "section_968"
  ]
  node [
    id 398
    label "section_969"
  ]
  node [
    id 399
    label "section_970"
  ]
  node [
    id 400
    label "section_971"
    class_name "section"
    text "&#167;971. Notification, suspension of shipment, and penalties with respect to importation and exportation of listed chemicals"
  ]
  node [
    id 401
    label "section_1031"
  ]
  node [
    id 402
    label "section_1032"
  ]
  node [
    id 403
    label "section_1033"
    class_name "section"
    text "&#167;1033. Definitions"
  ]
  node [
    id 404
    label "section_1034"
    class_name "section"
    text "&#167;1034. Inspection of egg products"
  ]
  node [
    id 405
    label "section_1035"
    class_name "section"
    text "&#167;1035. Sanitary operating practices in official plants"
  ]
  node [
    id 406
    label "section_1036"
    class_name "section"
    text "&#167;1036. Pasteurization and labeling of egg products at official plants"
  ]
  node [
    id 407
    label "section_1037"
    class_name "section"
    text "&#167;1037. Prohibited acts"
  ]
  node [
    id 408
    label "section_1038"
  ]
  node [
    id 409
    label "section_1039"
  ]
  node [
    id 410
    label "section_1040"
  ]
  node [
    id 411
    label "section_1041"
    class_name "section"
    text "&#167;1041. Enforcement provisions"
  ]
  node [
    id 412
    label "section_1042"
  ]
  node [
    id 413
    label "section_1043"
  ]
  node [
    id 414
    label "section_1044"
    class_name "section"
    text "&#167;1044. Exemption of certain activities"
  ]
  node [
    id 415
    label "section_1045"
  ]
  node [
    id 416
    label "section_1046"
    class_name "section"
    text "&#167;1046. Imports"
  ]
  node [
    id 417
    label "section_1047"
    class_name "section"
    text "&#167;1047. Refusal or withdrawal of inspection services; hearing; grounds; person deemed to have responsible connection with business; finality of order of Secretary; judicial review; other provisions for refusal of services unaffected"
  ]
  node [
    id 418
    label "section_1048"
  ]
  node [
    id 419
    label "section_1049"
    class_name "section"
    text "&#167;1049. Seizure and condemnation proceedings"
  ]
  node [
    id 420
    label "section_1050"
  ]
  node [
    id 421
    label "section_1051"
  ]
  node [
    id 422
    label "section_1052"
    class_name "section"
    text "&#167;1052. State or local regulation"
  ]
  node [
    id 423
    label "section_1053"
    class_name "section"
    text "&#167;1053. Inspection and administration costs"
  ]
  node [
    id 424
    label "section_1054"
    class_name "section"
    text "&#167;1054. Annual report to Congressional committees"
  ]
  node [
    id 425
    label "section_1055"
  ]
  node [
    id 426
    label "section_1056"
  ]
  node [
    id 427
    label "section_1101"
    class_name "section"
    text "&#167;1101. Congressional findings"
  ]
  node [
    id 428
    label "section_1102"
    class_name "section"
    text "&#167;1102. Congressional declaration of national policy"
  ]
  node [
    id 429
    label "section_1115"
    class_name "section"
    text "&#167;1115. Notice relating to the control of dangerous drugs"
  ]
  node [
    id 430
    label "section_1171"
    class_name "section"
    text "&#167;1171. Drug abuse prevention function appropriations"
  ]
  node [
    id 431
    label "section_1177"
    class_name "section"
    text "&#167;1177. Special project grants and contracts"
  ]
  node [
    id 432
    label "section_1178"
    class_name "section"
    text "&#167;1178. Records and audit"
  ]
  node [
    id 433
    label "section_1179"
    class_name "section"
    text "&#167;1179. National Drug Abuse Training Center"
  ]
  node [
    id 434
    label "section_1180"
    class_name "section"
    text "&#167;1180. Transferred"
  ]
  node [
    id 435
    label "section_1181"
  ]
  node [
    id 436
    label "section_1301"
  ]
  node [
    id 437
    label "section_1302"
    class_name "section"
    text "&#167;1302. Duties of Commission"
  ]
  node [
    id 438
    label "section_1303"
    class_name "section"
    text "&#167;1303. Membership"
  ]
  node [
    id 439
    label "section_1304"
    class_name "section"
    text "&#167;1304. Meetings"
  ]
  node [
    id 440
    label "section_1305"
    class_name "section"
    text "&#167;1305. Director and staff; experts and consultants"
  ]
  node [
    id 441
    label "section_1306"
    class_name "section"
    text "&#167;1306. Powers of Commission"
  ]
  node [
    id 442
    label "section_1307"
  ]
  node [
    id 443
    label "section_1308"
  ]
  node [
    id 444
    label "section_1401"
    class_name "section"
    text "&#167;1401. Pesticide monitoring and enforcement information"
  ]
  node [
    id 445
    label "section_1402"
    class_name "section"
    text "&#167;1402. Foreign pesticide information"
  ]
  node [
    id 446
    label "section_1403"
    class_name "section"
    text "&#167;1403. Pesticide analytical methods"
  ]
  node [
    id 447
    label "section_1501"
    class_name "section"
    text "&#167;1501. Establishment of Office of National Drug Control Policy"
  ]
  node [
    id 448
    label "section_1502"
    class_name "section"
    text "&#167;1502. Appointment and duties of Director, Deputy Directors, and Associate Director"
  ]
  node [
    id 449
    label "section_1502a"
    class_name "section"
    text "&#167;1502a. Transferred"
  ]
  node [
    id 450
    label "section_1503"
    class_name "section"
    text "&#167;1503. Coordination with executive branch departments and agencies"
  ]
  node [
    id 451
    label "section_1504"
    class_name "section"
    text "&#167;1504. Development and submission of National Drug Control Strategy"
  ]
  node [
    id 452
    label "section_1505"
    class_name "section"
    text "&#167;1505. Counter-Drug Technology Assessment Center"
  ]
  node [
    id 453
    label "section_1506"
  ]
  node [
    id 454
    label "section_1507"
    class_name "section"
    text "&#167;1507. Definitions"
  ]
  node [
    id 455
    label "section_1508"
  ]
  node [
    id 456
    label "section_1509"
    class_name "section"
    text "&#167;1509. Establishment of Special Forfeiture Fund"
  ]
  node [
    id 457
    label "section_14a_item_3"
    class_name "item"
    text "Section, act June 30, 1906, ch. 3915, &#167;10A, as added June 22, 1934, ch. 712, 48 Stat. 1204, and amended, which related to examination of sea food on request of packer, marking of food with results, fees, and penalties, was successively renumbered section 702A and then 706 of the Federal Food, Drug, and Cosmetic Act by act July 12, 1943, ch. 221, title II, &#167;201, 57 Stat. 500, and by Pub. L. 102&#8211;571, title I, &#167;106(3), Oct. 29, 1992, 106 Stat. 4498, and was successively classified to section 372a and then 376 of this title."
  ]
  node [
    id 458
    label "section_46a_item_2"
    class_name "item"
    text "(2) the approximate cost of the examinations;"
  ]
  node [
    id 459
    label "section_46a_item_1"
    class_name "item"
    text "(1) 10 cents for each hundred weight or fraction thereof of the tea or merchandise; or"
  ]
  node [
    id 460
    label "section_61_subsection_a"
    class_name "subsection"
    text "(a) The term &#8220;person&#8221; includes an individual, partnership, corporation, or association;"
  ]
  node [
    id 461
    label "section_61_subsection_c"
    class_name "subsection"
    text "(c) The term &#8220;filled milk&#8221; means any milk, cream, or skimmed milk, whether or not condensed, evaporated, concentrated, powdered, dried, or desiccated, to which has been added, or which has been blended or compounded with, any fat or oil other than milk fat, so that the resulting product is in imitation or semblance of milk, cream, or skimmed milk, whether or not condensed, evaporated, concentrated, powdered, dried, or desiccated. This definition shall not include any distinctive proprietary food compound not readily mistaken in taste for milk or cream or for evaporated, condensed, or powdered milk, or cream where such compound (1) is prepared and designed for feeding infants and young children and customarily used on the order of a physician; (2) is packed in individual cans containing not more than sixteen and one-half ounces and bearing a label in bold type that the content is to be used only for said purpose; (3) is shipped in interstate or foreign commerce exclusively to physicians, wholesale and retail druggists, orphan asylums, child-welfare associations, hospitals, and similar institutions and generally disposed of by them."
  ]
  node [
    id 462
    label "section_61_subsection_b"
    class_name "subsection"
    text "(b) The term &#8220;interstate or foreign commerce&#8221; means commerce (1) between any State, Territory, or possession, or the District of Columbia, and any place outside thereof; (2) between points within the same State, Territory, or possession, or within the District of Columbia, but through any place outside thereof; or (3) within any Territory or possession, or within the District of Columbia; and"
  ]
  node [
    id 463
    label "section_104_subsection_b"
    class_name "subsection"
    text "(b) Penalties"
  ]
  node [
    id 464
    label "section_104_subsection_b_item_1"
    class_name "item"
    text "(1) Criminal"
  ]
  node [
    id 465
    label "section_104_subsection_b_item_2"
    class_name "item"
    text "(2) Civil"
  ]
  node [
    id 466
    label "section_104_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 467
    label "section_114d_subsection_c_item_2"
    class_name "item"
    text "(2) Cooperative sales"
  ]
  node [
    id 468
    label "section_114d_subsection_b"
    class_name "subsection"
    text "(b) Terms of sale"
  ]
  node [
    id 469
    label "section_114d_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 470
    label "section_114d_subsection_c_item_1"
    class_name "item"
    text "(1) Independent sales"
  ]
  node [
    id 471
    label "section_114d_subsection_c"
    class_name "subsection"
    text "(c) Deposit of proceeds"
  ]
  node [
    id 472
    label "section_114g_item_2"
    class_name "item"
    text "In order to safeguard the health of the swine herds of the Nation, to prevent the spread of hog cholera, to decrease substantially the estimated $50,000,000 annual loss from hog cholera, to expand export markets for pork and pork products now restricted on account of hog cholera, and to otherwise protect the public interest, the Secretary of Agriculture is directed (1) to initiate a national hog cholera eradication program in cooperation with the several States under the provisions of section 114a of this title and related legislation, and (2) to prohibit or restrict, pursuant to the authority vested in him under the provisions of section 111 of this title the interstate movement of virulent hog cholera virus or other hog cholera virus to the extent he determines necessary in order to effectuate such eradication program."
  ]
  node [
    id 473
    label "section_114g_item_1"
    class_name "item"
    text "In order to safeguard the health of the swine herds of the Nation, to prevent the spread of hog cholera, to decrease substantially the estimated $50,000,000 annual loss from hog cholera, to expand export markets for pork and pork products now restricted on account of hog cholera, and to otherwise protect the public interest, the Secretary of Agriculture is directed (1) to initiate a national hog cholera eradication program in cooperation with the several States under the provisions of section 114a of this title and related legislation, and (2) to prohibit or restrict, pursuant to the authority vested in him under the provisions of section 111 of this title the interstate movement of virulent hog cholera virus or other hog cholera virus to the extent he determines necessary in order to effectuate such eradication program."
  ]
  node [
    id 474
    label "section_114h_subsection_b"
    class_name "subsection"
    text "(b) Functions"
  ]
  node [
    id 475
    label "section_114h_subsection_a_item_1"
    class_name "item"
    text "The Secretary of Agriculture is authorized and directed to establish an advisory committee composed of (1) eleven members selected from representatives of the swine and related industries, State and local government agencies, professional and scientific groups, and the general public, and (2) one member selected from the officers and employees of the Department of Agriculture who shall serve as chairman of the Committee. The Committee shall meet at the call of the Secretary."
  ]
  node [
    id 476
    label "section_114h_subsection_a_item_2"
    class_name "item"
    text "The Secretary of Agriculture is authorized and directed to establish an advisory committee composed of (1) eleven members selected from representatives of the swine and related industries, State and local government agencies, professional and scientific groups, and the general public, and (2) one member selected from the officers and employees of the Department of Agriculture who shall serve as chairman of the Committee. The Committee shall meet at the call of the Secretary."
  ]
  node [
    id 477
    label "section_114h_subsection_a"
    class_name "subsection"
    text "(a) Establishment; membership"
  ]
  node [
    id 478
    label "section_114h_subsection_c"
    class_name "subsection"
    text "(c) Employment status; expenses"
  ]
  node [
    id 479
    label "section_114i_subsection_a"
    class_name "subsection"
    text "(a) Findings"
  ]
  node [
    id 480
    label "section_114i_subsection_b"
    class_name "subsection"
    text "(b) Establishment of program"
  ]
  node [
    id 481
    label "section_114i_subsection_d"
    class_name "subsection"
    text "(d) Authorization of appropriations"
  ]
  node [
    id 482
    label "section_114i_subsection_c"
    class_name "subsection"
    text "(c) Use of funds for testing and control of pseudorabies"
  ]
  node [
    id 483
    label "section_117_subsection_a"
    class_name "subsection"
    text "(a) Criminal penalty"
  ]
  node [
    id 484
    label "section_117_subsection_b"
    class_name "subsection"
    text "(b) Civil penalty"
  ]
  node [
    id 485
    label "section_134_subsection_b"
    class_name "subsection"
    text "(b) The term &#8220;animals&#8221; means all members of the animal kingdom including birds, whether domesticated or wild, but not including man."
  ]
  node [
    id 486
    label "section_134_subsection_c"
    class_name "subsection"
    text "(c) The term &#8220;United States&#8221; means the States, Puerto Rico, Guam, the Virgin Islands of the United States, and the District of Columbia."
  ]
  node [
    id 487
    label "section_134_subsection_d"
    class_name "subsection"
    text "(d) The term &#8220;interstate&#8221; means from a State or other area included in the definition of &#8220;United States&#8221; to or through any other State or other such area."
  ]
  node [
    id 488
    label "section_134_subsection_a"
    class_name "subsection"
    text "(a) The term &#8220;Secretary&#8221; means the Secretary of Agriculture."
  ]
  node [
    id 489
    label "section_134a_subsection_a_item_2"
    class_name "item"
    text "The Secretary, whenever he deems it necessary in order to guard against the introduction or dissemination of a communicable disease of livestock or poultry, may seize, quarantine, and dispose of, in a reasonable manner taking into consideration the nature of the disease and the necessity of such action to protect the livestock or poultry of the United States: (1) any animals which he finds are moving or are being handled or have moved or have been handled in interstate or foreign commerce contrary to any law or regulation administered by him for the prevention of the introduction or dissemination of any communicable disease of livestock or poultry; (2) any animals which he finds are moving into the United States, or interstate, and are affected with or have been exposed to any communicable disease dangerous to livestock or poultry; and (3) any animals which he finds have moved into the United States, or interstate, and at the time of such movement were so affected or exposed."
  ]
  node [
    id 490
    label "section_134a_subsection_a_item_3"
    class_name "item"
    text "The Secretary, whenever he deems it necessary in order to guard against the introduction or dissemination of a communicable disease of livestock or poultry, may seize, quarantine, and dispose of, in a reasonable manner taking into consideration the nature of the disease and the necessity of such action to protect the livestock or poultry of the United States: (1) any animals which he finds are moving or are being handled or have moved or have been handled in interstate or foreign commerce contrary to any law or regulation administered by him for the prevention of the introduction or dissemination of any communicable disease of livestock or poultry; (2) any animals which he finds are moving into the United States, or interstate, and are affected with or have been exposed to any communicable disease dangerous to livestock or poultry; and (3) any animals which he finds have moved into the United States, or interstate, and at the time of such movement were so affected or exposed."
  ]
  node [
    id 491
    label "section_134a_subsection_c"
    class_name "subsection"
    text "(c) Notice to owner to quarantine or to dispose of animal, carcass, product, or article; action on failure to comply; costs"
  ]
  node [
    id 492
    label "section_134a_subsection_a"
    class_name "subsection"
    text "(a) Authority of Secretary"
  ]
  node [
    id 493
    label "section_134a_subsection_a_item_1"
    class_name "item"
    text "The Secretary, whenever he deems it necessary in order to guard against the introduction or dissemination of a communicable disease of livestock or poultry, may seize, quarantine, and dispose of, in a reasonable manner taking into consideration the nature of the disease and the necessity of such action to protect the livestock or poultry of the United States: (1) any animals which he finds are moving or are being handled or have moved or have been handled in interstate or foreign commerce contrary to any law or regulation administered by him for the prevention of the introduction or dissemination of any communicable disease of livestock or poultry; (2) any animals which he finds are moving into the United States, or interstate, and are affected with or have been exposed to any communicable disease dangerous to livestock or poultry; and (3) any animals which he finds have moved into the United States, or interstate, and at the time of such movement were so affected or exposed."
  ]
  node [
    id 494
    label "section_134a_subsection_b"
    class_name "subsection"
    text "(b) Determination of extraordinary emergency due to dangerous communicable disease; seizure, quarantine, and disposal of animals; action authorized only if adequate measures not taken by State or other jurisdiction; notice to State or other jurisdiction"
  ]
  node [
    id 495
    label "section_134a_subsection_e"
    class_name "subsection"
    text "(e) Restriction on payment of compensation in cases of violation of law or regulation"
  ]
  node [
    id 496
    label "section_134a_subsection_d"
    class_name "subsection"
    text "(d) Compensation of owner; fair market value; payments from State or other source; availability of funds"
  ]
  node [
    id 497
    label "section_134d_item_2"
    class_name "item"
    text "Employees of the Department of Agriculture designated by the Secretary for the purpose, when properly identified, shall have authority (1) to stop and inspect, without a warrant, any person or means of conveyance, moving into the United States from a foreign country, to determine whether such person or means of conveyance is carrying any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for prevention of the introduction or dissemination of any communicable animal disease; (2) to stop and inspect, without a warrant, any means of conveyance moving interstate upon probable cause to believe that such means of conveyance is carrying any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for the prevention of the introduction or dissemination of any communicable animal disease; and (3) to enter upon, with a warrant, any premises for the purpose of making inspections and seizures necessary under such laws and regulations. Any Federal judge, or any judge of a court of record in the United States, or any United States magistrate judge, may, within his jurisdiction, upon proper oath or affirmation indicating probable cause to believe that there is on certain premises any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for the prevention of the introduction or dissemination of any communicable animal disease, issue warrants for the entry upon such premises and for inspections and seizures necessary under such laws and regulations. Such warrants may be executed by any authorized employee of the Department of Agriculture."
  ]
  node [
    id 498
    label "section_134d_item_3"
    class_name "item"
    text "Employees of the Department of Agriculture designated by the Secretary for the purpose, when properly identified, shall have authority (1) to stop and inspect, without a warrant, any person or means of conveyance, moving into the United States from a foreign country, to determine whether such person or means of conveyance is carrying any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for prevention of the introduction or dissemination of any communicable animal disease; (2) to stop and inspect, without a warrant, any means of conveyance moving interstate upon probable cause to believe that such means of conveyance is carrying any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for the prevention of the introduction or dissemination of any communicable animal disease; and (3) to enter upon, with a warrant, any premises for the purpose of making inspections and seizures necessary under such laws and regulations. Any Federal judge, or any judge of a court of record in the United States, or any United States magistrate judge, may, within his jurisdiction, upon proper oath or affirmation indicating probable cause to believe that there is on certain premises any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for the prevention of the introduction or dissemination of any communicable animal disease, issue warrants for the entry upon such premises and for inspections and seizures necessary under such laws and regulations. Such warrants may be executed by any authorized employee of the Department of Agriculture."
  ]
  node [
    id 499
    label "section_134d_item_1"
    class_name "item"
    text "Employees of the Department of Agriculture designated by the Secretary for the purpose, when properly identified, shall have authority (1) to stop and inspect, without a warrant, any person or means of conveyance, moving into the United States from a foreign country, to determine whether such person or means of conveyance is carrying any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for prevention of the introduction or dissemination of any communicable animal disease; (2) to stop and inspect, without a warrant, any means of conveyance moving interstate upon probable cause to believe that such means of conveyance is carrying any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for the prevention of the introduction or dissemination of any communicable animal disease; and (3) to enter upon, with a warrant, any premises for the purpose of making inspections and seizures necessary under such laws and regulations. Any Federal judge, or any judge of a court of record in the United States, or any United States magistrate judge, may, within his jurisdiction, upon proper oath or affirmation indicating probable cause to believe that there is on certain premises any animal, carcass, product, or article regulated or subject to disposal under any law or regulation administered by the Secretary for the prevention of the introduction or dissemination of any communicable animal disease, issue warrants for the entry upon such premises and for inspections and seizures necessary under such laws and regulations. Such warrants may be executed by any authorized employee of the Department of Agriculture."
  ]
  node [
    id 500
    label "section_134e_subsection_a_item_2"
    class_name "item"
    text "(2) Whoever violates any such regulation may be assessed a civil penalty by the Secretary not exceeding $1,000. The Secretary may issue an order assessing such civil penalty only after notice and an opportunity for an agency hearing on the record. Such order shall be treated as a final order reviewable under chapter 158 of title 28. The validity of such order may not be reviewed in an action to collect such civil penalty."
  ]
  node [
    id 501
    label "section_134e_subsection_a"
    class_name "subsection"
    text "(a) Criminal and civil penalties"
  ]
  node [
    id 502
    label "section_134e_subsection_b"
    class_name "subsection"
    text "(b) Injunctive proceedings"
  ]
  node [
    id 503
    label "section_134e_subsection_a_item_1"
    class_name "item"
    text "(1) Whoever knowingly violates any regulation promulgated pursuant to the provisions of sections 134 through 134d of this title shall be punished by a fine not exceeding $5,000 or by imprisonment not exceeding one year, or both."
  ]
  node [
    id 504
    label "section_135a_subsection_a"
    class_name "subsection"
    text "(a) Criminal penalty"
  ]
  node [
    id 505
    label "section_135a_subsection_b"
    class_name "subsection"
    text "(b) Civil penalty"
  ]
  node [
    id 506
    label "section_136a_subsection_f_item_4"
    class_name "item"
    text "(4) United States"
  ]
  node [
    id 507
    label "section_136a_subsection_f_item_3"
    class_name "item"
    text "(3) Person"
  ]
  node [
    id 508
    label "section_136a_subsection_c_item_5_subitem_C"
    class_name "subitem"
    text "(C) Sales of animals, etc."
  ]
  node [
    id 509
    label "section_136a_subsection_f_item_1_subitem_O"
    class_name "subitem"
    text "(O) any other Act administered by the Secretary relating to plant or animal diseases or pests, other than the first section of Public Law 91&#8211;239 (21 U.S.C. 135)."
  ]
  node [
    id 510
    label "section_136a_subsection_e"
    class_name "subsection"
    text "(e) Recovery of amounts owed"
  ]
  node [
    id 511
    label "section_136a_subsection_a"
    class_name "subsection"
    text "(a) Quarantine, inspection and transportation fees"
  ]
  node [
    id 512
    label "section_136a_subsection_c_item_3"
    class_name "item"
    text "(3) Fees"
  ]
  node [
    id 513
    label "section_136a_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) Airport inspection services"
  ]
  node [
    id 514
    label "section_136a_subsection_f_item_1_subitem_F"
    class_name "subitem"
    text "(F) the Act of June 16, 1948 (62 Stat. 458, chapter 477; 21 U.S.C. 114e and 114f);"
  ]
  node [
    id 515
    label "section_136a_subsection_c_item_1"
    class_name "item"
    text "(1) Animal inspection"
  ]
  node [
    id 516
    label "section_136a_subsection_f_item_5"
    class_name "item"
    text "(5) Vessel"
  ]
  node [
    id 517
    label "section_136a_subsection_f_item_1_subitem_K"
    class_name "subitem"
    text "(K) the matter under the heading &#8220;Bureau of Animal Industry&#8221; of the Act of June 30, 1914 (38 Stat. 419, chapter 131; 21 U.S.C. 128);"
  ]
  node [
    id 518
    label "section_136a_subsection_f_item_1_subitem_C"
    class_name "subitem"
    text "(C) section 2 of the Act of February 2, 1903 (32 Stat. 792, chapter 349; 21 U.S.C. 111);"
  ]
  node [
    id 519
    label "section_136a_subsection_c_item_4"
    class_name "item"
    text "(4) Liability"
  ]
  node [
    id 520
    label "section_136a_subsection_f_item_1_subitem_N"
    class_name "subitem"
    text "(N) sections 1 through 6 and 11 through 13 of Public Law 87&#8211;518 (21 U.S.C. 134&#8211;134h); or"
  ]
  node [
    id 521
    label "section_136a_subsection_a_item_3_subitem_B_subsubitem_v"
    class_name "subsubitem"
    text "The Secretary of the Treasury shall use the Account to provide reimbursements to any appropriation accounts that incur the costs associated with the administration of this subsection and all other activities carried out by the Secretary at ports in the customs territory of the United States and at preclearance or preinspection sites outside the customs territory of the United States in connection with the enforcement of the animal quarantine laws. Any such reimbursement shall be subject to appropriations under clause (v)."
  ]
  node [
    id 522
    label "section_136a_subsection_a_item_3_subitem_B"
    class_name "subitem"
    text "(B) Amounts in Account"
  ]
  node [
    id 523
    label "section_136a_subsection_c"
    class_name "subsection"
    text "(c) Animal inspection and veterinary diagnostics"
  ]
  node [
    id 524
    label "section_136a_subsection_a_item_3"
    class_name "item"
    text "(3) Agricultural Quarantine Inspection User Fee Account"
  ]
  node [
    id 525
    label "section_136a_subsection_f_item_1_subitem_G"
    class_name "subitem"
    text "(G) Public Law 87&#8211;209 (21 U.S.C. 114g and 114h);"
  ]
  node [
    id 526
    label "section_136a_subsection_f_item_1_subitem_J"
    class_name "subitem"
    text "(J) the Act of March 3, 1905 (33 Stat. 1264, chapter 1496; 21 U.S.C. 123&#8211;127) (commonly known as the &#8220;Cattle Contagious Diseases Act of 1905&#8221;);"
  ]
  node [
    id 527
    label "section_136a_subsection_f_item_1"
    class_name "item"
    text "(1) Animal quarantine laws"
  ]
  node [
    id 528
    label "section_136a_subsection_c_item_2"
    class_name "item"
    text "(2) Omitted"
  ]
  node [
    id 529
    label "section_136a_subsection_v_item_1"
    class_name "item"
    text "Subject to the limits set forth in paragraph (1), the Secretary shall adjust the amount of the fees to be assessed under this subsection to reflect the cost to the Secretary in administering such subsection, in carrying out the activities at ports in customs territory of the United States and preclearance and preinspection sites outside the customs territory of the United States in connection with the provision of agricultural quarantine inspection services, and in maintaining a reasonable balance in the Account."
  ]
  node [
    id 530
    label "section_136a_subsection_a_item_3_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "Adjustments of reimbursements made under clause (ii) shall be made to the extent necessary to correct prior estimates that were in excess of, or less than, the amount required to be reimbursed under clause (iii)."
  ]
  node [
    id 531
    label "section_136a_subsection_a_item_3_subitem_A"
    class_name "subitem"
    text "(A) Establishment"
  ]
  node [
    id 532
    label "section_136a_subsection_f_item_1_subitem_E"
    class_name "subitem"
    text "(E) the Act of February 28, 1947 (61 Stat. 7, chapter 8; 21 U.S.C. 114b, 114c, and 114d&#8211;1);"
  ]
  node [
    id 533
    label "section_136a_subsection_v_item_4"
    class_name "item"
    text "(4) Adjustment in fee amounts"
  ]
  node [
    id 534
    label "section_136a_subsection_f_item_1_subitem_D"
    class_name "subitem"
    text "(D) the Act of May 29, 1884 (23 Stat. 32, chapter 60; 21 U.S.C. 112 to 114a&#8211;1, 115, 117&#8211;119, and 130) (commonly known as the &#8220;Animal Industry Act&#8221;);"
  ]
  node [
    id 535
    label "section_136a_subsection_c_item_5"
    class_name "item"
    text "(5) Leins&#160;2"
  ]
  node [
    id 536
    label "section_136a_subsection_a_item_3_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "Adjustments of reimbursements made under clause (ii) shall be made to the extent necessary to correct prior estimates that were in excess of, or less than, the amount required to be reimbursed under clause (iii)."
  ]
  node [
    id 537
    label "section_136a_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) sections 6 through 10 of the Act of August 30, 1890 (26 Stat. 416, chapter 839; 21 U.S.C. 101&#8211;105);"
  ]
  node [
    id 538
    label "section_136a_subsection_v"
    class_name "subsection"
    text "(v) Authorization of appropriations"
  ]
  node [
    id 539
    label "section_136a_subsection_f_item_2"
    class_name "item"
    text "(2) Customs territory"
  ]
  node [
    id 540
    label "section_136a_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) In general"
  ]
  node [
    id 541
    label "section_136a_subsection_c_item_5_subitem_A"
    class_name "subitem"
    text "(A) In general"
  ]
  node [
    id 542
    label "section_136a_subsection_f_item_1_subitem_I"
    class_name "subitem"
    text "(I) the Act of February 2, 1903 (32 Stat. 791, chapter 349; 21 U.S.C. 112 and 120&#8211;122) (commonly known as the &#8220;Cattle Contagious Diseases Act of 1903&#8221;);"
  ]
  node [
    id 543
    label "section_136a_subsection_a_item_3_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) Deposits"
  ]
  node [
    id 544
    label "section_136a_subsection_f_item_1_subitem_H"
    class_name "subitem"
    text "(H) the Act of May 31, 1920 (41 Stat. 699, chapter 217; 21 U.S.C. 116);"
  ]
  node [
    id 545
    label "section_136a_subsection_a_item_2"
    class_name "item"
    text "(2) Treasury"
  ]
  node [
    id 546
    label "section_136a_subsection_f"
    class_name "subsection"
    text "(f) Definitions"
  ]
  node [
    id 547
    label "section_136a_subsection_f_item_1_subitem_M"
    class_name "subitem"
    text "(M) the matter under the heading &#8220;Miscellaneous&#8221; of the Act of May 26, 1910 (36 Stat. 440, chapter 256; 21 U.S.C. 131);"
  ]
  node [
    id 548
    label "section_136a_subsection_c_item_5_subitem_B"
    class_name "subitem"
    text "(B) Other animals, etc."
  ]
  node [
    id 549
    label "section_136a_subsection_a_item_3_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) Adjustments"
  ]
  node [
    id 550
    label "section_136a_subsection_a_item_1"
    class_name "item"
    text "(1) Quarantine and inspection"
  ]
  node [
    id 551
    label "section_136a_subsection_a_item_1_subitem_D"
    class_name "subitem"
    text "(D) Costs"
  ]
  node [
    id 552
    label "section_136a_subsection_f_item_1_subitem_L"
    class_name "subitem"
    text "(L) section 101 of Public Law 92&#8211;73 (21 U.S.C. 129);"
  ]
  node [
    id 553
    label "section_136a_subsection_c_item_5_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Excess proceeds"
  ]
  node [
    id 554
    label "section_136a_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(A) section 306 of the Tariff Act of 1930 (19 U.S.C. 1306);"
  ]
  node [
    id 555
    label "section_136a_subsection_a_item_1_subitem_C"
    class_name "subitem"
    text "(C) Commercial truck and railroad car inspection services"
  ]
  node [
    id 556
    label "section_136a_subsection_d"
    class_name "subsection"
    text "(d) Regulations"
  ]
  node [
    id 557
    label "section_136a_subsection_c_item_5_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "If the sale proceeds under clause (i) exceed the fees due, any late payment penalty assessed, any accrued interest on such, and the expenses associated with the sale, such excess shall be paid to the owner of the animal, article, means of conveyance, or facility if such owner submits an application for such excess together with proof of ownership not later than 6 months after the date of such sale. If no such application is made, such excess shall be credited to accounts that incur the costs associated with the fees collected and shall remain available until expended, without fiscal year limitation. The Secretary shall suspend performance of services to persons who have failed to pay fees, late payment penalty, or accrued interest under this section."
  ]
  node [
    id 558
    label "section_142_item_1"
    class_name "item"
    text "Milk or cream shall be considered unfit for importation (1) when all cows producing such milk or cream are not healthy and a physical examination of all such cows has not been made within one year previous to such milk being offered for importation; (2) when such milk or cream, if raw, is not produced from cows which have passed a tuberculin test applied by a duly authorized official veterinarian of the United States, or of the country in which such milk or cream is produced, within one year previous to the time of the importation, showing that such cows are free from tuberculosis; (3) when the sanitary conditions of the dairy farm or plant in which such milk or cream is produced or handled do not score at least fifty points out of one hundred points according to the methods for scoring as provided by the score cards, used by the Bureau of Dairy Industry of the United States Department of Agriculture at the time such dairy farms or plants are scored; (4) in the case of raw milk if the number of bacteria per cubic centimeter exceeds three hundred thousand and in the case of raw cream seven hundred and fifty thousand, in the case of pasteurized milk if the number of bacteria per cubic centimeter exceeds one hundred thousand, and in the case of pasteurized cream five hundred thousand; (5) when the temperature of milk or cream at the time of importation exceeds fifty degrees Fahrenheit."
  ]
  node [
    id 559
    label "section_142_item_3"
    class_name "item"
    text "Milk or cream shall be considered unfit for importation (1) when all cows producing such milk or cream are not healthy and a physical examination of all such cows has not been made within one year previous to such milk being offered for importation; (2) when such milk or cream, if raw, is not produced from cows which have passed a tuberculin test applied by a duly authorized official veterinarian of the United States, or of the country in which such milk or cream is produced, within one year previous to the time of the importation, showing that such cows are free from tuberculosis; (3) when the sanitary conditions of the dairy farm or plant in which such milk or cream is produced or handled do not score at least fifty points out of one hundred points according to the methods for scoring as provided by the score cards, used by the Bureau of Dairy Industry of the United States Department of Agriculture at the time such dairy farms or plants are scored; (4) in the case of raw milk if the number of bacteria per cubic centimeter exceeds three hundred thousand and in the case of raw cream seven hundred and fifty thousand, in the case of pasteurized milk if the number of bacteria per cubic centimeter exceeds one hundred thousand, and in the case of pasteurized cream five hundred thousand; (5) when the temperature of milk or cream at the time of importation exceeds fifty degrees Fahrenheit."
  ]
  node [
    id 560
    label "section_142_item_2"
    class_name "item"
    text "Milk or cream shall be considered unfit for importation (1) when all cows producing such milk or cream are not healthy and a physical examination of all such cows has not been made within one year previous to such milk being offered for importation; (2) when such milk or cream, if raw, is not produced from cows which have passed a tuberculin test applied by a duly authorized official veterinarian of the United States, or of the country in which such milk or cream is produced, within one year previous to the time of the importation, showing that such cows are free from tuberculosis; (3) when the sanitary conditions of the dairy farm or plant in which such milk or cream is produced or handled do not score at least fifty points out of one hundred points according to the methods for scoring as provided by the score cards, used by the Bureau of Dairy Industry of the United States Department of Agriculture at the time such dairy farms or plants are scored; (4) in the case of raw milk if the number of bacteria per cubic centimeter exceeds three hundred thousand and in the case of raw cream seven hundred and fifty thousand, in the case of pasteurized milk if the number of bacteria per cubic centimeter exceeds one hundred thousand, and in the case of pasteurized cream five hundred thousand; (5) when the temperature of milk or cream at the time of importation exceeds fifty degrees Fahrenheit."
  ]
  node [
    id 561
    label "section_142_item_4"
    class_name "item"
    text "Milk or cream shall be considered unfit for importation (1) when all cows producing such milk or cream are not healthy and a physical examination of all such cows has not been made within one year previous to such milk being offered for importation; (2) when such milk or cream, if raw, is not produced from cows which have passed a tuberculin test applied by a duly authorized official veterinarian of the United States, or of the country in which such milk or cream is produced, within one year previous to the time of the importation, showing that such cows are free from tuberculosis; (3) when the sanitary conditions of the dairy farm or plant in which such milk or cream is produced or handled do not score at least fifty points out of one hundred points according to the methods for scoring as provided by the score cards, used by the Bureau of Dairy Industry of the United States Department of Agriculture at the time such dairy farms or plants are scored; (4) in the case of raw milk if the number of bacteria per cubic centimeter exceeds three hundred thousand and in the case of raw cream seven hundred and fifty thousand, in the case of pasteurized milk if the number of bacteria per cubic centimeter exceeds one hundred thousand, and in the case of pasteurized cream five hundred thousand; (5) when the temperature of milk or cream at the time of importation exceeds fifty degrees Fahrenheit."
  ]
  node [
    id 562
    label "section_142_item_5"
    class_name "item"
    text "Milk or cream shall be considered unfit for importation (1) when all cows producing such milk or cream are not healthy and a physical examination of all such cows has not been made within one year previous to such milk being offered for importation; (2) when such milk or cream, if raw, is not produced from cows which have passed a tuberculin test applied by a duly authorized official veterinarian of the United States, or of the country in which such milk or cream is produced, within one year previous to the time of the importation, showing that such cows are free from tuberculosis; (3) when the sanitary conditions of the dairy farm or plant in which such milk or cream is produced or handled do not score at least fifty points out of one hundred points according to the methods for scoring as provided by the score cards, used by the Bureau of Dairy Industry of the United States Department of Agriculture at the time such dairy farms or plants are scored; (4) in the case of raw milk if the number of bacteria per cubic centimeter exceeds three hundred thousand and in the case of raw cream seven hundred and fifty thousand, in the case of pasteurized milk if the number of bacteria per cubic centimeter exceeds one hundred thousand, and in the case of pasteurized cream five hundred thousand; (5) when the temperature of milk or cream at the time of importation exceeds fifty degrees Fahrenheit."
  ]
  node [
    id 563
    label "section_149_subsection_a"
    class_name "subsection"
    text "(a) The term &#8220;person&#8221; means an individual, partnership, association, or corporation."
  ]
  node [
    id 564
    label "section_149_subsection_b"
    class_name "subsection"
    text "(b) The term &#8220;United States&#8221; means the fifty States and the District of Columbia."
  ]
  node [
    id 565
    label "section_152_item_1"
    class_name "item"
    text "The importation into the United States of any virus, serum, toxin, or analogous product for use in the treatment of domestic animals, and the importation of any worthless, contaminated, dangerous, or harmful virus, serum, toxin, or analogous product for use in the treatment of domestic animals, is prohibited without (1) a permit from the Secretary of Agriculture, or (2) in the case of an article originating in Canada, such permit or, in lieu of such permit, such certification by Canada as may be prescribed by the Secretary of Agriculture."
  ]
  node [
    id 566
    label "section_152_item_2"
    class_name "item"
    text "The importation into the United States of any virus, serum, toxin, or analogous product for use in the treatment of domestic animals, and the importation of any worthless, contaminated, dangerous, or harmful virus, serum, toxin, or analogous product for use in the treatment of domestic animals, is prohibited without (1) a permit from the Secretary of Agriculture, or (2) in the case of an article originating in Canada, such permit or, in lieu of such permit, such certification by Canada as may be prescribed by the Secretary of Agriculture."
  ]
  node [
    id 567
    label "section_154a_item_2"
    class_name "item"
    text "(2) solely for administration to animals under a veterinarian-client-patient relationship in the course of the State licensed professional practice of veterinary medicine by such person, firm, or corporation; or"
  ]
  node [
    id 568
    label "section_154a_item_3_subitem_A"
    class_name "subitem"
    text "(A) may license virus, serum, toxin, and analogous products and establishments that produce such products;"
  ]
  node [
    id 569
    label "section_154a_item_3_subitem_E"
    class_name "subitem"
    text "(E) exercises the authority referred to in subclauses (A) through (D) consistent with the intent of this chapter of prohibiting the preparation, sale, barter, exchange, or shipment of worthless, contaminated, dangerous, or harmful virus, serum, toxin, or analogous products."
  ]
  node [
    id 570
    label "section_154a_item_3"
    class_name "item"
    text "(3) solely for distribution within the State of production pursuant to a license granted by such State under a program determined by the Secretary to meet criteria under which the State&#8212;"
  ]
  node [
    id 571
    label "section_154a_item_3_subitem_B"
    class_name "subitem"
    text "(B) may review the purity, safety, potency, and efficacy of such products prior to licensure;"
  ]
  node [
    id 572
    label "section_154a_item_1"
    class_name "item"
    text "(1) solely for administration to animals of such person, firm, or corporation;"
  ]
  node [
    id 573
    label "section_154a_item_3_subitem_D"
    class_name "subitem"
    text "(D) may deal effectively with violations of State law regulating virus, serum, toxin, and analogous products; and"
  ]
  node [
    id 574
    label "section_154a_item_3_subitem_C"
    class_name "subitem"
    text "(C) may review product test results to assure compliance with applicable standards for purity, safety, and potency, prior to release to the market;"
  ]
  node [
    id 575
    label "section_159_subsubitem_ii"
    class_name "subsubitem"
    text "The procedures of sections 672, 673, and 674 of this title (relating to detentions, seizures and condemnations, and injunctions, respectively) shall apply to the enforcement of this chapter with respect to any product prepared, sold, bartered, exchanged, or shipped in violation of this chapter or a regulation promulgated under this chapter. The provisions (including penalties) of section 675 of this title shall apply to the performance of official duties under this chapter. Congress finds that (i) the products and activities that are regulated under this chapter are either in interstate or foreign commerce or substantially affect such commerce or the free flow thereof, and (ii) regulation of the products and activities as provided in this chapter is necessary to prevent and eliminate burdens on such commerce and to effectively regulate such commerce."
  ]
  node [
    id 576
    label "section_159_subsubitem_i"
    class_name "subsubitem"
    text "The procedures of sections 672, 673, and 674 of this title (relating to detentions, seizures and condemnations, and injunctions, respectively) shall apply to the enforcement of this chapter with respect to any product prepared, sold, bartered, exchanged, or shipped in violation of this chapter or a regulation promulgated under this chapter. The provisions (including penalties) of section 675 of this title shall apply to the performance of official duties under this chapter. Congress finds that (i) the products and activities that are regulated under this chapter are either in interstate or foreign commerce or substantially affect such commerce or the free flow thereof, and (ii) regulation of the products and activities as provided in this chapter is necessary to prevent and eliminate burdens on such commerce and to effectively regulate such commerce."
  ]
  node [
    id 577
    label "section_321_subsection_z_item_1_subitem_F"
    class_name "subitem"
    text "(F) a concentrate, metabolite, constituent, extract, or combination of any ingredient described in clause (A), (B), (C), (D), or (E);"
  ]
  node [
    id 578
    label "section_321_subsection_x_item_4"
    class_name "item"
    text "(4) At the hearing the parties to the hearing shall have the right to hear a full and complete statement of the action of the Secretary which is the subject of the hearing together with the information and reasons supporting such action, to conduct reasonable questioning, and to present any oral or written information relevant to such action."
  ]
  node [
    id 579
    label "section_321_subsection_r"
    class_name "subsection"
    text "(r) The term &#8220;raw agricultural commodity&#8221; means any food in its raw or natural state, including all fruits that are washed, colored, or otherwise treated in their unpeeled natural form prior to marketing."
  ]
  node [
    id 580
    label "section_321_subsection_i"
    class_name "subsection"
    text "(i) The term &#8220;cosmetic&#8221; means (1) articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and (2) articles intended for use as a component of any such articles; except that such term shall not include soap."
  ]
  node [
    id 581
    label "section_321_subsection_t"
    class_name "subsection"
    text "(t)(1) The term &#8220;color additive&#8221; means a material which&#8212;"
  ]
  node [
    id 582
    label "section_321_subsection_v"
    class_name "subsection"
    text "(v) The term &#8220;new animal drug&#8221; means any drug intended for use for animals other than man, including any drug intended for use in animal feed but not including such animal feed,&#8212;"
  ]
  node [
    id 583
    label "section_321_subsection_t_item_1"
    class_name "item"
    text "(t)(1) The term &#8220;color additive&#8221; means a material which&#8212;"
  ]
  node [
    id 584
    label "section_321_subsection_z_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(A)(i) is intended for ingestion in a form described in section 350(c)(1)(B)(i) of this title; or"
  ]
  node [
    id 585
    label "section_321_subsection_z_item_1_subitem_D"
    class_name "subitem"
    text "(D) an amino acid;"
  ]
  node [
    id 586
    label "section_321_subsection_c"
    class_name "subsection"
    text "(c) The term &#8220;Department&#8221; means Department of Health and Human Services."
  ]
  node [
    id 587
    label "section_321_subsection_z_item_1"
    class_name "item"
    text "(1) means a product (other than tobacco) intended to supplement the diet that bears or contains one or more of the following dietary ingredients:"
  ]
  node [
    id 588
    label "section_321_subsection_w"
    class_name "subsection"
    text "(w) The term &#8220;animal feed&#8221;, as used in paragraph (w)&#160;1 of this section, in section 360b of this title, and in provisions of this chapter referring to such paragraph or section, means an article which is intended for use for food for animals other than man and which is intended for use as a substantial source of nutrients in the diet of the animal, and is not limited to a mixture intended to be the sole ration of the animal."
  ]
  node [
    id 589
    label "section_321_subsection_z_item_3"
    class_name "item"
    text "(3) does&#8212;"
  ]
  node [
    id 590
    label "section_321_subsection_k"
    class_name "subsection"
    text "(k) The term &#8220;label&#8221; means a display of written, printed, or graphic matter upon the immediate container of any article; and a requirement made by or under authority of this chapter that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be, of the retail package of such article, or is easily legible through the outside container or wrapper."
  ]
  node [
    id 591
    label "section_321_subsection_x_item_2"
    class_name "item"
    text "(2) Each party to the hearing shall have the right at all times to be advised and accompanied by an attorney."
  ]
  node [
    id 592
    label "section_321_subsection_t_item_1_subitem_B"
    class_name "subitem"
    text "(B) when added or applied to a food, drug, or cosmetic, or to the human body or any part thereof, is capable (alone or through reaction with other substance) of imparting color thereto;"
  ]
  node [
    id 593
    label "section_321_subsection_p"
    class_name "subsection"
    text "(p) The term &#8220;new drug&#8221; means&#8212;"
  ]
  node [
    id 594
    label "section_321_subsection_p_item_2"
    class_name "item"
    text "(2) Any drug (except a new animal drug or an animal feed bearing or containing a new animal drug) the composition of which is such that such drug, as a result of investigations to determine its safety and effectiveness for use under such conditions, has become so recognized, but which has not, otherwise than in such investigations, been used to a material extent or for a material time under such conditions."
  ]
  node [
    id 595
    label "section_321_subsection_m"
    class_name "subsection"
    text "(m) The term &#8220;labeling&#8221; means all labels and other written, printed, or graphic matter (1) upon any article or any of its containers or wrappers, or (2) accompanying such article."
  ]
  node [
    id 596
    label "section_321_subsection_z_item_2_subitem_C"
    class_name "subitem"
    text "(C) is labeled as a dietary supplement; and"
  ]
  node [
    id 597
    label "section_321_subsection_s_item_5"
    class_name "item"
    text "(5) a new animal drug; or"
  ]
  node [
    id 598
    label "section_321_subsection_f"
    class_name "subsection"
    text "(f) The term &#8220;food&#8221; means (1) articles used for food or drink for man or other animals, (2) chewing gum, and (3) articles used for components of any such article."
  ]
  node [
    id 599
    label "section_321_subsection_d"
    class_name "subsection"
    text "(d) The term &#8220;Secretary&#8221; means the Secretary of Health and Human Services."
  ]
  node [
    id 600
    label "section_321_subsection_j"
    class_name "subsection"
    text "(j) The term &#8220;official compendium&#8221; means the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, official National Formulary, or any supplement to any of them."
  ]
  node [
    id 601
    label "section_321_subsection_u"
    class_name "subsection"
    text "(u) The term &#8220;safe&#8221; as used in paragraph (s) of this section and in sections 348, 360b, and 379e of this title, has reference to the health of man or animal."
  ]
  node [
    id 602
    label "section_321_subsection_x"
    class_name "subsection"
    text "(x) The term &#8220;informal hearing&#8221; means a hearing which is not subject to section 554, 556, or 557 of title 5 and which provides for the following:"
  ]
  node [
    id 603
    label "section_321_subsection_a_item_1"
    class_name "item"
    text "(a)(1) The term &#8220;State&#8221;, except as used in the last sentence of section 372(a) of this title, means any State or Territory of the United States, the District of Columbia, and the Commonwealth of Puerto Rico."
  ]
  node [
    id 604
    label "section_321_subsection_n"
    class_name "subsection"
    text "(n) If an article is alleged to be misbranded because the labeling or advertising is misleading, then in determining whether the labeling or advertising is misleading there shall be taken into account (among other things) not only representations made or suggested by statement, word, design, device, or any combination thereof, but also the extent to which the labeling or advertising fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the article to which the labeling or advertising relates under the conditions of use prescribed in the labeling or advertising thereof or under such conditions of use as are customary or usual."
  ]
  node [
    id 605
    label "section_321_subsection_h_item_2"
    class_name "item"
    text "(2) intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or"
  ]
  node [
    id 606
    label "section_321_subsection_p_item_1"
    class_name "item"
    text "(1) Any drug (except a new animal drug or an animal feed bearing or containing a new animal drug) the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling thereof, except that such a drug not so recognized shall not be deemed to be a &#8220;new drug&#8221; if at any time prior to June 25, 1938, it was subject to the Food and Drugs Act of June 30, 1906, as amended, and if at such time its labeling contained the same representations concerning the conditions of its use; or"
  ]
  node [
    id 607
    label "section_321_subsection_t_item_3"
    class_name "item"
    text "(3) Nothing in subparagraph (1) of this paragraph shall be construed to apply to any pesticide chemical, soil or plant nutrient, or other agricultural chemical solely because of its effect in aiding, retarding, or otherwise affecting, directly or indirectly, the growth or other natural physiological processes of produce of the soil and thereby affecting its color, whether before or after harvest."
  ]
  node [
    id 608
    label "section_321_subsection_z_item_1_subitem_B"
    class_name "subitem"
    text "(B) a mineral;"
  ]
  node [
    id 609
    label "section_321_subsection_h"
    class_name "subsection"
    text "(h) The term &#8220;device&#8221; (except when used in paragraph (n) of this section and in sections 331(i), 343(f), 352(c), and 362(c) of this title) means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is&#8212;"
  ]
  node [
    id 610
    label "section_321_subsection_g_item_1"
    class_name "item"
    text "(g)(1) The term &#8220;drug&#8221; means (A) articles recognized in the official United States Pharmacopoeia, official Homoeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; and (B) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (C) articles (other than food) intended to affect the structure or any function of the body of man or other animals; and (D) articles intended for use as a component of any article specified in clause (A), (B), or (C). A food or dietary supplement for which a claim, subject to sections 343(r)(1)(B) and 343(r)(3) of this title or sections 343(r)(1)(B) and 343(r)(5)(D) of this title, is made in accordance with the requirements of section 343(r) of this title is not a drug solely because the label or the labeling contains such a claim. A food, dietary ingredient, or dietary supplement for which a truthful and not misleading statement is made in accordance with section 343(r)(6) of this title is not a drug under clause (C) solely because the label or the labeling contains such a statement."
  ]
  node [
    id 611
    label "section_321_subsection_x_item_5"
    class_name "item"
    text "(5) The presiding officer in such hearing shall prepare a written report of the hearing to which shall be attached all written material presented at the hearing. The participants in the hearing shall be given the opportunity to review and correct or supplement the presiding officer's report of the hearing."
  ]
  node [
    id 612
    label "section_321_subsection_l"
    class_name "subsection"
    text "(l) The term &#8220;immediate container&#8221; does not include package liners."
  ]
  node [
    id 613
    label "section_321_subsection_z_item_1_subitem_C"
    class_name "subitem"
    text "(C) an herb or other botanical;"
  ]
  node [
    id 614
    label "section_321_subsection_e"
    class_name "subsection"
    text "(e) The term &#8220;person&#8221; includes individual, partnership, corporation, and association."
  ]
  node [
    id 615
    label "section_321_subsection_s_item_1"
    class_name "item"
    text "(1) a pesticide chemical in or on a raw agricultural commodity; or"
  ]
  node [
    id 616
    label "section_321_subsection_v_item_2"
    class_name "item"
    text "(2) the composition of which is such that such drug, as a result of investigations to determine its safety and effectiveness for use under such conditions, has become so recognized but which has not, otherwise than in such investigations, been used to a material extent or for a material time under such conditions."
  ]
  node [
    id 617
    label "section_321_subsection_x_item_3"
    class_name "item"
    text "(3) Before the hearing, each party to the hearing shall be given reasonable notice of the matters to be considered at the hearing, including a comprehensive statement of the basis for the action taken or proposed by the Secretary which is the subject of the hearing and a general summary of the information which will be presented by the Secretary at the hearing in support of such action."
  ]
  node [
    id 618
    label "section_321_subsection_z"
    class_name "subsection"
    text "(z) The term &#8220;infant formula&#8221; means a food which purports to be or is represented for special dietary use solely as a food for infants by reason of its simulation of human milk or its suitability as a complete or partial substitute for human milk."
  ]
  node [
    id 619
    label "section_321_subsection_z_item_2"
    class_name "item"
    text "(2) means a product that&#8212;"
  ]
  node [
    id 620
    label "section_321_subsection_x_item_1"
    class_name "item"
    text "(1) The presiding officer in the hearing shall be designated by the Secretary from officers and employees of the Department who have not participated in any action of the Secretary which is the subject of the hearing and who are not directly responsible to an officer or employee of the Department who has participated in any such action."
  ]
  node [
    id 621
    label "section_321_subsection_h_item_1"
    class_name "item"
    text "(1) recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them,"
  ]
  node [
    id 622
    label "section_321_subsection_s_item_4"
    class_name "item"
    text "(4) any substance used in accordance with a sanction or approval granted prior to September 6, 1958, pursuant to this chapter, the Poultry Products Inspection Act [21 U.S.C. 451 et seq.] or the Meat Inspection Act of March 4, 1907, as amended and extended [21 U.S.C. 601 et seq.];"
  ]
  node [
    id 623
    label "section_321_subsection_v_item_1"
    class_name "item"
    text "(1) the composition of which is such that such drug is not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling thereof; except that such a drug not so recognized shall not be deemed to be a &#8220;new animal drug&#8221; if at any time prior to June 25, 1938, it was subject to the Food and Drug Act of June 30, 1906, as amended, and if at such time its labeling contained the same representations concerning the conditions of its use; or"
  ]
  node [
    id 624
    label "section_321_subsection_s_item_3"
    class_name "item"
    text "(3) a color additive; or"
  ]
  node [
    id 625
    label "section_321_subsection_g_item_2"
    class_name "item"
    text "(2) The term &#8220;counterfeit drugs&#8221; means a drug which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, or device, or any likeness thereof, of a drug manufacturer, processor, packer, or distributor other than the person or persons who in fact manufactured, processed, packed, or distributed such drug and which thereby falsely purports or is represented to be the product of, or to have been packed or distributed by, such other drug manufacturer, processor, packer, or distributor."
  ]
  node [
    id 626
    label "section_321_subsection_t_item_2"
    class_name "item"
    text "(2) The term &#8220;color&#8221; includes black, white, and intermediate grays."
  ]
  node [
    id 627
    label "section_321_subsection_z_item_3_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) an article that is approved as a new drug under section 355 of this title, certified as an antibiotic under section 357 of this title, or licensed as a biologic under section 262 of title 42, or"
  ]
  node [
    id 628
    label "section_321_subsection_s_item_6"
    class_name "item"
    text "(6) an ingredient described in paragraph (ff) in, or intended for use in, a dietary supplement."
  ]
  node [
    id 629
    label "section_321_subsection_g"
    class_name "subsection"
    text "(g)(1) The term &#8220;drug&#8221; means (A) articles recognized in the official United States Pharmacopoeia, official Homoeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; and (B) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (C) articles (other than food) intended to affect the structure or any function of the body of man or other animals; and (D) articles intended for use as a component of any article specified in clause (A), (B), or (C). A food or dietary supplement for which a claim, subject to sections 343(r)(1)(B) and 343(r)(3) of this title or sections 343(r)(1)(B) and 343(r)(5)(D) of this title, is made in accordance with the requirements of section 343(r) of this title is not a drug solely because the label or the labeling contains such a claim. A food, dietary ingredient, or dietary supplement for which a truthful and not misleading statement is made in accordance with section 343(r)(6) of this title is not a drug under clause (C) solely because the label or the labeling contains such a statement."
  ]
  node [
    id 630
    label "section_321_subsection_t_item_1_subitem_A"
    class_name "subitem"
    text "(A) is a dye, pigment, or other substance made by a process of synthesis or similar artifice, or extracted, isolated, or otherwise derived, with or without intermediate or final change of identity, from a vegetable, animal, mineral, or other source, and"
  ]
  node [
    id 631
    label "section_321_subsection_z_item_2_subitem_B"
    class_name "subitem"
    text "(B) is not represented for use as a conventional food or as a sole item of a meal or the diet; and"
  ]
  node [
    id 632
    label "section_321_subsection_o"
    class_name "subsection"
    text "(o) The representation of a drug, in its labeling, as an antiseptic shall be considered to be a representation that it is a germicide, except in the case of a drug purporting to be, or represented as, an antiseptic for inhibitory use as a wet dressing, ointment, dusting powder, or such other use as involves prolonged contact with the body."
  ]
  node [
    id 633
    label "section_321_subsection_s"
    class_name "subsection"
    text "(s) The term &#8220;food additive&#8221; means any substance the intended use of which results or may reasonably be expected to result, directly or indirectly, in its becoming a component or otherwise affecting the characteristics of any food (including any substance intended for use in producing, manufacturing, packing, processing, preparing, treating, packaging, transporting, or holding food; and including any source of radiation intended for any such use), if such substance is not generally recognized, among experts qualified by scientific training and experience to evaluate its safety, as having been adequately shown through scientific procedures (or, in the case as a substance used in food prior to January 1, 1958, through either scientific procedures or experience based on common use in food) to be safe under the conditions of its intended use; except that such term does not include&#8212;"
  ]
  node [
    id 634
    label "section_321_subsection_y"
    class_name "subsection"
    text "(y) The term &#8220;saccharin&#8221; includes calcium saccharin, sodium saccharin, and ammonium saccharin."
  ]
  node [
    id 635
    label "section_321_subsection_z_item_1_subitem_E"
    class_name "subitem"
    text "(E) a dietary substance for use by man to supplement the diet by increasing the total dietary intake; or"
  ]
  node [
    id 636
    label "section_321_subsection_z_item_3_subitem_A"
    class_name "subitem"
    text "(A) include an article that is approved as a new drug under section 355 of this title, certified as an antibiotic under section 357 of this title, or licensed as a biologic under section 262 of title 42 and was, prior to such approval, certification, or license, marketed as a dietary supplement or as a food unless the Secretary has issued a regulation, after notice and comment, finding that the article, when used as or in a dietary supplement under the conditions of use and dosages set forth in the labeling for such dietary supplement, is unlawful under section 342(f) of this title; and"
  ]
  node [
    id 637
    label "section_321_subsection_z_item_3_subitem_B"
    class_name "subitem"
    text "(B) not include&#8212;"
  ]
  node [
    id 638
    label "section_321_subsection_z_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) complies with section 350(c)(1)(B)(ii) of this title;"
  ]
  node [
    id 639
    label "section_321_subsection_z_item_3_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) an article authorized for investigation as a new drug, antibiotic, or biological for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public,"
  ]
  node [
    id 640
    label "section_321_subsection_q"
    class_name "subsection"
    text "(q) The term &#8220;pesticide chemical&#8221; means any substance which, alone, in chemical combination or in formulation with one or more other substances, is &#8220;a pesticide&#8221; within the meaning of the Federal Insecticide, Fungicide, and Rodenticide Act [7 U.S.C. 136 et seq.] as now in force or as hereafter amended, and which is used in the production, storage, or transportation of raw agricultural commodities."
  ]
  node [
    id 641
    label "section_321_subsection_a_item_2"
    class_name "item"
    text "(2) The term &#8220;Territory&#8221; means any Territory or possession of the United States, including the District of Columbia, and excluding the Commonwealth of Puerto Rico and the Canal Zone."
  ]
  node [
    id 642
    label "section_321_subsection_s_item_2"
    class_name "item"
    text "(2) a pesticide chemical to the extent that it is intended for use or is used in the production, storage, or transportation of any raw agricultural commodity; or"
  ]
  node [
    id 643
    label "section_321_subsection_b"
    class_name "subsection"
    text "(b) The term &#8220;interstate commerce&#8221; means (1) commerce between any State or Territory and any place outside thereof, and (2) commerce within the District of Columbia or within any other Territory not organized with a legislative body."
  ]
  node [
    id 644
    label "section_321_subsection_a"
    class_name "subsection"
    text "(a)(1) The term &#8220;State&#8221;, except as used in the last sentence of section 372(a) of this title, means any State or Territory of the United States, the District of Columbia, and the Commonwealth of Puerto Rico."
  ]
  node [
    id 645
    label "section_321_subsection_h_item_3"
    class_name "item"
    text "(3) intended to affect the structure or any function of the body of man or other animals, and"
  ]
  node [
    id 646
    label "section_321_subsection_z_item_2_subitem_A"
    class_name "subitem"
    text "(A)(i) is intended for ingestion in a form described in section 350(c)(1)(B)(i) of this title; or"
  ]
  node [
    id 647
    label "section_321_subsection_x_item_6"
    class_name "item"
    text "(6) The Secretary may require the hearing to be transcribed. A party to the hearing shall have the right to have the hearing transcribed at his expense. Any transcription of a hearing shall be included in the presiding officer's report of the hearing."
  ]
  node [
    id 648
    label "section_321_subsection_z_item_1_subitem_A"
    class_name "subitem"
    text "(A) a vitamin;"
  ]
  node [
    id 649
    label "section_331_subsection_l"
    class_name "subsection"
    text "(l) The using, on the labeling of any drug or device or in any advertising relating to such drug or device, of any representation or suggestion that approval of an application with respect to such drug or device is in effect under section 355, 360e, or 360j(g) of this title, as the case may be, or that such drug or device complies with the provisions of such section."
  ]
  node [
    id 650
    label "section_331_subsection_d"
    class_name "subsection"
    text "(d) The introduction or delivery for introduction into interstate commerce of any article in violation of section 344 or 355 of this title."
  ]
  node [
    id 651
    label "section_331_subsection_j"
    class_name "subsection"
    text "(j) The using by any person to his own advantage, or revealing, other than to the Secretary or officers or employees of the Department, or to the courts when relevant in any judicial proceeding under this chapter, any information acquired under authority of section 344, 348, 350a, 355, 356, 357, 360, 360b, 360c, 360d, 360e, 360f, 360h, 360i, 360j, 374, 379, or 379e of this title concerning any method or process which as a trade secret is entitled to protection. This paragraph does not authorize the withholding of information from either House of Congress or from, to the extent of matter within its jurisdiction, any committee or subcommittee of such committee or any joint committee of Congress or any subcommittee of such joint committee."
  ]
  node [
    id 652
    label "section_331_subsection_o"
    class_name "subsection"
    text "(o) In the case of a prescription drug distributed or offered for sale in interstate commerce, the failure of the manufacturer, packer, or distributor thereof to maintain for transmittal, or to transmit, to any practitioner licensed by applicable State law to administer such drug who makes written request for information as to such drug, true and correct copies of all printed matter which is required to be included in any package in which that drug is distributed or sold, or such other printed matter as is approved by the Secretary. Nothing in this paragraph shall be construed to exempt any person from any labeling requirement imposed by or under other provisions of this chapter."
  ]
  node [
    id 653
    label "section_331_subsection_f"
    class_name "subsection"
    text "(f) The refusal to permit entry or inspection as authorized by section 374 of this title."
  ]
  node [
    id 654
    label "section_331_subsection_n"
    class_name "subsection"
    text "(n) The using, in labeling, advertising or other sales promotion of any reference to any report or analysis furnished in compliance with section 374 of this title."
  ]
  node [
    id 655
    label "section_331_subsection_k"
    class_name "subsection"
    text "(k) The alteration, mutilation, destruction, obliteration, or removal of the whole or any part of the labeling of, or the doing of any other act with respect to, a food, drug, device, or cosmetic, if such act is done while such article is held for sale (whether or not the first sale) after shipment in interstate commerce and results in such article being adulterated or misbranded."
  ]
  node [
    id 656
    label "section_331_subsection_u"
    class_name "subsection"
    text "(u)&#160;1 The introduction or delivery for introduction into interstate commerce of a dietary supplement that is unsafe under section 350b of this title."
  ]
  node [
    id 657
    label "section_331_subsection_q_item_2"
    class_name "item"
    text "(2) With respect to any device, the submission of any report that is required by or under this chapter that is false or misleading in any material respect."
  ]
  node [
    id 658
    label "section_331_subsection_e"
    class_name "subsection"
    text "(e) The refusal to permit access to or copying of any record as required by section 350a or 373 of this title; or the failure to establish or maintain any record, or make any report, required under section 350a, 355(i) or (k), 357(d) or (g), 360b(a)(4)(C), 360b(j), (l), or (m), 360e(f), or 360i of this title, or the refusal to permit access to or verification or copying of any such required record."
  ]
  node [
    id 659
    label "section_331_subsection_s"
    class_name "subsection"
    text "(s) The failure to provide the notice required by section 350a(c) or 350a(e) of this title, the failure to make the reports required by section 350a(f)(1)(B) of this title, the failure to retain the records required by section 350a(b)(4) of this title, or the failure to meet the requirements prescribed under section 350a(f)(3) of this title."
  ]
  node [
    id 660
    label "section_331_subsection_a"
    class_name "subsection"
    text "(a) The introduction or delivery for introduction into interstate commerce of any food, drug, device, or cosmetic that is adulterated or misbranded."
  ]
  node [
    id 661
    label "section_331_subsection_i_item_3"
    class_name "item"
    text "(3) The doing of any act which causes a drug to be a counterfeit drug, or the sale or dispensing, or the holding for sale or dispensing, of a counterfeit drug."
  ]
  node [
    id 662
    label "section_331_subsection_q"
    class_name "subsection"
    text "(q)(1) The failure or refusal to (A) comply with any requirement prescribed under section 360h or 360j(g) of this title, (B) furnish any notification or other material or information required by or under section 360i or 360j(g) of this title, or (C) comply with a requirement under section 360l of this title."
  ]
  node [
    id 663
    label "section_331_subsection_i_item_2"
    class_name "item"
    text "(2) Making, selling, disposing of, or keeping in possession, control, or custody, or concealing any punch, die, plate, stone, or other thing designed to print, imprint, or reproduce the trademark, trade name, or other identifying mark, imprint, or device of another or any likeness of any of the foregoing upon any drug or container or labeling thereof so as to render such drug a counterfeit drug."
  ]
  node [
    id 664
    label "section_331_subsection_i"
    class_name "subsection"
    text "(i)(1) Forging, counterfeiting, simulating, or falsely representing, or without proper authority using any mark, stamp, tag, label, or other identification device authorized or required by regulations promulgated under the provisions of section 344, 356, 357, or 379e of this title."
  ]
  node [
    id 665
    label "section_331_subsection_i_item_1"
    class_name "item"
    text "(i)(1) Forging, counterfeiting, simulating, or falsely representing, or without proper authority using any mark, stamp, tag, label, or other identification device authorized or required by regulations promulgated under the provisions of section 344, 356, 357, or 379e of this title."
  ]
  node [
    id 666
    label "section_331_subsection_t"
    class_name "subsection"
    text "(t) The importation of a drug in violation of section 381(d)(1) of this title, the sale, purchase, or trade of a drug or drug sample or the offer to sell, purchase, or trade a drug or drug sample in violation of section 353(c) of this title, the sale, purchase, or trade of a coupon, the offer to sell, purchase, or trade such a coupon, or the counterfeiting of such a coupon in violation of section 353(c)(2) of this title, the distribution of a drug sample in violation of section 353(d) of this title or the failure to otherwise comply with the requirements of section 353(d) of this title, or the distribution of drugs in violation of section 353(e) of this title or the failure to otherwise comply with the requirements of section 353(e) of this title."
  ]
  node [
    id 667
    label "section_331_subsection_g"
    class_name "subsection"
    text "(g) The manufacture within any Territory of any food, drug, device, or cosmetic that is adulterated or misbranded."
  ]
  node [
    id 668
    label "section_331_subsection_b"
    class_name "subsection"
    text "(b) The adulteration or misbranding of any food, drug, device, or cosmetic in interstate commerce."
  ]
  node [
    id 669
    label "section_331_subsection_h"
    class_name "subsection"
    text "(h) The giving of a guaranty or undertaking referred to in section 333(c)(2) of this title, which guaranty or undertaking is false, except by a person who relied upon a guaranty or undertaking to the same effect signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the food, drug, device, or cosmetic; or the giving of a guaranty or undertaking referred to in section 333(c)(3) of this title, which guaranty or undertaking is false."
  ]
  node [
    id 670
    label "section_331_subsection_m"
    class_name "subsection"
    text "(m) The sale or offering for sale of colored oleomargarine or colored margarine, or the possession or serving of colored oleomargarine or colored margarine in violation of subsections (b) or (c) of section 347 of this title."
  ]
  node [
    id 671
    label "section_331_subsection_c"
    class_name "subsection"
    text "(c) The receipt in interstate commerce of any food, drug, device, or cosmetic that is adulterated or misbranded, and the delivery or proffered delivery thereof for pay or otherwise."
  ]
  node [
    id 672
    label "section_331_subsection_r"
    class_name "subsection"
    text "(r) The movement of a device in violation of an order under section 334(g) of this title or the removal or alteration of any mark or label required by the order to identify the device as detained."
  ]
  node [
    id 673
    label "section_331_subsection_q_item_1"
    class_name "item"
    text "(q)(1) The failure or refusal to (A) comply with any requirement prescribed under section 360h or 360j(g) of this title, (B) furnish any notification or other material or information required by or under section 360i or 360j(g) of this title, or (C) comply with a requirement under section 360l of this title."
  ]
  node [
    id 674
    label "section_331_subsection_p"
    class_name "subsection"
    text "(p) The failure to register in accordance with section 360 of this title, the failure to provide any information required by section 360(j) or 360(k) of this title, or the failure to provide a notice required by section 360(j)(2) of this title."
  ]
  node [
    id 675
    label "section_332_subsection_a_subsubitem_i"
    class_name "subsubitem"
    text "The district courts of the United States and the United States courts of the Territories shall have jurisdiction, for cause shown&#160;1 to restrain violations of section 331 of this title, except paragraphs (h), (i), and (j)."
  ]
  node [
    id 676
    label "section_332_subsection_a"
    class_name "subsection"
    text "(a) Jurisdiction of courts"
  ]
  node [
    id 677
    label "section_332_subsection_b"
    class_name "subsection"
    text "(b) Violation of injunction"
  ]
  node [
    id 678
    label "section_333_subsection_c_item_5_subsubitem_i"
    class_name "subsubitem"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section, (1) for having received in interstate commerce any article and delivered it or proffered delivery of it, if such delivery or proffer was made in good faith, unless he refuses to furnish on request of an officer or employee duly designated by the Secretary the name and address of the person from whom he purchased or received such article and copies of all documents, if any there be, pertaining to the delivery of the article to him; or (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect, in case of an alleged violation of section 331(a) of this title, that such article is not adulterated or misbranded, within the meaning of this chapter designating this chapter or to the effect, in case of an alleged violation of section 331(d) of this title, that such article is not an article which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce; or (3) for having violated section 331(a) of this title, where the violation exists because the article is adulterated by reason of containing a color additive not from a batch certified in accordance with regulations promulgated by the Secretary under this chapter, if such person establishes a guaranty or undertaking signed by, and containing the name and address of, the manufacturer of the color additive, to the effect that such color additive was from a batch certified in accordance with the applicable regulations promulgated by the Secretary under this chapter; or (4) for having violated section 331(b), (c) or (k) of this title by failure to comply with section 352(f) of this title in respect to an article received in interstate commerce to which neither section 353(a) nor 353(b)(1) of this title is applicable, if the delivery or proffered delivery was made in good faith and the labeling at the time thereof contained the same directions for use and warning statements as were contained in the labeling at the time of such receipt of such article; or (5) for having violated section 331(i)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a drug being a counterfeit drug, or for having violated section 331(i)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the drug was a counterfeit drug."
  ]
  node [
    id 679
    label "section_333_subsection_f_item_2"
    class_name "item"
    text "(2)(A) A civil penalty under paragraph (1) shall be assessed by the Secretary by an order made on the record after opportunity for a hearing provided in accordance with this subparagraph and section 554 of title 5. Before issuing such an order, the Secretary shall give written notice to the person to be assessed a civil penalty under such order of the Secretary's proposal to issue such order and provide such person an opportunity for a hearing on the order. In the course of any investigation, the Secretary may issue subpoenas requiring the attendance and testimony of witnesses and the production of evidence that relates to the matter under investigation."
  ]
  node [
    id 680
    label "section_333_subsection_d_item_1"
    class_name "item"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section for a violation of section 331 of this title involving misbranded food if the violation exists solely because the food is misbranded under section 343(a)(2) of this title because of its advertising."
  ]
  node [
    id 681
    label "section_333_subsection_c_item_5"
    class_name "item"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section, (1) for having received in interstate commerce any article and delivered it or proffered delivery of it, if such delivery or proffer was made in good faith, unless he refuses to furnish on request of an officer or employee duly designated by the Secretary the name and address of the person from whom he purchased or received such article and copies of all documents, if any there be, pertaining to the delivery of the article to him; or (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect, in case of an alleged violation of section 331(a) of this title, that such article is not adulterated or misbranded, within the meaning of this chapter designating this chapter or to the effect, in case of an alleged violation of section 331(d) of this title, that such article is not an article which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce; or (3) for having violated section 331(a) of this title, where the violation exists because the article is adulterated by reason of containing a color additive not from a batch certified in accordance with regulations promulgated by the Secretary under this chapter, if such person establishes a guaranty or undertaking signed by, and containing the name and address of, the manufacturer of the color additive, to the effect that such color additive was from a batch certified in accordance with the applicable regulations promulgated by the Secretary under this chapter; or (4) for having violated section 331(b), (c) or (k) of this title by failure to comply with section 352(f) of this title in respect to an article received in interstate commerce to which neither section 353(a) nor 353(b)(1) of this title is applicable, if the delivery or proffered delivery was made in good faith and the labeling at the time thereof contained the same directions for use and warning statements as were contained in the labeling at the time of such receipt of such article; or (5) for having violated section 331(i)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a drug being a counterfeit drug, or for having violated section 331(i)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the drug was a counterfeit drug."
  ]
  node [
    id 682
    label "section_333_subsection_c_item_4"
    class_name "item"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section, (1) for having received in interstate commerce any article and delivered it or proffered delivery of it, if such delivery or proffer was made in good faith, unless he refuses to furnish on request of an officer or employee duly designated by the Secretary the name and address of the person from whom he purchased or received such article and copies of all documents, if any there be, pertaining to the delivery of the article to him; or (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect, in case of an alleged violation of section 331(a) of this title, that such article is not adulterated or misbranded, within the meaning of this chapter designating this chapter or to the effect, in case of an alleged violation of section 331(d) of this title, that such article is not an article which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce; or (3) for having violated section 331(a) of this title, where the violation exists because the article is adulterated by reason of containing a color additive not from a batch certified in accordance with regulations promulgated by the Secretary under this chapter, if such person establishes a guaranty or undertaking signed by, and containing the name and address of, the manufacturer of the color additive, to the effect that such color additive was from a batch certified in accordance with the applicable regulations promulgated by the Secretary under this chapter; or (4) for having violated section 331(b), (c) or (k) of this title by failure to comply with section 352(f) of this title in respect to an article received in interstate commerce to which neither section 353(a) nor 353(b)(1) of this title is applicable, if the delivery or proffered delivery was made in good faith and the labeling at the time thereof contained the same directions for use and warning statements as were contained in the labeling at the time of such receipt of such article; or (5) for having violated section 331(i)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a drug being a counterfeit drug, or for having violated section 331(i)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the drug was a counterfeit drug."
  ]
  node [
    id 683
    label "section_333_subsection_e_item_4"
    class_name "item"
    text "(4) As used in this subsection the term &#8220;human growth hormone&#8221; means somatrem, somatropin, or an analogue of either of them."
  ]
  node [
    id 684
    label "section_333_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) A civil penalty of not more than $1,000,000 for each violation resulting in a conviction of any representative after the second conviction in any 10-year period."
  ]
  node [
    id 685
    label "section_333_subsection_b_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) If a manufacturer or distributor or any representative of such manufacturer or distributor provides information leading to the institution of a criminal proceeding against, and conviction of, any representative of that manufacturer or distributor for a violation of section 331(t) of this title because of a sale, purchase, or trade or offer to purchase, sell, or trade a drug sample in violation of section 353(c)(1) of this title or for a violation of State law prohibiting the sale, purchase, or trade or offer to sell, purchase, or trade a drug sample, the conviction of such representative shall not be considered as a violation for purposes of paragraph (2)."
  ]
  node [
    id 686
    label "section_333_subsection_a"
    class_name "subsection"
    text "(a) Violation of section 331 of this title; second violation; intent to defraud or mislead"
  ]
  node [
    id 687
    label "section_333_subsection_c_item_2_subsubitem_i"
    class_name "subsubitem"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section, (1) for having received in interstate commerce any article and delivered it or proffered delivery of it, if such delivery or proffer was made in good faith, unless he refuses to furnish on request of an officer or employee duly designated by the Secretary the name and address of the person from whom he purchased or received such article and copies of all documents, if any there be, pertaining to the delivery of the article to him; or (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect, in case of an alleged violation of section 331(a) of this title, that such article is not adulterated or misbranded, within the meaning of this chapter designating this chapter or to the effect, in case of an alleged violation of section 331(d) of this title, that such article is not an article which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce; or (3) for having violated section 331(a) of this title, where the violation exists because the article is adulterated by reason of containing a color additive not from a batch certified in accordance with regulations promulgated by the Secretary under this chapter, if such person establishes a guaranty or undertaking signed by, and containing the name and address of, the manufacturer of the color additive, to the effect that such color additive was from a batch certified in accordance with the applicable regulations promulgated by the Secretary under this chapter; or (4) for having violated section 331(b), (c) or (k) of this title by failure to comply with section 352(f) of this title in respect to an article received in interstate commerce to which neither section 353(a) nor 353(b)(1) of this title is applicable, if the delivery or proffered delivery was made in good faith and the labeling at the time thereof contained the same directions for use and warning statements as were contained in the labeling at the time of such receipt of such article; or (5) for having violated section 331(i)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a drug being a counterfeit drug, or for having violated section 331(i)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the drug was a counterfeit drug."
  ]
  node [
    id 688
    label "section_333_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) Except as provided in subparagraph (B), any person who violates a requirement of this chapter which relates to devices shall be liable to the United States for a civil penalty in an amount not to exceed $15,000 for each such violation, and not to exceed $1,000,000 for all such violations adjudicated in a single proceeding."
  ]
  node [
    id 689
    label "section_333_subsection_f_item_3"
    class_name "item"
    text "the Attorney General shall recover the amount assessed (plus interest at currently prevailing rates from the date of the expiration of the 60-day period referred to in paragraph (3) or the date of such final judgment, as the case may be) in an action brought in any appropriate district court of the United States. In such an action, the validity, amount, and appropriateness of such penalty shall not be subject to review."
  ]
  node [
    id 690
    label "section_333_subsection_f_item_4_subitem_A"
    class_name "subitem"
    text "(A) after the order making the assessment becomes final, and if such person does not file a petition for judicial review of the order in accordance with paragraph (3), or"
  ]
  node [
    id 691
    label "section_333_subsection_b_item_3"
    class_name "item"
    text "(3) Any manufacturer or distributor who violates section 331(t) of this title because of a failure to make a report required by section 353(d)(3)(E) of this title shall be subject to a civil penalty of not more than $100,000."
  ]
  node [
    id 692
    label "section_333_subsection_b_item_4"
    class_name "item"
    text "(4)(A) If a manufacturer or distributor or any representative of such manufacturer or distributor provides information leading to the institution of a criminal proceeding against, and conviction of, any representative of that manufacturer or distributor for a violation of section 331(t) of this title because of a sale, purchase, or trade or offer to purchase, sell, or trade a drug sample in violation of section 353(c)(1) of this title or for a violation of State law prohibiting the sale, purchase, or trade or offer to sell, purchase, or trade a drug sample, the conviction of such representative shall not be considered as a violation for purposes of paragraph (2)."
  ]
  node [
    id 693
    label "section_333_subsection_d_item_2"
    class_name "item"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section for a violation of section 331 of this title involving misbranded food if the violation exists solely because the food is misbranded under section 343(a)(2) of this title because of its advertising."
  ]
  node [
    id 694
    label "section_333_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) Subparagraph (A) shall not apply&#8212;"
  ]
  node [
    id 695
    label "section_333_subsection_b_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) that, except in the case of the conviction of a representative employed in a supervisory function, despite diligent implementation by the manufacturer or distributor of an independent audit and security system designed to detect such a violation, the manufacturer or distributor could not reasonably have been expected to have detected such violation,"
  ]
  node [
    id 696
    label "section_333_subsection_f_item_2_subitem_C"
    class_name "subitem"
    text "(C) The Secretary may compromise, modify, or remit, with or without conditions, any civil penalty which may be assessed under paragraph (1). The amount of such penalty, when finally determined, or the amount agreed upon in compromise, may be deducted from any sums owing by the United States to the person charged."
  ]
  node [
    id 697
    label "section_333_subsection_b_item_5"
    class_name "item"
    text "(5) If a person provides information leading to the institution of a criminal proceeding against, and conviction of, a person for a violation of section 331(t) of this title because of the sale, purchase, or trade of a drug sample or the offer to sell, purchase, or trade a drug sample in violation of section 353(c)(1) of this title, such person shall be entitled to one-half of the criminal fine imposed and collected for such violation but not more than $125,000."
  ]
  node [
    id 698
    label "section_333_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) A civil penalty of not more than $50,000 for each of the first two such violations resulting in a conviction of any representative of the manufacturer or distributor in any 10-year period."
  ]
  node [
    id 699
    label "section_333_subsection_b_item_1"
    class_name "item"
    text "(1) Notwithstanding subsection (a) of this section, any person who violates section 331(t) of this title by&#8212;"
  ]
  node [
    id 700
    label "section_333_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) knowingly selling, purchasing, or trading a drug or drug sample or knowingly offering to sell, purchase, or trade a drug or drug sample, in violation of section 353(c)(1) of this title,"
  ]
  node [
    id 701
    label "section_333_subsection_f_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) to any person who violates the requirements of section 360i(a) or 360j(f) of this title unless such violation constitutes (I) a significant or knowing departure from such requirements, or (II) a risk to public health,"
  ]
  node [
    id 702
    label "section_333_subsection_f_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) A civil penalty under paragraph (1) shall be assessed by the Secretary by an order made on the record after opportunity for a hearing provided in accordance with this subparagraph and section 554 of title 5. Before issuing such an order, the Secretary shall give written notice to the person to be assessed a civil penalty under such order of the Secretary's proposal to issue such order and provide such person an opportunity for a hearing on the order. In the course of any investigation, the Secretary may issue subpoenas requiring the attendance and testimony of witnesses and the production of evidence that relates to the matter under investigation."
  ]
  node [
    id 703
    label "section_333_subsection_e_item_1"
    class_name "item"
    text "(1) Except as provided in paragraph (2), whoever knowingly distributes, or possesses with intent to distribute, human growth hormone for any use in humans other than the treatment of a disease or other recognized medical condition, where such use has been authorized by the Secretary of Health and Human Services under section 355 of this title and pursuant to the order of a physician, is guilty of an offense punishable by not more than 5 years in prison, such fines as are authorized by title 18, or both."
  ]
  node [
    id 704
    label "section_333_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) knowingly selling, purchasing, or trading a coupon, knowingly offering to sell, purchase, or trade such a coupon, or knowingly counterfeiting such a coupon, in violation of section 353(c)(2) of this title, or"
  ]
  node [
    id 705
    label "section_333_subsection_c_item_3"
    class_name "item"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section, (1) for having received in interstate commerce any article and delivered it or proffered delivery of it, if such delivery or proffer was made in good faith, unless he refuses to furnish on request of an officer or employee duly designated by the Secretary the name and address of the person from whom he purchased or received such article and copies of all documents, if any there be, pertaining to the delivery of the article to him; or (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect, in case of an alleged violation of section 331(a) of this title, that such article is not adulterated or misbranded, within the meaning of this chapter designating this chapter or to the effect, in case of an alleged violation of section 331(d) of this title, that such article is not an article which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce; or (3) for having violated section 331(a) of this title, where the violation exists because the article is adulterated by reason of containing a color additive not from a batch certified in accordance with regulations promulgated by the Secretary under this chapter, if such person establishes a guaranty or undertaking signed by, and containing the name and address of, the manufacturer of the color additive, to the effect that such color additive was from a batch certified in accordance with the applicable regulations promulgated by the Secretary under this chapter; or (4) for having violated section 331(b), (c) or (k) of this title by failure to comply with section 352(f) of this title in respect to an article received in interstate commerce to which neither section 353(a) nor 353(b)(1) of this title is applicable, if the delivery or proffered delivery was made in good faith and the labeling at the time thereof contained the same directions for use and warning statements as were contained in the labeling at the time of such receipt of such article; or (5) for having violated section 331(i)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a drug being a counterfeit drug, or for having violated section 331(i)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the drug was a counterfeit drug."
  ]
  node [
    id 706
    label "section_333_subsection_f"
    class_name "subsection"
    text "(f) Violations related to devices"
  ]
  node [
    id 707
    label "section_333_subsection_f_item_1_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) to violations of section 351(a)(2)(A) of this title which involve one or more devices which are not defective."
  ]
  node [
    id 708
    label "section_333_subsection_f_item_4"
    class_name "item"
    text "(4) If any person fails to pay an assessment of a civil penalty&#8212;"
  ]
  node [
    id 709
    label "section_333_subsection_a_item_1"
    class_name "item"
    text "(1) Any person who violates a provision of section 331 of this title shall be imprisoned for not more than one year or fined not more than $1,000, or both."
  ]
  node [
    id 710
    label "section_333_subsection_a_item_2"
    class_name "item"
    text "(2) Notwithstanding the provisions of paragraph (1) of this section,1 if any person commits such a violation after a conviction of him under this section has become final, or commits such a violation with the intent to defraud or mislead, such person shall be imprisoned for not more than three years or fined not more than $10,000, or both."
  ]
  node [
    id 711
    label "section_333_subsection_f_item_4_subitem_B"
    class_name "subitem"
    text "(B) after a court in an action brought under paragraph (3) has entered a final judgment in favor of the Secretary,"
  ]
  node [
    id 712
    label "section_333_subsection_f_item_1"
    class_name "item"
    text "(1)(A) Except as provided in subparagraph (B), any person who violates a requirement of this chapter which relates to devices shall be liable to the United States for a civil penalty in an amount not to exceed $15,000 for each such violation, and not to exceed $1,000,000 for all such violations adjudicated in a single proceeding."
  ]
  node [
    id 713
    label "section_333_subsection_e"
    class_name "subsection"
    text "(e) Prohibited distribution of human growth hormone"
  ]
  node [
    id 714
    label "section_333_subsection_b"
    class_name "subsection"
    text "(b) Prescription drug marketing violations"
  ]
  node [
    id 715
    label "section_333_subsection_c"
    class_name "subsection"
    text "(c) Exceptions in certain cases of good faith, etc."
  ]
  node [
    id 716
    label "section_333_subsection_c_item_1"
    class_name "item"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section, (1) for having received in interstate commerce any article and delivered it or proffered delivery of it, if such delivery or proffer was made in good faith, unless he refuses to furnish on request of an officer or employee duly designated by the Secretary the name and address of the person from whom he purchased or received such article and copies of all documents, if any there be, pertaining to the delivery of the article to him; or (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect, in case of an alleged violation of section 331(a) of this title, that such article is not adulterated or misbranded, within the meaning of this chapter designating this chapter or to the effect, in case of an alleged violation of section 331(d) of this title, that such article is not an article which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce; or (3) for having violated section 331(a) of this title, where the violation exists because the article is adulterated by reason of containing a color additive not from a batch certified in accordance with regulations promulgated by the Secretary under this chapter, if such person establishes a guaranty or undertaking signed by, and containing the name and address of, the manufacturer of the color additive, to the effect that such color additive was from a batch certified in accordance with the applicable regulations promulgated by the Secretary under this chapter; or (4) for having violated section 331(b), (c) or (k) of this title by failure to comply with section 352(f) of this title in respect to an article received in interstate commerce to which neither section 353(a) nor 353(b)(1) of this title is applicable, if the delivery or proffered delivery was made in good faith and the labeling at the time thereof contained the same directions for use and warning statements as were contained in the labeling at the time of such receipt of such article; or (5) for having violated section 331(i)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a drug being a counterfeit drug, or for having violated section 331(i)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the drug was a counterfeit drug."
  ]
  node [
    id 717
    label "section_333_subsection_e_item_2"
    class_name "item"
    text "(2) Whoever commits any offense set forth in paragraph (1) and such offense involves an individual under 18 years of age is punishable by not more than 10 years imprisonment, such fines as are authorized by title 18, or both."
  ]
  node [
    id 718
    label "section_333_subsection_b_item_4_subitem_B"
    class_name "subitem"
    text "(B) If, in an action brought under paragraph (2) against a manufacturer or distributor relating to the conviction of a representative of such manufacturer or distributor for the sale, purchase, or trade of a drug or the offer to sell, purchase, or trade a drug, it is shown, by clear and convincing evidence&#8212;"
  ]
  node [
    id 719
    label "section_333_subsection_b_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) that the manufacturer or distributor conducted, before the institution of a criminal proceeding against such representative for the violation which resulted in such conviction, an investigation of events or transactions which would have led to the reporting of information leading to the institution of a criminal proceeding against, and conviction of, such representative for such purchase, sale, or trade or offer to purchase, sell, or trade, or"
  ]
  node [
    id 720
    label "section_333_subsection_d"
    class_name "subsection"
    text "(d) Exceptions involving misbranded food"
  ]
  node [
    id 721
    label "section_333_subsection_f_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) to any person who commits minor violations of section 360i(e) or 360i(f) of this title (only with respect to correction reports) if such person demonstrates substantial compliance with such section, or"
  ]
  node [
    id 722
    label "section_333_subsection_b_item_1_subitem_D"
    class_name "subitem"
    text "(D) knowingly distributing drugs in violation of section 353(e)(2)(A) of this title,"
  ]
  node [
    id 723
    label "section_333_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) knowingly importing a drug in violation of section 381(d)(1) of this title,"
  ]
  node [
    id 724
    label "section_333_subsection_f_item_2_subitem_B"
    class_name "subitem"
    text "(B) In determining the amount of a civil penalty, the Secretary shall take into account the nature, circumstances, extent, and gravity of the violation or violations and, with respect to the violator, ability to pay, effect on ability to continue to do business, any history of prior such violations, the degree of culpability, and such other matters as justice may require."
  ]
  node [
    id 725
    label "section_333_subsection_e_item_5"
    class_name "item"
    text "(5) The Drug Enforcement Administration is authorized to investigate offenses punishable by this subsection."
  ]
  node [
    id 726
    label "section_333_subsection_e_item_3"
    class_name "item"
    text "(3) Any conviction for a violation of paragraphs (1) and (2) of this subsection shall be considered a felony violation of the Controlled Substances Act [21 U.S.C. 801 et seq.] for the purposes of forfeiture under section 413 of such Act [21 U.S.C. 853]."
  ]
  node [
    id 727
    label "section_333_subsection_c_item_2"
    class_name "item"
    text "No person shall be subject to the penalties of subsection (a)(1) of this section, (1) for having received in interstate commerce any article and delivered it or proffered delivery of it, if such delivery or proffer was made in good faith, unless he refuses to furnish on request of an officer or employee duly designated by the Secretary the name and address of the person from whom he purchased or received such article and copies of all documents, if any there be, pertaining to the delivery of the article to him; or (2) for having violated section 331(a) or (d) of this title, if he establishes a guaranty or undertaking signed by, and containing the name and address of, the person residing in the United States from whom he received in good faith the article, to the effect, in case of an alleged violation of section 331(a) of this title, that such article is not adulterated or misbranded, within the meaning of this chapter designating this chapter or to the effect, in case of an alleged violation of section 331(d) of this title, that such article is not an article which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce; or (3) for having violated section 331(a) of this title, where the violation exists because the article is adulterated by reason of containing a color additive not from a batch certified in accordance with regulations promulgated by the Secretary under this chapter, if such person establishes a guaranty or undertaking signed by, and containing the name and address of, the manufacturer of the color additive, to the effect that such color additive was from a batch certified in accordance with the applicable regulations promulgated by the Secretary under this chapter; or (4) for having violated section 331(b), (c) or (k) of this title by failure to comply with section 352(f) of this title in respect to an article received in interstate commerce to which neither section 353(a) nor 353(b)(1) of this title is applicable, if the delivery or proffered delivery was made in good faith and the labeling at the time thereof contained the same directions for use and warning statements as were contained in the labeling at the time of such receipt of such article; or (5) for having violated section 331(i)(2) of this title if such person acted in good faith and had no reason to believe that use of the punch, die, plate, stone, or other thing involved would result in a drug being a counterfeit drug, or for having violated section 331(i)(3) of this title if the person doing the act or causing it to be done acted in good faith and had no reason to believe that the drug was a counterfeit drug."
  ]
  node [
    id 728
    label "section_333_subsection_b_item_2"
    class_name "item"
    text "the conviction of such representative shall not be considered as a conviction for purposes of paragraph (2)."
  ]
  node [
    id 729
    label "section_334_subsection_f"
    class_name "subsection"
    text "(f) Removal of case for trial"
  ]
  node [
    id 730
    label "section_334_subsection_a_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) is misbranded under section 343(a)(2) of this title because of its advertising, and"
  ]
  node [
    id 731
    label "section_334_subsection_a"
    class_name "subsection"
    text "(a) Grounds and jurisdiction"
  ]
  node [
    id 732
    label "section_334_subsection_g_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if not in final form for shipment, at the discretion of the manufacturer of the device for the purpose of completing the work required to put it in such form."
  ]
  node [
    id 733
    label "section_334_subsection_g_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) released by the Secretary, or"
  ]
  node [
    id 734
    label "section_334_subsection_g_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) in accordance with regulations prescribed by the Secretary, and"
  ]
  node [
    id 735
    label "section_334_subsection_a_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) Except as provided in subparagraph (B), no libel for condemnation may be instituted under paragraph (1) or (2) against any food which&#8212;"
  ]
  node [
    id 736
    label "section_334_subsection_g_item_2_subitem_B"
    class_name "subitem"
    text "(B) A device subject to a detention order under paragraph (1) may be moved&#8212;"
  ]
  node [
    id 737
    label "section_334_subsection_a_item_1"
    class_name "item"
    text "(1) Any article of food, drug, or cosmetic that is adulterated or misbranded when introduced into or while in interstate commerce or while held for sale (whether or not the first sale) after shipment in interstate commerce, or which may not, under the provisions of section 344 or 355 of this title, be introduced into interstate commerce, shall be liable to be proceeded against while in interstate commerce, or at any time thereafter, on libel of information and condemned in any district court of the United States or United States court of a Territory within the jurisdiction of which the article is found. No libel for condemnation shall be instituted under this chapter, for any alleged misbranding if there is pending in any court a libel for condemnation proceeding under this chapter based upon the same alleged misbranding, and not more than one such proceeding shall be instituted if no such proceeding is so pending, except that such limitations shall not apply (A) when such misbranding has been the basis of a prior judgment in favor of the United States, in a criminal, injunction, or libel for condemnation proceeding under this chapter, or (B) when the Secretary has probable cause to believe from facts found, without hearing, by him or any officer or employee of the Department that the misbranded article is dangerous to health, or that the labeling of the misbranded article is fraudulent, or would be in a material respect misleading to the injury or damage of the purchaser or consumer. In any case where the number of libel for condemnation proceedings is limited as above provided the proceeding pending or instituted shall, on application of the claimant, seasonably made, be removed for trial to any district agreed upon by stipulation between the parties, or, in case of failure to so stipulate within a reasonable time, the claimant may apply to the court of the district in which the seizure has been made, and such court (after giving the United States attorney for such district reasonable notice and opportunity to be heard) shall by order, unless good cause to the contrary is shown, specify a district of reasonable proximity to the claimant's principal place of business, to which the case shall be removed for trial."
  ]
  node [
    id 738
    label "section_334_subsection_a_item_3_subitem_i_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the owner or operator of such establishment used such advertising in the establishment to promote the sale of the food."
  ]
  node [
    id 739
    label "section_334_subsection_f_item_1"
    class_name "item"
    text "(1) The clerk of the court from which removal is made shall promptly transmit to the court in which the case is to be tried all records in the case necessary in order that such court may exercise jurisdiction."
  ]
  node [
    id 740
    label "section_334_subsection_g_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the expiration of the detention period applicable to such order,"
  ]
  node [
    id 741
    label "section_334_subsection_a_item_3_subitem_i_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) all or part of the cost of such advertising was paid by such owner or operator; and"
  ]
  node [
    id 742
    label "section_334_subsection_e"
    class_name "subsection"
    text "(e) Costs"
  ]
  node [
    id 743
    label "section_334_subsection_a_item_3"
    class_name "item"
    text "(3)(A) Except as provided in subparagraph (B), no libel for condemnation may be instituted under paragraph (1) or (2) against any food which&#8212;"
  ]
  node [
    id 744
    label "section_334_subsection_c"
    class_name "subsection"
    text "(c) Availability of samples of seized goods prior to trial"
  ]
  node [
    id 745
    label "section_334_subsection_g"
    class_name "subsection"
    text "(g) Administrative restraint; detention orders"
  ]
  node [
    id 746
    label "section_334_subsection_f_item_2"
    class_name "item"
    text "(2) The court to which such case was removed shall have the powers and be subject to the duties, for purposes of such case, which the court from which removal was made would have had, or to which such court would have been subject, if such case had not been removed."
  ]
  node [
    id 747
    label "section_334_subsection_a_item_3_subitem_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(i)(I) the food's advertising which resulted in the food being misbranded under section 343(a)(2) of this title was disseminated in the establishment in which the food is being held for sale to the ultimate consumer,"
  ]
  node [
    id 748
    label "section_334_subsection_a_item_2"
    class_name "item"
    text "(2) The following shall be liable to be proceeded against at any time on libel of information and condemned in any district court of the United States or United States court of a Territory within the jurisdiction of which they are found: (A) Any drug that is a counterfeit drug, (B) Any container of a counterfeit drug, (C) Any punch, die, plate, stone, labeling, container, or other thing used or designed for use in making a counterfeit drug or drugs, and (D) Any adulterated or misbranded device."
  ]
  node [
    id 749
    label "section_334_subsection_d_item_2"
    class_name "item"
    text "(2) The provisions of paragraph (1) of this subsection shall, to the extent deemed appropriate by the court, apply to any equipment or other thing which is not otherwise within the scope of such paragraph and which is referred to in paragraph (2) of subsection (a) of this section."
  ]
  node [
    id 750
    label "section_334_subsection_a_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) is being held for sale to the ultimate consumer in an establishment other than an establishment owned or operated by a manufacturer, packer, or distributor of the food."
  ]
  node [
    id 751
    label "section_334_subsection_d"
    class_name "subsection"
    text "(d) Disposition of goods after decree of condemnation; claims for remission or mitigation of forfeitures"
  ]
  node [
    id 752
    label "section_334_subsection_d_item_1"
    class_name "item"
    text "(1) Any food, drug, device, or cosmetic condemned under this section shall, after entry of the decree, be disposed of by destruction or sale as the court may, in accordance with the provisions of this section, direct and the proceeds thereof, if sold, less the legal costs and charges, shall be paid into the Treasury of the United States; but such article shall not be sold under such decree contrary to the provisions of this chapter or the laws of the jurisdiction in which sold. After entry of the decree and upon the payment of the costs of such proceedings and the execution of a good and sufficient bond conditioned that such article shall not be sold or disposed of contrary to the provisions of this chapter or the laws of any State or Territory in which sold, the court may by order direct that such article be delivered to the owner thereof to be destroyed or brought into compliance with the provisions of this chapter, under the supervision of an officer or employee duly designated by the Secretary, and the expenses of such supervision shall be paid by the person obtaining release of the article under bond. If the article was imported into the United States and the person seeking its release establishes (A) that the adulteration, misbranding, or violation did not occur after the article was imported, and (B) that he had no cause for believing that it was adulterated, misbranded, or in violation before it was released from customs custody, the court may permit the article to be delivered to the owner for exportation in lieu of destruction upon a showing by the owner that all of the conditions of section 381(e) of this title can and will be met. The provisions of this sentence shall not apply where condemnation is based upon violation of section 342(a)(1), (2), or (6), section 351(a)(3), section 352(j), or section 361(a) or (d) of this title. Where such exportation is made to the original foreign supplier, then paragraphs (1) and (2) of section 381(e) of this title and the preceding sentence shall not be applicable; and in all cases of exportation the bond shall be conditioned that the article shall not be sold or disposed of until the applicable conditions of section 381(e) of this title have been met. Any article condemned by reason of its being an article which may not, under section 344 or 355 of this title, be introduced into interstate commerce, shall be disposed of by destruction."
  ]
  node [
    id 753
    label "section_334_subsection_b_item_2"
    class_name "item"
    text "The article, equipment, or other thing proceeded against shall be liable to seizure by process pursuant to the libel, and the procedure in cases under this section shall conform, as nearly as may be, to the procedure in admiralty; except that on demand of either party any issue of fact joined in any such case shall be tried by jury. When libel for condemnation proceedings under this section, involving the same claimant and the same issues of adulteration or misbranding, are pending in two or more jurisdictions, such pending proceedings, upon application of the claimant seasonably made to the court of one such jurisdiction, shall be consolidated for trial by order of such court, and tried in (1) any district selected by the claimant where one of such proceedings is pending; or (2) a district agreed upon by stipulation between the parties. If no order for consolidation is so made within a reasonable time, the claimant may apply to the court of one such jurisdiction and such court (after giving the United States attorney for such district reasonable notice and opportunity to be heard) shall by order, unless good cause to the contrary is shown, specify a district of reasonable proximity to the claimant's principal place of business, in which all such pending proceedings shall be consolidated for trial and tried. Such order of consolidation shall not apply so as to require the removal of any case the date for trial of which has been fixed. The court granting such order shall give prompt notification thereof to the other courts having jurisdiction of the cases covered thereby."
  ]
  node [
    id 754
    label "section_334_subsection_b_item_1"
    class_name "item"
    text "The article, equipment, or other thing proceeded against shall be liable to seizure by process pursuant to the libel, and the procedure in cases under this section shall conform, as nearly as may be, to the procedure in admiralty; except that on demand of either party any issue of fact joined in any such case shall be tried by jury. When libel for condemnation proceedings under this section, involving the same claimant and the same issues of adulteration or misbranding, are pending in two or more jurisdictions, such pending proceedings, upon application of the claimant seasonably made to the court of one such jurisdiction, shall be consolidated for trial by order of such court, and tried in (1) any district selected by the claimant where one of such proceedings is pending; or (2) a district agreed upon by stipulation between the parties. If no order for consolidation is so made within a reasonable time, the claimant may apply to the court of one such jurisdiction and such court (after giving the United States attorney for such district reasonable notice and opportunity to be heard) shall by order, unless good cause to the contrary is shown, specify a district of reasonable proximity to the claimant's principal place of business, in which all such pending proceedings shall be consolidated for trial and tried. Such order of consolidation shall not apply so as to require the removal of any case the date for trial of which has been fixed. The court granting such order shall give prompt notification thereof to the other courts having jurisdiction of the cases covered thereby."
  ]
  node [
    id 755
    label "section_334_subsection_a_item_3_subitem_B"
    class_name "subitem"
    text "(B) A libel for condemnation may be instituted under paragraph (1) or (2) against a food described in subparagraph (A) if&#8212;"
  ]
  node [
    id 756
    label "section_334_subsection_a_item_3_subitem_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) such advertising was disseminated by, or under the direction of, the owner or operator of such establishment, or"
  ]
  node [
    id 757
    label "section_334_subsection_d_item_3"
    class_name "item"
    text "(3) Whenever in any proceeding under this section, involving paragraph (2) of subsection (a) of this section, the condemnation of any equipment or thing (other than a drug) is decreed, the court shall allow the claim of any claimant, to the extent of such claimant's interest, for remission or mitigation of such forfeiture if such claimant proves to the satisfaction of the court (i) that he has not committed or caused to be committed any prohibited act referred to in such paragraph (2) and has no interest in any drug referred to therein, (ii) that he has an interest in such equipment or other thing as owner or lienor or otherwise, acquired by him in good faith, and (iii) that he at no time had any knowledge or reason to believe that such equipment or other thing was being or would be used in, or to facilitate, the violation of laws of the United States relating to counterfeit drugs."
  ]
  node [
    id 758
    label "section_334_subsection_g_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Except as authorized by subparagraph (B), a device subject to a detention order issued under paragraph (1) shall not be moved by any person from the place at which it is ordered detained until&#8212;"
  ]
  node [
    id 759
    label "section_334_subsection_g_item_1"
    class_name "item"
    text "(1) If during an inspection conducted under section 374 of this title of a facility or a vehicle, a device which the officer or employee making the inspection has reason to believe is adulterated or misbranded is found in such facility or vehicle, such officer or employee may order the device detained (in accordance with regulations prescribed by the Secretary) for a reasonable period which may not exceed twenty days unless the Secretary determines that a period of detention greater than twenty days is required to institute an action under subsection (a) of this section or section 332 of this title, in which case he may authorize a detention period of not to exceed thirty days. Regulations of the Secretary prescribed under this paragraph shall require that before a device may be ordered detained under this paragraph the Secretary or an officer or employee designated by the Secretary approve such order. A detention order under this paragraph may require the labeling or marking of a device during the period of its detention for the purpose of identifying the device as detained. Any person who would be entitled to claim a device if it were seized under subsection (a) of this section may appeal to the Secretary a detention of such device under this paragraph. Within five days of the date an appeal of a detention is filed with the Secretary, the Secretary shall after affording opportunity for an informal hearing by order confirm the detention or revoke it."
  ]
  node [
    id 760
    label "section_334_subsection_b"
    class_name "subsection"
    text "(b) Procedure; multiplicity of pending proceedings"
  ]
  node [
    id 761
    label "section_334_subsection_a_item_3_subitem_i"
    class_name "subitem"
    text "(i)(I) the food's advertising which resulted in the food being misbranded under section 343(a)(2) of this title was disseminated in the establishment in which the food is being held for sale to the ultimate consumer,"
  ]
  node [
    id 762
    label "section_334_subsection_g_item_2"
    class_name "item"
    text "(2)(A) Except as authorized by subparagraph (B), a device subject to a detention order issued under paragraph (1) shall not be moved by any person from the place at which it is ordered detained until&#8212;"
  ]
  node [
    id 763
    label "section_335a_subsection_i_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "Any person that is debarred under subsection (a)(1) of this section (other than a person permanently debarred under subsection (c)(2)(A)(i) of this section) or any individual who is debarred under subsection (a)(2) of this section may apply to the Secretary for special termination of debarment under this subsection. Any information submitted to the Secretary under this subparagraph does not constitute an amendment or supplement to pending or approved abbreviated drug applications."
  ]
  node [
    id 764
    label "section_335a_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) a person other than an individual from submitting or assisting in the submission of any abbreviated drug application, or"
  ]
  node [
    id 765
    label "section_335a_subsection_i_item_1"
    class_name "item"
    text "Any person that is debarred under subsection (a)(1) of this section (other than a person permanently debarred under subsection (c)(2)(A)(i) of this section) or any individual who is debarred under subsection (a)(2) of this section may apply to the Secretary for special termination of debarment under this subsection. Any information submitted to the Secretary under this subparagraph does not constitute an amendment or supplement to pending or approved abbreviated drug applications."
  ]
  node [
    id 766
    label "section_335a_subsection_c_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) The period of debarment of a person (other than an individual) under subsection (a)(1) of this section shall not be less than 1 year or more than 10 years, but if an act leading to a subsequent debarment under subsection (a) of this section occurs within 10 years after such person has been debarred under subsection (a)(1) of this section, the period of debarment shall be permanent."
  ]
  node [
    id 767
    label "section_335a_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) an individual from providing services in any capacity to a person that has an approved or pending drug product application."
  ]
  node [
    id 768
    label "section_335a_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "If, at the end of the period described in subparagraph (A), the Secretary determines that a person has been criminally charged for an action described in subparagraph (B) of paragraph (1), the Secretary may extend the period of denial of approval of an application for a period not to exceed 18 months. The Secretary shall terminate such extension if the charges have been dismissed, if a judgment of acquittal has been entered, or if the Secretary determines that the finding described in subparagraph (A) was in error."
  ]
  node [
    id 769
    label "section_335a_subsection_a"
    class_name "subsection"
    text "(a) Mandatory debarment"
  ]
  node [
    id 770
    label "section_335a_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) the nature and extent of management participation in any offense involved, whether corporate policies and practices encouraged the offense, including whether inadequate institutional controls contributed to the offense,"
  ]
  node [
    id 771
    label "section_335a_subsection_j_item_2_subitem_B"
    class_name "subitem"
    text "Any person that is the subject of an adverse decision under clause (iii) or (iv) of subsection (b)(2)(B) of this section may obtain a review of such decision by the United States District Court for the District of Columbia or a district court of the United States for the district in which the person resides, by filing in such court (within 30 days following the date the person is notified of the Secretary's decision) a complaint requesting that the decision be modified or set aside. In such an action, the court shall determine the matter de novo."
  ]
  node [
    id 772
    label "section_335a_subsection_c_item_2_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) The period of debarment of any person under subsection (b)(2) of this section shall not be more than 5 years."
  ]
  node [
    id 773
    label "section_335a_subsection_b_item_1"
    class_name "item"
    text "The following persons are subject to debarment under paragraph (1):"
  ]
  node [
    id 774
    label "section_335a_subsection_f"
    class_name "subsection"
    text "(f) Temporary denial of approval"
  ]
  node [
    id 775
    label "section_335a_subsection_c_item_1_subitem_C"
    class_name "subitem"
    text "(C) shall, if the Secretary makes the finding described in paragraph (6) or (7) of section 335b(a) of this title, assess a civil penalty in accordance with section 335b of this title."
  ]
  node [
    id 776
    label "section_335a_subsection_f_item_1_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the Secretary determines that such finding was in error."
  ]
  node [
    id 777
    label "section_335a_subsection_g"
    class_name "subsection"
    text "(g) Suspension authority"
  ]
  node [
    id 778
    label "section_335a_subsection_i_item_4_subitem_A"
    class_name "subitem"
    text "(A) Application"
  ]
  node [
    id 779
    label "section_335a_subsection_i_subsubitem_iv_subsubsubitem_IV"
    class_name "subsubsubitem"
    text "(IV) did not report such actions, or did not cause such actions to be reported, to an officer, employee, or agent of the Department or to an appropriate law enforcement officer, or failed to take other appropriate action that would have ensured that the process for the regulation of drugs was not undermined, within a reasonable time after such agent first knew of such actions,"
  ]
  node [
    id 780
    label "section_335a_subsection_i"
    class_name "subsection"
    text "(i) Procedure"
  ]
  node [
    id 781
    label "section_335a_subsection_f_item_2_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the reliability of data in or concerning such person's abbreviated drug application."
  ]
  node [
    id 782
    label "section_335a_subsection_l_item_1"
    class_name "item"
    text "(1) Conviction"
  ]
  node [
    id 783
    label "section_335a_subsection_f_item_2_subitem_A"
    class_name "subitem"
    text "(A) In general"
  ]
  node [
    id 784
    label "section_335a_subsection_a_item_2"
    class_name "item"
    text "(2) Individuals"
  ]
  node [
    id 785
    label "section_335a_subsection_l_item_1_subitem_C"
    class_name "subitem"
    text "(C) when the person has entered into participation in a first offender, deferred adjudication, or other similar arrangement or program where judgment of conviction has been withheld."
  ]
  node [
    id 786
    label "section_335a_subsection_i_subitem_B"
    class_name "subitem"
    text "(B) Individuals"
  ]
  node [
    id 787
    label "section_335a_subsection_h_item_1_subitem_B"
    class_name "subitem"
    text "(B) changes in ownership, management, or operations&#8212;"
  ]
  node [
    id 788
    label "section_335a_subsection_g_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "The Secretary shall, on the Secretary's own initiative or in response to a petition, waive the suspension under paragraph (1) (involving an action described in paragraph (1)(A)(i)) with respect to any drug if the Secretary finds that such waiver is necessary to protect the public health because sufficient quantities of the drug would not otherwise be available. The Secretary shall act on any petition seeking action under this paragraph within 180 days of the date the petition is submitted to the Secretary."
  ]
  node [
    id 789
    label "section_335a_subsection_d_item_2"
    class_name "item"
    text "(2) Deadline"
  ]
  node [
    id 790
    label "section_335a_subsection_c_item_2_subitem_E"
    class_name "subitem"
    text "(E) whether the person to be debarred is able to present adequate evidence that current production of drugs subject to abbreviated drug applications and all pending abbreviated drug applications are free of fraud or material false statements, and"
  ]
  node [
    id 791
    label "section_335a_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) otherwise relating to the regulation of any drug product under this chapter,"
  ]
  node [
    id 792
    label "section_335a_subsection_e"
    class_name "subsection"
    text "(e) Publication and list of debarred persons"
  ]
  node [
    id 793
    label "section_335a_subsection_l"
    class_name "subsection"
    text "(l) Applicability"
  ]
  node [
    id 794
    label "section_335a_subsection_b_item_2"
    class_name "item"
    text "(2) Persons subject to permissive debarment"
  ]
  node [
    id 795
    label "section_335a_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) shall, during the period of a debarment under subsection (a)(2) or (b)(2)(B) of this section, debar an individual from providing services in any capacity to a person that has an approved or pending drug product application and shall not accept or review (other than in connection with an audit under this section) an abbreviated drug application from such individual, and"
  ]
  node [
    id 796
    label "section_335a_subsection_j_item_2_subsubitem_iv"
    class_name "subsubitem"
    text "Any person that is the subject of an adverse decision under clause (iii) or (iv) of subsection (b)(2)(B) of this section may obtain a review of such decision by the United States District Court for the District of Columbia or a district court of the United States for the district in which the person resides, by filing in such court (within 30 days following the date the person is notified of the Secretary's decision) a complaint requesting that the decision be modified or set aside. In such an action, the court shall determine the matter de novo."
  ]
  node [
    id 797
    label "section_335a_subsection_d_item_3"
    class_name "item"
    text "(3) Action by the Secretary"
  ]
  node [
    id 798
    label "section_335a_subsection_j"
    class_name "subsection"
    text "(j) Judicial review"
  ]
  node [
    id 799
    label "section_335a_subsection_i_item_2_subsubitem_ii"
    class_name "subsubitem"
    text "If the conviction which served as the basis for the debarment of an individual under subsection (a)(2) of this section or clause (i), (ii), (iii), or (iv) of subsection (b)(2)(B) of this section is reversed, the Secretary shall withdraw the order of debarment."
  ]
  node [
    id 800
    label "section_335a_subsection_j_item_2_subsubitem_iii"
    class_name "subsubitem"
    text "Any person that is the subject of an adverse decision under clause (iii) or (iv) of subsection (b)(2)(B) of this section may obtain a review of such decision by the United States District Court for the District of Columbia or a district court of the United States for the district in which the person resides, by filing in such court (within 30 days following the date the person is notified of the Secretary's decision) a complaint requesting that the decision be modified or set aside. In such an action, the court shall determine the matter de novo."
  ]
  node [
    id 801
    label "section_335a_subsection_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) terminating the debarment immediately, or"
  ]
  node [
    id 802
    label "section_335a_subsection_i_item_2_subitem_A"
    class_name "subitem"
    text "Upon an application submitted under subparagraph (A), the Secretary may take the action described in subparagraph (D) if the Secretary, after an informal hearing, finds that such individual has provided substantial assistance in the investigations or prosecutions of offenses which are described in subsection (a) or (b) of this section or which relate to any matter under the jurisdiction of the Food and Drug Administration."
  ]
  node [
    id 803
    label "section_335a_subsection_c"
    class_name "subsection"
    text "(c) Debarment period and considerations"
  ]
  node [
    id 804
    label "section_335a_subsection_l_item_2_subitem_B"
    class_name "subitem"
    text "Subsection (a) of this section, subparagraph (A) of subsection (b)(2) of this section, and clauses (i) and (ii) of subsection (b)(2)(B) of this section shall not apply to a conviction which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (a) or (b) of this section. Clauses (iii) and (iv) of subsection (b)(2)(B) of this section and subsections (f) and (g) of this section shall not apply to an act or action which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (b), (f), or (g) of this section. Clause (iv) of subsection (b)(2)(B) of this section shall not apply to an action which occurred before June 1, 1992. Subsection (k) of this section shall not apply to applications submitted to the Secretary before June 1, 1992."
  ]
  node [
    id 805
    label "section_335a_subsection_i_item_2_subitem_D"
    class_name "subitem"
    text "(D) Secretarial action"
  ]
  node [
    id 806
    label "section_335a_subsection_d_item_3_subitem_A"
    class_name "subitem"
    text "(A) Corporations"
  ]
  node [
    id 807
    label "section_335a_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) Corporations, partnerships, and associations"
  ]
  node [
    id 808
    label "section_335a_subsection_i_item_3_subsubitem_iii"
    class_name "subsubitem"
    text "An order of the Secretary under clause (iii) or (iv) of paragraph (2)(B) shall not take effect until 30 days after the order has been issued."
  ]
  node [
    id 809
    label "section_335a_subsection_i_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) Any high managerial agent whom the Secretary finds&#8212;"
  ]
  node [
    id 810
    label "section_335a_subsection_h_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) fully remedy the patterns or practices with respect to which the order was issued, and"
  ]
  node [
    id 811
    label "section_335a_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) relating to the development or approval, including the process for development or approval, of any drug product, or"
  ]
  node [
    id 812
    label "section_335a_subsection_i_subsubitem_iv_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) knew that the actions described in subclause (I) were violative of law, and"
  ]
  node [
    id 813
    label "section_335a_subsection_l_item_1_subitem_A"
    class_name "subitem"
    text "(A) when a judgment of conviction has been entered against the person by a Federal or State court, regardless of whether there is an appeal pending,"
  ]
  node [
    id 814
    label "section_335a_subsection_c_item_1"
    class_name "item"
    text "(1) Effect of debarment"
  ]
  node [
    id 815
    label "section_335a_subsection_c_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "In determining the appropriateness and the period of a debarment of a person under subsection (b) of this section and any period of debarment beyond the minimum specified in subparagraph (A)(i) of paragraph (2), the Secretary shall consider where applicable&#8212;"
  ]
  node [
    id 816
    label "section_335a_subsection_h_item_1"
    class_name "item"
    text "(1)(A) on the basis of an audit by the Food and Drug Administration or by experts acceptable to the Food and Drug Administration, or on the basis of other information, that the development, approval, manufacturing, and distribution of such drug is in substantial compliance with the applicable requirements of this chapter, and"
  ]
  node [
    id 817
    label "section_335a_subsection_i_item_2_subitem_D_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the person acted to mitigate any impact on the public of any offense involved, including the recall, or the discontinuation of the distribution, of any drug with respect to which the Secretary requested a recall or discontinuation of distribution due to concerns about the safety or efficacy of the drug."
  ]
  node [
    id 818
    label "section_335a_subsection_l_item_2_subsubitem_ii"
    class_name "subsubitem"
    text "Subsection (a) of this section, subparagraph (A) of subsection (b)(2) of this section, and clauses (i) and (ii) of subsection (b)(2)(B) of this section shall not apply to a conviction which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (a) or (b) of this section. Clauses (iii) and (iv) of subsection (b)(2)(B) of this section and subsections (f) and (g) of this section shall not apply to an act or action which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (b), (f), or (g) of this section. Clause (iv) of subsection (b)(2)(B) of this section shall not apply to an action which occurred before June 1, 1992. Subsection (k) of this section shall not apply to applications submitted to the Secretary before June 1, 1992."
  ]
  node [
    id 819
    label "section_335a_subsection_i_item_2_subsubitem_iii"
    class_name "subsubitem"
    text "If the conviction which served as the basis for the debarment of an individual under subsection (a)(2) of this section or clause (i), (ii), (iii), or (iv) of subsection (b)(2)(B) of this section is reversed, the Secretary shall withdraw the order of debarment."
  ]
  node [
    id 820
    label "section_335a_subsection_k_item_1"
    class_name "item"
    text "(1) a certification that the applicant did not and will not use in any capacity the services of any person debarred under subsection (a) or (b) of this section, in connection with such application, and"
  ]
  node [
    id 821
    label "section_335a_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(A) the nature and seriousness of any offense involved,"
  ]
  node [
    id 822
    label "section_335a_subsection_g_item_1_subitem_B"
    class_name "subitem"
    text "(B) such person is under an active investigation by a Federal authority in connection with a civil or criminal action involving conduct described in subparagraph (A),"
  ]
  node [
    id 823
    label "section_335a_subsection_i_item_3"
    class_name "item"
    text "The Secretary may not take any action under subsection (a), (b), (c), (d)(3), (g), or (h) of this section with respect to any person unless the Secretary has issued an order for such action made on the record after opportunity for an agency hearing on disputed issues of material fact. In the course of any investigation or hearing under this subsection, the Secretary may administer oaths and affirmations, examine witnesses, receive evidence, and issue subpoenas requiring the attendance and testimony of witnesses and the production of evidence that relates to the matter under investigation."
  ]
  node [
    id 824
    label "section_335a_subsection_c_item_2_subitem_F"
    class_name "subitem"
    text "(F) prior convictions under this chapter or under other Acts involving matters within the jurisdiction of the Food and Drug Administration."
  ]
  node [
    id 825
    label "section_335a_subsection_i_item_1_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) changes in ownership, management, or operations have fully corrected the causes of the offense involved and provide reasonable assurances that the offense will not occur in the future, and"
  ]
  node [
    id 826
    label "section_335a_subsection_h_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) on the basis of an audit by the Food and Drug Administration or by experts acceptable to the Food and Drug Administration, or on the basis of other information, that the development, approval, manufacturing, and distribution of such drug is in substantial compliance with the applicable requirements of this chapter, and"
  ]
  node [
    id 827
    label "section_335a_subsection_i_item_2_subitem_C"
    class_name "subitem"
    text "The action referred to in subparagraphs (B) and (C) is&#8212;"
  ]
  node [
    id 828
    label "section_335a_subsection_c_item_3"
    class_name "item"
    text "(3) Considerations"
  ]
  node [
    id 829
    label "section_335a_subsection_k_item_2"
    class_name "item"
    text "(2) if such application is an abbreviated drug application, a list of all convictions, described in subsections (a) and (b) of this section which occurred within the previous 5 years, of the applicant and affiliated persons responsible for the development or submission of such application."
  ]
  node [
    id 830
    label "section_335a_subsection_g_item_1"
    class_name "item"
    text "The Secretary shall, on the Secretary's own initiative or in response to a petition, waive the suspension under paragraph (1) (involving an action described in paragraph (1)(A)(i)) with respect to any drug if the Secretary finds that such waiver is necessary to protect the public health because sufficient quantities of the drug would not otherwise be available. The Secretary shall act on any petition seeking action under this paragraph within 180 days of the date the petition is submitted to the Secretary."
  ]
  node [
    id 831
    label "section_335a_subsection_f_item_1_subsubitem_i"
    class_name "subsubitem"
    text "(i) if the investigation with respect to which the finding was made does not result in a criminal charge against such person, if criminal charges have been brought and the charges have been dismissed, or if a judgment of acquittal has been entered, or"
  ]
  node [
    id 832
    label "section_335a_subsection_i_subsubitem_iv_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) worked for, or worked as a consultant for, the same person as another individual during the period in which such other individual took actions for which a felony conviction was obtained and which resulted in the debarment under subsection (a)(2) of this section, or clause (i), of such other individual,"
  ]
  node [
    id 833
    label "section_335a_subsection_f_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) has bribed or attempted to bribe, has paid or attempted to pay an illegal gratuity, or has induced or attempted to induce another person to bribe or pay an illegal gratuity to any officer, employee, or agent of the Department of Health and Human Services or to any other Federal, State, or local official in connection with any abbreviated drug application, or has conspired to commit, or aided or abetted, such actions, or"
  ]
  node [
    id 834
    label "section_335a_subsection_b"
    class_name "subsection"
    text "(b) Permissive debarment"
  ]
  node [
    id 835
    label "section_335a_subsection_c_item_2"
    class_name "item"
    text "In determining the appropriateness and the period of a debarment of a person under subsection (b) of this section and any period of debarment beyond the minimum specified in subparagraph (A)(i) of paragraph (2), the Secretary shall consider where applicable&#8212;"
  ]
  node [
    id 836
    label "section_335a_subsection_i_item_2_subitem_D_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the person fully cooperated with all investigations and promptly disclosed all wrongdoing to the appropriate authorities, and"
  ]
  node [
    id 837
    label "section_335a_subsection_i_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) in the case of an individual, limiting the period of debarment to less than permanent but to no less than 1 year,"
  ]
  node [
    id 838
    label "section_335a_subsection_i_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Application"
  ]
  node [
    id 839
    label "section_335a_subsection_l_item_2_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "Subsection (a) of this section, subparagraph (A) of subsection (b)(2) of this section, and clauses (i) and (ii) of subsection (b)(2)(B) of this section shall not apply to a conviction which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (a) or (b) of this section. Clauses (iii) and (iv) of subsection (b)(2)(B) of this section and subsections (f) and (g) of this section shall not apply to an act or action which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (b), (f), or (g) of this section. Clause (iv) of subsection (b)(2)(B) of this section shall not apply to an action which occurred before June 1, 1992. Subsection (k) of this section shall not apply to applications submitted to the Secretary before June 1, 1992."
  ]
  node [
    id 840
    label "section_335a_subsection_l_item_2"
    class_name "item"
    text "Subsection (a) of this section, subparagraph (A) of subsection (b)(2) of this section, and clauses (i) and (ii) of subsection (b)(2)(B) of this section shall not apply to a conviction which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (a) or (b) of this section. Clauses (iii) and (iv) of subsection (b)(2)(B) of this section and subsections (f) and (g) of this section shall not apply to an act or action which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (b), (f), or (g) of this section. Clause (iv) of subsection (b)(2)(B) of this section shall not apply to an action which occurred before June 1, 1992. Subsection (k) of this section shall not apply to applications submitted to the Secretary before June 1, 1992."
  ]
  node [
    id 841
    label "section_335a_subsection_i_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) a felony which is not described in subsection (a)(2) of this section or clause (i) of this subparagraph and which involves bribery, payment of illegal gratuities, fraud, perjury, false statement, racketeering, blackmail, extortion, falsification or destruction of records, or interference with, obstruction of an investigation into, or prosecution of, any criminal offense, or"
  ]
  node [
    id 842
    label "section_335a_subsection_i_item_4"
    class_name "item"
    text "(4) Special termination"
  ]
  node [
    id 843
    label "section_335a_subsection_g_item_1_subitem_A"
    class_name "subitem"
    text "The Secretary shall, on the Secretary's own initiative or in response to a petition, waive the suspension under paragraph (1) (involving an action described in paragraph (1)(A)(i)) with respect to any drug if the Secretary finds that such waiver is necessary to protect the public health because sufficient quantities of the drug would not otherwise be available. The Secretary shall act on any petition seeking action under this paragraph within 180 days of the date the petition is submitted to the Secretary."
  ]
  node [
    id 844
    label "section_335a_subsection_f_item_3"
    class_name "item"
    text "(3) Informal hearing"
  ]
  node [
    id 845
    label "section_335a_subsection_a_item_1"
    class_name "item"
    text "(1) Corporations, partnerships, and associations"
  ]
  node [
    id 846
    label "section_335a_subsection_f_item_1_subitem_C"
    class_name "subitem"
    text "Except as provided in subparagraph (B), a denial of approval of an application of a person under paragraph (1) shall be in effect for a period determined by the Secretary but not to exceed 18 months beginning on the date the Secretary finds that the conditions described in subparagraphs (A), (B), and (C) of paragraph (1) exist. The Secretary shall terminate such denial&#8212;"
  ]
  node [
    id 847
    label "section_335a_subsection_f_item_2"
    class_name "item"
    text "(2) Applicable period"
  ]
  node [
    id 848
    label "section_335a_subsection_d_item_1"
    class_name "item"
    text "The Secretary shall grant or deny any application respecting a debarment which is submitted under paragraph (1) within 180 days of the date the application is submitted."
  ]
  node [
    id 849
    label "section_335a_subsection_i_item_2_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) all individuals who were involved in the commission of the offense or who knew or should have known of the offense have been removed from employment involving the development or approval of any drug subject to sections 355 or 357 of this title,"
  ]
  node [
    id 850
    label "section_335a_subsection_f_item_2_subitem_B"
    class_name "subitem"
    text "Except as provided in subparagraph (B), a denial of approval of an application of a person under paragraph (1) shall be in effect for a period determined by the Secretary but not to exceed 18 months beginning on the date the Secretary finds that the conditions described in subparagraphs (A), (B), and (C) of paragraph (1) exist. The Secretary shall terminate such denial&#8212;"
  ]
  node [
    id 851
    label "section_335a_subsection_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) limiting the period of debarment to less than one year, and"
  ]
  node [
    id 852
    label "section_335a_subsection_l_item_2_subitem_A"
    class_name "subitem"
    text "Subsection (a) of this section, subparagraph (A) of subsection (b)(2) of this section, and clauses (i) and (ii) of subsection (b)(2)(B) of this section shall not apply to a conviction which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (a) or (b) of this section. Clauses (iii) and (iv) of subsection (b)(2)(B) of this section and subsections (f) and (g) of this section shall not apply to an act or action which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (b), (f), or (g) of this section. Clause (iv) of subsection (b)(2)(B) of this section shall not apply to an action which occurred before June 1, 1992. Subsection (k) of this section shall not apply to applications submitted to the Secretary before June 1, 1992."
  ]
  node [
    id 853
    label "section_335a_subsection_g_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) that a person has engaged in flagrant and repeated, material violations of good manufacturing practice or good laboratory practice in connection with the development, manufacturing, or distribution of one or more drugs approved under an abbreviated drug application during a 2-year period, and&#8212;"
  ]
  node [
    id 854
    label "section_335a_subsection_i_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) Any individual whom the Secretary finds materially participated in acts that were the basis for a conviction for an offense described in subsection (a) of this section or in clause (i) or (ii) for which a conviction was obtained, if the Secretary finds, on the basis of such participation and other information, that such individual has demonstrated a pattern of conduct sufficient to find that there is reason to believe that such individual may violate requirements under this chapter relating to drug products."
  ]
  node [
    id 855
    label "section_335a_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "In determining the appropriateness and the period of a debarment of a person under subsection (b) of this section and any period of debarment beyond the minimum specified in subparagraph (A)(i) of paragraph (2), the Secretary shall consider where applicable&#8212;"
  ]
  node [
    id 856
    label "section_335a_subsection_i_item_2_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(i) the person making the application under subparagraph (A) has demonstrated that the felony conviction which was the basis for such person's debarment involved the commission of an offense which was not authorized, requested, commanded, performed, or recklessly tolerated by the board of directors or by a high managerial agent acting on behalf of the person within the scope of the board's or agent's office or employment,"
  ]
  node [
    id 857
    label "section_335a_subsection_j_item_2"
    class_name "item"
    text "Any person that is the subject of an adverse decision under clause (iii) or (iv) of subsection (b)(2)(B) of this section may obtain a review of such decision by the United States District Court for the District of Columbia or a district court of the United States for the district in which the person resides, by filing in such court (within 30 days following the date the person is notified of the Secretary's decision) a complaint requesting that the decision be modified or set aside. In such an action, the court shall determine the matter de novo."
  ]
  node [
    id 858
    label "section_335a_subsection_i_item_1_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) sufficient audits, conducted by the Food and Drug Administration or by independent experts acceptable to the Food and Drug Administration, demonstrate that pending applications and the development of drugs being tested before the submission of an application are free of fraud or material false statements."
  ]
  node [
    id 859
    label "section_335a_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) shall not accept or review (other than in connection with an audit under this section) any abbreviated drug application submitted by or with the assistance of a person debarred under subsection (a)(1) or (b)(2)(A) of this section during the period such person is debarred,"
  ]
  node [
    id 860
    label "section_335a_subsection_k"
    class_name "subsection"
    text "(k) Certification"
  ]
  node [
    id 861
    label "section_335a_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "If, at the end of the period described in subparagraph (A), the Secretary determines that a person has been criminally charged for an action described in subparagraph (B) of paragraph (1), the Secretary may extend the period of denial of approval of an application for a period not to exceed 18 months. The Secretary shall terminate such extension if the charges have been dismissed, if a judgment of acquittal has been entered, or if the Secretary determines that the finding described in subparagraph (A) was in error."
  ]
  node [
    id 862
    label "section_335a_subsection_i_item_3_subsubitem_iv"
    class_name "subsubitem"
    text "An order of the Secretary under clause (iii) or (iv) of paragraph (2)(B) shall not take effect until 30 days after the order has been issued."
  ]
  node [
    id 863
    label "section_335a_subsection_i_item_2_subsubitem_iv"
    class_name "subsubitem"
    text "If the conviction which served as the basis for the debarment of an individual under subsection (a)(2) of this section or clause (i), (ii), (iii), or (iv) of subsection (b)(2)(B) of this section is reversed, the Secretary shall withdraw the order of debarment."
  ]
  node [
    id 864
    label "section_335a_subsection_c_item_2_subitem_D"
    class_name "subitem"
    text "(D) whether the extent to which changes in ownership, management, or operations have corrected the causes of any offense involved and provide reasonable assurances that the offense will not occur in the future,"
  ]
  node [
    id 865
    label "section_335a_subsection_g_item_2"
    class_name "item"
    text "(2) Public health waiver"
  ]
  node [
    id 866
    label "section_335a_subsection_i_item_1_subitem_B"
    class_name "subitem"
    text "(B) Individuals"
  ]
  node [
    id 867
    label "section_335a_subsection_g_item_1_subitem_A_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the causes of such violations have not been corrected within a reasonable period of time following notice of such violations by the Secretary, and"
  ]
  node [
    id 868
    label "section_335a_subsection_i_item_2_subitem_B"
    class_name "subitem"
    text "The action referred to in subparagraphs (B) and (C) is&#8212;"
  ]
  node [
    id 869
    label "section_335a_subsection_d"
    class_name "subsection"
    text "(d) Termination of debarment"
  ]
  node [
    id 870
    label "section_335a_subsection_f_item_2_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) the integrity of the approval process with respect to such abbreviated drug application, or"
  ]
  node [
    id 871
    label "section_335a_subsection_i_subsubitem_iv_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) had actual knowledge of the actions described in subclause (I) of such other individual, or took action to avoid such actual knowledge, or failed to take action for the purpose of avoiding such actual knowledge,"
  ]
  node [
    id 872
    label "section_335a_subsection_f_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) has knowingly made or caused to be made a pattern or practice of false statements or misrepresentations with respect to material facts relating to any abbreviated drug application, or the production of any drug subject to an abbreviated drug application, to any officer, employee, or agent of the Department of Health and Human Services, or has conspired to commit, or aided or abetted, such actions, and"
  ]
  node [
    id 873
    label "section_335a_subsection_l_item_2_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "Subsection (a) of this section, subparagraph (A) of subsection (b)(2) of this section, and clauses (i) and (ii) of subsection (b)(2)(B) of this section shall not apply to a conviction which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (a) or (b) of this section. Clauses (iii) and (iv) of subsection (b)(2)(B) of this section and subsections (f) and (g) of this section shall not apply to an act or action which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (b), (f), or (g) of this section. Clause (iv) of subsection (b)(2)(B) of this section shall not apply to an action which occurred before June 1, 1992. Subsection (k) of this section shall not apply to applications submitted to the Secretary before June 1, 1992."
  ]
  node [
    id 874
    label "section_335a_subsection_f_item_2_subitem_C"
    class_name "subitem"
    text "(C) if a significant question has been raised regarding&#8212;"
  ]
  node [
    id 875
    label "section_335a_subsection_c_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) The debarment of an individual under subsection (a)(2) of this section shall be permanent."
  ]
  node [
    id 876
    label "section_335a_subsection_l_item_1_subitem_B"
    class_name "subitem"
    text "(B) when a plea of guilty or nolo contendere by the person has been accepted by a Federal or State court, or"
  ]
  node [
    id 877
    label "section_335a_subsection_i_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Application"
  ]
  node [
    id 878
    label "section_335a_subsection_j_item_1"
    class_name "item"
    text "(1) In general"
  ]
  node [
    id 879
    label "section_335a_subsection_h"
    class_name "subsection"
    text "(h) Termination of suspension"
  ]
  node [
    id 880
    label "section_335a_subsection_i_item_2_subsubitem_i"
    class_name "subsubitem"
    text "If the conviction which served as the basis for the debarment of an individual under subsection (a)(2) of this section or clause (i), (ii), (iii), or (iv) of subsection (b)(2)(B) of this section is reversed, the Secretary shall withdraw the order of debarment."
  ]
  node [
    id 881
    label "section_335a_subsection_i_item_2"
    class_name "item"
    text "Any person that is debarred under subsection (a)(1) of this section (other than a person permanently debarred under subsection (c)(2)(A)(i) of this section) or any individual who is debarred under subsection (a)(2) of this section may apply to the Secretary for special termination of debarment under this subsection. Any information submitted to the Secretary under this subparagraph does not constitute an amendment or supplement to pending or approved abbreviated drug applications."
  ]
  node [
    id 882
    label "section_335a_subsection_i_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) a conspiracy to commit, or aiding or abetting, such felony,"
  ]
  node [
    id 883
    label "section_335a_subsection_l_item_2_subsubitem_i"
    class_name "subsubitem"
    text "Subsection (a) of this section, subparagraph (A) of subsection (b)(2) of this section, and clauses (i) and (ii) of subsection (b)(2)(B) of this section shall not apply to a conviction which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (a) or (b) of this section. Clauses (iii) and (iv) of subsection (b)(2)(B) of this section and subsections (f) and (g) of this section shall not apply to an act or action which occurred more than 5 years before the initiation of an agency action proposed to be taken under subsection (b), (f), or (g) of this section. Clause (iv) of subsection (b)(2)(B) of this section shall not apply to an action which occurred before June 1, 1992. Subsection (k) of this section shall not apply to applications submitted to the Secretary before June 1, 1992."
  ]
  node [
    id 884
    label "section_335a_subsection_h_item_2"
    class_name "item"
    text "(2) the initial determination was in error."
  ]
  node [
    id 885
    label "section_335a_subsection_h_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) provide reasonable assurances that such actions will not occur in the future, or"
  ]
  node [
    id 886
    label "section_335a_subsection_f_item_1"
    class_name "item"
    text "Within 10 days of the date an order is issued under paragraph (1), the Secretary shall provide such person with an opportunity for an informal hearing, to be held within such 10 days, on the decision of the Secretary to refuse approval of an abbreviated drug application. Within 60 days of the date on which such hearing is held, the Secretary shall notify the person given such hearing whether the Secretary's refusal of approval will be continued, terminated, or otherwise modified. Such notification shall be final agency action."
  ]
  node [
    id 887
    label "section_335a_subsection_c_item_2_subitem_C"
    class_name "subitem"
    text "(C) the nature and extent of voluntary steps to mitigate the impact on the public of any offense involved, including the recall or the discontinuation of the distribution of suspect drugs, full cooperation with any investigations (including the extent of disclosure to appropriate authorities of all wrongdoing), the relinquishing of profits on drug approvals fraudulently obtained, and any other actions taken to substantially limit potential or actual adverse effects on the public health,"
  ]
  node [
    id 888
    label "section_335a_subsection_g_item_1_subitem_A_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) such violations may undermine the safety and efficacy of such drugs, and"
  ]
  node [
    id 889
    label "section_335b_subsection_e_item_2"
    class_name "item"
    text "(2) one-half of the penalty so imposed and collected,"
  ]
  node [
    id 890
    label "section_335b_subsection_a_item_6_subitem_A"
    class_name "subitem"
    text "(A) employed or retained as a consultant or contractor, or"
  ]
  node [
    id 891
    label "section_335b_subsection_e_item_1"
    class_name "item"
    text "(1) $250,000, or"
  ]
  node [
    id 892
    label "section_335b_subsection_a_item_4"
    class_name "item"
    text "(4) knowingly failed to disclose, to an officer or employee of the Department of Health and Human Services, a material fact which such person had an obligation to disclose relating to any drug subject to an abbreviated drug application,"
  ]
  node [
    id 893
    label "section_335b_subsection_c"
    class_name "subsection"
    text "(c) Judicial review"
  ]
  node [
    id 894
    label "section_335b_subsection_a_item_1"
    class_name "item"
    text "(1) knowingly made or caused to be made, to any officer, employee, or agent of the Department of Health and Human Services, a false statement or misrepresentation of a material fact in connection with an abbreviated drug application,"
  ]
  node [
    id 895
    label "section_335b_subsection_b_item_3"
    class_name "item"
    text "(3) Limitation on actions"
  ]
  node [
    id 896
    label "section_335b_subsection_a_item_5"
    class_name "item"
    text "(5) knowingly obstructed an investigation of the Department of Health and Human Services into any drug subject to an abbreviated drug application,"
  ]
  node [
    id 897
    label "section_335b_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "In lieu of a proceeding under subparagraph (A), the Attorney General may, upon request of the Secretary, institute a civil action to recover a civil money penalty in the amount and for any of the acts set forth in subsection (a) of this section. Such an action may be instituted separately from or in connection with any other claim, civil or criminal, initiated by the Attorney General under this chapter."
  ]
  node [
    id 898
    label "section_335b_subsection_a_item_2"
    class_name "item"
    text "(2) bribed or attempted to bribe or paid or attempted to pay an illegal gratuity to any officer, employee, or agent of the Department of Health and Human Services in connection with an abbreviated drug application,"
  ]
  node [
    id 899
    label "section_335b_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "Any person that is the subject of an adverse decision under subsection (b)(1)(A) of this section may obtain a review of such decision by the United States Court of Appeals for the District of Columbia or for the circuit in which the person resides, by filing in such court (within 60 days following the date the person is notified of the Secretary's decision) a petition requesting that the decision be modified or set aside."
  ]
  node [
    id 900
    label "section_335b_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 901
    label "section_335b_subsection_b"
    class_name "subsection"
    text "(b) Procedure"
  ]
  node [
    id 902
    label "section_335b_subsection_d"
    class_name "subsection"
    text "(d) Recovery of penalties"
  ]
  node [
    id 903
    label "section_335b_subsection_a_item_7"
    class_name "item"
    text "(7) is an individual debarred under section 335a of this title and, during the period of debarment, provided services in any capacity to a person that had an approved or pending drug product application,"
  ]
  node [
    id 904
    label "section_335b_subsection_a_item_3"
    class_name "item"
    text "(3) destroyed, altered, removed, or secreted, or procured the destruction, alteration, removal, or secretion of, any material document or other material evidence which was the property of or in the possession of the Department of Health and Human Services for the purpose of interfering with that Department's discharge of its responsibilities in connection with an abbreviated drug application,"
  ]
  node [
    id 905
    label "section_335b_subsection_e"
    class_name "subsection"
    text "(e) Informants"
  ]
  node [
    id 906
    label "section_335b_subsection_b_item_3_subitem_A"
    class_name "subitem"
    text "(A) with respect to any act described in subsection (a) of this section that occurred before May 13, 1992, or"
  ]
  node [
    id 907
    label "section_335b_subsection_b_item_1"
    class_name "item"
    text "In determining the amount of a civil penalty under paragraph (1), the Secretary or the court shall take into account the nature, circumstances, extent, and gravity of the act subject to penalty, the person's ability to pay, the effect on the person's ability to continue to do business, any history of prior, similar acts, and such other matters as justice may require."
  ]
  node [
    id 908
    label "section_335b_subsection_c_item_1"
    class_name "item"
    text "Any person that is the subject of an adverse decision under subsection (b)(1)(A) of this section may obtain a review of such decision by the United States Court of Appeals for the District of Columbia or for the circuit in which the person resides, by filing in such court (within 60 days following the date the person is notified of the Secretary's decision) a petition requesting that the decision be modified or set aside."
  ]
  node [
    id 909
    label "section_335b_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) Action by the Attorney General"
  ]
  node [
    id 910
    label "section_335b_subsection_d_item_1"
    class_name "item"
    text "The Attorney General may recover any civil penalty (plus interest at the currently prevailing rates from the date the penalty became final) assessed under subsection (b)(1)(A) of this section in an action brought in the name of the United States. The amount of such penalty may be deducted, when the penalty has become final, from any sums then or later owing by the United States to the person against whom the penalty has been assessed. In an action brought under this subsection, the validity, amount, and appropriateness of the penalty shall not be subject to judicial review."
  ]
  node [
    id 911
    label "section_335b_subsection_b_item_3_subitem_B"
    class_name "subitem"
    text "(B) more than 6 years after the date when facts material to the act are known or reasonably should have been known by the Secretary but in no event more than 10 years after the date the act took place."
  ]
  node [
    id 912
    label "section_335b_subsection_a_item_6_subitem_B"
    class_name "subitem"
    text "(B) otherwise used in any capacity the services of,"
  ]
  node [
    id 913
    label "section_335b_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "The Attorney General may recover any civil penalty (plus interest at the currently prevailing rates from the date the penalty became final) assessed under subsection (b)(1)(A) of this section in an action brought in the name of the United States. The amount of such penalty may be deducted, when the penalty has become final, from any sums then or later owing by the United States to the person against whom the penalty has been assessed. In an action brought under this subsection, the validity, amount, and appropriateness of the penalty shall not be subject to judicial review."
  ]
  node [
    id 914
    label "section_335b_subsection_b_item_2"
    class_name "item"
    text "(2) Amount"
  ]
  node [
    id 915
    label "section_335b_subsection_a_item_6"
    class_name "item"
    text "(6) is a person that has an approved or pending drug product application and has knowingly&#8212;"
  ]
  node [
    id 916
    label "section_335c_subsection_b"
    class_name "subsection"
    text "(b) Procedure"
  ]
  node [
    id 917
    label "section_335c_subsection_a_item_1"
    class_name "item"
    text "(1) shall withdraw approval of an abbreviated drug application if the Secretary finds that the approval was obtained, expedited, or otherwise facilitated through bribery, payment of an illegal gratuity, or fraud or material false statement, and"
  ]
  node [
    id 918
    label "section_335c_subsection_a_item_2"
    class_name "item"
    text "(2) may withdraw approval of an abbreviated drug application if the Secretary finds that the applicant has repeatedly demonstrated a lack of ability to produce the drug for which the application was submitted in accordance with the formulations or manufacturing practice set forth in the abbreviated drug application and has introduced, or attempted to introduce, such adulterated or misbranded drug into commerce."
  ]
  node [
    id 919
    label "section_335c_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 920
    label "section_335c_subsection_d"
    class_name "subsection"
    text "(d) Judicial review"
  ]
  node [
    id 921
    label "section_335c_subsection_c"
    class_name "subsection"
    text "(c) Applicability"
  ]
  node [
    id 922
    label "section_337_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) before 30 days after the State has given notice to the Secretary that the State intends to bring such proceeding,"
  ]
  node [
    id 923
    label "section_337_subsection_b"
    class_name "subsection"
    text "(b)(1) A State may bring in its own name and within its jurisdiction proceedings for the civil enforcement, or to restrain violations, of section 341, 343(b), 343(c), 343(d), 343(e), 343(f), 343(g), 343(h), 343(i), 343(k), 343(q), or 343(r) of this title if the food that is the subject of the proceedings is located in the State."
  ]
  node [
    id 924
    label "section_337_subsection_b_item_1"
    class_name "item"
    text "(b)(1) A State may bring in its own name and within its jurisdiction proceedings for the civil enforcement, or to restrain violations, of section 341, 343(b), 343(c), 343(d), 343(e), 343(f), 343(g), 343(h), 343(i), 343(k), 343(q), or 343(r) of this title if the food that is the subject of the proceedings is located in the State."
  ]
  node [
    id 925
    label "section_337_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) before 90 days after the State has given notice to the Secretary of such intent if the Secretary has, within such 30 days, commenced an informal or formal enforcement action pertaining to the food which would be the subject of such proceeding, or"
  ]
  node [
    id 926
    label "section_337_subsection_b_item_2"
    class_name "item"
    text "(2) No proceeding may be commenced by a State under paragraph (1)&#8212;"
  ]
  node [
    id 927
    label "section_337_subsection_b_item_2_subitem_C"
    class_name "subitem"
    text "In any court proceeding described in subparagraph (C), a State may intervene as a matter of right."
  ]
  node [
    id 928
    label "section_337_subsection_a"
    class_name "subsection"
    text "(a) Except as provided in subsection (b) of this section, all such proceedings for the enforcement, or to restrain violations, of this chapter shall be by and in the name of the United States. Subpoenas for witnesses who are required to attend a court of the United States, in any district, may run into any other district in any proceeding under this section."
  ]
  node [
    id 929
    label "section_342_subsection_f_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if no conditions of use are suggested or recommended in the labeling, under ordinary conditions of use;"
  ]
  node [
    id 930
    label "section_342_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) is a new dietary ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury;"
  ]
  node [
    id 931
    label "section_342_subsection_a_item_1"
    class_name "item"
    text "(1) If it bears or contains any poisonous or deleterious substance which may render it injurious to health; but in case the substance is not an added substance such food shall not be considered adulterated under this clause if the quantity of such substance in such food does not ordinarily render it injurious to health.1 (2)(A) if it bears or contains any added poisonous or added deleterious substance (other than one which is (i) a pesticide chemical in or on a raw agricultural commodity; (ii) a food additive; (iii) a color additive; or (iv) a new animal drug) which is unsafe within the meaning of section 346 of this title, or (B) if it is a raw agricultural commodity and it bears or contains a pesticide chemical which is unsafe within the meaning of section 346a(a) of this title, or (C) if it is, or if it bears or contains, any food additive which is unsafe within the meaning of section 348 of this title: Provided, That where a pesticide chemical has been used in or on a raw agricultural commodity in conformity with an exemption granted or a tolerance prescribed under section 346a of this title and such raw agricultural commodity has been subjected to processing such as canning, cooking, freezing, dehydrating, or milling, the residue of such pesticide chemical remaining in or on such processed food shall, notwithstanding the provisions of sections 346 and 348 of this title, not be deemed unsafe if such residue in or on the raw agricultural commodity has been removed to the extent possible in good manufacturing practice and the concentration of such residue in the processed food when ready to eat is not greater than the tolerance prescribed for the raw agricultural commodity, or (D) if it is, or it bears or contains, a new animal drug (or conversion product thereof) which is unsafe within the meaning of section 360b of this title; (3) If&#160;2 it consists in whole or in part of any filthy, putrid, or decomposed substance, or if it is otherwise unfit for food; or (4) if it has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health; or (5) if it is, in whole or in part, the product of a diseased animal or of an animal which has died otherwise than by slaughter; or (6) if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health; or (7) if it has been intentionally subjected to radiation, unless the use of the radiation was in conformity with a regulation or exemption in effect pursuant to section 348 of this title."
  ]
  node [
    id 932
    label "section_342_subsection_d_item_3"
    class_name "item"
    text "(3) bears or contains any nonnutritive substance, except that this subparagraph shall not apply to a safe nonnutritive substance which is in or on confectionery by reason of its use for some practical functional purpose in the manufacture, packaging, or storage of such confectionery if the use of the substance does not promote deception of the consumer or otherwise result in adulteration or misbranding in violation of any provision of this chapter, except that the Secretary may, for the purpose of avoiding or resolving uncertainty as to the application of this subparagraph, issue regulations allowing or prohibiting the use of particular nonnutritive substances."
  ]
  node [
    id 933
    label "section_342_subsection_g_item_2"
    class_name "item"
    text "(2) The Secretary may by regulation prescribe good manufacturing practices for dietary supplements. Such regulations shall be modeled after current good manufacturing practice regulations for food and may not impose standards for which there is no current and generally available analytical methodology. No standard of current good manufacturing practice may be imposed unless such standard is included in a regulation promulgated after notice and opportunity for comment in accordance with chapter 5 of title 5."
  ]
  node [
    id 934
    label "section_342_subsection_e"
    class_name "subsection"
    text "(e) Oleomargarine containing filthy, putrid, etc., matter"
  ]
  node [
    id 935
    label "section_342_subsection_b"
    class_name "subsection"
    text "(b) Absence, substitution, or addition of constituents"
  ]
  node [
    id 936
    label "section_342_subsection_d_item_2"
    class_name "item"
    text "(2) bears or contains any alcohol other than alcohol not in excess of one-half of 1 per centum by volume derived solely from the use of flavoring extracts, except that this clause shall not apply to confectionery which is introduced or delivered for introduction into, or received or held for sale in, interstate commerce if the sale of such confectionery is permitted under the laws of the State in which such confectionery is intended to be offered for sale;"
  ]
  node [
    id 937
    label "section_342_subsection_f_item_1"
    class_name "item"
    text "(1) If it is a dietary supplement or contains a dietary ingredient that&#8212;"
  ]
  node [
    id 938
    label "section_342_subsection_f_item_1_subitem_C"
    class_name "subitem"
    text "(C) the Secretary declares to pose an imminent hazard to public health or safety, except that the authority to make such declaration shall not be delegated and the Secretary shall promptly after such a declaration initiate a proceeding in accordance with sections 554 and 556 of title 5 to affirm or withdraw the declaration; or"
  ]
  node [
    id 939
    label "section_342_subsection_f"
    class_name "subsection"
    text "(f) Dietary supplement or ingredient: safety"
  ]
  node [
    id 940
    label "section_342_subsection_g"
    class_name "subsection"
    text "(g) Dietary supplement: manufacturing practices"
  ]
  node [
    id 941
    label "section_342_subsection_g_item_1"
    class_name "item"
    text "(1) If it is a dietary supplement and it has been prepared, packed, or held under conditions that do not meet current good manufacturing practice regulations, including regulations requiring, when necessary, expiration date labeling, issued by the Secretary under subparagraph (2)."
  ]
  node [
    id 942
    label "section_342_subsection_d"
    class_name "subsection"
    text "(d) Confectionery containing alcohol or nonnutritive substance"
  ]
  node [
    id 943
    label "section_342_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(A) presents a significant or unreasonable risk of illness or injury under&#8212;"
  ]
  node [
    id 944
    label "section_342_subsection_f_item_2"
    class_name "item"
    text "(2) Before the Secretary may report to a United States attorney a violation of paragraph&#160;3 (1)(A) for a civil proceeding, the person against whom such proceeding would be initiated shall be given appropriate notice and the opportunity to present views, orally and in writing, at least 10 days before such notice, with regard to such proceeding."
  ]
  node [
    id 945
    label "section_342_subsection_b_item_1"
    class_name "item"
    text "(1) If any valuable constituent has been in whole or in part omitted or abstracted therefrom; or (2) if any substance has been substituted wholly or in part therefor; or (3) if damage or inferiority has been concealed in any manner; or (4) if any substance has been added thereto or mixed or packed therewith so as to increase its bulk or weight, or reduce its quality or strength, or make it appear better or of greater value than it is."
  ]
  node [
    id 946
    label "section_342_subsection_f_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) conditions of use recommended or suggested in labeling, or"
  ]
  node [
    id 947
    label "section_342_subsection_c"
    class_name "subsection"
    text "(c) Color additives"
  ]
  node [
    id 948
    label "section_342_subsection_d_item_1"
    class_name "item"
    text "(1) has partially or completely imbedded therein any nonnutritive object, except that this subparagraph shall not apply in the case of any nonnutritive object if, in the judgment of the Secretary as provided by regulations, such object is of practical functional value to the confectionery product and would not render the product injurious or hazardous to health;"
  ]
  node [
    id 949
    label "section_342_subsection_a"
    class_name "subsection"
    text "(a) Poisonous, insanitary, etc., ingredients"
  ]
  node [
    id 950
    label "section_342_subsection_f_item_1_subitem_D"
    class_name "subitem"
    text "(D) is or contains a dietary ingredient that renders it adulterated under paragraph (a)(1) under the conditions of use recommended or suggested in the labeling of such dietary supplement."
  ]
  node [
    id 951
    label "section_343_subsection_h_item_2"
    class_name "item"
    text "(2) a food for which a standard or standards of fill of container have been prescribed by regulations as provided by section 341 of this title, and it falls below the standard of fill of container applicable thereto, unless its label bears, in such manner and form as such regulations specify, a statement that it falls below such standard."
  ]
  node [
    id 952
    label "section_343_subsection_p_item_2"
    class_name "item"
    text "(2) Each manufacturer of food which contains saccharin and which is offered for sale by retail establishments but not for immediate consumption shall, in accordance with regulations promulgated by the Secretary pursuant to subparagraph (4), take such action as may be necessary to provide such retail establishments with the notice required by subparagraph (1)."
  ]
  node [
    id 953
    label "section_343_subsection_v_subsubitem_iv"
    class_name "subsubitem"
    text "(vi) For purposes of subclauses (i), (ii), (iii), (iv), and (v)&#8212;"
  ]
  node [
    id 954
    label "section_343_subsection_i_subitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(ii)(I) fails to have the identity and strength that the supplement is represented to have; or"
  ]
  node [
    id 955
    label "section_343_subsection_q_item_4_subitem_D_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) Regulations issued under subclause (i) shall permit the required information to be provided in each area of an establishment in which raw agricultural commodities and raw fish are offered for sale. The regulations shall permit food retailers to display the required information by supplying copies of the information provided by the Secretary, by making the information available in brochure, notebook or leaflet form, or by posting a sign disclosing the information. Such regulations shall also permit presentation of the required information to be supplemented by a video, live demonstration, or other media which the Secretary approves."
  ]
  node [
    id 956
    label "section_343_subsection_r_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Except as provided in subparagraphs (4)(A)(ii) and (4)(A)(iii) and clauses (A) through (C) of subparagraph (5), a claim described in subparagraph (1)(A)&#8212;"
  ]
  node [
    id 957
    label "section_343_subsection_v_subitem_E_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) During the 12-month period after the applicable date referred to in this sentence, the requirements of subparagraphs (1) and (2) shall not apply to any food product which was first introduced into interstate commerce before May 8, 1994, if the labeling for such product does not provide nutrition information or make a claim subject to paragraph (r), if such person provided the notice described in subclause (iii), and if&#8212;"
  ]
  node [
    id 958
    label "section_343_subsection_r_item_2_subitem_A_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the Secretary by regulation permits such a statement on the basis of a finding that such a statement would assist consumers in maintaining healthy dietary practices and the statement discloses that the nutrient is not usually present in the food,"
  ]
  node [
    id 959
    label "section_343_subsection_i_subitem_E"
    class_name "subitem"
    text "(E) the supplement&#8212;"
  ]
  node [
    id 960
    label "section_343_subsection_g_item_1"
    class_name "item"
    text "If it purports to be or is represented as a food for which a definition and standard of identity has been prescribed by regulations as provided by section 341 of this title, unless (1) it conforms to such definition and standard, and (2) its label bears the name of the food specified in the definition and standard, and, insofar as may be required by such regulations, the common names of optional ingredients (other than spices, flavoring, and coloring) present in such food."
  ]
  node [
    id 961
    label "section_343_subsection_v_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) if the claim meets the requirements of the regulations of the Secretary promulgated under clause (B), and"
  ]
  node [
    id 962
    label "section_343_subsection_a_item_1"
    class_name "item"
    text "If (1) its labeling is false or misleading in any particular, or (2) in the case of a food to which section 350 of this title applies, its advertising is false or misleading in a material respect or its labeling is in violation of section 350(b)(2) of this title."
  ]
  node [
    id 963
    label "section_343_subsection_v_subsubitem_v"
    class_name "subsubitem"
    text "(vi) For purposes of subclauses (i), (ii), (iii), (iv), and (v)&#8212;"
  ]
  node [
    id 964
    label "section_343_subsection_p"
    class_name "subsection"
    text "(p) Saccharin not for immediate consumption"
  ]
  node [
    id 965
    label "section_343_subsection_q_item_3"
    class_name "item"
    text "(3) For food that is received in bulk containers at a retail establishment, the Secretary may, by regulation, provide that the nutrition information required by subparagraphs (1) and (2) be displayed at the location in the retail establishment at which the food is offered for sale."
  ]
  node [
    id 966
    label "section_343_subsection_i_subitem_C"
    class_name "subitem"
    text "(C) the supplement contains an ingredient described in section 321(ff)(1)(C) of this title, and the label or labeling of the supplement fails to identify any part of the plant from which the ingredient is derived;"
  ]
  node [
    id 967
    label "section_343_subsection_r_item_2_subitem_A_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the label or labeling of the food discloses the level of such fat or saturated fat in immediate proximity to such claim and with appropriate prominence which shall be no less than one-half the size of the claim with respect to the level of cholesterol,"
  ]
  node [
    id 968
    label "section_343_subsection_o"
    class_name "subsection"
    text "(o) Saccharin for immediate consumption"
  ]
  node [
    id 969
    label "section_343_subsection_v_subitem_E_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) The notice referred to in subclauses (i) and (ii) shall be given to the Secretary prior to the beginning of the period during which the exemption under subclause (i) or (ii) is to be in effect, shall state that the person claiming such exemption for a food product has complied with the applicable requirements of subclause (i) or (ii), and shall&#8212;"
  ]
  node [
    id 970
    label "section_343_subsection_q_item_4_subitem_B"
    class_name "subitem"
    text "(B)(i) Upon the expiration of 12 months after November 8, 1990, the Secretary, after providing an opportunity for comment, shall issue guidelines for food retailers offering raw agricultural commodities or raw fish to provide nutrition information specified in subparagraphs (1) and (2). Such guidelines shall take into account the actions taken by food retailers during such 12-month period to provide to consumers nutrition information on raw agricultural commodities and raw fish. Such guidelines shall only apply&#8212;"
  ]
  node [
    id 971
    label "section_343_subsection_r_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) may not state the absence of a nutrient unless&#8212;"
  ]
  node [
    id 972
    label "section_343_subsection_q_item_2"
    class_name "item"
    text "(2)(A) If the Secretary determines that a nutrient other than a nutrient required by subparagraph (1)(C), (1)(D), or (1)(E) should be included in the label or labeling of food subject to subparagraph (1) for purposes of providing information regarding the nutritional value of such food that will assist consumers in maintaining healthy dietary practices, the Secretary may by regulation require that information relating to such additional nutrient be included in the label or labeling of such food."
  ]
  node [
    id 973
    label "section_343_subsection_q_item_4"
    class_name "item"
    text "(4)(A) The Secretary shall provide for furnishing the nutrition information required by subparagraphs (1) and (2) with respect to raw agricultural commodities and raw fish by issuing voluntary nutrition guidelines, as provided by clause (B) or by issuing regulations that are mandatory as provided by clause (D)."
  ]
  node [
    id 974
    label "section_343_subsection_v_item_6_subitem_A"
    class_name "subitem"
    text "(A) the statement claims a benefit related to a classical nutrient deficiency disease and discloses the prevalence of such disease in the United States, describes the role of a nutrient or dietary ingredient intended to affect the structure or function in humans, characterizes the documented mechanism by which a nutrient or dietary ingredient acts to maintain such structure or function, or describes general well-being from consumption of a nutrient or dietary ingredient,"
  ]
  node [
    id 975
    label "section_343_subsection_r_item_1"
    class_name "item"
    text "(1) Except as provided in clauses (A) through (C) of subparagraph (5), if it is a food intended for human consumption which is offered for sale and for which a claim is made in the label or labeling of the food which expressly or by implication&#8212;"
  ]
  node [
    id 976
    label "section_343_subsection_i_item_1"
    class_name "item"
    text "Unless its label bears (1) the common or usual name of the food, if any there be, and (2) in case it is fabricated from two or more ingredients, the common or usual name of each such ingredient and if the food purports to be a beverage containing vegetable or fruit juice, a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food; except that spices, flavorings, and colors not required to be certified under section 379e(c) of this title&#160;1 unless sold as spices, flavorings, or such colors, may be designated as spices, flavorings, and colorings without naming each. To the extent that compliance with the requirements of clause (2) of this paragraph is impracticable, or results in deception or unfair competition, exemptions shall be established by regulations promulgated by the Secretary."
  ]
  node [
    id 977
    label "section_343_subsection_q_item_5_subitem_A"
    class_name "subitem"
    text "(5)(A) Subparagraphs (1), (2), (3), and (4) shall not apply to food&#8212;"
  ]
  node [
    id 978
    label "section_343_subsection_s_item_2"
    class_name "item"
    text "(2)(A) the label or labeling of the supplement fails to list&#8212;"
  ]
  node [
    id 979
    label "section_343_subsection_v_subitem_F_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the listing of dietary ingredients may include the source of a dietary ingredient; and"
  ]
  node [
    id 980
    label "section_343_subsection_v_subitem_E_subsubitem_i_subsubsubitem_IV"
    class_name "subsubsubitem"
    text "(IV) in the case of a food product which was sold in the 12-month period preceding the period for which an exemption was claimed, fewer than 100,000 units of such product were sold in the United States during such preceding period, or in the case of a food product which was not sold in the 12-month period preceding the period for which such exemption is claimed, fewer than 100,000 units of such product are reasonably anticipated to be sold in the United States during the period for which such exemption is claimed."
  ]
  node [
    id 981
    label "section_343_subsection_v_subitem_E"
    class_name "subitem"
    text "(E) Subclauses (i) through (v) of subparagraph (2)(A) do not apply to a statement in the label or labeling of food which describes the percentage of vitamins and minerals in the food in relation to the amount of such vitamins and minerals recommended for daily consumption by the Secretary."
  ]
  node [
    id 982
    label "section_343_subsection_q_item_4_subitem_D"
    class_name "subitem"
    text "(D)(i) If the Secretary determines that there is not substantial compliance with the guidelines issued under clause (A), the Secretary shall at the time such determination is made issue proposed regulations requiring that any person who offers raw agricultural commodities or raw fish to consumers provide, in a manner prescribed by regulations, the nutrition information required by subparagraphs (1) and (2). The Secretary shall issue final regulations imposing such requirements 6 months after issuing the proposed regulations. The final regulations shall become effective 6 months after the date of their promulgation."
  ]
  node [
    id 983
    label "section_343_subsection_q_item_4_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If the Secretary finds that there is substantial compliance with the guidelines, the Secretary shall issue a report and make a determination of the type required in subclause (i) every two years."
  ]
  node [
    id 984
    label "section_343_subsection_v_subsubitem_v_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the term &#8220;food product&#8221; means food in any sized package which is manufactured by a single manufacturer or which bears the same brand name, which bears the same statement of identity, and which has similar preparation methods, and"
  ]
  node [
    id 985
    label "section_343_subsection_q_item_1_subitem_D"
    class_name "subitem"
    text "(D) the amount of the following nutrients: Total fat, saturated fat, cholesterol, sodium, total carbohydrates, complex carbohydrates, sugars, dietary fiber, and total protein contained in each serving size or other unit of measure,"
  ]
  node [
    id 986
    label "section_343_subsection_v_item_4_subitem_B"
    class_name "subitem"
    text "(B) A petition under clause (A)(i) respecting a claim described in subparagraph (1)(A) or (1)(B) shall include an explanation of the reasons why the claim meets the requirements of this paragraph and a summary of the scientific data which supports such reasons."
  ]
  node [
    id 987
    label "section_343_subsection_q_item_1_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) derived from any source, and"
  ]
  node [
    id 988
    label "section_343_subsection_q_item_4_subitem_B_subsubitem_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) in the case of raw agricultural commodities, to the 20 varieties of vegetables most frequently consumed during a year and the 20 varieties of fruit most frequently consumed during a year, and"
  ]
  node [
    id 989
    label "section_343_subsection_r_item_2"
    class_name "item"
    text "(2)(A) Except as provided in subparagraphs (4)(A)(ii) and (4)(A)(iii) and clauses (A) through (C) of subparagraph (5), a claim described in subparagraph (1)(A)&#8212;"
  ]
  node [
    id 990
    label "section_343_subsection_v_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the food for which the claim is made does not contain, as determined by the Secretary by regulation, any nutrient in an amount which increases to persons in the general population the risk of a disease or health-related condition which is diet related, taking into account the significance of the food in the total daily diet, except that the Secretary may by regulation permit such a claim based on a finding that such a claim would assist consumers in maintaining healthy dietary practices and based on a requirement that the label contain a disclosure of the type required by subparagraph (2)(B)."
  ]
  node [
    id 991
    label "section_343_subsection_g_item_2"
    class_name "item"
    text "If it purports to be or is represented as a food for which a definition and standard of identity has been prescribed by regulations as provided by section 341 of this title, unless (1) it conforms to such definition and standard, and (2) its label bears the name of the food specified in the definition and standard, and, insofar as may be required by such regulations, the common names of optional ingredients (other than spices, flavoring, and coloring) present in such food."
  ]
  node [
    id 992
    label "section_343_subsection_q_item_5_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) which is served in restaurants or other establishments in which food is served for immediate human consumption or which is sold for sale or use in such establishments,"
  ]
  node [
    id 993
    label "section_343_subsection_c"
    class_name "subsection"
    text "(c) Imitation of another food"
  ]
  node [
    id 994
    label "section_343_subsection_q_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) The Secretary shall provide for furnishing the nutrition information required by subparagraphs (1) and (2) with respect to raw agricultural commodities and raw fish by issuing voluntary nutrition guidelines, as provided by clause (B) or by issuing regulations that are mandatory as provided by clause (D)."
  ]
  node [
    id 995
    label "section_343_subsection_q_item_5_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) which is a medical food as defined in section 360ee(b) of this title, or"
  ]
  node [
    id 996
    label "section_343_subsection_h"
    class_name "subsection"
    text "(h) Representation as to standards of quality and fill of container"
  ]
  node [
    id 997
    label "section_343_subsection_p_item_4"
    class_name "item"
    text "(4) The Secretary shall by regulation prescribe the form, text, and manner of display of the notice required by subparagraph (1) and such other matters as may be required for the implementation of the requirements of that subparagraph and subparagraph (2). Regulations of the Secretary under this subparagraph shall be promulgated after an oral hearing but without regard to the National Environmental Policy Act of 1969 [42 U.S.C. 4321 et seq.] and chapter 5 of title 5. In any action brought for judicial review of any such regulation, the reviewing court may not postpone the effective date of such regulation."
  ]
  node [
    id 998
    label "section_343_subsection_q_item_4_subitem_F"
    class_name "subitem"
    text "(F) No person who offers raw agricultural commodities or raw fish to consumers may be prosecuted for minor violations of this subparagraph if there has been substantial compliance with the requirements of this paragraph."
  ]
  node [
    id 999
    label "section_343_subsection_e"
    class_name "subsection"
    text "(e) Package form"
  ]
  node [
    id 1000
    label "section_343_subsection_v_subsubitem_i"
    class_name "subsubitem"
    text "(vi) For purposes of subclauses (i), (ii), (iii), (iv), and (v)&#8212;"
  ]
  node [
    id 1001
    label "section_343_subsection_v_subitem_F_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the listing of dietary ingredients shall include the quantity of each such ingredient (or of a proprietary blend of such ingredients) per serving;"
  ]
  node [
    id 1002
    label "section_343_subsection_v_subitem_E_subsubitem_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the labeling for such product does not provide nutrition information or make a claim subject to paragraph (r),"
  ]
  node [
    id 1003
    label "section_343_subsection_q_item_4_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(C)(i) Upon the expiration of 30 months after November 8, 1990, the Secretary shall issue a report on actions taken by food retailers to provide consumers with nutrition information for raw agricultural commodities and raw fish under the guidelines issued under clause (A). Such report shall include a determination of whether there is substantial compliance with the guidelines."
  ]
  node [
    id 1004
    label "section_343_subsection_v_subitem_E_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) during the 12-month period preceding May 8, 1994, the person who claims for such product an exemption from such subparagraphs employed fewer than an average of 300 full-time equivalent employees and fewer than 600,000 units of such product were sold in the United States,"
  ]
  node [
    id 1005
    label "section_343_subsection_v_subsubitem_v_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) the term &#8220;person&#8221; in the case of a corporation includes all domestic and foreign affiliates of the corporation."
  ]
  node [
    id 1006
    label "section_343_subsection_i_item_2"
    class_name "item"
    text "Unless its label bears (1) the common or usual name of the food, if any there be, and (2) in case it is fabricated from two or more ingredients, the common or usual name of each such ingredient and if the food purports to be a beverage containing vegetable or fruit juice, a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food; except that spices, flavorings, and colors not required to be certified under section 379e(c) of this title&#160;1 unless sold as spices, flavorings, or such colors, may be designated as spices, flavorings, and colorings without naming each. To the extent that compliance with the requirements of clause (2) of this paragraph is impracticable, or results in deception or unfair competition, exemptions shall be established by regulations promulgated by the Secretary."
  ]
  node [
    id 1007
    label "section_343_subsection_q_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the use of the food is not typically expressed in a serving size, the common household unit of measure that expresses the serving size of the food,"
  ]
  node [
    id 1008
    label "section_343_subsection_k_subsubitem_i"
    class_name "subsubitem"
    text "If it bears or contains any artificial flavoring, artificial coloring, or chemical preservative, unless it bears labeling stating that fact, except that to the extent that compliance with the requirements of this paragraph is impracticable, exemptions shall be established by regulations promulgated by the Secretary. The provisions of this paragraph and paragraphs (g) and (i) with respect to artificial coloring shall not apply in the case of butter, cheese, or ice cream. The provisions of this paragraph with respect to chemical preservatives shall not apply to a pesticide chemical when used in or on a raw agricultural commodity which is the produce of the soil."
  ]
  node [
    id 1009
    label "section_343_subsection_q_item_4_subitem_C"
    class_name "subitem"
    text "(C)(i) Upon the expiration of 30 months after November 8, 1990, the Secretary shall issue a report on actions taken by food retailers to provide consumers with nutrition information for raw agricultural commodities and raw fish under the guidelines issued under clause (A). Such report shall include a determination of whether there is substantial compliance with the guidelines."
  ]
  node [
    id 1010
    label "section_343_subsection_v_item_4"
    class_name "item"
    text "(4)(A)(i) Any person may petition the Secretary to issue a regulation under subparagraph (2)(A)(i) or (3)(B) relating to a claim described in subparagraph (1)(A) or (1)(B). Not later than 100 days after the petition is received by the Secretary, the Secretary shall issue a final decision denying the petition or file the petition for further action by the Secretary. If the Secretary denies the petition, the petition shall not be made available to the public. If the Secretary files the petition, the Secretary shall deny the petition or issue a proposed regulation to take the action requested in the petition not later than 90 days after the date of such decision."
  ]
  node [
    id 1011
    label "section_343_subsection_v_item_3_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) A regulation described in subclause (i) shall describe&#8212;"
  ]
  node [
    id 1012
    label "section_343_subsection_v_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A)(i) Any person may petition the Secretary to issue a regulation under subparagraph (2)(A)(i) or (3)(B) relating to a claim described in subparagraph (1)(A) or (1)(B). Not later than 100 days after the petition is received by the Secretary, the Secretary shall issue a final decision denying the petition or file the petition for further action by the Secretary. If the Secretary denies the petition, the petition shall not be made available to the public. If the Secretary files the petition, the Secretary shall deny the petition or issue a proposed regulation to take the action requested in the petition not later than 90 days after the date of such decision."
  ]
  node [
    id 1013
    label "section_343_subsection_v_subitem_E_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) In the case of a person who claimed an exemption under subclause (i) or (ii), if, during the period of such exemption, the number of full-time equivalent employees of such person exceeds the number in such subclause or if the number of food products sold in the United States exceeds the number in such subclause, such exemption shall extend to the expiration of 18 months after the date the number of full-time equivalent employees or food products sold exceeded the applicable number."
  ]
  node [
    id 1014
    label "section_343_subsection_v_item_4_subitem_C"
    class_name "subitem"
    text "(C) If a petition for a regulation under subparagraph (3)(B) relies on a report from an authoritative scientific body of the United States, the Secretary shall consider such report and shall justify any decision rejecting the conclusions of such report."
  ]
  node [
    id 1015
    label "section_343_subsection_v_subitem_E_subsubitem_i"
    class_name "subsubitem"
    text "(E)(i) During the 12-month period for which an exemption from subparagraphs (1) and (2) is claimed pursuant to this subclause, the requirements of such subparagraphs shall not apply to any food product if&#8212;"
  ]
  node [
    id 1016
    label "section_343_subsection_g"
    class_name "subsection"
    text "(g) Representation as to definition and standard of identity"
  ]
  node [
    id 1017
    label "section_343_subsection_i_subitem_B"
    class_name "subitem"
    text "(B) the label or labeling of the dietary supplement fails to identify the product by using the term &#8220;dietary supplement&#8221;, which term may be modified with the name of such an ingredient;"
  ]
  node [
    id 1018
    label "section_343_subsection_i_subitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) fails to meet the quality (including tablet or capsule disintegration), purity, or compositional specifications, based on validated assay or other appropriate methods, that the supplement is represented to meet."
  ]
  node [
    id 1019
    label "section_343_subsection_v_subsubitem_v_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the term &#8220;unit&#8221; means the packaging or, if there is no packaging, the form in which a food product is offered for sale to consumers,"
  ]
  node [
    id 1020
    label "section_343_subsection_h_item_1"
    class_name "item"
    text "(1) a food for which a standard of quality has been prescribed by regulations as provided by section 341 of this title, and its quality falls below such standard, unless its label bears, in such manner and form as such regulations specify, a statement that it falls below such standard; or"
  ]
  node [
    id 1021
    label "section_343_subsection_v_subitem_F_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the nutrition information shall immediately precede the ingredient information required under subclause (i), except that no ingredient identified pursuant to subclause (i) shall be required to be identified a second time."
  ]
  node [
    id 1022
    label "section_343_subsection_r_item_1_subitem_A"
    class_name "subitem"
    text "A statement of the type required by paragraph (q) that appears as part of the nutrition information required or permitted by such paragraph is not a claim which is subject to this paragraph and a claim subject to clause (A) is not subject to clause (B)."
  ]
  node [
    id 1023
    label "section_343_subsection_v_item_6_subitem_B"
    class_name "subitem"
    text "(B) the manufacturer of the dietary supplement has substantiation that such statement is truthful and not misleading, and"
  ]
  node [
    id 1024
    label "section_343_subsection_q_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) Upon the expiration of 12 months after November 8, 1990, the Secretary, after providing an opportunity for comment, shall issue guidelines for food retailers offering raw agricultural commodities or raw fish to provide nutrition information specified in subparagraphs (1) and (2). Such guidelines shall take into account the actions taken by food retailers during such 12-month period to provide to consumers nutrition information on raw agricultural commodities and raw fish. Such guidelines shall only apply&#8212;"
  ]
  node [
    id 1025
    label "section_343_subsection_n"
    class_name "subsection"
    text "(n) Packaging or labeling of drugs in violation of regulations"
  ]
  node [
    id 1026
    label "section_343_subsection_l"
    class_name "subsection"
    text "(l) Pesticide chemicals on raw agricultural commodities"
  ]
  node [
    id 1027
    label "section_343_subsection_i"
    class_name "subsection"
    text "(i) is not covered by the specifications of an official compendium; and"
  ]
  node [
    id 1028
    label "section_343_subsection_v_item_5"
    class_name "item"
    text "(5)(A) This paragraph does not apply to infant formulas subject to section 350a(h) of this title and medical foods as defined in section 360ee(b) of this title."
  ]
  node [
    id 1029
    label "section_343_subsection_i_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(i) is covered by the specifications of an official compendium;"
  ]
  node [
    id 1030
    label "section_343_subsection_q_item_1_subitem_B"
    class_name "subitem"
    text "(B) the number of servings or other units of measure per container,"
  ]
  node [
    id 1031
    label "section_343_subsection_o_item_2"
    class_name "item"
    text "(2) The Secretary may by regulation review and revise or remove the requirement of subparagraph (1) if the Secretary determines such action is necessary to reflect the current state of knowledge concerning saccharin."
  ]
  node [
    id 1032
    label "section_343_subsection_v_subitem_E_subsubitem_ii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) during the 12-month period preceding May 8, 1996, the person who claims for such product an exemption from such subparagraphs employed fewer than an average of 200 full-time equivalent employees and fewer than 200,000 units of such product were sold in the United States."
  ]
  node [
    id 1033
    label "section_343_subsection_v_subitem_E_subsubitem_iii_subsubsubitem_IV"
    class_name "subsubsubitem"
    text "(IV) contain such information as the Secretary may require to verify the information required by the preceding provisions of this subclause if the Secretary has questioned the validity of such information."
  ]
  node [
    id 1034
    label "section_343_subsection_v_item_3_subitem_B_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the significance of each such nutrient in affecting such disease or health-related condition."
  ]
  node [
    id 1035
    label "section_343_subsection_q_item_5_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) which is an infant formula subject to section 350a of this title,"
  ]
  node [
    id 1036
    label "section_343_subsection_v_subitem_E_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) during the 12-month period preceding May 8, 1995, the person who claims for such product an exemption from such subparagraphs employed fewer than an average of 300 full-time equivalent employees and fewer than 400,000 units of such product were sold in the United States, or"
  ]
  node [
    id 1037
    label "section_343_subsection_v_item_5_subitem_A"
    class_name "subitem"
    text "(5)(A) This paragraph does not apply to infant formulas subject to section 350a(h) of this title and medical foods as defined in section 360ee(b) of this title."
  ]
  node [
    id 1038
    label "section_343_subsection_v_subitem_C"
    class_name "subitem"
    text "(C) Subparagraph (2)(A) does not apply to a claim described in subparagraph (1)(A) and contained in the label or labeling of a food if such claim is contained in the brand name of such food and such brand name was in use on such food before October 25, 1989, unless the brand name contains a term defined by the Secretary under subparagraph (2)(A)(i). Such a claim is subject to paragraph (a)."
  ]
  node [
    id 1039
    label "section_343_subsection_q_item_2_subitem_B"
    class_name "subitem"
    text "(B) If the Secretary determines that the information relating to a nutrient required by subparagraph (1)(C), (1)(D), or (1)(E) or clause (A) of this subparagraph to be included in the label or labeling of food is not necessary to assist consumers in maintaining healthy dietary practices, the Secretary may by regulation remove information relating to such nutrient from such requirement."
  ]
  node [
    id 1040
    label "section_343_subsection_q_item_1"
    class_name "item"
    text "(1) Except as provided in subparagraphs (3), (4), and (5), if it is a food intended for human consumption and is offered for sale, unless its label or labeling bears nutrition information that provides&#8212;"
  ]
  node [
    id 1041
    label "section_343_subsection_r_item_2_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) may not be made with respect to the level of cholesterol in the food if the food contains, as determined by the Secretary by regulation, fat or saturated fat in an amount which increases to persons in the general population the risk of disease or a health related condition which is diet related unless&#8212;"
  ]
  node [
    id 1042
    label "section_343_subsection_q_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Upon the expiration of 12 months after November 8, 1990, the Secretary shall issue a final regulation defining the circumstances that constitute substantial compliance by food retailers with the guidelines issued under subclause (i). The regulation shall provide that there is not substantial compliance if a significant number of retailers have failed to comply with the guidelines. The size of the retailers and the portion of the market served by retailers in compliance with the guidelines shall be considered in determining whether the substantial-compliance standard has been met."
  ]
  node [
    id 1043
    label "section_343_subsection_v_item_3_subitem_B"
    class_name "subitem"
    text "(B)(i) The Secretary shall promulgate regulations authorizing claims of the type described in subparagraph (1)(B) only if the Secretary determines, based on the totality of publicly available scientific evidence (including evidence from well-designed studies conducted in a manner which is consistent with generally recognized scientific procedures and principles), that there is significant scientific agreement, among experts qualified by scientific training and experience to evaluate such claims, that the claim is supported by such evidence."
  ]
  node [
    id 1044
    label "section_343_subsection_r_item_2_subitem_A_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the nutrient is usually present in the food or in a food which substitutes for the food as defined by the Secretary by regulation, or"
  ]
  node [
    id 1045
    label "section_343_subsection_v_item_5_subitem_D"
    class_name "subitem"
    text "(D) A subparagraph (1)(B) claim made with respect to a dietary supplement of vitamins, minerals, herbs, or other similar nutritional substances shall not be subject to subparagraph (3) but shall be subject to a procedure and standard, respecting the validity of such claim, established by regulation of the Secretary."
  ]
  node [
    id 1046
    label "section_343_subsection_q_item_1_subitem_E"
    class_name "subitem"
    text "(E) any vitamin, mineral, or other nutrient required to be placed on the label and labeling of food under this chapter before October 1, 1990, if the Secretary determines that such information will assist consumers in maintaining healthy dietary practices."
  ]
  node [
    id 1047
    label "section_343_subsection_q_item_4_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(D)(i) If the Secretary determines that there is not substantial compliance with the guidelines issued under clause (A), the Secretary shall at the time such determination is made issue proposed regulations requiring that any person who offers raw agricultural commodities or raw fish to consumers provide, in a manner prescribed by regulations, the nutrition information required by subparagraphs (1) and (2). The Secretary shall issue final regulations imposing such requirements 6 months after issuing the proposed regulations. The final regulations shall become effective 6 months after the date of their promulgation."
  ]
  node [
    id 1048
    label "section_343_subsection_q_item_4_subitem_B_subsubitem_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) to the 20 varieties of raw fish most frequently consumed during a year."
  ]
  node [
    id 1049
    label "section_343_subsection_v_subitem_B"
    class_name "subitem"
    text "(B) If a claim described in subparagraph (1)(A) is made with respect to a nutrient in a food, the label or labeling of such food shall contain, prominently and in immediate proximity to such claim, the following statement: &#8220;See __________ for nutrition information.&#8221;. In the statement&#8212;"
  ]
  node [
    id 1050
    label "section_343_subsection_v_item_4_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) Any person may petition the Secretary for permission to use an implied claim described in subparagraph (1)(A) in a brand name. After publishing notice of an opportunity to comment on the petition in the Federal Register and making the petition available to the public, the Secretary shall grant the petition if the Secretary finds that such claim is not misleading and is consistent with terms defined by the Secretary under subparagraph (2)(A)(i). The Secretary shall grant or deny the petition within 100 days of the date it is submitted to the Secretary and the petition shall be considered granted if the Secretary does not act on it within such 100 days."
  ]
  node [
    id 1051
    label "section_343_subsection_f"
    class_name "subsection"
    text "(f) Prominence of information on label"
  ]
  node [
    id 1052
    label "section_343_subsection_v_subitem_F"
    class_name "subitem"
    text "(F) Subclause (i) clause (A) does not apply to a statement in the labeling of a dietary supplement that characterizes the percentage level of a dietary ingredient for which the Secretary has not established a reference daily intake, daily recommended value, or other recommendation for daily consumption."
  ]
  node [
    id 1053
    label "section_343_subsection_v_subitem_F_subsubitem_i"
    class_name "subsubitem"
    text "(i) nutrition information shall first list those dietary ingredients that are present in the product in a significant amount and for which a recommendation for daily consumption has been established by the Secretary, except that a dietary ingredient shall not be required to be listed if it is not present in a significant amount, and shall list any other dietary ingredient present and identified as having no such recommendation;"
  ]
  node [
    id 1054
    label "section_343_subsection_v_subitem_E_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) state the approximate number of units the person claiming the exemption sold in the United States,"
  ]
  node [
    id 1055
    label "section_343_subsection_r_item_1_subitem_B"
    class_name "subitem"
    text "A statement of the type required by paragraph (q) that appears as part of the nutrition information required or permitted by such paragraph is not a claim which is subject to this paragraph and a claim subject to clause (A) is not subject to clause (B)."
  ]
  node [
    id 1056
    label "section_343_subsection_v_item_3_subitem_B_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the relationship between a nutrient of the type required in the label or labeling of food by paragraph (q)(1) or (q)(2) and a disease or health-related condition, and"
  ]
  node [
    id 1057
    label "section_343_subsection_r"
    class_name "subsection"
    text "(r) Nutrition levels and health-related claims"
  ]
  node [
    id 1058
    label "section_343_subsection_v_subitem_E_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) state the average number of full-time equivalent employees such person employed during the 12 months preceding the date such person claims such exemption,"
  ]
  node [
    id 1059
    label "section_343_subsection_v_item_3"
    class_name "item"
    text "(3)(A) Except as provided in subparagraph (5), a claim described in subparagraph (1)(B) may only be made&#8212;"
  ]
  node [
    id 1060
    label "section_343_subsection_i_subitem_D_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) fails to so conform; or"
  ]
  node [
    id 1061
    label "section_343_subsection_p_item_1"
    class_name "item"
    text "(1) If it contains saccharin and is offered for sale, but not for immediate consumption, at a retail establishment, unless such retail establishment displays prominently, where such food is held for sale, notice (provided by the manufacturer of such food pursuant to subparagraph (2) for consumers respecting the information required by paragraph (o) to be on food labels and labeling."
  ]
  node [
    id 1062
    label "section_343_subsection_v_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the Secretary determines that the food contains a nutrient at a level which increases to persons in the general population the risk of a disease or health-related condition which is diet related, taking into account the significance of the food in the total daily diet, the statement shall also identify such nutrient."
  ]
  node [
    id 1063
    label "section_343_subsection_m"
    class_name "subsection"
    text "(m) Color additives"
  ]
  node [
    id 1064
    label "section_343_subsection_r_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) may be made only if the characterization of the level made in the claim uses terms which are defined in regulations of the Secretary,"
  ]
  node [
    id 1065
    label "section_343_subsection_q_item_4_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Regulations issued under subclause (i) may require that the nutrition information required by subparagraphs (1) and (2) be provided for more than 20 varieties of vegetables, 20 varieties of fruit, and 20 varieties of fish most frequently consumed during a year if the Secretary finds that a larger number of such products are frequently consumed. Such regulations shall permit such information to be provided in a single location in each area in which raw agricultural commodities and raw fish are offered for sale. Such regulations may provide that information shall be expressed as an average or range per serving of the same type of raw agricultural commodity or raw fish. The Secretary shall develop and make available to the persons who offer such food to consumers the information required by subparagraphs (1) and (2)."
  ]
  node [
    id 1066
    label "section_343_subsection_r_item_2_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) may not be made with respect to the level of saturated fat in the food if the food contains cholesterol unless the label or labeling of the food discloses the level of cholesterol in the food in immediate proximity to such claim and with appropriate prominence which shall be no less than one-half the size of the claim with respect to the level of saturated fat,"
  ]
  node [
    id 1067
    label "section_343_subsection_v_item_3_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) A regulation described in subclause (i) shall require such claim to be stated in a manner so that the claim is an accurate representation of the matters set out in subclause (ii) and so that the claim enables the public to comprehend the information provided in the claim and to understand the relative significance of such information in the context of a total daily diet."
  ]
  node [
    id 1068
    label "section_343_subsection_v_subsubitem_ii"
    class_name "subsubitem"
    text "(vi) For purposes of subclauses (i), (ii), (iii), (iv), and (v)&#8212;"
  ]
  node [
    id 1069
    label "section_343_subsection_d"
    class_name "subsection"
    text "(d) Misleading container"
  ]
  node [
    id 1070
    label "section_343_subsection_j"
    class_name "subsection"
    text "(j) Representation for special dietary use"
  ]
  node [
    id 1071
    label "section_343_subsection_e_item_1"
    class_name "item"
    text "If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count, except that under clause (2) of this paragraph reasonable variations shall be permitted, and exemptions as to small packages shall be established, by regulations prescribed by the Secretary."
  ]
  node [
    id 1072
    label "section_343_subsection_v_subitem_E_subsubitem_i_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) such person provided the notice described in subclause (iii), and"
  ]
  node [
    id 1073
    label "section_343_subsection_q_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(A)(i) the serving size which is an amount customarily consumed and which is expressed in a common household measure that is appropriate to the food, or"
  ]
  node [
    id 1074
    label "section_343_subsection_v_item_6_subitem_C"
    class_name "subitem"
    text "(C) the statement contains, prominently displayed and in boldface type, the following: &#8220;This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.&#8221;."
  ]
  node [
    id 1075
    label "section_343_subsection_a_item_2"
    class_name "item"
    text "If (1) its labeling is false or misleading in any particular, or (2) in the case of a food to which section 350 of this title applies, its advertising is false or misleading in a material respect or its labeling is in violation of section 350(b)(2) of this title."
  ]
  node [
    id 1076
    label "section_343_subsection_v_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the blank shall identify the panel on which the information described in the statement may be found, and"
  ]
  node [
    id 1077
    label "section_343_subsection_v_item_3_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) The Secretary shall promulgate regulations authorizing claims of the type described in subparagraph (1)(B) only if the Secretary determines, based on the totality of publicly available scientific evidence (including evidence from well-designed studies conducted in a manner which is consistent with generally recognized scientific procedures and principles), that there is significant scientific agreement, among experts qualified by scientific training and experience to evaluate such claims, that the claim is supported by such evidence."
  ]
  node [
    id 1078
    label "section_343_subsection_v_subitem_E_subsubitem_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the person who claims for such product an exemption from such subparagraphs employed fewer than an average of 100 full-time equivalent employees,"
  ]
  node [
    id 1079
    label "section_343_subsection_e_item_2"
    class_name "item"
    text "If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count, except that under clause (2) of this paragraph reasonable variations shall be permitted, and exemptions as to small packages shall be established, by regulations prescribed by the Secretary."
  ]
  node [
    id 1080
    label "section_343_subsection_q_item_1_subitem_A"
    class_name "subitem"
    text "(A)(i) the serving size which is an amount customarily consumed and which is expressed in a common household measure that is appropriate to the food, or"
  ]
  node [
    id 1081
    label "section_343_subsection_v_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) Except as provided in subparagraph (5), a claim described in subparagraph (1)(B) may only be made&#8212;"
  ]
  node [
    id 1082
    label "section_343_subsection_q"
    class_name "subsection"
    text "(q) Nutrition information"
  ]
  node [
    id 1083
    label "section_343_subsection_v_subsubitem_iii"
    class_name "subsubitem"
    text "(vi) For purposes of subclauses (i), (ii), (iii), (iv), and (v)&#8212;"
  ]
  node [
    id 1084
    label "section_343_subsection_q_item_1_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) derived from the total fat,"
  ]
  node [
    id 1085
    label "section_343_subsection_v_subitem_E_subsubitem_iii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) if the exemption is claimed for a food product which was sold in the 12-month period preceding the period for which the exemption was claimed, state the approximate number of units of such product which were sold in the United States during such preceding period, and, if the exemption is claimed for a food product which was not sold in such preceding period, state the number of units of such product which such person reasonably anticipates will be sold in the United States during the period for which the exemption was claimed, and"
  ]
  node [
    id 1086
    label "section_343_subsection_b"
    class_name "subsection"
    text "(b) Offer for sale under another name"
  ]
  node [
    id 1087
    label "section_343_subsection_i_subitem_D"
    class_name "subitem"
    text "(D) the supplement&#8212;"
  ]
  node [
    id 1088
    label "section_343_subsection_k"
    class_name "subsection"
    text "(k) Artificial flavoring, artificial coloring, or chemical preservatives"
  ]
  node [
    id 1089
    label "section_343_subsection_a"
    class_name "subsection"
    text "(a) False or misleading label"
  ]
  node [
    id 1090
    label "section_343_subsection_q_item_5"
    class_name "item"
    text "(5)(A) Subparagraphs (1), (2), (3), and (4) shall not apply to food&#8212;"
  ]
  node [
    id 1091
    label "section_343_subsection_v_item_5_subitem_B"
    class_name "subitem"
    text "(B) Subclauses (iii) through (v) of subparagraph (2)(A) and subparagraph (2)(B) do not apply to food which is served in restaurants or other establishments in which food is served for immediate human consumption or which is sold for sale or use in such establishments."
  ]
  node [
    id 1092
    label "section_343_subsection_i_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) is represented as conforming to the specifications of an official compendium; and"
  ]
  node [
    id 1093
    label "section_343_subsection_p_item_3"
    class_name "item"
    text "(3) The Secretary may by regulation review and revise or remove the requirement of subparagraph (1) if he determines such action is necessary to reflect the current state of knowledge concerning saccharin."
  ]
  node [
    id 1094
    label "section_343_subsection_q_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) If the Secretary determines that a nutrient other than a nutrient required by subparagraph (1)(C), (1)(D), or (1)(E) should be included in the label or labeling of food subject to subparagraph (1) for purposes of providing information regarding the nutritional value of such food that will assist consumers in maintaining healthy dietary practices, the Secretary may by regulation require that information relating to such additional nutrient be included in the label or labeling of such food."
  ]
  node [
    id 1095
    label "section_343_subsection_i_subitem_ii"
    class_name "subitem"
    text "(ii)(I) fails to have the identity and strength that the supplement is represented to have; or"
  ]
  node [
    id 1096
    label "section_343_subsection_o_item_1"
    class_name "item"
    text "(1) If it contains saccharin, unless, except as provided in subparagraph (2), its label and labeling bear the following statement: &#8220;USE OF THIS PRODUCT MAY BE HAZARDOUS TO YOUR HEALTH. THIS PRODUCT CONTAINS SACCHARIN WHICH HAS BEEN DETERMINED TO CAUSE CANCER IN LABORATORY ANIMALS&#8221;. Such statement shall be located in a conspicuous place on such label and labeling as proximate as possible to the name of such food and shall appear in conspicuous and legible type in contrast by typography, layout, and color with other printed matter on such label and labeling."
  ]
  node [
    id 1097
    label "section_343_subsection_v_subitem_G"
    class_name "subitem"
    text "(G) Subparagraphs (1), (2), (3), and (4) shall not apply to food which is sold by a food distributor if the food distributor principally sells food to restaurants or other establishments in which food is served for immediate human consumption and does not manufacture, process, or repackage the food it sells."
  ]
  node [
    id 1098
    label "section_343_subsection_s_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) the label or labeling of the supplement fails to list&#8212;"
  ]
  node [
    id 1099
    label "section_343_subsection_s_item_1"
    class_name "item"
    text "(1) it is a dietary supplement; and"
  ]
  node [
    id 1100
    label "section_343_subsection_s"
    class_name "subsection"
    text "(s) Dietary supplements"
  ]
  node [
    id 1101
    label "section_343_subsection_q_item_1_subitem_C"
    class_name "subitem"
    text "(C) the total number of calories&#8212;"
  ]
  node [
    id 1102
    label "section_343_subsection_q_item_5_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) which is processed and prepared primarily in a retail establishment, which is ready for human consumption, which is of the type described in subclause (i), and which is offered for sale to consumers but not for immediate human consumption in such establishment and which is not offered for sale outside such establishment,"
  ]
  node [
    id 1103
    label "section_343_subsection_r_item_2_subitem_A_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the Secretary finds by regulation that the level of cholesterol is substantially less than the level usually present in the food or in a food which substitutes for the food and which has a significant market share, or the Secretary by regulation permits a statement regarding the absence of cholesterol on the basis of a finding that cholesterol is not usually present in the food and that such a statement would assist consumers in maintaining healthy dietary practices and the regulation requires that the statement disclose that cholesterol is not usually present in the food, and"
  ]
  node [
    id 1104
    label "section_343_subsection_v"
    class_name "subsection"
    text "(v) may not state that a food is high in dietary fiber unless the food is low in total fat as defined by the Secretary or the label or labeling discloses the level of total fat in the food in immediate proximity to such statement and with appropriate prominence which shall be no less than one-half the size of the claim with respect to the level of dietary fiber, and"
  ]
  node [
    id 1105
    label "section_343_subsection_v_item_6"
    class_name "item"
    text "(6) For purposes of paragraph (r)(1)(B), a statement for a dietary supplement may be made if&#8212;"
  ]
  node [
    id 1106
    label "section_343_subsection_v_item_5_subitem_C"
    class_name "subitem"
    text "(C) A subparagraph (1)(A) claim made with respect to a food which claim is required by a standard of identity issued under section 341 of this title shall not be subject to subparagraph (2)(A)(i) or (2)(B)."
  ]
  node [
    id 1107
    label "section_343_subsection_q_item_4_subitem_E"
    class_name "subitem"
    text "(E) For purposes of this subparagraph, the term &#8220;fish&#8221; includes freshwater or marine fin fish, crustaceans, and mollusks, including shellfish, amphibians, and other forms of aquatic animal life."
  ]
  node [
    id 1108
    label "section_343_subsection_v_subitem_D"
    class_name "subitem"
    text "(D) Subparagraph (2) does not apply to a claim described in subparagraph (1)(A) which uses the term &#8220;diet&#8221; and is contained in the label or labeling of a soft drink if (i) such claim is contained in the brand name of such soft drink, (ii) such brand name was in use on such soft drink before October 25, 1989, and (iii) the use of the term &#8220;diet&#8221; was in conformity with section 105.66 of title 21 of the Code of Federal Regulations. Such a claim is subject to paragraph (a)."
  ]
  node [
    id 1109
    label "section_343_subsection_v_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Any person may petition the Secretary for permission to use in a claim described in subparagraph (1)(A) terms that are consistent with the terms defined by the Secretary under subparagraph (2)(A)(i). Within 90 days of the submission of such a petition, the Secretary shall issue a final decision denying the petition or granting such permission."
  ]
  node [
    id 1110
    label "section_343&#8211;1_subsection_a_item_5"
    class_name "item"
    text "(5) any requirement respecting any claim of the type described in section 343(r)(1) of this title made in the label or labeling of food that is not identical to the requirement of section 343(r) of this title, except a requirement respecting a claim made in the label or labeling of food which is exempt under section 343(r)(5)(B) of this title."
  ]
  node [
    id 1111
    label "section_343&#8211;1_subsection_a_item_3"
    class_name "item"
    text "Paragraph (3) shall take effect in accordance with section 6(b) of the Nutrition Labeling and Education Act of 1990."
  ]
  node [
    id 1112
    label "section_343&#8211;1_subsection_b_item_1"
    class_name "item"
    text "(1) would not cause any food to be in violation of any applicable requirement under Federal law,"
  ]
  node [
    id 1113
    label "section_343&#8211;1_subsection_a"
    class_name "subsection"
    text "(a) Except as provided in subsection (b) of this section, no State or political subdivision of a State may directly or indirectly establish under any authority or continue in effect as to any food in interstate commerce&#8212;"
  ]
  node [
    id 1114
    label "section_343&#8211;1_subsection_b"
    class_name "subsection"
    text "(b) Upon petition of a State or a political subdivision of a State, the Secretary may exempt from subsection (a) of this section, under such conditions as may be prescribed by regulation, any State or local requirement that&#8212;"
  ]
  node [
    id 1115
    label "section_343&#8211;1_subsection_a_item_1"
    class_name "item"
    text "(1) any requirement for a food which is the subject of a standard of identity established under section 341 of this title that is not identical to such standard of identity or that is not identical to the requirement of section 343(g) of this title, except that this paragraph does not apply to a standard of identity of a State or political subdivision of a State for maple syrup that is of the type required by sections 341 and 343(g) of this title,"
  ]
  node [
    id 1116
    label "section_343&#8211;1_subsection_a_item_2"
    class_name "item"
    text "(2) any requirement for the labeling of food of the type required by section 343(c), 343(e), or 343(i)(2) of this title that is not identical to the requirement of such section, except that this paragraph does not apply to a requirement of a State or political subdivision of a State that is of the type required by section 343(c) of this title and that is applicable to maple syrup,"
  ]
  node [
    id 1117
    label "section_343&#8211;1_subsection_b_item_3"
    class_name "item"
    text "(3) is designed to address a particular need for information which need is not met by the requirements of the sections referred to in subsection (a) of this section."
  ]
  node [
    id 1118
    label "section_343&#8211;1_subsection_a_item_4"
    class_name "item"
    text "(4) any requirement for nutrition labeling of food that is not identical to the requirement of section 343(q) of this title, except a requirement for nutrition labeling of food which is exempt under subclause (i) or (ii) of section 343(q)(5)(A) of this title, or"
  ]
  node [
    id 1119
    label "section_343&#8211;1_subsection_b_item_2"
    class_name "item"
    text "(2) would not unduly burden interstate commerce, and"
  ]
  node [
    id 1120
    label "section_343&#8211;2_subsection_a_item_5"
    class_name "item"
    text "(5) does not have appended to it any information by sticker or any other method."
  ]
  node [
    id 1121
    label "section_343&#8211;2_subsection_a_item_4"
    class_name "item"
    text "(4) if displayed in an establishment, is physically separate from the dietary supplements; and"
  ]
  node [
    id 1122
    label "section_343&#8211;2_subsection_a_item_1"
    class_name "item"
    text "(1) is not false or misleading;"
  ]
  node [
    id 1123
    label "section_343&#8211;2_subsection_c"
    class_name "subsection"
    text "(c) Burden of proof"
  ]
  node [
    id 1124
    label "section_343&#8211;2_subsection_a_item_2"
    class_name "item"
    text "(2) does not promote a particular manufacturer or brand of a dietary supplement;"
  ]
  node [
    id 1125
    label "section_343&#8211;2_subsection_a_item_3"
    class_name "item"
    text "(3) is displayed or presented, or is displayed or presented with other such items on the same subject matter, so as to present a balanced view of the available scientific information on a dietary supplement;"
  ]
  node [
    id 1126
    label "section_343&#8211;2_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 1127
    label "section_343&#8211;2_subsection_b"
    class_name "subsection"
    text "(b) Application"
  ]
  node [
    id 1128
    label "section_343a_subsection_b"
    class_name "subsection"
    text "(b) Availability and distribution of information; review and revision"
  ]
  node [
    id 1129
    label "section_343a_subsection_a"
    class_name "subsection"
    text "(a) Statement on vending machines dispensing food containing saccharin respecting health risk; regulations"
  ]
  node [
    id 1130
    label "section_343a_subsection_b_item_1"
    class_name "item"
    text "The Secretary shall (1) prepare information respecting the nature of the controversy surrounding the use of food containing saccharin, and (2) provide for the distribution of such information for display by retail establishments where such food is sold but not for immediate consumption. The Secretary may review and revise such information if he determines such action is necessary to reflect the current state of knowledge concerning the risks to health presented by the use of saccharin."
  ]
  node [
    id 1131
    label "section_343a_subsection_b_item_2"
    class_name "item"
    text "The Secretary shall (1) prepare information respecting the nature of the controversy surrounding the use of food containing saccharin, and (2) provide for the distribution of such information for display by retail establishments where such food is sold but not for immediate consumption. The Secretary may review and revise such information if he determines such action is necessary to reflect the current state of knowledge concerning the risks to health presented by the use of saccharin."
  ]
  node [
    id 1132
    label "section_344_subsection_c"
    class_name "subsection"
    text "(c) Inspection of permit-holding establishments"
  ]
  node [
    id 1133
    label "section_344_subsection_a"
    class_name "subsection"
    text "(a) Conditions on manufacturing, processing, etc., as health measure"
  ]
  node [
    id 1134
    label "section_344_subsection_b"
    class_name "subsection"
    text "(b) Violation of permit; suspension and reinstatement"
  ]
  node [
    id 1135
    label "section_345_item_2"
    class_name "item"
    text "The Secretary shall promulgate regulations exempting from any labeling requirement of this chapter (1) small open containers of fresh fruits and fresh vegetables and (2) food which is, in accordance with the practice of the trade, to be processed, labeled, or repacked in substantial quantities at establishments other than those where originally processed or packed, on condition that such food is not adulterated or misbranded under the provisions of this chapter upon removal from such processing, labeling, or repacking establishment. This section does not apply to the labeling requirements of sections 343(q) and 343(r) of this title."
  ]
  node [
    id 1136
    label "section_345_item_1"
    class_name "item"
    text "The Secretary shall promulgate regulations exempting from any labeling requirement of this chapter (1) small open containers of fresh fruits and fresh vegetables and (2) food which is, in accordance with the practice of the trade, to be processed, labeled, or repacked in substantial quantities at establishments other than those where originally processed or packed, on condition that such food is not adulterated or misbranded under the provisions of this chapter upon removal from such processing, labeling, or repacking establishment. This section does not apply to the labeling requirements of sections 343(q) and 343(r) of this title."
  ]
  node [
    id 1137
    label "section_346_item_1"
    class_name "item"
    text "Any poisonous or deleterious substance added to any food, except where such substance is required in the production thereof or cannot be avoided by good manufacturing practice shall be deemed to be unsafe for purposes of the application of clause (2)(A) of section 342(a) of this title; but when such substance is so required or cannot be so avoided, the Secretary shall promulgate regulations limiting the quantity therein or thereon to such extent as he finds necessary for the protection of public health, and any quantity exceeding the limits so fixed shall also be deemed to be unsafe for purposes of the application of clause (2)(A) of section 342(a) of this title. While such a regulation is in effect limiting the quantity of any such substance in the case of any food, such food shall not, by reason of bearing or containing any added amount of such substance, be considered to be adulterated within the meaning of clause (1) of section 342(a) of this title. In determining the quantity of such added substance to be tolerated in or on different articles of food the Secretary shall take into account the extent to which the use of such substance is required or cannot be avoided in the production of each such article, and the other ways in which the consumer may be affected by the same or other poisonous or deleterious substances."
  ]
  node [
    id 1138
    label "section_346_item_2_subitem_A"
    class_name "subitem"
    text "Any poisonous or deleterious substance added to any food, except where such substance is required in the production thereof or cannot be avoided by good manufacturing practice shall be deemed to be unsafe for purposes of the application of clause (2)(A) of section 342(a) of this title; but when such substance is so required or cannot be so avoided, the Secretary shall promulgate regulations limiting the quantity therein or thereon to such extent as he finds necessary for the protection of public health, and any quantity exceeding the limits so fixed shall also be deemed to be unsafe for purposes of the application of clause (2)(A) of section 342(a) of this title. While such a regulation is in effect limiting the quantity of any such substance in the case of any food, such food shall not, by reason of bearing or containing any added amount of such substance, be considered to be adulterated within the meaning of clause (1) of section 342(a) of this title. In determining the quantity of such added substance to be tolerated in or on different articles of food the Secretary shall take into account the extent to which the use of such substance is required or cannot be avoided in the production of each such article, and the other ways in which the consumer may be affected by the same or other poisonous or deleterious substances."
  ]
  node [
    id 1139
    label "section_346_item_2"
    class_name "item"
    text "Any poisonous or deleterious substance added to any food, except where such substance is required in the production thereof or cannot be avoided by good manufacturing practice shall be deemed to be unsafe for purposes of the application of clause (2)(A) of section 342(a) of this title; but when such substance is so required or cannot be so avoided, the Secretary shall promulgate regulations limiting the quantity therein or thereon to such extent as he finds necessary for the protection of public health, and any quantity exceeding the limits so fixed shall also be deemed to be unsafe for purposes of the application of clause (2)(A) of section 342(a) of this title. While such a regulation is in effect limiting the quantity of any such substance in the case of any food, such food shall not, by reason of bearing or containing any added amount of such substance, be considered to be adulterated within the meaning of clause (1) of section 342(a) of this title. In determining the quantity of such added substance to be tolerated in or on different articles of food the Secretary shall take into account the extent to which the use of such substance is required or cannot be avoided in the production of each such article, and the other ways in which the consumer may be affected by the same or other poisonous or deleterious substances."
  ]
  node [
    id 1140
    label "section_346a_subsection_o_item_5"
    class_name "item"
    text "The Administrator shall by regulation require the payment of such fees as will in the aggregate, in the judgment of the Administrator, be sufficient over a reasonable term to provide, equip, and maintain an adequate service for the performance of the Secretary's&#160;10 functions under this section. Under such regulations, the performance of the Secretary's&#160;10 services or other functions pursuant to this section, including any one or more of the following, may be conditioned upon the payment of such fees: (1) The acceptance of filing of a petition submitted under subsection (d) of this section; (2) the promulgation of a regulation establishing a tolerance, or an exemption from the necessity of a tolerance, under this section, or the amendment or repeal of such a regulation; (3) the referral of a petition or proposal under this section to an advisory committee; (4) the acceptance for filing of objections under subsection (d)(5) of this section; or (5) the certification and filing in court of a transcript of the proceedings and the record under subsection (i)(2) of this section. Such regulations may further provide for waiver or refund of fees in whole or in part when in the judgment of the Administrator such waiver or refund is equitable and not contrary to the purposes of this subsection."
  ]
  node [
    id 1141
    label "section_346a_subsection_d_item_1_subitem_E"
    class_name "subitem"
    text "(E) practicable methods for removing residue which exceeds any proposed tolerance;"
  ]
  node [
    id 1142
    label "section_346a_subsection_a_item_2"
    class_name "item"
    text "(2) with respect to use in or on such raw agricultural commodity, the pesticide chemical has been exempted from the requirement of a tolerance by the Administrator under this section."
  ]
  node [
    id 1143
    label "section_346a_subsection_k"
    class_name "subsection"
    text "(k) Regulations based on public hearings before January 1, 1953"
  ]
  node [
    id 1144
    label "section_346a_subsection_d_item_2"
    class_name "item"
    text "(2) Within ninety days after a certification of usefulness by the Secretary of Agriculture&#160;3 under subsection (l) of this section with respect to the pesticide chemical named in the petition, the Administrator of Health and Human Services&#160;4 shall, after giving due consideration to the data submitted in the petition or otherwise before him, by order make public a regulation&#8212;"
  ]
  node [
    id 1145
    label "section_346a_subsection_b"
    class_name "subsection"
    text "(b) Establishment of tolerances"
  ]
  node [
    id 1146
    label "section_346a_subsection_l_item_2_subitem_B"
    class_name "subitem"
    text "In the event that the Secretary of Agriculture&#160;8 takes the action described in clause (2) of the preceding sentence, the person requesting the certification, within one week after receiving the proposed certification, may either (A) request the Secretary of Agriculture&#160;8 to certify to the Administrator of Health and Human Services&#160;9 on the basis of the proposed certification; (B) request a hearing on the proposed certification or the parts thereof objected to; or (C) request both such certification and such hearing. If no such action is taken, the Administrator may by order make the certification as proposed. In the event that the action described in clause (A) or (C) is taken, the Administrator shall by order make the certification as proposed with respect to such parts thereof as are requested. In the event a hearing is requested, the Secretary of Agriculture&#160;8 shall provide opportunity for a prompt hearing. The certification of the Secretary of Agriculture&#160;8 as the result of such hearing shall be made by order and shall be based only on substantial evidence of record at the hearing and shall set forth detailed findings of fact. In no event shall the time elapsing between the making of a request for a certification under this subsection and final certification by the Secretary of Agriculture&#160;8 exceed one hundred and sixty days. The Administrator shall submit to the Administrator of Health and Human Services&#160;9 with any certification of usefulness under this subsection an opinion, based on the data before him, whether the tolerance or exemption proposed by the petitioner reasonably reflects the amount of residue likely to result when the pesticide chemical is used in the manner proposed for the purpose for which the certification is made. The Secretary of Agriculture,8 after due notice and opportunity for public hearing, is authorized to promulgate rules and regulations for carrying out the provisions of this subsection."
  ]
  node [
    id 1147
    label "section_346a_subsection_f"
    class_name "subsection"
    text "(f) Data submitted as confidential"
  ]
  node [
    id 1148
    label "section_346a_subsection_o_item_2"
    class_name "item"
    text "The Administrator shall by regulation require the payment of such fees as will in the aggregate, in the judgment of the Administrator, be sufficient over a reasonable term to provide, equip, and maintain an adequate service for the performance of the Secretary's&#160;10 functions under this section. Under such regulations, the performance of the Secretary's&#160;10 services or other functions pursuant to this section, including any one or more of the following, may be conditioned upon the payment of such fees: (1) The acceptance of filing of a petition submitted under subsection (d) of this section; (2) the promulgation of a regulation establishing a tolerance, or an exemption from the necessity of a tolerance, under this section, or the amendment or repeal of such a regulation; (3) the referral of a petition or proposal under this section to an advisory committee; (4) the acceptance for filing of objections under subsection (d)(5) of this section; or (5) the certification and filing in court of a transcript of the proceedings and the record under subsection (i)(2) of this section. Such regulations may further provide for waiver or refund of fees in whole or in part when in the judgment of the Administrator such waiver or refund is equitable and not contrary to the purposes of this subsection."
  ]
  node [
    id 1149
    label "section_346a_subsection_o"
    class_name "subsection"
    text "(o) Payment of fees; services or functions as conditioned on; waiver or refund of fees"
  ]
  node [
    id 1150
    label "section_346a_subsection_e_item_5"
    class_name "item"
    text "The Administrator may at any time, upon his own initiative or upon the request of any interested person, propose the issuance of a regulation establishing a tolerance for a pesticide chemical or exempting it from the necessity of a tolerance. Thirty days after publication of such a proposal, the Administrator may by order publish a regulation based upon the proposal which shall become effective upon publication unless within such thirty-day period a person who has registered, or who has submitted an application for the registration of, a pesticide under the Federal Insecticide, Fungicide, and Rodenticide Act [7 U.S.C. 136 et seq.] containing the pesticide chemical named in the proposal, requests that the proposal be referred to an advisory committee. In the event of such a request, the Administrator shall forthwith submit the proposal and other relevant data before him to an advisory committee to be appointed in accordance with subsection (g) of this section. As soon as practicable after such referral, but not later than sixty days thereafter, unless extended as hereinafter provided, the committee shall, after independent study of the data submitted to it by the Administrator and other data before it, certify to the Administrator a report and recommendations on the proposal together with all underlying data and a statement of the reasons or basis for the recommendations. The sixty-day period provided for herein may be extended by the advisory committee for an additional thirty days if the advisory committee deems this necessary. Within thirty days after such certification, the Administrator may, after giving due consideration to all data before him, including such report, recommendations, underlying data and statement, by order publish a regulation establishing a tolerance for the pesticide chemical named in the proposal or exempting it from the necessity of a tolerance which shall become effective upon publication. Regulations issued under this subsection shall upon publication be subject to paragraph (5) of subsection (d) of this section."
  ]
  node [
    id 1151
    label "section_346a_subsection_b_item_1"
    class_name "item"
    text "The Administrator shall promulgate regulations establishing tolerances with respect to the use in or on raw agricultural commodities of poisonous or deleterious pesticide chemicals and of pesticide chemicals which are not generally recognized, among experts qualified by scientific training and experience to evaluate the safety of pesticide chemicals, as safe for use, to the extent necessary to protect the public health. In establishing any such regulation, the Administrator shall give appropriate consideration, among other relevant factors, (1) to the necessity for the production of an adequate, wholesome, and economical food supply; (2) to the other ways in which the consumer may be affected by the same pesticide chemical or by other related substances that are poisonous or deleterious; and (3) to the opinion of the Secretary of Agriculture&#160;1 as submitted with a certification of usefulness under subsection (l) of this section. Such regulations shall be promulgated in the manner prescribed in subsection (d) or (e) of this section. In carrying out the provisions of this section relating to the establishment of tolerances, the Administrator may establish the tolerance applicable with respect to the use of any pesticide chemical in or on any raw agricultural commodity at zero level if the scientific data before the Administrator does not justify the establishment of a greater tolerance."
  ]
  node [
    id 1152
    label "section_346a_subsection_d_item_1_subitem_D"
    class_name "subitem"
    text "(D) the results of tests on the amount of residue remaining, including a description of the analytical methods used;"
  ]
  node [
    id 1153
    label "section_346a_subsection_i_item_1"
    class_name "item"
    text "(1) In a case of actual controversy as to the validity of any order under subsection (d)(5), (e), or (l) of this section any person who will be adversely affected by such order may obtain judicial review by filing in the United States Court of Appeals for the circuit wherein such person resides or has his principal place of business, or in the United States Court of Appeals for the District of Columbia Circuit, within sixty days after the entry of such order, a petition praying that the order be set aside in whole or in part."
  ]
  node [
    id 1154
    label "section_346a_subsection_i_item_2"
    class_name "item"
    text "(2) In the case of a petition with respect to an order under subsection (d)(5) or (e) of this section, a copy of the petition shall be forthwith transmitted by the clerk of the court to the Administrator, or any officer designated by him for that purpose, and thereupon the Administrator shall file in the court the record of the proceedings on which he based his order, as provided in section 2112 of title 28. Upon the filing of such petition, the court shall have exclusive jurisdiction to affirm or set aside the order complained of in whole or in part. The findings of the Administrator with respect to questions of fact shall be sustained if supported by substantial evidence when considered on the record as a whole, including any report and recommendation of an advisory committee."
  ]
  node [
    id 1155
    label "section_346a_subsection_d_item_1"
    class_name "item"
    text "(1) Any person who has registered, or who has submitted an application for the registration of, a pesticide under the Federal Insecticide, Fungicide, and Rodenticide Act [7 U.S.C. 136 et seq.] may file with the Administrator of Health and Human Services,2 a petition proposing the issuance of a regulation establishing a tolerance for a pesticide chemical which constitutes, or is an ingredient of, such pesticide, or exempting the pesticide chemical from the requirement of a tolerance. The petition shall contain data showing&#8212;"
  ]
  node [
    id 1156
    label "section_346a_subsection_d_item_2_subitem_B"
    class_name "subitem"
    text "(B) exempting the pesticide chemical from the necessity of a tolerance for such purposes,"
  ]
  node [
    id 1157
    label "section_346a_subsection_o_item_3"
    class_name "item"
    text "The Administrator shall by regulation require the payment of such fees as will in the aggregate, in the judgment of the Administrator, be sufficient over a reasonable term to provide, equip, and maintain an adequate service for the performance of the Secretary's&#160;10 functions under this section. Under such regulations, the performance of the Secretary's&#160;10 services or other functions pursuant to this section, including any one or more of the following, may be conditioned upon the payment of such fees: (1) The acceptance of filing of a petition submitted under subsection (d) of this section; (2) the promulgation of a regulation establishing a tolerance, or an exemption from the necessity of a tolerance, under this section, or the amendment or repeal of such a regulation; (3) the referral of a petition or proposal under this section to an advisory committee; (4) the acceptance for filing of objections under subsection (d)(5) of this section; or (5) the certification and filing in court of a transcript of the proceedings and the record under subsection (i)(2) of this section. Such regulations may further provide for waiver or refund of fees in whole or in part when in the judgment of the Administrator such waiver or refund is equitable and not contrary to the purposes of this subsection."
  ]
  node [
    id 1158
    label "section_346a_subsection_g_item_5"
    class_name "item"
    text "Whenever the referral of a petition or proposal to an advisory committee is requested under this section, or the Administrator otherwise deems such referral necessary the Administrator shall forthwith appoint a committee of competent experts to review the petition or proposal and to make a report and recommendations thereon. Each such advisory committee shall be composed of experts, qualified in the subject matter of the petition and of adequately diversified professional background selected by the National Academy of Sciences and shall include one or more representatives from land-grant colleges. The size of the committee shall be determined by the Administrator. Members of an advisory committee shall receive compensation and travel expenses in accordance with subsection (b)(5)(D) of section 379e of this title. The members shall not be subject to any other provision of law regarding the appointment and compensation of employees of the United States. The Administrator shall furnish the Committee with adequate clerical and other assistance, and shall by rules and regulations prescribe the procedure to be followed by the committee."
  ]
  node [
    id 1159
    label "section_346a_subsection_h"
    class_name "subsection"
    text "(h) Right of consultation"
  ]
  node [
    id 1160
    label "section_346a_subsection_o_item_4"
    class_name "item"
    text "The Administrator shall by regulation require the payment of such fees as will in the aggregate, in the judgment of the Administrator, be sufficient over a reasonable term to provide, equip, and maintain an adequate service for the performance of the Secretary's&#160;10 functions under this section. Under such regulations, the performance of the Secretary's&#160;10 services or other functions pursuant to this section, including any one or more of the following, may be conditioned upon the payment of such fees: (1) The acceptance of filing of a petition submitted under subsection (d) of this section; (2) the promulgation of a regulation establishing a tolerance, or an exemption from the necessity of a tolerance, under this section, or the amendment or repeal of such a regulation; (3) the referral of a petition or proposal under this section to an advisory committee; (4) the acceptance for filing of objections under subsection (d)(5) of this section; or (5) the certification and filing in court of a transcript of the proceedings and the record under subsection (i)(2) of this section. Such regulations may further provide for waiver or refund of fees in whole or in part when in the judgment of the Administrator such waiver or refund is equitable and not contrary to the purposes of this subsection."
  ]
  node [
    id 1161
    label "section_346a_subsection_e"
    class_name "subsection"
    text "(e) Regulations pursuant to Administrator's proposals"
  ]
  node [
    id 1162
    label "section_346a_subsection_g"
    class_name "subsection"
    text "(g) Advisory committees; appointment; composition; compensation; clerical assistance"
  ]
  node [
    id 1163
    label "section_346a_subsection_c"
    class_name "subsection"
    text "(c) Exemptions"
  ]
  node [
    id 1164
    label "section_346a_subsection_n"
    class_name "subsection"
    text "(n) Guaranties"
  ]
  node [
    id 1165
    label "section_346a_subsection_d_item_3_subitem_B"
    class_name "subitem"
    text "(B) exempting the pesticide chemical from the necessity of a tolerance for such purposes."
  ]
  node [
    id 1166
    label "section_346a_subsection_l_item_2"
    class_name "item"
    text "In the event that the Secretary of Agriculture&#160;8 takes the action described in clause (2) of the preceding sentence, the person requesting the certification, within one week after receiving the proposed certification, may either (A) request the Secretary of Agriculture&#160;8 to certify to the Administrator of Health and Human Services&#160;9 on the basis of the proposed certification; (B) request a hearing on the proposed certification or the parts thereof objected to; or (C) request both such certification and such hearing. If no such action is taken, the Administrator may by order make the certification as proposed. In the event that the action described in clause (A) or (C) is taken, the Administrator shall by order make the certification as proposed with respect to such parts thereof as are requested. In the event a hearing is requested, the Secretary of Agriculture&#160;8 shall provide opportunity for a prompt hearing. The certification of the Secretary of Agriculture&#160;8 as the result of such hearing shall be made by order and shall be based only on substantial evidence of record at the hearing and shall set forth detailed findings of fact. In no event shall the time elapsing between the making of a request for a certification under this subsection and final certification by the Secretary of Agriculture&#160;8 exceed one hundred and sixty days. The Administrator shall submit to the Administrator of Health and Human Services&#160;9 with any certification of usefulness under this subsection an opinion, based on the data before him, whether the tolerance or exemption proposed by the petitioner reasonably reflects the amount of residue likely to result when the pesticide chemical is used in the manner proposed for the purpose for which the certification is made. The Secretary of Agriculture,8 after due notice and opportunity for public hearing, is authorized to promulgate rules and regulations for carrying out the provisions of this subsection."
  ]
  node [
    id 1167
    label "section_346a_subsection_i"
    class_name "subsection"
    text "(i) Judicial review"
  ]
  node [
    id 1168
    label "section_346a_subsection_l_item_1"
    class_name "item"
    text "(1) certify to the Administrator of Health and Human Services&#160;9 that such pesticide chemical is useful for the purpose for which a tolerance or exemption is sought; or"
  ]
  node [
    id 1169
    label "section_346a_subsection_l_item_2_subitem_C"
    class_name "subitem"
    text "In the event that the Secretary of Agriculture&#160;8 takes the action described in clause (2) of the preceding sentence, the person requesting the certification, within one week after receiving the proposed certification, may either (A) request the Secretary of Agriculture&#160;8 to certify to the Administrator of Health and Human Services&#160;9 on the basis of the proposed certification; (B) request a hearing on the proposed certification or the parts thereof objected to; or (C) request both such certification and such hearing. If no such action is taken, the Administrator may by order make the certification as proposed. In the event that the action described in clause (A) or (C) is taken, the Administrator shall by order make the certification as proposed with respect to such parts thereof as are requested. In the event a hearing is requested, the Secretary of Agriculture&#160;8 shall provide opportunity for a prompt hearing. The certification of the Secretary of Agriculture&#160;8 as the result of such hearing shall be made by order and shall be based only on substantial evidence of record at the hearing and shall set forth detailed findings of fact. In no event shall the time elapsing between the making of a request for a certification under this subsection and final certification by the Secretary of Agriculture&#160;8 exceed one hundred and sixty days. The Administrator shall submit to the Administrator of Health and Human Services&#160;9 with any certification of usefulness under this subsection an opinion, based on the data before him, whether the tolerance or exemption proposed by the petitioner reasonably reflects the amount of residue likely to result when the pesticide chemical is used in the manner proposed for the purpose for which the certification is made. The Secretary of Agriculture,8 after due notice and opportunity for public hearing, is authorized to promulgate rules and regulations for carrying out the provisions of this subsection."
  ]
  node [
    id 1170
    label "section_346a_subsection_l"
    class_name "subsection"
    text "(l) Pesticides under Federal Insecticide, Fungicide, and Rodenticide Act; functions of Administrator of the Environmental Protection Agency; certifications; hearing; time limitation; opinion; regulations"
  ]
  node [
    id 1171
    label "section_346a_subsection_m"
    class_name "subsection"
    text "(m) Amendment of regulations"
  ]
  node [
    id 1172
    label "section_346a_subsection_g_item_5_subitem_D"
    class_name "subitem"
    text "Whenever the referral of a petition or proposal to an advisory committee is requested under this section, or the Administrator otherwise deems such referral necessary the Administrator shall forthwith appoint a committee of competent experts to review the petition or proposal and to make a report and recommendations thereon. Each such advisory committee shall be composed of experts, qualified in the subject matter of the petition and of adequately diversified professional background selected by the National Academy of Sciences and shall include one or more representatives from land-grant colleges. The size of the committee shall be determined by the Administrator. Members of an advisory committee shall receive compensation and travel expenses in accordance with subsection (b)(5)(D) of section 379e of this title. The members shall not be subject to any other provision of law regarding the appointment and compensation of employees of the United States. The Administrator shall furnish the Committee with adequate clerical and other assistance, and shall by rules and regulations prescribe the procedure to be followed by the committee."
  ]
  node [
    id 1173
    label "section_346a_subsection_d_item_1_subitem_C"
    class_name "subitem"
    text "(C) full reports of investigations made with respect to the safety of the pesticide chemical;"
  ]
  node [
    id 1174
    label "section_346a_subsection_b_item_2"
    class_name "item"
    text "The Administrator shall promulgate regulations establishing tolerances with respect to the use in or on raw agricultural commodities of poisonous or deleterious pesticide chemicals and of pesticide chemicals which are not generally recognized, among experts qualified by scientific training and experience to evaluate the safety of pesticide chemicals, as safe for use, to the extent necessary to protect the public health. In establishing any such regulation, the Administrator shall give appropriate consideration, among other relevant factors, (1) to the necessity for the production of an adequate, wholesome, and economical food supply; (2) to the other ways in which the consumer may be affected by the same pesticide chemical or by other related substances that are poisonous or deleterious; and (3) to the opinion of the Secretary of Agriculture&#160;1 as submitted with a certification of usefulness under subsection (l) of this section. Such regulations shall be promulgated in the manner prescribed in subsection (d) or (e) of this section. In carrying out the provisions of this section relating to the establishment of tolerances, the Administrator may establish the tolerance applicable with respect to the use of any pesticide chemical in or on any raw agricultural commodity at zero level if the scientific data before the Administrator does not justify the establishment of a greater tolerance."
  ]
  node [
    id 1175
    label "section_346a_subsection_d_item_5"
    class_name "item"
    text "(5) Within thirty days after publication, any person adversely affected by a regulation published pursuant to paragraph (2) or (3) of this subsection, or pursuant to subsection (e) of this section, may file objections thereto with the Administrator, specifying with particularity the provisions of the regulation deemed objectionable, stating reasonable grounds therefor, and requesting a public hearing upon such objections. A copy of the objections filed by a person other than the petitioner shall be served on the petitioner, if the regulation was issued pursuant to a petition. The petitioner shall have two weeks to make a written reply to the objections. The Administrator shall thereupon, after due notice, hold such public hearing for the purpose of receiving evidence relevant and material to the issues raised by such objections. Any report, recommendations, underlying data, and reasons certified to the Administrator by an advisory committee shall be made a part of the record of the hearing, if relevant and material, subject to the provisions of section 556(c)&#160;5 of title 5. The National Academy of Sciences shall designate a member of the advisory committee to appear and testify at any such hearing with respect to the report and recommendations of such committee upon request of the Administrator, the petitioner, or the officer conducting the hearing: Provided, That this shall not preclude any other member of the advisory committee from appearing and testifying at such hearing. As soon as practicable after completion of the hearing, the Administrator shall act upon such objections and by order make public a regulation. Such regulation shall be based only on substantial evidence of record at such hearing, including any report, recommendations, underlying data, and reasons certified to the Administrator by an advisory committee, and shall set forth detailed findings of fact upon which the regulation is based. No such order shall take effect prior to the ninetieth day after its publication, unless the Administrator finds that emergency conditions exist necessitating an earlier effective date, in which event the Administrator shall specify in the order his findings as to such conditions."
  ]
  node [
    id 1176
    label "section_346a_subsection_d_item_1_subitem_F"
    class_name "subitem"
    text "(F) proposed tolerances for the pesticide chemical if tolerances are proposed; and"
  ]
  node [
    id 1177
    label "section_346a_subsection_d"
    class_name "subsection"
    text "(d) Regulations pursuant to petition; publication of notice; time for issuance; referral to advisory committees; effective date; hearings"
  ]
  node [
    id 1178
    label "section_346a_subsection_i_item_3"
    class_name "item"
    text "(3) In the case of a petition with respect to an order under subsection (l) of this section, a copy of the petition shall be forthwith transmitted by the clerk of the court to the Secretary of Agriculture,6 or any officer designated by him for that purpose, and thereupon the Administrator shall file in the court the record of the proceedings on which he based his order, as provided in section 2112 of title 28. Upon the filing of such petition, the court shall have exclusive jurisdiction to affirm or set aside the order complained of in whole or in part. The findings of the Administrator with respect to questions of fact shall be sustained if supported by substantial evidence when considered on the record as a whole."
  ]
  node [
    id 1179
    label "section_346a_subsection_l_item_2_subitem_A"
    class_name "subitem"
    text "In the event that the Secretary of Agriculture&#160;8 takes the action described in clause (2) of the preceding sentence, the person requesting the certification, within one week after receiving the proposed certification, may either (A) request the Secretary of Agriculture&#160;8 to certify to the Administrator of Health and Human Services&#160;9 on the basis of the proposed certification; (B) request a hearing on the proposed certification or the parts thereof objected to; or (C) request both such certification and such hearing. If no such action is taken, the Administrator may by order make the certification as proposed. In the event that the action described in clause (A) or (C) is taken, the Administrator shall by order make the certification as proposed with respect to such parts thereof as are requested. In the event a hearing is requested, the Secretary of Agriculture&#160;8 shall provide opportunity for a prompt hearing. The certification of the Secretary of Agriculture&#160;8 as the result of such hearing shall be made by order and shall be based only on substantial evidence of record at the hearing and shall set forth detailed findings of fact. In no event shall the time elapsing between the making of a request for a certification under this subsection and final certification by the Secretary of Agriculture&#160;8 exceed one hundred and sixty days. The Administrator shall submit to the Administrator of Health and Human Services&#160;9 with any certification of usefulness under this subsection an opinion, based on the data before him, whether the tolerance or exemption proposed by the petitioner reasonably reflects the amount of residue likely to result when the pesticide chemical is used in the manner proposed for the purpose for which the certification is made. The Secretary of Agriculture,8 after due notice and opportunity for public hearing, is authorized to promulgate rules and regulations for carrying out the provisions of this subsection."
  ]
  node [
    id 1180
    label "section_346a_subsection_f_item_3"
    class_name "item"
    text "All data submitted to the Administrator or to an advisory committee in support of a petition under this section shall be considered confidential by the Administrator and by such advisory committee until publication of a regulation under paragraph (2) or (3) of subsection (d) of this section. Until such publication, such data shall not be revealed to any person other than those authorized by the Administrator or by an advisory committee in the carrying out of their official duties under this section."
  ]
  node [
    id 1181
    label "section_346a_subsection_a"
    class_name "subsection"
    text "(a) Conditions of safety"
  ]
  node [
    id 1182
    label "section_346a_subsection_d_item_3"
    class_name "item"
    text "(3) In the event that the person filing the petition requests, within ninety days after a certification of usefulness by the Secretary of Agriculture&#160;3 under subsection (l) of this section with respect to the pesticide chemical named in the petition, that the petition be referred to an advisory committee, or in the event the Administrator of Health and Human Services&#160;4 within such period otherwise deems such referral necessary, the Administrator of Health and Human Services&#160;4 shall forthwith submit the petition and other data before him to an advisory committee to be appointed in accordance with subsection (g) of this section. As soon as practicable after such referral, but not later than sixty days thereafter, unless extended as hereinafter provided, the committee shall, after independent study of the data submitted to it by the Administrator and other data before it, certify to the Administrator a report and recommendations on the proposal in the petition to the Administrator, together with all underlying data and a statement of the reasons or basis for the recommendations. The sixty-day period provided for herein may be extended by the advisory committee for an additional thirty days if the advisory committee deems this necessary. Within thirty days after such certification, the Administrator shall, after giving due consideration to all data then before him, including such report, recommendations, underlying data, and statement, by order make public a regulation&#8212;"
  ]
  node [
    id 1183
    label "section_346a_subsection_d_item_2_subitem_A"
    class_name "subitem"
    text "(A) establishing a tolerance for the pesticide chemical named in the petition for the purposes for which it is so certified as useful, or"
  ]
  node [
    id 1184
    label "section_346a_subsection_d_item_1_subitem_G"
    class_name "subitem"
    text "(G) reasonable grounds in support of the petition."
  ]
  node [
    id 1185
    label "section_346a_subsection_f_item_2"
    class_name "item"
    text "All data submitted to the Administrator or to an advisory committee in support of a petition under this section shall be considered confidential by the Administrator and by such advisory committee until publication of a regulation under paragraph (2) or (3) of subsection (d) of this section. Until such publication, such data shall not be revealed to any person other than those authorized by the Administrator or by an advisory committee in the carrying out of their official duties under this section."
  ]
  node [
    id 1186
    label "section_346a_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) the amount, frequency, and time of application of the pesticide chemical;"
  ]
  node [
    id 1187
    label "section_346a_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(A) the name, chemical identity, and composition of the pesticide chemical;"
  ]
  node [
    id 1188
    label "section_346a_subsection_j"
    class_name "subsection"
    text "(j) Temporary tolerances"
  ]
  node [
    id 1189
    label "section_346a_subsection_d_item_4"
    class_name "item"
    text "(4) The regulations published under paragraph (2) or (3) of this subsection will be effective upon publication."
  ]
  node [
    id 1190
    label "section_346a_subsection_i_item_5"
    class_name "item"
    text "(5) The judgment of the court affirming or setting aside, in whole or in part, any order under this section shall be final, subject to review by the Supreme Court of the United States upon certiorari or certification as provided in section 1254 of title 28. The commencement of proceedings under this section shall not, unless specifically ordered by the court to the contrary, operate as a stay of an order."
  ]
  node [
    id 1191
    label "section_346a_subsection_b_item_3"
    class_name "item"
    text "The Administrator shall promulgate regulations establishing tolerances with respect to the use in or on raw agricultural commodities of poisonous or deleterious pesticide chemicals and of pesticide chemicals which are not generally recognized, among experts qualified by scientific training and experience to evaluate the safety of pesticide chemicals, as safe for use, to the extent necessary to protect the public health. In establishing any such regulation, the Administrator shall give appropriate consideration, among other relevant factors, (1) to the necessity for the production of an adequate, wholesome, and economical food supply; (2) to the other ways in which the consumer may be affected by the same pesticide chemical or by other related substances that are poisonous or deleterious; and (3) to the opinion of the Secretary of Agriculture&#160;1 as submitted with a certification of usefulness under subsection (l) of this section. Such regulations shall be promulgated in the manner prescribed in subsection (d) or (e) of this section. In carrying out the provisions of this section relating to the establishment of tolerances, the Administrator may establish the tolerance applicable with respect to the use of any pesticide chemical in or on any raw agricultural commodity at zero level if the scientific data before the Administrator does not justify the establishment of a greater tolerance."
  ]
  node [
    id 1192
    label "section_346a_subsection_i_item_4"
    class_name "item"
    text "(4) If application is made to the court for leave to adduce additional evidence, the court may order such additional evidence to be taken before the Administrator of Health and Human Services&#160;7 or the Secretary of Agriculture,6 as the case may be, and to be adduced upon the hearing in such manner and upon such terms and conditions as to the court may seem proper, if such evidence is material and there were reasonable grounds for failure to adduce such evidence in the proceedings below. The Administrator of Health and Human Services&#160;7 or the Secretary of Agriculture,6 as the case may be, may modify his findings as to the facts and order by reason of the additional evidence so taken, and shall file with the court such modified findings and order."
  ]
  node [
    id 1193
    label "section_346a_subsection_d_item_3_subitem_A"
    class_name "subitem"
    text "(A) establishing a tolerance for the pesticide chemical named in the petition for the purposes for which it is so certified as useful; or"
  ]
  node [
    id 1194
    label "section_346a_subsection_a_item_1"
    class_name "item"
    text "While a tolerance or exemption from tolerance is in effect for a pesticide chemical with respect to any raw agricultural commodity, such raw agricultural commodity shall not, by reason of bearing or containing any added amount of such pesticide chemical, be considered to be adulterated within the meaning of clause (1) of section 342(a) of this title."
  ]
  node [
    id 1195
    label "section_346a_subsection_o_item_5_subsubitem_i"
    class_name "subsubitem"
    text "The Administrator shall by regulation require the payment of such fees as will in the aggregate, in the judgment of the Administrator, be sufficient over a reasonable term to provide, equip, and maintain an adequate service for the performance of the Secretary's&#160;10 functions under this section. Under such regulations, the performance of the Secretary's&#160;10 services or other functions pursuant to this section, including any one or more of the following, may be conditioned upon the payment of such fees: (1) The acceptance of filing of a petition submitted under subsection (d) of this section; (2) the promulgation of a regulation establishing a tolerance, or an exemption from the necessity of a tolerance, under this section, or the amendment or repeal of such a regulation; (3) the referral of a petition or proposal under this section to an advisory committee; (4) the acceptance for filing of objections under subsection (d)(5) of this section; or (5) the certification and filing in court of a transcript of the proceedings and the record under subsection (i)(2) of this section. Such regulations may further provide for waiver or refund of fees in whole or in part when in the judgment of the Administrator such waiver or refund is equitable and not contrary to the purposes of this subsection."
  ]
  node [
    id 1196
    label "section_346a_subsection_o_item_1"
    class_name "item"
    text "The Administrator shall by regulation require the payment of such fees as will in the aggregate, in the judgment of the Administrator, be sufficient over a reasonable term to provide, equip, and maintain an adequate service for the performance of the Secretary's&#160;10 functions under this section. Under such regulations, the performance of the Secretary's&#160;10 services or other functions pursuant to this section, including any one or more of the following, may be conditioned upon the payment of such fees: (1) The acceptance of filing of a petition submitted under subsection (d) of this section; (2) the promulgation of a regulation establishing a tolerance, or an exemption from the necessity of a tolerance, under this section, or the amendment or repeal of such a regulation; (3) the referral of a petition or proposal under this section to an advisory committee; (4) the acceptance for filing of objections under subsection (d)(5) of this section; or (5) the certification and filing in court of a transcript of the proceedings and the record under subsection (i)(2) of this section. Such regulations may further provide for waiver or refund of fees in whole or in part when in the judgment of the Administrator such waiver or refund is equitable and not contrary to the purposes of this subsection."
  ]
  node [
    id 1197
    label "section_346b_item_2"
    class_name "item"
    text "There are authorized to be appropriated, out of any moneys in the Treasury not otherwise appropriated, such sums as may be necessary for the purpose and administration of sections 321(q), (r), 342(a)(2), and 346a of this title."
  ]
  node [
    id 1198
    label "section_347_subsection_b_item_3"
    class_name "item"
    text "(3) there appears on the label of the package (A) the word &#8220;oleomargarine&#8221; or &#8220;margarine&#8221; in type or lettering at least as large as any other type or lettering on such label, and (B) a full and accurate statement of all the ingredients contained in such oleomargarine or margarine, and"
  ]
  node [
    id 1199
    label "section_347_subsection_a"
    class_name "subsection"
    text "(a) Law governing"
  ]
  node [
    id 1200
    label "section_347_subsection_b_item_4"
    class_name "item"
    text "(4) each part of the contents of the package is contained in a wrapper which bears the word &#8220;oleomargarine&#8221; or &#8220;margarine&#8221; in type or lettering not smaller than 20-point type."
  ]
  node [
    id 1201
    label "section_347_subsection_e"
    class_name "subsection"
    text "(e) Color content of oleomargarine"
  ]
  node [
    id 1202
    label "section_347_subsection_b_item_2"
    class_name "item"
    text "(2) the net weight of the contents of any package sold in a retail establishment is one pound or less,"
  ]
  node [
    id 1203
    label "section_347_subsection_b"
    class_name "subsection"
    text "(b) Labeling and packaging requirements"
  ]
  node [
    id 1204
    label "section_347_subsection_b_item_1"
    class_name "item"
    text "(1) such oleomargarine or margarine is packaged,"
  ]
  node [
    id 1205
    label "section_347_subsection_c_item_1"
    class_name "item"
    text "No person shall possess in a form ready for serving colored oleomargarine or colored margarine at a public eating place unless a notice that oleomargarine or margarine is served is displayed prominently and conspicuously in such place and in such manner as to render it likely to be read and understood by the ordinary individual being served in such eating place or is printed or is otherwise set forth on the menu in type or lettering not smaller than that normally used to designate the serving of other food items. No person shall serve colored oleomargarine or colored margarine at a public eating place, whether or not any charge is made therefor, unless (1) each separate serving bears or is accompanied by labeling identifying it as oleomargarine or margarine, or (2) each separate serving thereof is triangular in shape."
  ]
  node [
    id 1206
    label "section_347_subsection_c"
    class_name "subsection"
    text "(c) Sales in public eating places"
  ]
  node [
    id 1207
    label "section_347_subsection_d"
    class_name "subsection"
    text "(d) Exemption from labeling requirements"
  ]
  node [
    id 1208
    label "section_347_subsection_c_item_2"
    class_name "item"
    text "No person shall possess in a form ready for serving colored oleomargarine or colored margarine at a public eating place unless a notice that oleomargarine or margarine is served is displayed prominently and conspicuously in such place and in such manner as to render it likely to be read and understood by the ordinary individual being served in such eating place or is printed or is otherwise set forth on the menu in type or lettering not smaller than that normally used to designate the serving of other food items. No person shall serve colored oleomargarine or colored margarine at a public eating place, whether or not any charge is made therefor, unless (1) each separate serving bears or is accompanied by labeling identifying it as oleomargarine or margarine, or (2) each separate serving thereof is triangular in shape."
  ]
  node [
    id 1209
    label "section_348_subsection_c_item_5_subitem_B"
    class_name "subitem"
    text "(B) the cumulative effect of such additive in the diet of man or animals, taking into account any chemically or pharmacologically related substance or substances in such diet; and"
  ]
  node [
    id 1210
    label "section_348_subsection_b_item_5"
    class_name "item"
    text "(5) Notice of the regulation proposed by the petitioner shall be published in general terms by the Secretary within thirty days after filing."
  ]
  node [
    id 1211
    label "section_348_subsection_c_item_5_subitem_A"
    class_name "subitem"
    text "(A) the probable consumption of the additive and of any substance formed in or on food because of the use of the additive;"
  ]
  node [
    id 1212
    label "section_348_subsection_a_item_1"
    class_name "item"
    text "While such a regulation relating to a food additive is in effect, a food shall not, by reason of bearing or containing such an additive in accordance with the regulation, be considered adulterated within the meaning of clause (1) of section 342(a) of this title."
  ]
  node [
    id 1213
    label "section_348_subsection_c_item_5"
    class_name "item"
    text "(5) In determining, for the purposes of this section, whether a proposed use of a food additive is safe, the Secretary shall consider among other relevant factors&#8212;"
  ]
  node [
    id 1214
    label "section_348_subsection_d"
    class_name "subsection"
    text "(d) Regulation issued on Secretary's initiative"
  ]
  node [
    id 1215
    label "section_348_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) by order deny the petition, and shall notify the petitioner of such order and of the reasons for such action."
  ]
  node [
    id 1216
    label "section_348_subsection_a"
    class_name "subsection"
    text "(a) Unsafe food additives; exception for conformity with exemption or regulation"
  ]
  node [
    id 1217
    label "section_348_subsection_f_item_3"
    class_name "item"
    text "(3) The Secretary shall specify in the order the date on which it shall take effect, except that it shall not be made to take effect prior to the ninetieth day after its publication, unless the Secretary finds that emergency conditions exist necessitating an earlier effective date, in which event the Secretary shall specify in the order his findings as to such conditions."
  ]
  node [
    id 1218
    label "section_348_subsection_g"
    class_name "subsection"
    text "(g) Judicial review"
  ]
  node [
    id 1219
    label "section_348_subsection_c_item_1"
    class_name "item"
    text "(1) The Secretary shall&#8212;"
  ]
  node [
    id 1220
    label "section_348_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "(A) fails to establish that the proposed use of the food additive, under the conditions of use to be specified in the regulation, will be safe: Provided, That no additive shall be deemed to be safe if it is found to induce cancer when ingested by man or animal, or if it is found, after tests which are appropriate for the evaluation of the safety of food additives, to induce cancer in man or animal, except that this proviso shall not apply with respect to the use of a substance as an ingredient of feed for animals which are raised for food production, if the Secretary finds (i) that, under the conditions of use and feeding specified in proposed labeling and reasonably certain to be followed in practice, such additive will not adversely affect the animals for which such feed is intended, and (ii) that no residue of the additive will be found (by methods of examination prescribed or approved by the Secretary by regulations, which regulations shall not be subject to subsections (f) and (g) of this section) in any edible portion of such animal after slaughter or in any food yielded by or derived from the living animal; or"
  ]
  node [
    id 1221
    label "section_348_subsection_b_item_2"
    class_name "item"
    text "(2) Such petition shall, in addition to any explanatory or supporting data, contain&#8212;"
  ]
  node [
    id 1222
    label "section_348_subsection_c_item_4_subitem_B"
    class_name "subitem"
    text "(B) shall not establish a regulation for such proposed use if he finds upon a fair evaluation of the data before him that such data do not establish that such use would accomplish the intended physical or other technical effect."
  ]
  node [
    id 1223
    label "section_348_subsection_b_item_4"
    class_name "item"
    text "(4) Upon request of the Secretary, the petitioner shall furnish samples of the food additive involved, or articles used as components thereof, and of the food in or on which the additive is proposed to be used."
  ]
  node [
    id 1224
    label "section_348_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) the name and all pertinent information concerning such food additive, including, where available, its chemical identity and composition;"
  ]
  node [
    id 1225
    label "section_348_subsection_b_item_2_subitem_E"
    class_name "subitem"
    text "(E) full reports of investigations made with respect to the safety for use of such additive, including full information as to the methods and controls used in conducting such investigations."
  ]
  node [
    id 1226
    label "section_348_subsection_f_item_1"
    class_name "item"
    text "(1) Within thirty days after publication of an order made pursuant to subsection (c) or (d) of this section, any person adversely affected by such an order may file objections thereto with the Secretary, specifying with particularity the provisions of the order deemed objectionable, stating reasonable grounds therefor, and requesting a public hearing upon such objections. The Secretary shall, after due notice, as promptly as possible hold such public hearing for the purpose of receiving evidence relevant and material to the issues raised by such objections. As soon as practicable after completion of the hearing, the Secretary shall by order act upon such objections and make such order public."
  ]
  node [
    id 1227
    label "section_348_subsection_g_item_4"
    class_name "item"
    text "(4) If application is made to the court for leave to adduce additional evidence, the court may order such additional evidence to be taken before the Secretary and to be adduced upon the hearing in such manner and upon such terms and conditions as to the court may seem proper, if such evidence is material and there were reasonable grounds for failure to adduce such evidence in the proceedings below. The Secretary may modify his findings as to the facts and order by reason of the additional evidence so taken, and shall file with the court such modified findings and order."
  ]
  node [
    id 1228
    label "section_348_subsection_a_item_2_subitem_C"
    class_name "subitem"
    text "A food additive shall, with respect to any particular use or intended use of such additives, be deemed to be unsafe for the purposes of the application of clause (2)(C) of section 342(a) of this title, unless&#8212;"
  ]
  node [
    id 1229
    label "section_348_subsection_g_item_1"
    class_name "item"
    text "(1) In a case of actual controversy as to the validity of any order issued under subsection (f) of this section, including any order thereunder with respect to amendment or repeal of a regulation issued under this section, any person who will be adversely affected by such order may obtain judicial review by filing in the United States Court of Appeals for the circuit wherein such person resides or has his principal place of business, or in the United States Court of Appeals for the District of Columbia Circuit, within sixty days after the entry of such order, a petition praying that the order be set aside in whole or in part."
  ]
  node [
    id 1230
    label "section_348_subsection_g_item_2"
    class_name "item"
    text "(2) A copy of such petition shall be forthwith transmitted by the clerk of the court to the Secretary, or any officer designated by him for that purpose, and thereupon the Secretary shall file in the court the record of the proceedings on which he based his order, as provided in section 2112 of title 28. Upon the filing of such petition the court shall have jurisdiction, which upon the filing of the record with it shall be exclusive, to affirm or set aside the order complained of in whole or in part. Until the filing of the record the Secretary may modify or set aside his order. The findings of the Secretary with respect to questions of fact shall be sustained if based upon a fair evaluation of the entire record at such hearing."
  ]
  node [
    id 1231
    label "section_348_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) by order establish a regulation (whether or not in accord with that proposed by the petitioner) prescribing, with respect to one or more proposed uses of the food additive involved, the conditions under which such additive may be safely used (including, but not limited to, specifications as to the particular food or classes of food in or in which such additive may be used, the maximum quantity which may be used or permitted to remain in or on such food, the manner in which such additive may be added to or used in or on such food, and any directions or other labeling or packaging requirements for such additive deemed necessary by him to assure the safety of such use), and shall notify the petitioner of such order and the reasons for such action; or"
  ]
  node [
    id 1232
    label "section_348_subsection_e"
    class_name "subsection"
    text "(e) Publication and effective date of orders"
  ]
  node [
    id 1233
    label "section_348_subsection_b_item_2_subitem_C"
    class_name "subitem"
    text "(C) all relevant data bearing on the physical or other technical effect such additive is intended to produce, and the quantity of such additive required to produce such effect;"
  ]
  node [
    id 1234
    label "section_348_subsection_c_item_2"
    class_name "item"
    text "(2) The order required by paragraph (1)(A) or (B) of this subsection shall be issued within ninety days after the date of filing of the petition, except that the Secretary may (prior to such ninetieth day), by written notice to the petitioner, extend such ninety-day period to such time (not more than one hundred and eighty days after the date of filing of the petition) as the Secretary deems necessary to enable him to study and investigate the petition."
  ]
  node [
    id 1235
    label "section_348_subsection_c"
    class_name "subsection"
    text "(c) Approval or denial of petition; time for issuance of order; evaluation of data; factors"
  ]
  node [
    id 1236
    label "section_348_subsection_a_item_2"
    class_name "item"
    text "(2) there is in effect, and it and its use or intended use are in conformity with, a regulation issued under this section prescribing the conditions under which such additive may be safely used."
  ]
  node [
    id 1237
    label "section_348_subsection_g_item_5"
    class_name "item"
    text "(5) The judgment of the court affirming or setting aside, in whole or in part, any order under this section shall be final, subject to review by the Supreme Court of the United States upon certiorari or certification as provided in section 1254 of title 28. The commencement of proceedings under this section shall not, unless specifically ordered by the court to the contrary, operate as a stay of an order."
  ]
  node [
    id 1238
    label "section_348_subsection_b_item_2_subitem_D"
    class_name "subitem"
    text "(D) a description of practicable methods for determining the quantity of such additive in or on food, and any substance formed in or on food, because of its use; and"
  ]
  node [
    id 1239
    label "section_348_subsection_c_item_5_subitem_C"
    class_name "subitem"
    text "(C) safety factors which in the opinion of experts qualified by scientific training and experience to evaluate the safety of food additives are generally recognized as appropriate for the use of animal experimentation data."
  ]
  node [
    id 1240
    label "section_348_subsection_b_item_1"
    class_name "item"
    text "(1) Any person may, with respect to any intended use of a food additive, file with the Secretary a petition proposing the issuance of a regulation prescribing the conditions under which such additive may be safely used."
  ]
  node [
    id 1241
    label "section_348_subsection_f"
    class_name "subsection"
    text "(f) Objections and public hearing; basis and contents of order; statement"
  ]
  node [
    id 1242
    label "section_348_subsection_h"
    class_name "subsection"
    text "(h) Amendment or repeal of regulations"
  ]
  node [
    id 1243
    label "section_348_subsection_c_item_4"
    class_name "item"
    text "(4) If, in the judgment of the Secretary, based upon a fair evaluation of the data before him, a tolerance limitation is required in order to assure that the proposed use of an additive will be safe, the Secretary&#8212;"
  ]
  node [
    id 1244
    label "section_348_subsection_b_item_3"
    class_name "item"
    text "(3) Upon request of the Secretary, the petitioner shall furnish (or, if the petitioner is not the manufacturer of such additive, the petitioner shall have the manufacturer of such additive furnish, without disclosure to the petitioner) a full description of the methods used in, and the facilities and controls used for, the production of such additive."
  ]
  node [
    id 1245
    label "section_348_subsection_b"
    class_name "subsection"
    text "(b) Petition for regulation prescribing conditions of safe use; contents; description of production methods and controls; samples; notice of regulation"
  ]
  node [
    id 1246
    label "section_348_subsection_c_item_4_subitem_A"
    class_name "subitem"
    text "(A) shall not fix such tolerance limitation at a level higher than he finds to be reasonably required to accomplish the physical or other technical effect for which such additive is intended; and"
  ]
  node [
    id 1247
    label "section_348_subsection_g_item_3"
    class_name "item"
    text "(3) The court, on such judicial review, shall not sustain the order of the Secretary if he failed to comply with any requirement imposed on him by subsection (f)(2) of this section."
  ]
  node [
    id 1248
    label "section_348_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) a statement of the conditions of the proposed use of such additive, including all directions, recommendations, and suggestions proposed for the use of such additive, and including specimens of its proposed labeling;"
  ]
  node [
    id 1249
    label "section_348_subsection_c_item_3_subitem_B"
    class_name "subitem"
    text "(B) shows that the proposed use of the additive would promote deception of the consumer in violation of this chapter or would otherwise result in adulteration or in misbranding of food within the meaning of this chapter."
  ]
  node [
    id 1250
    label "section_348_subsection_c_item_3"
    class_name "item"
    text "(3) No such regulation shall issue if a fair evaluation of the data before the Secretary&#8212;"
  ]
  node [
    id 1251
    label "section_348_subsection_f_item_2"
    class_name "item"
    text "(2) Such order shall be based upon a fair evaluation of the entire record at such hearing, and shall include a statement setting forth in detail the findings and conclusions upon which the order is based."
  ]
  node [
    id 1252
    label "section_348_subsection_i"
    class_name "subsection"
    text "(i) Exemptions for investigational use"
  ]
  node [
    id 1253
    label "section_350_subsection_c_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if not intended for ingestion in such a form, is not represented as conventional food and is not represented for use as a sole item of a meal or of the diet."
  ]
  node [
    id 1254
    label "section_350_subsection_a_item_1_subitem_C_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) other ingredient of food,"
  ]
  node [
    id 1255
    label "section_350_subsection_b_item_2"
    class_name "item"
    text "(2) The labeling for any food to which this section applies may not list its ingredients which are not dietary supplement ingredients described in section 321(ff) of this title (i) except as a part of a list of all the ingredients of such food, and (ii) unless such ingredients are listed in accordance with applicable regulations under section 343 of this title. To the extent that compliance with clause (i) of this subparagraph is impracticable or results in deception or unfair competition, exemptions shall be established by regulations promulgated by the Secretary."
  ]
  node [
    id 1256
    label "section_350_subsection_c_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) is intended for ingestion in tablet, capsule, powder, softgel, gelcap, or liquid form, or"
  ]
  node [
    id 1257
    label "section_350_subsection_b"
    class_name "subsection"
    text "(b) Labeling and advertising requirements for foods"
  ]
  node [
    id 1258
    label "section_350_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) which is or contains any natural or synthetic vitamin or mineral, and"
  ]
  node [
    id 1259
    label "section_350_subsection_c_item_3"
    class_name "item"
    text "(3) For purposes of paragraph (1) and of section 343(j) of this title insofar as that section is applicable to food to which this section applies, the term &#8220;special dietary use&#8221; as applied to food used by man means a particular use for which a food purports or is represented to be used, including but not limited to the following:"
  ]
  node [
    id 1260
    label "section_350_subsection_a_item_1_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) mineral, or"
  ]
  node [
    id 1261
    label "section_350_subsection_c_item_3_subitem_C"
    class_name "subitem"
    text "(C) Supplying a special dietary need by reason of being a food for use as the sole item of the diet."
  ]
  node [
    id 1262
    label "section_350_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) the Secretary may not establish, under section 321(n), 341, or 343 of this title, maximum limits on the potency of any synthetic or natural vitamin or mineral within a food to which this section applies;"
  ]
  node [
    id 1263
    label "section_350_subsection_c"
    class_name "subsection"
    text "(c) Definitions"
  ]
  node [
    id 1264
    label "section_350_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) the Secretary may not classify any natural or synthetic vitamin or mineral (or combination thereof) as a drug solely because it exceeds the level of potency which the Secretary determines is nutritionally rational or useful;"
  ]
  node [
    id 1265
    label "section_350_subsection_a_item_2"
    class_name "item"
    text "(2) Paragraph (1) shall not apply in the case of a vitamin, mineral, other ingredient of food, or food, which is represented for use by individuals in the treatment or management of specific diseases or disorders, by children, or by pregnant or lactating women. For purposes of this subparagraph,1 the term &#8220;children&#8221; means individuals who are under the age of twelve years."
  ]
  node [
    id 1266
    label "section_350_subsection_b_item_1"
    class_name "item"
    text "(1) A food to which this section applies shall not be deemed under section 343 of this title to be misbranded solely because its label bears, in accordance with section 343(i)(2) of this title, all the ingredients in the food or its advertising contains references to ingredients in the food which are not vitamins or minerals."
  ]
  node [
    id 1267
    label "section_350_subsection_c_item_3_subitem_B"
    class_name "subitem"
    text "(B) Supplying a vitamin, mineral, or other ingredient for use by man to supplement his diet by increasing the total dietary intake."
  ]
  node [
    id 1268
    label "section_350_subsection_a"
    class_name "subsection"
    text "(a) Authority and limitations of Secretary; applicability"
  ]
  node [
    id 1269
    label "section_350_subsection_a_item_1_subitem_C"
    class_name "subitem"
    text "(C) the Secretary may not limit, under section 321(n), 341, or 343 of this title, the combination or number of any synthetic or natural&#8212;"
  ]
  node [
    id 1270
    label "section_350_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "(A) Supplying a special dietary need that exists by reason of a physical, physiological, pathological, or other condition, including but not limited to the condition of disease, convalescence, pregnancy, lactation, infancy, allergic hypersensitivity to food, underweight, overweight, or the need to control the intake of sodium."
  ]
  node [
    id 1271
    label "section_350_subsection_a_item_1_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) vitamin,"
  ]
  node [
    id 1272
    label "section_350_subsection_c_item_2"
    class_name "item"
    text "(2) For purposes of paragraph (1)(B)(i), a food shall be considered as intended for ingestion in liquid form only if it is formulated in a fluid carrier and it is intended for ingestion in daily quantities measured in drops or similar small units of measure."
  ]
  node [
    id 1273
    label "section_350_subsection_a_item_1"
    class_name "item"
    text "(1) Except as provided in paragraph (2)&#8212;"
  ]
  node [
    id 1274
    label "section_350_subsection_c_item_1"
    class_name "item"
    text "(1) For purposes of this section, the term &#8220;food to which this section applies&#8221; means a food for humans which is a food for special dietary use&#8212;"
  ]
  node [
    id 1275
    label "section_350_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) which&#8212;"
  ]
  node [
    id 1276
    label "section_350a_subsection_b_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) regularly scheduled testing, by the manufacturer of an infant formula or an agent of such manufacturer, of samples of infant formulas during the shelf life of such formulas to ensure that such formulas are in compliance with this section,"
  ]
  node [
    id 1277
    label "section_350a_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) such person has at least 90 days before marketing such new infant formula, made the submission to the Secretary required by subsection (c)(1) of this section."
  ]
  node [
    id 1278
    label "section_350a_subsection_e"
    class_name "subsection"
    text "(e) Additional notice requirements for manufacturer"
  ]
  node [
    id 1279
    label "section_350a_subsection_i"
    class_name "subsection"
    text "(i) Nutrient requirements"
  ]
  node [
    id 1280
    label "section_350a_subsection_d_item_3"
    class_name "item"
    text "(3) If the manufacturer of an infant formula for commercial or charitable distribution for human consumption determines that a change in the formulation of the formula or a change in the processing of the formula may affect whether the formula is adulterated under subsection (a) of this section, the manufacturer shall, before the first processing of such formula, make the submission to the Secretary required by paragraph (1)."
  ]
  node [
    id 1281
    label "section_350a_subsection_i_item_2_subitem_B"
    class_name "subitem"
    text "(B) revise the required level for any nutrient required by the table."
  ]
  node [
    id 1282
    label "section_350a_subsection_b_item_4_subitem_A_subsubitem_iv_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) all records pertaining to food packaging materials which show that such materials do not cause an infant formula to be adulterated within the meaning of section 342(a)(2)(C) of this title,"
  ]
  node [
    id 1283
    label "section_350a_subsection_i_item_2"
    class_name "item"
    text "(2) The Secretary may by regulation&#8212;"
  ]
  node [
    id 1284
    label "section_350a_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) The Secretary shall by regulation establish good manufacturing practices for infant formulas, including quality control procedures that the Secretary determines are necessary to assure that an infant formula provides nutrients in accordance with this subsection and subsection (i) of this section and is manufactured in a manner designed to prevent adulteration of the infant formula."
  ]
  node [
    id 1285
    label "section_350a_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(A) the quantitative formulation of the infant formula,"
  ]
  node [
    id 1286
    label "section_350a_subsection_b_item_4_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the retention by a premix supplier of all records necessary to confirm the accuracy of all premix certifications and guarantees of analysis,"
  ]
  node [
    id 1287
    label "section_350a_subsection_v_subitem_B"
    class_name "subitem"
    text "(B)(i) Records required under subparagraph (A) with respect to an infant formula shall be retained for at least one year after the expiration of the shelf life of such infant formula. Except as provided in clause (ii), such records shall be made available to the Secretary for review and duplication upon request of the Secretary."
  ]
  node [
    id 1288
    label "section_350a_subsection_d_item_1_subitem_D"
    class_name "subitem"
    text "(D) assurances that the processing of the infant formula complies with subsection (b)(2) of this section."
  ]
  node [
    id 1289
    label "section_350a_subsection_h_item_1_subitem_B"
    class_name "subitem"
    text "is exempt from the requirements of subsections (a), (b), and (c) of this section. The manufacturer of an infant formula exempt under this paragraph shall, in the case of the exempt formula, be required to provide the notice required by subsection (e)(1) of this section only with respect to adulteration or misbranding described in subsection (e)(1)(B) of this section and to comply with the regulations prescribed by the Secretary under paragraph (2)."
  ]
  node [
    id 1290
    label "section_350a_subsection_c_item_2"
    class_name "item"
    text "For purposes of this paragraph, the term &#8220;major change&#8221; has the meaning given to such term in section 106.30(c)(2) of title 21, Code of Federal Regulations (as in effect on August 1, 1986), and guidelines issued thereunder."
  ]
  node [
    id 1291
    label "section_350a_subsection_h"
    class_name "subsection"
    text "(h) Exemptions; regulatory oversight"
  ]
  node [
    id 1292
    label "section_350a_subsection_a_item_3"
    class_name "item"
    text "(3) the processing of such infant formula is not in compliance with the good manufacturing practices and the quality control procedures prescribed by the Secretary under subsection (b)(2) of this section."
  ]
  node [
    id 1293
    label "section_350a_subsection_a_item_1"
    class_name "item"
    text "(1) such infant formula does not provide nutrients as required by subsection (i) of this section,"
  ]
  node [
    id 1294
    label "section_350a_subsection_h_item_1_subitem_A"
    class_name "subitem"
    text "(A) who has an inborn error of metabolism or a low birth weight, or"
  ]
  node [
    id 1295
    label "section_350a_subsection_b_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) At the final product stage, each batch of infant formula shall be tested for vitamin A, vitamin B1, vitamin C, and vitamin E to ensure that such infant formula is in compliance with the requirements of this subsection and subsection (i) of this section relating to such vitamins."
  ]
  node [
    id 1296
    label "section_350a_subsection_b_item_3_subitem_B"
    class_name "subitem"
    text "(B) Each nutrient premix used in the manufacture of an infant formula shall be tested for each relied upon nutrient required by subsection (i) of this section which is contained in such premix to ensure that such premix is in compliance with its specifications or certifications by a premix supplier."
  ]
  node [
    id 1297
    label "section_350a_subsection_b_item_1"
    class_name "item"
    text "(1) The Secretary shall by regulation establish requirements for quality factors for infant formulas to the extent possible consistent with current scientific knowledge, including quality factor requirements for the nutrients required by subsection (i) of this section."
  ]
  node [
    id 1298
    label "section_350a_subsection_a_item_2"
    class_name "item"
    text "(2) such infant formula does not meet the quality factor requirements prescribed by the Secretary under subsection (b)(1) of this section, or"
  ]
  node [
    id 1299
    label "section_350a_subsection_e_item_2"
    class_name "item"
    text "(2) For purposes of paragraph (1), the term &#8220;knowledge&#8221; as applied to a manufacturer means (A) the actual knowledge that the manufacturer had, or (B) the knowledge which a reasonable person would have had under like circumstances or which would have been obtained upon the exercise of due care."
  ]
  node [
    id 1300
    label "section_350a_subsection_b"
    class_name "subsection"
    text "(b) Requirements for quality factors, good manufacturing practices, and retention of records"
  ]
  node [
    id 1301
    label "section_350a_subsection_d_item_1"
    class_name "item"
    text "(1) A person shall, with respect to any infant formula subject to subsection (c) of this section, make a submission to the Secretary which shall include&#8212;"
  ]
  node [
    id 1302
    label "section_350a_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) an infant formula manufactured by a person which has previously manufactured infant formula and in which there is a major change, in processing or formulation, from a current or any previous formulation produced by such manufacturer."
  ]
  node [
    id 1303
    label "section_350a_subsection_b_item_2"
    class_name "item"
    text "(2)(A) The Secretary shall by regulation establish good manufacturing practices for infant formulas, including quality control procedures that the Secretary determines are necessary to assure that an infant formula provides nutrients in accordance with this subsection and subsection (i) of this section and is manufactured in a manner designed to prevent adulteration of the infant formula."
  ]
  node [
    id 1304
    label "section_350a_subsection_i_item_1"
    class_name "item"
    text "(1) An infant formula shall contain nutrients in accordance with the table set out in this subsection or, if revised by the Secretary under paragraph (2), as so revised."
  ]
  node [
    id 1305
    label "section_350a_subsection_b_item_2_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) in-process controls including, where necessary, testing required by good manufacturing practices designed to prevent adulteration of each batch of infant formula, and"
  ]
  node [
    id 1306
    label "section_350a_subsection_b_item_2_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "In prescribing requirements for audits under clause (iv), the Secretary shall provide that such audits be conducted by appropriately trained individuals who do not have any direct responsibility for the manufacture or production of infant formula."
  ]
  node [
    id 1307
    label "section_350a_subsection_h_item_2"
    class_name "item"
    text "(2) The Secretary may by regulation establish terms and conditions for the exemption of an infant formula from the requirements of subsections (a), (b), and (c) of this section. An exemption of an infant formula under paragraph (1) may be withdrawn by the Secretary if such formula is not in compliance with applicable terms and conditions prescribed under this paragraph."
  ]
  node [
    id 1308
    label "section_350a_subsection_v_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) Records required under subparagraph (A) with respect to an infant formula shall be retained for at least one year after the expiration of the shelf life of such infant formula. Except as provided in clause (ii), such records shall be made available to the Secretary for review and duplication upon request of the Secretary."
  ]
  node [
    id 1309
    label "section_350a_subsection_g"
    class_name "subsection"
    text "(g) Recordkeeping requirements for manufacturer; regulatory oversight and enforcement"
  ]
  node [
    id 1310
    label "section_350a_subsection_b_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) The Secretary shall by regulation establish requirements respecting the retention of records. Such requirements shall provide for&#8212;"
  ]
  node [
    id 1311
    label "section_350a_subsection_b_item_4_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) the retention of all records necessary to demonstrate compliance with the good manufacturing practices and quality control procedures prescribed by the Secretary under paragraph (2), including records containing the results of all testing required under paragraph (2)(B),"
  ]
  node [
    id 1312
    label "section_350a_subsection_b_item_3_subitem_E"
    class_name "subitem"
    text "(E) For purposes of this paragraph, the term &#8220;final product stage&#8221; means the point in the manufacturing process, before distribution of an infant formula, at which an infant formula is homogenous and is not subject to further degradation."
  ]
  node [
    id 1313
    label "section_350a_subsection_e_item_1"
    class_name "item"
    text "(1) If the manufacturer of an infant formula has knowledge which reasonably supports the conclusion that an infant formula which has been processed by the manufacturer and which has left an establishment subject to the control of the manufacturer&#8212;"
  ]
  node [
    id 1314
    label "section_350a_subsection_b_item_4"
    class_name "item"
    text "(4)(A) The Secretary shall by regulation establish requirements respecting the retention of records. Such requirements shall provide for&#8212;"
  ]
  node [
    id 1315
    label "section_350a_subsection_b_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the retention of all certifications or guarantees of analysis by premix suppliers,"
  ]
  node [
    id 1316
    label "section_350a_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) may be otherwise adulterated or misbranded,"
  ]
  node [
    id 1317
    label "section_350a_subsection_d_item_2"
    class_name "item"
    text "(2) After the first production of an infant formula subject to subsection (c) of this section, and before the introduction into interstate commerce of such formula, the manufacturer of such formula shall submit to the Secretary, in such form as may be prescribed by the Secretary, a written verification which summarizes test results and records demonstrating that such formula complies with the requirements of subsections (b)(1), (b)(2)(A), (b)(2)(B)(i), (b)(2)(B)(iii), (b)(3)(A), (b)(3)(C), and (i) of this section."
  ]
  node [
    id 1318
    label "section_350a_subsection_v"
    class_name "subsection"
    text "(v) the retention of all records of the results of regularly scheduled audits conducted pursuant to the requirements prescribed by the Secretary under paragraph (2)(B)(iv), and"
  ]
  node [
    id 1319
    label "section_350a_subsection_f_item_3"
    class_name "item"
    text "(3) The Secretary shall by regulation require each manufacturer of an infant formula who begins a recall of such formula because of a risk to human health to request each retail establishment at which such formula is sold or available for sale to post at the point of purchase of such formula a notice of such recall at such establishment for such time that the Secretary determines necessary to inform the public of such recall."
  ]
  node [
    id 1320
    label "section_350a_subsection_v_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) A manufacturer need only provide written assurances to the Secretary that the regularly scheduled audits required by paragraph (2)(B)(iv) are being conducted by the manufacturer, and need not make available to the Secretary the actual written reports of such audits."
  ]
  node [
    id 1321
    label "section_350a_subsection_b_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the testing, in accordance with paragraph (3) and by the manufacturer of an infant formula or an agent of such manufacturer, of each batch of infant formula for each nutrient required by subsection (i) of this section before the distribution of such batch,"
  ]
  node [
    id 1322
    label "section_350a_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(A) may not provide the nutrients required by subsection (i) of this section, or"
  ]
  node [
    id 1323
    label "section_350a_subsection_b_item_3_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) ensure that each batch of such infant formula is in compliance with the requirements of subsection (i) of this section relating to such nutrients, and"
  ]
  node [
    id 1324
    label "section_350a_subsection_i_item_2_subitem_A"
    class_name "subitem"
    text "(A) revise the list of nutrients in the table in this subsection, and"
  ]
  node [
    id 1325
    label "section_350a_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) The good manufacturing practices and quality control procedures prescribed by the Secretary under subparagraph (A) shall include requirements for&#8212;"
  ]
  node [
    id 1326
    label "section_350a_subsection_b_item_3_subitem_D"
    class_name "subitem"
    text "(D) If the Secretary adds a nutrient to the list of nutrients in the table in subsection (i) of this section, the Secretary shall by regulation require that the manufacturer of an infant formula test each batch of such formula for such new nutrient in accordance with subparagraph (A), (B), or (C)."
  ]
  node [
    id 1327
    label "section_350a_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) a description of any reformulation of the formula or change in processing of the infant formula,"
  ]
  node [
    id 1328
    label "section_350a_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) the manufacturer shall, not later than the 14th day after the beginning of such recall and at least once every 14 days thereafter until the recall is terminated, report to the Secretary the actions taken to implement the recall."
  ]
  node [
    id 1329
    label "section_350a_subsection_f_item_1"
    class_name "item"
    text "(1) If a recall of infant formula is begun by a manufacturer, the recall shall be carried out in accordance with such requirements as the Secretary shall prescribe under paragraph (2) and&#8212;"
  ]
  node [
    id 1330
    label "section_350a_subsection_c_item_1"
    class_name "item"
    text "(1) No person shall introduce or deliver for introduction into interstate commerce any new infant formula unless&#8212;"
  ]
  node [
    id 1331
    label "section_350a_subsection_a"
    class_name "subsection"
    text "(a) Adulteration"
  ]
  node [
    id 1332
    label "section_350a_subsection_c"
    class_name "subsection"
    text "(c) Registration of persons distributing new infant formula"
  ]
  node [
    id 1333
    label "section_350a_subsection_b_item_4_subitem_A_subsubitem_iv_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) all records pertaining to the microbiological quality and purity of raw materials used in infant formula powder and in finished infant formula, and"
  ]
  node [
    id 1334
    label "section_350a_subsection_h_item_1"
    class_name "item"
    text "is exempt from the requirements of subsections (a), (b), and (c) of this section. The manufacturer of an infant formula exempt under this paragraph shall, in the case of the exempt formula, be required to provide the notice required by subsection (e)(1) of this section only with respect to adulteration or misbranding described in subsection (e)(1)(B) of this section and to comply with the regulations prescribed by the Secretary under paragraph (2)."
  ]
  node [
    id 1335
    label "section_350a_subsection_d"
    class_name "subsection"
    text "(d) Submission of information about new infant formula required"
  ]
  node [
    id 1336
    label "section_350a_subsection_f_item_2"
    class_name "item"
    text "(2) The Secretary shall by regulation prescribe the scope and extent of recalls of infant formulas necessary and appropriate for the degree of risks to human health presented by the formula subject to the recall."
  ]
  node [
    id 1337
    label "section_350a_subsection_d_item_1_subitem_C"
    class_name "subitem"
    text "(C) assurances that the infant formula will not be marketed unless it meets the requirements of subsections (b)(1) and (i) of this section, as demonstrated by the testing required under subsection (b)(3) of this section, and"
  ]
  node [
    id 1338
    label "section_350a_subsection_g_item_1"
    class_name "item"
    text "(1) Each manufacturer of an infant formula shall make and retain such records respecting the distribution of the infant formula through any establishment owned or operated by such manufacturer as may be necessary to effect and monitor recalls of the formula. Such records shall be retained for at least one year after the expiration of the shelf life of the infant formula."
  ]
  node [
    id 1339
    label "section_350a_subsection_g_item_2"
    class_name "item"
    text "(2) To the extent that the Secretary determines that records are not being made or maintained in accordance with paragraph (1), the Secretary may by regulation prescribe the records required to be made under paragraph (1) and requirements respecting the retention of such records under such paragraph. Such regulations shall take effect on such date as the Secretary prescribes but not sooner than the 180th day after the date such regulations are promulgated. Such regulations shall apply only with respect to distributions of infant formulas made after such effective date."
  ]
  node [
    id 1340
    label "section_350a_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(A) an infant formula manufactured by a person which has not previously manufactured an infant formula, and"
  ]
  node [
    id 1341
    label "section_350a_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(A) the Secretary shall, not later than the 15th day after the beginning of such recall and at least once every 15 days thereafter until the recall is terminated, review the actions taken under the recall to determine whether the recall meets the requirements prescribed under paragraph (2), and"
  ]
  node [
    id 1342
    label "section_350a_subsection_b_item_4_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the retention of&#8212;"
  ]
  node [
    id 1343
    label "section_350a_subsection_f"
    class_name "subsection"
    text "(f) Procedures applicable to recalls by manufacturer; regulatory oversight"
  ]
  node [
    id 1344
    label "section_350a_subsection_b_item_3"
    class_name "item"
    text "(3)(A) At the final product stage, each batch of infant formula shall be tested for vitamin A, vitamin B1, vitamin C, and vitamin E to ensure that such infant formula is in compliance with the requirements of this subsection and subsection (i) of this section relating to such vitamins."
  ]
  node [
    id 1345
    label "section_350a_subsection_b_item_3_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) confirm that nutrients contained in any nutrient premix used in such infant formula are present in each batch of such infant formula in the proper concentration."
  ]
  node [
    id 1346
    label "section_350a_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) such person has, before introducing such new infant formula, or delivering such new infant formula for introduction, into interstate commerce, registered with the Secretary the name of such person, the place of business of such person, and all establishments at which such person intends to manufacture such new infant formula, and"
  ]
  node [
    id 1347
    label "section_350a_subsection_b_item_3_subitem_C"
    class_name "subitem"
    text "(C) During the manufacturing process or at the final product stage and before distribution of an infant formula, an infant formula shall be tested for all nutrients required to be included in such formula by subsection (i) of this section for which testing has not been conducted pursuant to subparagraph (A) or (B). Testing under this subparagraph shall be conducted to&#8212;"
  ]
  node [
    id 1348
    label "section_350b_subsection_b"
    class_name "subsection"
    text "(b) Petition"
  ]
  node [
    id 1349
    label "section_350b_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 1350
    label "section_350b_subsection_a_item_2"
    class_name "item"
    text "The Secretary shall keep confidential any information provided under paragraph (2) for 90 days following its receipt. After the expiration of such 90 days, the Secretary shall place such information on public display, except matters in the information which are trade secrets or otherwise confidential, commercial information."
  ]
  node [
    id 1351
    label "section_350b_subsection_a_item_1"
    class_name "item"
    text "(1) The dietary supplement contains only dietary ingredients which have been present in the food supply as an article used for food in a form in which the food has not been chemically altered."
  ]
  node [
    id 1352
    label "section_350b_subsection_c"
    class_name "subsection"
    text "(c) &#8220;New dietary ingredient&#8221; defined"
  ]
  node [
    id 1353
    label "section_351_subsection_a"
    class_name "subsection"
    text "(a) Poisonous, insanitary, etc., ingredients; adequate controls in manufacture"
  ]
  node [
    id 1354
    label "section_351_subsection_f_item_2"
    class_name "item"
    text "(2)(A) In the case of a device classified under section 360c(f) of this title into class III and intended solely for investigational use, paragraph&#160;1 (1)(B) shall not apply with respect to such device during the period ending on the ninetieth day after the date of the promulgation of the regulations prescribing the procedures and conditions required by section 360j(g)(2) of this title."
  ]
  node [
    id 1355
    label "section_351_subsection_f_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) which was classified under section 360c(f) of this title into class III, which under section 360e(a) of this title is required to have in effect an approved application for premarket approval, and which is not exempt from section 360e of this title under section 360j(g) of this title, and"
  ]
  node [
    id 1356
    label "section_351_subsection_h"
    class_name "subsection"
    text "(h) Manufacture, packing, storage, or installation of device not in conformity with applicable requirements or conditions"
  ]
  node [
    id 1357
    label "section_351_subsection_f_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) which has an application which has been suspended or is otherwise not in effect; or"
  ]
  node [
    id 1358
    label "section_351_subsection_d_item_1"
    class_name "item"
    text "If it is a drug and any substance has been (1) mixed or packed therewith so as to reduce its quality or strength or (2) substituted wholly or in part therefor."
  ]
  node [
    id 1359
    label "section_351_subsection_d_item_2"
    class_name "item"
    text "If it is a drug and any substance has been (1) mixed or packed therewith so as to reduce its quality or strength or (2) substituted wholly or in part therefor."
  ]
  node [
    id 1360
    label "section_351_subsection_f_item_1_subitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) for which such an application was filed and approval of the application has been denied, suspended, or withdrawn, or such a notice was filed and has been declared not completed or the approval of the device under the protocol has been withdrawn;"
  ]
  node [
    id 1361
    label "section_351_subsection_f_item_1_subitem_ii"
    class_name "subitem"
    text "(ii)(I) for which an application for premarket approval or a notice of completion of a product development protocol was not filed with the Secretary within the ninety-day period beginning on the date of the promulgation of such regulation, or"
  ]
  node [
    id 1362
    label "section_351_subsection_f_item_1"
    class_name "item"
    text "(1) If it is a class III device&#8212;"
  ]
  node [
    id 1363
    label "section_351_subsection_f_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) on the last day of the thirtieth calendar month beginning after the month in which the classification of the device in class III became effective under section 360c of this title, or"
  ]
  node [
    id 1364
    label "section_351_subsection_i"
    class_name "subsection"
    text "(i) Failure to comply with requirements under which device was exempted for investigational use"
  ]
  node [
    id 1365
    label "section_351_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B)(i) which was classified under section 360c(f) of this title into class III, which under section 360e(a) of this title is required to have in effect an approved application for premarket approval, and which is not exempt from section 360e of this title under section 360j(g) of this title, and"
  ]
  node [
    id 1366
    label "section_351_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(A)(i) which is required by a regulation promulgated under subsection (b) of section 360e of this title to have an approval under such section of an application for premarket approval and which is not exempt from section 360e of this title under section 360j(g) of this title, and"
  ]
  node [
    id 1367
    label "section_351_subsection_f"
    class_name "subsection"
    text "(f) Certain class III devices"
  ]
  node [
    id 1368
    label "section_351_subsection_f_item_1_subitem_C"
    class_name "subitem"
    text "(C) which was classified under section 360j(l) of this title into class III, which under such section is required to have in effect an approved application under section 360e of this title, and which has an application which has been suspended or is otherwise not in effect."
  ]
  node [
    id 1369
    label "section_351_subsection_f_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) In the case of a device classified under section 360c(f) of this title into class III and intended solely for investigational use, paragraph&#160;1 (1)(B) shall not apply with respect to such device during the period ending on the ninetieth day after the date of the promulgation of the regulations prescribing the procedures and conditions required by section 360j(g)(2) of this title."
  ]
  node [
    id 1370
    label "section_351_subsection_d"
    class_name "subsection"
    text "(d) Mixture with or substitution of another substance"
  ]
  node [
    id 1371
    label "section_351_subsection_a_item_1"
    class_name "item"
    text "(1) If it consists in whole or in part of any filthy, putrid, or decomposed substance; or (2)(A) if it has been prepared, packed, or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health; or (B) if it is a drug and the methods used in, or the facilities or controls used for, its manufacture, processing, packing, or holding do not conform to or are not operated or administered in conformity with current good manufacturing practice to assure that such drug meets the requirements of this chapter as to safety and has the identity and strength, and meets the quality and purity characteristics, which it purports or is represented to possess; or (3) if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health; or (4) if (A) it bears or contains, for purposes of coloring only, a color additive which is unsafe within the meaning of section 379e(a) of this title, or (B) it is a color additive the intended use of which in or on drugs or devices is for purposes of coloring only and is unsafe within the meaning of section 379e(a) of this title; or (5) if it is a new animal drug which is unsafe within the meaning of section 360b of this title; or (6) if it is an animal feed bearing or containing a new animal drug, and such animal feed is unsafe within the meaning of section 360b of this title."
  ]
  node [
    id 1372
    label "section_351_subsection_f_item_1_subitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(ii)(I) for which an application for premarket approval or a notice of completion of a product development protocol was not filed with the Secretary within the ninety-day period beginning on the date of the promulgation of such regulation, or"
  ]
  node [
    id 1373
    label "section_351_subsection_h_item_2"
    class_name "item"
    text "If it is a device and the methods used in, or the facilities or controls used for, its manufacture, packing, storage, or installation are not in conformity with applicable requirements under section 360j(f)(1) of this title or an applicable condition prescribed by an order under section 360j(f)(2) of this title."
  ]
  node [
    id 1374
    label "section_351_subsection_f_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(A)(i) which is required by a regulation promulgated under subsection (b) of section 360e of this title to have an approval under such section of an application for premarket approval and which is not exempt from section 360e of this title under section 360j(g) of this title, and"
  ]
  node [
    id 1375
    label "section_351_subsection_f_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) on the ninetieth day after the date of the promulgation of such regulation,"
  ]
  node [
    id 1376
    label "section_351_subsection_c"
    class_name "subsection"
    text "(c) Misrepresentation of strength, etc., where drug is unrecognized in compendium"
  ]
  node [
    id 1377
    label "section_351_subsection_e"
    class_name "subsection"
    text "(e) Devices not in conformity with performance standards"
  ]
  node [
    id 1378
    label "section_351_subsection_f_item_2_subitem_B"
    class_name "subitem"
    text "(B) In the case of a device subject to a regulation promulgated under subsection (b) of section 360e of this title, paragraph&#160;1 (1) shall not apply with respect to such device during the period ending&#8212;"
  ]
  node [
    id 1379
    label "section_351_subsection_b"
    class_name "subsection"
    text "(b) Strength, quality, or purity differing from official compendium"
  ]
  node [
    id 1380
    label "section_351_subsection_h_item_1"
    class_name "item"
    text "If it is a device and the methods used in, or the facilities or controls used for, its manufacture, packing, storage, or installation are not in conformity with applicable requirements under section 360j(f)(1) of this title or an applicable condition prescribed by an order under section 360j(f)(2) of this title."
  ]
  node [
    id 1381
    label "section_351_subsection_g"
    class_name "subsection"
    text "(g) Banned devices"
  ]
  node [
    id 1382
    label "section_352_subsection_p"
    class_name "subsection"
    text "(p) Packaging or labeling of drugs in violation of regulations"
  ]
  node [
    id 1383
    label "section_352_subsection_l"
    class_name "subsection"
    text "(l) Antibiotic drugs improperly certified"
  ]
  node [
    id 1384
    label "section_352_subsection_e_item_3"
    class_name "item"
    text "(3) As used in subparagraph (1), the term &#8220;established name&#8221;, with respect to a drug or ingredient thereof, means (A) the applicable official name designated pursuant to section 358 of this title, or (B), if there is no such name and such drug, or such ingredient, is an article recognized in an official compendium, then the official title thereof in such compendium, or (C) if neither clause (A) nor clause (B) of this subparagraph applies, then the common or usual name, if any, of such drug or of such ingredient, except that where clause (B) of this subparagraph applies to an article recognized in the United States Pharmacopeia and in the Homoeopathic Pharmacopoeia under different official titles, the official title used in the United States Pharmacopeia shall apply unless it is labeled and offered for sale as a homoeopathic drug, in which case the official title used in the Homoeopathic Pharmacopoeia shall apply."
  ]
  node [
    id 1385
    label "section_352_subsection_e_item_2"
    class_name "item"
    text "(2) If it is a device and it has an established name, unless its label bears, to the exclusion of any other nonproprietary name, its established name (as defined in subparagraph (4)) prominently printed in type at least half as large as that used thereon for any proprietary name or designation for such device, except that to the extent compliance with the requirements of this subparagraph is impracticable, exemptions shall be established by regulations promulgated by the Secretary."
  ]
  node [
    id 1386
    label "section_352_subsection_q_item_2"
    class_name "item"
    text "In the case of any restricted device distributed or offered for sale in any State, if (1) its advertising is false or misleading in any particular, or (2) it is sold, distributed, or used in violation of regulations prescribed under section 360j(e) of this title."
  ]
  node [
    id 1387
    label "section_352_subsection_b_item_2"
    class_name "item"
    text "If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count: Provided, That under clause (2) of this paragraph reasonable variations shall be permitted, and exemptions as to small packages shall be established, by regulations prescribed by the Secretary."
  ]
  node [
    id 1388
    label "section_352_subsection_r_item_1"
    class_name "item"
    text "In the case of any restricted device distributed or offered for sale in any State, unless the manufacturer, packer, or distributor thereof includes in all advertisements and other descriptive printed matter issued or caused to be issued by the manufacturer, packer, or distributor with respect to that device (1) a true statement of the device's established name as defined in subsection (e) of this section, printed prominently and in type at least half as large as that used for any trade or brand name thereof, and (2) a brief statement of the intended uses of the device and relevant warnings, precautions, side effects, and contraindications and, in the case of specific devices made subject to a finding by the Secretary after notice and opportunity for comment that such action is necessary to protect the public health, a full description of the components of such device or the formula showing quantitatively each ingredient of such device to the extent required in regulations which shall be issued by the Secretary after an opportunity for a hearing. Except in extraordinary circumstances, no regulation issued under this paragraph shall require prior approval by the Secretary of the content of any advertisement and no advertisement of a restricted device, published after the effective date of this paragraph shall, with respect to the matters specified in this paragraph or covered by regulations issued hereunder, be subject to the provisions of sections 52 through 55 of title 15. This paragraph shall not be applicable to any printed matter which the Secretary determines to be labeling as defined in section 321(m) of this title."
  ]
  node [
    id 1389
    label "section_352_subsection_t_item_2"
    class_name "item"
    text "If it is a device and there was a failure or refusal (1) to comply with any requirement prescribed under section 360h of this title respecting the device, (2) to furnish any material or information required by or under section 360i of this title respecting the device, or (3) to comply with a requirement under section 360l of this title."
  ]
  node [
    id 1390
    label "section_352_subsection_j"
    class_name "subsection"
    text "(j) Health-endangering when used as prescribed"
  ]
  node [
    id 1391
    label "section_352_subsection_q_item_1"
    class_name "item"
    text "In the case of any restricted device distributed or offered for sale in any State, if (1) its advertising is false or misleading in any particular, or (2) it is sold, distributed, or used in violation of regulations prescribed under section 360j(e) of this title."
  ]
  node [
    id 1392
    label "section_352_subsection_e"
    class_name "subsection"
    text "(e) Designation of drugs or devices by established names"
  ]
  node [
    id 1393
    label "section_352_subsection_o"
    class_name "subsection"
    text "(o) Drugs or devices from nonregistered establishments"
  ]
  node [
    id 1394
    label "section_352_subsection_i_item_1"
    class_name "item"
    text "(1) If it is a drug and its container is so made, formed, or filled as to be misleading; or (2) if it is an imitation of another drug; or (3) if it is offered for sale under the name of another drug."
  ]
  node [
    id 1395
    label "section_352_subsection_f"
    class_name "subsection"
    text "(f) Directions for use and warnings on label"
  ]
  node [
    id 1396
    label "section_352_subsection_e_item_4"
    class_name "item"
    text "(4) As used in subparagraph (2), the term &#8220;established name&#8221; with respect to a device means (A) the applicable official name of the device designated pursuant to section 358 of this title, (B) if there is no such name and such device is an article recognized in an official compendium, then the official title thereof in such compendium, or (C) if neither clause (A) nor clause (B) of this subparagraph applies, then any common or usual name of such device."
  ]
  node [
    id 1397
    label "section_352_subsection_r_item_2"
    class_name "item"
    text "In the case of any restricted device distributed or offered for sale in any State, unless the manufacturer, packer, or distributor thereof includes in all advertisements and other descriptive printed matter issued or caused to be issued by the manufacturer, packer, or distributor with respect to that device (1) a true statement of the device's established name as defined in subsection (e) of this section, printed prominently and in type at least half as large as that used for any trade or brand name thereof, and (2) a brief statement of the intended uses of the device and relevant warnings, precautions, side effects, and contraindications and, in the case of specific devices made subject to a finding by the Secretary after notice and opportunity for comment that such action is necessary to protect the public health, a full description of the components of such device or the formula showing quantitatively each ingredient of such device to the extent required in regulations which shall be issued by the Secretary after an opportunity for a hearing. Except in extraordinary circumstances, no regulation issued under this paragraph shall require prior approval by the Secretary of the content of any advertisement and no advertisement of a restricted device, published after the effective date of this paragraph shall, with respect to the matters specified in this paragraph or covered by regulations issued hereunder, be subject to the provisions of sections 52 through 55 of title 15. This paragraph shall not be applicable to any printed matter which the Secretary determines to be labeling as defined in section 321(m) of this title."
  ]
  node [
    id 1398
    label "section_352_subsection_n_item_2"
    class_name "item"
    text "In the case of any prescription drug distributed or offered for sale in any State, unless the manufacturer, packer, or distributor thereof includes in all advertisements and other descriptive printed matter issued or caused to be issued by the manufacturer, packer, or distributor with respect to that drug a true statement of (1) the established name as defined in paragraph (e) of this section, printed prominently and in type at least half as large as that used for any trade or brand name thereof, (2) the formula showing quantitatively each ingredient of such drug to the extent required for labels under paragraph (e) of this section, and (3) such other information in brief summary relating to side effects, contraindications, and effectiveness as shall be required in regulations which shall be issued by the Secretary in accordance with the procedure specified in section 371(e) of this title, except that (A) except in extraordinary circumstances, no regulation issued under this paragraph shall require prior approval by the Secretary of the content of any advertisement, and (B) no advertisement of a prescription drug, published after the effective date of regulations issued under this paragraph applicable to advertisements of prescription drugs, shall with respect to the matters specified in this paragraph or covered by such regulations, be subject to the provisions of sections 52 to 57 of title 15. This paragraph (n) shall not be applicable to any printed matter which the Secretary determines to be labeling as defined in section 321(m) of this title. Nothing in the Convention on Psychotropic Substances, signed at Vienna, Austria, on February 21, 1971, shall be construed to prevent drug price communications to consumers."
  ]
  node [
    id 1399
    label "section_352_subsection_k_item_1"
    class_name "item"
    text "If it is, or purports to be, or is represented as a drug composed wholly or partly of insulin, unless (1) it is from a batch with respect to which a certificate or release has been issued pursuant to section 356 of this title, and (2) such certificate or release is in effect with respect to such drug."
  ]
  node [
    id 1400
    label "section_352_subsection_b"
    class_name "subsection"
    text "(b) Package form; contents of label"
  ]
  node [
    id 1401
    label "section_352_subsection_m"
    class_name "subsection"
    text "(m) Color additives; packing and labeling"
  ]
  node [
    id 1402
    label "section_352_subsection_k"
    class_name "subsection"
    text "(k) Insulin not properly certified"
  ]
  node [
    id 1403
    label "section_352_subsection_c"
    class_name "subsection"
    text "(c) Prominence of information on label"
  ]
  node [
    id 1404
    label "section_352_subsection_n"
    class_name "subsection"
    text "(n) Prescription drug advertisements: established name; quantitative formula; side effects, contraindications, and effectiveness; prior approval; false advertising; labeling; construction of the Convention on Psychotropic Substances"
  ]
  node [
    id 1405
    label "section_352_subsection_k_item_2"
    class_name "item"
    text "If it is, or purports to be, or is represented as a drug composed wholly or partly of insulin, unless (1) it is from a batch with respect to which a certificate or release has been issued pursuant to section 356 of this title, and (2) such certificate or release is in effect with respect to such drug."
  ]
  node [
    id 1406
    label "section_352_subsection_l_item_1"
    class_name "item"
    text "If it is, or purports to be, or is represented as a drug (except a drug for use in animals other than man) composed wholly or partly of any kind of penicillin, streptomycin, chlortetracycline, chloramphenicol, bacitracin, or any other antibiotic drug, or any derivative thereof, unless (1) it is from a batch with respect to which a certificate or release has been issued pursuant to section 357 of this title, and (2) such certificate or release is in effect with respect to such drug: Provided, That this paragraph shall not apply to any drug or class of drugs exempted by regulations promulgated under section 357(c) or (d) of this title."
  ]
  node [
    id 1407
    label "section_352_subsection_t_item_1"
    class_name "item"
    text "If it is a device and there was a failure or refusal (1) to comply with any requirement prescribed under section 360h of this title respecting the device, (2) to furnish any material or information required by or under section 360i of this title respecting the device, or (3) to comply with a requirement under section 360l of this title."
  ]
  node [
    id 1408
    label "section_352_subsection_n_item_3_subitem_B"
    class_name "subitem"
    text "In the case of any prescription drug distributed or offered for sale in any State, unless the manufacturer, packer, or distributor thereof includes in all advertisements and other descriptive printed matter issued or caused to be issued by the manufacturer, packer, or distributor with respect to that drug a true statement of (1) the established name as defined in paragraph (e) of this section, printed prominently and in type at least half as large as that used for any trade or brand name thereof, (2) the formula showing quantitatively each ingredient of such drug to the extent required for labels under paragraph (e) of this section, and (3) such other information in brief summary relating to side effects, contraindications, and effectiveness as shall be required in regulations which shall be issued by the Secretary in accordance with the procedure specified in section 371(e) of this title, except that (A) except in extraordinary circumstances, no regulation issued under this paragraph shall require prior approval by the Secretary of the content of any advertisement, and (B) no advertisement of a prescription drug, published after the effective date of regulations issued under this paragraph applicable to advertisements of prescription drugs, shall with respect to the matters specified in this paragraph or covered by such regulations, be subject to the provisions of sections 52 to 57 of title 15. This paragraph (n) shall not be applicable to any printed matter which the Secretary determines to be labeling as defined in section 321(m) of this title. Nothing in the Convention on Psychotropic Substances, signed at Vienna, Austria, on February 21, 1971, shall be construed to prevent drug price communications to consumers."
  ]
  node [
    id 1409
    label "section_352_subsection_t"
    class_name "subsection"
    text "(t) Devices for which there has been a failure or refusal to give required notification or to furnish required material or information"
  ]
  node [
    id 1410
    label "section_352_subsection_s"
    class_name "subsection"
    text "(s) Devices subject to performance standards not bearing requisite labeling"
  ]
  node [
    id 1411
    label "section_352_subsection_a"
    class_name "subsection"
    text "(a) False or misleading label"
  ]
  node [
    id 1412
    label "section_352_subsection_b_item_1"
    class_name "item"
    text "If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count: Provided, That under clause (2) of this paragraph reasonable variations shall be permitted, and exemptions as to small packages shall be established, by regulations prescribed by the Secretary."
  ]
  node [
    id 1413
    label "section_352_subsection_r"
    class_name "subsection"
    text "(r) Restricted devices not carrying requisite accompanying statements in advertisements and other descriptive printed matter"
  ]
  node [
    id 1414
    label "section_352_subsection_n_item_3"
    class_name "item"
    text "In the case of any prescription drug distributed or offered for sale in any State, unless the manufacturer, packer, or distributor thereof includes in all advertisements and other descriptive printed matter issued or caused to be issued by the manufacturer, packer, or distributor with respect to that drug a true statement of (1) the established name as defined in paragraph (e) of this section, printed prominently and in type at least half as large as that used for any trade or brand name thereof, (2) the formula showing quantitatively each ingredient of such drug to the extent required for labels under paragraph (e) of this section, and (3) such other information in brief summary relating to side effects, contraindications, and effectiveness as shall be required in regulations which shall be issued by the Secretary in accordance with the procedure specified in section 371(e) of this title, except that (A) except in extraordinary circumstances, no regulation issued under this paragraph shall require prior approval by the Secretary of the content of any advertisement, and (B) no advertisement of a prescription drug, published after the effective date of regulations issued under this paragraph applicable to advertisements of prescription drugs, shall with respect to the matters specified in this paragraph or covered by such regulations, be subject to the provisions of sections 52 to 57 of title 15. This paragraph (n) shall not be applicable to any printed matter which the Secretary determines to be labeling as defined in section 321(m) of this title. Nothing in the Convention on Psychotropic Substances, signed at Vienna, Austria, on February 21, 1971, shall be construed to prevent drug price communications to consumers."
  ]
  node [
    id 1415
    label "section_352_subsection_n_item_1"
    class_name "item"
    text "In the case of any prescription drug distributed or offered for sale in any State, unless the manufacturer, packer, or distributor thereof includes in all advertisements and other descriptive printed matter issued or caused to be issued by the manufacturer, packer, or distributor with respect to that drug a true statement of (1) the established name as defined in paragraph (e) of this section, printed prominently and in type at least half as large as that used for any trade or brand name thereof, (2) the formula showing quantitatively each ingredient of such drug to the extent required for labels under paragraph (e) of this section, and (3) such other information in brief summary relating to side effects, contraindications, and effectiveness as shall be required in regulations which shall be issued by the Secretary in accordance with the procedure specified in section 371(e) of this title, except that (A) except in extraordinary circumstances, no regulation issued under this paragraph shall require prior approval by the Secretary of the content of any advertisement, and (B) no advertisement of a prescription drug, published after the effective date of regulations issued under this paragraph applicable to advertisements of prescription drugs, shall with respect to the matters specified in this paragraph or covered by such regulations, be subject to the provisions of sections 52 to 57 of title 15. This paragraph (n) shall not be applicable to any printed matter which the Secretary determines to be labeling as defined in section 321(m) of this title. Nothing in the Convention on Psychotropic Substances, signed at Vienna, Austria, on February 21, 1971, shall be construed to prevent drug price communications to consumers."
  ]
  node [
    id 1416
    label "section_352_subsection_i"
    class_name "subsection"
    text "(i) Drug; misleading container; imitation; offer for sale under another name"
  ]
  node [
    id 1417
    label "section_352_subsection_h"
    class_name "subsection"
    text "(h) Deteriorative drugs; packing and labeling"
  ]
  node [
    id 1418
    label "section_352_subsection_q"
    class_name "subsection"
    text "(q) Restricted devices using false or misleading advertising or used in violation of regulations"
  ]
  node [
    id 1419
    label "section_352_subsection_l_item_2"
    class_name "item"
    text "If it is, or purports to be, or is represented as a drug (except a drug for use in animals other than man) composed wholly or partly of any kind of penicillin, streptomycin, chlortetracycline, chloramphenicol, bacitracin, or any other antibiotic drug, or any derivative thereof, unless (1) it is from a batch with respect to which a certificate or release has been issued pursuant to section 357 of this title, and (2) such certificate or release is in effect with respect to such drug: Provided, That this paragraph shall not apply to any drug or class of drugs exempted by regulations promulgated under section 357(c) or (d) of this title."
  ]
  node [
    id 1420
    label "section_352_subsection_f_item_2"
    class_name "item"
    text "Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users, except that where any requirement of clause (1) of this paragraph, as applied to any drug or device, is not necessary for the protection of the public health, the Secretary shall promulgate regulations exempting such drug or device from such requirement."
  ]
  node [
    id 1421
    label "section_352_subsection_n_item_3_subitem_A"
    class_name "subitem"
    text "In the case of any prescription drug distributed or offered for sale in any State, unless the manufacturer, packer, or distributor thereof includes in all advertisements and other descriptive printed matter issued or caused to be issued by the manufacturer, packer, or distributor with respect to that drug a true statement of (1) the established name as defined in paragraph (e) of this section, printed prominently and in type at least half as large as that used for any trade or brand name thereof, (2) the formula showing quantitatively each ingredient of such drug to the extent required for labels under paragraph (e) of this section, and (3) such other information in brief summary relating to side effects, contraindications, and effectiveness as shall be required in regulations which shall be issued by the Secretary in accordance with the procedure specified in section 371(e) of this title, except that (A) except in extraordinary circumstances, no regulation issued under this paragraph shall require prior approval by the Secretary of the content of any advertisement, and (B) no advertisement of a prescription drug, published after the effective date of regulations issued under this paragraph applicable to advertisements of prescription drugs, shall with respect to the matters specified in this paragraph or covered by such regulations, be subject to the provisions of sections 52 to 57 of title 15. This paragraph (n) shall not be applicable to any printed matter which the Secretary determines to be labeling as defined in section 321(m) of this title. Nothing in the Convention on Psychotropic Substances, signed at Vienna, Austria, on February 21, 1971, shall be construed to prevent drug price communications to consumers."
  ]
  node [
    id 1422
    label "section_352_subsection_f_item_1"
    class_name "item"
    text "Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may be dangerous to health, or against unsafe dosage or methods or duration of administration or application, in such manner and form, as are necessary for the protection of users, except that where any requirement of clause (1) of this paragraph, as applied to any drug or device, is not necessary for the protection of the public health, the Secretary shall promulgate regulations exempting such drug or device from such requirement."
  ]
  node [
    id 1423
    label "section_352_subsection_e_item_1"
    class_name "item"
    text "(1) If it is a drug, unless (A) its label bears, to the exclusion of any other nonproprietary name (except the applicable systematic chemical name or the chemical formula), (i) the established name (as defined in subparagraph (3)) of the drug, if such there be, and (ii), in case it is fabricated from two or more ingredients, the established name and quantity of each active ingredient, including the quantity, kind, and proportion of any alcohol, and also including, whether active or not, the established name and quantity or proportion of any bromides, ether, chloroform, acetanilid, acetphenetidin, amidopyrine, antipyrine, atropine, hyoscine, hyoscyamine, arsenic, digitalis, digitalis glucosides, mercury ouabain strophanthin, strychnine, thyroid, or any derivative or preparation of any such substances, contained therein; Provided, That the requirement for stating the quantity of the active ingredients, other than the quantity of those specifically named in this paragraph, shall apply only to prescription drugs; and (B) for any prescription drug the established name of such drug or ingredient, as the case may be, on such label (and on any labeling on which a name for such drug or ingredient is used) is printed prominently and in type at least half as large as that used thereon for any proprietary name or designation for such drug or ingredient: Provided, That to the extent that compliance with the requirements of clause (A)(ii) or clause (B) of this subparagraph is impracticable, exemptions shall be established by regulations promulgated by the Secretary."
  ]
  node [
    id 1424
    label "section_352_subsection_d"
    class_name "subsection"
    text "(d) Habit forming substances"
  ]
  node [
    id 1425
    label "section_352_subsection_t_item_3"
    class_name "item"
    text "If it is a device and there was a failure or refusal (1) to comply with any requirement prescribed under section 360h of this title respecting the device, (2) to furnish any material or information required by or under section 360i of this title respecting the device, or (3) to comply with a requirement under section 360l of this title."
  ]
  node [
    id 1426
    label "section_352_subsection_g"
    class_name "subsection"
    text "(g) Representations as recognized drug; packing and labeling; inconsistent requirements for designation of drug"
  ]
  node [
    id 1427
    label "section_353_subsection_f_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) when dispensed by filling the lawful order of a licensed veterinarian, the drug bears a label containing the name and address of the dispenser, the serial number and date of the order or of its filling, the name of the licensed veterinarian, and the directions for use and cautionary statements, if any, contained in such order."
  ]
  node [
    id 1428
    label "section_353_subsection_b_item_1"
    class_name "item"
    text "(1) A drug intended for use by man which&#8212;"
  ]
  node [
    id 1429
    label "section_353_subsection_e_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) No person may engage in the wholesale distribution in interstate commerce of drugs subject to subsection (b) of this section in a State unless such person is licensed by the State in accordance with the guidelines issued under subparagraph (B)."
  ]
  node [
    id 1430
    label "section_353_subsection_b_item_1_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "shall be dispensed only (i) upon a written prescription of a practitioner licensed by law to administer such drug, or (ii) upon an oral prescription of such practitioner which is reduced promptly to writing and filed by the pharmacist, or (iii) by refilling any such written or oral prescription if such refilling is authorized by the prescriber either in the original prescription or by oral order which is reduced promptly to writing and filed by the pharmacist. The act of dispensing a drug contrary to the provisions of this paragraph shall be deemed to be an act which results in the drug being misbranded while held for sale."
  ]
  node [
    id 1431
    label "section_353_subsection_d_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the name, address, professional designation, and signature of the practitioner making the request,"
  ]
  node [
    id 1432
    label "section_353_subsection_d_item_3_subitem_A"
    class_name "subitem"
    text "(A) Drug samples may only be distributed&#8212;"
  ]
  node [
    id 1433
    label "section_353_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) Each person who is engaged in the wholesale distribution of a drug subject to subsection (b) of this section and who is not the manufacturer or an authorized distributor of record of such drug shall, before each wholesale distribution of such drug (including each distribution to an authorized distributor of record or to a retail pharmacy), provide to the person who receives the drug a statement (in such form and containing such information as the Secretary may require) identifying each prior sale, purchase, or trade of such drug (including the date of the transaction and the names and addresses of all parties to the transaction)."
  ]
  node [
    id 1434
    label "section_353_subsection_d_item_2_subitem_C"
    class_name "subitem"
    text "(C) Each drug manufacturer or authorized distributor of record which makes distributions by mail or common carrier under this paragraph shall maintain, for a period of 3 years, the request forms submitted for such distributions and the receipts submitted for such distributions and shall maintain a record of distributions of drug samples which identifies the drugs distributed and the recipients of the distributions. Forms, receipts, and records required to be maintained under this subparagraph shall be made available by the drug manufacturer or authorized distributor of record to Federal and State officials engaged in the regulation of drugs and in the enforcement of laws applicable to drugs."
  ]
  node [
    id 1435
    label "section_353_subsection_f"
    class_name "subsection"
    text "(f) Veterinary prescription drugs"
  ]
  node [
    id 1436
    label "section_353_subsection_g_item_4_subitem_B"
    class_name "subitem"
    text "(B) The term &#8220;market clearance&#8221; includes&#8212;"
  ]
  node [
    id 1437
    label "section_353_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) No person may sell, purchase, or trade, or offer to sell, purchase, or trade, any drug&#8212;"
  ]
  node [
    id 1438
    label "section_353_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, is not safe for use except under the supervision of a practitioner licensed by law to administer such drug; or"
  ]
  node [
    id 1439
    label "section_353_subsection_d_item_3_subitem_E"
    class_name "subitem"
    text "(E) Drug manufacturers or authorized distributors of record shall report to the Secretary any conviction of their representatives for violations of subsection (c)(1) of this section or a State law because of the sale, purchase, or trade of a drug sample or the offer to sell, purchase, or trade a drug sample."
  ]
  node [
    id 1440
    label "section_353_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) health care professional acting at the direction and under the supervision of such a practitioner, or"
  ]
  node [
    id 1441
    label "section_353_subsection_d_item_3"
    class_name "item"
    text "(3) The manufacturer or authorized distributor of record of a drug subject to subsection (b) of this section may, by means other than mail or common carrier, distribute drug samples only if the manufacturer or authorized distributor of record makes the distributions in accordance with subparagraph (A) and carries out the activities described in subparagraphs (B) through (F) as follows:"
  ]
  node [
    id 1442
    label "section_353_subsection_b_item_4"
    class_name "item"
    text "(4) A drug which is subject to paragraph (1) of this subsection shall be deemed to be misbranded if at any time prior to dispensing its label fails to bear the statement &#8220;Caution: Federal law prohibits dispensing without prescription&#8221;. A drug to which paragraph (1) of this subsection does not apply shall be deemed to be misbranded if at any time prior to dispensing its label bears the caution statement quoted in the preceding sentence."
  ]
  node [
    id 1443
    label "section_353_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) is limited by an approved application under section 355 of this title to use under the professional supervision of a practitioner licensed by law to administer such drug;"
  ]
  node [
    id 1444
    label "section_353_subsection_d_item_2_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the name of the manufacturer of the drug sample requested, and"
  ]
  node [
    id 1445
    label "section_353_subsection_d"
    class_name "subsection"
    text "(d) Distribution of drug samples"
  ]
  node [
    id 1446
    label "section_353_subsection_g_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) a finding of substantial equivalence under this part, and"
  ]
  node [
    id 1447
    label "section_353_subsection_e_item_2"
    class_name "item"
    text "(2)(A) No person may engage in the wholesale distribution in interstate commerce of drugs subject to subsection (b) of this section in a State unless such person is licensed by the State in accordance with the guidelines issued under subparagraph (B)."
  ]
  node [
    id 1448
    label "section_353_subsection_e_item_3_subitem_B"
    class_name "subitem"
    text "(B) the term &#8220;wholesale distribution&#8221; means distribution of drugs subject to subsection (b) of this section to other than the consumer or patient but does not include intracompany sales and does not include distributions of drugs described in subsection (c)(3)(B) of this section."
  ]
  node [
    id 1449
    label "section_353_subsection_g"
    class_name "subsection"
    text "(g) Regulation of combination products"
  ]
  node [
    id 1450
    label "section_353_subsection_g_item_4_subitem_A"
    class_name "subitem"
    text "(A) The term &#8220;biological product&#8221; has the meaning given the term in section 262(a) of title 42."
  ]
  node [
    id 1451
    label "section_353_subsection_c_item_2"
    class_name "item"
    text "(2) No person may sell, purchase, or trade, offer to sell, purchase, or trade, or counterfeit any coupon. For purposes of this paragraph, the term &#8220;coupon&#8221; means a form which may be redeemed, at no cost or at a reduced cost, for a drug which is prescribed in accordance with subsection (b) of this section."
  ]
  node [
    id 1452
    label "section_353_subsection_g_item_2"
    class_name "item"
    text "(2) Nothing in this subsection shall prevent the Secretary from using any agency resources of the Food and Drug Administration necessary to ensure adequate review of the safety, effectiveness, or substantial equivalence of an article."
  ]
  node [
    id 1453
    label "section_353_subsection_i"
    class_name "subsection"
    text "(i) which is subject to subsection (b) of this section, and"
  ]
  node [
    id 1454
    label "section_353_subsection_f_item_2_subitem_A"
    class_name "subitem"
    text "(A) shall be exempt from the requirements of section 352 of this title, except subsections (a), (g), (h), (i)(2), (i)(3), and (p) of such section, and"
  ]
  node [
    id 1455
    label "section_353_subsection_f_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) is limited by an approved application under subsection (b) of section 360b of this title to use under the professional supervision of a licensed veterinarian,"
  ]
  node [
    id 1456
    label "section_353_subsection_e_item_3"
    class_name "item"
    text "(3) For the purposes of this subsection and subsection (d) of this section&#8212;"
  ]
  node [
    id 1457
    label "section_353_subsection_b"
    class_name "subsection"
    text "(b) Prescription by physician; exemption from labeling and prescription requirements; misbranded drugs; compliance with narcotic and marihuana laws"
  ]
  node [
    id 1458
    label "section_353_subsection_g_item_1"
    class_name "item"
    text "(1) The Secretary shall designate a component of the Food and Drug Administration to regulate products that constitute a combination of a drug, device, or biological product. The Secretary shall determine the primary mode of action of the combination product. If the Secretary determines that the primary mode of action is that of&#8212;"
  ]
  node [
    id 1459
    label "section_353_subsection_i_subitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(ii)(I) which was purchased by a public or private hospital or other health care entity, or"
  ]
  node [
    id 1460
    label "section_353_subsection_d_item_3_subitem_F"
    class_name "subitem"
    text "(F) Drug manufacturers or authorized distributors of record shall provide to the Secretary the name and telephone number of the individual responsible for responding to a request for information respecting drug samples."
  ]
  node [
    id 1461
    label "section_353_subsection_b_item_3"
    class_name "item"
    text "(3) The Secretary may by regulation remove drugs subject to sections 352(d) and 355 of this title from the requirements of paragraph (1) of this subsection when such requirements are not necessary for the protection of the public health."
  ]
  node [
    id 1462
    label "section_353_subsection_f_item_1_subitem_C"
    class_name "subitem"
    text "(C) The act of dispensing a drug contrary to the provisions of this paragraph shall be deemed to be an act which results in the drug being misbranded while held for sale."
  ]
  node [
    id 1463
    label "section_353_subsection_f_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) when dispensed by a licensed veterinarian, the drug bears a label containing the name and address of the practitioner and any directions for use and cautionary statements specified by the practitioner, or"
  ]
  node [
    id 1464
    label "section_353_subsection_f_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) is, if an oral order, promptly reduced to writing by the person lawfully filling the order, and filed by that person, and"
  ]
  node [
    id 1465
    label "section_353_subsection_f_item_1"
    class_name "item"
    text "(1)(A) A drug intended for use by animals other than man which&#8212;"
  ]
  node [
    id 1466
    label "section_353_subsection_f_item_4"
    class_name "item"
    text "(4) A drug which is subject to paragraph (1) shall be deemed to be misbranded if at any time prior to dispensing its label fails to bear the statement &#8220;Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.&#8221;. A drug to which paragraph (1) does not apply shall be deemed to be misbranded if at any time prior to dispensing its label bears the statement specified in the preceding sentence."
  ]
  node [
    id 1467
    label "section_353_subsection_f_item_2"
    class_name "item"
    text "(2) Any drug when dispensed in accordance with paragraph (1) of this subsection&#8212;"
  ]
  node [
    id 1468
    label "section_353_subsection_f_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) is a prescription or other order authorized by law,"
  ]
  node [
    id 1469
    label "section_353_subsection_c_item_3"
    class_name "item"
    text "(3)(A) No person may sell, purchase, or trade, or offer to sell, purchase, or trade, any drug&#8212;"
  ]
  node [
    id 1470
    label "section_353_subsection_b_item_2"
    class_name "item"
    text "(2) Any drug dispensed by filling or refilling a written or oral prescription of a practitioner licensed by law to administer such drug shall be exempt from the requirements of section 352 of this title, except paragraphs (a), (i)(2) and (3), (k), and (l), and the packaging requirements of paragraphs (g), (h), and (p), if the drug bears a label containing the name and address of the dispenser, the serial number and date of the prescription or of its filling, the name of the prescriber, and, if stated in the prescription, the name of the patient, and the directions for use and cautionary statements, if any, contained in such prescription. This exemption shall not apply to any drug dispensed in the course of the conduct of a business of dispensing drugs pursuant to diagnosis by mail, or to a drug dispensed in violation of paragraph (1) of this subsection."
  ]
  node [
    id 1471
    label "section_353_subsection_d_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) at the written request of such a licensed practitioner, to pharmacies of hospitals or other health care entities."
  ]
  node [
    id 1472
    label "section_353_subsection_b_item_1_subitem_C_subsubitem_iii"
    class_name "subsubitem"
    text "shall be dispensed only (i) upon a written prescription of a practitioner licensed by law to administer such drug, or (ii) upon an oral prescription of such practitioner which is reduced promptly to writing and filed by the pharmacist, or (iii) by refilling any such written or oral prescription if such refilling is authorized by the prescriber either in the original prescription or by oral order which is reduced promptly to writing and filed by the pharmacist. The act of dispensing a drug contrary to the provisions of this paragraph shall be deemed to be an act which results in the drug being misbranded while held for sale."
  ]
  node [
    id 1473
    label "section_353_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) Each manufacturer of a drug subject to subsection (b) of this section shall maintain at its corporate offices a current list of the authorized distributors of record of such drug."
  ]
  node [
    id 1474
    label "section_353_subsection_g_item_1_subitem_A"
    class_name "subitem"
    text "(A) a drug (other than a biological product), the persons charged with premarket review of drugs shall have primary jurisdiction,"
  ]
  node [
    id 1475
    label "section_353_subsection_d_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) to practitioners licensed to prescribe such drugs if they make a written request for the drug samples, or"
  ]
  node [
    id 1476
    label "section_353_subsection_d_item_3_subitem_D"
    class_name "subitem"
    text "(D) Drug manufacturers or authorized distributors of record shall notify the Secretary of any significant loss of drug samples and any known theft of drug samples."
  ]
  node [
    id 1477
    label "section_353_subsection_d_item_3_subitem_C"
    class_name "subitem"
    text "(C) Drug manufacturers or authorized distributors of record shall conduct, at least annually, a complete and accurate inventory of all drug samples in the possession of representatives of the manufacturer or authorized distributor of record. Drug manufacturers or authorized distributors of record shall maintain lists of the names and address of each of their representatives who distribute drug samples and of the sites where drug samples are stored. Drug manufacturers or authorized distributors of record shall maintain records for at least 3 years of all drug samples distributed, destroyed, or returned to the manufacturer or authorized distributor of record, of all inventories maintained under this subparagraph, of all thefts or significant losses of drug samples, and of all requests made under subparagraph (A) for drug samples. Records and lists maintained under this subparagraph shall be made available by the drug manufacturer or authorized distributor of record to the Secretary upon request."
  ]
  node [
    id 1478
    label "section_353_subsection_i_subitem_B"
    class_name "subitem"
    text "(B) Subparagraph (A) does not apply to&#8212;"
  ]
  node [
    id 1479
    label "section_353_subsection_i_subitem_ii"
    class_name "subitem"
    text "(ii)(I) which was purchased by a public or private hospital or other health care entity, or"
  ]
  node [
    id 1480
    label "section_353_subsection_v"
    class_name "subsection"
    text "(v) a sale, purchase, or trade of a drug, an offer to sell, purchase, or trade a drug, or the dispensing of a drug pursuant to a prescription executed in accordance with subsection (b) of this section."
  ]
  node [
    id 1481
    label "section_353_subsection_g_item_4"
    class_name "item"
    text "(4) As used in this subsection:"
  ]
  node [
    id 1482
    label "section_353_subsection_i_subitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) which was donated or supplied at a reduced price to a charitable organization described in section 501(c)(3) of title 26."
  ]
  node [
    id 1483
    label "section_353_subsection_e_item_1"
    class_name "item"
    text "(1)(A) Each person who is engaged in the wholesale distribution of a drug subject to subsection (b) of this section and who is not the manufacturer or an authorized distributor of record of such drug shall, before each wholesale distribution of such drug (including each distribution to an authorized distributor of record or to a retail pharmacy), provide to the person who receives the drug a statement (in such form and containing such information as the Secretary may require) identifying each prior sale, purchase, or trade of such drug (including the date of the transaction and the names and addresses of all parties to the transaction)."
  ]
  node [
    id 1484
    label "section_353_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(A) practitioner licensed to prescribe such drug,"
  ]
  node [
    id 1485
    label "section_353_subsection_g_item_4_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) approval of a product or establishment license under subsection (a) or (d) of section 262 of title 42."
  ]
  node [
    id 1486
    label "section_353_subsection_g_item_1_subitem_C"
    class_name "subitem"
    text "(C) a biological product, the persons charged with premarket review of biological products shall have primary jurisdiction."
  ]
  node [
    id 1487
    label "section_353_subsection_i_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) a sale, purchase, or trade of a drug or an offer to sell, purchase, or trade a drug among hospitals or other health care entities which are under common control,"
  ]
  node [
    id 1488
    label "section_353_subsection_f_item_2_subitem_B"
    class_name "subitem"
    text "(B) shall be exempt from the packaging requirements of subsections (g), (h), and (p) of such section, if&#8212;"
  ]
  node [
    id 1489
    label "section_353_subsection_i_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the sale, purchase, or trade of a drug or an offer to sell, purchase, or trade a drug by an organization described in subparagraph (A)(ii)(II) to a nonprofit affiliate of the organization to the extent otherwise permitted by law,"
  ]
  node [
    id 1490
    label "section_353_subsection_i_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) a sale, purchase, or trade of a drug or an offer to sell, purchase, or trade a drug for emergency medical reasons, or"
  ]
  node [
    id 1491
    label "section_353_subsection_f_item_1_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) is refilled only if authorized in the original order or in a subsequent oral order promptly reduced to writing by the person lawfully filling the order, and filed by that person."
  ]
  node [
    id 1492
    label "section_353_subsection_g_item_3"
    class_name "item"
    text "(3) The Secretary shall promulgate regulations to implement market clearance procedures in accordance with paragraphs (1) and (2) not later than 1 year after November 28, 1990."
  ]
  node [
    id 1493
    label "section_353_subsection_d_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) under a system which requires the recipient of the drug sample to execute a written receipt for the drug sample upon its delivery and the return of the receipt to the manufacturer or authorized distributor of record."
  ]
  node [
    id 1494
    label "section_353_subsection_e"
    class_name "subsection"
    text "(e) Wholesale distributors; guidelines for licensing; definitions"
  ]
  node [
    id 1495
    label "section_353_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) A drug intended for use by animals other than man which&#8212;"
  ]
  node [
    id 1496
    label "section_353_subsection_e_item_3_subitem_A"
    class_name "subitem"
    text "(A) the term &#8220;authorized distributors of record&#8221; means those distributors with whom a manufacturer has established an ongoing relationship to distribute such manufacturer's products, and"
  ]
  node [
    id 1497
    label "section_353_subsection_d_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) in response to a written request for drug samples made on a form which meets the requirements of subparagraph (B), and"
  ]
  node [
    id 1498
    label "section_353_subsection_c_item_1"
    class_name "item"
    text "(1) No person may sell, purchase, or trade or offer to sell, purchase, or trade any drug sample. For purposes of this paragraph and subsection (d) of this section, the term &#8220;drug sample&#8221; means a unit of a drug, subject to subsection (b) of this section, which is not intended to be sold and is intended to promote the sale of the drug. Nothing in this paragraph shall subject an officer or executive of a drug manufacturer or distributor to criminal liability solely because of a sale, purchase, trade, or offer to sell, purchase, or trade in violation of this paragraph by other employees of the manufacturer or distributor."
  ]
  node [
    id 1499
    label "section_353_subsection_b_item_5"
    class_name "item"
    text "(5) Nothing in this subsection shall be construed to relieve any person from any requirement prescribed by or under authority of law with respect to drugs now included or which may hereafter be included within the classifications stated in sections 4721, 6001, and 6151 of title 26, or to marihuana as defined in section 4761 of title 26."
  ]
  node [
    id 1500
    label "section_353_subsection_d_item_2"
    class_name "item"
    text "(2)(A) The manufacturer or authorized distributor of record of a drug subject to subsection (b) of this section may, in accordance with this paragraph, distribute drug samples by mail or common carrier to practitioners licensed to prescribe such drugs or, at the request of a licensed practitioner, to pharmacies of hospitals or other health care entities. Such a distribution of drug samples may only be made&#8212;"
  ]
  node [
    id 1501
    label "section_353_subsection_d_item_3_subitem_B"
    class_name "subitem"
    text "(B) Drug manufacturers or authorized distributors of record shall store drug samples under conditions that will maintain their stability, integrity, and effectiveness and will assure that the drug samples will be free of contamination, deterioration, and adulteration."
  ]
  node [
    id 1502
    label "section_353_subsection_i_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the purchase or other acquisition by a hospital or other health care entity which is a member of a group purchasing organization of a drug for its own use from the group purchasing organization or from other hospitals or health care entities which are members of such organization,"
  ]
  node [
    id 1503
    label "section_353_subsection_f_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary for its use, is not safe for animal use except under the professional supervision of a licensed veterinarian, or"
  ]
  node [
    id 1504
    label "section_353_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) For purposes of subparagraph (A), an order is lawful if the order&#8212;"
  ]
  node [
    id 1505
    label "section_353_subsection_d_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) The manufacturer or authorized distributor of record of a drug subject to subsection (b) of this section may, in accordance with this paragraph, distribute drug samples by mail or common carrier to practitioners licensed to prescribe such drugs or, at the request of a licensed practitioner, to pharmacies of hospitals or other health care entities. Such a distribution of drug samples may only be made&#8212;"
  ]
  node [
    id 1506
    label "section_353_subsection_a"
    class_name "subsection"
    text "(a) Regulations for goods to be processed, labeled, or repacked elsewhere"
  ]
  node [
    id 1507
    label "section_353_subsection_d_item_2_subitem_B"
    class_name "subitem"
    text "(B) A written request for a drug sample required by subparagraph (A)(i) shall contain&#8212;"
  ]
  node [
    id 1508
    label "section_353_subsection_d_item_1"
    class_name "item"
    text "(1) Except as provided in paragraphs (2) and (3), no person may distribute any drug sample. For purposes of this subsection, the term &#8220;distribute&#8221; does not include the providing of a drug sample to a patient by a&#8212;"
  ]
  node [
    id 1509
    label "section_353_subsection_f_item_3"
    class_name "item"
    text "(3) The Secretary may by regulation exempt drugs for animals other than man subject to section 360b of this title from the requirements of paragraph (1) when such requirements are not necessary for the protection of the public health."
  ]
  node [
    id 1510
    label "section_353_subsection_g_item_1_subitem_B"
    class_name "subitem"
    text "(B) a device, the persons charged with premarket review of devices shall have primary jurisdiction, or"
  ]
  node [
    id 1511
    label "section_353_subsection_g_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) approval of an application under section 355, 357, 360e, or 360j(g) of this title,"
  ]
  node [
    id 1512
    label "section_353_subsection_b_item_1_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "shall be dispensed only (i) upon a written prescription of a practitioner licensed by law to administer such drug, or (ii) upon an oral prescription of such practitioner which is reduced promptly to writing and filed by the pharmacist, or (iii) by refilling any such written or oral prescription if such refilling is authorized by the prescriber either in the original prescription or by oral order which is reduced promptly to writing and filed by the pharmacist. The act of dispensing a drug contrary to the provisions of this paragraph shall be deemed to be an act which results in the drug being misbranded while held for sale."
  ]
  node [
    id 1513
    label "section_353_subsection_d_item_2_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the date of the request."
  ]
  node [
    id 1514
    label "section_353_subsection_c"
    class_name "subsection"
    text "(c) Sales restrictions"
  ]
  node [
    id 1515
    label "section_353_subsection_e_item_2_subitem_B"
    class_name "subitem"
    text "(B) The Secretary shall by regulation issue guidelines establishing minimum standards, terms, and conditions for the licensing of persons to make wholesale distributions in interstate commerce of drugs subject to subsection (b) of this section. Such guidelines shall prescribe requirements for the storage and handling of such drugs and for the establishment and maintenance of records of the distributions of such drugs."
  ]
  node [
    id 1516
    label "section_353_subsection_d_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the identity of the drug sample requested and the quantity requested,"
  ]
  node [
    id 1517
    label "section_353_subsection_d_item_1_subitem_C"
    class_name "subitem"
    text "(C) pharmacy of a hospital or of another health care entity that is acting at the direction of such a practitioner and that received such sample pursuant to paragraph (2) or (3)."
  ]
  node [
    id 1518
    label "section_353_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) is a habit-forming drug to which section 352(d) of this title applies; or"
  ]
  node [
    id 1519
    label "section_355_subsection_b_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) that such patent information has not been filed,"
  ]
  node [
    id 1520
    label "section_355_subsection_v_item_6_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the listed drug has been withdrawn from sale, for the period of withdrawal from sale or, if earlier, the period ending on the date the Secretary determines that the withdrawal from sale is not for safety or effectiveness reasons."
  ]
  node [
    id 1521
    label "section_355_subsection_e_item_5"
    class_name "item"
    text "The Secretary shall, after due notice and opportunity for hearing to the applicant, withdraw approval of an application with respect to any drug under this section if the Secretary finds (1) that clinical or other experience, tests, or other scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved; (2) that new evidence of clinical experience, not contained in such application or not available to the Secretary until after such application was approved, or tests by new methods, or tests by methods not deemed reasonably applicable when such application was approved, evaluated together with the evidence available to the Secretary when the application was approved, shows that such drug is not shown to be safe for use under the conditions of use upon the basis of which the application was approved; or (3) on the basis of new information before him with respect to such drug, evaluated together with the evidence available to him when the application was approved, that there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling thereof; or (4) the patent information prescribed by subsection (c) of this section was not filed within thirty days after the receipt of written notice from the Secretary specifying the failure to file such information; or (5) that the application contains any untrue statement of a material fact: Provided, That if the Secretary (or in his absence the officer acting as Secretary) finds that there is an imminent hazard to the public health, he may suspend the approval of such application immediately, and give the applicant prompt notice of his action and afford the applicant the opportunity for an expedited hearing under this subsection; but the authority conferred by this proviso to suspend the approval of an application shall not be delegated. The Secretary may also, after due notice and opportunity for hearing to the applicant, withdraw the approval of an application submitted under subsection (b) or (j) of this section with respect to any drug under this section if the Secretary finds (1) that the applicant has failed to establish a system for maintaining required records, or has repeatedly or deliberately failed to maintain such records or to make required reports, in accordance with a regulation or order under subsection (k) of this section or to comply with the notice requirements of section 360(k)(2) of this title, or the applicant has refused to permit access to, or copying or verification of, such records as required by paragraph (2) of such subsection; or (2) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to assure and preserve its identity, strength, quality, and purity and were not made adequate within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of; or (3) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the labeling of such drug, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of. Any order under this subsection shall state the findings upon which it is based."
  ]
  node [
    id 1522
    label "section_355_subsection_d_item_1"
    class_name "item"
    text "If the Secretary finds, after due notice to the applicant in accordance with subsection (c) of this section and giving him an opportunity for a hearing, in accordance with said subsection, that (1) the investigations, reports of which are required to be submitted to the Secretary pursuant to subsection (b) of this section, do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions; (3) the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to preserve its identity, strength, quality, and purity; (4) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, he has insufficient information to determine whether such drug is safe for use under such conditions; or (5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection (b) of this section; or (7) based on a fair evaluation of all material facts, such labeling is false or misleading in any particular; he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that clauses (1) through (6) do not apply, he shall issue an order approving the application. As used in this subsection and subsection (e) of this section, the term &#8220;substantial evidence&#8221; means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof."
  ]
  node [
    id 1523
    label "section_355_subsection_v_item_2_subitem_D"
    class_name "subitem"
    text "(D)(i) If an application (other than an abbreviated new drug application) submitted under subsection (b) of this section for a drug, no active ingredient (including any ester or salt of the active ingredient) of which has been approved in any other application under subsection (b) of this section, was approved during the period beginning January 1, 1982, and ending on September 24, 1984, the Secretary may not make the approval of an application submitted under this subsection which refers to the drug for which the subsection (b) application was submitted effective before the expiration of ten years from the date of the approval of the application under subsection (b) of this section."
  ]
  node [
    id 1524
    label "section_355_subsection_c_item_3_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if before the expiration of such period the court decides that such patent has been infringed, the approval may be made effective on such date as the court orders under section 271(e)(4)(A) of title 35, or"
  ]
  node [
    id 1525
    label "section_355_subsection_v_item_1"
    class_name "item"
    text "(vi) the items specified in clauses (B) through (F) of subsection (b)(1) of this section;"
  ]
  node [
    id 1526
    label "section_355_subsection_v_item_1_subitem_C"
    class_name "subitem"
    text "(C) If a person wants to submit an abbreviated application for a new drug which has a different active ingredient or whose route of administration, dosage form, or strength differ from that of a listed drug, such person shall submit a petition to the Secretary seeking permission to file such an application. The Secretary shall approve or disapprove a petition submitted under this subparagraph within ninety days of the date the petition is submitted. The Secretary shall approve such a petition unless the Secretary finds&#8212;"
  ]
  node [
    id 1527
    label "section_355_subsection_b_item_3_subitem_C"
    class_name "subitem"
    text "(C) If an application is amended to include a certification described in paragraph (2)(A)(iv), the notice required by subparagraph (B) shall be given when the amended application is submitted."
  ]
  node [
    id 1528
    label "section_355_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) approve the application if he then finds that none of the grounds for denying approval specified in subsection (d) of this section applies, or"
  ]
  node [
    id 1529
    label "section_355_subsection_v_item_2_subitem_K"
    class_name "subitem"
    text "(K) the application contains an untrue statement of material fact."
  ]
  node [
    id 1530
    label "section_355_subsection_l"
    class_name "subsection"
    text "(l) Public disclosure of safety and effectiveness data"
  ]
  node [
    id 1531
    label "section_355_subsection_c_item_3"
    class_name "item"
    text "In such an action, each of the parties shall reasonably cooperate in expediting the action. Until the expiration of forty-five days from the date the notice made under paragraph (3)(B) is received, no action may be brought under section 2201 of title 28 for a declaratory judgment with respect to the patent. Any action brought under such section 2201 shall be brought in the judicial district where the defendant has its principal place of business or a regular and established place of business."
  ]
  node [
    id 1532
    label "section_355_subsection_d_item_5"
    class_name "item"
    text "If the Secretary finds, after due notice to the applicant in accordance with subsection (c) of this section and giving him an opportunity for a hearing, in accordance with said subsection, that (1) the investigations, reports of which are required to be submitted to the Secretary pursuant to subsection (b) of this section, do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions; (3) the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to preserve its identity, strength, quality, and purity; (4) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, he has insufficient information to determine whether such drug is safe for use under such conditions; or (5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection (b) of this section; or (7) based on a fair evaluation of all material facts, such labeling is false or misleading in any particular; he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that clauses (1) through (6) do not apply, he shall issue an order approving the application. As used in this subsection and subsection (e) of this section, the term &#8220;substantial evidence&#8221; means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof."
  ]
  node [
    id 1533
    label "section_355_subsection_v_subitem_F"
    class_name "subitem"
    text "(vi) the items specified in clauses (B) through (F) of subsection (b)(1) of this section;"
  ]
  node [
    id 1534
    label "section_355_subsection_v_item_2_subitem_J"
    class_name "subitem"
    text "(J) the application does not meet any other requirement of paragraph (2)(A); or"
  ]
  node [
    id 1535
    label "section_355_subsection_k_item_2"
    class_name "item"
    text "(2) Every person required under this section to maintain records, and every person in charge or custody thereof, shall, upon request of an officer or employee designated by the Secretary, permit such officer or employee at all reasonable times to have access to and copy and verify such records."
  ]
  node [
    id 1536
    label "section_355_subsection_v_item_2_subitem_C"
    class_name "subitem"
    text "(C) If the Secretary decides to disapprove an application, the Secretary shall give the applicant notice of an opportunity for a hearing before the Secretary on the question of whether such application is approvable. If the applicant elects to accept the opportunity for hearing by written request within thirty days after such notice, such hearing shall commence not more than ninety days after the expiration of such thirty days unless the Secretary and the applicant otherwise agree. Any such hearing shall thereafter be conducted on an expedited basis and the Secretary's order thereon shall be issued within ninety days after the date fixed by the Secretary for filing final briefs."
  ]
  node [
    id 1537
    label "section_355_subsection_v_item_7_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the extent of absorption of the drug does not show a significant difference from the extent of absorption of the listed drug when administered at the same molar dose of the therapeutic ingredient under similar experimental conditions in either a single dose or multiple doses and the difference from the listed drug in the rate of absorption of the drug is intentional, is reflected in its proposed labeling, is not essential to the attainment of effective body drug concentrations on chronic use, and is considered medically insignificant for the drug."
  ]
  node [
    id 1538
    label "section_355_subsection_v_item_8"
    class_name "item"
    text "(8) The Secretary shall, with respect to each application submitted under this subsection, maintain a record of&#8212;"
  ]
  node [
    id 1539
    label "section_355_subsection_b_item_1"
    class_name "item"
    text "(1) Any person may file with the Secretary an application with respect to any drug subject to the provisions of subsection (a) of this section. Such person shall submit to the Secretary as a part of the application (A) full reports of investigations which have been made to show whether or not such drug is safe for use and whether such drug is effective in use; (B) a full list of the articles used as components of such drug; (C) a full statement of the composition of such drug; (D) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug; (E) such samples of such drug and of the articles used as components thereof as the Secretary may require; and (F) specimens of the labeling proposed to be used for such drug. The applicant shall file with the application the patent number and the expiration date of any patent which claims the drug for which the applicant submitted the application or which claims a method of using such drug and with respect to which a claim of patent infringement could reasonably be asserted if a person not licensed by the owner engaged in the manufacture, use, or sale of the drug. If an application is filed under this subsection for a drug and a patent which claims such drug or a method of using such drug is issued after the filing date but before approval of the application, the applicant shall amend the application to include the information required by the preceding sentence. Upon approval of the application, the Secretary shall publish information submitted under the two preceding sentences."
  ]
  node [
    id 1540
    label "section_355_subsection_v_subitem_B"
    class_name "subitem"
    text "(vi) the items specified in clauses (B) through (F) of subsection (b)(1) of this section;"
  ]
  node [
    id 1541
    label "section_355_subsection_c_item_3_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(D)(i) If an application (other than an abbreviated new drug application) submitted under subsection (b) of this section for a drug, no active ingredient (including any ester or salt of the active ingredient) of which has been approved in any other application under subsection (b) of this section, was approved during the period beginning January 1, 1982, and ending on September 24, 1984, the Secretary may not make the approval of another application for a drug for which the investigations described in clause (A) of subsection (b)(1) of this section and relied upon by the applicant for approval of the application were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted effective before the expiration of ten years from the date of the approval of the application previously approved under subsection (b) of this section."
  ]
  node [
    id 1542
    label "section_355_subsection_j"
    class_name "subsection"
    text "(j) Abbreviated new drug applications"
  ]
  node [
    id 1543
    label "section_355_subsection_v_item_8_subitem_A"
    class_name "subitem"
    text "(A) the name of the applicant,"
  ]
  node [
    id 1544
    label "section_355_subsection_i_subitem_ii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) if the listed drug referred to in clause (i) has more than one active ingredient and if one of the active ingredients of the new drug is different and the application is filed pursuant to the approval of a petition filed under subparagraph (C), information to show that the other active ingredients of the new drug are the same as the active ingredients of the listed drug, information to show that the different active ingredient is an active ingredient of a listed drug or of a drug which does not meet the requirements of section 321(p) of this title, and such other information respecting the different active ingredient with respect to which the petition was filed as the Secretary may require;"
  ]
  node [
    id 1545
    label "section_355_subsection_v_item_1_subitem_B_subsubitem_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) each owner of the patent which is the subject of the certification or the representative of such owner designated to receive such notice, and"
  ]
  node [
    id 1546
    label "section_355_subsection_v_item_1_subsubitem_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) that such patent information has not been filed,"
  ]
  node [
    id 1547
    label "section_355_subsection_v_item_1_subsubitem_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) that such patent has expired,"
  ]
  node [
    id 1548
    label "section_355_subsection_l_item_4"
    class_name "item"
    text "(4) if the Secretary has determined that such drug is not a new drug, or"
  ]
  node [
    id 1549
    label "section_355_subsection_v_item_8_subitem_B"
    class_name "subitem"
    text "(B) the name of the drug covered by the application,"
  ]
  node [
    id 1550
    label "section_355_subsection_v_item_6_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Every thirty days after the publication of the first list under clause (i) the Secretary shall revise the list to include each drug which has been approved for safety and effectiveness under subsection (c) of this section or approved under this subsection during the thirty-day period."
  ]
  node [
    id 1551
    label "section_355_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) a certification, in the opinion of the applicant and to the best of his knowledge, with respect to each patent which claims the drug for which such investigations were conducted or which claims a use for such drug for which the applicant is seeking approval under this subsection and for which information is required to be filed under paragraph (1) or subsection (c) of this section&#8212;"
  ]
  node [
    id 1552
    label "section_355_subsection_v_item_6_subitem_A"
    class_name "subitem"
    text "(6)(A)(i) Within sixty days of September 24, 1984, the Secretary shall publish and make available to the public&#8212;"
  ]
  node [
    id 1553
    label "section_355_subsection_v_item_6_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) for the same period as the withdrawal or suspension under subsection (e) of this section or paragraph (5), or"
  ]
  node [
    id 1554
    label "section_355_subsection_v_item_7_subitem_B"
    class_name "subitem"
    text "(B) A drug shall be considered to be bioequivalent to a listed drug if&#8212;"
  ]
  node [
    id 1555
    label "section_355_subsection_c_item_3_subitem_C_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) if before the expiration of such period the court grants a preliminary injunction prohibiting the applicant from engaging in the commercial manufacture or sale of the drug until the court decides the issues of patent validity and infringement and if the court decides that such patent is invalid or not infringed, the approval shall be made effective on the date of such court decision."
  ]
  node [
    id 1556
    label "section_355_subsection_c_item_1"
    class_name "item"
    text "(1) Within one hundred and eighty days after the filing of an application under subsection (b) of this section, or such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall either&#8212;"
  ]
  node [
    id 1557
    label "section_355_subsection_v_item_4_subitem_B_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) if before the expiration of such period the court decides that such patent is invalid or not infringed, the approval shall be made effective on the date of the court decision,"
  ]
  node [
    id 1558
    label "section_355_subsection_v_item_6_subitem_B"
    class_name "subitem"
    text "(B) A drug approved for safety and effectiveness under subsection (c) of this section or approved under this subsection shall, for purposes of this subsection, be considered to have been published under subparagraph (A) on the date of its approval or September 24, 1984, whichever is later."
  ]
  node [
    id 1559
    label "section_355_subsection_i_subitem_ii_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) information to show that the new drug is bioequivalent to the listed drug referred to in clause (i), except that if the application is filed pursuant to the approval of a petition filed under subparagraph (C), information to show that the active ingredients of the new drug are of the same pharmacological or therapeutic class as those of the listed drug referred to in clause (i) and the new drug can be expected to have the same therapeutic effect as the listed drug when administered to patients for a condition of use referred to in clause (i);"
  ]
  node [
    id 1560
    label "section_355_subsection_v_item_2_subitem_D_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) If an application submitted under subsection (b) of this section for a drug, which includes an active ingredient (including any ester or salt of the active ingredient) that has been approved in another application approved under subsection (b) of this section, is approved after September 24, 1984, and if such application contains reports of new clinical investigations (other than bioavailability studies) essential to the approval of the application and conducted or sponsored by the applicant, the Secretary may not make the approval of an application submitted under this subsection for the conditions of approval of such drug in the subsection (b) application effective before the expiration of three years from the date of the approval of the application under subsection (b) of this section for such drug."
  ]
  node [
    id 1561
    label "section_355_subsection_v_item_6_subitem_C"
    class_name "subitem"
    text "(C) If the approval of a drug was withdrawn or suspended for grounds described in the first sentence of subsection (e) of this section or was withdrawn or suspended under paragraph (5) or if the Secretary determines that a drug has been withdrawn from sale for safety or effectiveness reasons, it may not be published in the list under subparagraph (A) or, if the withdrawal or suspension occurred after its publication in such list, it shall be immediately removed from such list&#8212;"
  ]
  node [
    id 1562
    label "section_355_subsection_v_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If the applicant made a certification described in subclause (III) of paragraph (2)(A)(vii), the approval may be made effective on the date certified under subclause (III)."
  ]
  node [
    id 1563
    label "section_355_subsection_v_item_1_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) that investigations must be conducted to show the safety and effectiveness of the drug or of any of its active ingredients, the route of administration, the dosage form, or strength which differ from the listed drug; or"
  ]
  node [
    id 1564
    label "section_355_subsection_v_item_1_subsubitem_i_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) of the date on which such patent will expire, or"
  ]
  node [
    id 1565
    label "section_355_subsection_v_item_8_subitem_C"
    class_name "subitem"
    text "(C) the name of each person to whom the review of the chemistry of the application was assigned and the date of such assignment, and"
  ]
  node [
    id 1566
    label "section_355_subsection_f"
    class_name "subsection"
    text "(f) Revocation of order refusing, withdrawing or suspending approval of application"
  ]
  node [
    id 1567
    label "section_355_subsection_d_item_2"
    class_name "item"
    text "If the Secretary finds, after due notice to the applicant in accordance with subsection (c) of this section and giving him an opportunity for a hearing, in accordance with said subsection, that (1) the investigations, reports of which are required to be submitted to the Secretary pursuant to subsection (b) of this section, do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions; (3) the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to preserve its identity, strength, quality, and purity; (4) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, he has insufficient information to determine whether such drug is safe for use under such conditions; or (5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection (b) of this section; or (7) based on a fair evaluation of all material facts, such labeling is false or misleading in any particular; he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that clauses (1) through (6) do not apply, he shall issue an order approving the application. As used in this subsection and subsection (e) of this section, the term &#8220;substantial evidence&#8221; means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof."
  ]
  node [
    id 1568
    label "section_355_subsection_v_item_8_subitem_D"
    class_name "subitem"
    text "(D) the name of each person to whom the bioequivalence review for such application was assigned and the date of such assignment."
  ]
  node [
    id 1569
    label "section_355_subsection_h"
    class_name "subsection"
    text "(h) Appeal from order"
  ]
  node [
    id 1570
    label "section_355_subsection_v_item_3_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(C)(i) if the listed drug has only one active ingredient, information submitted with the application is insufficient to show that the active ingredient is the same as that of the listed drug;"
  ]
  node [
    id 1571
    label "section_355_subsection_g"
    class_name "subsection"
    text "(g) Service of orders"
  ]
  node [
    id 1572
    label "section_355_subsection_v_item_1_subsubitem_i"
    class_name "subsubitem"
    text "The Secretary may not require that an abbreviated application contain information in addition to that required by clauses (i) through (viii)."
  ]
  node [
    id 1573
    label "section_355_subsection_c_item_3_subitem_B"
    class_name "subitem"
    text "In such an action, each of the parties shall reasonably cooperate in expediting the action. Until the expiration of forty-five days from the date the notice made under paragraph (3)(B) is received, no action may be brought under section 2201 of title 28 for a declaratory judgment with respect to the patent. Any action brought under such section 2201 shall be brought in the judicial district where the defendant has its principal place of business or a regular and established place of business."
  ]
  node [
    id 1574
    label "section_355_subsection_j_item_1"
    class_name "item"
    text "(1) Any person may file with the Secretary an abbreviated application for the approval of a new drug."
  ]
  node [
    id 1575
    label "section_355_subsection_v_item_2_subitem_B_subsubitem_iv_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the date of a decision of a court in an action described in clause (iii) holding the patent which is the subject of the certification to be invalid or not infringed,"
  ]
  node [
    id 1576
    label "section_355_subsection_b_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) that such patent has expired,"
  ]
  node [
    id 1577
    label "section_355_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) if with respect to the drug for which investigations described in paragraph (1)(A) were conducted information was filed under paragraph (1) or subsection (c) of this section for a method of use patent which does not claim a use for which the applicant is seeking approval under this subsection, a statement that the method of use patent does not claim such a use."
  ]
  node [
    id 1578
    label "section_355_subsection_v_item_7_subitem_A"
    class_name "subitem"
    text "(A) The term &#8220;bioavailability&#8221; means the rate and extent to which the active ingredient or therapeutic ingredient is absorbed from a drug and becomes available at the site of drug action."
  ]
  node [
    id 1579
    label "section_355_subsection_g_item_1"
    class_name "item"
    text "Orders of the Secretary issued under this section shall be served (1) in person by any officer or employee of the department designated by the Secretary or (2) by mailing the order by registered mail or by certified mail addressed to the applicant or respondent at his last-known address in the records of the Secretary."
  ]
  node [
    id 1580
    label "section_355_subsection_b_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) An applicant who makes a certification described in paragraph (2)(A)(iv) shall include in the application a statement that the applicant will give the notice required by subparagraph (B) to&#8212;"
  ]
  node [
    id 1581
    label "section_355_subsection_k"
    class_name "subsection"
    text "(k) Records and reports; required information; regulations and orders; access to records"
  ]
  node [
    id 1582
    label "section_355_subsection_d_item_4"
    class_name "item"
    text "If the Secretary finds, after due notice to the applicant in accordance with subsection (c) of this section and giving him an opportunity for a hearing, in accordance with said subsection, that (1) the investigations, reports of which are required to be submitted to the Secretary pursuant to subsection (b) of this section, do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions; (3) the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to preserve its identity, strength, quality, and purity; (4) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, he has insufficient information to determine whether such drug is safe for use under such conditions; or (5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection (b) of this section; or (7) based on a fair evaluation of all material facts, such labeling is false or misleading in any particular; he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that clauses (1) through (6) do not apply, he shall issue an order approving the application. As used in this subsection and subsection (e) of this section, the term &#8220;substantial evidence&#8221; means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof."
  ]
  node [
    id 1583
    label "section_355_subsection_v_item_3_subitem_C"
    class_name "subitem"
    text "(C)(i) if the listed drug has only one active ingredient, information submitted with the application is insufficient to show that the active ingredient is the same as that of the listed drug;"
  ]
  node [
    id 1584
    label "section_355_subsection_v_item_2_subitem_B_subsubitem_iv_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the date the Secretary receives notice from the applicant under the previous application of the first commercial marketing of the drug under the previous application, or"
  ]
  node [
    id 1585
    label "section_355_subsection_e_item_2"
    class_name "item"
    text "The Secretary shall, after due notice and opportunity for hearing to the applicant, withdraw approval of an application with respect to any drug under this section if the Secretary finds (1) that clinical or other experience, tests, or other scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved; (2) that new evidence of clinical experience, not contained in such application or not available to the Secretary until after such application was approved, or tests by new methods, or tests by methods not deemed reasonably applicable when such application was approved, evaluated together with the evidence available to the Secretary when the application was approved, shows that such drug is not shown to be safe for use under the conditions of use upon the basis of which the application was approved; or (3) on the basis of new information before him with respect to such drug, evaluated together with the evidence available to him when the application was approved, that there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling thereof; or (4) the patent information prescribed by subsection (c) of this section was not filed within thirty days after the receipt of written notice from the Secretary specifying the failure to file such information; or (5) that the application contains any untrue statement of a material fact: Provided, That if the Secretary (or in his absence the officer acting as Secretary) finds that there is an imminent hazard to the public health, he may suspend the approval of such application immediately, and give the applicant prompt notice of his action and afford the applicant the opportunity for an expedited hearing under this subsection; but the authority conferred by this proviso to suspend the approval of an application shall not be delegated. The Secretary may also, after due notice and opportunity for hearing to the applicant, withdraw the approval of an application submitted under subsection (b) or (j) of this section with respect to any drug under this section if the Secretary finds (1) that the applicant has failed to establish a system for maintaining required records, or has repeatedly or deliberately failed to maintain such records or to make required reports, in accordance with a regulation or order under subsection (k) of this section or to comply with the notice requirements of section 360(k)(2) of this title, or the applicant has refused to permit access to, or copying or verification of, such records as required by paragraph (2) of such subsection; or (2) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to assure and preserve its identity, strength, quality, and purity and were not made adequate within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of; or (3) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the labeling of such drug, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of. Any order under this subsection shall state the findings upon which it is based."
  ]
  node [
    id 1586
    label "section_355_subsection_v_item_2_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(D)(i) If an application (other than an abbreviated new drug application) submitted under subsection (b) of this section for a drug, no active ingredient (including any ester or salt of the active ingredient) of which has been approved in any other application under subsection (b) of this section, was approved during the period beginning January 1, 1982, and ending on September 24, 1984, the Secretary may not make the approval of an application submitted under this subsection which refers to the drug for which the subsection (b) application was submitted effective before the expiration of ten years from the date of the approval of the application under subsection (b) of this section."
  ]
  node [
    id 1587
    label "section_355_subsection_v_item_6_subitem_A_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) whether in vitro or in vivo bioequivalence studies, or both such studies, are required for applications filed under this subsection which will refer to the drug published."
  ]
  node [
    id 1588
    label "section_355_subsection_v_item_4_subitem_B"
    class_name "subitem"
    text "(B) The approval of an application submitted under paragraph (2) shall be made effective on the last applicable date determined under the following:"
  ]
  node [
    id 1589
    label "section_355_subsection_c_item_3_subitem_D_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) If an application submitted under subsection (b) of this section for a drug, which includes an active ingredient (including any ester or salt of the active ingredient) that has been approved in another application approved under subsection (b) of this section, is approved after September 24, 1984, and if such application contains reports of new clinical investigations (other than bioavailability studies) essential to the approval of the application and conducted or sponsored by the applicant, the Secretary may not make the approval of an application submitted under subsection (b) of this section for the conditions of approval of such drug in the approved subsection (b) application effective before the expiration of three years from the date of the approval of the application under subsection (b) of this section if the investigations described in clause (A) of subsection (b)(1) of this section and relied upon by the applicant for approval of the application were not conducted by or for the applicant and if the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted."
  ]
  node [
    id 1590
    label "section_355_subsection_v_item_1_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) that any drug with a different active ingredient may not be adequately evaluated for approval as safe and effective on the basis of the information required to be submitted in an abbreviated application."
  ]
  node [
    id 1591
    label "section_355_subsection_v_item_2_subitem_H"
    class_name "subitem"
    text "(H) information submitted in the application or any other information available to the Secretary shows that (i) the inactive ingredients of the drug are unsafe for use under the conditions prescribed, recommended, or suggested in the labeling proposed for the drug, or (ii) the composition of the drug is unsafe under such conditions because of the type or quantity of inactive ingredients included or the manner in which the inactive ingredients are included;"
  ]
  node [
    id 1592
    label "section_355_subsection_d"
    class_name "subsection"
    text "(d) Grounds for refusing application; approval of application; &#8220;substantial evidence&#8221; defined"
  ]
  node [
    id 1593
    label "section_355_subsection_v_item_2_subitem_D_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) If a supplement to an application approved under subsection (b) of this section is approved after September 24, 1984, and the supplement contains reports of new clinical investigations (other than bioavailability studies) essential to the approval of the supplement and conducted or sponsored by the person submitting the supplement, the Secretary may not make the approval of an application submitted under this subsection for a change approved in the supplement effective before the expiration of three years from the date of the approval of the supplement under subsection (b) of this section."
  ]
  node [
    id 1594
    label "section_355_subsection_l_item_2"
    class_name "item"
    text "(2) if the Secretary has determined that the application is not approvable and all legal appeals have been exhausted,"
  ]
  node [
    id 1595
    label "section_355_subsection_c_item_3_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If an application submitted under subsection (b) of this section for a drug, no active ingredient (including any ester or salt of the active ingredient) of which has been approved in any other application under subsection (b) of this section, is approved after September 24, 1984, no application which refers to the drug for which the subsection (b) application was submitted and for which the investigations described in clause (A) of subsection (b)(1) of this section and relied upon by the applicant for approval of the application were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted may be submitted under subsection (b) of this section before the expiration of five years from the date of the approval of the application under subsection (b) of this section, except that such an application may be submitted under subsection (b) of this section after the expiration of four years from the date of the approval of the subsection (b) application if it contains a certification of patent invalidity or noninfringement described in clause (iv) of subsection (b)(2)(A) of this section. The approval of such an application shall be made effective in accordance with this paragraph except that, if an action for patent infringement is commenced during the one-year period beginning forty-eight months after the date of the approval of the subsection (b) application, the thirty-month period referred to in subparagraph (C) shall be extended by such amount of time (if any) which is required for seven and one-half years to have elapsed from the date of approval of the subsection (b) application."
  ]
  node [
    id 1596
    label "section_355_subsection_v_item_7_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the rate and extent of absorption of the drug do not show a significant difference from the rate and extent of absorption of the listed drug when administered at the same molar dose of the therapeutic ingredient under similar experimental conditions in either a single dose or multiple doses; or"
  ]
  node [
    id 1597
    label "section_355_subsection_v_item_6_subitem_A_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) a list in alphabetical order of the official and proprietary name of each drug which has been approved for safety and effectiveness under subsection (c) of this section before September 24, 1984;"
  ]
  node [
    id 1598
    label "section_355_subsection_v_item_4_subitem_B_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) if before the expiration of such period the court decides that such patent has been infringed, the approval shall be made effective on such date as the court orders under section 271(e)(4)(A) of title 35, or"
  ]
  node [
    id 1599
    label "section_355_subsection_d_item_3"
    class_name "item"
    text "If the Secretary finds, after due notice to the applicant in accordance with subsection (c) of this section and giving him an opportunity for a hearing, in accordance with said subsection, that (1) the investigations, reports of which are required to be submitted to the Secretary pursuant to subsection (b) of this section, do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions; (3) the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to preserve its identity, strength, quality, and purity; (4) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, he has insufficient information to determine whether such drug is safe for use under such conditions; or (5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection (b) of this section; or (7) based on a fair evaluation of all material facts, such labeling is false or misleading in any particular; he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that clauses (1) through (6) do not apply, he shall issue an order approving the application. As used in this subsection and subsection (e) of this section, the term &#8220;substantial evidence&#8221; means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof."
  ]
  node [
    id 1600
    label "section_355_subsection_b_item_3"
    class_name "item"
    text "(3)(A) An applicant who makes a certification described in paragraph (2)(A)(iv) shall include in the application a statement that the applicant will give the notice required by subparagraph (B) to&#8212;"
  ]
  node [
    id 1601
    label "section_355_subsection_c"
    class_name "subsection"
    text "(c) Period for approval of application; period for, notice, and expedition of hearing; period for issuance of order"
  ]
  node [
    id 1602
    label "section_355_subsection_v_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) The notice referred to in clause (i) shall state that an application, which contains data from bioavailability or bioequivalence studies, has been submitted under this subsection for the drug with respect to which the certification is made to obtain approval to engage in the commercial manufacture, use, or sale of such drug before the expiration of the patent referred to in the certification. Such notice shall include a detailed statement of the factual and legal basis of the applicant's opinion that the patent is not valid or will not be infringed."
  ]
  node [
    id 1603
    label "section_355_subsection_g_item_2"
    class_name "item"
    text "Orders of the Secretary issued under this section shall be served (1) in person by any officer or employee of the department designated by the Secretary or (2) by mailing the order by registered mail or by certified mail addressed to the applicant or respondent at his last-known address in the records of the Secretary."
  ]
  node [
    id 1604
    label "section_355_subsection_v_item_2_subitem_E"
    class_name "subitem"
    text "(E) if the application was filed pursuant to the approval of a petition under paragraph (2)(C), the application did not contain the information required by the Secretary respecting the active ingredient, route of administration, dosage form, or strength which is not the same;"
  ]
  node [
    id 1605
    label "section_355_subsection_b_item_2"
    class_name "item"
    text "(2) An application submitted under paragraph (1) for a drug for which the investigations described in clause (A) of such paragraph and relied upon by the applicant for approval of the application were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted shall also include&#8212;"
  ]
  node [
    id 1606
    label "section_355_subsection_j_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) An abbreviated application for a new drug shall contain&#8212;"
  ]
  node [
    id 1607
    label "section_355_subsection_l_item_1"
    class_name "item"
    text "(1) if no work is being or will be undertaken to have the application approved,"
  ]
  node [
    id 1608
    label "section_355_subsection_i"
    class_name "subsection"
    text "(i) information to show that the conditions of use prescribed, recommended, or suggested in the labeling proposed for the new drug have been previously approved for a drug listed under paragraph (6) (hereinafter in this subsection referred to as a &#8220;listed drug&#8221;);"
  ]
  node [
    id 1609
    label "section_355_subsection_b_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) each owner of the patent which is the subject of the certification or the representative of such owner designated to receive such notice, and"
  ]
  node [
    id 1610
    label "section_355_subsection_i_subitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) if the listed drug referred to in clause (i) has more than one active ingredient, information to show that the active ingredients of the new drug are the same as those of the listed drug, or"
  ]
  node [
    id 1611
    label "section_355_subsection_i_item_3"
    class_name "item"
    text "(3) the establishment and maintenance of such records, and the making of such reports to the Secretary, by the manufacturer or the sponsor of the investigation of such drug, of data (including but not limited to analytical reports by investigators) obtained as the result of such investigational use of such drug, as the Secretary finds will enable him to evaluate the safety and effectiveness of such drug in the event of the filing of an application pursuant to subsection (b) of this section."
  ]
  node [
    id 1612
    label "section_355_subsection_v_item_2_subitem_I"
    class_name "subitem"
    text "(I) the approval under subsection (c) of this section of the listed drug referred to in the application under this subsection has been withdrawn or suspended for grounds described in the first sentence of subsection (e) of this section, the Secretary has published a notice of opportunity for hearing to withdraw approval of the listed drug under subsection (c) of this section for grounds described in the first sentence of subsection (e) of this section, the approval under this subsection of the listed drug referred to in the application under this subsection has been withdrawn or suspended under paragraph (5), or the Secretary has determined that the listed drug has been withdrawn from sale for safety or effectiveness reasons;"
  ]
  node [
    id 1613
    label "section_355_subsection_v_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) An applicant who makes a certification described in subparagraph (A)(vii)(IV) shall include in the application a statement that the applicant will give the notice required by clause (ii) to&#8212;"
  ]
  node [
    id 1614
    label "section_355_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) give the applicant notice of an opportunity for a hearing before the Secretary under subsection (d) of this section on the question whether such application is approvable. If the applicant elects to accept the opportunity for hearing by written request within thirty days after such notice, such hearing shall commence not more than ninety days after the expiration of such thirty days unless the Secretary and the applicant otherwise agree. Any such hearing shall thereafter be conducted on an expedited basis and the Secretary's order thereon shall be issued within ninety days after the date fixed by the Secretary for filing final briefs."
  ]
  node [
    id 1615
    label "section_355_subsection_v_item_4_subitem_B_subsubitem_iii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) if before the expiration of such period the court grants a preliminary injunction prohibiting the applicant from engaging in the commercial manufacture or sale of the drug until the court decides the issues of patent validity and infringement and if the court decides that such patent is invalid or not infringed, the approval shall be made effective on the date of such court decision."
  ]
  node [
    id 1616
    label "section_355_subsection_a"
    class_name "subsection"
    text "(a) Necessity of effective approval of application"
  ]
  node [
    id 1617
    label "section_355_subsection_e_item_3"
    class_name "item"
    text "The Secretary shall, after due notice and opportunity for hearing to the applicant, withdraw approval of an application with respect to any drug under this section if the Secretary finds (1) that clinical or other experience, tests, or other scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved; (2) that new evidence of clinical experience, not contained in such application or not available to the Secretary until after such application was approved, or tests by new methods, or tests by methods not deemed reasonably applicable when such application was approved, evaluated together with the evidence available to the Secretary when the application was approved, shows that such drug is not shown to be safe for use under the conditions of use upon the basis of which the application was approved; or (3) on the basis of new information before him with respect to such drug, evaluated together with the evidence available to him when the application was approved, that there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling thereof; or (4) the patent information prescribed by subsection (c) of this section was not filed within thirty days after the receipt of written notice from the Secretary specifying the failure to file such information; or (5) that the application contains any untrue statement of a material fact: Provided, That if the Secretary (or in his absence the officer acting as Secretary) finds that there is an imminent hazard to the public health, he may suspend the approval of such application immediately, and give the applicant prompt notice of his action and afford the applicant the opportunity for an expedited hearing under this subsection; but the authority conferred by this proviso to suspend the approval of an application shall not be delegated. The Secretary may also, after due notice and opportunity for hearing to the applicant, withdraw the approval of an application submitted under subsection (b) or (j) of this section with respect to any drug under this section if the Secretary finds (1) that the applicant has failed to establish a system for maintaining required records, or has repeatedly or deliberately failed to maintain such records or to make required reports, in accordance with a regulation or order under subsection (k) of this section or to comply with the notice requirements of section 360(k)(2) of this title, or the applicant has refused to permit access to, or copying or verification of, such records as required by paragraph (2) of such subsection; or (2) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to assure and preserve its identity, strength, quality, and purity and were not made adequate within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of; or (3) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the labeling of such drug, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of. Any order under this subsection shall state the findings upon which it is based."
  ]
  node [
    id 1618
    label "section_355_subsection_v_item_2_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If an application submitted under subsection (b) of this section for a drug, no active ingredient (including any ester or salt of the active ingredient) of which has been approved in any other application under subsection (b) of this section, is approved after September 24, 1984, no application may be submitted under this subsection which refers to the drug for which the subsection (b) application was submitted before the expiration of five years from the date of the approval of the application under subsection (b) of this section, except that such an application may be submitted under this subsection after the expiration of four years from the date of the approval of the subsection (b) application if it contains a certification of patent invalidity or noninfringement described in subclause (IV) of paragraph (2)(A)(vii). The approval of such an application shall be made effective in accordance with subparagraph (B) except that, if an action for patent infringement is commenced during the one-year period beginning forty-eight months after the date of the approval of the subsection (b) application, the thirty-month period referred to in subparagraph (B)(iii) shall be extended by such amount of time (if any) which is required for seven and one-half years to have elapsed from the date of approval of the subsection (b) application."
  ]
  node [
    id 1619
    label "section_355_subsection_v_item_3_subitem_A"
    class_name "subitem"
    text "(A) the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of the drug are inadequate to assure and preserve its identity, strength, quality, and purity;"
  ]
  node [
    id 1620
    label "section_355_subsection_i_subitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(ii)(I) if the listed drug referred to in clause (i) has only one active ingredient, information to show that the active ingredient of the new drug is the same as that of the listed drug;"
  ]
  node [
    id 1621
    label "section_355_subsection_b"
    class_name "subsection"
    text "(b) Filing application; contents"
  ]
  node [
    id 1622
    label "section_355_subsection_v_item_7"
    class_name "item"
    text "(7) For purposes of this subsection:"
  ]
  node [
    id 1623
    label "section_355_subsection_v_item_6"
    class_name "item"
    text "(6)(A)(i) Within sixty days of September 24, 1984, the Secretary shall publish and make available to the public&#8212;"
  ]
  node [
    id 1624
    label "section_355_subsection_e_item_4"
    class_name "item"
    text "The Secretary shall, after due notice and opportunity for hearing to the applicant, withdraw approval of an application with respect to any drug under this section if the Secretary finds (1) that clinical or other experience, tests, or other scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved; (2) that new evidence of clinical experience, not contained in such application or not available to the Secretary until after such application was approved, or tests by new methods, or tests by methods not deemed reasonably applicable when such application was approved, evaluated together with the evidence available to the Secretary when the application was approved, shows that such drug is not shown to be safe for use under the conditions of use upon the basis of which the application was approved; or (3) on the basis of new information before him with respect to such drug, evaluated together with the evidence available to him when the application was approved, that there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling thereof; or (4) the patent information prescribed by subsection (c) of this section was not filed within thirty days after the receipt of written notice from the Secretary specifying the failure to file such information; or (5) that the application contains any untrue statement of a material fact: Provided, That if the Secretary (or in his absence the officer acting as Secretary) finds that there is an imminent hazard to the public health, he may suspend the approval of such application immediately, and give the applicant prompt notice of his action and afford the applicant the opportunity for an expedited hearing under this subsection; but the authority conferred by this proviso to suspend the approval of an application shall not be delegated. The Secretary may also, after due notice and opportunity for hearing to the applicant, withdraw the approval of an application submitted under subsection (b) or (j) of this section with respect to any drug under this section if the Secretary finds (1) that the applicant has failed to establish a system for maintaining required records, or has repeatedly or deliberately failed to maintain such records or to make required reports, in accordance with a regulation or order under subsection (k) of this section or to comply with the notice requirements of section 360(k)(2) of this title, or the applicant has refused to permit access to, or copying or verification of, such records as required by paragraph (2) of such subsection; or (2) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to assure and preserve its identity, strength, quality, and purity and were not made adequate within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of; or (3) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the labeling of such drug, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of. Any order under this subsection shall state the findings upon which it is based."
  ]
  node [
    id 1625
    label "section_355_subsection_v_item_5_subitem_B"
    class_name "subitem"
    text "(B) if the listed drug has been withdrawn from sale, for the period of withdrawal from sale or, if earlier, the period ending on the date the Secretary determines that the withdrawal from sale is not for safety or effectiveness reasons."
  ]
  node [
    id 1626
    label "section_355_subsection_i_subitem_ii_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) information to show that the route of administration, the dosage form, and the strength of the new drug are the same as those of the listed drug referred to in clause (i) or, if the route of administration, the dosage form, or the strength of the new drug is different and the application is filed pursuant to the approval of a petition filed under subparagraph (C), such information respecting the route of administration, dosage form, or strength with respect to which the petition was filed as the Secretary may require;"
  ]
  node [
    id 1627
    label "section_355_subsection_v_item_6_subitem_A_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the date of approval if the drug is approved after 1981 and the number of the application which was approved; and"
  ]
  node [
    id 1628
    label "section_355_subsection_b_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the holder of the approved application under subsection (b) of this section for the drug which is claimed by the patent or a use of which is claimed by the patent or the representative of such holder designated to receive such notice."
  ]
  node [
    id 1629
    label "section_355_subsection_i_subitem_ii"
    class_name "subitem"
    text "(ii)(I) if the listed drug referred to in clause (i) has only one active ingredient, information to show that the active ingredient of the new drug is the same as that of the listed drug;"
  ]
  node [
    id 1630
    label "section_355_subsection_v_item_2_subitem_B"
    class_name "subitem"
    text "In such an action, each of the parties shall reasonably cooperate in expediting the action. Until the expiration of forty-five days from the date the notice made under paragraph (2)(B)(i) is received, no action may be brought under section 2201 of title 28, for a declaratory judgment with respect to the patent. Any action brought under section 2201 shall be brought in the judicial district where the defendant has its principal place of business or a regular and established place of business."
  ]
  node [
    id 1631
    label "section_355_subsection_i_item_2"
    class_name "item"
    text "(2) the manufacturer or the sponsor of the investigation of a new drug proposed to be distributed to investigators for clinical testing obtaining a signed agreement from each of such investigators that patients to whom the drug is administered will be under his personal supervision, or under the supervision of investigators responsible to him, and that he will not supply such drug to any other investigator, or to clinics, for administration to human beings; and"
  ]
  node [
    id 1632
    label "section_355_subsection_d_item_6"
    class_name "item"
    text "If the Secretary finds, after due notice to the applicant in accordance with subsection (c) of this section and giving him an opportunity for a hearing, in accordance with said subsection, that (1) the investigations, reports of which are required to be submitted to the Secretary pursuant to subsection (b) of this section, do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions; (3) the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to preserve its identity, strength, quality, and purity; (4) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, he has insufficient information to determine whether such drug is safe for use under such conditions; or (5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection (b) of this section; or (7) based on a fair evaluation of all material facts, such labeling is false or misleading in any particular; he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that clauses (1) through (6) do not apply, he shall issue an order approving the application. As used in this subsection and subsection (e) of this section, the term &#8220;substantial evidence&#8221; means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof."
  ]
  node [
    id 1633
    label "section_355_subsection_v_item_4"
    class_name "item"
    text "(4)(A) Within one hundred and eighty days of the initial receipt of an application under paragraph (2) or within such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall approve or disapprove the application."
  ]
  node [
    id 1634
    label "section_355_subsection_e_item_1"
    class_name "item"
    text "The Secretary shall, after due notice and opportunity for hearing to the applicant, withdraw approval of an application with respect to any drug under this section if the Secretary finds (1) that clinical or other experience, tests, or other scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved; (2) that new evidence of clinical experience, not contained in such application or not available to the Secretary until after such application was approved, or tests by new methods, or tests by methods not deemed reasonably applicable when such application was approved, evaluated together with the evidence available to the Secretary when the application was approved, shows that such drug is not shown to be safe for use under the conditions of use upon the basis of which the application was approved; or (3) on the basis of new information before him with respect to such drug, evaluated together with the evidence available to him when the application was approved, that there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling thereof; or (4) the patent information prescribed by subsection (c) of this section was not filed within thirty days after the receipt of written notice from the Secretary specifying the failure to file such information; or (5) that the application contains any untrue statement of a material fact: Provided, That if the Secretary (or in his absence the officer acting as Secretary) finds that there is an imminent hazard to the public health, he may suspend the approval of such application immediately, and give the applicant prompt notice of his action and afford the applicant the opportunity for an expedited hearing under this subsection; but the authority conferred by this proviso to suspend the approval of an application shall not be delegated. The Secretary may also, after due notice and opportunity for hearing to the applicant, withdraw the approval of an application submitted under subsection (b) or (j) of this section with respect to any drug under this section if the Secretary finds (1) that the applicant has failed to establish a system for maintaining required records, or has repeatedly or deliberately failed to maintain such records or to make required reports, in accordance with a regulation or order under subsection (k) of this section or to comply with the notice requirements of section 360(k)(2) of this title, or the applicant has refused to permit access to, or copying or verification of, such records as required by paragraph (2) of such subsection; or (2) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to assure and preserve its identity, strength, quality, and purity and were not made adequate within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of; or (3) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the labeling of such drug, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of. Any order under this subsection shall state the findings upon which it is based."
  ]
  node [
    id 1635
    label "section_355_subsection_v"
    class_name "subsection"
    text "(v) If an application (or supplement to an application) submitted under subsection (b) of this section for a drug, which includes an active ingredient (including any ester or salt of the active ingredient) that has been approved in another application under subsection (b) of this section, was approved during the period beginning January 1, 1982, and ending on September 24, 1984, the Secretary may not make the approval of an application submitted under this subsection which refers to the drug for which the subsection (b) application was submitted or which refers to a change approved in a supplement to the subsection (b) application effective before the expiration of two years from September 24, 1984."
  ]
  node [
    id 1636
    label "section_355_subsection_v_item_1_subsubitem_i_subsubsubitem_IV"
    class_name "subsubsubitem"
    text "(IV) that such patent is invalid or will not be infringed by the manufacture, use, or sale of the new drug for which the application is submitted; and"
  ]
  node [
    id 1637
    label "section_355_subsection_v_item_1_subitem_B_subsubitem_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the holder of the approved application under subsection (b) of this section for the drug which is claimed by the patent or a use of which is claimed by the patent or the representative of such holder designated to receive such notice."
  ]
  node [
    id 1638
    label "section_355_subsection_e"
    class_name "subsection"
    text "(e) Withdrawal of approval; grounds; immediate suspension upon finding imminent hazard to public health"
  ]
  node [
    id 1639
    label "section_355_subsection_i_item_1"
    class_name "item"
    text "(1) the submission to the Secretary, before any clinical testing of a new drug is undertaken, of reports, by the manufacturer or the sponsor of the investigation of such drug, of preclinical tests (including tests on animals) of such drug adequate to justify the proposed clinical testing;"
  ]
  node [
    id 1640
    label "section_355_subsection_l_item_5"
    class_name "item"
    text "(5) upon the effective date of the approval of the first application under subsection (j) of this section which refers to such drug or upon the date upon which the approval of an application under subsection (j) of this section which refers to such drug could be made effective if such an application had been submitted."
  ]
  node [
    id 1641
    label "section_355_subsection_c_item_3_subitem_D"
    class_name "subitem"
    text "(D)(i) If an application (other than an abbreviated new drug application) submitted under subsection (b) of this section for a drug, no active ingredient (including any ester or salt of the active ingredient) of which has been approved in any other application under subsection (b) of this section, was approved during the period beginning January 1, 1982, and ending on September 24, 1984, the Secretary may not make the approval of another application for a drug for which the investigations described in clause (A) of subsection (b)(1) of this section and relied upon by the applicant for approval of the application were not conducted by or for the applicant and for which the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted effective before the expiration of ten years from the date of the approval of the application previously approved under subsection (b) of this section."
  ]
  node [
    id 1642
    label "section_355_subsection_v_item_3_subitem_C_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) if the listed drug has more than one active ingredient and if the application is for a drug which has an active ingredient different from the listed drug, information submitted with the application is insufficient to show&#8212;"
  ]
  node [
    id 1643
    label "section_355_subsection_b_item_2_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) of the date on which such patent will expire, or"
  ]
  node [
    id 1644
    label "section_355_subsection_v_item_3_subitem_C_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) that the other active ingredients are the same as the active ingredients of the listed drug, or"
  ]
  node [
    id 1645
    label "section_355_subsection_v_item_2"
    class_name "item"
    text "In such an action, each of the parties shall reasonably cooperate in expediting the action. Until the expiration of forty-five days from the date the notice made under paragraph (2)(B)(i) is received, no action may be brought under section 2201 of title 28, for a declaratory judgment with respect to the patent. Any action brought under section 2201 shall be brought in the judicial district where the defendant has its principal place of business or a regular and established place of business."
  ]
  node [
    id 1646
    label "section_355_subsection_j_item_2"
    class_name "item"
    text "(2)(A) An abbreviated application for a new drug shall contain&#8212;"
  ]
  node [
    id 1647
    label "section_355_subsection_v_item_1_subitem_B"
    class_name "subitem"
    text "(B)(i) An applicant who makes a certification described in subparagraph (A)(vii)(IV) shall include in the application a statement that the applicant will give the notice required by clause (ii) to&#8212;"
  ]
  node [
    id 1648
    label "section_355_subsection_v_item_5"
    class_name "item"
    text "(5) If a drug approved under this subsection refers in its approved application to a drug the approval of which was withdrawn or suspended for grounds described in the first sentence of subsection (e) of this section or was withdrawn or suspended under this paragraph or which, as determined by the Secretary, has been withdrawn from sale for safety or effectiveness reasons, the approval of the drug under this subsection shall be withdrawn or suspended&#8212;"
  ]
  node [
    id 1649
    label "section_355_subsection_v_item_2_subitem_F"
    class_name "subitem"
    text "(F) information submitted in the application is insufficient to show that the drug is bioequivalent to the listed drug referred to in the application or, if the application was filed pursuant to a petition approved under paragraph (2)(C), information submitted in the application is insufficient to show that the active ingredients of the new drug are of the same pharmacological or therapeutic class as those of the listed drug referred to in paragraph (2)(A)(i) and that the new drug can be expected to have the same therapeutic effect as the listed drug when administered to patients for a condition of use referred to in such paragraph;"
  ]
  node [
    id 1650
    label "section_355_subsection_b_item_2_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) that such patent is invalid or will not be infringed by the manufacture, use, or sale of the new drug for which the application is submitted; and"
  ]
  node [
    id 1651
    label "section_355_subsection_v_item_1_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) If an application is amended to include a certification described in subparagraph (A)(vii)(IV), the notice required by clause (ii) shall be given when the amended application is submitted."
  ]
  node [
    id 1652
    label "section_355_subsection_v_item_3_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the listed drug has more than one active ingredient, information submitted with the application is insufficient to show that the active ingredients are the same as the active ingredients of the listed drug, or"
  ]
  node [
    id 1653
    label "section_355_subsection_k_item_1"
    class_name "item"
    text "(1) In the case of any drug for which an approval of an application filed under subsection (b) or (j) of this section is in effect, the applicant shall establish and maintain such records, and make such reports to the Secretary, of data relating to clinical experience and other data or information, received or otherwise obtained by such applicant with respect to such drug, as the Secretary may by general regulation, or by order with respect to such application, prescribe on the basis of a finding that such records and reports are necessary in order to enable the Secretary to determine, or facilitate a determination, whether there is or may be ground for invoking subsection (e) of this section. Regulations and orders issued under this subsection and under subsection (i) of this section shall have due regard for the professional ethics of the medical profession and the interests of patients and shall provide, where the Secretary deems it to be appropriate, for the examination, upon request, by the persons to whom such regulations or orders are applicable, of similar information received or otherwise obtained by the Secretary."
  ]
  node [
    id 1654
    label "section_355_subsection_v_item_3_subitem_B"
    class_name "subitem"
    text "(B) information submitted with the application is insufficient to show that each of the proposed conditions of use have been previously approved for the listed drug referred to in the application;"
  ]
  node [
    id 1655
    label "section_355_subsection_v_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) If the applicant only made a certification described in subclause (I) or (II) of paragraph (2)(A)(vii) or in both such subclauses, the approval may be made effective immediately."
  ]
  node [
    id 1656
    label "section_355_subsection_v_item_3"
    class_name "item"
    text "(3) Subject to paragraph (4), the Secretary shall approve an application for a drug unless the Secretary finds&#8212;"
  ]
  node [
    id 1657
    label "section_355_subsection_v_item_6_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) When patent information submitted under subsection (b) or (c) of this section respecting a drug included on the list is to be published by the Secretary, the Secretary shall, in revisions made under clause (ii), include such information for such drug."
  ]
  node [
    id 1658
    label "section_355_subsection_c_item_3_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) if before the expiration of such period the court decides that such patent is invalid or not infringed, the approval may be made effective on the date of the court decision,"
  ]
  node [
    id 1659
    label "section_355_subsection_v_item_4_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) If the applicant made a certification described in subclause (IV) of paragraph (2)(A)(vii), the approval shall be made effective immediately unless an action is brought for infringement of a patent which is the subject of the certification before the expiration of forty-five days from the date the notice provided under paragraph (2)(B)(i) is received. If such an action is brought before the expiration of such days, the approval shall be made effective upon the expiration of the thirty-month period beginning on the date of the receipt of the notice provided under paragraph (2)(B)(i) or such shorter or longer period as the court may order because either party to the action failed to reasonably cooperate in expediting the action, except that&#8212;"
  ]
  node [
    id 1660
    label "section_355_subsection_l_item_3"
    class_name "item"
    text "(3) if approval of the application under subsection (c) of this section is withdrawn and all legal appeals have been exhausted,"
  ]
  node [
    id 1661
    label "section_355_subsection_v_item_2_subitem_G"
    class_name "subitem"
    text "(G) information submitted in the application is insufficient to show that the labeling proposed for the drug is the same as the labeling approved for the listed drug referred to in the application except for changes required because of differences approved under a petition filed under paragraph (2)(C) or because the drug and the listed drug are produced or distributed by different manufacturers;"
  ]
  node [
    id 1662
    label "section_355_subsection_c_item_3_subitem_C"
    class_name "subitem"
    text "(C) If the applicant made a certification described in clause (iv) of subsection (b)(2)(A) of this section, the approval shall be made effective immediately unless an action is brought for infringement of a patent which is the subject of the certification before the expiration of forty-five days from the date the notice provided under paragraph (3)(B) is received. If such an action is brought before the expiration of such days, the approval may be made effective upon the expiration of the thirty-month period beginning on the date of the receipt of the notice provided under paragraph (3)(B) or such shorter or longer period as the court may order because either party to the action failed to reasonably cooperate in expediting the action, except that&#8212;"
  ]
  node [
    id 1663
    label "section_355_subsection_v_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) Within one hundred and eighty days of the initial receipt of an application under paragraph (2) or within such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall approve or disapprove the application."
  ]
  node [
    id 1664
    label "section_355_subsection_c_item_3_subitem_D_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) If a supplement to an application approved under subsection (b) of this section is approved after September 24, 1984, and the supplement contains reports of new clinical investigations (other than bioavailabilty&#160;1 studies) essential to the approval of the supplement and conducted or sponsored by the person submitting the supplement, the Secretary may not make the approval of an application submitted under subsection (b) of this section for a change approved in the supplement effective before the expiration of three years from the date of the approval of the supplement under subsection (b) of this section if the investigations described in clause (A) of subsection (b)(1) of this section and relied upon by the applicant for approval of the application were not conducted by or for the applicant and if the applicant has not obtained a right of reference or use from the person by or for whom the investigations were conducted."
  ]
  node [
    id 1665
    label "section_355_subsection_d_item_7"
    class_name "item"
    text "If the Secretary finds, after due notice to the applicant in accordance with subsection (c) of this section and giving him an opportunity for a hearing, in accordance with said subsection, that (1) the investigations, reports of which are required to be submitted to the Secretary pursuant to subsection (b) of this section, do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions; (3) the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to preserve its identity, strength, quality, and purity; (4) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, he has insufficient information to determine whether such drug is safe for use under such conditions; or (5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection (b) of this section; or (7) based on a fair evaluation of all material facts, such labeling is false or misleading in any particular; he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that clauses (1) through (6) do not apply, he shall issue an order approving the application. As used in this subsection and subsection (e) of this section, the term &#8220;substantial evidence&#8221; means evidence consisting of adequate and well-controlled investigations, including clinical investigations, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and responsibly be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof."
  ]
  node [
    id 1666
    label "section_355_subsection_v_item_2_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) If the application contains a certification described in subclause (IV) of paragraph (2)(A)(vii) and is for a drug for which a previous application has been submitted under this subsection continuing such a certification, the application shall be made effective not earlier than one hundred and eighty days after&#8212;"
  ]
  node [
    id 1667
    label "section_355_subsection_c_item_2"
    class_name "item"
    text "(2) If the patent information described in subsection (b) of this section could not be filed with the submission of an application under subsection (b) of this section because the application was filed before the patent information was required under subsection (b) of this section or a patent was issued after the application was approved under such subsection, the holder of an approved application shall file with the Secretary the patent number and the expiration date of any patent which claims the drug for which the application was submitted or which claims a method of using such drug and with respect to which a claim of patent infringement could reasonably be asserted if a person not licensed by the owner engaged in the manufacture, use, or sale of the drug. If the holder of an approved application could not file patent information under subsection (b) of this section because it was not required at the time the application was approved, the holder shall file such information under this subsection not later than thirty days after September 24, 1984, and if the holder of an approved application could not file patent information under subsection (b) of this section because no patent had been issued when an application was filed or approved, the holder shall file such information under this subsection not later than thirty days after the date the patent involved is issued. Upon the submission of patent information under this subsection, the Secretary shall publish it."
  ]
  node [
    id 1668
    label "section_355_subsection_v_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "In such an action, each of the parties shall reasonably cooperate in expediting the action. Until the expiration of forty-five days from the date the notice made under paragraph (2)(B)(i) is received, no action may be brought under section 2201 of title 28, for a declaratory judgment with respect to the patent. Any action brought under section 2201 shall be brought in the judicial district where the defendant has its principal place of business or a regular and established place of business."
  ]
  node [
    id 1669
    label "section_355_subsection_v_item_3_subitem_C_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) that the different active ingredient is an active ingredient of a listed drug or a drug which does not meet the requirements of section 321(p) of this title,"
  ]
  node [
    id 1670
    label "section_355_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "(A) If the applicant only made a certification described in clause (i) or (ii) of subsection (b)(2)(A) of this section or in both such clauses, the approval may be made effective immediately."
  ]
  node [
    id 1671
    label "section_355_subsection_b_item_3_subitem_B"
    class_name "subitem"
    text "(B) The notice referred to in subparagraph (A) shall state that an application has been submitted under this subsection for the drug with respect to which the certification is made to obtain approval to engage in the commercial manufacture, use, or sale of the drug before the expiration of the patent referred to in the certification. Such notice shall include a detailed statement of the factual and legal basis of the applicant's opinion that the patent is not valid or will not be infringed."
  ]
  node [
    id 1672
    label "section_355_subsection_m"
    class_name "subsection"
    text "(m) &#8220;Patent&#8221; defined"
  ]
  node [
    id 1673
    label "section_355_subsection_v_item_5_subitem_A"
    class_name "subitem"
    text "(A) for the same period as the withdrawal or suspension under subsection (e) of this section or this paragraph, or"
  ]
  node [
    id 1674
    label "section_356_subsection_c"
    class_name "subsection"
    text "(c) Tests or methods of assay; revision"
  ]
  node [
    id 1675
    label "section_356_subsection_b_item_2"
    class_name "item"
    text "Regulations providing for such certification shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe no standard of identity or of strength, quality, or purity for any drug different from the standard of identity, strength, quality, or purity set forth for such drug in an official compendium."
  ]
  node [
    id 1676
    label "section_356_subsection_b_item_1"
    class_name "item"
    text "Regulations providing for such certification shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe no standard of identity or of strength, quality, or purity for any drug different from the standard of identity, strength, quality, or purity set forth for such drug in an official compendium."
  ]
  node [
    id 1677
    label "section_356_subsection_b"
    class_name "subsection"
    text "(b) Regulations"
  ]
  node [
    id 1678
    label "section_356_subsection_b_item_3"
    class_name "item"
    text "Regulations providing for such certification shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe no standard of identity or of strength, quality, or purity for any drug different from the standard of identity, strength, quality, or purity set forth for such drug in an official compendium."
  ]
  node [
    id 1679
    label "section_356_subsection_b_item_5"
    class_name "item"
    text "Regulations providing for such certification shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe no standard of identity or of strength, quality, or purity for any drug different from the standard of identity, strength, quality, or purity set forth for such drug in an official compendium."
  ]
  node [
    id 1680
    label "section_356_subsection_a"
    class_name "subsection"
    text "(a) Standards for certification"
  ]
  node [
    id 1681
    label "section_356_subsection_b_item_4"
    class_name "item"
    text "Regulations providing for such certification shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe no standard of identity or of strength, quality, or purity for any drug different from the standard of identity, strength, quality, or purity set forth for such drug in an official compendium."
  ]
  node [
    id 1682
    label "section_357_subsection_d"
    class_name "subsection"
    text "(d) Exemption of drugs stored, processed, and labeled at plants other than manufacturer's, used in manufacture of other drugs or for investigational purposes; discretionary and mandatory conditions; direct reports to Secretary"
  ]
  node [
    id 1683
    label "section_357_subsection_h_item_2"
    class_name "item"
    text "In the case of a drug for which, on the day immediately preceding May 1, 1963, a prior approval of an application under section 355 of this title had not been withdrawn under section 355(e) of this title, the initial issuance of regulations providing for certification or exemption of such drug under this section shall, with respect to the conditions of use prescribed, recommended, or suggested in the labeling covered by such application, not be conditioned upon an affirmative finding of the efficacy of such drug. Any subsequent amendment or repeal of such regulations so as no longer to provide for such certification or exemption on the ground of a lack of efficacy of such drug for use under such conditions of use may be effected only on or after May 1, 1963, which would be applicable to such drug under such conditions of use if such drug were subject to section 355(e) of this title, and then only if (1) such amendment or repeal is made in accordance with the procedure specified in subsection (f) of this section (except that such amendment or repeal may be initiated either by a proposal of the Secretary or by a petition of any interested person) and (2) the Secretary finds, on the basis of new information with respect to such drug evaluated together with the information before him when the application under section 355 of this title became effective or was approved, that there is a lack of substantial evidence (as defined in section 355(d) of this title) that the drug has the effect it purports or is represented to have under such conditions of use."
  ]
  node [
    id 1684
    label "section_357_subsection_e"
    class_name "subsection"
    text "(e) Exempted new drugs subject to section 355 of this title; request for certification of exempted drug; determination of compliance with sections 351(b) and 352(g) of this title"
  ]
  node [
    id 1685
    label "section_357_subsection_f"
    class_name "subsection"
    text "(f) Filing of petitions; contents; notice; answer; public hearing; orders"
  ]
  node [
    id 1686
    label "section_357_subsection_h_item_1"
    class_name "item"
    text "In the case of a drug for which, on the day immediately preceding May 1, 1963, a prior approval of an application under section 355 of this title had not been withdrawn under section 355(e) of this title, the initial issuance of regulations providing for certification or exemption of such drug under this section shall, with respect to the conditions of use prescribed, recommended, or suggested in the labeling covered by such application, not be conditioned upon an affirmative finding of the efficacy of such drug. Any subsequent amendment or repeal of such regulations so as no longer to provide for such certification or exemption on the ground of a lack of efficacy of such drug for use under such conditions of use may be effected only on or after May 1, 1963, which would be applicable to such drug under such conditions of use if such drug were subject to section 355(e) of this title, and then only if (1) such amendment or repeal is made in accordance with the procedure specified in subsection (f) of this section (except that such amendment or repeal may be initiated either by a proposal of the Secretary or by a petition of any interested person) and (2) the Secretary finds, on the basis of new information with respect to such drug evaluated together with the information before him when the application under section 355 of this title became effective or was approved, that there is a lack of substantial evidence (as defined in section 355(d) of this title) that the drug has the effect it purports or is represented to have under such conditions of use."
  ]
  node [
    id 1687
    label "section_357_subsection_g"
    class_name "subsection"
    text "(g) Records and reports; professional ethics and interests of patients; examination of data; access to records"
  ]
  node [
    id 1688
    label "section_357_subsection_b_item_2"
    class_name "item"
    text "Regulations providing for such certifications shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe only such tests and methods of assay as will provide for certification or rejection within the shortest time consistent with the purposes of this section."
  ]
  node [
    id 1689
    label "section_357_subsection_b_item_5"
    class_name "item"
    text "Regulations providing for such certifications shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe only such tests and methods of assay as will provide for certification or rejection within the shortest time consistent with the purposes of this section."
  ]
  node [
    id 1690
    label "section_357_subsection_b_item_3"
    class_name "item"
    text "Regulations providing for such certifications shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe only such tests and methods of assay as will provide for certification or rejection within the shortest time consistent with the purposes of this section."
  ]
  node [
    id 1691
    label "section_357_subsection_c_item_1"
    class_name "item"
    text "(1) whether such drug or class of drugs is manufactured by a person who has, or hereafter shall have, produced fifty consecutive batches of such drug or class of drugs in compliance with the regulations for the certification thereof within a period of not more than eighteen calendar months, upon the application by such person to the Secretary; or"
  ]
  node [
    id 1692
    label "section_357_subsection_c"
    class_name "subsection"
    text "(c) Exemption of drugs not involving safety and efficacy of use; considerations; certification after exemption; labeling and advertising claims"
  ]
  node [
    id 1693
    label "section_357_subsection_d_item_2"
    class_name "item"
    text "(2) the manufacturer or the sponsor of the investigation of a new drug proposed to be distributed to investigators for clinical testing obtaining a signed agreement from each of such investigators that patients to whom the drug is administered will be under his personal supervision, or under the supervision of investigators responsible to him, and that he will not supply such drug to any other investigator, or to clinics, for administration to human beings; and"
  ]
  node [
    id 1694
    label "section_357_subsection_a"
    class_name "subsection"
    text "(a) Regulations prescribed by Secretary; release prior to certification; &#8220;antibiotic drug&#8221; defined"
  ]
  node [
    id 1695
    label "section_357_subsection_b"
    class_name "subsection"
    text "(b) Provisions of regulations"
  ]
  node [
    id 1696
    label "section_357_subsection_b_item_4"
    class_name "item"
    text "Regulations providing for such certifications shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe only such tests and methods of assay as will provide for certification or rejection within the shortest time consistent with the purposes of this section."
  ]
  node [
    id 1697
    label "section_357_subsection_b_item_1"
    class_name "item"
    text "Regulations providing for such certifications shall contain such provisions as are necessary to carry out the purposes of this section, including provisions prescribing (1) standards of identity and of strength, quality, and purity; (2) tests and methods of assay to determine compliance with such standards; (3) effective periods for certificates, and other conditions under which they shall cease to be effective as to certified batches and as to portions thereof; (4) administration and procedure; and (5) such fees, specified in such regulations, as are necessary to provide, equip, and maintain an adequate certification service. Such regulations shall prescribe only such tests and methods of assay as will provide for certification or rejection within the shortest time consistent with the purposes of this section."
  ]
  node [
    id 1698
    label "section_357_subsection_g_item_2"
    class_name "item"
    text "(2) Every person required under this section to maintain records, and every person having charge or custody thereof, shall, upon request of an officer or employee designated by the Secretary, permit such officer or employee at all reasonable times to have access to and copy and verify such records."
  ]
  node [
    id 1699
    label "section_357_subsection_g_item_1"
    class_name "item"
    text "(1) Every person engaged in manufacturing, compounding, or processing any drug within the purview of this section with respect to which a certificate or release has been issued pursuant to this section shall establish and maintain such records, and make such reports to the Secretary, of data relating to clinical experience and other data or information, received or otherwise obtained by such person with respect to such drug, as the Secretary may by general regulation, or by order with respect to such certification or release, prescribe on the basis of a finding that such records and reports are necessary in order to enable the Secretary to make, or to facilitate, a determination as to whether such certification or release should be rescinded or whether any regulation issued under this section should be amended or repealed. Regulations and orders issued under this subsection and under clause (3) of subsection (d) of this section shall have due regard for the professional ethics of the medical profession and the interests of patients and shall provide, where the Secretary deems it to be appropriate, for the examination, upon request, by the persons to whom such regulations or orders are applicable, of similar information received or otherwise obtained by the Secretary."
  ]
  node [
    id 1700
    label "section_357_subsection_h"
    class_name "subsection"
    text "(h) Issuance of regulations; conditions; amendment or repeal of regulations; effective date; procedure; lack of substantial evidence"
  ]
  node [
    id 1701
    label "section_357_subsection_d_item_3"
    class_name "item"
    text "(3) the establishment and maintenance of such records, and the making of such reports to the Secretary, by the manufacturer or the sponsor of the investigation of such drug, of data (including but not limited to analytical reports by investigators) obtained as the result of such investigational use of such drug, as the Secretary finds will enable him to evaluate the safety and effectiveness of such drug in the event of the filing of an application for certification or release pursuant to subsection (a) of this section."
  ]
  node [
    id 1702
    label "section_357_subsection_c_item_2"
    class_name "item"
    text "(2) whether such drug or class of drugs is manufactured by any person who has otherwise demonstrated such consistency in the production of such drug or class of drugs, in compliance with the regulations for the certification thereof, as in the judgment of the Secretary is adequate to insure the safety and efficacy of use thereof."
  ]
  node [
    id 1703
    label "section_357_subsection_d_item_1"
    class_name "item"
    text "(1) the submission to the Secretary, before any clinical testing of a new drug is undertaken, of reports, by the manufacturer or the sponsor of the investigation of such drug, of preclinical tests (including tests on animals) of such drug adequate to justify the proposed clinical testing;"
  ]
  node [
    id 1704
    label "section_358_subsection_a"
    class_name "subsection"
    text "(a) Necessity or desirability; use in official compendiums; infringement of trademarks"
  ]
  node [
    id 1705
    label "section_358_subsection_c_item_2"
    class_name "item"
    text "Whenever he determines after any such review that (1) any such official name is unduly complex or is not useful for any other reason, (2) two or more official names have been applied to a single drug or device, or to two or more drugs which are identical in chemical structure and pharmacological action and which are substantially identical in strength, quality, and purity, or to two or more devices which are substantially equivalent in design and purpose or (3) no official name has been applied to a medically useful drug or device, he shall transmit in writing to the compiler of each official compendium in which that drug or drugs or device are identified and recognized his request for the recommendation of a single official name for such drug or drugs or device which will have usefulness and simplicity. Whenever such a single official name has not been recommended within one hundred and eighty days after such request, or the Secretary determines that any name so recommended is not useful for any reason, he shall designate a single official name for such drug or drugs or device. Whenever he determines that the name so recommended is useful, he shall designate that name as the official name of such drug or drugs or device. Such designation shall be made as a regulation upon public notice and in accordance with the procedure set forth in section 553 of title 5."
  ]
  node [
    id 1706
    label "section_358_subsection_c_item_3"
    class_name "item"
    text "Whenever he determines after any such review that (1) any such official name is unduly complex or is not useful for any other reason, (2) two or more official names have been applied to a single drug or device, or to two or more drugs which are identical in chemical structure and pharmacological action and which are substantially identical in strength, quality, and purity, or to two or more devices which are substantially equivalent in design and purpose or (3) no official name has been applied to a medically useful drug or device, he shall transmit in writing to the compiler of each official compendium in which that drug or drugs or device are identified and recognized his request for the recommendation of a single official name for such drug or drugs or device which will have usefulness and simplicity. Whenever such a single official name has not been recommended within one hundred and eighty days after such request, or the Secretary determines that any name so recommended is not useful for any reason, he shall designate a single official name for such drug or drugs or device. Whenever he determines that the name so recommended is useful, he shall designate that name as the official name of such drug or drugs or device. Such designation shall be made as a regulation upon public notice and in accordance with the procedure set forth in section 553 of title 5."
  ]
  node [
    id 1707
    label "section_358_subsection_e"
    class_name "subsection"
    text "(e) Request by compiler of official compendium for designation of name"
  ]
  node [
    id 1708
    label "section_358_subsection_c_item_1"
    class_name "item"
    text "Whenever he determines after any such review that (1) any such official name is unduly complex or is not useful for any other reason, (2) two or more official names have been applied to a single drug or device, or to two or more drugs which are identical in chemical structure and pharmacological action and which are substantially identical in strength, quality, and purity, or to two or more devices which are substantially equivalent in design and purpose or (3) no official name has been applied to a medically useful drug or device, he shall transmit in writing to the compiler of each official compendium in which that drug or drugs or device are identified and recognized his request for the recommendation of a single official name for such drug or drugs or device which will have usefulness and simplicity. Whenever such a single official name has not been recommended within one hundred and eighty days after such request, or the Secretary determines that any name so recommended is not useful for any reason, he shall designate a single official name for such drug or drugs or device. Whenever he determines that the name so recommended is useful, he shall designate that name as the official name of such drug or drugs or device. Such designation shall be made as a regulation upon public notice and in accordance with the procedure set forth in section 553 of title 5."
  ]
  node [
    id 1709
    label "section_358_subsection_d"
    class_name "subsection"
    text "(d) Revised official names; compilation, publication, and public distribution of listings"
  ]
  node [
    id 1710
    label "section_358_subsection_c"
    class_name "subsection"
    text "(c) Determinations of complexity, usefulness, multiplicity, or lack of name; designation by Secretary"
  ]
  node [
    id 1711
    label "section_358_subsection_b"
    class_name "subsection"
    text "(b) Review of names in official compendiums"
  ]
  node [
    id 1712
    label "section_360_subsection_e"
    class_name "subsection"
    text "(e) Registration number; uniform system for identification of devices intended for human use"
  ]
  node [
    id 1713
    label "section_360_subsection_c"
    class_name "subsection"
    text "(c) New producers"
  ]
  node [
    id 1714
    label "section_360_subsection_j_item_1_subitem_D"
    class_name "subitem"
    text "(D) if the registrant filing a list has determined that a particular drug product or device contained in such list is not subject to section 355, 356, 357, or 360b of this title, or the particular device contained in such list is not subject to a performance standard established under section 360d of this title or to section 360e of this title or is not a restricted device a brief statement of the basis upon which the registrant made such determination if the Secretary requests such a statement with respect to that particular drug product or device."
  ]
  node [
    id 1715
    label "section_360_subsection_j_item_2_subitem_D"
    class_name "subitem"
    text "(D) Any material change in any information previously submitted pursuant to this paragraph or paragraph (1)."
  ]
  node [
    id 1716
    label "section_360_subsection_g_item_2"
    class_name "item"
    text "(2) practitioners licensed by law to prescribe or administer drugs or devices and who manufacture, prepare, propagate, compound, or process drugs or devices solely for use in the course of their professional practice;"
  ]
  node [
    id 1717
    label "section_360_subsection_j_item_2_subitem_A"
    class_name "subitem"
    text "(A) A list of each drug or device introduced by the registrant for commercial distribution which has not been included in any list previously filed by him with the Secretary under this subparagraph or paragraph (1) of this subsection. A list under this subparagraph shall list a drug or device by its established name (as defined in section 352(e) of this title), and by any proprietary name it may have and shall be accompanied by the other information required by paragraph (1)."
  ]
  node [
    id 1718
    label "section_360_subsection_j_item_1_subitem_C"
    class_name "subitem"
    text "(C) in the case of any drug contained in an applicable list which is described in subparagraph (B), a quantitative listing of its active ingredient or ingredients, except that with respect to a particular drug product the Secretary may require the submission of a quantitative listing of all ingredients if he finds that such submission is necessary to carry out the purposes of this chapter; and"
  ]
  node [
    id 1719
    label "section_360_subsection_k"
    class_name "subsection"
    text "(k) Report preceding introduction of devices into interstate commerce"
  ]
  node [
    id 1720
    label "section_360_subsection_a_item_1"
    class_name "item"
    text "(1) the term &#8220;manufacture, preparation, propagation, compounding, or processing&#8221; shall include repackaging or otherwise changing the container, wrapper, or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer or user; and"
  ]
  node [
    id 1721
    label "section_360_subsection_j_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) which drug is subject to section 353(b)(1) of this title, or which device is a restricted device, a copy of all labeling for such drug or device, a representative sampling of advertisements for such drug or device, and, upon request made by the Secretary for good cause, a copy of all advertisements for a particular drug product or device, or"
  ]
  node [
    id 1722
    label "section_360_subsection_g_item_4"
    class_name "item"
    text "(4) such other classes of persons as the Secretary may by regulation exempt from the application of this section upon a finding that registration by such classes of persons in accordance with this section is not necessary for the protection of the public health."
  ]
  node [
    id 1723
    label "section_360_subsection_j_item_2_subitem_C"
    class_name "subitem"
    text "(C) If since the date the registrant reported pursuant to subparagraph (B) a notice of discontinuance he has resumed the manufacture, preparation, propagation, compounding, or processing for commercial distribution of the drug or device with respect to which such notice of discontinuance was reported; notice of such resumption, the date of such resumption, the identity of such drug or device (each by established name (as defined in section 352(e) of this title) and by any proprietary name), and the other information required by paragraph (1), unless the registrant has previously reported such resumption to the Secretary pursuant to this subparagraph."
  ]
  node [
    id 1724
    label "section_360_subsection_j_item_1"
    class_name "item"
    text "(1) Every person who registers with the Secretary under subsection (b), (c), or (d) of this section shall, at the time of registration under any such subsection, file with the Secretary a list of all drugs and a list of all devices and a brief statement of the basis for believing that each device included in the list is a device rather than a drug (with each drug and device in each list listed by its established name (as defined in section 352(e) of this title) and by any proprietary name) which are being manufactured, prepared, propagated, compounded, or processed by him for commercial distribution and which he has not included in any list of drugs or devices filed by him with the Secretary under this paragraph or paragraph (2) before such time of registration. Such list shall be prepared in such form and manner as the Secretary may prescribe and shall be accompanied by&#8212;"
  ]
  node [
    id 1725
    label "section_360_subsection_j_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) which drug is not subject to section 353(b)(1) of this title or which device is not a restricted device, the label and package insert for such drug or device and a representative sampling of any other labeling for such drug or device;"
  ]
  node [
    id 1726
    label "section_360_subsection_i"
    class_name "subsection"
    text "(i) Foreign establishments"
  ]
  node [
    id 1727
    label "section_360_subsection_g"
    class_name "subsection"
    text "(g) Exclusions from application of section"
  ]
  node [
    id 1728
    label "section_360_subsection_j"
    class_name "subsection"
    text "(j) Filing of lists of drugs and devices manufactured, prepared, propagated and compounded by registrants; statements; accompanying disclosures"
  ]
  node [
    id 1729
    label "section_360_subsection_j_item_2_subitem_B"
    class_name "subitem"
    text "(B) If since the date the registrant last made a report under this paragraph (or if he has not made a report under this paragraph, since February 1, 1973) he has discontinued the manufacture, preparation, propagation, compounding, or processing for commercial distribution of a drug or device included in a list filed by him under subparagraph (A) or paragraph (1); notice of such discontinuance, the date of such discontinuance, and the identity (by established name (as defined in section 352(e) of this title) and by any proprietary name) of such drug or device."
  ]
  node [
    id 1730
    label "section_360_subsection_g_item_3"
    class_name "item"
    text "(3) persons who manufacture, prepare, propagate, compound, or process drugs or devices solely for use in research, teaching, or chemical analysis and not for sale;"
  ]
  node [
    id 1731
    label "section_360_subsection_b"
    class_name "subsection"
    text "(b) Annual registration"
  ]
  node [
    id 1732
    label "section_360_subsection_h"
    class_name "subsection"
    text "(h) Inspection of premises"
  ]
  node [
    id 1733
    label "section_360_subsection_a"
    class_name "subsection"
    text "(a) Definitions"
  ]
  node [
    id 1734
    label "section_360_subsection_d"
    class_name "subsection"
    text "(d) Additional establishments"
  ]
  node [
    id 1735
    label "section_360_subsection_j_item_3"
    class_name "item"
    text "(3) The Secretary may also require each registrant under this section to submit a list of each drug product which (A) the registrant is manufacturing, preparing, propagating, compounding, or processing for commercial distribution, and (B) contains a particular ingredient. The Secretary may not require the submission of such a list unless he has made a finding that the submission of such a list is necessary to carry out the purposes of this chapter."
  ]
  node [
    id 1736
    label "section_360_subsection_j_item_1_subitem_A"
    class_name "subitem"
    text "(A) in the case of a drug contained in the applicable list and subject to sections 355, 356, 357, or 360b of this title, or a device intended for human use contained in the applicable list with respect to which a performance standard has been established under section 360d of this title or which is subject to section 360e of this title, a reference to the authority for the marketing of such drug or device and a copy of all labeling for such drug or device;"
  ]
  node [
    id 1737
    label "section_360_subsection_f_item_1"
    class_name "item"
    text "The Secretary shall make available for inspection, to any person so requesting, any registration filed pursuant to this section; except that any list submitted pursuant to paragraph (3) of subsection (j) of this section and the information accompanying any list or notice filed under paragraph (1) or (2) of that subsection shall be exempt from such inspection unless the Secretary finds that such an exemption would be inconsistent with protection of the public health."
  ]
  node [
    id 1738
    label "section_360_subsection_j_item_2"
    class_name "item"
    text "(2) Each person who registers with the Secretary under this section shall report to the Secretary once during the month of June of each year and once during the month of December of each year the following information:"
  ]
  node [
    id 1739
    label "section_360_subsection_g_item_1"
    class_name "item"
    text "(1) pharmacies which maintain establishments in conformance with any applicable local laws regulating the practice of pharmacy and medicine and which are regularly engaged in dispensing prescription drugs or devices, upon prescriptions of practitioners licensed to administer such drugs or devices to patients under the care of such practitioners in the course of their professional practice, and which do not manufacture, prepare, propagate, compound, or process drugs or devices for sale other than in the regular course of their business of dispensing or selling drugs or devices at retail;"
  ]
  node [
    id 1740
    label "section_360_subsection_f"
    class_name "subsection"
    text "(f) Availability of registrations for inspection"
  ]
  node [
    id 1741
    label "section_360_subsection_a_item_2"
    class_name "item"
    text "(2) the term &#8220;name&#8221; shall include in the case of a partnership the name of each partner and, in the case of a corporation, the name of each corporate officer and director, and the State of incorporation."
  ]
  node [
    id 1742
    label "section_360_subsection_f_item_2"
    class_name "item"
    text "The Secretary shall make available for inspection, to any person so requesting, any registration filed pursuant to this section; except that any list submitted pursuant to paragraph (3) of subsection (j) of this section and the information accompanying any list or notice filed under paragraph (1) or (2) of that subsection shall be exempt from such inspection unless the Secretary finds that such an exemption would be inconsistent with protection of the public health."
  ]
  node [
    id 1743
    label "section_360_subsection_f_item_3"
    class_name "item"
    text "The Secretary shall make available for inspection, to any person so requesting, any registration filed pursuant to this section; except that any list submitted pursuant to paragraph (3) of subsection (j) of this section and the information accompanying any list or notice filed under paragraph (1) or (2) of that subsection shall be exempt from such inspection unless the Secretary finds that such an exemption would be inconsistent with protection of the public health."
  ]
  node [
    id 1744
    label "section_360_subsection_k_item_1"
    class_name "item"
    text "(1) the class in which the device is classified under section 360c of this title or if such person determines that the device is not classified under such section, a statement of that determination and the basis for such person's determination that the device is or is not so classified, and"
  ]
  node [
    id 1745
    label "section_360_subsection_k_item_2"
    class_name "item"
    text "(2) action taken by such person to comply with requirements under section 360d or 360e of this title which are applicable to the device."
  ]
  node [
    id 1746
    label "section_360_subsection_j_item_1_subitem_B"
    class_name "subitem"
    text "(B) in the case of any other drug or device contained in an applicable list&#8212;"
  ]
  node [
    id 1747
    label "section_360b_subsection_e_item_1_subitem_F"
    class_name "subitem"
    text "(F) that the applicant has made any changes from the standpoint of safety or effectiveness beyond the variations provided for in the application unless he has supplemented the application by filing with the Secretary adequate information respecting all such changes and unless there is in effect an approval of the supplemental application. The supplemental application shall be treated in the same manner as the original application."
  ]
  node [
    id 1748
    label "section_360b_subsection_v_item_3_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(viii) information submitted in the application or any other information available to the Secretary shows that (I) the inactive ingredients of the drug are unsafe for use under the conditions prescribed, recommended, or suggested in the labeling proposed for the drug, (II) the composition of the drug is unsafe under such conditions because of the type or quantity of inactive ingredients included or the manner in which the inactive ingredients are included, or (III) in the case of a drug for food producing animals, the inactive ingredients of the drug or its composition may be unsafe with respect to human food safety;"
  ]
  node [
    id 1749
    label "section_360b_subsection_x_item_2_subitem_B_subsubitem_iv_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the date of a decision of a court in an action described in subclause (III)&#160;1 holding the patent which is the subject of the certification to be invalid or not infringed,"
  ]
  node [
    id 1750
    label "section_360b_subsection_p_item_2_subitem_B"
    class_name "subitem"
    text "(B) without obtaining from any person to whom the data and information are disclosed an identical verified statement, a copy of which is to be provided by such person to the Secretary, which meets the requirements of this paragraph."
  ]
  node [
    id 1751
    label "section_360b_subsection_e_item_1_subitem_D"
    class_name "subitem"
    text "(D) the patent information prescribed by subsection (c)(3) of this section was not filed within 30 days after the receipt of written notice from the Secretary specifying the failure to file such information;"
  ]
  node [
    id 1752
    label "section_360b_subsection_a_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) will, if the consignee is not a user of the drug, ship such drug only to a holder of an approved application under subsection (m) of this section."
  ]
  node [
    id 1753
    label "section_360b_subsection_n_item_1_subitem_H_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) that such patent has expired,"
  ]
  node [
    id 1754
    label "section_360b_subsection_v_item_3_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(viii) information submitted in the application or any other information available to the Secretary shows that (I) the inactive ingredients of the drug are unsafe for use under the conditions prescribed, recommended, or suggested in the labeling proposed for the drug, (II) the composition of the drug is unsafe under such conditions because of the type or quantity of inactive ingredients included or the manner in which the inactive ingredients are included, or (III) in the case of a drug for food producing animals, the inactive ingredients of the drug or its composition may be unsafe with respect to human food safety;"
  ]
  node [
    id 1755
    label "section_360b_subsection_d_item_1_subitem_E"
    class_name "subitem"
    text "(E) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof;"
  ]
  node [
    id 1756
    label "section_360b_subsection_n_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the holder of the approved application under subsection (c)(1) of this section for the drug which is claimed by the patent or a use of which is claimed by the patent or the representative of such holder designated to receive such notice."
  ]
  node [
    id 1757
    label "section_360b_subsection_x_item_2_subitem_E"
    class_name "subitem"
    text "(E) If the Secretary decides to disapprove an application, the Secretary shall give the applicant notice of an opportunity for a hearing before the Secretary on the question of whether such application is approvable. If the applicant elects to accept the opportunity for hearing by written request within 30 days after such notice, such hearing shall commence not more than 90 days after the expiration of such 30 days unless the Secretary and the applicant otherwise agree. Any such hearing shall thereafter be conducted on an expedited basis and the Secretary's order thereon shall be issued within 90 days after the date fixed by the Secretary for filing final briefs."
  ]
  node [
    id 1758
    label "section_360b_subsection_l_item_2"
    class_name "item"
    text "(2) Every person required under this subsection to maintain records, and every person in charge or custody thereof, shall, upon request of an officer or employee designated by the Secretary, permit such officer or employee at all reasonable times to have access to and copy and verify such records."
  ]
  node [
    id 1759
    label "section_360b_subsection_d_item_2"
    class_name "item"
    text "(2) In determining whether such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof, the Secretary shall consider, among other relevant factors, (A) the probable consumption of such drug and of any substance formed in or on food because of the use of such drug, (B) the cumulative effect on man or animal of such drug, taking into account any chemically or pharmacologically related substance, (C) safety factors which in the opinion of experts, qualified by scientific training and experience to evaluate the safety of such drugs, are appropriate for the use of animal experimentation data, and (D) whether the conditions of use prescribed, recommended, or suggested in the proposed labeling are reasonably certain to be followed in practice. Any order issued under this subsection refusing to approve an application shall state the findings upon which it is based."
  ]
  node [
    id 1760
    label "section_360b_subsection_m"
    class_name "subsection"
    text "(m)(1) Filing application for uses of animal feed containing new animal drug; contents"
  ]
  node [
    id 1761
    label "section_360b_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) such drug, its labeling, and such use conform to such approved application."
  ]
  node [
    id 1762
    label "section_360b_subsection_b"
    class_name "subsection"
    text "(b) Filing application for uses of new animal drug; contents; patent information; abbreviated application"
  ]
  node [
    id 1763
    label "section_360b_subsection_d_item_1"
    class_name "item"
    text "(1) If the Secretary finds, after due notice to the applicant in accordance with subsection (c) of this section and giving him an opportunity for a hearing, in accordance with said subsection, that&#8212;"
  ]
  node [
    id 1764
    label "section_360b_subsection_v_subitem_H_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) A new animal drug shall be considered to be bioequivalent to the approved new animal drug referred to in its application under subsection (n) of this section if&#8212;"
  ]
  node [
    id 1765
    label "section_360b_subsection_n_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) An applicant who makes a certification described in paragraph (1)(G)(iv) shall include in the application a statement that the applicant will give the notice required by subparagraph (B) to&#8212;"
  ]
  node [
    id 1766
    label "section_360b_subsection_n_item_1_subitem_H"
    class_name "subitem"
    text "(H) a certification, in the opinion of the applicant and to the best of his knowledge, with respect to each patent which claims the approved new animal drug or which claims a use for such approved new animal drug for which the applicant is seeking approval under this subsection and for which information is required to be filed under subsection (b)(1) or (c)(3) of this section&#8212;"
  ]
  node [
    id 1767
    label "section_360b_subsection_n_item_5_subitem_A"
    class_name "subitem"
    text "(A) is relied on by the applicant for the approval of the application, and"
  ]
  node [
    id 1768
    label "section_360b_subsection_e"
    class_name "subsection"
    text "(e) Withdrawal of approval; grounds; immediate suspension upon finding imminent hazard to health of man or animals"
  ]
  node [
    id 1769
    label "section_360b_subsection_a_item_5_subitem_B"
    class_name "subitem"
    text "(B) is in compliance with regulations promulgated by the Secretary that establish the conditions for the use or intended use of the drug in animals."
  ]
  node [
    id 1770
    label "section_360b_subsection_k"
    class_name "subsection"
    text "(k) Food containing new animal drug considered unadulterated while approval of application for such drug is effective"
  ]
  node [
    id 1771
    label "section_360b_subsection_m_item_4"
    class_name "item"
    text "(4) Withdrawal of approval; grounds; immediate suspension upon finding imminent hazard to health of man or animals"
  ]
  node [
    id 1772
    label "section_360b_subsection_n_item_2"
    class_name "item"
    text "such application shall be considered to be an application filed under subsection (b)(2) of this section."
  ]
  node [
    id 1773
    label "section_360b_subsection_n_item_1_subitem_B"
    class_name "subitem"
    text "(B)(i) information to show that the active ingredients of the new animal drug are the same as those of the approved new animal drug, and"
  ]
  node [
    id 1774
    label "section_360b_subsection_m_item_3"
    class_name "item"
    text "(3) Grounds for refusing application; approval of application; approval effective during existence of subsection (i) regulation"
  ]
  node [
    id 1775
    label "section_360b_subsection_p_item_1_subitem_E"
    class_name "subitem"
    text "(E) upon the effective date of the approval of the first application filed under subsection (b)(2) of this section which refers to such drug or upon the date upon which the approval of an application filed under subsection (b)(2) of this section which refers to such drug could be made effective if such an application had been filed."
  ]
  node [
    id 1776
    label "section_360b_subsection_n_item_4_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) When patent information submitted under subsection (b)(1) or (c)(3) of this section respecting a new animal drug included on the list is to be published by the Secretary, the Secretary shall, in revisions made under clause (ii), include such information for such drug."
  ]
  node [
    id 1777
    label "section_360b_subsection_m_item_1_subitem_C"
    class_name "subitem"
    text "Any person may file with the Secretary an application with respect to any intended use or uses of an animal feed bearing or containing a new animal drug. Such person shall submit to the Secretary as part of the application (A) a full statement of the composition of such animal feed, (B) an identification of the regulation or regulations (relating to the new animal drug or drugs to be used in such feed), published pursuant to subsection (i) of this section, on which he relies as a basis for approval of his application with respect to the use of such drug in such feed, (C) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such animal feed, (D) specimens of the labeling proposed to be used for such animal feed, and (E) if so requested by the Secretary, samples of such animal feed or components thereof."
  ]
  node [
    id 1778
    label "section_360b_subsection_n_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) information to show that the withdrawal period at which residues of the new animal drug will be consistent with the tolerances established for the approved new animal drug is the same as the withdrawal period previously established for the approved new animal drug or, if the withdrawal period is proposed to be different, information showing that the residues of the new animal drug at the proposed different withdrawal period will be consistent with the tolerances established for the approved new animal drug;"
  ]
  node [
    id 1779
    label "section_360b_subsection_x_item_2_subitem_F"
    class_name "subitem"
    text "(F)(i) If an application submitted under subsection (b)(1) of this section for a drug, no active ingredient (including any ester or salt of the active ingredient) of which has been approved in any other application under subsection (b)(1) of this section, is approved after November 16, 1988, no application may be submitted under subsection (b)(2) of this section which refers to the drug for which the subsection (b)(1) application was submitted before the expiration of 5 years from the date of the approval of the application under subsection (b)(1) of this section, except that such an application may be submitted under subsection (b)(2) of this section after the expiration of 4 years from the date of the approval of the subsection (b)(1) application if it contains a certification of patent invalidity or noninfringement described in clause (iv) of subsection (n)(1)(G) of this section. The approval of such an application shall be made effective in accordance with subparagraph (B) except that, if an action for patent infringement is commenced during the one-year period beginning 48 months after the date of the approval of the subsection (b) application, the 30 month period referred to in subparagraph (D)(iii) shall be extended by such amount of time (if any) which is required for seven and one-half years to have elapsed from the date of approval of the subsection (b) application."
  ]
  node [
    id 1780
    label "section_360b_subsection_m_item_5_subitem_A"
    class_name "subitem"
    text "(A) the applicant shall establish and maintain such records, and make such reports to the Secretary, or (at the option of the Secretary) to the appropriate person or persons holding an approved application filed under subsection (b) of this section, as the Secretary may by general regulation, or by order with respect to such application, prescribe on the basis of a finding that such records and reports are necessary in order to enable the Secretary to determine, or facilitate a determination, whether there is or may be ground for invoking subsection (e) of this section or paragraph (4) of this subsection."
  ]
  node [
    id 1781
    label "section_360b_subsection_m_item_1_subitem_E"
    class_name "subitem"
    text "Any person may file with the Secretary an application with respect to any intended use or uses of an animal feed bearing or containing a new animal drug. Such person shall submit to the Secretary as part of the application (A) a full statement of the composition of such animal feed, (B) an identification of the regulation or regulations (relating to the new animal drug or drugs to be used in such feed), published pursuant to subsection (i) of this section, on which he relies as a basis for approval of his application with respect to the use of such drug in such feed, (C) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such animal feed, (D) specimens of the labeling proposed to be used for such animal feed, and (E) if so requested by the Secretary, samples of such animal feed or components thereof."
  ]
  node [
    id 1782
    label "section_360b_subsection_c_item_2_subitem_iv_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(iv)(I) if the application is for a drug whose active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed is the same as the active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed of the approved new animal drug referred to in the application, information submitted in the application is insufficient to show that the active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed is the same as that of the approved new animal drug, or"
  ]
  node [
    id 1783
    label "section_360b_subsection_m_item_3_subitem_B"
    class_name "subitem"
    text "Within ninety days after the filing of an application pursuant to paragraph (1) of this subsection, or such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall either (A) issue an order approving the application if he then finds that none of the grounds for denying approval specified in paragraph (3) applies, or (B) give the applicant notice of an opportunity for a hearing before the Secretary under paragraph (3) on the question whether such application is approvable. The procedure governing such a hearing shall be the procedure set forth in the last two sentences of subsection (c) of this section."
  ]
  node [
    id 1784
    label "section_360b_subsection_v_subitem_G"
    class_name "subitem"
    text "(G) If an approved application submitted under subsection (b)(2) of this section for a new animal drug refers to a drug the approval of which was withdrawn or suspended for grounds described in paragraph (1) or (2) of subsection (e) of this section or was withdrawn or suspended under this subparagraph or which, as determined by the Secretary, has been withdrawn from sale for safety or effectiveness reasons, the approval of the drug under this paragraph shall be withdrawn or suspended&#8212;"
  ]
  node [
    id 1785
    label "section_360b_subsection_x_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If the applicant made a certification described in clause (iii) of subsection (n)(1)(G) of this section, the approval may be made effective on the date certified under clause (iii)."
  ]
  node [
    id 1786
    label "section_360b_subsection_m_item_2_subitem_D"
    class_name "subitem"
    text "he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that subparagraphs (A) through (D) do not apply, he shall issue an order approving the application. An order under this subsection approving an application with respect to an animal feed bearing or containing a new animal drug shall be effective only while there is in effect a regulation pursuant to subsection (i) of this section, on the basis of which such application (or a supplement thereto) was approved, relating to the use of such drug in or on such feed."
  ]
  node [
    id 1787
    label "section_360b_subsection_g"
    class_name "subsection"
    text "(g) Service of orders"
  ]
  node [
    id 1788
    label "section_360b_subsection_n_item_4_subitem_C"
    class_name "subitem"
    text "(C) If the approval of a new animal drug was withdrawn or suspended under subsection (c)(2)(G) of this section or for grounds described in subsection (e) of this section or if the Secretary determines that a drug has been withdrawn from sale for safety or effectiveness reasons, it may not be published in the list under subparagraph (A) or, if the withdrawal or suspension occurred after its publication in such list, it shall be immediately removed from such list&#8212;"
  ]
  node [
    id 1789
    label "section_360b_subsection_x_item_2_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) If the application contains a certification described in clause (iv) of subsection (n)(1)(G) of this section and is for a drug for which a previous application has been filed under this subsection containing such a certification, the application shall be made effective not earlier than 180 days after&#8212;"
  ]
  node [
    id 1790
    label "section_360b_subsection_n_item_1_subitem_A"
    class_name "subitem"
    text "The Secretary may not require that an abbreviated application contain information in addition to that required by subparagraphs (A) through (I)."
  ]
  node [
    id 1791
    label "section_360b_subsection_e_item_1_subitem_E"
    class_name "subitem"
    text "(E) that the application contains any untrue statement of a material fact; or"
  ]
  node [
    id 1792
    label "section_360b_subsection_n_item_3_subitem_B"
    class_name "subitem"
    text "(B) whose use with other animal drugs in animal feed differs from that of an approved new animal drug,"
  ]
  node [
    id 1793
    label "section_360b_subsection_x_subitem_B"
    class_name "subitem"
    text "(B) If the Secretary finds that a new animal drug for which an application is submitted under subsection (b)(2) of this section is bioequivalent to the approved new animal drug referred to in such application and that residues of the new animal drug are consistent with the tolerances established for such approved new animal drug but at a withdrawal period which is different than the withdrawal period approved for such approved new animal drug, the Secretary may establish, on the basis of information submitted, such different withdrawal period as the withdrawal period for the new animal drug for purposes of the approval of such application for such drug."
  ]
  node [
    id 1794
    label "section_360b_subsection_m_item_2"
    class_name "item"
    text "If the Secretary, after due notice to the applicant in accordance with paragraph (2) and giving him an opportunity for a hearing in accordance with such paragraph, finds, on the basis of information submitted to him as part of the application or on the basis of any other information before him&#8212;"
  ]
  node [
    id 1795
    label "section_360b_subsection_n_item_1"
    class_name "item"
    text "(1) An abbreviated application for a new animal drug shall contain&#8212;"
  ]
  node [
    id 1796
    label "section_360b_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) there is in effect an approval of an application filed pursuant to subsection (b) of this section with respect to such use or intended use of such drug, and"
  ]
  node [
    id 1797
    label "section_360b_subsection_a_item_5_subitem_A"
    class_name "subitem"
    text "(A) is by or on the lawful written or oral order of a licensed veterinarian within the context of a veterinarian-client-patient relationship, as defined by the Secretary; and"
  ]
  node [
    id 1798
    label "section_360b_subsection_i"
    class_name "subsection"
    text "(i) Publication in Federal Register; effective date and revocation or suspension of regulation"
  ]
  node [
    id 1799
    label "section_360b_subsection_a_item_4_subitem_B"
    class_name "subitem"
    text "(B) If the Secretary finds that there is a reasonable probability that a use of an animal drug authorized under subparagraph (A) may present a risk to the public health, the Secretary may&#8212;"
  ]
  node [
    id 1800
    label "section_360b_subsection_p_item_1_subitem_D"
    class_name "subitem"
    text "(D) if the Secretary has determined that such drug is not a new drug, or"
  ]
  node [
    id 1801
    label "section_360b_subsection_n_item_2_subitem_C"
    class_name "subitem"
    text "(C) If an application is amended to include a certification described in paragraph (1)(G)(iv), the notice required by subparagraph (B) shall be given when the amended application is filed."
  ]
  node [
    id 1802
    label "section_360b_subsection_n_item_3"
    class_name "item"
    text "(3) If a person wants to submit an abbreviated application for a new animal drug&#8212;"
  ]
  node [
    id 1803
    label "section_360b_subsection_m_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) that on the basis of new information before him, evaluated together with the evidence before him when such application was approved, the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of such animal feed are inadequate to assure and preserve the identity, strength, quality, and purity of the new animal drug therein, and were not made adequate within a reasonable time after receipt of written notice from the Secretary, specifying the matter complained of; or"
  ]
  node [
    id 1804
    label "section_360b_subsection_b_item_2"
    class_name "item"
    text "(2) Any person may file with the Secretary an abbreviated application for the approval of a new animal drug. An abbreviated application shall contain the information required by subsection (n) of this section."
  ]
  node [
    id 1805
    label "section_360b_subsection_p_item_1_subitem_B"
    class_name "subitem"
    text "(B) if the Secretary has determined that the application is not approvable and all legal appeals have been exhausted,"
  ]
  node [
    id 1806
    label "section_360b_subsection_v_item_3"
    class_name "item"
    text "(3) If the patent information described in subsection (b)(1) of this section could not be filed with the submission of an application under subsection (b)(1) of this section because the application was filed before the patent information was required under subsection (b)(1) of this section or a patent was issued after the application was approved under such subsection, the holder of an approved application shall file with the Secretary the patent number and the expiration date of any patent which claims the new animal drug for which the application was filed or which claims a method of using such drug and with respect to which a claim of patent infringement could reasonably be asserted if a person not licensed by the owner engaged in the manufacture, use, or sale of the drug. If the holder of an approved application could not file patent information under subsection (b)(1) of this section because it was not required at the time the application was approved, the holder shall file such information under this subsection not later than 30 days after November 16, 1988, and if the holder of an approved application could not file patent information under subsection (b)(1) of this section because no patent had been issued when an application was filed or approved, the holder shall file such information under this subsection not later than 30 days after the date the patent involved is issued. Upon the submission of patent information under this subsection, the Secretary shall publish it."
  ]
  node [
    id 1807
    label "section_360b_subsection_m_item_4_subitem_C"
    class_name "subitem"
    text "(C) Any order under paragraph (4) of this subsection shall state the findings upon which it is based."
  ]
  node [
    id 1808
    label "section_360b_subsection_a_item_1"
    class_name "item"
    text "The use of an animal drug that results in residues exceeding a safe level established under clause (i) shall be considered an unsafe use of such drug under paragraph (1). Safe levels may be established under clause (i) either by regulation or order."
  ]
  node [
    id 1809
    label "section_360b_subsection_p"
    class_name "subsection"
    text "(p) Safety and effectiveness data"
  ]
  node [
    id 1810
    label "section_360b_subsection_m_item_1_subitem_A"
    class_name "subitem"
    text "Within ninety days after the filing of an application pursuant to paragraph (1) of this subsection, or such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall either (A) issue an order approving the application if he then finds that none of the grounds for denying approval specified in paragraph (3) applies, or (B) give the applicant notice of an opportunity for a hearing before the Secretary under paragraph (3) on the question whether such application is approvable. The procedure governing such a hearing shall be the procedure set forth in the last two sentences of subsection (c) of this section."
  ]
  node [
    id 1811
    label "section_360b_subsection_a_item_2"
    class_name "item"
    text "(2) An animal feed bearing or containing a new animal drug shall, with respect to any particular use or intended use of such animal feed, be deemed unsafe for the purposes of section 351(a)(6) of this title unless&#8212;"
  ]
  node [
    id 1812
    label "section_360b_subsection_c"
    class_name "subsection"
    text "(c) Period for approval of application; period for, notice, and expedition of hearing; period for issuance of order; abbreviated applications; withdrawal periods; effective date of approval; relationship to other applications; withdrawal or suspension of approval; bioequivalence; filing of additional patent information"
  ]
  node [
    id 1813
    label "section_360b_subsection_a_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) is the holder of an approved application under subsection (m) of this section; or"
  ]
  node [
    id 1814
    label "section_360b_subsection_p_item_2"
    class_name "item"
    text "(2) Any request for data and information pursuant to paragraph (1) shall include a verified statement by the person making the request that any data or information received under such paragraph shall not be disclosed by such person to any other person&#8212;"
  ]
  node [
    id 1815
    label "section_360b_subsection_x_item_2_subitem_B"
    class_name "subitem"
    text "In such an action, each of the parties shall reasonably cooperate in expediting the action. Until the expiration of 45 days from the date the notice made under subsection (n)(2)(B) of this section is received, no action may be brought under section 2201 of title 28 for a declaratory judgment with respect to the patent. Any action brought under section 2201 of title 28 shall be brought in the judicial district where the defendant has its principal place of business or a regular and established place of business."
  ]
  node [
    id 1816
    label "section_360b_subsection_n"
    class_name "subsection"
    text "(n) Abbreviated applications for new animal drugs; contents, filing, etc.; lists of approved drugs"
  ]
  node [
    id 1817
    label "section_360b_subsection_x_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(i) If the applicant only made a certification described in clause (i) or (ii) of subsection (n)(1)(G) of this section or in both such clauses, the approval may be made effective immediately."
  ]
  node [
    id 1818
    label "section_360b_subsection_e_item_2_subitem_B"
    class_name "subitem"
    text "(B) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to assure and preserve its identity, strength, quality, and purity and were not made adequate within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of; or"
  ]
  node [
    id 1819
    label "section_360b_subsection_e_item_2"
    class_name "item"
    text "(2) The Secretary may also, after due notice and opportunity for hearing to the applicant, issue an order withdrawing the approval of an application with respect to any new animal drug under this section if the Secretary finds&#8212;"
  ]
  node [
    id 1820
    label "section_360b_subsection_n_item_3_subitem_C"
    class_name "subitem"
    text "(C) investigations must be conducted to show the safety and effectiveness, in animals to be treated with the drug, of the active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed which differ from the approved new animal drug, or"
  ]
  node [
    id 1821
    label "section_360b_subsection_m_item_2_subitem_A"
    class_name "subitem"
    text "he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that subparagraphs (A) through (D) do not apply, he shall issue an order approving the application. An order under this subsection approving an application with respect to an animal feed bearing or containing a new animal drug shall be effective only while there is in effect a regulation pursuant to subsection (i) of this section, on the basis of which such application (or a supplement thereto) was approved, relating to the use of such drug in or on such feed."
  ]
  node [
    id 1822
    label "section_360b_subsection_e_item_2_subitem_C"
    class_name "subitem"
    text "(C) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the labeling of such drug, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of."
  ]
  node [
    id 1823
    label "section_360b_subsection_g_item_2"
    class_name "item"
    text "Orders of the Secretary issued under this section (other than orders issuing, amending, or repealing regulations) shall be served (1) in person by any officer or employee of the department designated by the Secretary or (2) by mailing the order by registered mail or by certified mail addressed to the applicant or respondent at his last known address in the records of the Secretary."
  ]
  node [
    id 1824
    label "section_360b_subsection_v_item_3_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(viii) information submitted in the application or any other information available to the Secretary shows that (I) the inactive ingredients of the drug are unsafe for use under the conditions prescribed, recommended, or suggested in the labeling proposed for the drug, (II) the composition of the drug is unsafe under such conditions because of the type or quantity of inactive ingredients included or the manner in which the inactive ingredients are included, or (III) in the case of a drug for food producing animals, the inactive ingredients of the drug or its composition may be unsafe with respect to human food safety;"
  ]
  node [
    id 1825
    label "section_360b_subsection_c_item_2_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) information submitted with the application is insufficient to show that the active ingredients are the same as those of the approved new animal drug referred to in the application;"
  ]
  node [
    id 1826
    label "section_360b_subsection_v_item_1"
    class_name "item"
    text "(ix) the approval under subsection (b)(1) of this section of the approved new animal drug referred to in the application filed under subsection (b)(2) of this section has been withdrawn or suspended for grounds described in paragraph (1) of subsection (e) of this section, the Secretary has published a notice of a hearing to withdraw approval of the approved new animal drug for such grounds, the approval under this paragraph of the new animal drug for which the application under subsection (b)(2) of this section was filed has been withdrawn or suspended under subparagraph (G) for such grounds, or the Secretary has determined that the approved new animal drug has been withdrawn from sale for safety or effectiveness reasons;"
  ]
  node [
    id 1827
    label "section_360b_subsection_x_subitem_D_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the court decides that such patent has been infringed, the approval shall be made effective on such date as the court orders under section 271(e)(4)(A) of title 35, or"
  ]
  node [
    id 1828
    label "section_360b_subsection_a"
    class_name "subsection"
    text "(a) Unsafe new animal drugs and animal feed containing such drugs; conditions of safety; exemption of drugs for research"
  ]
  node [
    id 1829
    label "section_360b_subsection_m_item_4_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) that the application contains any untrue statement of a material fact; or"
  ]
  node [
    id 1830
    label "section_360b_subsection_n_item_1_subitem_C_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) information to show either that the different animal drug proposed for use with the approved new animal drug in animal feed is an approved new animal drug permitted to be used in animal feed or does not meet the requirements of section 321(v) of this title when used with another animal drug in animal feed,"
  ]
  node [
    id 1831
    label "section_360b_subsection_n_item_4_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the listed drug has been withdrawn from sale, for the period of withdrawal from sale or, if earlier, the period ending on the date the Secretary determines that the withdrawal from sale is not for safety or effectiveness reasons."
  ]
  node [
    id 1832
    label "section_360b_subsection_a_item_4"
    class_name "item"
    text "(4)(A) Except as provided in subparagraph (B), if an approval of an application filed under subsection (b) of this section is in effect with respect to a particular use or intended use of a new animal drug, the drug shall not be deemed unsafe for the purposes of paragraph (1) and shall be exempt from the requirements of section 352(f) of this title with respect to a different use or intended use of the drug, other than a use in or on animal feed, if such use or intended use&#8212;"
  ]
  node [
    id 1833
    label "section_360b_subsection_n_item_3_subitem_D"
    class_name "subitem"
    text "(D) investigations must be conducted to show the safety for human consumption of any residues in food resulting from the proposed active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed for the new animal drug which is different from the active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed of the approved new animal drug."
  ]
  node [
    id 1834
    label "section_360b_subsection_m_item_2_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearing, the Secretary finds that subparagraphs (A) through (D) do not apply, he shall issue an order approving the application. An order under this subsection approving an application with respect to an animal feed bearing or containing a new animal drug shall be effective only while there is in effect a regulation pursuant to subsection (i) of this section, on the basis of which such application (or a supplement thereto) was approved, relating to the use of such drug in or on such feed."
  ]
  node [
    id 1835
    label "section_360b_subsection_a_item_1_subitem_C"
    class_name "subitem"
    text "(C) The Secretary may by general regulation provide access to the records of veterinarians to ascertain any use or intended use authorized under subparagraph (A) that the Secretary has determined may present a risk to the public health."
  ]
  node [
    id 1836
    label "section_360b_subsection_c_item_2"
    class_name "item"
    text "(2)(A) Subject to subparagraph (C), the Secretary shall approve an abbreviated application for a drug unless the Secretary finds&#8212;"
  ]
  node [
    id 1837
    label "section_360b_subsection_n_item_3_subitem_A"
    class_name "subitem"
    text "(A) whose active ingredients, route of administration, dosage form, or strength differ from that of an approved new animal drug, or"
  ]
  node [
    id 1838
    label "section_360b_subsection_n_item_1_subitem_B_subsubitem_ii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) such other information respecting the different active ingredients as the Secretary may require;"
  ]
  node [
    id 1839
    label "section_360b_subsection_v_subitem_H_subsubitem_i"
    class_name "subsubitem"
    text "(i) The term &#8220;bioequivalence&#8221; means the rate and extent to which the active ingredient or therapeutic ingredient is absorbed from a new animal drug and becomes available at the site of drug action."
  ]
  node [
    id 1840
    label "section_360b_subsection_a_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) Except as provided in subparagraph (B), if an approval of an application filed under subsection (b) of this section is in effect with respect to a particular use or intended use of a new animal drug, the drug shall not be deemed unsafe for the purposes of paragraph (1) and shall be exempt from the requirements of section 352(f) of this title with respect to a different use or intended use of the drug, other than a use in or on animal feed, if such use or intended use&#8212;"
  ]
  node [
    id 1841
    label "section_360b_subsection_m_item_4_subitem_B"
    class_name "subitem"
    text "(B) The Secretary may also, after due notice and opportunity for hearing to the applicant, issue an order withdrawing the approval of an application with respect to any animal feed under this subsection if the Secretary finds&#8212;"
  ]
  node [
    id 1842
    label "section_360b_subsection_n_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(A)(i) except as provided in clause (ii), information to show that the conditions of use or similar limitations (whether in the labeling or published pursuant to subsection (i) of this section) prescribed, recommended, or suggested in the labeling proposed for the new animal drug have been previously approved for a new animal drug listed under paragraph (4) (hereinafter in this subsection referred to as an &#8220;approved new animal drug&#8221;), and"
  ]
  node [
    id 1843
    label "section_360b_subsection_x_subitem_D"
    class_name "subitem"
    text "(D) The approval of an application filed under subsection (b)(2) of this section shall be made effective on the last applicable date determined under the following:"
  ]
  node [
    id 1844
    label "section_360b_subsection_e_item_2_subitem_A"
    class_name "subitem"
    text "(A) that the applicant has failed to establish a system for maintaining required records, or has repeatedly or deliberately failed to maintain such records or to make required reports in accordance with a regulation or order under subsection (1) of this section, or the applicant has refused to permit access to, or copying or verification of, such records as required by paragraph (2) of such subsection;"
  ]
  node [
    id 1845
    label "section_360b_subsection_a_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "The regulations promulgated by the Secretary under clause (ii) may prohibit particular uses of an animal drug and shall not permit such different use of an animal drug if the labeling of another animal drug that contains the same active ingredient and which is in the same dosage form and concentration provides for such different use."
  ]
  node [
    id 1846
    label "section_360b_subsection_v_subitem_H"
    class_name "subitem"
    text "(H) For purposes of this paragraph:"
  ]
  node [
    id 1847
    label "section_360b_subsection_a_item_1_subitem_D"
    class_name "subitem"
    text "(D) If the Secretary finds, after affording an opportunity for public comment, that a use of an animal drug authorized under subparagraph (A) presents a risk to the public health or that an analytical method required under subparagraph (B) has not been developed and submitted to the Secretary, the Secretary may, by order, prohibit any such use."
  ]
  node [
    id 1848
    label "section_360b_subsection_x_subitem_C"
    class_name "subitem"
    text "(C) Within 180 days of the initial receipt of an application under subsection (b)(2) of this section or within such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall approve or disapprove the application."
  ]
  node [
    id 1849
    label "section_360b_subsection_o"
    class_name "subsection"
    text "(o) &#8220;Patent&#8221; defined"
  ]
  node [
    id 1850
    label "section_360b_subsection_m_item_5"
    class_name "item"
    text "(5) Records and reports; regulations and orders; access to records"
  ]
  node [
    id 1851
    label "section_360b_subsection_v_subitem_G_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the approved new animal drug has been withdrawn from sale, for the period of withdrawal from sale or, if earlier, the period ending on the date the Secretary determines that the withdrawal from sale is not for safety or effectiveness reasons."
  ]
  node [
    id 1852
    label "section_360b_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Subject to subparagraph (C), the Secretary shall approve an abbreviated application for a drug unless the Secretary finds&#8212;"
  ]
  node [
    id 1853
    label "section_360b_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearings, the Secretary finds that subparagraphs (A) through (I) do not apply, he shall issue an order approving the application."
  ]
  node [
    id 1854
    label "section_360b_subsection_m_item_1_subitem_B"
    class_name "subitem"
    text "Any person may file with the Secretary an application with respect to any intended use or uses of an animal feed bearing or containing a new animal drug. Such person shall submit to the Secretary as part of the application (A) a full statement of the composition of such animal feed, (B) an identification of the regulation or regulations (relating to the new animal drug or drugs to be used in such feed), published pursuant to subsection (i) of this section, on which he relies as a basis for approval of his application with respect to the use of such drug in such feed, (C) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such animal feed, (D) specimens of the labeling proposed to be used for such animal feed, and (E) if so requested by the Secretary, samples of such animal feed or components thereof."
  ]
  node [
    id 1855
    label "section_360b_subsection_n_item_1_subitem_D"
    class_name "subitem"
    text "(D) information to show that the route of administration, the dosage form, and the strength of the new animal drug are the same as those of the approved new animal drug or, if the route of administration, the dosage form, or the strength of the new animal drug is different and the application is filed pursuant to the approval of a petition filed under paragraph (3), such information respecting the route of administration, dosage form, or strength with respect to which the petition was filed as the Secretary may require;"
  ]
  node [
    id 1856
    label "section_360b_subsection_p_item_2_subitem_A"
    class_name "subitem"
    text "(A) for the purpose of, or as part of a plan, scheme, or device for, obtaining the right to make, use, or market, or making, using, or marketing, outside the United States, the drug identified in the application filed under subsection (b)(1) of this section, and"
  ]
  node [
    id 1857
    label "section_360b_subsection_n_item_2_subitem_B"
    class_name "subitem"
    text "(B) The notice referred to in subparagraph (A) shall state that an application, which contains data from bioequivalence studies, has been filed under this subsection for the drug with respect to which the certification is made to obtain approval to engage in the commercial manufacture, use, or sale of such drug before the expiration of the patent referred to in the certification. Such notice shall include a detailed statement of the factual and legal basis of the applicant's opinion that the patent is not valid or will not be infringed."
  ]
  node [
    id 1858
    label "section_360b_subsection_a_item_2_subitem_C"
    class_name "subitem"
    text "(C) such animal feed, its labeling, and such use conform to the conditions and indications of use published pursuant to subsection (i) of this section and to the application with respect thereto approved under subsection (m) of this section."
  ]
  node [
    id 1859
    label "section_360b_subsection_n_item_1_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(C)(i) if the approved new animal drug is permitted to be used with one or more animal drugs in animal feed, information to show that the proposed uses of the new animal drug with other animal drugs in animal feed are the same as the uses of the approved new animal drug, and"
  ]
  node [
    id 1860
    label "section_360b_subsection_e_item_3"
    class_name "item"
    text "(3) Any order under this subsection shall state the findings upon which it is based."
  ]
  node [
    id 1861
    label "section_360b_subsection_x_item_2_subitem_F_subsubitem_i"
    class_name "subsubitem"
    text "(F)(i) If an application submitted under subsection (b)(1) of this section for a drug, no active ingredient (including any ester or salt of the active ingredient) of which has been approved in any other application under subsection (b)(1) of this section, is approved after November 16, 1988, no application may be submitted under subsection (b)(2) of this section which refers to the drug for which the subsection (b)(1) application was submitted before the expiration of 5 years from the date of the approval of the application under subsection (b)(1) of this section, except that such an application may be submitted under subsection (b)(2) of this section after the expiration of 4 years from the date of the approval of the subsection (b)(1) application if it contains a certification of patent invalidity or noninfringement described in clause (iv) of subsection (n)(1)(G) of this section. The approval of such an application shall be made effective in accordance with subparagraph (B) except that, if an action for patent infringement is commenced during the one-year period beginning 48 months after the date of the approval of the subsection (b) application, the 30 month period referred to in subparagraph (D)(iii) shall be extended by such amount of time (if any) which is required for seven and one-half years to have elapsed from the date of approval of the subsection (b) application."
  ]
  node [
    id 1862
    label "section_360b_subsection_n_item_1_subitem_H_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) that such patent is invalid or will not be infringed by the manufacture, use, or sale of the new animal drug for which the application is filed; and"
  ]
  node [
    id 1863
    label "section_360b_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) there is in effect an approval of an application pursuant to subsection (m)(1) of this section with respect to such animal feed, and"
  ]
  node [
    id 1864
    label "section_360b_subsection_d_item_1_subitem_C"
    class_name "subitem"
    text "(C) the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug are inadequate to preserve its identity, strength, quality, and purity;"
  ]
  node [
    id 1865
    label "section_360b_subsection_n_item_1_subitem_E"
    class_name "subitem"
    text "(E) information to show that the new animal drug is bioequivalent to the approved new animal drug, except that if the application is filed pursuant to the approval of a petition filed under paragraph (3) for the purposes described in subparagraph (B) or (C), information to show that the active ingredients of the new animal drug are of the same pharmacological or therapeutic class as the pharmacological or therapeutic class of the approved new animal drug and that the new animal drug can be expected to have the same therapeutic effect as the approved new animal drug when used in accordance with the labeling;"
  ]
  node [
    id 1866
    label "section_360b_subsection_d"
    class_name "subsection"
    text "(d) Grounds for refusing application; approval of application; factors; &#8220;substantial evidence&#8221; defined"
  ]
  node [
    id 1867
    label "section_360b_subsection_d_item_1_subitem_I"
    class_name "subitem"
    text "he shall issue an order refusing to approve the application. If, after such notice and opportunity for hearings, the Secretary finds that subparagraphs (A) through (I) do not apply, he shall issue an order approving the application."
  ]
  node [
    id 1868
    label "section_360b_subsection_x_item_2"
    class_name "item"
    text "In such an action, each of the parties shall reasonably cooperate in expediting the action. Until the expiration of 45 days from the date the notice made under subsection (n)(2)(B) of this section is received, no action may be brought under section 2201 of title 28 for a declaratory judgment with respect to the patent. Any action brought under section 2201 of title 28 shall be brought in the judicial district where the defendant has its principal place of business or a regular and established place of business."
  ]
  node [
    id 1869
    label "section_360b_subsection_c_item_2_subitem_iv"
    class_name "subitem"
    text "(iv)(I) if the application is for a drug whose active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed is the same as the active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed of the approved new animal drug referred to in the application, information submitted in the application is insufficient to show that the active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed is the same as that of the approved new animal drug, or"
  ]
  node [
    id 1870
    label "section_360b_subsection_v"
    class_name "subsection"
    text "(v) If an application (including any supplement to a new animal drug application) submitted under subsection (b)(1) of this section for a new animal drug for a food-producing animal use, which includes an active ingredient (including any ester or salt of the active ingredient) which has been the subject of a waiver under subparagraph (B)(iv) is approved after November 16, 1988, and if the application contains reports of clinical or field investigations or human food safety studies (other than bioequivalence or residue studies) essential to the new approval of the application and conducted or sponsored by the applicant, the Secretary may not make the approval of an application (including any supplement to such application) submitted under subsection (b)(2) of this section for the new conditions of approval of such drug in the subsection (b)(1) application effective before the expiration of five years from the date of approval of the application under subsection (b)(1) of this section for such drug. The provisions of this paragraph shall apply only to the first approval for a food-producing animal use for the same applicant after the waiver under subparagraph (B)(iv)."
  ]
  node [
    id 1871
    label "section_360b_subsection_x_subitem_D_subsubitem_iii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) the court grants a preliminary injunction prohibiting the applicant from engaging in the commercial manufacture or sale of the drug until the court decides the issues of patent validity and infringement and if the court decides that such patent is invalid or not infringed, the approval shall be made effective on the date of such court decision."
  ]
  node [
    id 1872
    label "section_360b_subsection_n_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the approved new animal drug has more than one active ingredient, and if one of the active ingredients of the new animal drug is different from one of the active ingredients of the approved new animal drug and the application is filed pursuant to the approval of a petition filed under paragraph (3)&#8212;"
  ]
  node [
    id 1873
    label "section_360b_subsection_x_item_2_subitem_B_subsubitem_iv_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the date the Secretary receives notice from the applicant under the previous application of the first commercial marketing of the drug under the previous application, or"
  ]
  node [
    id 1874
    label "section_360b_subsection_n_item_1_subitem_C"
    class_name "subitem"
    text "(C)(i) if the approved new animal drug is permitted to be used with one or more animal drugs in animal feed, information to show that the proposed uses of the new animal drug with other animal drugs in animal feed are the same as the uses of the approved new animal drug, and"
  ]
  node [
    id 1875
    label "section_360b_subsection_c_item_1"
    class_name "item"
    text "(1) Within one hundred and eighty days after the filing of an application pursuant to subsection (b) of this section, or such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall either (A) issue an order approving the application if he then finds that none of the grounds for denying approval specified in subsection (d) of this section applies, or (B) give the applicant notice of an opportunity for a hearing before the Secretary under subsection (d) of this section on the question whether such application is approvable. If the applicant elects to accept the opportunity for a hearing by written request within thirty days after such notice, such hearing shall commence not more than ninety days after the expiration of such thirty days unless the Secretary and the applicant otherwise agree. Any such hearing shall thereafter be conducted on an expedited basis and the Secretary's order thereon shall be issued within ninety days after the date fixed by the Secretary for filing final briefs."
  ]
  node [
    id 1876
    label "section_360b_subsection_d_item_1_subitem_F"
    class_name "subitem"
    text "(F) upon the basis of the information submitted to him as part of the application or any other information before him with respect to such drug, the tolerance limitation proposed, if any, exceeds that reasonably required to accomplish the physical or other technical effect for which the drug is intended;"
  ]
  node [
    id 1877
    label "section_360b_subsection_n_item_1_subitem_C_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) information to show that other animal drugs proposed for use with the new animal drug in animal feed are the same as the other animal drugs permitted to be used with the approved new animal drug, and"
  ]
  node [
    id 1878
    label "section_360b_subsection_x_item_2_subitem_F_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) An applicant under subsection (b)(1) of this section who comes within the provisions of clause (i) of this subparagraph as a result of an application which seeks approval for a use solely in non-food producing animals, may elect, within 10 days of receiving such approval, to waive clause (i) of this subparagraph, in which event the limitation on approval of applications submitted under subsection (b)(2) of this section set forth in clause (ii) of this subparagraph shall be applicable to the subsection (b)(1) application."
  ]
  node [
    id 1879
    label "section_360b_subsection_k_subsubitem_i"
    class_name "subsubitem"
    text "While approval of an application for a new animal drug is effective, a food shall not, by reason of bearing or containing such drug or any substance formed in or on the food because of its use in accordance with such application (including the conditions and indications of use prescribed pursuant to subsection (i) of this section), be considered adulterated within the meaning of clause (1) of section 342(a) of this title."
  ]
  node [
    id 1880
    label "section_360b_subsection_n_item_4_subitem_B"
    class_name "subitem"
    text "(B) A new animal drug approved for safety and effectiveness before November 16, 1988, or approved for safety and effectiveness under subsection (c) of this section shall, for purposes of this subsection, be considered to have been published under subparagraph (A) on the date of its approval or November 16, 1988, whichever is later."
  ]
  node [
    id 1881
    label "section_360b_subsection_x_item_2_subitem_F_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) If a supplement to an application approved under subsection (b)(1) of this section is approved after November 16, 1988, and the supplement contains reports of new clinical or field investigations (other than bioequivalence or residue studies) and, in the case of food producing animals, human food safety studies (other than bioequivalence or residue studies) essential to the approval of the supplement and conducted or sponsored by the person submitting the supplement, the Secretary may not make the approval of an application submitted under subsection (b)(2) of this section for a change approved in the supplement effective before the expiration of 3 years from the date of the approval of the supplement."
  ]
  node [
    id 1882
    label "section_360b_subsection_j"
    class_name "subsection"
    text "(j) Exemption of drugs for research; discretionary and mandatory conditions"
  ]
  node [
    id 1883
    label "section_360b_subsection_x_subitem_D_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the court decides that such patent is invalid or not infringed, the approval shall be made effective on the date of the court decision,"
  ]
  node [
    id 1884
    label "section_360b_subsection_n_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A)(i) Within 60 days of November 16, 1988, the Secretary shall publish and make available to the public a list in alphabetical order of the official and proprietary name of each new animal drug which has been approved for safety and effectiveness before November 16, 1988."
  ]
  node [
    id 1885
    label "section_360b_subsection_n_item_1_subitem_G"
    class_name "subitem"
    text "(G) the items specified in clauses (B) through (F) of subsection (b)(1) of this section;"
  ]
  node [
    id 1886
    label "section_360b_subsection_v_subitem_H_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "If the approved new animal drug referred to in the application for a new animal drug under subsection (n) of this section is approved for use in more than one animal species, the bioequivalency information described in subclauses (I), (II), and (III) shall be obtained for one species, or if the Secretary deems appropriate based on scientific principles, shall be obtained for more than one species. The Secretary may prescribe the dose to be used in determining bioequivalency under subclause (I), (II), or (III). To assure that the residues of the new animal drug will be consistent with the established tolerances for the approved new animal drug referred to in the application under subsection (b)(2) of this section upon the expiration of the withdrawal period contained in the application for the new animal drug, the Secretary shall require bioequivalency data or residue depletion studies of the new animal drug or such other data or studies as the Secretary considers appropriate based on scientific principles. If the Secretary requires one or more residue studies under the preceding sentence, the Secretary may not require that the assay methodology used to determine the withdrawal period of the new animal drug be more rigorous than the methodology used to determine the withdrawal period for the approved new animal drug referred to in the application. If such studies are required and if the approved new animal drug, referred to in the application for the new animal drug for which such studies are required, is approved for use in more than one animal species, such studies shall be conducted for one species, or if the Secretary deems appropriate based on scientific principles, shall be conducted for more than one species."
  ]
  node [
    id 1887
    label "section_360b_subsection_m_item_5_subitem_B"
    class_name "subitem"
    text "(B) every person required under this subsection to maintain records, and every person in charge or custody thereof, shall, upon request of an officer or employee designated by the Secretary, permit such officer or employee at all reasonable times to have access to and copy and verify such records."
  ]
  node [
    id 1888
    label "section_360b_subsection_n_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) information to show that the active ingredients of the new animal drug are the same as those of the approved new animal drug, and"
  ]
  node [
    id 1889
    label "section_360b_subsection_n_item_1_subitem_H_subsubitem_i"
    class_name "subsubitem"
    text "(i) that such patent information has not been filed,"
  ]
  node [
    id 1890
    label "section_360b_subsection_m_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "Any person may file with the Secretary an application with respect to any intended use or uses of an animal feed bearing or containing a new animal drug. Such person shall submit to the Secretary as part of the application (A) a full statement of the composition of such animal feed, (B) an identification of the regulation or regulations (relating to the new animal drug or drugs to be used in such feed), published pursuant to subsection (i) of this section, on which he relies as a basis for approval of his application with respect to the use of such drug in such feed, (C) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such animal feed, (D) specimens of the labeling proposed to be used for such animal feed, and (E) if so requested by the Secretary, samples of such animal feed or components thereof."
  ]
  node [
    id 1891
    label "section_360b_subsection_v_subitem_G_subsubitem_i"
    class_name "subsubitem"
    text "(i) for the same period as the withdrawal or suspension under subsection (e) of this section or this subparagraph, or"
  ]
  node [
    id 1892
    label "section_360b_subsection_m_item_2_subitem_C"
    class_name "subitem"
    text "(C) that the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such animal feed are inadequate to preserve the identity, strength, quality, and purity of the new animal drug therein; or"
  ]
  node [
    id 1893
    label "section_360b_subsection_n_item_1_subitem_F"
    class_name "subitem"
    text "(F) information to show that the labeling proposed for the new animal drug is the same as the labeling approved for the approved new animal drug except for changes required because of differences approved under a petition filed under paragraph (3), because of a different withdrawal period, or because the new animal drug and the approved new animal drug are produced or distributed by different manufacturers;"
  ]
  node [
    id 1894
    label "section_360b_subsection_a_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "The use of an animal drug that results in residues exceeding a safe level established under clause (i) shall be considered an unsafe use of such drug under paragraph (1). Safe levels may be established under clause (i) either by regulation or order."
  ]
  node [
    id 1895
    label "section_360b_subsection_x"
    class_name "subsection"
    text "(x) the application does not meet any other requirement of subsection (n) of this section; or"
  ]
  node [
    id 1896
    label "section_360b_subsection_a_item_4_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) is by or on the lawful written or oral order of a licensed veterinarian within the context of a veterinarian-client-patient relationship, as defined by the Secretary; and"
  ]
  node [
    id 1897
    label "section_360b_subsection_p_item_1_subitem_C"
    class_name "subitem"
    text "(C) if approval of the application under subsection (c) of this section is withdrawn and all legal appeals have been exhausted,"
  ]
  node [
    id 1898
    label "section_360b_subsection_n_item_1_subitem_I"
    class_name "subitem"
    text "The Secretary may not require that an abbreviated application contain information in addition to that required by subparagraphs (A) through (I)."
  ]
  node [
    id 1899
    label "section_360b_subsection_m_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) that the applicant has failed to establish a system for maintaining required records, or has repeatedly or deliberately failed to maintain such records or to make required reports in accordance with a regulation or order under paragraph (5)(A) of this subsection, or the applicant has refused to permit access to, or copying or verification of, such records as required by subparagraph (B) of such paragraph;"
  ]
  node [
    id 1900
    label "section_360b_subsection_a_item_1_subsubitem_i"
    class_name "subsubitem"
    text "The use of an animal drug that results in residues exceeding a safe level established under clause (i) shall be considered an unsafe use of such drug under paragraph (1). Safe levels may be established under clause (i) either by regulation or order."
  ]
  node [
    id 1901
    label "section_360b_subsection_e_item_1"
    class_name "item"
    text "(1) The Secretary shall, after due notice and opportunity for hearing to the applicant, issue an order withdrawing approval of an application filed pursuant to subsection (b) of this section with respect to any new animal drug if the Secretary finds&#8212;"
  ]
  node [
    id 1902
    label "section_360b_subsection_a_item_3"
    class_name "item"
    text "(3) A new animal drug or an animal feed bearing or containing a new animal drug shall not be deemed unsafe for the purposes of section 351(a)(5) or (6) of this title if such article is for investigational use and conforms to the terms of an exemption in effect with respect thereto under subsection (j) of this section."
  ]
  node [
    id 1903
    label "section_360b_subsection_c_item_2_subitem_iv_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) if the application is for a drug whose active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed is different from that of the approved new animal drug referred to in the application, no petition to file an application for the drug with the different active ingredients, route of administration, dosage form, strength, or use with other animal drugs in animal feed was approved under subsection (n)(3) of this section;"
  ]
  node [
    id 1904
    label "section_360b_subsection_l_item_1"
    class_name "item"
    text "(1) In the case of any new animal drug for which an approval of an application filed pursuant to subsection (b) of this section is in effect, the applicant shall establish and maintain such records, and make such reports to the Secretary, of data relating to experience, including experience with uses authorized under subsection (a)(4)(A) of this section, and other data or information, received or otherwise obtained by such applicant with respect to such drug, or with respect to animal feeds bearing or containing such drug, as the Secretary may by general regulation, or by order with respect to such application, prescribe on the basis of a finding that such records and reports are necessary in order to enable the Secretary to determine, or facilitate a determination, whether there is or may be ground for invoking subsection (e) or subsection (m)(4) of this section. Such regulation or order shall provide, where the Secretary deems it to be appropriate, for the examination, upon request, by the persons to whom such regulation or order is applicable, of similar information received or otherwise obtained by the Secretary."
  ]
  node [
    id 1905
    label "section_360b_subsection_n_item_5"
    class_name "item"
    text "(5) If an application contains the information required by clauses (A), (G), and (H) of subsection (b)(1) of this section and such information&#8212;"
  ]
  node [
    id 1906
    label "section_360b_subsection_n_item_1_subitem_C_subsubitem_ii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) such other information respecting the different animal drug or combination with respect to which the petition was filed as the Secretary may require,"
  ]
  node [
    id 1907
    label "section_360b_subsection_v_item_2"
    class_name "item"
    text "If the approved new animal drug referred to in the application for a new animal drug under subsection (n) of this section is approved for use in more than one animal species, the bioequivalency information described in subclauses (I), (II), and (III) shall be obtained for one species, or if the Secretary deems appropriate based on scientific principles, shall be obtained for more than one species. The Secretary may prescribe the dose to be used in determining bioequivalency under subclause (I), (II), or (III). To assure that the residues of the new animal drug will be consistent with the established tolerances for the approved new animal drug referred to in the application under subsection (b)(2) of this section upon the expiration of the withdrawal period contained in the application for the new animal drug, the Secretary shall require bioequivalency data or residue depletion studies of the new animal drug or such other data or studies as the Secretary considers appropriate based on scientific principles. If the Secretary requires one or more residue studies under the preceding sentence, the Secretary may not require that the assay methodology used to determine the withdrawal period of the new animal drug be more rigorous than the methodology used to determine the withdrawal period for the approved new animal drug referred to in the application. If such studies are required and if the approved new animal drug, referred to in the application for the new animal drug for which such studies are required, is approved for use in more than one animal species, such studies shall be conducted for one species, or if the Secretary deems appropriate based on scientific principles, shall be conducted for more than one species."
  ]
  node [
    id 1908
    label "section_360b_subsection_m_item_2_subitem_B"
    class_name "subitem"
    text "(B) that such animal feed (including the proposed use of any new animal drug therein or thereon) does not conform to an applicable regulation published pursuant to subsection (i) of this section referred to in the application, or that the purposes and conditions or indications of use prescribed, recommended, or suggested in the labeling of such feed do not conform to the applicable purposes and conditions or indications of use (including warnings) published pursuant to subsection (i) of this section or such labeling omits or fails to conform to other applicable information published pursuant to subsection (i) of this section;"
  ]
  node [
    id 1909
    label "section_360b_subsection_n_item_4_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) for the same period as the withdrawal or suspension under subsection (c)(2)(G) or (e) of this section, or"
  ]
  node [
    id 1910
    label "section_360b_subsection_d_item_3"
    class_name "item"
    text "(3) As used in this subsection and subsection (e) of this section, the term &#8220;substantial evidence&#8221; means evidence consisting of adequate and well-controlled investigations, including field investigation, by experts qualified by scientific training and experience to evaluate the effectiveness of the drug involved, on the basis of which it could fairly and reasonably be concluded by such experts that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling or proposed labeling thereof."
  ]
  node [
    id 1911
    label "section_360b_subsection_p_item_1"
    class_name "item"
    text "(1) Safety and effectiveness data and information which has been submitted in an application filed under subsection (b)(1) of this section for a drug and which has not previously been disclosed to the public shall be made available to the public, upon request, unless extraordinary circumstances are shown&#8212;"
  ]
  node [
    id 1912
    label "section_360b_subsection_x_subitem_D_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) If the applicant made a certification described in clause (iv) of subsection (n)(1)(G) of this section, the approval shall be made effective immediately unless an action is brought for infringement of a patent which is the subject of the certification before the expiration of 45 days from the date the notice provided under subsection (n)(2)(B)(i) of this section is received. If such an action is brought before the expiration of such days, the approval shall be made effective upon the expiration of the 30 month period beginning on the date of the receipt of the notice provided under subsection (n)(2)(B) of this section or such shorter or longer period as the court may order because either party to the action failed to reasonably cooperate in expediting the action, except that if before the expiration of such period&#8212;"
  ]
  node [
    id 1913
    label "section_360b_subsection_d_item_1_subitem_H"
    class_name "subitem"
    text "(H) based on a fair evaluation of all material facts, such labeling is false or misleading in any particular; or"
  ]
  node [
    id 1914
    label "section_360b_subsection_p_item_1_subitem_A"
    class_name "subitem"
    text "(A) if no work is being or will be undertaken to have the application approved,"
  ]
  node [
    id 1915
    label "section_360b_subsection_n_item_1_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the approved new animal drug is permitted to be used with one or more other animal drugs in animal feed, and one of the other animal drugs proposed for use with the new animal drug in animal feed is different from one of the other animal drugs permitted to be used in animal feed with the approved new animal drug, and the application is filed pursuant to the approval of a petition filed under paragraph (3)&#8212;"
  ]
  node [
    id 1916
    label "section_360b_subsection_n_item_1_subitem_B_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) information to show either that the different active ingredient is an active ingredient of another approved new animal drug or of an animal drug which does not meet the requirements of section 321(v) of this title, and"
  ]
  node [
    id 1917
    label "section_360b_subsection_f"
    class_name "subsection"
    text "(f) Revocation of order refusing, withdrawing or suspending approval of application"
  ]
  node [
    id 1918
    label "section_360b_subsection_i_subsubitem_i"
    class_name "subsubitem"
    text "When a new animal drug application filed pursuant to subsection (b) of this section is approved, the Secretary shall by notice, which upon publication shall be effective as a regulation, publish in the Federal Register the name and address of the applicant and the conditions and indications of use of the new animal drug covered by such application, including any tolerance and withdrawal period or other use restrictions and, if such new animal drug is intended for use in animal feed, appropriate purposes and conditions of use (including special labeling requirements) applicable to any animal feed for use in which such drug is approved, and such other information, upon the basis of which such application was approved, as the Secretary deems necessary to assure the safe and effective use of such drug. Upon withdrawal of approval of such new animal drug application or upon its suspension, the Secretary shall forthwith revoke or suspend, as the case may be, the regulation published pursuant to this subsection (i) insofar as it is based on the approval of such application."
  ]
  node [
    id 1919
    label "section_360b_subsection_k_item_1"
    class_name "item"
    text "While approval of an application for a new animal drug is effective, a food shall not, by reason of bearing or containing such drug or any substance formed in or on the food because of its use in accordance with such application (including the conditions and indications of use prescribed pursuant to subsection (i) of this section), be considered adulterated within the meaning of clause (1) of section 342(a) of this title."
  ]
  node [
    id 1920
    label "section_360b_subsection_m_item_4_subitem_A"
    class_name "subitem"
    text "(A) The Secretary shall, after due notice and opportunity for hearing to the applicant, issue an order withdrawing approval of an application with respect to any animal feed under this subsection if the Secretary finds&#8212;"
  ]
  node [
    id 1921
    label "section_360b_subsection_n_item_1_subitem_B_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) information to show that the other active ingredients of the new animal drug are the same as the active ingredients of the approved new animal drug,"
  ]
  node [
    id 1922
    label "section_360b_subsection_n_item_1_subitem_H_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) of the date on which such patent will expire, or"
  ]
  node [
    id 1923
    label "section_360b_subsection_n_item_4"
    class_name "item"
    text "(4)(A)(i) Within 60 days of November 16, 1988, the Secretary shall publish and make available to the public a list in alphabetical order of the official and proprietary name of each new animal drug which has been approved for safety and effectiveness before November 16, 1988."
  ]
  node [
    id 1924
    label "section_360b_subsection_a_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) require the development of a practical, analytical method for the detection of residues of such drug above the safe level established under clause (i)."
  ]
  node [
    id 1925
    label "section_360b_subsection_n_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) each owner of the patent which is the subject of the certification or the representative of such owner designated to receive such notice, and"
  ]
  node [
    id 1926
    label "section_360b_subsection_v_subitem_H_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "If the approved new animal drug referred to in the application for a new animal drug under subsection (n) of this section is approved for use in more than one animal species, the bioequivalency information described in subclauses (I), (II), and (III) shall be obtained for one species, or if the Secretary deems appropriate based on scientific principles, shall be obtained for more than one species. The Secretary may prescribe the dose to be used in determining bioequivalency under subclause (I), (II), or (III). To assure that the residues of the new animal drug will be consistent with the established tolerances for the approved new animal drug referred to in the application under subsection (b)(2) of this section upon the expiration of the withdrawal period contained in the application for the new animal drug, the Secretary shall require bioequivalency data or residue depletion studies of the new animal drug or such other data or studies as the Secretary considers appropriate based on scientific principles. If the Secretary requires one or more residue studies under the preceding sentence, the Secretary may not require that the assay methodology used to determine the withdrawal period of the new animal drug be more rigorous than the methodology used to determine the withdrawal period for the approved new animal drug referred to in the application. If such studies are required and if the approved new animal drug, referred to in the application for the new animal drug for which such studies are required, is approved for use in more than one animal species, such studies shall be conducted for one species, or if the Secretary deems appropriate based on scientific principles, shall be conducted for more than one species."
  ]
  node [
    id 1927
    label "section_360b_subsection_m_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) that the applicant has made any changes from the standpoint of safety or effectiveness beyond the variations provided for in the application unless he has supplemented the application by filing with the Secretary adequate information respecting all such changes and unless there is in effect an approval of the supplemental application. The supplemental application shall be treated in the same manner as the original application."
  ]
  node [
    id 1928
    label "section_360b_subsection_n_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Every 30 days after the publication of the first list under clause (i) the Secretary shall revise the list to include each new animal drug which has been approved for safety and effectiveness under subsection (c) of this section during the 30 day period."
  ]
  node [
    id 1929
    label "section_360b_subsection_m_item_1"
    class_name "item"
    text "Within ninety days after the filing of an application pursuant to paragraph (1) of this subsection, or such additional period as may be agreed upon by the Secretary and the applicant, the Secretary shall either (A) issue an order approving the application if he then finds that none of the grounds for denying approval specified in paragraph (3) applies, or (B) give the applicant notice of an opportunity for a hearing before the Secretary under paragraph (3) on the question whether such application is approvable. The procedure governing such a hearing shall be the procedure set forth in the last two sentences of subsection (c) of this section."
  ]
  node [
    id 1930
    label "section_360b_subsection_b_item_1"
    class_name "item"
    text "(1) Any person may file with the Secretary an application with respect to any intended use or uses of a new animal drug. Such person shall submit to the Secretary as a part of the application (A) full reports of investigations which have been made to show whether or not such drug is safe and effective for use; (B) a full list of the articles used as components of such drug; (C) a full statement of the composition of such drug; (D) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such drug; (E) such samples of such drug and of the articles used as components thereof, of any animal feed for use in or on which such drug is intended, and of the edible portions or products (before or after slaughter) of animals to which such drug (directly or in or on animal feed) is intended to be administered, as the Secretary may require; (F) specimens of the labeling proposed to be used for such drug, or in case such drug is intended for use in animal feed, proposed labeling appropriate for such use, and specimens of the labeling for the drug to be manufactured, packed, or distributed by the applicant; (G) a description of practicable methods for determining the quantity, if any, of such drug in or on food, and any substance formed in or on food, because of its use; and (H) the proposed tolerance or withdrawal period or other use restrictions for such drug if any tolerance or withdrawal period or other use restrictions are required in order to assure that the proposed use of such drug will be safe. The applicant shall file with the application the patent number and the expiration date of any patent which claims the new animal drug for which the applicant filed the application or which claims a method of using such drug and with respect to which a claim of patent infringement could reasonably be asserted if a person not licensed by the owner engaged in the manufacture, use, or sale of the drug. If an application is filed under this subsection for a drug and a patent which claims such drug or a method of using such drug is issued after the filing date but before approval of the application, the applicant shall amend the application to include the information required by the preceding sentence. Upon approval of the application, the Secretary shall publish information submitted under the two preceding sentences."
  ]
  node [
    id 1931
    label "section_360b_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) the results of such tests show that such drug is unsafe for use under such conditions or do not show that such drug is safe for use under such conditions;"
  ]
  node [
    id 1932
    label "section_360b_subsection_n_item_5_subitem_B"
    class_name "subitem"
    text "(B) is not information derived either from investigations, studies, or tests conducted by or for the applicant or for which the applicant had obtained a right of reference or use from the person by or for whom the investigations, studies, or tests were conducted,"
  ]
  node [
    id 1933
    label "section_360b_subsection_x_item_2_subitem_F_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If an application submitted under subsection (b)(1) of this section for a drug, which includes an active ingredient (including any ester or salt of the active ingredient) that has been approved in another application approved under such subsection, is approved after November 16, 1988, and if such application contains reports of new clinical or field investigations (other than bioequivalence or residue studies) and, in the case of food producing animals, human food safety studies (other than bioequivalence or residue studies) essential to the approval of the application and conducted or sponsored by the applicant, the Secretary may not make the approval of an application submitted under subsection (b)(2) of this section for the conditions of approval of such drug in the subsection (b)(1) application effective before the expiration of 3 years from the date of the approval of the application under subsection (b)(1) of this section for such drug."
  ]
  node [
    id 1934
    label "section_360b_subsection_g_item_1"
    class_name "item"
    text "Orders of the Secretary issued under this section (other than orders issuing, amending, or repealing regulations) shall be served (1) in person by any officer or employee of the department designated by the Secretary or (2) by mailing the order by registered mail or by certified mail addressed to the applicant or respondent at his last known address in the records of the Secretary."
  ]
  node [
    id 1935
    label "section_360b_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) that new evidence not contained in such application or not available to the Secretary until after such application was approved, or tests by new methods, or tests by methods not deemed reasonably applicable when such application was approved, evaluated together with the evidence available to the Secretary when the application was approved, shows that such drug is not shown to be safe for use under the conditions of use upon the basis of which the application was approved or that subparagraph (I) of paragraph (1) of subsection (d) of this section applies to such drug;"
  ]
  node [
    id 1936
    label "section_360b_subsection_m_item_1_subitem_D"
    class_name "subitem"
    text "Any person may file with the Secretary an application with respect to any intended use or uses of an animal feed bearing or containing a new animal drug. Such person shall submit to the Secretary as part of the application (A) a full statement of the composition of such animal feed, (B) an identification of the regulation or regulations (relating to the new animal drug or drugs to be used in such feed), published pursuant to subsection (i) of this section, on which he relies as a basis for approval of his application with respect to the use of such drug in such feed, (C) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of such animal feed, (D) specimens of the labeling proposed to be used for such animal feed, and (E) if so requested by the Secretary, samples of such animal feed or components thereof."
  ]
  node [
    id 1937
    label "section_360b_subsection_v_item_2_subitem_G"
    class_name "subitem"
    text "(ix) the approval under subsection (b)(1) of this section of the approved new animal drug referred to in the application filed under subsection (b)(2) of this section has been withdrawn or suspended for grounds described in paragraph (1) of subsection (e) of this section, the Secretary has published a notice of a hearing to withdraw approval of the approved new animal drug for such grounds, the approval under this paragraph of the new animal drug for which the application under subsection (b)(2) of this section was filed has been withdrawn or suspended under subparagraph (G) for such grounds, or the Secretary has determined that the approved new animal drug has been withdrawn from sale for safety or effectiveness reasons;"
  ]
  node [
    id 1938
    label "section_360b_subsection_d_item_1_subitem_D"
    class_name "subitem"
    text "(D) upon the basis of the information submitted to him as part of the application, or upon the basis of any other information before him with respect to such drug, he has insufficient information to determine whether such drug is safe for use under such conditions;"
  ]
  node [
    id 1939
    label "section_360b_subsection_d_item_1_subitem_G"
    class_name "subitem"
    text "(G) the application failed to contain the patent information prescribed by subsection (b)(1) of this section;"
  ]
  node [
    id 1940
    label "section_360b_subsection_m_item_4_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) that on the basis of new information before him, evaluated together with the evidence before him when the application was approved, the labeling of such animal feed, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary specifying the matter complained of."
  ]
  node [
    id 1941
    label "section_360b_subsection_l"
    class_name "subsection"
    text "(l) Records and reports; required information; regulations and orders; examination of data; access to records"
  ]
  node [
    id 1942
    label "section_360b_subsection_c_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the conditions of use prescribed, recommended, or suggested in the proposed labeling are not reasonably certain to be followed in practice or, except as provided in subparagraph (B), information submitted with the application is insufficient to show that each of the proposed conditions of use or similar limitations (whether in the labeling or published pursuant to subsection (i) of this section) have been previously approved for the approved new animal drug referred to in the application;"
  ]
  node [
    id 1943
    label "section_360b_subsection_e_item_1_subitem_C"
    class_name "subitem"
    text "(C) on the basis of new information before him with respect to such drug, evaluated together with the evidence available to him when the application was approved, that there is a lack of substantial evidence that such drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling thereof;"
  ]
  node [
    id 1944
    label "section_360b_subsection_c_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) the methods used in, or the facilities and controls used for, the manufacture, processing, and packing of the drug are inadequate to assure and preserve its identity, strength, quality, and purity;"
  ]
  node [
    id 1945
    label "section_360b_subsection_h"
    class_name "subsection"
    text "(h) Appeal from order"
  ]
  node [
    id 1946
    label "section_360b_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) there is in effect an approval of an application filed pursuant to subsection (b) of this section with respect to such drugs, as used in such animal feed,"
  ]
  node [
    id 1947
    label "section_360b_subsection_a_item_5"
    class_name "item"
    text "(5) If the approval of an application filed under section 355 of this title is in effect, the drug under such application shall not be deemed unsafe for purposes of paragraph (1) and shall be exempt from the requirements of section 352(f) of this title with respect to a use or intended use of the drug in animals if such use or intended use&#8212;"
  ]
  node [
    id 1948
    label "section_360b_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(A) that experience or scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved or the condition of use authorized under subsection (a)(4)(A) of this section;"
  ]
  node [
    id 1949
    label "section_360b_subsection_v_subitem_H_subsubitem_ii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "If the approved new animal drug referred to in the application for a new animal drug under subsection (n) of this section is approved for use in more than one animal species, the bioequivalency information described in subclauses (I), (II), and (III) shall be obtained for one species, or if the Secretary deems appropriate based on scientific principles, shall be obtained for more than one species. The Secretary may prescribe the dose to be used in determining bioequivalency under subclause (I), (II), or (III). To assure that the residues of the new animal drug will be consistent with the established tolerances for the approved new animal drug referred to in the application under subsection (b)(2) of this section upon the expiration of the withdrawal period contained in the application for the new animal drug, the Secretary shall require bioequivalency data or residue depletion studies of the new animal drug or such other data or studies as the Secretary considers appropriate based on scientific principles. If the Secretary requires one or more residue studies under the preceding sentence, the Secretary may not require that the assay methodology used to determine the withdrawal period of the new animal drug be more rigorous than the methodology used to determine the withdrawal period for the approved new animal drug referred to in the application. If such studies are required and if the approved new animal drug, referred to in the application for the new animal drug for which such studies are required, is approved for use in more than one animal species, such studies shall be conducted for one species, or if the Secretary deems appropriate based on scientific principles, shall be conducted for more than one species."
  ]
  node [
    id 1950
    label "section_360c_subsection_f_item_1"
    class_name "item"
    text "(1) Any device intended for human use which was not introduced or delivered for introduction into interstate commerce for commercial distribution before May 28, 1976, is classified in class III unless&#8212;"
  ]
  node [
    id 1951
    label "section_360c_subsection_i_item_1"
    class_name "item"
    text "(1)(A) For purposes of determinations of substantial equivalence under subsection (f) of this section and section 360j(l) of this title, the term &#8220;substantially equivalent&#8221; or &#8220;substantial equivalence&#8221; means, with respect to a device being compared to a predicate device, that the device has the same intended use as the predicate device and that the Secretary by order has found that the device&#8212;"
  ]
  node [
    id 1952
    label "section_360c_subsection_a_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "is to be regulated by the controls referred to in clause (i)."
  ]
  node [
    id 1953
    label "section_360c_subsection_b_item_1"
    class_name "item"
    text "(1) For purposes of&#8212;"
  ]
  node [
    id 1954
    label "section_360c_subsection_c_item_2"
    class_name "item"
    text "(2)(A) Upon completion of a panel's review of a device referred to it under paragraph (1), the panel shall, subject to subparagraphs (B) and (C), submit to the Secretary its recommendation for the classification of the device. Any such recommendation shall (i) contain (I) a summary of the reasons for the recommendation, (II) a summary of the data upon which the recommendation is based, and (III) an identification of the risks to health (if any) presented by the device with respect to which the recommendation is made, and (ii) to the extent practicable, include a recommendation for the assignment of a priority for the application of the requirements of section 360d or 360e of this title to a device recommended to be classified in class II or class III."
  ]
  node [
    id 1955
    label "section_360c_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Upon completion of a panel's review of a device referred to it under paragraph (1), the panel shall, subject to subparagraphs (B) and (C), submit to the Secretary its recommendation for the classification of the device. Any such recommendation shall (i) contain (I) a summary of the reasons for the recommendation, (II) a summary of the data upon which the recommendation is based, and (III) an identification of the risks to health (if any) presented by the device with respect to which the recommendation is made, and (ii) to the extent practicable, include a recommendation for the assignment of a priority for the application of the requirements of section 360d or 360e of this title to a device recommended to be classified in class II or class III."
  ]
  node [
    id 1956
    label "section_360c_subsection_b_item_3"
    class_name "item"
    text "(3) Panel members (other than officers or employees of the United States), while attending meetings or conferences of a panel or otherwise engaged in its business, shall be entitled to receive compensation at rates to be fixed by the Secretary, but not at rates exceeding the daily equivalent of the rate in effect for grade GS&#8211;18 of the General Schedule, for each day so engaged, including traveltime; and while so serving away from their homes or regular places of business each member may be allowed travel expenses (including per diem in lieu of subsistence) as authorized by section 5703 of title 5, for persons in the Government service employed intermittently."
  ]
  node [
    id 1957
    label "section_360c_subsection_d_item_2_subitem_B"
    class_name "subitem"
    text "(B) A device described in subsection (c)(2)(C) of this section shall be classified in class III unless the Secretary determines that classification of the device in such class is not necessary to provide reasonable assurance of its safety and effectiveness. A proposed regulation under paragraph (1) classifying such a device in a class other than class III shall be accompanied by a full statement of the reasons of the Secretary (and supporting documentation and data) for not classifying such device in such class and an identification of the risks to health (if any) presented by such device."
  ]
  node [
    id 1958
    label "section_360c_subsection_i_subitem_B"
    class_name "subitem"
    text "(B) For purposes of subparagraph (A), the term &#8220;different technological characteristics&#8221; means, with respect to a device being compared to a predicate device, that there is a significant change in the materials, design, energy source, or other features of the device from those of the predicate device."
  ]
  node [
    id 1959
    label "section_360c_subsection_d_item_1"
    class_name "item"
    text "(1) Upon receipt of a recommendation from a panel respecting a device, the Secretary shall publish in the Federal Register the panel's recommendation and a proposed regulation classifying such device and shall provide interested persons an opportunity to submit comments on such recommendation and the proposed regulation. After reviewing such comments, the Secretary shall, subject to paragraph (2), by regulation classify such device."
  ]
  node [
    id 1960
    label "section_360c_subsection_f_item_3_subitem_B"
    class_name "subitem"
    text "(B) which was introduced or delivered for introduction into interstate commerce for commercial distribution before December 1, 1990, and"
  ]
  node [
    id 1961
    label "section_360c_subsection_e"
    class_name "subsection"
    text "(e) Classification changes"
  ]
  node [
    id 1962
    label "section_360c_subsection_h_item_1"
    class_name "item"
    text "(1) a reference to &#8220;general controls&#8221; is a reference to the controls authorized by or under sections 351, 352, 360, 360f, 360h, 360i, and 360j of this title,"
  ]
  node [
    id 1963
    label "section_360c_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(A) the device&#8212;"
  ]
  node [
    id 1964
    label "section_360c_subsection_a_item_1"
    class_name "item"
    text "(1) There are established the following classes of devices intended for human use:"
  ]
  node [
    id 1965
    label "section_360c_subsection_i_item_3"
    class_name "item"
    text "(3)(A) As part of a submission under section 360(k) of this title respecting a device, the person required to file a premarket notification under such section shall provide an adequate summary of any information respecting safety and effectiveness or state that such information will be made available upon request by any person."
  ]
  node [
    id 1966
    label "section_360c_subsection_g"
    class_name "subsection"
    text "(g) Information"
  ]
  node [
    id 1967
    label "section_360c_subsection_e_item_2_subitem_A"
    class_name "subitem"
    text "(A) to class II if the Secretary determines that special controls would provide reasonable assurance of the safety and effectiveness of the device and that general controls would not provide reasonable assurance of the safety and effectiveness of the device, or"
  ]
  node [
    id 1968
    label "section_360c_subsection_b_item_2"
    class_name "item"
    text "(2) The Secretary shall appoint to each panel established under paragraph (1) persons who are qualified by training and experience to evaluate the safety and effectiveness of the devices to be referred to the panel and who, to the extent feasible, possess skill in the use of, or experience in the development, manufacture, or utilization of, such devices. The Secretary shall make appointments to each panel so that each panel shall consist of members with adequately diversified expertise in such fields as clinical and administrative medicine, engineering, biological and physical sciences, and other related professions. In addition, each panel shall include as nonvoting members a representative of consumer interests and a representative of interests of the device manufacturing industry. Scientific, trade, and consumer organizations shall be afforded an opportunity to nominate individuals for appointment to the panels. No individual who is in the regular full-time employ of the United States and engaged in the administration of this chapter may be a member of any panel. The Secretary shall designate one of the members of each panel to serve as chairman thereof."
  ]
  node [
    id 1969
    label "section_360c_subsection_i_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) For purposes of determinations of substantial equivalence under subsection (f) of this section and section 360j(l) of this title, the term &#8220;substantially equivalent&#8221; or &#8220;substantial equivalence&#8221; means, with respect to a device being compared to a predicate device, that the device has the same intended use as the predicate device and that the Secretary by order has found that the device&#8212;"
  ]
  node [
    id 1970
    label "section_360c_subsection_d_item_3"
    class_name "item"
    text "(3) In the case of devices classified in class II and devices classified under this subsection in class III and described in section 360e(b)(1) of this title the Secretary may establish priorities which, in his discretion, shall be used in applying sections 360d and 360e of this title, as appropriate, to such devices."
  ]
  node [
    id 1971
    label "section_360c_subsection_c"
    class_name "subsection"
    text "(c) Classification panel organization and operation"
  ]
  node [
    id 1972
    label "section_360c_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) providing notice to the manufacturers and importers of such devices to enable them to prepare for the application of such requirements to devices manufactured or imported by them,"
  ]
  node [
    id 1973
    label "section_360c_subsection_i_subitem_ii"
    class_name "subitem"
    text "(ii)(I) has different technological characteristics and the information submitted that the device is substantially equivalent to the predicate device contains information, including clinical data if deemed necessary by the Secretary, that demonstrates that the device is as safe and effective as a legally marketed device, and (II) does not raise different questions of safety and efficacy than the predicate device."
  ]
  node [
    id 1974
    label "section_360c_subsection_h_item_2"
    class_name "item"
    text "(2) a reference to &#8220;class I&#8221;, &#8220;class II&#8221;, or &#8220;class III&#8221; is a reference to a class of medical devices described in subparagraph (A), (B), or (C) of subsection (a)(1) of this section, and"
  ]
  node [
    id 1975
    label "section_360c_subsection_f_item_2"
    class_name "item"
    text "(2)(A) The Secretary may initiate the reclassification of a device classified into class III under paragraph (1) of this subsection or the manufacturer or importer of a device classified under paragraph (1) may petition the Secretary (in such form and manner as he shall prescribe) for the issuance of an order classifying the device in class I or class II. Within thirty days of the filing of such a petition, the Secretary shall notify the petitioner of any deficiencies in the petition which prevent the Secretary from making a decision on the petition."
  ]
  node [
    id 1976
    label "section_360c_subsection_f_item_2_subitem_C"
    class_name "subitem"
    text "(C)(i) Within ninety days from the date the Secretary receives the recommendation of a panel respecting a petition (but not later than 210 days after the filing of such petition) the Secretary shall by order deny or approve the petition. If the Secretary approves the petition, the Secretary shall order the classification of the device into class I or class II in accordance with the criteria prescribed by subsection (a)(1)(A) or (a)(1)(B) of this section. In the case of a petition for a device which is intended to be implanted in the human body or which is purported or represented to be for a use in supporting or sustaining human life, the Secretary shall deny the petition unless the Secretary determines that the classification in class III of the device is not necessary to provide reasonable assurance of its safety and effectiveness. An order approving such petition shall be accompanied by a full statement of the reasons of the Secretary (and supporting documentation and data) for approving the petition and an identification of the risks to health (if any) presented by the device to which such order applies."
  ]
  node [
    id 1977
    label "section_360c_subsection_i_subitem_ii_subsubitem_I"
    class_name "subsubitem"
    text "(ii)(I) has different technological characteristics and the information submitted that the device is substantially equivalent to the predicate device contains information, including clinical data if deemed necessary by the Secretary, that demonstrates that the device is as safe and effective as a legally marketed device, and (II) does not raise different questions of safety and efficacy than the predicate device."
  ]
  node [
    id 1978
    label "section_360c_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) the Secretary in response to a petition submitted under paragraph (2) has classified such device in class I or II."
  ]
  node [
    id 1979
    label "section_360c_subsection_i"
    class_name "subsection"
    text "(i) has the same technological characteristics as the predicate device, or"
  ]
  node [
    id 1980
    label "section_360c_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) Class I, General Controls.&#8212;"
  ]
  node [
    id 1981
    label "section_360c_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) Class II, Special Controls.&#8212;A device which cannot be classified as a class I device because the general controls by themselves are insufficient to provide reasonable assurance of the safety and effectiveness of the device, and for which there is sufficient information to establish special controls to provide such assurance, including the promulgation of performance standards, postmarket surveillance, patient registries, development and dissemination of guidelines (including guidelines for the submission of clinical data in premarket notification submissions in accordance with section 360(k) of this title), recommendations, and other appropriate actions as the Secretary deems necessary to provide such assurance. For a device that is purported or represented to be for a use in supporting or sustaining human life, the Secretary shall examine and identify the special controls, if any, that are necessary to provide adequate assurance of safety and effectiveness and describe how such controls provide such assurance."
  ]
  node [
    id 1982
    label "section_360c_subsection_i_item_3_subitem_B"
    class_name "subitem"
    text "(B) Any summary under subparagraph (A) respecting a device shall contain detailed information regarding data concerning adverse health effects and shall be made available to the public by the Secretary within 30 days of the issuance of a determination that such device is substantially equivalent to another device."
  ]
  node [
    id 1983
    label "section_360c_subsection_e_item_2_subitem_B"
    class_name "subitem"
    text "(B) to class I if the Secretary determines that general controls would provide reasonable assurance of the safety and effectiveness of the device."
  ]
  node [
    id 1984
    label "section_360c_subsection_i_item_3_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) from which it can fairly and responsibly be concluded by qualified experts that the device will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the labeling of the device,"
  ]
  node [
    id 1985
    label "section_360c_subsection_i_item_2"
    class_name "item"
    text "(2) A device may not be found to be substantially equivalent to a predicate device that has been removed from the market at the initiative of the Secretary or that has been determined to be misbranded or adulterated by a judicial order."
  ]
  node [
    id 1986
    label "section_360c_subsection_a_item_1_subitem_C"
    class_name "subitem"
    text "(C) Class III, Premarket Approval.&#8212;A device which because&#8212;"
  ]
  node [
    id 1987
    label "section_360c_subsection_d_item_2"
    class_name "item"
    text "(2)(A) A regulation under paragraph (1) classifying a device in class I shall prescribe which, if any, of the requirements of section 360, 360i, or 360j(f) of this title shall not apply to the device. A regulation which makes a requirement of section 360, 360i, or 360j(f) of this title inapplicable to a device shall be accompanied by a statement of the reasons of the Secretary for making such requirement inapplicable."
  ]
  node [
    id 1988
    label "section_360c_subsection_f_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) The requirements of paragraphs (1) and (2) of subsection (c) of this section (relating to opportunities for submission of data and views and recommendations respecting priorities and exemptions from sections 360, 360i, and 360j(f) of this title) shall apply with respect to consideration by panels of petitions submitted under subparagraph (A)."
  ]
  node [
    id 1989
    label "section_360c_subsection_f_item_2_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) The requirements of paragraphs (1) and (2)(A) of subsection (d) of this section (relating to publication of recommendations, opportunity for submission of comments, and exemption from sections 360, 360i, and 360j(f) of this title) shall apply with respect to action by the Secretary on petitions submitted under subparagraph (A)."
  ]
  node [
    id 1990
    label "section_360c_subsection_f_item_3_subitem_C"
    class_name "subitem"
    text "(C) for which no final regulation requiring premarket approval has been promulgated under section 360e(b) of this title,"
  ]
  node [
    id 1991
    label "section_360c_subsection_i_subitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) is within a type of device which was so introduced or delivered before such date and is substantially equivalent to another device within that type,"
  ]
  node [
    id 1992
    label "section_360c_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) determining which devices intended for human use should be subject to the requirements of general controls, performance standards, or premarket approval, and"
  ]
  node [
    id 1993
    label "section_360c_subsection_h_item_3"
    class_name "item"
    text "(3) a reference to a &#8220;panel under section 360c of this title&#8221; is a reference to a panel established or authorized to be used under this section."
  ]
  node [
    id 1994
    label "section_360c_subsection_d_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) A regulation under paragraph (1) classifying a device in class I shall prescribe which, if any, of the requirements of section 360, 360i, or 360j(f) of this title shall not apply to the device. A regulation which makes a requirement of section 360, 360i, or 360j(f) of this title inapplicable to a device shall be accompanied by a statement of the reasons of the Secretary for making such requirement inapplicable."
  ]
  node [
    id 1995
    label "section_360c_subsection_f_item_3_subitem_A"
    class_name "subitem"
    text "(A) which the Secretary has classified as a class III device under subsection (b) of this section,"
  ]
  node [
    id 1996
    label "section_360c_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) A recommendation of a panel for the classification of a device in class I shall include a recommendation as to whether the device should be exempted from the requirements of section 360, 360i, or 360j(f) of this title."
  ]
  node [
    id 1997
    label "section_360c_subsection_i_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) As part of a submission under section 360(k) of this title respecting a device, the person required to file a premarket notification under such section shall provide an adequate summary of any information respecting safety and effectiveness or state that such information will be made available upon request by any person."
  ]
  node [
    id 1998
    label "section_360c_subsection_h"
    class_name "subsection"
    text "(h) Definitions"
  ]
  node [
    id 1999
    label "section_360c_subsection_f_item_2_subitem_B"
    class_name "subitem"
    text "(B)(i) Upon determining that a petition does not contain any deficiency which prevents the Secretary from making a decision on the petition, the Secretary may for good cause shown refer the petition to an appropriate panel established or authorized to be used under subsection (b) of this section. A panel to which such a petition has been referred shall not later than ninety days after the referral of the petition make a recommendation to the Secretary respecting approval or denial of the petition. Any such recommendation shall contain (I) a summary of the reasons for the recommendation, (II) a summary of the data upon which the recommendation is based, and (III) an identification of the risks to health (if any) presented by the device with respect to which the petition was filed. In the case of a petition for a device which is intended to be implanted in the human body or which is purported or represented to be for a use in supporting or sustaining human life, the panel shall recommend that the petition be denied unless the panel determines that the classification in class III of the device is not necessary to provide reasonable assurance of its safety and effectiveness. If the panel recommends that such petition be approved, it shall in its recommendation to the Secretary set forth its reasons for such recommendation."
  ]
  node [
    id 2000
    label "section_360c_subsection_f_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) Upon determining that a petition does not contain any deficiency which prevents the Secretary from making a decision on the petition, the Secretary may for good cause shown refer the petition to an appropriate panel established or authorized to be used under subsection (b) of this section. A panel to which such a petition has been referred shall not later than ninety days after the referral of the petition make a recommendation to the Secretary respecting approval or denial of the petition. Any such recommendation shall contain (I) a summary of the reasons for the recommendation, (II) a summary of the data upon which the recommendation is based, and (III) an identification of the risks to health (if any) presented by the device with respect to which the petition was filed. In the case of a petition for a device which is intended to be implanted in the human body or which is purported or represented to be for a use in supporting or sustaining human life, the panel shall recommend that the petition be denied unless the panel determines that the classification in class III of the device is not necessary to provide reasonable assurance of its safety and effectiveness. If the panel recommends that such petition be approved, it shall in its recommendation to the Secretary set forth its reasons for such recommendation."
  ]
  node [
    id 2001
    label "section_360c_subsection_c_item_1"
    class_name "item"
    text "(1) The Secretary shall organize the panels according to the various fields of clinical medicine and fundamental sciences in which devices intended for human use are used. The Secretary shall refer a device to be classified under this section to an appropriate panel established or authorized to be used under subsection (b) of this section for its review and for its recommendation respecting the classification of the device. The Secretary shall by regulation prescribe the procedure to be followed by the panels in making their reviews and recommendations. In making their reviews of devices, the panels, to the maximum extent practicable, shall provide an opportunity for interested persons to submit data and views on the classification of the devices."
  ]
  node [
    id 2002
    label "section_360c_subsection_i_item_3_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) which is sufficient to determine the effectiveness of a device, and"
  ]
  node [
    id 2003
    label "section_360c_subsection_a_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) A device for which insufficient information exists to determine that the controls referred to in clause (i) are sufficient to provide reasonable assurance of the safety and effectiveness of the device or to establish special controls to provide such assurance, but because it&#8212;"
  ]
  node [
    id 2004
    label "section_360c_subsection_f"
    class_name "subsection"
    text "(f) Initial classification and reclassification of certain devices"
  ]
  node [
    id 2005
    label "section_360c_subsection_d"
    class_name "subsection"
    text "(d) Panel recommendation; publication; priorities"
  ]
  node [
    id 2006
    label "section_360c_subsection_f_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) is substantially equivalent to another device within such type, or"
  ]
  node [
    id 2007
    label "section_360c_subsection_b_item_4"
    class_name "item"
    text "(4) The Secretary shall furnish each panel with adequate clerical and other necessary assistance."
  ]
  node [
    id 2008
    label "section_360c_subsection_a_item_1_subitem_A_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) does not present a potential unreasonable risk of illness or injury,"
  ]
  node [
    id 2009
    label "section_360c_subsection_c_item_2_subitem_C"
    class_name "subitem"
    text "(C) In the case of a device which has been referred under paragraph (1) to a panel, and which&#8212;"
  ]
  node [
    id 2010
    label "section_360c_subsection_i_item_2_subitem_C"
    class_name "subitem"
    text "(C) weighing any probable benefit to health from the use of the device against any probable risk of injury or illness from such use."
  ]
  node [
    id 2011
    label "section_360c_subsection_e_item_2"
    class_name "item"
    text "(2) By regulation promulgated under paragraph (1), the Secretary may change the classification of a device from class III&#8212;"
  ]
  node [
    id 2012
    label "section_360c_subsection_a"
    class_name "subsection"
    text "(a) Classes of devices"
  ]
  node [
    id 2013
    label "section_360c_subsection_e_item_1"
    class_name "item"
    text "(1) Based on new information respecting a device, the Secretary may, upon his own initiative or upon petition of an interested person, by regulation (A) change such device's classification, and (B) revoke, because of the change in classification, any regulation or requirement in effect under section 360d or 360e of this title with respect to such device. In the promulgation of such a regulation respecting a device's classification, the Secretary may secure from the panel to which the device was last referred pursuant to subsection (c) of this section a recommendation respecting the proposed change in the device's classification and shall publish in the Federal Register any recommendation submitted to the Secretary by the panel respecting such change. A regulation under this subsection changing the classification of a device from class III to class II may provide that such classification shall not take effect until the effective date of a performance standard established under section 360d of this title for such device."
  ]
  node [
    id 2014
    label "section_360c_subsection_f_item_3"
    class_name "item"
    text "(3) If a manufacturer reports to the Secretary under section 360(k) of this title that a device is substantially equivalent to another device&#8212;"
  ]
  node [
    id 2015
    label "section_360c_subsection_i_subitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(ii)(I) has been introduced or delivered for introduction into interstate commerce for commercial distribution before May 28, 1976, or"
  ]
  node [
    id 2016
    label "section_360c_subsection_f_item_2_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(C)(i) Within ninety days from the date the Secretary receives the recommendation of a panel respecting a petition (but not later than 210 days after the filing of such petition) the Secretary shall by order deny or approve the petition. If the Secretary approves the petition, the Secretary shall order the classification of the device into class I or class II in accordance with the criteria prescribed by subsection (a)(1)(A) or (a)(1)(B) of this section. In the case of a petition for a device which is intended to be implanted in the human body or which is purported or represented to be for a use in supporting or sustaining human life, the Secretary shall deny the petition unless the Secretary determines that the classification in class III of the device is not necessary to provide reasonable assurance of its safety and effectiveness. An order approving such petition shall be accompanied by a full statement of the reasons of the Secretary (and supporting documentation and data) for approving the petition and an identification of the risks to health (if any) presented by the device to which such order applies."
  ]
  node [
    id 2017
    label "section_360c_subsection_f_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) is within a type of device (I) which was introduced or delivered for introduction into interstate commerce for commercial distribution before such date and which is to be classified pursuant to subsection (b) of this section, or (II) which was not so introduced or delivered before such date and has been classified in class I or II, and"
  ]
  node [
    id 2018
    label "section_360c_subsection_b"
    class_name "subsection"
    text "(b) Classification panels"
  ]
  node [
    id 2019
    label "section_360c_subsection_i_item_2_subitem_B"
    class_name "subitem"
    text "(B) with respect to the conditions of use prescribed, recommended, or suggested in the labeling of the device, and"
  ]
  node [
    id 2020
    label "section_360c_subsection_i_item_2_subitem_A"
    class_name "subitem"
    text "(A) with respect to the persons for whose use the device is represented or intended,"
  ]
  node [
    id 2021
    label "section_360c_subsection_f_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) The Secretary may initiate the reclassification of a device classified into class III under paragraph (1) of this subsection or the manufacturer or importer of a device classified under paragraph (1) may petition the Secretary (in such form and manner as he shall prescribe) for the issuance of an order classifying the device in class I or class II. Within thirty days of the filing of such a petition, the Secretary shall notify the petitioner of any deficiencies in the petition which prevent the Secretary from making a decision on the petition."
  ]
  node [
    id 2022
    label "section_360c_subsection_a_item_1_subitem_A_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) is not purported or represented to be for a use in supporting or sustaining human life or for a use which is of substantial importance in preventing impairment of human health, and"
  ]
  node [
    id 2023
    label "section_360d_subsection_b_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) set forth a finding with supporting justification that the performance standard is appropriate and necessary to provide reasonable assurance of the safety and effectiveness of the device,"
  ]
  node [
    id 2024
    label "section_360d_subsection_a_item_2_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) provisions for the measurement of the performance characteristics of the device,"
  ]
  node [
    id 2025
    label "section_360d_subsection_b_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) The Secretary, upon his own initiative or upon petition of an interested person may by regulation, promulgated in accordance with the requirements of paragraphs (1), (2), and (3)(B) of this subsection, amend or revoke a performance standard."
  ]
  node [
    id 2026
    label "section_360d_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) A notice of proposed rulemaking for the revocation of a performance standard shall set forth a finding with supporting justification that the performance standard is no longer necessary to provide reasonable assurance of the safety and effectiveness of a device."
  ]
  node [
    id 2027
    label "section_360d_subsection_v_item_4"
    class_name "item"
    text "(4) In carrying out his duties under this section, the Secretary shall, to the maximum extent practicable&#8212;"
  ]
  node [
    id 2028
    label "section_360d_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) The Secretary shall publish in the Federal Register a notice of proposed rulemaking for the establishment, amendment, or revocation of any performance standard for a device."
  ]
  node [
    id 2029
    label "section_360d_subsection_b_item_1_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) invite interested persons to submit to the Secretary, within 30 days of the publication of the notice, requests for changes in the classification of the device pursuant to section 360c(e) of this title based on new information relevant to the classification, and"
  ]
  node [
    id 2030
    label "section_360d_subsection_b_item_3"
    class_name "item"
    text "(3)(A) After the expiration of the period for comment on a notice of proposed rulemaking published under paragraph (1) respecting a performance standard and after consideration of such comments and any report from an advisory committee under paragraph (5), the Secretary shall (i) promulgate a regulation establishing a performance standard and publish in the Federal Register findings on the matters referred to in paragraph (1), or (ii) publish a notice terminating the proceeding for the development of the standard together with the reasons for such termination. If a notice of termination is published, the Secretary shall (unless such notice is issued because the device is a banned device under section 360f of this title) initiate a proceeding under section 360c(e) of this title to reclassify the device subject to the proceeding terminated by such notice."
  ]
  node [
    id 2031
    label "section_360d_subsection_b_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) After the expiration of the period for comment on a notice of proposed rulemaking published under paragraph (1) respecting a performance standard and after consideration of such comments and any report from an advisory committee under paragraph (5), the Secretary shall (i) promulgate a regulation establishing a performance standard and publish in the Federal Register findings on the matters referred to in paragraph (1), or (ii) publish a notice terminating the proceeding for the development of the standard together with the reasons for such termination. If a notice of termination is published, the Secretary shall (unless such notice is issued because the device is a banned device under section 360f of this title) initiate a proceeding under section 360c(e) of this title to reclassify the device subject to the proceeding terminated by such notice."
  ]
  node [
    id 2032
    label "section_360d_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) A notice of proposed rulemaking for the establishment or amendment of a performance standard for a device shall&#8212;"
  ]
  node [
    id 2033
    label "section_360d_subsection_a_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) provisions for the testing (on a sample basis or, if necessary, on an individual basis) of the device or, if it is determined that no other more practicable means are available to the Secretary to assure the conformity of the device to the standard, provisions for the testing (on a sample basis or, if necessary, on an individual basis) by the Secretary or by another person at the direction of the Secretary,"
  ]
  node [
    id 2034
    label "section_360d_subsection_b_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) set forth proposed findings with respect to the risk of illness or injury that the performance standard is intended to reduce or eliminate,"
  ]
  node [
    id 2035
    label "section_360d_subsection_v_subitem_C"
    class_name "subitem"
    text "(C) shall, where appropriate, require the use and prescribe the form and content of labeling for the proper installation, maintenance, operation, and use of the device."
  ]
  node [
    id 2036
    label "section_360d_subsection_b_item_5"
    class_name "item"
    text "(5)(A) The Secretary&#8212;"
  ]
  node [
    id 2037
    label "section_360d_subsection_a_item_1"
    class_name "item"
    text "(1) The special controls required by section 360c(a)(1)(B) of this title shall include performance standards for a class II device if the Secretary determines that a performance standard is necessary to provide reasonable assurance of the safety and effectiveness of the device. A class III device may also be considered a class II device for purposes of establishing a standard for the device under this section if the device has been reclassified as a class II device under a regulation under section 360c(e) of this title but such regulation provides that the reclassification is not to take effect until the effective date of such a standard for the device."
  ]
  node [
    id 2038
    label "section_360d_subsection_b_item_4"
    class_name "item"
    text "(4)(A) The Secretary, upon his own initiative or upon petition of an interested person may by regulation, promulgated in accordance with the requirements of paragraphs (1), (2), and (3)(B) of this subsection, amend or revoke a performance standard."
  ]
  node [
    id 2039
    label "section_360d_subsection_b_item_5_subitem_B"
    class_name "subitem"
    text "(B) The Secretary shall establish advisory committees (which may not be panels under section 360c of this title) to receive referrals under subparagraph (A). The Secretary shall appoint as members of any such advisory committee persons qualified in the subject matter to be referred to the committee and of appropriately diversified professional background, except that the Secretary may not appoint to such a committee any individual who is in the regular full-time employ of the United States and engaged in the administration of this chapter. Each such committee shall include as nonvoting members a representative of consumer interests and a representative of interests of the device manufacturing industry. Members of an advisory committee who are not officers or employees of the United States, while attending conferences or meetings of their committee or otherwise serving at the request of the Secretary, shall be entitled to receive compensation at rates to be fixed by the Secretary, which rates may not exceed the daily equivalent of the rate in effect for grade GS&#8211;18 of the General Schedule, for each day (including traveltime) they are so engaged; and while so serving away from their homes or regular places of business each member may be allowed travel expenses, including per diem in lieu of subsistence, as authorized by section 5703 of title 5 for persons in the Government service employed intermittently. The Secretary shall designate one of the members of each advisory committee to serve as chairman thereof. The Secretary shall furnish each advisory committee with clerical and other assistance, and shall by regulation prescribe the procedures to be followed by each such committee in acting on referrals made under subparagraph (A)."
  ]
  node [
    id 2040
    label "section_360d_subsection_v_item_3"
    class_name "item"
    text "(3) The Secretary shall provide for periodic evaluation of performance standards established under this section to determine if such standards should be changed to reflect new medical, scientific, or other technological data."
  ]
  node [
    id 2041
    label "section_360d_subsection_b_item_2"
    class_name "item"
    text "(2) If, after publication of a notice in accordance with paragraph (1), the Secretary receives a request for a change in the classification of the device, the Secretary shall, within 60 days of the publication of the notice, after consultation with the appropriate panel under section 360c of this title, either deny the request or give notice of an intent to initiate such change under section 360c(e) of this title."
  ]
  node [
    id 2042
    label "section_360d_subsection_a"
    class_name "subsection"
    text "(a) Reasonable assurance of safe and effective performance; periodic evaluation"
  ]
  node [
    id 2043
    label "section_360d_subsection_b_item_1_subitem_D"
    class_name "subitem"
    text "(D) The Secretary shall provide for a comment period of not less than 60 days."
  ]
  node [
    id 2044
    label "section_360d_subsection_b_item_5_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) shall, upon the request of an interested person which demonstrates good cause for referral and which is made before the expiration of the period for submission of comments on such proposed regulation refer such proposed regulation,"
  ]
  node [
    id 2045
    label "section_360d_subsection_a_item_2_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) provisions requiring that the results of each or of certain of the tests of the device required to be made under clause (ii) show that the device is in conformity with the portions of the standard for which the test or tests were required, and"
  ]
  node [
    id 2046
    label "section_360d_subsection_v_item_4_subitem_A"
    class_name "subitem"
    text "(A) use personnel, facilities, and other technical support available in other Federal agencies,"
  ]
  node [
    id 2047
    label "section_360d_subsection_b_item_1_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) invite interested persons to submit an existing performance standard for the device, including a draft or proposed performance standard, for consideration by the Secretary."
  ]
  node [
    id 2048
    label "section_360d_subsection_b_item_5_subitem_A"
    class_name "subitem"
    text "(5)(A) The Secretary&#8212;"
  ]
  node [
    id 2049
    label "section_360d_subsection_v"
    class_name "subsection"
    text "(v) a provision requiring that the sale and distribution of the device be restricted but only to the extent that the sale and distribution of a device may be restricted under a regulation under section 360j(e) of this title; and"
  ]
  node [
    id 2050
    label "section_360d_subsection_v_item_4_subitem_C"
    class_name "subitem"
    text "(C) invite appropriate participation, through joint or other conferences, workshops, or other means, by informed persons representative of scientific, professional, industry, or consumer organizations who in his judgment can make a significant contribution."
  ]
  node [
    id 2051
    label "section_360d_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) shall include provisions to provide reasonable assurance of its safe and effective performance;"
  ]
  node [
    id 2052
    label "section_360d_subsection_b_item_5_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) may on his own initiative refer a proposed regulation for the establishment, amendment, or revocation of a performance standard, or"
  ]
  node [
    id 2053
    label "section_360d_subsection_b"
    class_name "subsection"
    text "(b) Establishment of a standard"
  ]
  node [
    id 2054
    label "section_360d_subsection_a_item_2"
    class_name "item"
    text "(2) A performance standard established under this section for a device&#8212;"
  ]
  node [
    id 2055
    label "section_360d_subsection_a_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) provisions respecting the construction, components, ingredients, and properties of the device and its compatibility with power systems and connections to such systems,"
  ]
  node [
    id 2056
    label "section_360d_subsection_b_item_1"
    class_name "item"
    text "(1)(A) The Secretary shall publish in the Federal Register a notice of proposed rulemaking for the establishment, amendment, or revocation of any performance standard for a device."
  ]
  node [
    id 2057
    label "section_360d_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) shall, where necessary to provide reasonable assurance of its safe and effective performance, include&#8212;"
  ]
  node [
    id 2058
    label "section_360d_subsection_b_item_3_subitem_B"
    class_name "subitem"
    text "(B) A regulation establishing a performance standard shall set forth the date or dates upon which the standard shall take effect, but no such regulation may take effect before one year after the date of its publication unless (i) the Secretary determines that an earlier effective date is necessary for the protection of the public health and safety, or (ii) such standard has been established for a device which, effective upon the effective date of the standard, has been reclassified from class III to class II. Such date or dates shall be established so as to minimize, consistent with the public health and safety, economic loss to, and disruption or dislocation of, domestic and international trade."
  ]
  node [
    id 2059
    label "section_360d_subsection_b_item_4_subitem_B"
    class_name "subitem"
    text "(B) The Secretary may declare a proposed amendment of a performance standard to be effective on and after its publication in the Federal Register and until the effective date of any final action taken on such amendment if he determines that making it so effective is in the public interest. A proposed amendment of a performance standard made so effective under the preceding sentence may not prohibit, during the period in which it is so effective, the introduction or delivery for introduction into interstate commerce of a device which conforms to such standard without the change or changes provided by such proposed amendment."
  ]
  node [
    id 2060
    label "section_360d_subsection_v_item_4_subitem_B"
    class_name "subitem"
    text "(B) consult with other Federal agencies concerned with standard-setting and other nationally or internationally recognized standard-setting entities, and"
  ]
  node [
    id 2061
    label "section_360e_subsection_e"
    class_name "subsection"
    text "(e) Withdrawal and temporary suspension of approval of application"
  ]
  node [
    id 2062
    label "section_360e_subsection_i_item_3"
    class_name "item"
    text "(3) The Secretary shall, as promptly as is reasonably achievable, but not later than 12 months after the effective date of the regulation requiring a device to remain in class III, establish a schedule for the promulgation of a subsection (b) of this section regulation for each device which is subject to the regulation requiring the device to remain in class III."
  ]
  node [
    id 2063
    label "section_360e_subsection_v_item_5"
    class_name "item"
    text "(5) At any time after a product development protocol for a device has been approved pursuant to paragraph (4), the person for whom the protocol was approved may submit a notice of completion&#8212;"
  ]
  node [
    id 2064
    label "section_360e_subsection_g_item_2"
    class_name "item"
    text "(2)(A) Upon petition for review of&#8212;"
  ]
  node [
    id 2065
    label "section_360e_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B)(i) The Secretary may not enter into an agreement to extend the period in which to take action with respect to an application submitted for a device subject to a regulation promulgated under subsection (b) of this section unless he finds that the continued availability of the device is necessary for the public health."
  ]
  node [
    id 2066
    label "section_360e_subsection_f_item_2"
    class_name "item"
    text "(2) Any person may submit to the Secretary a proposed product development protocol with respect to a device. Such a protocol shall be accompanied by data supporting it. If, within thirty days of the receipt of such a protocol, the Secretary determines that it appears to be appropriate to apply the requirements of this subsection to the device with respect to which the protocol is submitted, he shall refer the proposed protocol to the appropriate panel under section 360c of this title for its recommendation respecting approval of the protocol."
  ]
  node [
    id 2067
    label "section_360e_subsection_d"
    class_name "subsection"
    text "(d) Action on application for premarket approval"
  ]
  node [
    id 2068
    label "section_360e_subsection_c_item_1_subitem_G"
    class_name "subitem"
    text "(G) such other information relevant to the subject matter of the application as the Secretary, with the concurrence of the appropriate panel under section 360c of this title, may require."
  ]
  node [
    id 2069
    label "section_360e_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) A proceeding for the promulgation of a regulation under paragraph (1) respecting a device shall be initiated by the publication in the Federal Register of a notice of proposed rulemaking. Such notice shall contain&#8212;"
  ]
  node [
    id 2070
    label "section_360e_subsection_d_item_2_subitem_B"
    class_name "subitem"
    text "(B) there is a lack of a showing of reasonable assurance that the device is effective under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof;"
  ]
  node [
    id 2071
    label "section_360e_subsection_g_item_1"
    class_name "item"
    text "(1) Upon petition for review of&#8212;"
  ]
  node [
    id 2072
    label "section_360e_subsection_e_item_1"
    class_name "item"
    text "(1) The Secretary shall, upon obtaining, where appropriate, advice on scientific matters from a panel or panels under section 360c of this title, and after due notice and opportunity for informal hearing to the holder of an approved application for a device, issue an order withdrawing approval of the application if the Secretary finds&#8212;"
  ]
  node [
    id 2073
    label "section_360e_subsection_d_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) deny approval of the application if he finds (and sets forth the basis for such finding as part of or accompanying such denial) that one or more grounds for denial specified in paragraph (2) of this subsection apply."
  ]
  node [
    id 2074
    label "section_360e_subsection_i_item_2_subitem_A"
    class_name "subitem"
    text "(A) which the Secretary has classified as a class III device, and"
  ]
  node [
    id 2075
    label "section_360e_subsection_v_item_6_subitem_B"
    class_name "subitem"
    text "(B) After the receipt of a notice of completion of an approved protocol the Secretary shall, within the ninety-day period beginning on the date such notice is received, by order either declare the protocol completed or declare it not completed. An order declaring a protocol not completed may take effect only after the Secretary has provided the person who has the protocol opportunity for an informal hearing on the order. Such an order may be issued only if the Secretary finds&#8212;"
  ]
  node [
    id 2076
    label "section_360e_subsection_i_item_1"
    class_name "item"
    text "(1) Before December 1, 1995, the Secretary shall by order require manufacturers of devices, which were introduced or delivered for introduction into interstate commerce for commercial distribution before May 28, 1976, and which are subject to revision of classification under paragraph (2), to submit to the Secretary a summary of and citation to any information known or otherwise available to the manufacturer respecting such devices, including adverse safety or effectiveness information which has not been submitted under section 360i of this title. The Secretary may require the manufacturer to submit the adverse safety or effectiveness data for which a summary and citation were submitted, if such data are available to the manufacturer."
  ]
  node [
    id 2077
    label "section_360e_subsection_v_item_6_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) such person has failed substantially to comply with the requirements of the protocol,"
  ]
  node [
    id 2078
    label "section_360e_subsection_d_item_2_subitem_E"
    class_name "subitem"
    text "(E) such device is not shown to conform in all respects to a performance standard in effect under section 360d of this title compliance with which is a condition to approval of the application and there is a lack of adequate information to justify the deviation from such standard."
  ]
  node [
    id 2079
    label "section_360e_subsection_v_item_4"
    class_name "item"
    text "(4) The Secretary shall approve or disapprove a proposed product development protocol submitted under paragraph (2) within one hundred and twenty days of its receipt unless an additional period is agreed upon by the Secretary and the person who submitted the protocol. Approval of a protocol or denial of approval of a protocol is final agency action subject to judicial review under chapter 7 of title 5."
  ]
  node [
    id 2080
    label "section_360e_subsection_i_item_2_subitem_B"
    class_name "subitem"
    text "(B) for which no final regulation has been promulgated under subsection (b) of this section,"
  ]
  node [
    id 2081
    label "section_360e_subsection_e_item_1_subitem_E"
    class_name "subitem"
    text "(E) on the basis of new information before him with respect to such device, evaluated together with the evidence before him when the application was approved, that the methods used in, or the facilities and controls used for, the manufacture, processing, packing, or installation of such device do not conform with the requirements of section 360j(f) of this title and were not brought into conformity with such requirements within a reasonable time after receipt of written notice from the Secretary of nonconformity;"
  ]
  node [
    id 2082
    label "section_360e_subsection_f_item_1"
    class_name "item"
    text "(1) In the case of a class III device which is required to have an approval of an application submitted under subsection (c) of this section, such device shall be considered as having such an approval if a notice of completion of testing conducted in accordance with a product development protocol approved under paragraph (4) has been declared completed under paragraph (6)."
  ]
  node [
    id 2083
    label "section_360e_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) If, within fifteen days after publication of a notice under subparagraph (A), the Secretary receives a request for a change in the classification of a device, he shall, within sixty days of the publication of such notice and after consultation with the appropriate panel under section 360c of this title, by order published in the Federal Register, either deny the request for change in classification or give notice of his intent to initiate such a change under section 360c(e) of this title."
  ]
  node [
    id 2084
    label "section_360e_subsection_g_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) an order under subsection (f)(6)(A) of this section revoking an approved protocol, under subsection (f)(6)(B) of this section declaring that an approved protocol has not been completed, or under subsection (f)(7) of this section revoking the approval of a device,"
  ]
  node [
    id 2085
    label "section_360e_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(A) that such device is unsafe or ineffective under the conditions of use prescribed, recommended, or suggested in the labeling thereof;"
  ]
  node [
    id 2086
    label "section_360e_subsection_g_item_2_subitem_B"
    class_name "subitem"
    text "(B) The Secretary shall establish advisory committees (which may not be panels under section 360c of this title) to receive referrals under subparagraph (A). The Secretary shall appoint as members of any such advisory committee persons qualified in the subject matter to be referred to the committee and of appropriately diversified professional backgrounds, except that the Secretary may not appoint to such a committee any individual who is in the regular full-time employ of the United States and engaged in the administration of this chapter. Members of an advisory committee (other than officers or employees of the United States), while attending conferences or meetings of their committee or otherwise serving at the request of the Secretary, shall be entitled to receive compensation at rates to be fixed by the Secretary, which rates may not exceed the daily equivalent for grade GS&#8211;18 of the General Schedule for each day (including traveltime) they are so engaged; and while so serving away from their homes or regular places of business each member may be allowed travel expenses, including per diem in lieu of subsistence, as authorized by section 5703 of title 5 for persons in the Government service employed intermittently. The Secretary shall designate the chairman of an advisory committee from its members. The Secretary shall furnish each advisory committee with clerical and other assistance, and shall by regulation prescribe the procedures to be followed by each such committee in acting on referrals made under subparagraph (A)."
  ]
  node [
    id 2087
    label "section_360e_subsection_g"
    class_name "subsection"
    text "(g) Review"
  ]
  node [
    id 2088
    label "section_360e_subsection_b_item_2"
    class_name "item"
    text "(2)(A) A proceeding for the promulgation of a regulation under paragraph (1) respecting a device shall be initiated by the publication in the Federal Register of a notice of proposed rulemaking. Such notice shall contain&#8212;"
  ]
  node [
    id 2089
    label "section_360e_subsection_c_item_1_subitem_F"
    class_name "subitem"
    text "(F) specimens of the labeling proposed to be used for such device; and"
  ]
  node [
    id 2090
    label "section_360e_subsection_g_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Upon petition for review of&#8212;"
  ]
  node [
    id 2091
    label "section_360e_subsection_f_item_3_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) a description of the methods to be used in, and the facilities and controls to be used for, the manufacture, processing, and, when relevant, packing and installation of the device,"
  ]
  node [
    id 2092
    label "section_360e_subsection_f_item_3_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) a description of the preclinical trials (if any) of the device and a specification of (I) the results from such trials to be required before the commencement of clinical trials of the device, and (II) any permissible variations in preclinical trials and the results therefrom,"
  ]
  node [
    id 2093
    label "section_360e_subsection_v_item_6_subitem_C"
    class_name "subitem"
    text "(C) A final order issued under subparagraph (A) or (B) shall be in writing and shall contain the reasons to support the conclusions thereof."
  ]
  node [
    id 2094
    label "section_360e_subsection_v_item_6"
    class_name "item"
    text "(6)(A) The Secretary may, after providing the person who has an approved protocol and opportunity for an informal hearing and at any time prior to receipt of notice of completion of such protocol, issue a final order to revoke such protocol if he finds that&#8212;"
  ]
  node [
    id 2095
    label "section_360e_subsection_b_item_4"
    class_name "item"
    text "(4) The Secretary, upon his own initiative or upon petition of an interested person, may by regulation amend or revoke any regulation promulgated under this subsection. A regulation to amend or revoke a regulation under this subsection shall be promulgated in accordance with the requirements prescribed by this subsection for the promulgation of the regulation to be amended or revoked."
  ]
  node [
    id 2096
    label "section_360e_subsection_c"
    class_name "subsection"
    text "(c) Application for premarket approval"
  ]
  node [
    id 2097
    label "section_360e_subsection_h_item_1"
    class_name "item"
    text "Orders of the Secretary under this section shall be served (1) in person by any officer or employee of the department designated by the Secretary, or (2) by mailing the order by registered mail or certified mail addressed to the applicant at his last known address in the records of the Secretary."
  ]
  node [
    id 2098
    label "section_360e_subsection_c_item_1"
    class_name "item"
    text "(1) Any person may file with the Secretary an application for premarket approval for a class III device. Such an application for a device shall contain&#8212;"
  ]
  node [
    id 2099
    label "section_360e_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) a full statement of the components, ingredients, and properties and of the principle or principles of operation, of such device;"
  ]
  node [
    id 2100
    label "section_360e_subsection_c_item_1_subitem_C"
    class_name "subitem"
    text "(C) a full description of the methods used in, and the facilities and controls used for, the manufacture, processing, and, when relevant, packing and installation of, such device;"
  ]
  node [
    id 2101
    label "section_360e_subsection_v_item_6_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the results of the trials conducted under the protocol or available new information do not demonstrate that the device tested under the protocol does not present an unreasonable risk to health and safety."
  ]
  node [
    id 2102
    label "section_360e_subsection_i_item_2"
    class_name "item"
    text "(2) After the issuance of an order under paragraph (1) but before December 1, 1995, the Secretary shall publish a regulation in the Federal Register for each device&#8212;"
  ]
  node [
    id 2103
    label "section_360e_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) As promptly as possible, but in no event later than one hundred and eighty days after the receipt of an application under subsection (c) of this section (except as provided in section 360j(l)(3)(D)(ii) of this title or unless, in accordance with subparagraph (B)(i), an additional period as agreed upon by the Secretary and the applicant), the Secretary, after considering the report and recommendation submitted under paragraph (2) of such subsection, shall&#8212;"
  ]
  node [
    id 2104
    label "section_360e_subsection_v_item_6_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the results of the trials obtained under the protocol differ substantially from the results required by the protocol, or"
  ]
  node [
    id 2105
    label "section_360e_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) was introduced or delivered for introduction into interstate commerce for commercial distribution before May 28, 1976; or"
  ]
  node [
    id 2106
    label "section_360e_subsection_f_item_3_subitem_B"
    class_name "subitem"
    text "(B) the Secretary determines that the proposed protocol provides&#8212;"
  ]
  node [
    id 2107
    label "section_360e_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) full reports of all information, published or known to or which should reasonably be known to the applicant, concerning investigations which have been made to show whether or not such device is safe and effective;"
  ]
  node [
    id 2108
    label "section_360e_subsection_f_item_3"
    class_name "item"
    text "(3) A proposed product development protocol for a device may be approved only if&#8212;"
  ]
  node [
    id 2109
    label "section_360e_subsection_b_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) the proposed regulation;"
  ]
  node [
    id 2110
    label "section_360e_subsection_e_item_1_subitem_D"
    class_name "subitem"
    text "(D) that the applicant (i) has failed to establish a system for maintaining records, or has repeatedly or deliberately failed to maintain records or to make reports, required by an applicable regulation under section 360i(a) of this title, (ii) has refused to permit access to, or copying or verification of, such records as required by section 374 of this title, or (iii) has not complied with the requirements of section 360 of this title;"
  ]
  node [
    id 2111
    label "section_360e_subsection_d_item_2_subitem_A"
    class_name "subitem"
    text "(A) there is a lack of a showing of reasonable assurance that such device is safe under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof;"
  ]
  node [
    id 2112
    label "section_360e_subsection_e_item_2"
    class_name "item"
    text "(2) The holder of an application subject to an order issued under paragraph (1) withdrawing approval of the application may, by petition filed on or before the thirtieth day after the date upon which he receives notice of such withdrawal, obtain review thereof in accordance with either paragraph (1) or (2) of subsection (g) of this section."
  ]
  node [
    id 2113
    label "section_360e_subsection_d_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) issue an order approving the application if he finds that none of the grounds for denying approval specified in paragraph (2) of this subsection applies; or"
  ]
  node [
    id 2114
    label "section_360e_subsection_d_item_2"
    class_name "item"
    text "(2) The Secretary shall deny approval of an application for a device if, upon the basis of the information submitted to the Secretary as part of the application and any other information before him with respect to such device, the Secretary finds that&#8212;"
  ]
  node [
    id 2115
    label "section_360e_subsection_e_item_3"
    class_name "item"
    text "(3) If, after providing an opportunity for an informal hearing, the Secretary determines there is reasonable probability that the continuation of distribution of a device under an approved application would cause serious, adverse health consequences or death, the Secretary shall by order temporarily suspend the approval of the application approved under this section. If the Secretary issues such an order, the Secretary shall proceed expeditiously under paragraph (1) to withdraw such application."
  ]
  node [
    id 2116
    label "section_360e_subsection_v_item_6_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) there is a lack of a showing of reasonable assurance of the safety and effectiveness of the device under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof."
  ]
  node [
    id 2117
    label "section_360e_subsection_v_item_8"
    class_name "item"
    text "(8) A person who has an approved protocol subject to an order issued under paragraph (6)(A) revoking such protocol, a person who has an approved protocol with respect to which an order under paragraph (6)(B) was issued declaring that the protocol had not been completed, or a person subject to an order issued under paragraph (7) revoking the approval of a device may, by petition filed on or before the thirtieth day after the date upon which he receives notice of such order, obtain review thereof in accordance with either paragraph (1) or (2) of subsection (g) of this section."
  ]
  node [
    id 2118
    label "section_360e_subsection_d_item_1"
    class_name "item"
    text "(1)(A) As promptly as possible, but in no event later than one hundred and eighty days after the receipt of an application under subsection (c) of this section (except as provided in section 360j(l)(3)(D)(ii) of this title or unless, in accordance with subparagraph (B)(i), an additional period as agreed upon by the Secretary and the applicant), the Secretary, after considering the report and recommendation submitted under paragraph (2) of such subsection, shall&#8212;"
  ]
  node [
    id 2119
    label "section_360e_subsection_g_item_1_subitem_B"
    class_name "subitem"
    text "(B) an order under subsection (f)(6)(A) of this section revoking an approved protocol, under subsection (f)(6)(B) of this section declaring that an approved protocol has not been completed, or under subsection (f)(7) of this section revoking the approval of a device,"
  ]
  node [
    id 2120
    label "section_360e_subsection_a_item_1"
    class_name "item"
    text "(1) which is subject to a regulation promulgated under subsection (b) of this section; or"
  ]
  node [
    id 2121
    label "section_360e_subsection_e_item_1_subitem_G"
    class_name "subitem"
    text "(G) on the basis of new information before him, evaluated together with the evidence before him when the application was approved, that such device is not shown to conform in all respects to a performance standard which is in effect under section 360d of this title compliance with which was a condition to approval of the application and that there is a lack of adequate information to justify the deviation from such standard."
  ]
  node [
    id 2122
    label "section_360e_subsection_e_item_1_subitem_F"
    class_name "subitem"
    text "(F) on the basis of new information before him, evaluated together with the evidence before him when the application was approved, that the labeling of such device, based on a fair evaluation of all material facts, is false or misleading in any particular and was not corrected within a reasonable time after receipt of written notice from the Secretary of such fact; or"
  ]
  node [
    id 2123
    label "section_360e_subsection_d_item_3"
    class_name "item"
    text "(3) An applicant whose application has been denied approval may, by petition filed on or before the thirtieth day after the date upon which he receives notice of such denial, obtain review thereof in accordance with either paragraph (1) or (2) of subsection (g) of this section, and any interested person may obtain review, in accordance with paragraph (1) or (2) of subsection (g) of this section, of an order of the Secretary approving an application."
  ]
  node [
    id 2124
    label "section_360e_subsection_a_item_2"
    class_name "item"
    text "(2) which is a class III device because of section 360c(f) of this title,"
  ]
  node [
    id 2125
    label "section_360e_subsection_e_item_1_subitem_C"
    class_name "subitem"
    text "(C) that the application contained or was accompanied by an untrue statement of a material fact;"
  ]
  node [
    id 2126
    label "section_360e_subsection_g_item_2_subitem_C"
    class_name "subitem"
    text "(C) The Secretary shall make public the report and recommendation made by an advisory committee with respect to an application and shall by order, stating the reasons therefor, either affirm the order referred to the advisory committee or reverse such order and, if appropriate, approve or deny approval of the application, reinstate the application's approval, approve the protocol, or place in effect a notice of completion."
  ]
  node [
    id 2127
    label "section_360e_subsection_c_item_1_subitem_D"
    class_name "subitem"
    text "(D) an identifying reference to any performance standard under section 360d of this title which would be applicable to any aspect of such device if it were a class II device, and either adequate information to show that such aspect of such device fully meets such performance standard or adequate information to justify any deviation from such standard;"
  ]
  node [
    id 2128
    label "section_360e_subsection_i"
    class_name "subsection"
    text "(i) Revision"
  ]
  node [
    id 2129
    label "section_360e_subsection_v_item_6_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) such person has failed substantially to comply with the requirements of the protocol,"
  ]
  node [
    id 2130
    label "section_360e_subsection_v_item_6_subitem_A"
    class_name "subitem"
    text "(6)(A) The Secretary may, after providing the person who has an approved protocol and opportunity for an informal hearing and at any time prior to receipt of notice of completion of such protocol, issue a final order to revoke such protocol if he finds that&#8212;"
  ]
  node [
    id 2131
    label "section_360e_subsection_d_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) The Secretary may not enter into an agreement to extend the period in which to take action with respect to an application submitted for a device subject to a regulation promulgated under subsection (b) of this section unless he finds that the continued availability of the device is necessary for the public health."
  ]
  node [
    id 2132
    label "section_360e_subsection_v_item_5_subitem_A"
    class_name "subitem"
    text "(A) stating (i) his determination that the requirements of the protocol have been fulfilled and that, to the best of his knowledge, there is no reason bearing on safety or effectiveness why the notice of completion should not become effective, and (ii) the data and other information upon which such determination was made, and"
  ]
  node [
    id 2133
    label "section_360e_subsection_c_item_2"
    class_name "item"
    text "(2) Upon receipt of an application meeting the requirements set forth in paragraph (1), the Secretary&#8212;"
  ]
  node [
    id 2134
    label "section_360e_subsection_v"
    class_name "subsection"
    text "(v) an identifying reference to any performance standard under section 360d of this title to be applicable to any aspect of such device,"
  ]
  node [
    id 2135
    label "section_360e_subsection_d_item_2_subitem_C"
    class_name "subitem"
    text "(C) the methods used in, or the facilities or controls used for, the manufacture, processing, packing, or installation of such device do not conform to the requirements of section 360j(f) of this title;"
  ]
  node [
    id 2136
    label "section_360e_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) is (i) of a type so introduced or delivered, and (ii) is substantially equivalent to another device within that type,"
  ]
  node [
    id 2137
    label "section_360e_subsection_a"
    class_name "subsection"
    text "(a) General requirement"
  ]
  node [
    id 2138
    label "section_360e_subsection_b_item_1"
    class_name "item"
    text "(1) In the case of a class III device which&#8212;"
  ]
  node [
    id 2139
    label "section_360e_subsection_h"
    class_name "subsection"
    text "(h) Service of orders"
  ]
  node [
    id 2140
    label "section_360e_subsection_v_item_7"
    class_name "item"
    text "(7) At any time after a notice of completion has become effective, the Secretary may issue an order (after due notice and opportunity for an informal hearing to the person for whom the notice is effective) revoking the approval of a device provided by a notice of completion which has become effective as provided in subparagraph (B) if he finds that any of the grounds listed in subparagraphs (A) through (G) of subsection (e)(1) of this section apply. Each reference in such subparagraphs to an application shall be considered for purposes of this paragraph as a reference to a protocol and the notice of completion of such protocol, and each reference to the time when an application was approved shall be considered for purposes of this paragraph as a reference to the time when a notice of completion took effect."
  ]
  node [
    id 2141
    label "section_360e_subsection_v_item_5_subitem_B"
    class_name "subitem"
    text "(B) setting forth the results of the trials required by the protocol and all the information required by subsection (c)(1) of this section."
  ]
  node [
    id 2142
    label "section_360e_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) shall, upon the request of an applicant unless the Secretary finds that the information in the application which would be reviewed by a panel substantially duplicates information which has previously been reviewed by a panel appointed under section 360c of this title,"
  ]
  node [
    id 2143
    label "section_360e_subsection_c_item_1_subitem_E"
    class_name "subitem"
    text "(E) such samples of such device and of components thereof as the Secretary may reasonably require, except that where the submission of such samples is impracticable or unduly burdensome, the requirement of this subparagraph may be met by the submission of complete information concerning the location of one or more such devices readily available for examination and testing;"
  ]
  node [
    id 2144
    label "section_360e_subsection_f"
    class_name "subsection"
    text "(f) Product development protocol"
  ]
  node [
    id 2145
    label "section_360e_subsection_f_item_3_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) a description of the device and the changes which may be made in the device,"
  ]
  node [
    id 2146
    label "section_360e_subsection_d_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) An order approving an application for a device may require as a condition to such approval that the sale and distribution of the device be restricted but only to the extent that the sale and distribution of a device may be restricted under a regulation under section 360j(e) of this title."
  ]
  node [
    id 2147
    label "section_360e_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(A) may on the Secretary's own initiative, or"
  ]
  node [
    id 2148
    label "section_360e_subsection_b_item_2_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) opportunity to request a change in the classification of the device based on new information relevant to the classification of the device."
  ]
  node [
    id 2149
    label "section_360e_subsection_f_item_3_subitem_A"
    class_name "subitem"
    text "(A) the Secretary determines that it is appropriate to apply the requirements of this subsection to the device in lieu of the requirement of approval of an application submitted under subsection (c) of this section; and"
  ]
  node [
    id 2150
    label "section_360e_subsection_f_item_3_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) a description of the clinical trials (if any) of the device and a specification of (I) the results from such trials to be required before the filing of a notice of completion of the requirements of the protocol, and (II) any permissible variations in such trials and the results therefrom,"
  ]
  node [
    id 2151
    label "section_360e_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) on the basis of new information before him with respect to such device, evaluated together with the evidence available to him when the application was approved, that there is a lack of a showing of reasonable assurance that the device is safe or effective under the conditions of use prescribed, recommended, or suggested in the labeling thereof;"
  ]
  node [
    id 2152
    label "section_360e_subsection_v_item_6_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the results of the trials obtained under the protocol differ so substantially from the results required by the protocol that further trials cannot be justified, or"
  ]
  node [
    id 2153
    label "section_360e_subsection_b_item_3"
    class_name "item"
    text "(3) After the expiration of the period for comment on a proposed regulation and proposed findings published under paragraph (2) and after consideration of comments submitted on such proposed regulation and findings, the Secretary shall (A) promulgate such regulation and publish in the Federal Register findings on the matters referred to in paragraph (2)(A)(ii), or (B) publish a notice terminating the proceeding for the promulgation of the regulation together with the reasons for such termination. If a notice of termination is published, the Secretary shall (unless such notice is issued because the device is a banned device under section 360f of this title) initiate a proceeding under section 360c(e) of this title to reclassify the device subject to the proceeding terminated by such notice."
  ]
  node [
    id 2154
    label "section_360e_subsection_b"
    class_name "subsection"
    text "(b) Regulation to require premarket approval"
  ]
  node [
    id 2155
    label "section_360e_subsection_h_item_2"
    class_name "item"
    text "Orders of the Secretary under this section shall be served (1) in person by any officer or employee of the department designated by the Secretary, or (2) by mailing the order by registered mail or certified mail addressed to the applicant at his last known address in the records of the Secretary."
  ]
  node [
    id 2156
    label "section_360e_subsection_b_item_2_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) opportunity for the submission of comments on the proposed regulation and the proposed findings; and"
  ]
  node [
    id 2157
    label "section_360e_subsection_g_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) an order under subsection (d) of this section approving or denying approval of an application or an order under subsection (e) of this section withdrawing approval of an application, or"
  ]
  node [
    id 2158
    label "section_360e_subsection_d_item_2_subitem_D"
    class_name "subitem"
    text "(D) based on a fair evaluation of all material facts, the proposed labeling is false or misleading in any particular; or"
  ]
  node [
    id 2159
    label "section_360e_subsection_g_item_1_subitem_A"
    class_name "subitem"
    text "(A) an order under subsection (d) of this section approving or denying approval of an application or an order under subsection (e) of this section withdrawing approval of an application, or"
  ]
  node [
    id 2160
    label "section_360e_subsection_b_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) proposed findings with respect to the degree of risk of illness or injury designed to be eliminated or reduced by requiring the device to have an approved application for premarket approval and the benefit to the public from use of the device;"
  ]
  node [
    id 2161
    label "section_360f_subsection_a"
    class_name "subsection"
    text "(a) General rule"
  ]
  node [
    id 2162
    label "section_360f_subsection_b_item_1"
    class_name "item"
    text "The Secretary may declare a proposed regulation under subsection (a) of this section to be effective upon its publication in the Federal Register and until the effective date of any final action taken respecting such regulation if (1) he determines, on the basis of all available data and information, that the deception or risk of illness or injury associated with the use of the device which is subject to the regulation presents an unreasonable, direct, and substantial danger to the health of individuals, and (2) before the date of the publication of such regulation, the Secretary notifies the manufacturer of such device that such regulation is to be made so effective. If the Secretary makes a proposed regulation so effective, he shall, as expeditiously as possible, give interested persons prompt notice of his action under this subsection, provide reasonable opportunity for an informal hearing on the proposed regulation, and either affirm, modify, or revoke such proposed regulation."
  ]
  node [
    id 2163
    label "section_360f_subsection_b_item_2"
    class_name "item"
    text "The Secretary may declare a proposed regulation under subsection (a) of this section to be effective upon its publication in the Federal Register and until the effective date of any final action taken respecting such regulation if (1) he determines, on the basis of all available data and information, that the deception or risk of illness or injury associated with the use of the device which is subject to the regulation presents an unreasonable, direct, and substantial danger to the health of individuals, and (2) before the date of the publication of such regulation, the Secretary notifies the manufacturer of such device that such regulation is to be made so effective. If the Secretary makes a proposed regulation so effective, he shall, as expeditiously as possible, give interested persons prompt notice of his action under this subsection, provide reasonable opportunity for an informal hearing on the proposed regulation, and either affirm, modify, or revoke such proposed regulation."
  ]
  node [
    id 2164
    label "section_360f_subsection_a_item_1"
    class_name "item"
    text "(1) a device intended for human use presents substantial deception or an unreasonable and substantial risk of illness or injury; and"
  ]
  node [
    id 2165
    label "section_360f_subsection_a_item_2"
    class_name "item"
    text "(2) in the case of substantial deception or an unreasonable and substantial risk of illness or injury which the Secretary determined could be corrected or eliminated by labeling or change in labeling and with respect to which the Secretary provided written notice to the manufacturer specifying the deception or risk of illness or injury, the labeling or change in labeling to correct the deception or eliminate or reduce such risk, and the period within which such labeling or change in labeling was to be done, such labeling or change in labeling was not done within such period;"
  ]
  node [
    id 2166
    label "section_360f_subsection_b"
    class_name "subsection"
    text "(b) Special effective date"
  ]
  node [
    id 2167
    label "section_360g_subsection_a_item_9"
    class_name "item"
    text "(9) a regulation under section 360e(i)(2) or 360j(l)(5)(B) of this title, or"
  ]
  node [
    id 2168
    label "section_360g_subsection_b"
    class_name "subsection"
    text "(b) Additional data, views, and arguments"
  ]
  node [
    id 2169
    label "section_360g_subsection_a_item_3"
    class_name "item"
    text "(3) the issuance of an order under section 360d(b)(2) or 360e(b)(2)(B) of this title denying a request for reclassification of a device,"
  ]
  node [
    id 2170
    label "section_360g_subsection_c"
    class_name "subsection"
    text "(c) Standard for review"
  ]
  node [
    id 2171
    label "section_360g_subsection_a_item_6"
    class_name "item"
    text "(6) the issuance of an order under section 360j(f)(2) of this title,"
  ]
  node [
    id 2172
    label "section_360g_subsection_a_item_7"
    class_name "item"
    text "(7) an order under section 360j(g)(4) of this title disapproving an application for an exemption of a device for investigational use or an order under section 360j(g)(5) of this title withdrawing such an exemption for a device,"
  ]
  node [
    id 2173
    label "section_360g_subsection_e"
    class_name "subsection"
    text "(e) Remedies"
  ]
  node [
    id 2174
    label "section_360g_subsection_a_item_4"
    class_name "item"
    text "(4) the promulgation of a regulation under paragraph (3) of section 360e(b) of this title requiring a device to have an approval of a premarket application, a regulation under paragraph (4) of that section amending or revoking a regulation under paragraph (3), or an order pursuant to section 360e(g)(1) or 360e(g)(2)(C) of this title,"
  ]
  node [
    id 2175
    label "section_360g_subsection_c_item_5"
    class_name "item"
    text "Upon the filing of the petition under subsection (a) of this section for judicial review of a regulation or order, the court shall have jurisdiction to review the regulation or order in accordance with chapter 7 of title 5 and to grant appropriate relief, including interim relief, as provided in such chapter. A regulation described in paragraph (2) or (5) of subsection (a) of this section and an order issued after the review provided by section 360e(g) of this title shall not be affirmed if it is found to be unsupported by substantial evidence on the record taken as a whole."
  ]
  node [
    id 2176
    label "section_360g_subsection_a_item_2"
    class_name "item"
    text "(2) the promulgation of a regulation under section 360d of this title establishing, amending, or revoking a performance standard for a device,"
  ]
  node [
    id 2177
    label "section_360g_subsection_c_item_2"
    class_name "item"
    text "Upon the filing of the petition under subsection (a) of this section for judicial review of a regulation or order, the court shall have jurisdiction to review the regulation or order in accordance with chapter 7 of title 5 and to grant appropriate relief, including interim relief, as provided in such chapter. A regulation described in paragraph (2) or (5) of subsection (a) of this section and an order issued after the review provided by section 360e(g) of this title shall not be affirmed if it is found to be unsupported by substantial evidence on the record taken as a whole."
  ]
  node [
    id 2178
    label "section_360g_subsection_a"
    class_name "subsection"
    text "(a) Petition; record"
  ]
  node [
    id 2179
    label "section_360g_subsection_a_item_8"
    class_name "item"
    text "(8) an order pursuant to section 360c(i) of this title,"
  ]
  node [
    id 2180
    label "section_360g_subsection_d"
    class_name "subsection"
    text "(d) Finality of judgments"
  ]
  node [
    id 2181
    label "section_360g_subsection_a_item_1"
    class_name "item"
    text "(1) the promulgation of a regulation under section 360c of this title classifying a device in class I or changing the classification of a device to class I or an order under subsection (f)(2) of such section reclassifying a device or denying a petition for reclassification of a device,"
  ]
  node [
    id 2182
    label "section_360g_subsection_a_item_10"
    class_name "item"
    text "(10) an order under section 360j(h)(4)(B) of this title,"
  ]
  node [
    id 2183
    label "section_360g_subsection_a_item_5"
    class_name "item"
    text "(5) the promulgation of a regulation under section 360f of this title (other than a proposed regulation made effective under subsection (b) of such section upon the regulation's publication) making a device a banned device,"
  ]
  node [
    id 2184
    label "section_360g_subsection_f"
    class_name "subsection"
    text "(f) Statement of reasons"
  ]
  node [
    id 2185
    label "section_360h_subsection_e_item_2"
    class_name "item"
    text "(2)(A) If, after providing an opportunity for an informal hearing under paragraph (1), the Secretary determines that the order should be amended to include a recall of the device with respect to which the order was issued, the Secretary shall, except as provided in subparagraphs (B) and (C), amend the order to require a recall. The Secretary shall specify a timetable in which the device recall will occur and shall require periodic reports to the Secretary describing the progress of the recall."
  ]
  node [
    id 2186
    label "section_360h_subsection_b_item_2_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) at the time the device user receives actual notice of the unreasonable risk with respect to which the order was issued under paragraph (1),"
  ]
  node [
    id 2187
    label "section_360h_subsection_b_item_1_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the notification authorized by subsection (a) of this section would not by itself be sufficient to eliminate the unreasonable risk and action described in paragraph (2) of this subsection is necessary to eliminate such risk,"
  ]
  node [
    id 2188
    label "section_360h_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) To repair the device so that it does not present the unreasonable risk of substantial harm with respect to which the order under paragraph (1) was issued."
  ]
  node [
    id 2189
    label "section_360h_subsection_b_item_1"
    class_name "item"
    text "(1)(A) If, after affording opportunity for an informal hearing, the Secretary determines that&#8212;"
  ]
  node [
    id 2190
    label "section_360h_subsection_b_item_2"
    class_name "item"
    text "(2) The actions which may be taken under a plan submitted under an order issued under paragraph (1) are as follows:"
  ]
  node [
    id 2191
    label "section_360h_subsection_e"
    class_name "subsection"
    text "(e) Recall authority"
  ]
  node [
    id 2192
    label "section_360h_subsection_i"
    class_name "subsection"
    text "(i) shall&#8212;"
  ]
  node [
    id 2193
    label "section_360h_subsection_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) not include recall of a device from individuals, and"
  ]
  node [
    id 2194
    label "section_360h_subsection_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) not include recall of a device from device user facilities if the Secretary determines that the risk of recalling such device from the facilities presents a greater health risk than the health risk of not recalling the device from use, and"
  ]
  node [
    id 2195
    label "section_360h_subsection_b_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) a device intended for human use which is introduced or delivered for introduction into interstate commerce for commercial distribution presents an unreasonable risk of substantial harm to the public health,"
  ]
  node [
    id 2196
    label "section_360h_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) If, after affording opportunity for an informal hearing, the Secretary determines that&#8212;"
  ]
  node [
    id 2197
    label "section_360h_subsection_c"
    class_name "subsection"
    text "(c) Reimbursement"
  ]
  node [
    id 2198
    label "section_360h_subsection_i_subsubitem_ii"
    class_name "subsubitem"
    text "In providing the notice required by clause (ii), the Secretary may use the assistance of health professionals who prescribed or used such a device for individuals. If a significant number of such individuals cannot be identified, the Secretary shall notify such individuals pursuant to section 375(b) of this title."
  ]
  node [
    id 2199
    label "section_360h_subsection_a_item_2"
    class_name "item"
    text "(2) notification under this subsection is necessary to eliminate the unreasonable risk of such harm and no more practicable means is available under the provisions of this chapter (other than this section) to eliminate such risk,"
  ]
  node [
    id 2200
    label "section_360h_subsection_e_item_2_subitem_B"
    class_name "subitem"
    text "(B) An amended order under subparagraph (A)&#8212;"
  ]
  node [
    id 2201
    label "section_360h_subsection_b_item_2_subitem_C"
    class_name "subitem"
    text "(C) To refund the purchase price of the device (less a reasonable allowance for use if such device has been in the possession of the device user for one year or more&#8212;"
  ]
  node [
    id 2202
    label "section_360h_subsection_d"
    class_name "subsection"
    text "(d) Effect on other liability"
  ]
  node [
    id 2203
    label "section_360h_subsection_i_item_3"
    class_name "item"
    text "(3) The remedy provided by this subsection shall be in addition to remedies provided by subsections (a), (b), and (c) of this section."
  ]
  node [
    id 2204
    label "section_360h_subsection_e_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) If, after providing an opportunity for an informal hearing under paragraph (1), the Secretary determines that the order should be amended to include a recall of the device with respect to which the order was issued, the Secretary shall, except as provided in subparagraphs (B) and (C), amend the order to require a recall. The Secretary shall specify a timetable in which the device recall will occur and shall require periodic reports to the Secretary describing the progress of the recall."
  ]
  node [
    id 2205
    label "section_360h_subsection_b_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) there are reasonable grounds to believe that the device was not properly designed or manufactured with reference to the state of the art as it existed at the time of its design or manufacture,"
  ]
  node [
    id 2206
    label "section_360h_subsection_e_item_1"
    class_name "item"
    text "(1) If the Secretary finds that there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the Secretary shall issue an order requiring the appropriate person (including the manufacturers, importers, distributors, or retailers of the device)&#8212;"
  ]
  node [
    id 2207
    label "section_360h_subsection_a"
    class_name "subsection"
    text "(a) Notification"
  ]
  node [
    id 2208
    label "section_360h_subsection_a_item_1"
    class_name "item"
    text "(1) a device intended for human use which is introduced or delivered for introduction into interstate commerce for commercial distribution presents an unreasonable risk of substantial harm to the public health, and"
  ]
  node [
    id 2209
    label "section_360h_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) to immediately notify health professionals and device user facilities of the order and to instruct such professionals and facilities to cease use of such device."
  ]
  node [
    id 2210
    label "section_360h_subsection_b_item_3"
    class_name "item"
    text "(3) No charge shall be made to any person (other than a manufacturer, importer, distributor or retailer) for availing himself of any remedy, described in paragraph (2) and provided under an order issued under paragraph (1), and the person subject to the order shall reimburse each person (other than a manufacturer, importer, distributor, or retailer) who is entitled to such a remedy for any reasonable and foreseeable expenses actually incurred by such person in availing himself of such remedy."
  ]
  node [
    id 2211
    label "section_360h_subsection_b_item_2_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) at the time of notification ordered under subsection (a) of this section, or"
  ]
  node [
    id 2212
    label "section_360h_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(A) to immediately cease distribution of such device, and"
  ]
  node [
    id 2213
    label "section_360h_subsection_b"
    class_name "subsection"
    text "(b) Repair, replacement, or refund"
  ]
  node [
    id 2214
    label "section_360h_subsection_b_item_1_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) there are reasonable grounds to believe that the unreasonable risk was not caused by failure of a person other than a manufacturer, importer, distributor, or retailer of the device to exercise due care in the installation, maintenance, repair, or use of the device, and"
  ]
  node [
    id 2215
    label "section_360h_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) To replace the device with a like or equivalent device which is in conformity with all applicable requirements of this chapter."
  ]
  node [
    id 2216
    label "section_360i_subsection_b_item_5"
    class_name "item"
    text "(5) For purposes of this subsection:"
  ]
  node [
    id 2217
    label "section_360i_subsection_b_item_3_subitem_C"
    class_name "subitem"
    text "(C) a physician who is not required to make such a report,"
  ]
  node [
    id 2218
    label "section_360i_subsection_a_item_8_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) not in the possession of the manufacturer, importer, or distributor, or"
  ]
  node [
    id 2219
    label "section_360i_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) has malfunctioned and that such device or a similar device marketed by the manufacturer or importer would be likely to cause or contribute to a death or serious injury if the malfunction were to recur;"
  ]
  node [
    id 2220
    label "section_360i_subsection_b_item_3"
    class_name "item"
    text "(3) No report made under paragraph (1) by&#8212;"
  ]
  node [
    id 2221
    label "section_360i_subsection_a_item_2"
    class_name "item"
    text "(2) shall define the term &#8220;serious injury&#8221; to mean an injury that&#8212;"
  ]
  node [
    id 2222
    label "section_360i_subsection_a_item_8_subitem_B"
    class_name "subitem"
    text "(B) to submit for such a device to the Secretary any report or information&#8212;"
  ]
  node [
    id 2223
    label "section_360i_subsection_a_item_5"
    class_name "item"
    text "(5) which prescribe the procedure for making requests for reports or information shall require that each request made under such regulations for submission of a report or information to the Secretary state the reason or purpose for such request and identify to the fullest extent practicable such report or information;"
  ]
  node [
    id 2224
    label "section_360i_subsection_a_item_8_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) on a periodic basis,"
  ]
  node [
    id 2225
    label "section_360i_subsection_a_item_8"
    class_name "item"
    text "(8) may not require a manufacturer, importer, or distributor of a class I device to&#8212;"
  ]
  node [
    id 2226
    label "section_360i_subsection_b_item_2"
    class_name "item"
    text "(2) The Secretary may not disclose the identity of a device user facility which makes a report under paragraph (1) except in connection with&#8212;"
  ]
  node [
    id 2227
    label "section_360i_subsection_b_item_1_subitem_C_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the name and the address of the manufacturer of such device, and"
  ]
  node [
    id 2228
    label "section_360i_subsection_b_item_1"
    class_name "item"
    text "This paragraph does not prohibit the Secretary from disclosing the identity of a device user facility making a report under paragraph (1) or any information in such a report to employees of the Department of Health and Human Services, to the Department of Justice, or to the duly authorized committees and subcommittees of the Congress."
  ]
  node [
    id 2229
    label "section_360i_subsection_a_item_9"
    class_name "item"
    text "(9) shall require distributors who submit such reports to submit copies of the reports to the manufacturer of the device for which the report was made."
  ]
  node [
    id 2230
    label "section_360i_subsection_b_item_5_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) results in permanent impairment of a body function or permanent damage to a body structure, or"
  ]
  node [
    id 2231
    label "section_360i_subsection_b_item_5_subitem_B"
    class_name "subitem"
    text "(B) The terms &#8220;serious illness&#8221; and &#8220;serious injury&#8221; mean illness or injury, respectively, that&#8212;"
  ]
  node [
    id 2232
    label "section_360i_subsection_b_item_1_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) in the case of any product which was the subject of a report, the product name, serial number, and model number,"
  ]
  node [
    id 2233
    label "section_360i_subsection_a"
    class_name "subsection"
    text "(a) General rule"
  ]
  node [
    id 2234
    label "section_360i_subsection_a_item_6"
    class_name "item"
    text "(6) which require submission of a report or information to the Secretary shall state the reason or purpose for the submission of such report or information and identify to the fullest extent practicable such report or information;"
  ]
  node [
    id 2235
    label "section_360i_subsection_f_item_1"
    class_name "item"
    text "(1) Except as provided in paragraph (2), the Secretary shall by regulation require a manufacturer, importer, or distributor of a device to report promptly to the Secretary any correction or removal of a device undertaken by such manufacturer, importer, or distributor if the removal or correction was undertaken&#8212;"
  ]
  node [
    id 2236
    label "section_360i_subsection_c"
    class_name "subsection"
    text "(c) Persons exempt"
  ]
  node [
    id 2237
    label "section_360i_subsection_a_item_4"
    class_name "item"
    text "(4) shall not impose requirements unduly burdensome to a device manufacturer, importer, or distributor taking into account his cost of complying with such requirements and the need for the protection of the public health and the implementation of this chapter;"
  ]
  node [
    id 2238
    label "section_360i_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) Whenever a device user facility receives or otherwise becomes aware of information that reasonably suggests that a device has or may have caused or contributed to the death of a patient of the facility, the facility shall, as soon as practicable but not later than 10 working days after becoming aware of the information, report the information to the Secretary and, if the identity of the manufacturer is known, to the manufacturer of the device. In the case of deaths, the Secretary may by regulation prescribe a shorter period for the reporting of such information."
  ]
  node [
    id 2239
    label "section_360i_subsection_a_item_3"
    class_name "item"
    text "(3) shall require reporting of other significant adverse device experiences as determined by the Secretary to be necessary to be reported;"
  ]
  node [
    id 2240
    label "section_360i_subsection_b_item_1_subitem_D"
    class_name "subitem"
    text "(D) For purposes of subparagraphs (A), (B), and (C), a device user facility shall be treated as having received or otherwise become aware of information with respect to a device of that facility when medical personnel who are employed by or otherwise formally affiliated with the facility receive or otherwise become aware of information with respect to that device in the course of their duties."
  ]
  node [
    id 2241
    label "section_360i_subsection_a_item_1"
    class_name "item"
    text "(1) shall require a device manufacturer or importer to report to the Secretary whenever the manufacturer or importer receives or otherwise becomes aware of information that reasonably suggests that one of its marketed devices&#8212;"
  ]
  node [
    id 2242
    label "section_360i_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) to remedy a violation of this chapter caused by the device which may present a risk to health."
  ]
  node [
    id 2243
    label "section_360i_subsection_b_item_1_subitem_C_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) a brief description of the event reported to the manufacturer."
  ]
  node [
    id 2244
    label "section_360i_subsection_b_item_3_subitem_A"
    class_name "subitem"
    text "(A) a device user facility,"
  ]
  node [
    id 2245
    label "section_360i_subsection_d"
    class_name "subsection"
    text "(d) Certification"
  ]
  node [
    id 2246
    label "section_360i_subsection_f_item_2"
    class_name "item"
    text "(2) No report of the corrective action or removal of a device may be required under paragraph (1) if a report of the corrective action or removal is required and has been submitted under subsection (a) of this section."
  ]
  node [
    id 2247
    label "section_360i_subsection_e"
    class_name "subsection"
    text "(e) Device tracking"
  ]
  node [
    id 2248
    label "section_360i_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) may have caused or contributed to a death or serious injury, or"
  ]
  node [
    id 2249
    label "section_360i_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) an action brought to enforce section 331(q) of this title,"
  ]
  node [
    id 2250
    label "section_360i_subsection_b_item_5_subitem_A"
    class_name "subitem"
    text "(A) The term &#8220;device user facility&#8221; means a hospital, ambulatory surgical facility, nursing home, or outpatient treatment facility which is not a physician's office. The Secretary may by regulation include an outpatient diagnostic facility which is not a physician's office in such term."
  ]
  node [
    id 2251
    label "section_360i_subsection_b_item_5_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) is life threatening,"
  ]
  node [
    id 2252
    label "section_360i_subsection_b_item_2_subitem_C"
    class_name "subitem"
    text "(C) a disclosure required under subsection (a) of this section."
  ]
  node [
    id 2253
    label "section_360i_subsection_a_item_2_subitem_C"
    class_name "subitem"
    text "(C) necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure;"
  ]
  node [
    id 2254
    label "section_360i_subsection_b_item_1_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) sufficient information to identify the facility which made the reports for which the summary is submitted,"
  ]
  node [
    id 2255
    label "section_360i_subsection_b_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) other significant adverse device experiences as determined by the Secretary by regulation to be necessary to be reported,"
  ]
  node [
    id 2256
    label "section_360i_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) results in permanent impairment of a body function or permanent damage to a body structure, or"
  ]
  node [
    id 2257
    label "section_360i_subsection_c_item_1"
    class_name "item"
    text "(1) any practitioner who is licensed by law to prescribe or administer devices intended for use in humans and who manufactures or imports devices solely for use in the course of his professional practice;"
  ]
  node [
    id 2258
    label "section_360i_subsection_b_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) information that reasonably suggests that a device has or may have caused or contributed to the serious illness of, or serious injury to, a patient of the facility, or"
  ]
  node [
    id 2259
    label "section_360i_subsection_b_item_4"
    class_name "item"
    text "(4) A report made under paragraph (1) does not affect any obligation of a manufacturer who receives the report to file a report as required under subsection (a) of this section."
  ]
  node [
    id 2260
    label "section_360i_subsection_e_item_1"
    class_name "item"
    text "(1) a device the failure of which would be reasonably likely to have serious adverse health consequences and which is (A) a permanently implantable device, or (B) a life sustaining or life supporting device used outside a device user facility, or"
  ]
  node [
    id 2261
    label "section_360i_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) is life threatening,"
  ]
  node [
    id 2262
    label "section_360i_subsection_a_item_7"
    class_name "item"
    text "In prescribing such regulations, the Secretary shall have due regard for the professional ethics of the medical profession and the interests of patients. The prohibitions of paragraph (7) of this subsection continue to apply to records, reports, and information concerning any individual who has been a patient, irrespective of whether or when he ceases to be a patient."
  ]
  node [
    id 2263
    label "section_360i_subsection_d_item_2"
    class_name "item"
    text "(2) the manufacturer, importer, or distributor did not file any report under subsection (a) of this section."
  ]
  node [
    id 2264
    label "section_360i_subsection_b"
    class_name "subsection"
    text "(b) User reports"
  ]
  node [
    id 2265
    label "section_360i_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) Each device user facility shall submit to the Secretary on a semi-annual basis a summary of the reports made under subparagraphs (A) and (B). Such summary shall be submitted on January 1 and July 1 of each year. The summary shall be in such form and contain such information from such reports as the Secretary may require and shall include&#8212;"
  ]
  node [
    id 2266
    label "section_360i_subsection_f"
    class_name "subsection"
    text "(f) Reports of removals and corrections"
  ]
  node [
    id 2267
    label "section_360i_subsection_a_item_8_subitem_A"
    class_name "subitem"
    text "(A) maintain for such a device records respecting information not in the possession of the manufacturer, importer, or distributor, or"
  ]
  node [
    id 2268
    label "section_360i_subsection_b_item_3_subitem_B"
    class_name "subitem"
    text "(B) an individual who is employed by or otherwise formally affiliated with such a facility, or"
  ]
  node [
    id 2269
    label "section_360i_subsection_c_item_2"
    class_name "item"
    text "(2) any person who manufactures or imports devices intended for use in humans solely for such person's use in research or teaching and not for sale (including any person who uses a device under an exemption granted under section 360j(g) of this title); and"
  ]
  node [
    id 2270
    label "section_360i_subsection_d_item_1"
    class_name "item"
    text "(1) the manufacturer, importer, or distributor did file a certain number of such reports, or"
  ]
  node [
    id 2271
    label "section_360i_subsection_f_item_3"
    class_name "item"
    text "(3) For purposes of paragraphs (1) and (2), the terms &#8220;correction&#8221; and &#8220;removal&#8221; do not include routine servicing."
  ]
  node [
    id 2272
    label "section_360i_subsection_c_item_3"
    class_name "item"
    text "(3) any other class of persons as the Secretary may by regulation exempt from subsection (a) of this section upon a finding that compliance with the requirements of such subsection by such class with respect to a device is not necessary to (A) assure that a device is not adulterated or misbranded or (B) otherwise to assure its safety and effectiveness."
  ]
  node [
    id 2273
    label "section_360i_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(A) to reduce a risk to health posed by the device, or"
  ]
  node [
    id 2274
    label "section_360i_subsection_e_item_2"
    class_name "item"
    text "(2) any other device which the Secretary may designate,"
  ]
  node [
    id 2275
    label "section_360i_subsection_b_item_5_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure."
  ]
  node [
    id 2276
    label "section_360i_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) a communication to a manufacturer of a device which is the subject of a report under paragraph (1), or"
  ]
  node [
    id 2277
    label "section_360i_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) Whenever a device user facility receives or otherwise becomes aware of&#8212;"
  ]
  node [
    id 2278
    label "section_360j_subsection_m_item_2_subitem_C"
    class_name "subitem"
    text "(C) the device will not expose patients to an unreasonable or significant risk of illness or injury and the probable benefit to health from the use of the device outweighs the risk of injury or illness from its use, taking into account the probable risks and benefits of currently available devices or alternative forms of treatment."
  ]
  node [
    id 2279
    label "section_360j_subsection_l_item_5_subitem_A"
    class_name "subitem"
    text "(5)(A) Before December 1, 1991, the Secretary shall by order require manufacturers of devices described in paragraph (1), which are subject to revision of classification under subparagraph (B), to submit to the Secretary a summary of and citation to any information known or otherwise available to the manufacturers respecting the devices, including adverse safety or effectiveness information which has not been submitted under section 360i of this title. The Secretary may require a manufacturer to submit the adverse safety or effectiveness data for which a summary and citation were submitted, if such data are available to the manufacturer."
  ]
  node [
    id 2280
    label "section_360j_subsection_i_item_5"
    class_name "item"
    text "Each panel under section 360c of this title and each advisory committee established under section 360d(b)(5)(B) or 360e(g) of this title or under subsection (f) of this section shall make and maintain a transcript of any proceeding of the panel or committee. Each such panel and committee shall delete from any transcript made pursuant to this subsection information which under subsection (c) of this section is to be considered confidential."
  ]
  node [
    id 2281
    label "section_360j_subsection_f_item_3_subitem_B"
    class_name "subitem"
    text "(B) Two of the members shall be appointed from persons who are representative of interests of the device manufacturing industry; two of the members shall be appointed from persons who are representative of the interests of physicians and other health professionals; and two of the members shall be representative of the interests of the general public."
  ]
  node [
    id 2282
    label "section_360j_subsection_f_item_2"
    class_name "item"
    text "(2)(A) Any person subject to any requirement prescribed by regulations under paragraph (1) may petition the Secretary for an exemption or variance from such requirement. Such a petition shall be submitted to the Secretary in such form and manner as he shall prescribe and shall&#8212;"
  ]
  node [
    id 2283
    label "section_360j_subsection_h_item_4"
    class_name "item"
    text "(4)(A) Any information contained in an application for premarket approval filed with the Secretary pursuant to section 360e(c) of this title, including clinical and preclinical tests or studies, but excluding descriptions of methods of manufacture and product composition, that demonstrates the safety and effectiveness of a device shall be available 1 year after the original application for the fourth device of a kind has been approved by the Secretary, for use by the Secretary in approving devices, or determining whether a product development protocol has been completed, under section 360e of this title, establishing a performance standard under section 360d of this title, and reclassifying devices under subsections (e) and (f) of section 360c of this title, and subsection (l)(2) of this section. The Secretary shall deem devices that incorporate the same technologies, have the same principles of operation, and are intended for the same use or uses to be within a kind of device."
  ]
  node [
    id 2284
    label "section_360j_subsection_h_item_4_subitem_D_subsubitem_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) on November 15, 1991, for devices not described in subclause (I)."
  ]
  node [
    id 2285
    label "section_360j_subsection_g_item_4_subitem_B"
    class_name "subitem"
    text "(B) The Secretary may disapprove an application only if he finds that the investigation with respect to which the application is submitted does not conform to procedures and conditions prescribed under regulations under paragraph (2). Such a notification shall contain the order of disapproval and a complete statement of the reasons for the Secretary's disapproval of the application and afford the applicant opportunity for an informal hearing on the disapproval order."
  ]
  node [
    id 2286
    label "section_360j_subsection_m"
    class_name "subsection"
    text "(m) Humanitarian device exemption"
  ]
  node [
    id 2287
    label "section_360j_subsection_d"
    class_name "subsection"
    text "(d) Notices and findings"
  ]
  node [
    id 2288
    label "section_360j_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "if, because of its potentiality for harmful effect or the collateral measures necessary to its use, the Secretary determines that there cannot otherwise be reasonable assurance of its safety and effectiveness. No condition prescribed under subparagraph (B) may restrict the use of a device to persons with specific training or experience in its use or to persons for use in certain facilities unless the Secretary determines that such a restriction is required for the safe and effective use of the device. No such condition may exclude a person from using a device solely because the person does not have the training or experience to make him eligible for certification by a certifying board recognized by the American Board of Medical Specialties or has not been certified by such a Board. A device subject to a regulation under this subsection is a restricted device."
  ]
  node [
    id 2289
    label "section_360j_subsection_h_item_4_subitem_B"
    class_name "subitem"
    text "(B) The Secretary, contemporaneously with the approval of the fourth device of a kind, shall publish an order in the Federal Register identifying the four devices of a kind that have been approved under section 360e of this title and the date on which the data contained in premarket approval applications for the devices will be available to the Secretary for use, as described in subparagraph (A)."
  ]
  node [
    id 2290
    label "section_360j_subsection_k"
    class_name "subsection"
    text "(k) Research and development"
  ]
  node [
    id 2291
    label "section_360j_subsection_l_item_2_subsubitem_i"
    class_name "subsubitem"
    text "within the sixty-day period beginning on the enactment date (or within such greater period as the Secretary, after making the finding required under section 360e(d)(1)(B) of this title, and the petitioner or applicant may agree upon), the Secretary shall act on such petition or application in accordance with paragraph (2) or section 360e of this title except that the period within which the Secretary must act on the petition or application shall be within the one hundred and twenty-day period beginning on the date the petition or application is filed. If such a petition or application is filed within such sixty-day (or greater) period, clause (i) of this subparagraph shall not apply to such device before the expiration of such one hundred and twenty-day period, or if such petition is denied or such application is denied approval, before the date of such denial, whichever occurs first."
  ]
  node [
    id 2292
    label "section_360j_subsection_g_item_5"
    class_name "item"
    text "(5) The Secretary may by order withdraw an exemption granted under this subsection for a device if the Secretary determines that the conditions applicable to the device under this subsection for such exemption are not met. Such an order may be issued only after opportunity for an informal hearing, except that such an order may be issued before the provision of an opportunity for an informal hearing if the Secretary determines that the continuation of testing under the exemption with respect to which the order is to be issued will result in an unreasonable risk to the public health."
  ]
  node [
    id 2293
    label "section_360j_subsection_l_item_3_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If&#8212;"
  ]
  node [
    id 2294
    label "section_360j_subsection_e"
    class_name "subsection"
    text "(e) Restricted devices"
  ]
  node [
    id 2295
    label "section_360j_subsection_g_item_2_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) Such other requirements as the Secretary may determine to be necessary for the protection of the public health and safety."
  ]
  node [
    id 2296
    label "section_360j_subsection_l_item_1_subitem_E"
    class_name "subitem"
    text "(E) which the Secretary in a notice published in the Federal Register before the enactment date has declared to be a new drug subject to section 355 of this title; or"
  ]
  node [
    id 2297
    label "section_360j_subsection_f_item_2_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) a petition for a variance for a device from a requirement if he determines that the methods to be used in, and the facilities and controls to be used for, the manufacture, packing, storage, and installation of the device in lieu of the methods, controls, and facilities prescribed by the requirement are sufficient to assure that the device will be safe and effective and otherwise in compliance with this chapter."
  ]
  node [
    id 2298
    label "section_360j_subsection_f_item_3_subitem_A"
    class_name "subitem"
    text "(A) Three of the members shall be appointed from persons who are officers or employees of any State or local government or of the Federal Government."
  ]
  node [
    id 2299
    label "section_360j_subsection_g_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) The Secretary shall, within the one hundred and twenty-day period beginning on May 28, 1976, by regulation prescribe procedures and conditions under which devices intended for human use may upon application be granted an exemption from the requirements of section 352, 360, 360d, 360e, 360f, 360i, or 379e of this title or subsection (e) or (f) of this section or from any combination of such requirements to permit the investigational use of such devices by experts qualified by scientific training and experience to investigate the safety and effectiveness of such devices."
  ]
  node [
    id 2300
    label "section_360j_subsection_g_item_3"
    class_name "item"
    text "(3) Procedures and conditions prescribed pursuant to paragraph (2)(A) shall require, as a condition to the exemption of any device to be the subject of testing involving human subjects, that the person applying for the exemption&#8212;"
  ]
  node [
    id 2301
    label "section_360j_subsection_c_item_2"
    class_name "item"
    text "Any information reported to or otherwise obtained by the Secretary or his representative under section 360c, 360d, 360e, 360f, 360h, 360i, or 374 of this title or under subsection (f) or (g) of this section which is exempt from disclosure pursuant to subsection (a) of section 552 of title 5 by reason of subsection (b)(4) of such section shall be considered confidential and shall not be disclosed and may not be used by the Secretary as the basis for the reclassification of a device from class III to class II or class I or as the basis for the establishment or amendment of a performance standard under section 360d of this title for a device reclassified from class III to class II, except (1) in accordance with subsection (h) of this section, and (2) that such information may be disclosed to other officers or employees concerned with carrying out this chapter or when relevant in any proceeding under this chapter (other than section 360c or 360d of this title)."
  ]
  node [
    id 2302
    label "section_360j_subsection_l_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) In the case of a device which is described in paragraph (1)(A) and which is in class III&#8212;"
  ]
  node [
    id 2303
    label "section_360j_subsection_g"
    class_name "subsection"
    text "(g) Exemption for devices for investigational use"
  ]
  node [
    id 2304
    label "section_360j_subsection_b_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) is intended to meet the special needs of such physician or dentist (or other specially qualified person so designated) in the course of the professional practice of such physician or dentist (or other specially qualified person so designated), and"
  ]
  node [
    id 2305
    label "section_360j_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A)(i) is intended for use by an individual patient named in such order of such physician or dentist (or other specially qualified person so designated) and is to be made in a specific form for such patient, or"
  ]
  node [
    id 2306
    label "section_360j_subsection_i"
    class_name "subsection"
    text "(i) Proceedings of advisory panels and committees"
  ]
  node [
    id 2307
    label "section_360j_subsection_l_item_1_subitem_A"
    class_name "subitem"
    text "(A) for which on May 28, 1976 (hereinafter in this subsection referred to as the &#8220;enactment date&#8221;) an approval of an application submitted under section 355(b) of this title was in effect;"
  ]
  node [
    id 2308
    label "section_360j_subsection_a"
    class_name "subsection"
    text "(a) General rule"
  ]
  node [
    id 2309
    label "section_360j_subsection_g_item_3_subitem_A_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the Secretary finds that the process of review by such committee is inadequate (whether or not the plan for such testing has been approved by such committee),"
  ]
  node [
    id 2310
    label "section_360j_subsection_m_item_2"
    class_name "item"
    text "(2) The Secretary may grant a request for an exemption from the effectiveness requirements of sections 360d and 360e of this title for a device for which the Secretary finds that&#8212;"
  ]
  node [
    id 2311
    label "section_360j_subsection_h_item_4_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(D)(i) This paragraph shall become effective&#8212;"
  ]
  node [
    id 2312
    label "section_360j_subsection_f_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the date the petition was submitted to the Secretary under subparagraph (A), or"
  ]
  node [
    id 2313
    label "section_360j_subsection_d_item_1"
    class_name "item"
    text "(1) the manner in which interested persons may examine data and other information on which the notice or findings is based, and"
  ]
  node [
    id 2314
    label "section_360j_subsection_m_item_5"
    class_name "item"
    text "(5) An exemption under paragraph (2) shall be for a term of 18 months and may only be initially granted in the 5-year period beginning on the date regulations under paragraph (6) take effect. The Secretary may extend such an exemption for a period of 18 months if the Secretary is able to make the findings set forth in paragraph (2) and if the applicant supplies information demonstrating compliance with paragraph (3). An exemption may be extended more than once and may be extended after the expiration of such 5-year period."
  ]
  node [
    id 2315
    label "section_360j_subsection_l_item_4_subitem_A"
    class_name "subitem"
    text "(A) In the case of such a device which is classified into class I, such requirements shall apply to such device until the effective date of the regulation classifying the device into such class."
  ]
  node [
    id 2316
    label "section_360j_subsection_f_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) in the case of a petition for a variance from a requirement, set forth the methods proposed to be used in, and the facilities and controls proposed to be used for, the manufacture, packing, storage, and installation of the device in lieu of the methods, facilities, and controls prescribed by the requirement, and"
  ]
  node [
    id 2317
    label "section_360j_subsection_g_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) to the local institutional review committee which has been established in accordance with regulations of the Secretary to supervise clinical testing of devices in the facilities where the proposed clinical testing is to be conducted, or"
  ]
  node [
    id 2318
    label "section_360j_subsection_g_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) A requirement that the person applying for an exemption for a device assure the establishment and maintenance of such records, and the making of such reports to the Secretary of data obtained as a result of the investigational use of the device during the exemption, as the Secretary determines will enable him to assure compliance with such conditions, review the progress of the investigation, and evaluate the safety and effectiveness of the device."
  ]
  node [
    id 2319
    label "section_360j_subsection_f_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) afford opportunity for an oral hearing."
  ]
  node [
    id 2320
    label "section_360j_subsection_g_item_1"
    class_name "item"
    text "(1) It is the purpose of this subsection to encourage, to the extent consistent with the protection of the public health and safety and with ethical standards, the discovery and development of useful devices intended for human use and to that end to maintain optimum freedom for scientific investigators in their pursuit of that purpose."
  ]
  node [
    id 2321
    label "section_360j_subsection_f_item_2_subitem_B"
    class_name "subitem"
    text "(B) The Secretary may refer to the advisory committee established under paragraph (3) any petition submitted under subparagraph (A). The advisory committee shall report its recommendations to the Secretary with respect to a petition referred to it within sixty days of the date of the petition's referral. Within sixty days after&#8212;"
  ]
  node [
    id 2322
    label "section_360j_subsection_i_item_5_subitem_B"
    class_name "subitem"
    text "Each panel under section 360c of this title and each advisory committee established under section 360d(b)(5)(B) or 360e(g) of this title or under subsection (f) of this section shall make and maintain a transcript of any proceeding of the panel or committee. Each such panel and committee shall delete from any transcript made pursuant to this subsection information which under subsection (c) of this section is to be considered confidential."
  ]
  node [
    id 2323
    label "section_360j_subsection_g_item_4"
    class_name "item"
    text "(4)(A) An application, submitted in accordance with the procedures prescribed by regulations under paragraph (2), for an exemption for a device (other than an exemption from section 360f of this title) shall be deemed approved on the thirtieth day after the submission of the application to the Secretary unless on or before such day the Secretary by order disapproves the application and notifies the applicant of the disapproval of the application."
  ]
  node [
    id 2324
    label "section_360j_subsection_l_item_5"
    class_name "item"
    text "(5)(A) Before December 1, 1991, the Secretary shall by order require manufacturers of devices described in paragraph (1), which are subject to revision of classification under subparagraph (B), to submit to the Secretary a summary of and citation to any information known or otherwise available to the manufacturers respecting the devices, including adverse safety or effectiveness information which has not been submitted under section 360i of this title. The Secretary may require a manufacturer to submit the adverse safety or effectiveness data for which a summary and citation were submitted, if such data are available to the manufacturer."
  ]
  node [
    id 2325
    label "section_360j_subsection_f_item_2_subitem_C"
    class_name "subitem"
    text "(C) The Secretary may approve&#8212;"
  ]
  node [
    id 2326
    label "section_360j_subsection_l_item_5_subitem_B"
    class_name "subitem"
    text "(B) Except as provided in subparagraph (C), after the issuance of an order under subparagraph (A) but before December 1, 1992, the Secretary shall publish a regulation in the Federal Register for each device which is classified in class III under paragraph (1) revising the classification of the device so that the device is classified into class I or class II, unless the regulation requires the device to remain in class III. In determining whether to revise the classification of a device or to require a device to remain in class III, the Secretary shall apply the criteria set forth in section 360c(a) of this title. Before the publication of a regulation requiring a device to remain in class III or revising its classification, the Secretary shall publish a proposed regulation respecting the classification of a device under this subparagraph and provide an opportunity for the submission of comments on any such regulation. No regulation under this subparagraph requiring a device to remain in class III or revising its classification may take effect before the expiration of 90 days from the date of the publication in the Federal Register of the proposed regulation."
  ]
  node [
    id 2327
    label "section_360j_subsection_l_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) such device shall on the enactment date be considered a device with an approved application under section 360e of this title, and"
  ]
  node [
    id 2328
    label "section_360j_subsection_l_item_3_subitem_D_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) a petition is filed under paragraph (2) for a device described in subparagraph (D), (E), or (F) of paragraph (1), or"
  ]
  node [
    id 2329
    label "section_360j_subsection_m_item_4"
    class_name "item"
    text "(4) Devices granted an exemption under paragraph (2) may only be used&#8212;"
  ]
  node [
    id 2330
    label "section_360j_subsection_l_item_2_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) In the case of a device which is described in subparagraph (E) of paragraph (1), which the Secretary in a notice published in the Federal Register after March 31, 1976, declared to be a new drug subject to section 355 of this title, and which is in class III&#8212;"
  ]
  node [
    id 2331
    label "section_360j_subsection_j"
    class_name "subsection"
    text "(j) Traceability"
  ]
  node [
    id 2332
    label "section_360j_subsection_l_item_4_subitem_B"
    class_name "subitem"
    text "(B) In the case of such a device which is classified into class II, such requirements shall apply to such device until the effective date of a performance standard applicable to the device under section 360d of this title."
  ]
  node [
    id 2333
    label "section_360j_subsection_b_item_1"
    class_name "item"
    text "Sections 360d and 360e of this title do not apply to any device which, in order to comply with the order of an individual physician or dentist (or any other specially qualified person designated under regulations promulgated by the Secretary after an opportunity for an oral hearing) necessarily deviates from an otherwise applicable performance standard or requirement prescribed by or under section 360e of this title if (1) the device is not generally available in finished form for purchase or for dispensing upon prescription and is not offered through labeling or advertising by the manufacturer, importer, or distributor thereof for commercial distribution, and (2) such device&#8212;"
  ]
  node [
    id 2334
    label "section_360j_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "The Secretary shall provide the advisory committee a reasonable time to make its recommendation with respect to proposed regulations under subparagraph (A)."
  ]
  node [
    id 2335
    label "section_360j_subsection_g_item_3_subitem_C"
    class_name "subitem"
    text "(C) in the case of a device to be distributed to investigators for testing, obtain signed agreements from each of such investigators that any testing of the device involving human subjects will be under such investigator's supervision and in accordance with subparagraph (D) and submit such agreements to the Secretary; and"
  ]
  node [
    id 2336
    label "section_360j_subsection_l_item_2_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the Secretary may, during the period beginning one hundred and eighty days after the enactment date and ending eighteen months after such date, restrict the use of the device to investigational use by experts qualified by scientific training and experience to investigate the safety and effectiveness of such device, and to investigational use in accordance with the requirements applicable under regulations under subsection (g) of this section to investigational use of devices granted an exemption under such subsection."
  ]
  node [
    id 2337
    label "section_360j_subsection_l_item_1_subitem_D"
    class_name "subitem"
    text "(D) which is within a type of device described in subparagraph (A), (B), or (C) and is substantially equivalent to another device within that type;"
  ]
  node [
    id 2338
    label "section_360j_subsection_l_item_3_subitem_B"
    class_name "subitem"
    text "(B) In the case of a device which is described in paragraph (1)(B) and which is in class III, an application for such device shall be considered as having been filed under section 360e of this title on the enactment date. The period in which the Secretary shall act on such application in accordance with section 360e(d)(1) of this title shall be one hundred and eighty days from the enactment date (or such greater period as the Secretary and the applicant may agree upon after the Secretary has made the finding required by section 360e(d)(1)(B)(i) of this title) less the number of days in the period beginning on the date an application for such device was filed under section 355 of this title and ending on the enactment date. After the expiration of such period such device is required, unless exempt under subsection (g) of this section, to have in effect an approved application under section 360e of this title."
  ]
  node [
    id 2339
    label "section_360j_subsection_m_item_6"
    class_name "item"
    text "(6) Within one year of November 28, 1990, the Secretary shall issue regulations to implement this subsection."
  ]
  node [
    id 2340
    label "section_360j_subsection_h_item_4_subitem_D_subsubitem_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) on November 15, 1990, for devices for which four devices of a kind were approved on or before December 31, 1987, and"
  ]
  node [
    id 2341
    label "section_360j_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) is not generally available to or generally used by other physicians or dentists (or other specially qualified persons so designated)."
  ]
  node [
    id 2342
    label "section_360j_subsection_l_item_5_subitem_C"
    class_name "subitem"
    text "(C) The Secretary may by notice published in the Federal Register extend the period prescribed by subparagraph (B) for a device for an additional period not to exceed 1 year."
  ]
  node [
    id 2343
    label "section_360j_subsection_h_item_1_subitem_A"
    class_name "subitem"
    text "(A) an order under section 360e(d)(1)(A) of this title approving an application for premarket approval for the device or denying approval of such an application or an order under section 360e(e) of this title withdrawing approval of such an application for the device,"
  ]
  node [
    id 2344
    label "section_360j_subsection_f_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Any person subject to any requirement prescribed by regulations under paragraph (1) may petition the Secretary for an exemption or variance from such requirement. Such a petition shall be submitted to the Secretary in such form and manner as he shall prescribe and shall&#8212;"
  ]
  node [
    id 2345
    label "section_360j_subsection_f"
    class_name "subsection"
    text "(f) Good manufacturing practice requirements"
  ]
  node [
    id 2346
    label "section_360j_subsection_l_item_1_subitem_F"
    class_name "subitem"
    text "(F) with respect to which on the enactment date an action is pending in a United States court under section 332, 333, or 334 of this title for an alleged violation of a provision of section 331 of this title which enforces a requirement of section 355 of this title or for an alleged violation of section 355(a) of this title,"
  ]
  node [
    id 2347
    label "section_360j_subsection_c_item_4"
    class_name "item"
    text "Any information reported to or otherwise obtained by the Secretary or his representative under section 360c, 360d, 360e, 360f, 360h, 360i, or 374 of this title or under subsection (f) or (g) of this section which is exempt from disclosure pursuant to subsection (a) of section 552 of title 5 by reason of subsection (b)(4) of such section shall be considered confidential and shall not be disclosed and may not be used by the Secretary as the basis for the reclassification of a device from class III to class II or class I or as the basis for the establishment or amendment of a performance standard under section 360d of this title for a device reclassified from class III to class II, except (1) in accordance with subsection (h) of this section, and (2) that such information may be disclosed to other officers or employees concerned with carrying out this chapter or when relevant in any proceeding under this chapter (other than section 360c or 360d of this title)."
  ]
  node [
    id 2348
    label "section_360j_subsection_l_item_3_subitem_D"
    class_name "subitem"
    text "(D)(i) Except as provided in clauses (ii) and (iii), a device which is described in subparagraph (D), (E), or (F) of paragraph (1) and which is in class III is required, unless exempt under subsection (g) of this section, to have on and after sixty days after the enactment date in effect an approved application under section 360e of this title."
  ]
  node [
    id 2349
    label "section_360j_subsection_f_item_3"
    class_name "item"
    text "(3) The Secretary shall establish an advisory committee for the purpose of advising and making recommendations to him with respect to regulations proposed to be promulgated under paragraph (1)(A) and the approval or disapproval of petitions submitted under paragraph (2). The advisory committee shall be composed of nine members as follows:"
  ]
  node [
    id 2350
    label "section_360j_subsection_h_item_2"
    class_name "item"
    text "(2) The Secretary shall promulgate regulations under which each advisory committee established under section 360e(g)(2)(B) of this title shall make available to the public a detailed summary of information respecting the safety and effectiveness of a device which information was submitted to the advisory committee and which was the basis for its recommendation to the Secretary made pursuant to section 360e(g)(2)(A) of this title. A summary of information upon which such a recommendation is based shall be made available pursuant to this paragraph only after the issuance of the order with respect to which the recommendation was made and each summary shall include information respecting any adverse effect on health of the device subject to such order."
  ]
  node [
    id 2351
    label "section_360j_subsection_g_item_2_subitem_B"
    class_name "subitem"
    text "(B) The conditions prescribed pursuant to subparagraph (A) shall include the following:"
  ]
  node [
    id 2352
    label "section_360j_subsection_m_item_1"
    class_name "item"
    text "(1) To the extent consistent with the protection of the public health and safety and with ethical standards, it is the purpose of this subsection to encourage the discovery and use of devices intended to benefit patients in the treatment and diagnosis of diseases or conditions that affect fewer than 4,000 individuals in the United States."
  ]
  node [
    id 2353
    label "section_360j_subsection_l_item_4_subitem_C"
    class_name "subitem"
    text "(C) In the case of such a device which is classified into class III, such requirements shall apply to such device until the date on which the device is required to have in effect an approved application under section 360e of this title."
  ]
  node [
    id 2354
    label "section_360j_subsection_h"
    class_name "subsection"
    text "(h) Release of information respecting safety and effectiveness"
  ]
  node [
    id 2355
    label "section_360j_subsection_h_item_1"
    class_name "item"
    text "(1) The Secretary shall promulgate regulations under which a detailed summary of information respecting the safety and effectiveness of a device which information was submitted to the Secretary and which was the basis for&#8212;"
  ]
  node [
    id 2356
    label "section_360j_subsection_l_item_1_subitem_C"
    class_name "subitem"
    text "(C) for which on the enactment date an exemption under subsection (i) of such section was in effect;"
  ]
  node [
    id 2357
    label "section_360j_subsection_g_item_2"
    class_name "item"
    text "(2)(A) The Secretary shall, within the one hundred and twenty-day period beginning on May 28, 1976, by regulation prescribe procedures and conditions under which devices intended for human use may upon application be granted an exemption from the requirements of section 352, 360, 360d, 360e, 360f, 360i, or 379e of this title or subsection (e) or (f) of this section or from any combination of such requirements to permit the investigational use of such devices by experts qualified by scientific training and experience to investigate the safety and effectiveness of such devices."
  ]
  node [
    id 2358
    label "section_360j_subsection_l_item_2_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the device shall, after eighteen months after the enactment date, have in effect an approved application under section 360e of this title unless exempt under subsection (g) of this section, and"
  ]
  node [
    id 2359
    label "section_360j_subsection_h_item_4_subitem_D"
    class_name "subitem"
    text "(D)(i) This paragraph shall become effective&#8212;"
  ]
  node [
    id 2360
    label "section_360j_subsection_f_item_2_subitem_D"
    class_name "subitem"
    text "(D) After the issuance of an order under subparagraph (B) respecting a petition, the petitioner shall have an opportunity for an informal hearing on such order."
  ]
  node [
    id 2361
    label "section_360j_subsection_d_item_2"
    class_name "item"
    text "(2) the period within which interested persons may present their comments on the notice or findings (including the need therefor) orally or in writing, which period shall be at least sixty days but may not exceed ninety days unless the time is extended by the Secretary by a notice published in the Federal Register stating good cause therefor."
  ]
  node [
    id 2362
    label "section_360j_subsection_g_item_3_subitem_A_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) no such committee exists, or"
  ]
  node [
    id 2363
    label "section_360j_subsection_m_item_3"
    class_name "item"
    text "(3) No person granted an exemption under paragraph (2) with respect to a device may sell the device for an amount that exceeds the costs of research and development, fabrication, and distribution of the device."
  ]
  node [
    id 2364
    label "section_360j_subsection_g_item_2_subitem_C"
    class_name "subitem"
    text "(C) Procedures and conditions prescribed pursuant to subparagraph (A) for an exemption may appropriately vary depending on (i) the scope and duration of clinical testing to be conducted under such exemption, (ii) the number of human subjects that are to be involved in such testing, (iii) the need to permit changes to be made in the device subject to the exemption during testing conducted in accordance with a clinical testing plan required under paragraph (3)(A), and (iv) whether the clinical testing of such device is for the purpose of developing data to obtain approval for the commercial distribution of such device."
  ]
  node [
    id 2365
    label "section_360j_subsection_h_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) Any information contained in an application for premarket approval filed with the Secretary pursuant to section 360e(c) of this title, including clinical and preclinical tests or studies, but excluding descriptions of methods of manufacture and product composition, that demonstrates the safety and effectiveness of a device shall be available 1 year after the original application for the fourth device of a kind has been approved by the Secretary, for use by the Secretary in approving devices, or determining whether a product development protocol has been completed, under section 360e of this title, establishing a performance standard under section 360d of this title, and reclassifying devices under subsections (e) and (f) of section 360c of this title, and subsection (l)(2) of this section. The Secretary shall deem devices that incorporate the same technologies, have the same principles of operation, and are intended for the same use or uses to be within a kind of device."
  ]
  node [
    id 2366
    label "section_360j_subsection_h_item_4_subitem_C"
    class_name "subitem"
    text "(C) The publicly available detailed summaries of information respecting the safety and effectiveness of devices required by paragraph (1)(A) shall be available for use by the Secretary as the evidentiary basis for the regulatory action described in subparagraph (A)."
  ]
  node [
    id 2367
    label "section_360j_subsection_l_item_2"
    class_name "item"
    text "within the sixty-day period beginning on the enactment date (or within such greater period as the Secretary, after making the finding required under section 360e(d)(1)(B) of this title, and the petitioner or applicant may agree upon), the Secretary shall act on such petition or application in accordance with paragraph (2) or section 360e of this title except that the period within which the Secretary must act on the petition or application shall be within the one hundred and twenty-day period beginning on the date the petition or application is filed. If such a petition or application is filed within such sixty-day (or greater) period, clause (i) of this subparagraph shall not apply to such device before the expiration of such one hundred and twenty-day period, or if such petition is denied or such application is denied approval, before the date of such denial, whichever occurs first."
  ]
  node [
    id 2368
    label "section_360j_subsection_b"
    class_name "subsection"
    text "(b) Custom devices"
  ]
  node [
    id 2369
    label "section_360j_subsection_h_item_4_subitem_E"
    class_name "subitem"
    text "(E)(i) Except as provided in clause (ii), the approval date of a device, for purposes of this paragraph, shall be the date of the letter of the Secretary to the applicant approving a device under section 360e of this title and permitting the applicant to commercially distribute the device."
  ]
  node [
    id 2370
    label "section_360j_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) Before the Secretary may promulgate any regulation under subparagraph (A) he shall&#8212;"
  ]
  node [
    id 2371
    label "section_360j_subsection_l_item_3_subitem_C"
    class_name "subitem"
    text "(C) A device which is described in paragraph (1)(C) and which is in class III shall be considered a new drug until the expiration of the ninety-day period beginning on the date of the promulgation of regulations under subsection (g) of this section. After the expiration of such period such device is required, unless exempt under subsection (g) of this section, to have in effect an approved application under section 360e of this title."
  ]
  node [
    id 2372
    label "section_360j_subsection_l"
    class_name "subsection"
    text "(l) Transitional provisions for devices considered as new drugs or antibiotic drugs"
  ]
  node [
    id 2373
    label "section_360j_subsection_f_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) if the petition was referred to an advisory committee, the expiration of the sixty-day period beginning on the date the petition was referred to the advisory committee,"
  ]
  node [
    id 2374
    label "section_360j_subsection_h_item_4_subitem_E_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) For each device described in subparagraph (D)(i)(II) for which the original application for a fourth device of a kind is approved by the Secretary before November 1, 1991, the approval date of the fourth device of a kind shall be deemed to be November 15, 1991."
  ]
  node [
    id 2375
    label "section_360j_subsection_h_item_1_subitem_C"
    class_name "subitem"
    text "(C) an order approving an application under subsection (g) of this section for an exemption for the device from section 360f of this title or an order disapproving, or withdrawing approval of, an application for an exemption under such subsection for the device,"
  ]
  node [
    id 2376
    label "section_360j_subsection_m_item_2_subitem_A"
    class_name "subitem"
    text "(A) the device is designed to treat or diagnose a disease or condition that affects fewer than 4,000 individuals in the United States,"
  ]
  node [
    id 2377
    label "section_360j_subsection_c_item_1"
    class_name "item"
    text "Any information reported to or otherwise obtained by the Secretary or his representative under section 360c, 360d, 360e, 360f, 360h, 360i, or 374 of this title or under subsection (f) or (g) of this section which is exempt from disclosure pursuant to subsection (a) of section 552 of title 5 by reason of subsection (b)(4) of such section shall be considered confidential and shall not be disclosed and may not be used by the Secretary as the basis for the reclassification of a device from class III to class II or class I or as the basis for the establishment or amendment of a performance standard under section 360d of this title for a device reclassified from class III to class II, except (1) in accordance with subsection (h) of this section, and (2) that such information may be disclosed to other officers or employees concerned with carrying out this chapter or when relevant in any proceeding under this chapter (other than section 360c or 360d of this title)."
  ]
  node [
    id 2378
    label "section_360j_subsection_h_item_4_subitem_E_subsubitem_i"
    class_name "subsubitem"
    text "(E)(i) Except as provided in clause (ii), the approval date of a device, for purposes of this paragraph, shall be the date of the letter of the Secretary to the applicant approving a device under section 360e of this title and permitting the applicant to commercially distribute the device."
  ]
  node [
    id 2379
    label "section_360j_subsection_f_item_2_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) contain such other information as the Secretary shall prescribe."
  ]
  node [
    id 2380
    label "section_360j_subsection_l_item_3_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(D)(i) Except as provided in clauses (ii) and (iii), a device which is described in subparagraph (D), (E), or (F) of paragraph (1) and which is in class III is required, unless exempt under subsection (g) of this section, to have on and after sixty days after the enactment date in effect an approved application under section 360e of this title."
  ]
  node [
    id 2381
    label "section_360j_subsection_l_item_1"
    class_name "item"
    text "within the sixty-day period beginning on the enactment date (or within such greater period as the Secretary, after making the finding required under section 360e(d)(1)(B) of this title, and the petitioner or applicant may agree upon), the Secretary shall act on such petition or application in accordance with paragraph (2) or section 360e of this title except that the period within which the Secretary must act on the petition or application shall be within the one hundred and twenty-day period beginning on the date the petition or application is filed. If such a petition or application is filed within such sixty-day (or greater) period, clause (i) of this subparagraph shall not apply to such device before the expiration of such one hundred and twenty-day period, or if such petition is denied or such application is denied approval, before the date of such denial, whichever occurs first."
  ]
  node [
    id 2382
    label "section_360j_subsection_b_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(A)(i) is intended for use by an individual patient named in such order of such physician or dentist (or other specially qualified person so designated) and is to be made in a specific form for such patient, or"
  ]
  node [
    id 2383
    label "section_360j_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(A) only upon the written or oral authorization of a practitioner licensed by law to administer or use such device, or"
  ]
  node [
    id 2384
    label "section_360j_subsection_f_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) in the case of a petition for an exemption from a requirement, set forth the basis for the petitioner's determination that compliance with the requirement is not required to assure that the device will be safe and effective and otherwise in compliance with this chapter,"
  ]
  node [
    id 2385
    label "section_360j_subsection_h_item_3"
    class_name "item"
    text "(3) Except as provided in paragraph (4), any information respecting a device which is made available pursuant to paragraph (1) or (2) of this subsection (A) may not be used to establish the safety or effectiveness of another device for purposes of this chapter by any person other than the person who submitted the information so made available, and (B) shall be made available subject to subsection (c) of this section."
  ]
  node [
    id 2386
    label "section_360j_subsection_g_item_3_subitem_A"
    class_name "subitem"
    text "(A) submit a plan for any proposed clinical testing of the device and a report of prior investigations of the device (including, where appropriate, tests on animals) adequate to justify the proposed clinical testing&#8212;"
  ]
  node [
    id 2387
    label "section_360j_subsection_g_item_3_subitem_D"
    class_name "subitem"
    text "The determination required by subparagraph (D) shall be concurred in by a licensed physician who is not involved in the testing of the human subject with respect to which such determination is made unless immediate use of the device is required to save the life of the human subject of such testing and there is not sufficient time to obtain such concurrence."
  ]
  node [
    id 2388
    label "section_360j_subsection_f_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) afford the advisory committee established under paragraph (3) an opportunity to submit recommendations to him with respect to the regulation proposed to be promulgated, and"
  ]
  node [
    id 2389
    label "section_360j_subsection_f_item_1"
    class_name "item"
    text "(1)(A) The Secretary may, in accordance with subparagraph (B), prescribe regulations requiring that the methods used in, and the facilities and controls used for, the manufacture, pre-production design validation (including a process to assess the performance of a device but not including an evaluation of the safety or effectiveness of a device), packing, storage, and installation of a device conform to current good manufacturing practice, as prescribed in such regulations, to assure that the device will be safe and effective and otherwise in compliance with this chapter."
  ]
  node [
    id 2390
    label "section_360j_subsection_g_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) to the Secretary, if&#8212;"
  ]
  node [
    id 2391
    label "section_360j_subsection_g_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) An application, submitted in accordance with the procedures prescribed by regulations under paragraph (2), for an exemption for a device (other than an exemption from section 360f of this title) shall be deemed approved on the thirtieth day after the submission of the application to the Secretary unless on or before such day the Secretary by order disapproves the application and notifies the applicant of the disapproval of the application."
  ]
  node [
    id 2392
    label "section_360j_subsection_l_item_3"
    class_name "item"
    text "(3)(A) In the case of a device which is described in paragraph (1)(A) and which is in class III&#8212;"
  ]
  node [
    id 2393
    label "section_360j_subsection_h_item_1_subitem_B"
    class_name "subitem"
    text "(B) an order under section 360e(f)(6)(A) of this title revoking an approved protocol for the device, an order under section 360e(f)(6)(B) of this title declaring a protocol for the device completed or not completed, or an order under section 360e(f)(7) of this title revoking the approval of the device, or"
  ]
  node [
    id 2394
    label "section_360j_subsection_m_item_4_subitem_A"
    class_name "subitem"
    text "(A) in facilities that have established, in accordance with regulations of the Secretary, a local institutional review committee to supervise clinical testing of devices in the facilities, and"
  ]
  node [
    id 2395
    label "section_360j_subsection_m_item_4_subitem_B"
    class_name "subitem"
    text "(B) if, before the use of a device, an institutional review committee approves the use in the treatment or diagnosis of a disease or condition referred to in paragraph (2)(A)."
  ]
  node [
    id 2396
    label "section_360j_subsection_g_item_3_subitem_B"
    class_name "subitem"
    text "(B) promptly notify the Secretary (under such circumstances and in such manner as the Secretary prescribes) of approval by a local institutional review committee of any clinical testing plan submitted to it in accordance with subparagraph (A);"
  ]
  node [
    id 2397
    label "section_360j_subsection_e_item_1"
    class_name "item"
    text "(1) The Secretary may by regulation require that a device be restricted to sale, distribution, or use&#8212;"
  ]
  node [
    id 2398
    label "section_360j_subsection_m_item_2_subitem_B"
    class_name "subitem"
    text "(B) the device would not be available to a person with a disease or condition referred to in subparagraph (A) unless the Secretary grants such an exemption and there is no comparable device, other than under this exemption, available to treat or diagnose such disease or condition, and"
  ]
  node [
    id 2399
    label "section_360j_subsection_l_item_3_subitem_D_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) an application for premarket approval is filed under section 360e of this title for such a device,"
  ]
  node [
    id 2400
    label "section_360j_subsection_e_item_2"
    class_name "item"
    text "(2) The label of a restricted device shall bear such appropriate statements of the restrictions required by a regulation under paragraph (1) as the Secretary may in such regulation prescribe."
  ]
  node [
    id 2401
    label "section_360j_subsection_l_item_4"
    class_name "item"
    text "(4) Any device intended for human use which on the enactment date was subject to the requirements of section 357 of this title shall be subject to such requirements as follows:"
  ]
  node [
    id 2402
    label "section_360j_subsection_h_item_4_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) For each device described in clause (i)(I), the Secretary shall publish a notice in the Federal Register setting forth the date, which shall be not earlier than 1 year after the date of the notice, that data identified in subparagraph (A) shall be available for the use of the Secretary."
  ]
  node [
    id 2403
    label "section_360j_subsection_h_item_4_subitem_F"
    class_name "subitem"
    text "(F) Any challenge to an order under subparagraph (B) shall be made not later than 30 days after the date of the Federal Register notice referred to in such subparagraph."
  ]
  node [
    id 2404
    label "section_360j_subsection_g_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) A requirement that an application be submitted to the Secretary before an exemption may be granted and that the application be submitted in such form and manner as the Secretary shall specify."
  ]
  node [
    id 2405
    label "section_360j_subsection_l_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the requirements applicable to such device before the enactment date under section 355 of this title shall continue to apply to such device until changed by the Secretary as authorized by this chapter."
  ]
  node [
    id 2406
    label "section_360j_subsection_c"
    class_name "subsection"
    text "(c) Trade secrets"
  ]
  node [
    id 2407
    label "section_360j_subsection_b_item_2"
    class_name "item"
    text "Sections 360d and 360e of this title do not apply to any device which, in order to comply with the order of an individual physician or dentist (or any other specially qualified person designated under regulations promulgated by the Secretary after an opportunity for an oral hearing) necessarily deviates from an otherwise applicable performance standard or requirement prescribed by or under section 360e of this title if (1) the device is not generally available in finished form for purchase or for dispensing upon prescription and is not offered through labeling or advertising by the manufacturer, importer, or distributor thereof for commercial distribution, and (2) such device&#8212;"
  ]
  node [
    id 2408
    label "section_360j_subsection_l_item_1_subitem_B"
    class_name "subitem"
    text "within the sixty-day period beginning on the enactment date (or within such greater period as the Secretary, after making the finding required under section 360e(d)(1)(B) of this title, and the petitioner or applicant may agree upon), the Secretary shall act on such petition or application in accordance with paragraph (2) or section 360e of this title except that the period within which the Secretary must act on the petition or application shall be within the one hundred and twenty-day period beginning on the date the petition or application is filed. If such a petition or application is filed within such sixty-day (or greater) period, clause (i) of this subparagraph shall not apply to such device before the expiration of such one hundred and twenty-day period, or if such petition is denied or such application is denied approval, before the date of such denial, whichever occurs first."
  ]
  node [
    id 2409
    label "section_360j_subsection_f_item_2_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) a petition for an exemption for a device from a requirement if he determines that compliance with such requirement is not required to assure that the device will be safe and effective and otherwise in compliance with this chapter, and"
  ]
  node [
    id 2410
    label "section_360k_subsection_a"
    class_name "subsection"
    text "(a) General rule"
  ]
  node [
    id 2411
    label "section_360k_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) is required by compelling local conditions, and"
  ]
  node [
    id 2412
    label "section_360k_subsection_b_item_2"
    class_name "item"
    text "(2) the requirement&#8212;"
  ]
  node [
    id 2413
    label "section_360k_subsection_b"
    class_name "subsection"
    text "(b) Exempt requirements"
  ]
  node [
    id 2414
    label "section_360k_subsection_b_item_1"
    class_name "item"
    text "(1) the requirement is more stringent than a requirement under this chapter which would be applicable to the device if an exemption were not in effect under this subsection; or"
  ]
  node [
    id 2415
    label "section_360k_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) compliance with the requirement would not cause the device to be in violation of any applicable requirement under this chapter."
  ]
  node [
    id 2416
    label "section_360k_subsection_a_item_1"
    class_name "item"
    text "(1) which is different from, or in addition to, any requirement applicable under this chapter to the device, and"
  ]
  node [
    id 2417
    label "section_360k_subsection_a_item_2"
    class_name "item"
    text "(2) which relates to the safety or effectiveness of the device or to any other matter included in a requirement applicable to the device under this chapter."
  ]
  node [
    id 2418
    label "section_360l_subsection_a_item_1_subitem_C"
    class_name "subitem"
    text "(C) potentially presents a serious risk to human health."
  ]
  node [
    id 2419
    label "section_360l_subsection_a_item_1"
    class_name "item"
    text "(1) Required surveillance"
  ]
  node [
    id 2420
    label "section_360l_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) is intended for a use in supporting or sustaining human life, or"
  ]
  node [
    id 2421
    label "section_360l_subsection_b_item_2"
    class_name "item"
    text "Each manufacturer required to conduct a surveillance of a device under subsection (a)(1) of this section shall, within 30 days of the first introduction or delivery for introduction of such device into interstate commerce, submit, for the approval of the Secretary, a protocol for the required surveillance. Each manufacturer required to conduct a surveillance of a device under subsection (a)(2) of this section shall, within 30 days after receiving notice that the manufacturer is required to conduct such surveillance, submit, for the approval of the Secretary, a protocol for the required surveillance. The Secretary, within 60 days of the receipt of such protocol, shall determine if the principal investigator proposed to be used in the surveillance has sufficient qualifications and experience to conduct such surveillance and if such protocol will result in collection of useful data or other information necessary to protect the public health and to provide safety and effectiveness information for the device. The Secretary may not approve such a protocol until it has been reviewed by an appropriately qualified scientific and technical review committee established by the Secretary."
  ]
  node [
    id 2422
    label "section_360l_subsection_b"
    class_name "subsection"
    text "(b) Surveillance approval"
  ]
  node [
    id 2423
    label "section_360l_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 2424
    label "section_360l_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) is a permanent implant the failure of which may cause serious, adverse health consequences or death,"
  ]
  node [
    id 2425
    label "section_360l_subsection_b_item_1"
    class_name "item"
    text "Each manufacturer required to conduct a surveillance of a device under subsection (a)(1) of this section shall, within 30 days of the first introduction or delivery for introduction of such device into interstate commerce, submit, for the approval of the Secretary, a protocol for the required surveillance. Each manufacturer required to conduct a surveillance of a device under subsection (a)(2) of this section shall, within 30 days after receiving notice that the manufacturer is required to conduct such surveillance, submit, for the approval of the Secretary, a protocol for the required surveillance. The Secretary, within 60 days of the receipt of such protocol, shall determine if the principal investigator proposed to be used in the surveillance has sufficient qualifications and experience to conduct such surveillance and if such protocol will result in collection of useful data or other information necessary to protect the public health and to provide safety and effectiveness information for the device. The Secretary may not approve such a protocol until it has been reviewed by an appropriately qualified scientific and technical review committee established by the Secretary."
  ]
  node [
    id 2426
    label "section_360l_subsection_a_item_2"
    class_name "item"
    text "(2) Discretionary surveillance"
  ]
  node [
    id 2427
    label "section_361_subsection_e"
    class_name "subsection"
    text "(e) If it is not a hair dye and it is, or it bears or contains, a color additive which is unsafe within the meaning of section 379e(a) of this title."
  ]
  node [
    id 2428
    label "section_361_subsection_d"
    class_name "subsection"
    text "(d) If its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health."
  ]
  node [
    id 2429
    label "section_361_subsection_b"
    class_name "subsection"
    text "(b) If it consists in whole or in part of any filthy, putrid, or decomposed substance."
  ]
  node [
    id 2430
    label "section_361_subsection_a"
    class_name "subsection"
    text "(a) If it bears or contains any poisonous or deleterious substance which may render it injurious to users under the conditions of use prescribed in the labeling thereof, or under such conditions of use as are customary or usual, except that this provision shall not apply to coal-tar hair dye, the label of which bears the following legend conspicuously displayed thereon: &#8220;Caution&#8212;This product contains ingredients which may cause skin irritation on certain individuals and a preliminary test according to accompanying directions should first be made. This product must not be used for dyeing the eyelashes or eyebrows; to do so may cause blindness.&#8221;, and the labeling of which bears adequate directions for such preliminary testing. For the purposes of this paragraph and paragraph (e) the term &#8220;hair dye&#8221; shall not include eyelash dyes or eyebrow dyes."
  ]
  node [
    id 2431
    label "section_361_subsection_c"
    class_name "subsection"
    text "(c) If it has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health."
  ]
  node [
    id 2432
    label "section_362_subsection_a"
    class_name "subsection"
    text "(a) If its labeling is false or misleading in any particular."
  ]
  node [
    id 2433
    label "section_362_subsection_f"
    class_name "subsection"
    text "(f) If its packaging or labeling is in violation of an applicable regulation issued pursuant to section 1472 or 1473 of title 15."
  ]
  node [
    id 2434
    label "section_362_subsection_d"
    class_name "subsection"
    text "(d) If its container is so made, formed, or filled as to be misleading."
  ]
  node [
    id 2435
    label "section_362_subsection_e"
    class_name "subsection"
    text "(e) If it is a color additive, unless its packaging and labeling are in conformity with such packaging and labeling requirements, applicable to such color additive, as may be contained in regulations issued under section 379e of this title. This paragraph shall not apply to packages of color additives which, with respect to their use for cosmetics, are marketed and intended for use only in or on hair dyes (as defined in the last sentence of section 361(a) of this title)."
  ]
  node [
    id 2436
    label "section_362_subsection_b"
    class_name "subsection"
    text "(b) If in package form unless it bears a label containing (1) the name and place of business of the manufacturer, packer, or distributor; and (2) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count: Provided, That under clause (2) of this paragraph reasonable variations shall be permitted, and exemptions as to small packages shall be established, by regulations prescribed by the Secretary."
  ]
  node [
    id 2437
    label "section_362_subsection_c"
    class_name "subsection"
    text "(c) If any word, statement, or other information required by or under authority of this chapter to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use."
  ]
  node [
    id 2438
    label "section_371_subsection_f_item_1"
    class_name "item"
    text "(1) In a case of actual controversy as to the validity of any order under subsection (e) of this section, any person who will be adversely affected by such order if placed in effect may at any time prior to the ninetieth day after such order is issued file a petition with the United States court of appeals for the circuit wherein such person resides or has his principal place of business, for a judicial review of such order. A copy of the petition shall be forthwith transmitted by the clerk of the court to the Secretary or other officer designated by him for that purpose. The Secretary thereupon shall file in the court the record of the proceedings on which the Secretary based his order, as provided in section 2112 of title 28."
  ]
  node [
    id 2439
    label "section_371_subsection_g"
    class_name "subsection"
    text "(g) Copies of records of hearings"
  ]
  node [
    id 2440
    label "section_371_subsection_e"
    class_name "subsection"
    text "(e) Procedure for establishment"
  ]
  node [
    id 2441
    label "section_371_subsection_f_item_3"
    class_name "item"
    text "(3) Upon the filing of the petition referred to in paragraph (1) of this subsection, the court shall have jurisdiction to affirm the order, or to set it aside in whole or in part, temporarily or permanently. If the order of the Secretary refuses to issue, amend, or repeal a regulation and such order is not in accordance with law the court shall by its judgment order the Secretary to take action, with respect to such regulation, in accordance with law. The findings of the Secretary as to the facts, if supported by substantial evidence, shall be conclusive."
  ]
  node [
    id 2442
    label "section_371_subsection_f_item_6"
    class_name "item"
    text "(6) The remedies provided for in this subsection shall be in addition to and not in substitution for any other remedies provided by law."
  ]
  node [
    id 2443
    label "section_371_subsection_f_item_2"
    class_name "item"
    text "(2) If the petitioner applies to the court for leave to adduce additional evidence, and shows to the satisfaction of the court that such additional evidence is material and that there were reasonable grounds for the failure to adduce such evidence in the proceeding before the Secretary, the court may order such additional evidence (and evidence in rebuttal thereof) to be taken before the Secretary, and to be adduced upon the hearing, in such manner and upon such terms and conditions as to the court may seem proper. The Secretary may modify his findings as to the facts, or make new findings, by reason of the additional evidence so taken, and he shall file such modified or new findings, and his recommendation, if any, for the modification or setting aside of his original order, with the return of such additional evidence."
  ]
  node [
    id 2444
    label "section_371_subsection_f"
    class_name "subsection"
    text "(f) Review of order"
  ]
  node [
    id 2445
    label "section_371_subsection_c"
    class_name "subsection"
    text "(c) Conduct of hearings"
  ]
  node [
    id 2446
    label "section_371_subsection_f_item_4"
    class_name "item"
    text "(4) The judgment of the court affirming or setting aside, in whole or in part, any such order of the Secretary shall be final, subject to review by the Supreme Court of the United States upon certiorari or certification as provided in section 1254 of title 28."
  ]
  node [
    id 2447
    label "section_371_subsection_b"
    class_name "subsection"
    text "(b) Regulations for imports and exports"
  ]
  node [
    id 2448
    label "section_371_subsection_d"
    class_name "subsection"
    text "(d) Effectiveness of definitions and standards of identity"
  ]
  node [
    id 2449
    label "section_371_subsection_e_item_1"
    class_name "item"
    text "(1) Any action for the issuance, amendment, or repeal of any regulation under section 343(j), 344(a), 346, 351(b), or 352(d) or (h) of this title, and any action for the amendment or repeal of any definition and standard of identity under section 341 of this title for any dairy product (including products regulated under parts 131, 133 and 135 of title 21, Code of Federal Regulations) shall be begun by a proposal made (A) by the Secretary on his own initiative, or (B) by petition of any interested person, showing reasonable grounds therefor, filed with the Secretary. The Secretary shall publish such proposal and shall afford all interested persons an opportunity to present their views thereon, orally or in writing. As soon as practicable thereafter, the Secretary shall by order act upon such proposal and shall make such order public. Except as provided in paragraph (2), the order shall become effective at such time as may be specified therein, but not prior to the day following the last day on which objections may be filed under such paragraph."
  ]
  node [
    id 2450
    label "section_371_subsection_f_item_5"
    class_name "item"
    text "(5) Any action instituted under this subsection shall survive notwithstanding any change in the person occupying the office of Secretary or any vacancy in such office."
  ]
  node [
    id 2451
    label "section_371_subsection_e_item_2"
    class_name "item"
    text "(2) On or before the thirtieth day after the date on which an order entered under paragraph (1) is made public, any person who will be adversely affected by such order if placed in effect may file objections thereto with the Secretary, specifying with particularity the provisions of the order deemed objectionable, stating the grounds therefor, and requesting a public hearing upon such objections. Until final action upon such objections is taken by the Secretary under paragraph (3), the filing of such objections shall operate to stay the effectiveness of those provisions of the order to which the objections are made. As soon as practicable after the time for filing objections has expired the Secretary shall publish a notice in the Federal Register specifying those parts of the order which have been stayed by the filing of objections and, if no objections have been filed, stating that fact."
  ]
  node [
    id 2452
    label "section_371_subsection_e_item_3"
    class_name "item"
    text "(3) As soon as practicable after such request for a public hearing, the Secretary, after due notice, shall hold such a public hearing for the purpose of receiving evidence relevant and material to the issues raised by such objections. At the hearing, any interested person may be heard in person or by representative. As soon as practicable after completion of the hearing, the Secretary shall by order act upon such objections and make such order public. Such order shall be based only on substantial evidence of record at such hearing and shall set forth, as part of the order, detailed findings of fact on which the order is based. The Secretary shall specify in the order the date on which it shall take effect, except that it shall not be made to take effect prior to the ninetieth day after its publication unless the Secretary finds that emergency conditions exist necessitating an earlier effective date, in which event the Secretary shall specify in the order his findings as to such conditions."
  ]
  node [
    id 2453
    label "section_371_subsection_a"
    class_name "subsection"
    text "(a) Authority to promulgate regulations"
  ]
  node [
    id 2454
    label "section_372_subsection_e_item_5"
    class_name "item"
    text "(5) make, prior to the institution of libel proceedings under section 334(a)(2) of this title, seizures of drugs or containers or of equipment, punches, dies, plates, stones, labeling, or other things, if they are, or he has reasonable grounds to believe that they are, subject to seizure and condemnation under such section 334(a)(2). In the event of seizure pursuant to this paragraph (5), libel proceedings under section 334(a)(2) of this title shall be instituted promptly and the property seized be placed under the jurisdiction of the court."
  ]
  node [
    id 2455
    label "section_372_subsection_d"
    class_name "subsection"
    text "(d) Information on patents for drugs"
  ]
  node [
    id 2456
    label "section_372_subsection_c"
    class_name "subsection"
    text "(c) Records of other departments and agencies"
  ]
  node [
    id 2457
    label "section_372_subsection_b"
    class_name "subsection"
    text "(b) Availability to owner of part of analysis samples"
  ]
  node [
    id 2458
    label "section_372_subsection_e_item_1"
    class_name "item"
    text "(1) carry firearms;"
  ]
  node [
    id 2459
    label "section_372_subsection_e_item_2"
    class_name "item"
    text "(2) execute and serve search warrants and arrest warrants;"
  ]
  node [
    id 2460
    label "section_372_subsection_e_item_4"
    class_name "item"
    text "(4) make arrests without warrant for offenses under this chapter with respect to such drugs if the offense is committed in his presence or, in the case of a felony, if he has probable cause to believe that the person so arrested has committed, or is committing, such offense; and"
  ]
  node [
    id 2461
    label "section_372_subsection_e"
    class_name "subsection"
    text "(e) Powers of enforcement personnel"
  ]
  node [
    id 2462
    label "section_372_subsection_a"
    class_name "subsection"
    text "(a) Authority to conduct"
  ]
  node [
    id 2463
    label "section_372_subsection_e_item_3"
    class_name "item"
    text "(3) execute seizure by process issued pursuant to libel under section 334 of this title;"
  ]
  node [
    id 2464
    label "section_372a_item_3"
    class_name "item"
    text "Section, act June 25, 1938, ch. 675, &#167;702A, formerly June 30, 1906, ch. 3915, &#167;10A, as added June 22, 1934, ch. 712, 48 Stat. 1204, and amended, which related to examination of sea food, was renumbered section 706 of act June 25, 1938, by Pub. L. 102&#8211;571, title I, &#167;106(3), Oct. 29, 1992, 106 Stat. 4498, and transferred to section 376 of this title."
  ]
  node [
    id 2465
    label "section_374_subsection_a_item_3_subitem_B"
    class_name "subitem"
    text "(B) required to be maintained under section 350a of this title."
  ]
  node [
    id 2466
    label "section_374_subsection_b_item_1"
    class_name "item"
    text "Upon completion of any such inspection of a factory, warehouse, consulting laboratory, or other establishment, and prior to leaving the premises, the officer or employee making the inspection shall give to the owner, operator, or agent in charge a report in writing setting forth any conditions or practices observed by him which, in his judgment, indicate that any food, drug, device, or cosmetic in such establishment (1) consists in whole or in part of any filthy, putrid, or decomposed substance, or (2) has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health. A copy of such report shall be sent promptly to the Secretary."
  ]
  node [
    id 2467
    label "section_374_subsection_a_item_3"
    class_name "item"
    text "(3) An officer or employee making an inspection under paragraph (1) for purposes of enforcing the requirements of section 350a of this title applicable to infant formulas shall be permitted, at all reasonable times, to have access to and to copy and verify any records&#8212;"
  ]
  node [
    id 2468
    label "section_374_subsection_d"
    class_name "subsection"
    text "(d) Analysis of samples furnished owner"
  ]
  node [
    id 2469
    label "section_374_subsection_a_item_2"
    class_name "item"
    text "(2) The provisions of the second sentence of paragraph (1) shall not apply to&#8212;"
  ]
  node [
    id 2470
    label "section_374_subsection_a"
    class_name "subsection"
    text "(a) Right of agents to enter; scope of inspection; notice; promptness; exclusions"
  ]
  node [
    id 2471
    label "section_374_subsection_a_item_1"
    class_name "item"
    text "(1) For purposes of enforcement of this chapter, officers or employees duly designated by the Secretary, upon presenting appropriate credentials and a written notice to the owner, operator, or agent in charge, are authorized (A) to enter, at reasonable times, any factory, warehouse, or establishment in which food, drugs, devices, or cosmetics are manufactured, processed, packed, or held, for introduction into interstate commerce or after such introduction, or to enter any vehicle being used to transport or hold such food, drugs, devices, or cosmetics in interstate commerce; and (B) to inspect, at reasonable times and within reasonable limits and in a reasonable manner, such factory, warehouse, establishment, or vehicle and all pertinent equipment, finished and unfinished materials, containers, and labeling therein. In the case of any factory, warehouse, establishment, or consulting laboratory in which prescription drugs or restricted devices are manufactured, processed, packed, or held, the inspection shall extend to all things therein (including records, files, papers, processes, controls, and facilities) bearing on whether prescription drugs or restricted devices which are adulterated or misbranded within the meaning of this chapter, or which may not be manufactured, introduced into interstate commerce, or sold, or offered for sale by reason of any provision of this chapter, have been or are being manufactured, processed, packed, transported, or held in any such place, or otherwise bearing on violation of this chapter. No inspection authorized by the preceding sentence or by paragraph (3) shall extend to financial data, sales data other than shipment data, pricing data, personnel data (other than data as to qualification of technical and professional personnel performing functions subject to this chapter), and research data (other than data relating to new drugs, antibiotic drugs, and devices and subject to reporting and inspection under regulations lawfully issued pursuant to section 355(i) or (k), section 357(d) or (g), section 360i, or 360j(g) of this title, and data relating to other drugs or devices which in the case of a new drug would be subject to reporting or inspection under lawful regulations issued pursuant to section 355(j) of this title). A separate notice shall be given for each such inspection, but a notice shall not be required for each entry made during the period covered by the inspection. Each such inspection shall be commenced and completed with reasonable promptness."
  ]
  node [
    id 2472
    label "section_374_subsection_b_item_2"
    class_name "item"
    text "Upon completion of any such inspection of a factory, warehouse, consulting laboratory, or other establishment, and prior to leaving the premises, the officer or employee making the inspection shall give to the owner, operator, or agent in charge a report in writing setting forth any conditions or practices observed by him which, in his judgment, indicate that any food, drug, device, or cosmetic in such establishment (1) consists in whole or in part of any filthy, putrid, or decomposed substance, or (2) has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health. A copy of such report shall be sent promptly to the Secretary."
  ]
  node [
    id 2473
    label "section_374_subsection_e"
    class_name "subsection"
    text "(e) Accessibility of records"
  ]
  node [
    id 2474
    label "section_374_subsection_a_item_2_subitem_C"
    class_name "subitem"
    text "(C) persons who manufacture, prepare, propagate, compound, or process drugs or manufacture or process devices, solely for use in research, teaching, or chemical analysis and not for sale;"
  ]
  node [
    id 2475
    label "section_374_subsection_c"
    class_name "subsection"
    text "(c) Receipt for samples taken"
  ]
  node [
    id 2476
    label "section_374_subsection_a_item_2_subitem_D"
    class_name "subitem"
    text "(D) such other classes of persons as the Secretary may by regulation exempt from the application of this section upon a finding that inspection as applied to such classes of persons in accordance with this section is not necessary for the protection of the public health."
  ]
  node [
    id 2477
    label "section_374_subsection_b"
    class_name "subsection"
    text "(b) Written report to owner; copy to Secretary"
  ]
  node [
    id 2478
    label "section_374_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) pharmacies which maintain establishments in conformance with any applicable local laws regulating the practice of pharmacy and medicine and which are regularly engaged in dispensing prescription drugs or devices, upon prescriptions of practitioners licensed to administer such drugs or devices to patients under the care of such practitioners in the course of their professional practice, and which do not, either through a subsidiary or otherwise, manufacture, prepare, propagate, compound, or process drugs or devices for sale other than in the regular course of their business of dispensing or selling drugs or devices at retail;"
  ]
  node [
    id 2479
    label "section_374_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) practitioners licensed by law to prescribe or administer drugs, or prescribe or use devices, as the case may be, and who manufacture, prepare, propagate, compound, or process drugs, or manufacture or process devices, solely for use in the course of their professional practice;"
  ]
  node [
    id 2480
    label "section_374_subsection_a_item_3_subitem_A"
    class_name "subitem"
    text "(A) bearing on whether the infant formula manufactured or held in the facility inspected meets the requirements of section 350a of this title, or"
  ]
  node [
    id 2481
    label "section_375_subsection_b"
    class_name "subsection"
    text "(b) Information regarding certain goods"
  ]
  node [
    id 2482
    label "section_375_subsection_a"
    class_name "subsection"
    text "(a) Reports"
  ]
  node [
    id 2483
    label "section_378_subsection_d"
    class_name "subsection"
    text "(d) Coordination of action by Secretary with Federal Trade Commission"
  ]
  node [
    id 2484
    label "section_378_subsection_a_item_2"
    class_name "item"
    text "(2) The notice required by paragraph (1) shall&#8212;"
  ]
  node [
    id 2485
    label "section_378_subsection_b_item_1"
    class_name "item"
    text "(1) If the Secretary notifies the Federal Trade Commission under subsection (a) of this section of action proposed to be taken under subchapter III of this chapter with respect to a food or food advertising and the Commission notifies the Secretary in writing, within the 30-day period beginning on the date of the receipt of such notice, that&#8212;"
  ]
  node [
    id 2486
    label "section_378_subsection_a"
    class_name "subsection"
    text "(a) Determination of misbranding; notification of Federal Trade Commission by Secretary; contents"
  ]
  node [
    id 2487
    label "section_378_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) contain (i) a description of the action the Secretary proposes to take and of the advertising which the Secretary has determined causes a food to be misbranded, (ii) a statement of the reasons for the Secretary's determination that such advertising has caused such food to be misbranded, and"
  ]
  node [
    id 2488
    label "section_378_subsection_a_item_1"
    class_name "item"
    text "(1) Except as provided in subsection (c) of this section, before the Secretary may initiate any action under subchapter III of this chapter&#8212;"
  ]
  node [
    id 2489
    label "section_378_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) with respect to any food which the Secretary determines is misbranded under section 343(a)(2) of this title because of its advertising, or"
  ]
  node [
    id 2490
    label "section_378_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) be accompanied by the records, documents, and other written materials which the Secretary determines supports his determination that such food is misbranded because of such advertising."
  ]
  node [
    id 2491
    label "section_378_subsection_c"
    class_name "subsection"
    text "(c) Secretary's determination of imminent hazard to health as suspending applicability of provisions"
  ]
  node [
    id 2492
    label "section_378_subsection_b_item_2_subitem_C"
    class_name "subitem"
    text "(C) the Commission does not (as described in subparagraph (D) of such paragraph) make a certification to the Attorney General respecting such advertising, or, if the Commission does make such a certification to the Attorney General respecting such advertising, the Attorney General, before the expiration of such period, does not cause appropriate criminal proceedings to be brought against such advertising,"
  ]
  node [
    id 2493
    label "section_378_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) it has commenced (or intends to commence) a civil action under section 5, 13, or 19 [15 U.S.C. 45, 53, or 57b] with respect to such advertising or the Attorney General has commenced (or intends to commence) a civil action under section 5 [15 U.S.C. 45] with respect to such advertising,"
  ]
  node [
    id 2494
    label "section_378_subsection_b_item_2"
    class_name "item"
    text "(2) If, before the expiration of the 60-day period beginning on the date the Secretary receives a notice described in paragraph (1) from the Federal Trade Commission in response to a notice of the Secretary under subsection (a) of this section&#8212;"
  ]
  node [
    id 2495
    label "section_378_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) with respect to a food's advertising which the Secretary determines causes the food to be so misbranded,"
  ]
  node [
    id 2496
    label "section_378_subsection_b"
    class_name "subsection"
    text "(b) Action by Federal Trade Commission precluding action by Secretary; exception"
  ]
  node [
    id 2497
    label "section_378_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) the Commission or the Attorney General does not commence a civil action described in subparagraph (B) of paragraph (1) of this subsection respecting the advertising described in the Secretary's notice,"
  ]
  node [
    id 2498
    label "section_378_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) it has issued and served (or intends to issue and serve) a complaint under section 5(b) of such Act [15 U.S.C. 45(b)] respecting such advertising, or"
  ]
  node [
    id 2499
    label "section_378_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) the Commission does not issue and serve a complaint described in subparagraph (C) of such paragraph respecting such advertising, or"
  ]
  node [
    id 2500
    label "section_378_subsection_b_item_1_subitem_D"
    class_name "subitem"
    text "(D) pursuant to section 16(b) of such Act [15 U.S.C. 56(b)] it has made a certification to the Attorney General respecting such advertising,"
  ]
  node [
    id 2501
    label "section_378_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) it has initiated under the Federal Trade Commission Act [15 U.S.C. 41 et seq.] an investigation of such advertising to determine if it is prohibited by such Act or any order or rule under such Act,"
  ]
  node [
    id 2502
    label "section_379_item_4"
    class_name "item"
    text "The Secretary may provide any information which is exempt from disclosure pursuant to subsection (a) of section 552 of title 5 by reason of subsection (b)(4) of such section to a person other than an officer or employee of the Department if the Secretary determines such other person requires the information in connection with an activity which is undertaken under contract with the Secretary, which relates to the administration of this chapter, and with respect to which the Secretary (or an officer or employee of the Department) is not prohibited from using such information. The Secretary shall require as a condition to the provision of information under this section that the person receiving it take such security precautions respecting the information as the Secretary may by regulation prescribe."
  ]
  node [
    id 2503
    label "section_379b_subsection_a"
    class_name "subsection"
    text "(a) Authority"
  ]
  node [
    id 2504
    label "section_379b_subsection_d"
    class_name "subsection"
    text "(d) Authorization of appropriations"
  ]
  node [
    id 2505
    label "section_379b_subsection_b"
    class_name "subsection"
    text "(b) Awarding of contract"
  ]
  node [
    id 2506
    label "section_379b_subsection_c"
    class_name "subsection"
    text "(c) Donations"
  ]
  node [
    id 2507
    label "section_379c_item_6"
    class_name "item"
    text "Section, act June 25, 1938, ch. 675, &#167;711, as added Nov. 28, 1990, Pub. L. 101&#8211;635, title II, &#167;201, 104 Stat. 4584, which related to recovery and retention of fees for freedom of information requests, was renumbered section 731 of act June 25, 1938, by Pub. L. 102&#8211;571, title I, &#167;106(6), Oct. 29, 1992, 106 Stat. 4499, and transferred to section 379f of this title."
  ]
  node [
    id 2508
    label "section_379d_subsection_b"
    class_name "subsection"
    text "(b) Authorization of appropriations"
  ]
  node [
    id 2509
    label "section_379d_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 2510
    label "section_379e_subsection_f"
    class_name "subsection"
    text "(f) Exemptions"
  ]
  node [
    id 2511
    label "section_379e_subsection_b_item_5_subitem_B"
    class_name "subitem"
    text "(B) A color additive (i) shall be deemed unsafe, and shall not be listed, for any use which will or may result in ingestion of all or part of such additive, if the additive is found by the Secretary to induce cancer when ingested by man or animal, or if it is found by the Secretary, after tests which are appropriate for the evaluation of the safety of additives for use in food, to induce cancer in man or animal, and (ii) shall be deemed unsafe, and shall not be listed, for any use which will not result in ingestion of any part of such additive, if, after tests which are appropriate for the evaluation of the safety of additives for such use, or after other relevant exposure of man or animal to such additive, it is found by the Secretary to induce cancer in man or animal: Provided, That clause (i) of this subparagraph (B) shall not apply with respect to the use of a color additive as an ingredient of feed for animals which are raised for food production, if the Secretary finds that, under the conditions of use and feeding specified in proposed labeling and reasonably certain to be followed in practice, such additive will not adversely affect the animals for which such feed is intended, and that no residue of the additive will be found (by methods of examination prescribed or approved by the Secretary by regulations, which regulations shall not be subject to subsection (d) of this section) in any edible portion of such animals after slaughter or in any food yielded by or derived from the living animal."
  ]
  node [
    id 2512
    label "section_379e_subsection_d_item_4"
    class_name "item"
    text "(4) the scope of judicial review of such order shall be in accordance with the fourth sentence of paragraph (2), and with the provisions of paragraph (3), of section 348(g) of this title."
  ]
  node [
    id 2513
    label "section_379e_subsection_b_item_5_subitem_C_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) by reason of subparagraph (B) of this paragraph, the Secretary has initiated a proposal to remove from listing a color additive previously listed pursuant to this section; and"
  ]
  node [
    id 2514
    label "section_379e_subsection_b_item_5_subitem_C_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) a request has been made for referral of such proposal to an advisory committee;"
  ]
  node [
    id 2515
    label "section_379e_subsection_d_item_1"
    class_name "item"
    text "(1) if the proceeding is commenced by the filing of a petition, notice of the proposal made by the petition shall be published in general terms by the Secretary within thirty days after such filing, and the Secretary's order (required by paragraph (1) of section 371(e) of this title) acting upon such proposal shall, in the absence of prior referral (or request for referral) to an advisory committee, be issued within ninety days after the date of such filing, except that the Secretary may (prior to such ninetieth day), by written notice to the petitioner, extend such ninety-day period to such time (not more than one hundred and eighty days after the date of filing of the petition) as the Secretary deems necessary to enable him to study and investigate the petition;"
  ]
  node [
    id 2516
    label "section_379e_subsection_b_item_7_subitem_A"
    class_name "subitem"
    text "(A) shall not list the additive for such use if he finds that the data before him do not establish that such additive, if used within a safe tolerance limitation, would achieve the intended physical or other technical effect; and"
  ]
  node [
    id 2517
    label "section_379e_subsection_b_item_5_subitem_C_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) Where&#8212;"
  ]
  node [
    id 2518
    label "section_379e_subsection_a_item_2"
    class_name "item"
    text "(2) such additive and such use thereof conform to the terms of an exemption which is in effect pursuant to subsection (f) of this section."
  ]
  node [
    id 2519
    label "section_379e_subsection_b_item_5_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(C)(i) In any proceeding for the issuance, amendment, or repeal of a regulation listing a color additive, whether commenced by a proposal of the Secretary on his own initiative or by a proposal contained in a petition, the petitioner, or any other person who will be adversely affected by such proposal or by the Secretary's order issued in accordance with paragraph (1) of section 371(e) of this title if placed in effect, may request, within the time specified in this subparagraph, that the petition or order thereon, or the Secretary's proposal, be referred to an advisory committee for a report and recommendations with respect to any matter arising under subparagraph (B) of this paragraph, which is involved in such proposal or order and which requires the exercise of scientific judgment. Upon such request, or if the Secretary within such time deems such a referral necessary, the Secretary shall forthwith appoint an advisory committee under subparagraph (D) of this paragraph and shall refer to it, together with all the data before him, such matter arising under subparagraph (B) for study thereof and for a report and recommendations on such matter. A person who has filed a petition or who has requested the referral of a matter to an advisory committee pursuant to this subparagraph (C), as well as representatives of the Department, shall have the right to consult with such advisory committee in connection with the matter referred to it. The request for referral under this subparagraph, or the Secretary's referral on his own initiative, may be made at any time before, or within thirty days after, publication of an order of the Secretary acting upon the petition or proposal."
  ]
  node [
    id 2520
    label "section_379e_subsection_b_item_5"
    class_name "item"
    text "(5)(A) In determining, for the purposes of this section, whether a proposed use of a color additive is safe, the Secretary shall consider, among other relevant factors&#8212;"
  ]
  node [
    id 2521
    label "section_379e_subsection_b_item_3"
    class_name "item"
    text "(3) Such regulations shall, to the extent deemed necessary by the Secretary to assure the safety of the use or uses for which a particular color additive is listed, prescribe the conditions under which such additive may be safely employed for such use or uses (including, but not limited to, specifications, hereafter in this section referred to as tolerance limitations, as to the maximum quantity or quantities which may be used or permitted to remain in or on the article or articles in or on which it is used; specifications as to the manner in which such additive may be added to or used in or on such article or articles; and directions or other labeling or packaging requirements for such additive)."
  ]
  node [
    id 2522
    label "section_379e_subsection_b_item_6"
    class_name "item"
    text "(6) The Secretary shall not list a color additive under this subsection for a proposed use if the data before him show that such proposed use would promote deception of the consumer in violation of this chapter or would otherwise result in misbranding or adulteration within the meaning of this chapter."
  ]
  node [
    id 2523
    label "section_379e_subsection_b_item_7_subitem_B"
    class_name "subitem"
    text "(B) shall not fix such tolerance limitation at a level higher than he finds to be reasonably required to accomplish the intended physical or other technical effect."
  ]
  node [
    id 2524
    label "section_379e_subsection_e"
    class_name "subsection"
    text "(e) Fees"
  ]
  node [
    id 2525
    label "section_379e_subsection_d_item_2"
    class_name "item"
    text "(2) any report, recommendations, underlying data, and reasons certified to the Secretary by an advisory committee appointed pursuant to subparagraph (D) of subsection (b)(5) of this section, shall be made a part of the record of any hearing if relevant and material, subject to the provisions of section 556(d) of title 5. The advisory committee shall designate a member to appear and testify at any such hearing with respect to the report and recommendations of such committee upon request of the Secretary, the petitioner, or the officer conducting the hearing, but this shall not preclude any other member of the advisory committee from appearing and testifying at such hearing;"
  ]
  node [
    id 2526
    label "section_379e_subsection_b_item_2"
    class_name "item"
    text "(2)(A) Such regulations may list any color additive for use generally in or on food, or in or on drugs or devices, or in or on cosmetics, if the Secretary finds that such additive is suitable and may safely be employed for such general use."
  ]
  node [
    id 2527
    label "section_379e_subsection_b_item_5_subitem_A"
    class_name "subitem"
    text "(5)(A) In determining, for the purposes of this section, whether a proposed use of a color additive is safe, the Secretary shall consider, among other relevant factors&#8212;"
  ]
  node [
    id 2528
    label "section_379e_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) If the data before the Secretary do not establish that the additive satisfies the requirements for listing such additive on the applicable list pursuant to subparagraph (A) of this paragraph, or if the proposal is for listing such additive for a more limited use or uses, such regulations may list such additive only for any more limited use or uses for which it is suitable and may safely be employed."
  ]
  node [
    id 2529
    label "section_379e_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Such regulations may list any color additive for use generally in or on food, or in or on drugs or devices, or in or on cosmetics, if the Secretary finds that such additive is suitable and may safely be employed for such general use."
  ]
  node [
    id 2530
    label "section_379e_subsection_a_item_4"
    class_name "item"
    text "A color additive shall, with respect to any particular use (for which it is being used or intended to be used or is represented as suitable) in or on food or drugs or devices or cosmetics, be deemed unsafe for the purposes of the application of section 342(c), 351(a)(4), or 361(e) of this title, as the case may be, unless&#8212;"
  ]
  node [
    id 2531
    label "section_379e_subsection_b_item_5_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "the Secretary may not act by order on such proposal until the advisory committee has made a report and recommendations to him under clause (ii) of this subparagraph and he has considered such recommendations, unless the Secretary finds that emergency conditions exist necessitating the issuance of an order notwithstanding this clause."
  ]
  node [
    id 2532
    label "section_379e_subsection_c"
    class_name "subsection"
    text "(c) Certification of colors"
  ]
  node [
    id 2533
    label "section_379e_subsection_b_item_5_subitem_C"
    class_name "subitem"
    text "(C)(i) In any proceeding for the issuance, amendment, or repeal of a regulation listing a color additive, whether commenced by a proposal of the Secretary on his own initiative or by a proposal contained in a petition, the petitioner, or any other person who will be adversely affected by such proposal or by the Secretary's order issued in accordance with paragraph (1) of section 371(e) of this title if placed in effect, may request, within the time specified in this subparagraph, that the petition or order thereon, or the Secretary's proposal, be referred to an advisory committee for a report and recommendations with respect to any matter arising under subparagraph (B) of this paragraph, which is involved in such proposal or order and which requires the exercise of scientific judgment. Upon such request, or if the Secretary within such time deems such a referral necessary, the Secretary shall forthwith appoint an advisory committee under subparagraph (D) of this paragraph and shall refer to it, together with all the data before him, such matter arising under subparagraph (B) for study thereof and for a report and recommendations on such matter. A person who has filed a petition or who has requested the referral of a matter to an advisory committee pursuant to this subparagraph (C), as well as representatives of the Department, shall have the right to consult with such advisory committee in connection with the matter referred to it. The request for referral under this subparagraph, or the Secretary's referral on his own initiative, may be made at any time before, or within thirty days after, publication of an order of the Secretary acting upon the petition or proposal."
  ]
  node [
    id 2534
    label "section_379e_subsection_a"
    class_name "subsection"
    text "(a) Unsafe color additives"
  ]
  node [
    id 2535
    label "section_379e_subsection_c_item_1"
    class_name "item"
    text "The Secretary shall further, by regulation, provide (1) for the certification, with safe diluents or without diluents, of batches of color additives listed pursuant to subsection (b) of this section and conforming to the requirements for such additives established by regulations under such subsection and this subsection, and (2) for exemption from the requirement of certification in the case of any such additive, or any listing or use thereof, for which he finds such requirement not to be necessary in the interest of the protection of the public health: Provided, That, with respect to any use in or on food for which a listed color additive is deemed to be safe by reason of the proviso to paragraph (4) of subsection (b), the requirement of certification shall be deemed not to be necessary in the interest of public health protection."
  ]
  node [
    id 2536
    label "section_379e_subsection_b_item_8"
    class_name "item"
    text "(8) If, having regard to the aggregate quantity of color additive likely to be consumed in the diet or to be applied to the human body, the Secretary finds that the data before him fail to show that it would be safe and otherwise permissible to list a color additive (or pharmacologically related color additives) for all the uses proposed therefor and at the levels of concentration proposed, the Secretary shall, in determining for which use or uses such additive (or such related additives) shall be or remain listed, or how the aggregate allowable safe tolerance for such additive or additives shall be allocated by him among the uses under consideration, take into account, among other relevant factors (and subject to the paramount criterion of safety), (A) the relative marketability of the articles involved as affected by the proposed uses of the color additive (or of such related additives) in or on such articles, and the relative dependence of the industries concerned on such uses; (B) the relative aggregate amounts of such color additive which he estimates would be consumed in the diet or applied to the human body by reason of the various uses and levels of concentration proposed; and (C) the availability, if any, of other color additives suitable and safe for one or more of the uses proposed."
  ]
  node [
    id 2537
    label "section_379e_subsection_b_item_5_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) safety factors which, in the opinion of experts qualified by scientific training and experience to evaluate the safety of color additives for the use or uses for which the additive is proposed to be listed, are generally recognized as appropriate for the use of animal experimentation data; and"
  ]
  node [
    id 2538
    label "section_379e_subsection_b_item_4"
    class_name "item"
    text "(4) The Secretary shall not list a color additive under this section for a proposed use unless the data before him establish that such use, under the conditions of use specified in the regulations, will be safe: Provided, however, That a color additive shall be deemed to be suitable and safe for the purpose of listing under this subsection for use generally in or on food, while there is in effect a published finding of the Secretary declaring such substance exempt from the term &#8220;food additive&#8221; because of its being generally recognized by qualified experts as safe for its intended use, as provided in section 321(s) of this title."
  ]
  node [
    id 2539
    label "section_379e_subsection_b_item_5_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the availability of any needed practicable methods of analysis for determining the identity and quantity of (I) the pure dye and all intermediates and other impurities contained in such color additive, (II) such additive in or on any article of food, drug or device, or cosmetic, and (III) any substance formed in or on such article because of the use of such additive."
  ]
  node [
    id 2540
    label "section_379e_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) there is in effect, and such additive and such use are in conformity with, a regulation issued under subsection (b) of this section listing such additive for such use, including any provision of such regulation prescribing the conditions under which such additive may be safely used, and (B) such additive either (i) is from a batch certified, in accordance with regulations issued pursuant to subsection (c) of this section, for such use, or (ii) has, with respect to such use, been exempted by the Secretary from the requirement of certification; or"
  ]
  node [
    id 2541
    label "section_379e_subsection_b_item_5_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) the probable consumption of, or other relevant exposure from, the additive and of any substance formed in or on food, drugs or devices, or cosmetics because of the use of the additive;"
  ]
  node [
    id 2542
    label "section_379e_subsection_d"
    class_name "subsection"
    text "(d) Procedure for issuance, amendment, or repeal of regulations"
  ]
  node [
    id 2543
    label "section_379e_subsection_c_item_2"
    class_name "item"
    text "The Secretary shall further, by regulation, provide (1) for the certification, with safe diluents or without diluents, of batches of color additives listed pursuant to subsection (b) of this section and conforming to the requirements for such additives established by regulations under such subsection and this subsection, and (2) for exemption from the requirement of certification in the case of any such additive, or any listing or use thereof, for which he finds such requirement not to be necessary in the interest of the protection of the public health: Provided, That, with respect to any use in or on food for which a listed color additive is deemed to be safe by reason of the proviso to paragraph (4) of subsection (b), the requirement of certification shall be deemed not to be necessary in the interest of public health protection."
  ]
  node [
    id 2544
    label "section_379e_subsection_d_subitem_C"
    class_name "subitem"
    text "The provisions of section 371(e), (f), and (g) of this title shall, subject to the provisions of subparagraph (C) of subsection (b)(5) of this section, apply to and in all respects govern proceedings for the issuance, amendment, or repeal of regulations under subsection (b) or (c) of this section (including judicial review of the Secretary's action in such proceedings) and the admissibility of transcripts of the record of such proceedings in other proceedings, except that&#8212;"
  ]
  node [
    id 2545
    label "section_379e_subsection_c_item_4"
    class_name "item"
    text "The Secretary shall further, by regulation, provide (1) for the certification, with safe diluents or without diluents, of batches of color additives listed pursuant to subsection (b) of this section and conforming to the requirements for such additives established by regulations under such subsection and this subsection, and (2) for exemption from the requirement of certification in the case of any such additive, or any listing or use thereof, for which he finds such requirement not to be necessary in the interest of the protection of the public health: Provided, That, with respect to any use in or on food for which a listed color additive is deemed to be safe by reason of the proviso to paragraph (4) of subsection (b), the requirement of certification shall be deemed not to be necessary in the interest of public health protection."
  ]
  node [
    id 2546
    label "section_379e_subsection_b_item_7"
    class_name "item"
    text "(7) If, in the judgment of the Secretary, a tolerance limitation is required in order to assure that a proposed use of a color additive will be safe, the Secretary&#8212;"
  ]
  node [
    id 2547
    label "section_379e_subsection_b"
    class_name "subsection"
    text "(b) Listing of colors; regulations; issuance, amendment or repeal; referral to advisory committee; report and recommendations; appointment and compensation of advisory committee"
  ]
  node [
    id 2548
    label "section_379e_subsection_d_item_3"
    class_name "item"
    text "(3) the Secretary's order after public hearing (acting upon objections filed to an order made prior to hearing) shall be subject to the requirements of section 348(f)(2) of this title; and"
  ]
  node [
    id 2549
    label "section_379e_subsection_b_item_5_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the cumulative effect, if any, of such additive in the diet of man or animals, taking into account the same or any chemically or pharmacologically related substance or substances in such diet;"
  ]
  node [
    id 2550
    label "section_379e_subsection_b_item_1"
    class_name "item"
    text "(1) The Secretary shall, by regulation, provide for separately listing color additives for use in or on food, color additives for use in or on drugs, or devices, and color additives for use in or on cosmetics, if and to the extent that such additives are suitable and safe for any such use when employed in accordance with such regulations."
  ]
  node [
    id 2551
    label "section_379e_subsection_d_item_5"
    class_name "item"
    text "The provisions of section 371(e), (f), and (g) of this title shall, subject to the provisions of subparagraph (C) of subsection (b)(5) of this section, apply to and in all respects govern proceedings for the issuance, amendment, or repeal of regulations under subsection (b) or (c) of this section (including judicial review of the Secretary's action in such proceedings) and the admissibility of transcripts of the record of such proceedings in other proceedings, except that&#8212;"
  ]
  node [
    id 2552
    label "section_379e_subsection_a_item_1"
    class_name "item"
    text "While there are in effect regulations under subsections (b) and (c) of this section relating to a color additive or an exemption pursuant to subsection (f) of this section with respect to such additive, an article shall not, by reason of bearing or containing such additive in all respects in accordance with such regulations or such exemption, be considered adulterated within the meaning of clause (1) of section 342(a) of this title if such article is a food, or within the meaning of section 361(a) of this title if such article is a cosmetic other than a hair dye (as defined in the last sentence of section 361(a) of this title). A color additive for use in or on a device shall be subject to this section only if the color additive comes in direct contact with the body of man or other animals for a significant period of time. The Secretary may by regulation designate the uses of color additives in or on devices which are subject to this section."
  ]
  node [
    id 2553
    label "section_379e_subsection_b_item_5_subitem_D"
    class_name "subitem"
    text "(D) The advisory committee referred to in subparagraph (C) of this paragraph shall be composed of experts selected by the National Academy of Sciences, qualified in the subject matter referred to the committee and of adequately diversified professional background, except that in the event of the inability or refusal of the National Academy of Sciences to act, the Secretary shall select the members of the committee. The size of the committee shall be determined by the Secretary. Members of any advisory committee established under this chapter, while attending conferences or meetings of their committees or otherwise serving at the request of the Secretary, shall be entitled to receive compensation at rates to be fixed by the Secretary but at rates not exceeding the daily equivalent of the rate specified at the time of such service for grade GS&#8211;18 of the General Schedule, including traveltime; and while away from their homes or regular places of business they may be allowed travel expenses, including per diem in lieu of subsistence, as authorized by section 5703 of title 5 for persons in the Government service employed intermittently. The members shall not be subject to any other provisions of law regarding the appointment and compensation of employees of the United States. The Secretary shall furnish the committee with adequate clerical and other assistance, and shall by rules and regulations prescribe the procedure to be followed by the committee."
  ]
  node [
    id 2554
    label "section_379f_subsection_a_item_1"
    class_name "item"
    text "(1) set and charge fees, in accordance with section 552(a)(4)(A) of title 5, to recover all reasonable costs incurred in processing requests made under section 552 of title 5 for records obtained or created under this chapter or any other Federal law for which responsibility for administration has been delegated to the Commissioner by the Secretary;"
  ]
  node [
    id 2555
    label "section_379f_subsection_a_item_3"
    class_name "item"
    text "(3) establish an accounting system and procedures to control receipts and expenditures of fees received under this section."
  ]
  node [
    id 2556
    label "section_379f_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 2557
    label "section_379f_subsection_a_item_2"
    class_name "item"
    text "(2) retain all fees charged for such requests; and"
  ]
  node [
    id 2558
    label "section_379f_subsection_b_item_1"
    class_name "item"
    text "The Secretary and the Commissioner of Food and Drugs shall not use fees received under this section for any purpose other than funding the processing of requests described in subsection (a)(1) of this section. Such fees shall not be used to reduce the amount of funds made to carry out other provisions of this chapter."
  ]
  node [
    id 2559
    label "section_379f_subsection_b"
    class_name "subsection"
    text "(b) Use of fees"
  ]
  node [
    id 2560
    label "section_379f_subsection_c_item_4"
    class_name "item"
    text "Nothing in this section shall supersede the right of a requester to obtain a waiver of fees pursuant to section 552(a)(4)(A) of title 5."
  ]
  node [
    id 2561
    label "section_379f_subsection_c_item_4_subitem_A"
    class_name "subitem"
    text "Nothing in this section shall supersede the right of a requester to obtain a waiver of fees pursuant to section 552(a)(4)(A) of title 5."
  ]
  node [
    id 2562
    label "section_379f_subsection_c"
    class_name "subsection"
    text "(c) Waiver of fees"
  ]
  node [
    id 2563
    label "section_379g_item_6"
    class_name "item"
    text "(6) The term &#8220;process for the review of human drug applications&#8221; means the following activities of the Secretary with respect to the review of human drug applications and supplements:"
  ]
  node [
    id 2564
    label "section_379g_item_8"
    class_name "item"
    text "(8) The term &#8220;adjustment factor&#8221; applicable to a fiscal year is the lower of&#8212;"
  ]
  node [
    id 2565
    label "section_379g_item_7_subitem_B"
    class_name "subitem"
    text "(B) management of information, and the acquisition, maintenance, and repair of computer resources,"
  ]
  node [
    id 2566
    label "section_379g_item_2"
    class_name "item"
    text "(2) The term &#8220;supplement&#8221; means a request to the Secretary to approve a change in a human drug application which has been approved."
  ]
  node [
    id 2567
    label "section_379g_item_3_subitem_A"
    class_name "subitem"
    text "(A) for which a human drug application has been approved, and"
  ]
  node [
    id 2568
    label "section_379g_item_7_subitem_A"
    class_name "subitem"
    text "(A) officers and employees of the Food and Drug Administration, employees under contract with the Food and Drug Administration who work in facilities owned or leased for the Food and Drug Administration, advisory committees, and costs related to such officers, employees, and committees,"
  ]
  node [
    id 2569
    label "section_379g_item_8_subitem_B"
    class_name "subitem"
    text "The terms &#8220;budget authority&#8221; and &#8220;category&#8221; in subparagraph (B) are as defined in the Balanced Budget and Emergency Deficit Control Act of 1985 [2 U.S.C. 900 et seq.], as in effect as of September 1, 1992."
  ]
  node [
    id 2570
    label "section_379g_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) an indication for a use,"
  ]
  node [
    id 2571
    label "section_379g_item_1_subitem_D"
    class_name "subitem"
    text "(D) licensure of a biological product under section 262 of title 42."
  ]
  node [
    id 2572
    label "section_379g_item_4"
    class_name "item"
    text "(4) The term &#8220;final dosage form&#8221; means, with respect to a prescription drug product, a finished dosage form which is approved for administration to a patient without further manufacturing."
  ]
  node [
    id 2573
    label "section_379g_item_6_subitem_B"
    class_name "subitem"
    text "(B) The issuance of action letters which approve human drug applications or which set forth in detail the specific deficiencies in such applications and, where appropriate, the actions necessary to place such applications in condition for approval."
  ]
  node [
    id 2574
    label "section_379g_item_5_subitem_B"
    class_name "subitem"
    text "(B) under the management of a person that is listed as the applicant in a human drug application for a prescription drug product with respect to at least one such product."
  ]
  node [
    id 2575
    label "section_379g_item_1_subitem_C"
    class_name "subitem"
    text "(C) initial certification or initial approval of an antibiotic drug under section 357 of this title, or"
  ]
  node [
    id 2576
    label "section_379g_item_3"
    class_name "item"
    text "(3) The term &#8220;prescription drug product&#8221; means a specific strength or potency of a drug in final dosage form&#8212;"
  ]
  node [
    id 2577
    label "section_379g_item_7"
    class_name "item"
    text "(7) The term &#8220;costs of resources allocated for the process for the review of human drug applications&#8221; means the expenses incurred in connection with the process for the review of human drug applications for&#8212;"
  ]
  node [
    id 2578
    label "section_379g_item_6_subitem_A"
    class_name "subitem"
    text "(A) The activities necessary for the review of human drug applications and supplements."
  ]
  node [
    id 2579
    label "section_379g_item_8_subitem_A"
    class_name "subitem"
    text "(A) the Consumer Price Index for all urban consumers (all items; United States city average) for August of the preceding fiscal year divided by such Index for August 1992, or"
  ]
  node [
    id 2580
    label "section_379g_item_1_subitem_B"
    class_name "subitem"
    text "(B) approval of a new drug submitted under section 355(b)(2) of this title after September 30, 1992, which requests approval of&#8212;"
  ]
  node [
    id 2581
    label "section_379g_item_5"
    class_name "item"
    text "(5) The term &#8220;prescription drug establishment&#8221; means a foreign or domestic place of business which is&#8212;"
  ]
  node [
    id 2582
    label "section_379g_item_1"
    class_name "item"
    text "(1) The term &#8220;human drug application&#8221; means an application for&#8212;"
  ]
  node [
    id 2583
    label "section_379g_item_3_subitem_B"
    class_name "subitem"
    text "(B) which may be dispensed only under prescription pursuant to section 353(b) of this title."
  ]
  node [
    id 2584
    label "section_379g_item_5_subitem_A"
    class_name "subitem"
    text "(A) at one general physical location consisting of one or more buildings all of which are within 5 miles of each other, at which one or more prescription drug products are manufactured in final dosage form, and"
  ]
  node [
    id 2585
    label "section_379g_item_6_subitem_E"
    class_name "subitem"
    text "(E) Monitoring of research conducted in connection with the review of human drug applications."
  ]
  node [
    id 2586
    label "section_379g_item_7_subitem_D"
    class_name "subitem"
    text "(D) collecting fees under section 379h of this title and accounting for resources allocated for the review of human drug applications and supplements."
  ]
  node [
    id 2587
    label "section_379g_item_6_subitem_C"
    class_name "subitem"
    text "(C) The inspection of prescription drug establishments and other facilities undertaken as part of the Secretary's review of pending human drug applications and supplements."
  ]
  node [
    id 2588
    label "section_379g_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) a molecular entity which is an active ingredient (including any salt or ester of an active ingredient), or"
  ]
  node [
    id 2589
    label "section_379g_item_1_subitem_A"
    class_name "subitem"
    text "(A) approval of a new drug submitted under section 355(b)(1) of this title,"
  ]
  node [
    id 2590
    label "section_379g_item_7_subitem_C"
    class_name "subitem"
    text "(C) leasing, maintenance, renovation, and repair of facilities and acquisition, maintenance, and repair of fixtures, furniture, scientific equipment, and other necessary materials and supplies, and"
  ]
  node [
    id 2591
    label "section_379g_item_6_subitem_D"
    class_name "subitem"
    text "(D) Activities necessary for the review of applications for licensure of establishments subject to section 262 of title 42 and for the release of lots of biologics under such section."
  ]
  node [
    id 2592
    label "section_379h_subsection_f"
    class_name "subsection"
    text "(f) Assessment of fees"
  ]
  node [
    id 2593
    label "section_379h_subsection_g"
    class_name "subsection"
    text "(g) Crediting and availability of fees"
  ]
  node [
    id 2594
    label "section_379h_subsection_b_item_1"
    class_name "item"
    text "Any business which has fewer than 500 employees, including employees of affiliates, and which does not have a prescription drug product introduced or delivered for introduction into interstate commerce shall pay one-half the amount of the fee for human drug applications it submits and shall pay the entire amount of the fee for supplements it submits. Such a business shall not be required to pay any portion of any fee required under subsection (a)(1)(A) of this section until 1 year after the date of the submission of the application involved. For purposes of this paragraph, one business is an affiliate of another business when, directly or indirectly, one business controls, or has the power to control, the other business or a third party controls, or has the power to control, both businesses."
  ]
  node [
    id 2595
    label "section_379h_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "Any business which has fewer than 500 employees, including employees of affiliates, and which does not have a prescription drug product introduced or delivered for introduction into interstate commerce shall pay one-half the amount of the fee for human drug applications it submits and shall pay the entire amount of the fee for supplements it submits. Such a business shall not be required to pay any portion of any fee required under subsection (a)(1)(A) of this section until 1 year after the date of the submission of the application involved. For purposes of this paragraph, one business is an affiliate of another business when, directly or indirectly, one business controls, or has the power to control, the other business or a third party controls, or has the power to control, both businesses."
  ]
  node [
    id 2596
    label "section_379h_subsection_d"
    class_name "subsection"
    text "(d) Fee waiver or reduction"
  ]
  node [
    id 2597
    label "section_379h_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) In general"
  ]
  node [
    id 2598
    label "section_379h_subsection_g_item_2"
    class_name "item"
    text "(2) Collections and appropriation acts"
  ]
  node [
    id 2599
    label "section_379h_subsection_g_item_2_subitem_B"
    class_name "subitem"
    text "(B) shall only be collected and available to defray increases in the costs of the resources allocated for the process for the review of human drug applications (including increases in such costs for an additional number of full-time equivalent positions in the Department of Health and Human Services to be engaged in such process) over such costs for fiscal year 1992 multiplied by the adjustment factor."
  ]
  node [
    id 2600
    label "section_379h_subsection_d_item_2"
    class_name "item"
    text "(2) the assessment of the fee would present a significant barrier to innovation because of limited resources available to such person or other circumstances,"
  ]
  node [
    id 2601
    label "section_379h_subsection_i_item_2_subitem_B"
    class_name "subitem"
    text "(B) after September 1, 1992, had pending before the Secretary a human drug application or supplement,"
  ]
  node [
    id 2602
    label "section_379h_subsection_g_item_1"
    class_name "item"
    text "as adjusted to reflect increases in the total fee revenues made under subsection (c)(1) of this section."
  ]
  node [
    id 2603
    label "section_379h_subsection_i_subitem_C"
    class_name "subitem"
    text "(C) Exception for previously filed application or supplement"
  ]
  node [
    id 2604
    label "section_379h_subsection_i_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "The Secretary shall refund 50 percent of the fee paid under subparagraph (B)(i) for any application or supplement which is not accepted for filing."
  ]
  node [
    id 2605
    label "section_379h_subsection_a_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) A fee established in subsection (b) of this section for a human drug application for which clinical data with respect to safety or effectiveness are not required or a supplement for which clinical data (other than bioavailability or bioequivalence studies) with respect to safety or effectiveness are required."
  ]
  node [
    id 2606
    label "section_379h_subsection_c_item_3"
    class_name "item"
    text "(3) Limit"
  ]
  node [
    id 2607
    label "section_379h_subsection_f_item_2"
    class_name "item"
    text "(2) Authority"
  ]
  node [
    id 2608
    label "section_379h_subsection_i_subitem_B"
    class_name "subitem"
    text "The Secretary shall refund 50 percent of the fee paid under subparagraph (B)(i) for any application or supplement which is not accepted for filing."
  ]
  node [
    id 2609
    label "section_379h_subsection_c_item_2"
    class_name "item"
    text "The total amount of fees charged, as adjusted under paragraph (2), for a fiscal year may not exceed the total costs for such fiscal year for the resources allocated for the process for the review of human drug applications."
  ]
  node [
    id 2610
    label "section_379h_subsection_i_item_2_subitem_A"
    class_name "subitem"
    text "(A) owns a prescription drug establishment, at which is manufactured at least 1 prescription drug product which is not the, or not the same as a, product approved under an application filed under section 355(b)(2) or 355(j) of this title, and"
  ]
  node [
    id 2611
    label "section_379h_subsection_i_subitem_A_subsubsubitem_II"
    class_name "subsubsubitem"
    text "The designation under subclause (I) or the waiver under subclause (II) shall be solely in the discretion of the Secretary and shall not be reviewable."
  ]
  node [
    id 2612
    label "section_379h_subsection_c_item_1"
    class_name "item"
    text "Subject to the amount appropriated for a fiscal year under subsection (g) of this section, the Secretary shall, within 60 days after the end of each fiscal year beginning after October 1, 1992, adjust the fees established by the schedule in subsection (b)(1) of this section for the following fiscal year to achieve the total fee revenues, as may be increased under paragraph (1). Such fees shall be adjusted under this paragraph to maintain the proportions established in such schedule."
  ]
  node [
    id 2613
    label "section_379h_subsection_i_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Final payment"
  ]
  node [
    id 2614
    label "section_379h_subsection_i_item_3_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) who is named as the applicant in a human drug application for a prescription drug product which is listed under section 360 of this title, and"
  ]
  node [
    id 2615
    label "section_379h_subsection_g_item_3_subitem_B"
    class_name "subitem"
    text "(B) $54,000,000 for fiscal year 1994,"
  ]
  node [
    id 2616
    label "section_379h_subsection_i_item_3"
    class_name "item"
    text "(3) Prescription drug product fee"
  ]
  node [
    id 2617
    label "section_379h_subsection_i_subitem_D"
    class_name "subitem"
    text "(D) Refund of fee if application not accepted for filing"
  ]
  node [
    id 2618
    label "section_379h_subsection_a_item_1"
    class_name "item"
    text "(1) Human drug application and supplement fee"
  ]
  node [
    id 2619
    label "section_379h_subsection_i_item_3_subitem_B"
    class_name "subitem"
    text "(B) Exception"
  ]
  node [
    id 2620
    label "section_379h_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) the total percentage increase that occurred during the preceding fiscal year in the Consumer Price Index for all urban consumers (all items; U.S. city average), or"
  ]
  node [
    id 2621
    label "section_379h_subsection_g_item_3_subitem_D"
    class_name "subitem"
    text "(D) $78,000,000 for fiscal year 1996, and"
  ]
  node [
    id 2622
    label "section_379h_subsection_h"
    class_name "subsection"
    text "(h) Collection of unpaid fees"
  ]
  node [
    id 2623
    label "section_379h_subsection_i_subitem_A"
    class_name "subitem"
    text "If a human drug application or supplement was submitted by a person that paid the fee for such application or supplement, was accepted for filing, and was not approved or was withdrawn (without a waiver), the submission of a human drug application or a supplement for the same product by the same person (or the person's licensee, assignee, or successor) shall not be subject to a fee under subparagraph (A)."
  ]
  node [
    id 2624
    label "section_379h_subsection_f_item_1"
    class_name "item"
    text "If the Secretary does not assess fees under subsection (a) of this section during any portion of a fiscal year because of paragraph (1) and if at a later date in such fiscal year the Secretary may assess such fees, the Secretary may assess and collect such fees, without any modification in the rate, for human drug applications and supplements, prescription drug establishments, and prescription drug products at any time in such fiscal year notwithstanding the provisions of subsection (a) of this section relating to the date fees are to be paid."
  ]
  node [
    id 2625
    label "section_379h_subsection_a"
    class_name "subsection"
    text "(a) Types of fees"
  ]
  node [
    id 2626
    label "section_379h_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) Payment schedule"
  ]
  node [
    id 2627
    label "section_379h_subsection_d_item_4"
    class_name "item"
    text "(4) assessment of the fee for an application or a supplement filed under section 355(b)(1) of this title pertaining to a drug containing an active ingredient would be inequitable because an application for a product containing the same active ingredient filed by another person under section 355(b)(2) of this title could not be assessed fees under subsection (a)(1) of this section."
  ]
  node [
    id 2628
    label "section_379h_subsection_b"
    class_name "subsection"
    text "(b) Fee amounts"
  ]
  node [
    id 2629
    label "section_379h_subsection_g_item_3"
    class_name "item"
    text "(3) Authorization of appropriations"
  ]
  node [
    id 2630
    label "section_379h_subsection_g_item_3_subitem_A"
    class_name "subitem"
    text "(A) $36,000,000 for fiscal year 1993,"
  ]
  node [
    id 2631
    label "section_379h_subsection_i_item_3_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) who, after September 1, 1992, had pending before the Secretary a human drug application or supplement,"
  ]
  node [
    id 2632
    label "section_379h_subsection_g_item_2_subitem_A"
    class_name "subitem"
    text "(A) shall be collected in each fiscal year in an amount equal to the amount specified in appropriation Acts for such fiscal year, and"
  ]
  node [
    id 2633
    label "section_379h_subsection_d_item_3"
    class_name "item"
    text "In making the finding in paragraph (3), the Secretary may use standard costs."
  ]
  node [
    id 2634
    label "section_379h_subsection_i"
    class_name "subsection"
    text "(i) Construction"
  ]
  node [
    id 2635
    label "section_379h_subsection_b_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "Subsection (a)(1)(A)(i) fee"
  ]
  node [
    id 2636
    label "section_379h_subsection_g_item_3_subitem_C"
    class_name "subitem"
    text "(C) $75,000,000 for fiscal year 1995,"
  ]
  node [
    id 2637
    label "section_379h_subsection_d_item_1"
    class_name "item"
    text "(1) such waiver or reduction is necessary to protect the public health,"
  ]
  node [
    id 2638
    label "section_379h_subsection_i_item_2"
    class_name "item"
    text "The listing of a prescription drug product under section 360 of this title shall not require the person who listed such product to pay the fee prescribed by subparagraph (A) if such product is the same product as a product approved under an application filed under section 355(b)(2) or 355(j) of this title."
  ]
  node [
    id 2639
    label "section_379h_subsection_a_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) A fee established in subsection (b) of this section for a human drug application for which clinical data (other than bioavailability or bioequivalence studies) with respect to safety or effectiveness are required for approval."
  ]
  node [
    id 2640
    label "section_379h_subsection_i_subitem_A_subsubsubitem_I"
    class_name "subsubsubitem"
    text "The designation under subclause (I) or the waiver under subclause (II) shall be solely in the discretion of the Secretary and shall not be reviewable."
  ]
  node [
    id 2641
    label "section_379h_subsection_b_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "Subsection (a)(1)(A)(ii) fee"
  ]
  node [
    id 2642
    label "section_379h_subsection_i_item_3_subitem_A"
    class_name "subitem"
    text "The listing of a prescription drug product under section 360 of this title shall not require the person who listed such product to pay the fee prescribed by subparagraph (A) if such product is the same product as a product approved under an application filed under section 355(b)(2) or 355(j) of this title."
  ]
  node [
    id 2643
    label "section_379h_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) the total percentage increase for such fiscal year in basic pay under the General Schedule in accordance with section 5332 of title 5, as adjusted by any locality-based comparability payment pursuant to section 5304 of such title for Federal employees stationed in the District of Columbia."
  ]
  node [
    id 2644
    label "section_379h_subsection_c"
    class_name "subsection"
    text "(c) Increases and adjustments"
  ]
  node [
    id 2645
    label "section_379h_subsection_g_item_3_subitem_E"
    class_name "subitem"
    text "(E) $84,000,000 for fiscal year 1997,"
  ]
  node [
    id 2646
    label "section_379h_subsection_e"
    class_name "subsection"
    text "(e) Effect of failure to pay fees"
  ]
  node [
    id 2647
    label "section_379h_subsection_b_item_2"
    class_name "item"
    text "(2) Small business exception"
  ]
  node [
    id 2648
    label "section_381_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) is not in conflict with the laws of the country to which it is intended for export,"
  ]
  node [
    id 2649
    label "section_381_subsection_c"
    class_name "subsection"
    text "(c) Charges concerning refused articles"
  ]
  node [
    id 2650
    label "section_381_subsection_e_item_1_subitem_C"
    class_name "subitem"
    text "(C) is labeled on the outside of the shipping package that it is intended for export, and"
  ]
  node [
    id 2651
    label "section_381_subsection_a_item_1"
    class_name "item"
    text "The Secretary of the Treasury shall deliver to the Secretary of Health and Human Services, upon his request, samples of food, drugs, devices, and cosmetics which are being imported or offered for import into the United States, giving notice thereof to the owner or consignee, who may appear before the Secretary of Health and Human Services and have the right to introduce testimony. The Secretary of Health and Human Services shall furnish to the Secretary of the Treasury a list of establishments registered pursuant to subsection (i) of section 360 of this title and shall request that if any drugs and devices manufactured, prepared, propagated, compounded, or processed in an establishment not so registered are imported or offered for import into the United States, samples of such drugs and devices be delivered to the Secretary of Health and Human Services, with notice of such delivery to the owner or consignee, who may appear before the Secretary of Health and Human Services and have the right to introduce testimony. If it appears from the examination of such samples or otherwise that (1) such article has been manufactured, processed, or packed under insanitary conditions or, in the case of a device, the methods used in, or the facilities or controls used for, the manufacture, packing, storage, or installation of the device do not conform to the requirements of section 360j(f) of this title, or (2) such article is forbidden or restricted in sale in the country in which it was produced or from which it was exported, or (3) such article is adulterated, misbranded, or in violation of section 355 of this title, then such article shall be refused admission, except as provided in subsection (b) of this section. The Secretary of the Treasury shall cause the destruction of any such article refused admission unless such article is exported, under regulations prescribed by the Secretary of the Treasury, within ninety days of the date of notice of such refusal or within such additional time as may be permitted pursuant to such regulations. Clause (2) of the third sentence of this paragraph&#160;1 shall not be construed to prohibit the admission of narcotic drugs the importation of which is permitted under the Controlled Substances Import and Export Act [21 U.S.C. 951 et seq.]."
  ]
  node [
    id 2652
    label "section_381_subsection_e_item_1_subitem_D"
    class_name "subitem"
    text "(D) is not sold or offered for sale in domestic commerce."
  ]
  node [
    id 2653
    label "section_381_subsection_d_item_1"
    class_name "item"
    text "(1) Except as provided in paragraph (2), no drug subject to section 353(b) of this title which is manufactured in a State and exported may be imported into the United States unless the drug is imported by the manufacturer of the drug."
  ]
  node [
    id 2654
    label "section_381_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(A) accords to the specifications of the foreign purchaser,"
  ]
  node [
    id 2655
    label "section_381_subsection_a_item_3"
    class_name "item"
    text "The Secretary of the Treasury shall deliver to the Secretary of Health and Human Services, upon his request, samples of food, drugs, devices, and cosmetics which are being imported or offered for import into the United States, giving notice thereof to the owner or consignee, who may appear before the Secretary of Health and Human Services and have the right to introduce testimony. The Secretary of Health and Human Services shall furnish to the Secretary of the Treasury a list of establishments registered pursuant to subsection (i) of section 360 of this title and shall request that if any drugs and devices manufactured, prepared, propagated, compounded, or processed in an establishment not so registered are imported or offered for import into the United States, samples of such drugs and devices be delivered to the Secretary of Health and Human Services, with notice of such delivery to the owner or consignee, who may appear before the Secretary of Health and Human Services and have the right to introduce testimony. If it appears from the examination of such samples or otherwise that (1) such article has been manufactured, processed, or packed under insanitary conditions or, in the case of a device, the methods used in, or the facilities or controls used for, the manufacture, packing, storage, or installation of the device do not conform to the requirements of section 360j(f) of this title, or (2) such article is forbidden or restricted in sale in the country in which it was produced or from which it was exported, or (3) such article is adulterated, misbranded, or in violation of section 355 of this title, then such article shall be refused admission, except as provided in subsection (b) of this section. The Secretary of the Treasury shall cause the destruction of any such article refused admission unless such article is exported, under regulations prescribed by the Secretary of the Treasury, within ninety days of the date of notice of such refusal or within such additional time as may be permitted pursuant to such regulations. Clause (2) of the third sentence of this paragraph&#160;1 shall not be construed to prohibit the admission of narcotic drugs the importation of which is permitted under the Controlled Substances Import and Export Act [21 U.S.C. 951 et seq.]."
  ]
  node [
    id 2656
    label "section_381_subsection_e_item_2_subitem_B"
    class_name "subitem"
    text "(B) which under section 360j(g) of this title is exempt from either such section, or"
  ]
  node [
    id 2657
    label "section_381_subsection_e"
    class_name "subsection"
    text "(e) Exports"
  ]
  node [
    id 2658
    label "section_381_subsection_b_item_3"
    class_name "item"
    text "Pending decision as to the admission of an article being imported or offered for import, the Secretary of the Treasury may authorize delivery of such article to the owner or consignee upon the execution by him of a good and sufficient bond providing for the payment of such liquidated damages in the event of default as may be required pursuant to regulations of the Secretary of the Treasury. If it appears to the Secretary of Health and Human Services that an article included within the provisions of clause (3) of subsection (a) of this section can, by relabeling or other action, be brought into compliance with this chapter or rendered other than a food, drug, device, or cosmetic, final determination as to admission of such article may be deferred and, upon filing of timely written application by the owner or consignee and the execution by him of a bond as provided in the preceding provisions of this subsection, the Secretary may, in accordance with regulations, authorize the applicant to perform such relabeling or other action specified in such authorization (including destruction or export of rejected articles or portions thereof, as may be specified in the Secretary's authorization). All such relabeling or other action pursuant to such authorization shall in accordance with regulations be under the supervision of an officer or employee of the Department of Health and Human Services designated by the Secretary, or an officer or employee of the Department of the Treasury designated by the Secretary of the Treasury."
  ]
  node [
    id 2659
    label "section_381_subsection_d"
    class_name "subsection"
    text "(d) Reimportation"
  ]
  node [
    id 2660
    label "section_381_subsection_e_item_2_subitem_A"
    class_name "subitem"
    text "(A) which does not comply with an applicable requirement of section 360d or 360e of this title,"
  ]
  node [
    id 2661
    label "section_381_subsection_d_item_2"
    class_name "item"
    text "(2) The Secretary may authorize the importation of a drug the importation of which is prohibited by paragraph (1) if the drug is required for emergency medical care."
  ]
  node [
    id 2662
    label "section_381_subsection_a"
    class_name "subsection"
    text "(a) Imports; list of registered foreign establishments; samples from unregistered foreign establishments; examination and refusal of admission"
  ]
  node [
    id 2663
    label "section_381_subsection_a_subsubitem_i"
    class_name "subsubitem"
    text "The Secretary of the Treasury shall deliver to the Secretary of Health and Human Services, upon his request, samples of food, drugs, devices, and cosmetics which are being imported or offered for import into the United States, giving notice thereof to the owner or consignee, who may appear before the Secretary of Health and Human Services and have the right to introduce testimony. The Secretary of Health and Human Services shall furnish to the Secretary of the Treasury a list of establishments registered pursuant to subsection (i) of section 360 of this title and shall request that if any drugs and devices manufactured, prepared, propagated, compounded, or processed in an establishment not so registered are imported or offered for import into the United States, samples of such drugs and devices be delivered to the Secretary of Health and Human Services, with notice of such delivery to the owner or consignee, who may appear before the Secretary of Health and Human Services and have the right to introduce testimony. If it appears from the examination of such samples or otherwise that (1) such article has been manufactured, processed, or packed under insanitary conditions or, in the case of a device, the methods used in, or the facilities or controls used for, the manufacture, packing, storage, or installation of the device do not conform to the requirements of section 360j(f) of this title, or (2) such article is forbidden or restricted in sale in the country in which it was produced or from which it was exported, or (3) such article is adulterated, misbranded, or in violation of section 355 of this title, then such article shall be refused admission, except as provided in subsection (b) of this section. The Secretary of the Treasury shall cause the destruction of any such article refused admission unless such article is exported, under regulations prescribed by the Secretary of the Treasury, within ninety days of the date of notice of such refusal or within such additional time as may be permitted pursuant to such regulations. Clause (2) of the third sentence of this paragraph&#160;1 shall not be construed to prohibit the admission of narcotic drugs the importation of which is permitted under the Controlled Substances Import and Export Act [21 U.S.C. 951 et seq.]."
  ]
  node [
    id 2664
    label "section_381_subsection_a_item_2"
    class_name "item"
    text "The Secretary of the Treasury shall deliver to the Secretary of Health and Human Services, upon his request, samples of food, drugs, devices, and cosmetics which are being imported or offered for import into the United States, giving notice thereof to the owner or consignee, who may appear before the Secretary of Health and Human Services and have the right to introduce testimony. The Secretary of Health and Human Services shall furnish to the Secretary of the Treasury a list of establishments registered pursuant to subsection (i) of section 360 of this title and shall request that if any drugs and devices manufactured, prepared, propagated, compounded, or processed in an establishment not so registered are imported or offered for import into the United States, samples of such drugs and devices be delivered to the Secretary of Health and Human Services, with notice of such delivery to the owner or consignee, who may appear before the Secretary of Health and Human Services and have the right to introduce testimony. If it appears from the examination of such samples or otherwise that (1) such article has been manufactured, processed, or packed under insanitary conditions or, in the case of a device, the methods used in, or the facilities or controls used for, the manufacture, packing, storage, or installation of the device do not conform to the requirements of section 360j(f) of this title, or (2) such article is forbidden or restricted in sale in the country in which it was produced or from which it was exported, or (3) such article is adulterated, misbranded, or in violation of section 355 of this title, then such article shall be refused admission, except as provided in subsection (b) of this section. The Secretary of the Treasury shall cause the destruction of any such article refused admission unless such article is exported, under regulations prescribed by the Secretary of the Treasury, within ninety days of the date of notice of such refusal or within such additional time as may be permitted pursuant to such regulations. Clause (2) of the third sentence of this paragraph&#160;1 shall not be construed to prohibit the admission of narcotic drugs the importation of which is permitted under the Controlled Substances Import and Export Act [21 U.S.C. 951 et seq.]."
  ]
  node [
    id 2665
    label "section_381_subsection_e_item_1"
    class_name "item"
    text "unless, in addition to the requirements of paragraph (1), the Secretary has determined that the exportation of the device is not contrary to public health and safety and has the approval of the country to which it is intended for export."
  ]
  node [
    id 2666
    label "section_381_subsection_b"
    class_name "subsection"
    text "(b) Disposition of refused articles"
  ]
  node [
    id 2667
    label "section_381_subsection_e_item_2_subitem_C"
    class_name "subitem"
    text "(C) which is a banned device under section 360f of this title,"
  ]
  node [
    id 2668
    label "section_381_subsection_e_item_2"
    class_name "item"
    text "(2) Paragraph (1) does not apply to any device&#8212;"
  ]
  node [
    id 2669
    label "section_382_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) requires licensing by the Secretary under section 262 of title 42 or by the Secretary of Agriculture under the Act of March 4, 1913 [21 U.S.C. 151 et seq.] (known as the Virus Serum Toxin Act),"
  ]
  node [
    id 2670
    label "section_382_subsection_b"
    class_name "subsection"
    text "(b) Conditions for export; active pursuit of drug approval or licensing; application for export, contents, approval or disapproval; list of eligible countries for export; criteria for list change"
  ]
  node [
    id 2671
    label "section_382_subsection_v_item_4_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(C)(i) Before the expiration of 30 days after the date an application is submitted to the Secretary, the Secretary shall review the application to determine if the application meets the requirements of clauses (i), (ii), (iv), (v), (vi), and (vii) of subparagraph (B) and contains the certifications described in clauses (iii) (other than the certification required by clause (iii)(II)) and (iv). If the Secretary determines that the application meets such requirements and contains such certifications the Secretary shall conditionally approve the application. An application which is so conditionally approved shall be finally approved within 5 days of the submission of the certification required by clause (iii)(II)."
  ]
  node [
    id 2672
    label "section_382_subsection_f_item_2"
    class_name "item"
    text "(2) Any person may apply to have a drug exported under paragraph (1). The application shall&#8212;"
  ]
  node [
    id 2673
    label "section_382_subsection_i_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) for which the licensing of the biological product under such Act is actively being pursued by the person who has the authority, or"
  ]
  node [
    id 2674
    label "section_382_subsection_v_item_4_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) Canada,"
  ]
  node [
    id 2675
    label "section_382_subsection_i_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) for which authority has been granted under the Virus-Serum Toxin Act [21 U.S.C. 151 et seq.] for the preparation of an experimental drug product, and"
  ]
  node [
    id 2676
    label "section_382_subsection_v_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) The countries to which a drug may be exported under paragraph (1) are&#8212;"
  ]
  node [
    id 2677
    label "section_382_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "then before taking action against the holder of an application for which a determination was made under subparagraph (A) or (B), the Secretary shall notify the holder in writing of the determination and provide the holder 30 days to take such action as may be required so that the Secretary would be unable to make such determination. When the Secretary takes action against such holder because of such a determination, the Secretary shall provide the holder a written statement specifying the reasons for such determination and provide the person, on request, an opportunity for an informal hearing with respect to such determination."
  ]
  node [
    id 2678
    label "section_382_subsection_v_item_4_subitem_D"
    class_name "subitem"
    text "(D) If the holder of an application approved under subparagraph (C) for the export of a drug intends to export such drug to a country listed in paragraph (4) which is not listed in such application, such holder shall submit an amendment to such application to the Secretary not later than 30 days before the date of the proposed export to such country identifying the country to which the holder intends to export such drug and containing information sufficient to show that the drug is approved by such country and has not been withdrawn from sale in such country. The Secretary shall approve or disapprove the export of such drug to such country within 15 days of the receipt of the notice required by this subparagraph."
  ]
  node [
    id 2679
    label "section_382_subsection_g_item_1"
    class_name "item"
    text "(1) a reference to the Secretary shall in the case of a biological product which is required to be licensed under the Virus-Serum Toxin Act [21 U.S.C. 151 et seq.] be considered to be a reference to the Secretary of Agriculture, and"
  ]
  node [
    id 2680
    label "section_382_subsection_e_item_3_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) such export presents an imminent hazard to the public health in such country,"
  ]
  node [
    id 2681
    label "section_382_subsection_e_item_5"
    class_name "item"
    text "(5) If the Secretary receives credible evidence that the holder of an application approved under subsection (b) of this section is exporting a drug to a country which is not listed under subsection (b)(4) of this section, the Secretary shall give the holder 60 days to provide information to the Secretary respecting such evidence and shall provide the holder an opportunity for an informal hearing on such evidence. Upon the expiration of such 60 days the Secretary shall prohibit the export of such drug to such country if the Secretary determines that the holder of the application is exporting the drug to a country which is not listed under subsection (b)(4) of this section."
  ]
  node [
    id 2682
    label "section_382_subsection_i_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) Any person may apply to have a drug exported under paragraph (1). Such an application shall be filed at least 90 days before the date the applicant proposes to export the drug for which the application is submitted. Before the expiration of 10 days from the date of the submission of such an application, the Secretary shall publish a notice in the Federal Register which identifies the applicant under such application, the drug proposed to be exported under such application, and the country to which the drug is proposed to be exported."
  ]
  node [
    id 2683
    label "section_382_subsection_v_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Statutory or regulatory requirements that the methods used in, and the facilities and controls used for, the manufacture, processing, and packing of drugs in the country are adequate to preserve their identity, quality, purity, and strength."
  ]
  node [
    id 2684
    label "section_382_subsection_e_item_3_subitem_B"
    class_name "subitem"
    text "(B) The authority conferred by subparagraph (A) shall not be delegated by the Secretary. A determination by the Secretary under subparagraph (A) may not be stayed pending final action by a reviewing court."
  ]
  node [
    id 2685
    label "section_382_subsection_e_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) the holder of an approved application under subsection (b) of this section is exporting a drug from the United States to an importer,"
  ]
  node [
    id 2686
    label "section_382_subsection_v_item_4_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) Belgium,"
  ]
  node [
    id 2687
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) contain a certification by the holder of the exemption or authority for such drug described in paragraph (1)(A) that the holder will actively pursue the approval or licensing of the drug,"
  ]
  node [
    id 2688
    label "section_382_subsection_i_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) biological product for human use&#8212;"
  ]
  node [
    id 2689
    label "section_382_subsection_f_item_2_subitem_A"
    class_name "subitem"
    text "(A) describe the drug to be exported,"
  ]
  node [
    id 2690
    label "section_382_subsection_g"
    class_name "subsection"
    text "(g) Reference to Secretary and holder of application"
  ]
  node [
    id 2691
    label "section_382_subsection_f_item_2_subitem_C"
    class_name "subitem"
    text "(C) contain a certification by the applicant that the drug will not be exported to a country for which the Secretary cannot make a finding described in paragraph (1)(A),"
  ]
  node [
    id 2692
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) list each country to which the drug is to be exported and list the persons in each such country to which the drug is to be exported,"
  ]
  node [
    id 2693
    label "section_382_subsection_v_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) Austria,"
  ]
  node [
    id 2694
    label "section_382_subsection_i_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) biological product for animal use&#8212;"
  ]
  node [
    id 2695
    label "section_382_subsection_v_item_4"
    class_name "item"
    text "(4)(A) The countries to which a drug may be exported under paragraph (1) are&#8212;"
  ]
  node [
    id 2696
    label "section_382_subsection_e_item_2"
    class_name "item"
    text "(2) If the Secretary determines that the approval of a drug is not being actively pursued as required by subsection (b)(1)(A) of this section, the Secretary shall give the holder of the application authorizing the export of such drug 60 days to assure that actions are taken to actively pursue such approval. During the 60-day period the Secretary shall give the holder an opportunity for an informal hearing on the determination of the Secretary. If upon the expiration of such 60-day period the Secretary determines that approval of such drug is not being actively pursued, the Secretary shall prohibit the export of such drug."
  ]
  node [
    id 2697
    label "section_382_subsection_f_item_2_subitem_E"
    class_name "subitem"
    text "(E) demonstrate to the Secretary that the drug meets the requirements of paragraph (1)."
  ]
  node [
    id 2698
    label "section_382_subsection_e_item_3"
    class_name "item"
    text "(3)(A) If at any time the Secretary, or in the absence of the Secretary the individual acting as the Secretary, determines that&#8212;"
  ]
  node [
    id 2699
    label "section_382_subsection_v_item_4_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) Australia,"
  ]
  node [
    id 2700
    label "section_382_subsection_f_item_3_subitem_B"
    class_name "subitem"
    text "(B) the receipt of any information indicating any adverse reactions to such drug."
  ]
  node [
    id 2701
    label "section_382_subsection_e_item_6"
    class_name "item"
    text "(6) If the Secretary receives credible evidence that an importer is exporting a drug to a country which is not listed under subsection (b)(4) of this section, the Secretary shall notify the holder of the application authorizing the export of such drug of such evidence and shall require the holder to investigate the export by such importer and to report to the Secretary within 14 days of the receipt of such notice the findings of the holder. If the Secretary determines that the importer has exported a drug to such a country, the Secretary shall prohibit such holder from exporting such drug to the importer unless the Secretary determines that the export by the importer was unintentional."
  ]
  node [
    id 2702
    label "section_382_subsection_d_item_1"
    class_name "item"
    text "(1) an approval of such drug is withdrawn by such country,"
  ]
  node [
    id 2703
    label "section_382_subsection_i_subitem_D"
    class_name "subitem"
    text "(D) the drug is manufactured, processed, packaged, and held in conformity with current good manufacturing practice and is not adulterated under paragraph (a)(1), (a)(2)(A), (a)(3), (c), or (d) of section 351 of this title,"
  ]
  node [
    id 2704
    label "section_382_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) the drug contains the same active ingredient as a&#8212;"
  ]
  node [
    id 2705
    label "section_382_subsection_f_item_1"
    class_name "item"
    text "(1) A drug (including a biological product) which is to be used in the prevention or treatment of a tropical disease may, upon approval of an application submitted under paragraph (2), be exported if&#8212;"
  ]
  node [
    id 2706
    label "section_382_subsection_f_item_1_subitem_D"
    class_name "subitem"
    text "(D) the drug is not the subject of a notice by the Secretary or the Secretary of Agriculture of a determination that the manufacture of the drug in the United States for export to a country is contrary to the public health and safety of the United States, and"
  ]
  node [
    id 2707
    label "section_382_subsection_e_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) If at any time the Secretary, or in the absence of the Secretary the individual acting as the Secretary, determines that&#8212;"
  ]
  node [
    id 2708
    label "section_382_subsection_i_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) new animal drug&#8212;"
  ]
  node [
    id 2709
    label "section_382_subsection_f_item_4_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) such export presents an imminent hazard to the public health in such country,"
  ]
  node [
    id 2710
    label "section_382_subsection_f_item_2_subitem_B"
    class_name "subitem"
    text "(B) list each country to which the drug is to be exported,"
  ]
  node [
    id 2711
    label "section_382_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "The reporting of an event described in subparagraph (A), (B), or (C) shall be made within 15 days of the occurrence of the event and the reporting of the receipt of information under subparagraph (D) shall be made within 15 days of the receipt of such information."
  ]
  node [
    id 2712
    label "section_382_subsection_d_item_2"
    class_name "item"
    text "(2) the drug is withdrawn from sale in such country,"
  ]
  node [
    id 2713
    label "section_382_subsection_v_item_4_subitem_C_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) that the applicant has 60 days after receiving the statement to correct such deficiencies."
  ]
  node [
    id 2714
    label "section_382_subsection_a"
    class_name "subsection"
    text "(a) Drugs intended for human or animal use which require approval or licensing"
  ]
  node [
    id 2715
    label "section_382_subsection_e_item_1"
    class_name "item"
    text "(1) If the Secretary determines that&#8212;"
  ]
  node [
    id 2716
    label "section_382_subsection_c"
    class_name "subsection"
    text "(c) Report to Secretary by holder of approved application; events requiring report; annual report to Secretary on pursuit of approval of drug"
  ]
  node [
    id 2717
    label "section_382_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) requires approval by the Secretary under section 355 of this title or section 360b of this title, or"
  ]
  node [
    id 2718
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) contain a certification by the applicant that&#8212;"
  ]
  node [
    id 2719
    label "section_382_subsection_e_item_4_subitem_B"
    class_name "subitem"
    text "(B) The authority conferred by subparagraph (A) shall not be delegated by the Secretary. A determination by the Secretary under subparagraph (A) may not be stayed pending final action by a reviewing court."
  ]
  node [
    id 2720
    label "section_382_subsection_f_item_4_subitem_D"
    class_name "subitem"
    text "(D) If the Secretary receives credible evidence that the holder of an application approved under paragraph (2) is exporting a drug to a country for which the Secretary cannot make a finding under paragraph (1)(A), the Secretary shall give the holder 60 days to provide information to the Secretary respecting such evidence and shall provide the holder an opportunity for an informal hearing on such evidence. Upon the expiration of such 60 days the Secretary shall prohibit the export of such drug to such country if the Secretary determines the holder is exporting the drug to a country for which the Secretary cannot make a finding under paragraph (1)(A)."
  ]
  node [
    id 2721
    label "section_382_subsection_i_item_3_subitem_B"
    class_name "subitem"
    text "(B) An application for the export of a drug shall&#8212;"
  ]
  node [
    id 2722
    label "section_382_subsection_f_item_4_subitem_E"
    class_name "subitem"
    text "(E) If the Secretary receives credible evidence that an importer is exporting a drug to a country for which the Secretary cannot make a finding under paragraph (1)(A), the Secretary shall notify the holder of the application authorizing the export of such drug of such evidence and shall require the holder to investigate the export by such importer and to report to the Secretary within 14 days of the receipt of such notice the findings of the holder. If the Secretary determines that the importer has exported a drug to such a country, the Secretary shall prohibit such holder from exporting such drug to the importer unless the Secretary determines that the export by the importer was unintentional."
  ]
  node [
    id 2723
    label "section_382_subsection_f_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) such importer is exporting the drug to a country for which the Secretary cannot make a finding under paragraph (1)(A), and"
  ]
  node [
    id 2724
    label "section_382_subsection_a_item_2"
    class_name "item"
    text "(2) which does not have such approval or license, which is not exempt from such sections or Act, and which is introduced or delivered for introduction into interstate commerce to a country,"
  ]
  node [
    id 2725
    label "section_382_subsection_v_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) Statutory or regulatory requirements for the reporting of adverse reactions to drugs and procedures to withdraw approval and remove drugs found not to be safe or effective."
  ]
  node [
    id 2726
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_iii_subsubsubitem_IV"
    class_name "subsubsubitem"
    text "(IV) the drug will be labeled in accordance with paragraph (1)(E), and"
  ]
  node [
    id 2727
    label "section_382_subsection_f_item_4_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "then before taking action against the holder of an application for which a determination was made under clause (i), (ii), or (iii), the Secretary shall notify the holder in writing of the determination and provide the holder 30 days to take such action as may be required so that the Secretary would be unable to make such determination. When the Secretary takes action against such holder because of such a determination, the Secretary shall provide the holder a written statement specifying the reasons for such determination and provide the person, on request, an opportunity for an informal hearing with respect to such determination."
  ]
  node [
    id 2728
    label "section_382_subsection_a_item_1"
    class_name "item"
    text "(1) which&#8212;"
  ]
  node [
    id 2729
    label "section_382_subsection_v_item_4_subitem_C_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the deficiencies which the applicant must correct in order to enable the Secretary to approve the application, and"
  ]
  node [
    id 2730
    label "section_382_subsection_f_item_3"
    class_name "item"
    text "(3) The holder of an approved application for the export of a drug under this subsection shall report to the Secretary&#8212;"
  ]
  node [
    id 2731
    label "section_382_subsection_i_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) for which licensing of the biological product under section 262 of title 42 is actively being pursued by the person who has the exemption,"
  ]
  node [
    id 2732
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_iii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) the applicant will export the drug only to a country which is listed in paragraph (4) and in which the drug is approved unless the drug is authorized to be exported under paragraph (2) and will export only those quantities of the drug which may reasonably be sold in each country to which it is to be exported,"
  ]
  node [
    id 2733
    label "section_382_subsection_v_item_4_subitem_C"
    class_name "subitem"
    text "(C)(i) Before the expiration of 30 days after the date an application is submitted to the Secretary, the Secretary shall review the application to determine if the application meets the requirements of clauses (i), (ii), (iv), (v), (vi), and (vii) of subparagraph (B) and contains the certifications described in clauses (iii) (other than the certification required by clause (iii)(II)) and (iv). If the Secretary determines that the application meets such requirements and contains such certifications the Secretary shall conditionally approve the application. An application which is so conditionally approved shall be finally approved within 5 days of the submission of the certification required by clause (iii)(II)."
  ]
  node [
    id 2734
    label "section_382_subsection_i"
    class_name "subsection"
    text "(i) new drug&#8212;"
  ]
  node [
    id 2735
    label "section_382_subsection_f_item_1_subitem_C"
    class_name "subitem"
    text "(C) the outside of the shipping package is labeled with the following statement: &#8220;This drug may be sold or offered for sale only in the following countries: &#160;&#160;&#160;&#160;&#160;&#160;&#8221;, the blank space being filled with a list of the countries to which export of the drug is authorized under this subsection,"
  ]
  node [
    id 2736
    label "section_382_subsection_i_subitem_E"
    class_name "subitem"
    text "(E) the outside of the shipping package is labeled with the following statement: &#8220;This drug may be sold or offered for sale only in the following countries: &#160;&#160;&#160;&#160;&#160;&#160;&#8221;, the blank space being filled with a list of the countries to which export of the drug is authorized under this subsection,"
  ]
  node [
    id 2737
    label "section_382_subsection_e_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) If the Secretary, or in the absence of the Secretary the individual acting as the Secretary, determines that the holder of an approved application under subsection (b) of this section is exporting a drug to a country which is not listed under subsection (b)(4) of this section and that the export of the drug presents an imminent hazard, the Secretary shall immediately prohibit the export of the drug to such country, give the holder prompt notice of the determination, and afford the holder an opportunity for an expedited hearing."
  ]
  node [
    id 2738
    label "section_382_subsection_c_item_2"
    class_name "item"
    text "(2) The holder of an approved application under subsection (b) of this section authorizing the export of a drug shall report annually to the Secretary after the date of the approval of the application of the actions taken by the holder in pursuit of the approval of such drug during the year reported on. Not later than 90 days from the date of the receipt of a report under this paragraph the Secretary shall determine if the holder is actively pursuing the approval of such drug."
  ]
  node [
    id 2739
    label "section_382_subsection_i_subitem_B"
    class_name "subitem"
    text "(B) except as provided in paragraph (2), the drug is exported to a country which is listed under paragraph (4) and in which the drug is approved and has not been withdrawn from sale,"
  ]
  node [
    id 2740
    label "section_382_subsection_b_item_1"
    class_name "item"
    text "(1) A drug (including a biological product) may, upon approval of an application submitted under paragraph (3), be exported if&#8212;"
  ]
  node [
    id 2741
    label "section_382_subsection_v_subsubitem_xx"
    class_name "subsubitem"
    text "(xx) Switzerland, and"
  ]
  node [
    id 2742
    label "section_382_subsection_i_subsubitem_iv_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) for which approval is actively being pursued by the person who has the exemption,"
  ]
  node [
    id 2743
    label "section_382_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(A) the Secretary finds, based on credible scientific evidence, including clinical investigations, that the drug is safe and effective in the country to which it is to be exported in the prevention or treatment of a tropical disease in such country,"
  ]
  node [
    id 2744
    label "section_382_subsection_i_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) for which approval is actively being pursued by the person who has the exemption,"
  ]
  node [
    id 2745
    label "section_382_subsection_i_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) which has an exemption under section 355(i) of this title, and"
  ]
  node [
    id 2746
    label "section_382_subsection_f_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the holder of an approved application under paragraph (2) is exporting a drug from the United States to an importer,"
  ]
  node [
    id 2747
    label "section_382_subsection_c_item_1"
    class_name "item"
    text "(1) The holder of an approved application under subsection (b) of this section authorizing the export of a drug shall report to the Secretary&#8212;"
  ]
  node [
    id 2748
    label "section_382_subsection_f_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) If the Secretary determines that&#8212;"
  ]
  node [
    id 2749
    label "section_382_subsection_d"
    class_name "subsection"
    text "(d) Export of drug under approved application prohibited"
  ]
  node [
    id 2750
    label "section_382_subsection_v_item_4_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If the Secretary proposes to disapprove an application, the Secretary shall provide the applicant with a written statement specifying&#8212;"
  ]
  node [
    id 2751
    label "section_382_subsection_f_item_4_subitem_C"
    class_name "subitem"
    text "(C) If the Secretary, or in the absence of the Secretary the individual acting as the Secretary, determines that the holder of an approved application under paragraph (2) is exporting a drug to a country for which the Secretary cannot make a finding under paragraph (1)(A), and that the export of the drug presents an imminent hazard, the Secretary shall immediately prohibit the export of the drug to such country, give the holder prompt notice of the determination, and afford the holder an opportunity for an expedited hearing. A determination by the Secretary under this subparagraph may not be stayed pending final action by a reviewing court. The authority conferred by this subparagraph shall not be delegated by the Secretary."
  ]
  node [
    id 2752
    label "section_382_subsection_f_item_4_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "then before taking action against the holder of an application for which a determination was made under clause (i), (ii), or (iii), the Secretary shall notify the holder in writing of the determination and provide the holder 30 days to take such action as may be required so that the Secretary would be unable to make such determination. When the Secretary takes action against such holder because of such a determination, the Secretary shall provide the holder a written statement specifying the reasons for such determination and provide the person, on request, an opportunity for an informal hearing with respect to such determination."
  ]
  node [
    id 2753
    label "section_382_subsection_g_item_2"
    class_name "item"
    text "(2) a reference in paragraph (3), (4), (5), or (6) of subsection (e) of this section and in subparagraph (B), (C), (D), or (E) of subsection (f)(4) of this section to the holder of an application shall be considered a reference to any person which is under common control with holder, is controlled by the holder, controls the holder, is owned by the holder, or owns the holder."
  ]
  node [
    id 2754
    label "section_382_subsection_v_subitem_B"
    class_name "subitem"
    text "(B) Changes in the list contained in subparagraph (A) shall be based on the following criteria:"
  ]
  node [
    id 2755
    label "section_382_subsection_f_item_4"
    class_name "item"
    text "(4)(A) If the Secretary determines that&#8212;"
  ]
  node [
    id 2756
    label "section_382_subsection_c_item_1_subitem_D"
    class_name "subitem"
    text "The reporting of an event described in subparagraph (A), (B), or (C) shall be made within 15 days of the occurrence of the event and the reporting of the receipt of information under subparagraph (D) shall be made within 15 days of the receipt of such information."
  ]
  node [
    id 2757
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) identify the drug to be exported,"
  ]
  node [
    id 2758
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_iii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the drug is approved by each country to which it is to be exported unless the drug is authorized to be exported under paragraph (2) and the drug has not been withdrawn from sale in such country,"
  ]
  node [
    id 2759
    label "section_382_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "then before taking action against the holder of an application for which a determination was made under subparagraph (A) or (B), the Secretary shall notify the holder in writing of the determination and provide the holder 30 days to take such action as may be required so that the Secretary would be unable to make such determination. When the Secretary takes action against such holder because of such a determination, the Secretary shall provide the holder a written statement specifying the reasons for such determination and provide the person, on request, an opportunity for an informal hearing with respect to such determination."
  ]
  node [
    id 2760
    label "section_382_subsection_d_item_4"
    class_name "item"
    text "(4) an application for such drug under such section or Act is withdrawn or if an exemption for such drug under section 355(i) or 360b(j) of this title or the authority granted for such drug to prepare an experimental drug product under the Virus-Serum Toxin Act [21 U.S.C. 151 et seq.] is withdrawn and no application for approval of such drug has been submitted under section 355 or 360b of this title, section 262 of title 42, or the Virus-Serum Toxin Act."
  ]
  node [
    id 2761
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_iii_subsubsubitem_V"
    class_name "subsubsubitem"
    text "(V) the drug meets the requirements of paragraphs (1)(C) and (1)(G),"
  ]
  node [
    id 2762
    label "section_382_subsection_e"
    class_name "subsection"
    text "(e) Determination by Secretary of noncompliance, failure of active pursuit of drug approval, imminent hazard of drug to public health, or exportation of drug to noneligible country; notices and hearings; prohibition on exportation of drug"
  ]
  node [
    id 2763
    label "section_382_subsection_i_subsubitem_iv_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) which has an exemption under section 360b(j) of this title, and"
  ]
  node [
    id 2764
    label "section_382_subsection_c_item_1_subitem_C"
    class_name "subitem"
    text "The reporting of an event described in subparagraph (A), (B), or (C) shall be made within 15 days of the occurrence of the event and the reporting of the receipt of information under subparagraph (D) shall be made within 15 days of the receipt of such information."
  ]
  node [
    id 2765
    label "section_382_subsection_v_subsubitem_x"
    class_name "subsubitem"
    text "(x) Ireland,"
  ]
  node [
    id 2766
    label "section_382_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "The reporting of an event described in subparagraph (A), (B), or (C) shall be made within 15 days of the occurrence of the event and the reporting of the receipt of information under subparagraph (D) shall be made within 15 days of the receipt of such information."
  ]
  node [
    id 2767
    label "section_382_subsection_i_subitem_C"
    class_name "subitem"
    text "(C) an application for the drug under section 355 or 360b of this title, section 262 of title 42, or the Virus-Serum Toxin Act [21 U.S.C. 151 et seq.] has not been disapproved by an order of the Secretary under section 355(d) or 360b(d) of this title or section 262 of title 42 or by the Secretary of Agriculture in the case of an application under the Virus-Serum Toxin Act,"
  ]
  node [
    id 2768
    label "section_382_subsection_d_item_3"
    class_name "item"
    text "(3) the Secretary issues an order refusing to approve an application of the holder of such application under section 355 or 360b of this title, section 262 of title 42, or the Virus-Serum Toxin Act [21 U.S.C. 151 et seq.], or"
  ]
  node [
    id 2769
    label "section_382_subsection_v_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) Statutory or regulatory requirements that the labeling and promotion of drugs must be in accordance with the approval of the drug."
  ]
  node [
    id 2770
    label "section_382_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) the drug is manufactured, processed, packaged, and held in conformity with current good manufacturing practice and is not adulterated under paragraph (a)(1), (a)(2)(A), (a)(3), (c), or (d) of section 351 of this title,"
  ]
  node [
    id 2771
    label "section_382_subsection_v_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) Statutory or regulatory requirements which require the review of drugs for safety and effectiveness by an entity of the government of such country and which authorize the approval of only those drugs which have been determined to be safe and effective by experts employed by or acting on behalf of such entity and qualified by scientific training and experience to evaluate the safety and effectiveness of drugs on the basis of adequate and well-controlled investigations, including clinical investigations, conducted by experts qualified by scientific training and experience to evaluate the safety and effectiveness of drugs."
  ]
  node [
    id 2772
    label "section_382_subsection_v"
    class_name "subsection"
    text "(v) Denmark,"
  ]
  node [
    id 2773
    label "section_382_subsection_f_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "then before taking action against the holder of an application for which a determination was made under clause (i), (ii), or (iii), the Secretary shall notify the holder in writing of the determination and provide the holder 30 days to take such action as may be required so that the Secretary would be unable to make such determination. When the Secretary takes action against such holder because of such a determination, the Secretary shall provide the holder a written statement specifying the reasons for such determination and provide the person, on request, an opportunity for an informal hearing with respect to such determination."
  ]
  node [
    id 2774
    label "section_382_subsection_i_item_2"
    class_name "item"
    text "(2) The Secretary may permit the export of a drug under paragraph (1) to a country which is listed under paragraph (4) and in which the drug is not approved if the drug is exported to such country solely for the purpose of further export to a country listed in paragraph (4) in which the drug is approved."
  ]
  node [
    id 2775
    label "section_382_subsection_f_item_2_subitem_D"
    class_name "subitem"
    text "(D) identify the establishments in which the drug is manufactured, and"
  ]
  node [
    id 2776
    label "section_382_subsection_f_item_3_subitem_A"
    class_name "subitem"
    text "(A) the receipt of any information indicating that the drug is being or may have been exported from a country for which the Secretary made a finding under paragraph (1)(A) to a country for which the Secretary cannot make such a finding, and"
  ]
  node [
    id 2777
    label "section_382_subsection_i_item_3_subitem_B_subsubitem_iii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) the drug meets the requirements of paragraph (1)(D),"
  ]
  node [
    id 2778
    label "section_382_subsection_i_subitem_F"
    class_name "subitem"
    text "(F) the drug is not the subject of a notice by the Secretary or the Secretary of Agriculture of a determination that the manufacture of the drug in the United States for export to a country is contrary to the public health and safety of the United States,"
  ]
  node [
    id 2779
    label "section_382_subsection_i_subitem_G"
    class_name "subitem"
    text "(G) the requirements of subparagraphs (A) through (D) of section 381(d)(1) of this title have been met."
  ]
  node [
    id 2780
    label "section_382_subsection_f_item_1_subitem_E"
    class_name "subitem"
    text "(E) the requirements of subparagraphs (A) through (D) of section 381(d)(1) of this title have been met."
  ]
  node [
    id 2781
    label "section_382_subsection_i_item_3"
    class_name "item"
    text "(3)(A) Any person may apply to have a drug exported under paragraph (1). Such an application shall be filed at least 90 days before the date the applicant proposes to export the drug for which the application is submitted. Before the expiration of 10 days from the date of the submission of such an application, the Secretary shall publish a notice in the Federal Register which identifies the applicant under such application, the drug proposed to be exported under such application, and the country to which the drug is proposed to be exported."
  ]
  node [
    id 2782
    label "section_382_subsection_e_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) such importer is exporting the drug to a country which is not listed under subsection (b)(4) of this section, and"
  ]
  node [
    id 2783
    label "section_382_subsection_e_item_4"
    class_name "item"
    text "(4)(A) If the Secretary, or in the absence of the Secretary the individual acting as the Secretary, determines that the holder of an approved application under subsection (b) of this section is exporting a drug to a country which is not listed under subsection (b)(4) of this section and that the export of the drug presents an imminent hazard, the Secretary shall immediately prohibit the export of the drug to such country, give the holder prompt notice of the determination, and afford the holder an opportunity for an expedited hearing."
  ]
  node [
    id 2784
    label "section_382_subsection_f"
    class_name "subsection"
    text "(f) Drugs used in prevention or treatment of tropical disease"
  ]
  node [
    id 2785
    label "section_382_subsection_f_item_4_subitem_B"
    class_name "subitem"
    text "(B) If at any time the Secretary, or in the absence of the Secretary the individual acting as the Secretary, determines that&#8212;"
  ]
  node [
    id 2786
    label "section_382_subsection_i_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) which has an exemption under section 355(i) of this title, and"
  ]
  node [
    id 2787
    label "section_383_subsection_b"
    class_name "subsection"
    text "(b) In carrying out the functions of the office under subsection (a) of this section, the Secretary may enter into agreements with foreign countries to facilitate commerce in devices between the United States and such countries consistent with the requirements of this chapter. In such agreements, the Secretary shall encourage the mutual recognition of&#8212;"
  ]
  node [
    id 2788
    label "section_383_subsection_b_item_1"
    class_name "item"
    text "(1) good manufacturing practice regulations promulgated under section 360j(f) of this title, and"
  ]
  node [
    id 2789
    label "section_383_subsection_a"
    class_name "subsection"
    text "(a) There is established in the Department of Health and Human Services an Office of International Relations."
  ]
  node [
    id 2790
    label "section_383_subsection_b_item_2"
    class_name "item"
    text "(2) other regulations and testing protocols as the Secretary determines to be appropriate."
  ]
  node [
    id 2791
    label "section_392_subsection_a"
    class_name "subsection"
    text "(a) Law determinative of exemption"
  ]
  node [
    id 2792
    label "section_392_subsection_b"
    class_name "subsection"
    text "(b) Laws unaffected"
  ]
  node [
    id 2793
    label "section_393_subsection_c"
    class_name "subsection"
    text "(c) Technical and scientific review groups"
  ]
  node [
    id 2794
    label "section_393_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) providing overall direction to the Food and Drug Administration and establishing and implementing general policies respecting the management and operation of programs and activities of the Food and Drug Administration;"
  ]
  node [
    id 2795
    label "section_393_subsection_b_item_1"
    class_name "item"
    text "(1) Appointment"
  ]
  node [
    id 2796
    label "section_393_subsection_b_item_2"
    class_name "item"
    text "(2) General powers"
  ]
  node [
    id 2797
    label "section_393_subsection_b_item_2_subitem_D"
    class_name "subitem"
    text "(D) conducting educational and public information programs relating to the responsibilities of the Food and Drug Administration; and"
  ]
  node [
    id 2798
    label "section_393_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) coordinating and overseeing the operation of all administrative entities within the Administration;"
  ]
  node [
    id 2799
    label "section_393_subsection_b_item_2_subitem_C"
    class_name "subitem"
    text "(C) research relating to foods, drugs, cosmetics, and devices in carrying out this chapter;"
  ]
  node [
    id 2800
    label "section_393_subsection_b"
    class_name "subsection"
    text "(b) Commissioner"
  ]
  node [
    id 2801
    label "section_393_subsection_b_item_2_subitem_E"
    class_name "subitem"
    text "(E) performing such other functions as the Secretary may prescribe."
  ]
  node [
    id 2802
    label "section_393_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 2803
    label "section_394_item_2"
    class_name "item"
    text "(2) appoint and pay the members of such groups, except that officers and employees of the United States shall not receive additional compensation for service as members of such groups."
  ]
  node [
    id 2804
    label "section_394_item_1"
    class_name "item"
    text "(1) establish such technical and scientific review groups as are needed to carry out the functions of the Food and Drug Administration (including functions prescribed under this chapter); and"
  ]
  node [
    id 2805
    label "section_395_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 2806
    label "section_395_subsection_c"
    class_name "subsection"
    text "(c) Authorization of appropriations"
  ]
  node [
    id 2807
    label "section_395_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) has a substantial amount of educational loans relative to income; and"
  ]
  node [
    id 2808
    label "section_395_subsection_a_item_2"
    class_name "item"
    text "(2) Limitation"
  ]
  node [
    id 2809
    label "section_395_subsection_a_item_1"
    class_name "item"
    text "The Secretary may not enter into an agreement with a health professional pursuant to paragraph (1) unless such professional&#8212;"
  ]
  node [
    id 2810
    label "section_395_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) agrees to serve as an employee of the Food and Drug Administration for purposes of paragraph (1) for a period of not less than 3 years."
  ]
  node [
    id 2811
    label "section_395_subsection_b"
    class_name "subsection"
    text "(b) Applicability of certain provisions"
  ]
  node [
    id 2812
    label "section_453_subsection_g"
    class_name "subsection"
    text "(g) The term &#8220;adulterated&#8221; shall apply to any poultry product under one or more of the following circumstances:"
  ]
  node [
    id 2813
    label "section_453_subsection_q"
    class_name "subsection"
    text "(q) The term &#8220;inspection service&#8221; means the official Government service within the Department of Agriculture designated by the Secretary as having the responsibility for carrying out the provisions of this chapter."
  ]
  node [
    id 2814
    label "section_453_subsection_y"
    class_name "subsection"
    text "(y) The terms &#8220;pesticide chemical,&#8221; &#8220;food additive&#8221;, &#8220;color additive&#8221;, and &#8220;raw agricultural commodity&#8221; shall have the same meanings for purposes of this chapter as under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.]."
  ]
  node [
    id 2815
    label "section_453_subsection_h_item_1"
    class_name "item"
    text "(1) if its labeling is false or misleading in any particular;"
  ]
  node [
    id 2816
    label "section_453_subsection_d"
    class_name "subsection"
    text "(d) The term &#8220;United States&#8221; means the States, the District of Columbia, and the territories of the United States."
  ]
  node [
    id 2817
    label "section_453_subsection_g_item_8"
    class_name "item"
    text "(8) if any valuable constituent has been in whole or in part omitted or abstracted therefrom; or if any substance has been substituted, wholly or in part therefor; or if damage or inferiority has been concealed in any manner; or if any substance has been added thereto or mixed or packed therewith so as to increase its bulk or weight, or reduce its quality or strength, or make it appear better or of greater value than it is."
  ]
  node [
    id 2818
    label "section_453_subsection_h_item_7"
    class_name "item"
    text "(7) if it purports to be or is represented as a food for which a definition and standard of identity or composition has been prescribed by regulations of the Secretary under section 457 of this title unless (A) it conforms to such definition and standard, and (B) its label bears the name of the food specified in the definition and standard and, insofar as may be required by such regulations, the common names of optional ingredients (other than spices, flavoring, and coloring) present in such food;"
  ]
  node [
    id 2819
    label "section_453_subsection_h"
    class_name "subsection"
    text "(h) The term &#8220;misbranded&#8221; shall apply to any poultry product under one or more of the following circumstances:"
  ]
  node [
    id 2820
    label "section_453_subsection_g_item_2"
    class_name "item"
    text "(2)(A) if it bears or contains (by reason of administration of any substance to the live poultry or otherwise) any added poisonous or added deleterious substance (other than one which is (i) a pesticide chemical in or on a raw agricultural commodity; (ii) a food additive; or (iii) a color additive) which may, in the judgment of the Secretary, make such article unfit for human food;"
  ]
  node [
    id 2821
    label "section_453_subsection_m"
    class_name "subsection"
    text "(m) The term &#8220;official inspection legend&#8221; means any symbol prescribed by regulations of the Secretary showing that an article was inspected for wholesomeness in accordance with this chapter."
  ]
  node [
    id 2822
    label "section_453_subsection_k"
    class_name "subsection"
    text "(k) The term &#8220;inspector&#8221; means: (1) an employee or official of the United States Government authorized by the Secretary to inspect poultry and poultry products under the authority of this chapter, or (2) any employee or official of the government of any State or territory or the District of Columbia authorized by the Secretary to inspect poultry and poultry products under authority of this chapter, under an agreement entered into between the Secretary and the appropriate State or other agency."
  ]
  node [
    id 2823
    label "section_453_subsection_h_item_2"
    class_name "item"
    text "(2) if it is offered for sale under the name of another food;"
  ]
  node [
    id 2824
    label "section_453_subsection_g_item_3"
    class_name "item"
    text "(3) if it consists in whole or in part of any filthy, putrid, or decomposed substance or is for any other reason unsound, unhealthful, unwholesome, or otherwise unfit for human food;"
  ]
  node [
    id 2825
    label "section_453_subsection_f"
    class_name "subsection"
    text "(f) The term &#8220;poultry product&#8221; means any poultry carcass, or part thereof; or any product which is made wholly or in part from any poultry carcass or part thereof, excepting products which contain poultry ingredients only in a relatively small proportion or historically have not been considered by consumers as products of the poultry food industry, and which are exempted by the Secretary from definition as a poultry product under such conditions as the Secretary may prescribe to assure that the poultry ingredients in such products are not adulterated and that such products are not represented as poultry products."
  ]
  node [
    id 2826
    label "section_453_subsection_n"
    class_name "subsection"
    text "(n) The term &#8220;official certificate&#8221; means any certificate prescribed by regulations of the Secretary for issuance by an inspector or other person performing official functions under this chapter."
  ]
  node [
    id 2827
    label "section_453_subsection_x"
    class_name "subsection"
    text "(x) The term &#8220;Federal Food, Drug, and Cosmetic Act&#8221; means the Act so entitled, approved June 25, 1938 (52 Stat. 1040) [21 U.S.C. 301 et seq.], and Acts amendatory thereof or supplementary thereto."
  ]
  node [
    id 2828
    label "section_453_subsection_g_item_2_subitem_B"
    class_name "subitem"
    text "(B) if it is, in whole or in part, a raw agricultural commodity and such commodity bears or contains a pesticide chemical which is unsafe within the meaning of section 346a of this title;"
  ]
  node [
    id 2829
    label "section_453_subsection_h_item_9"
    class_name "item"
    text "(9) if it is not subject to the provisions of subparagraph (7), unless its label bears (A) the common or usual name of the food, if any there be, and (B) in case it is fabricated from two or more ingredients, the common or usual name of each such ingredient; except that spices, flavorings, and colorings may, when authorized by the Secretary, be designated as spices, flavorings, and colorings without naming each: Provided, That to the extent that compliance with the requirements of clause (B) of this subparagraph (9) is impracticable or results in deception or unfair competition, exemptions shall be established by regulations promulgated by the Secretary;"
  ]
  node [
    id 2830
    label "section_453_subsection_i"
    class_name "subsection"
    text "(i) The term &#8220;Secretary&#8221; means the Secretary of Agriculture or his delegate."
  ]
  node [
    id 2831
    label "section_453_subsection_l"
    class_name "subsection"
    text "(l) The term &#8220;official mark&#8221; means the official inspection legend or any other symbol prescribed by regulation of the Secretary to identify the status of any article or poultry under this chapter."
  ]
  node [
    id 2832
    label "section_453_subsection_z"
    class_name "subsection"
    text "(z) The term &#8220;poultry products broker&#8221; means any person engaged in the business of buying or selling poultry products on commission, or otherwise negotiating purchases or sales of such articles other than for his own account or as an employee of another person."
  ]
  node [
    id 2833
    label "section_453_subsection_w"
    class_name "subsection"
    text "(w) The term &#8220;processed&#8221; means slaughtered, canned, salted, stuffed, rendered, boned, cut up, or otherwise manufactured or processed."
  ]
  node [
    id 2834
    label "section_453_subsection_g_item_4"
    class_name "item"
    text "(4) if it has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health;"
  ]
  node [
    id 2835
    label "section_453_subsection_g_item_1"
    class_name "item"
    text "(1) if it bears or contains any poisonous or deleterious substance which may render it injurious to health; but in case the substance is not an added substance, such article shall not be considered adulterated under this clause if the quantity of such substance in or on such article does not ordinarily render it injurious to health;"
  ]
  node [
    id 2836
    label "section_453_subsection_g_item_2_subitem_D"
    class_name "subitem"
    text "(D) if it bears or contains any color additive which is unsafe within the meaning of section 379e of this title: Provided, That an article which is not otherwise deemed adulterated under clause (B), (C), or (D) shall nevertheless be deemed adulterated if use of the pesticide chemical, food additive, or color additive in or on such article is prohibited by regulations of the Secretary in official establishments;"
  ]
  node [
    id 2837
    label "section_453_subsection_g_item_7"
    class_name "item"
    text "(7) if it has been intentionally subjected to radiation, unless the use of the radiation was in conformity with a regulation or exemption in effect pursuant to section 348 of this title;"
  ]
  node [
    id 2838
    label "section_453_subsection_c"
    class_name "subsection"
    text "(c) The term &#8220;territory&#8221; means Guam, the Virgin Islands of the United States, American Samoa, and any other territory or possession of the United States, excluding the Canal Zone."
  ]
  node [
    id 2839
    label "section_453_subsection_g_item_5"
    class_name "item"
    text "(5) if it is, in whole or in part, the product of any poultry which has died otherwise than by slaughter;"
  ]
  node [
    id 2840
    label "section_453_subsection_g_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) if it bears or contains (by reason of administration of any substance to the live poultry or otherwise) any added poisonous or added deleterious substance (other than one which is (i) a pesticide chemical in or on a raw agricultural commodity; (ii) a food additive; or (iii) a color additive) which may, in the judgment of the Secretary, make such article unfit for human food;"
  ]
  node [
    id 2841
    label "section_453_subsection_h_item_12"
    class_name "item"
    text "(12) if it fails to bear on its containers, and in the case of nonconsumer packaged carcasses (if the Secretary so requires) directly thereon, as the Secretary may by regulations prescribe, the official inspection legend and official establishment number of the establishment where the article was processed, and, unrestricted by any of the foregoing, such other information as the Secretary may require in such regulations to assure that it will not have false or misleading labeling and that the public will be informed of the manner of handling required to maintain the article in a wholesome condition."
  ]
  node [
    id 2842
    label "section_453_subsection_p"
    class_name "subsection"
    text "(p) The term &#8220;official establishment&#8221; means any establishment as determined by the Secretary at which inspection of the slaughter of poultry, or the processing of poultry products, is maintained under the authority of this chapter."
  ]
  node [
    id 2843
    label "section_453_subsection_r"
    class_name "subsection"
    text "(r) The term &#8220;container&#8221; or &#8220;package&#8221; includes any box, can, tin, cloth, plastic, or other receptacle, wrapper, or cover."
  ]
  node [
    id 2844
    label "section_453_subsection_s"
    class_name "subsection"
    text "(s) The term &#8220;label&#8221; means a display of written, printed, or graphic matter upon any article or the immediate container (not including packaged liners) of any article; and the term &#8220;labeling&#8221; means all labels and other written, printed, or graphic matter (1) upon any article or any of its containers or wrappers, or (2) accompanying such article."
  ]
  node [
    id 2845
    label "section_453_subsection_a"
    class_name "subsection"
    text "(a) The term &#8220;commerce&#8221; means commerce between any State, any territory, or the District of Columbia, and any place outside thereof; or within any territory not organized with a legislative body, or the District of Columbia."
  ]
  node [
    id 2846
    label "section_453_subsection_t"
    class_name "subsection"
    text "(t) The term &#8220;shipping container&#8221; means any container used or intended for use in packaging the product packed in an immediate container."
  ]
  node [
    id 2847
    label "section_453_subsection_h_item_3"
    class_name "item"
    text "(3) if it is an imitation of another food, unless its label bears, in type of uniform size and prominence, the word &#8220;imitation&#8221; and immediately thereafter, the name of the food imitated;"
  ]
  node [
    id 2848
    label "section_453_subsection_j"
    class_name "subsection"
    text "(j) The term &#8220;person&#8221; means any individual, partnership, corporation, association, or other business unit."
  ]
  node [
    id 2849
    label "section_453_subsection_u"
    class_name "subsection"
    text "(u) The term &#8220;immediate container&#8221; includes any consumer package; or any other container in which poultry products, not consumer packaged, are packed."
  ]
  node [
    id 2850
    label "section_453_subsection_h_item_4"
    class_name "item"
    text "(4) if its container is so made, formed, or filled as to be misleading;"
  ]
  node [
    id 2851
    label "section_453_subsection_h_item_6"
    class_name "item"
    text "(6) if any word, statement, or other information required by or under authority of this chapter to appear on the label or other labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use;"
  ]
  node [
    id 2852
    label "section_453_subsection_h_item_10"
    class_name "item"
    text "(10) if it purports to be or is represented for special dietary uses unless its label bears such information concerning its vitamin, mineral, and other dietary properties as the Secretary, after consultation with the Secretary of Health and Human Services, determines to be, and by regulations prescribes as, necessary in order fully to inform purchasers as to its value for such uses;"
  ]
  node [
    id 2853
    label "section_453_subsection_h_item_11"
    class_name "item"
    text "(11) if it bears or contains any artificial flavoring, artificial coloring, or chemical preservative unless it bears labeling stating that fact: Provided, That, to the extent that compliance with the requirements of this subparagraph (11) is impracticable, exemptions shall be established by regulations promulgated by the Secretary; or"
  ]
  node [
    id 2854
    label "section_453_subsection_o"
    class_name "subsection"
    text "(o) The term &#8220;official device&#8221; means any device prescribed or authorized by the Secretary for use in applying any official mark."
  ]
  node [
    id 2855
    label "section_453_subsection_g_item_6"
    class_name "item"
    text "(6) if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health;"
  ]
  node [
    id 2856
    label "section_453_subsection_v"
    class_name "subsection"
    text "(v) The term &#8220;capable of use as human food&#8221; shall apply to any carcass, or part or product of a carcass, of any poultry, unless it is denatured or otherwise identified as required by regulations prescribed by the Secretary to deter its use as human foods, or it is naturally inedible by humans."
  ]
  node [
    id 2857
    label "section_453_subsection_b"
    class_name "subsection"
    text "(b) Except as otherwise provided in this chapter, the term &#8220;State&#8221; means any State of the United States and the Commonwealth of Puerto Rico."
  ]
  node [
    id 2858
    label "section_453_subsection_e"
    class_name "subsection"
    text "(e) The term &#8220;poultry&#8221; means any domesticated bird, whether live or dead."
  ]
  node [
    id 2859
    label "section_453_subsection_g_item_2_subitem_C"
    class_name "subitem"
    text "(C) if it bears or contains any food additive which is unsafe within the meaning of section 348 of this title;"
  ]
  node [
    id 2860
    label "section_453_subsection_h_item_5"
    class_name "item"
    text "(5) unless it bears a label showing (A) the name and the place of business of the manufacturer, packer, or distributor; and (B) an accurate statement of the quantity of the product in terms of weight, measure, or numerical count: Provided, That under clause (B) of this subparagraph (5), reasonable variations may be permitted, and exemptions as to small packages or articles not in packages or other containers may be established by regulations prescribed by the Secretary;"
  ]
  node [
    id 2861
    label "section_453_subsection_h_item_8"
    class_name "item"
    text "(8) if it purports to be or is represented as a food for which a standard or standards of fill of container have been prescribed by regulations of the Secretary under section 457 of this title, and it falls below the standard to fill of container applicable thereto, unless its label bears, in such manner and form as such regulations specify, a statement that it falls below such standard;"
  ]
  node [
    id 2862
    label "section_454_subsection_a_item_1"
    class_name "item"
    text "(1) The Secretary is authorized, whenever he determines that it would effectuate the purposes of this chapter, to cooperate with the appropriate State agency in developing and administering a State poultry product inspection program in any State which has enacted a mandatory State poultry product inspection law that imposes ante mortem and post mortem inspection, reinspection and sanitation requirements that are at least equal to those under this chapter, with respect to all or certain classes of persons engaged in the State in slaughtering poultry or processing poultry products for use as human food solely for distribution within such State."
  ]
  node [
    id 2863
    label "section_454_subsection_a_item_3"
    class_name "item"
    text "(3) Cooperation with State agencies under this section may include furnishing to the appropriate State agency (i) advisory assistance in planning and otherwise developing an adequate State program under the State law; and (ii) technical and laboratory assistance and training (including necessary curricular and instructional materials and equipment), and financial and other aid for administration of such a program. The amount to be contributed to any State by the Secretary under this section from Federal funds for any year shall not exceed 50 per centum of the estimated total cost of the cooperative program; and the Federal funds shall be allocated among the States desiring to cooperate on an equitable basis. Such cooperation and payment shall be contingent at all times upon the administration of the State program in a manner which the Secretary, in consultation with the appropriate advisory committee appointed under subparagraph (4), deems adequate to effectuate the purposes of this section."
  ]
  node [
    id 2864
    label "section_454_subsection_a_item_4"
    class_name "item"
    text "(4) The Secretary may appoint advisory committees consisting of such representatives of appropriate State agencies as the Secretary and the State agencies may designate to consult with him concerning State and Federal programs with respect to poultry product inspection and other matters within the scope of this chapter, including evaluating State programs for purposes of this chapter, and obtaining better coordination and more uniformity among the State programs and between the Federal and State programs and adequate protection of consumers."
  ]
  node [
    id 2865
    label "section_454_subsection_c_item_1"
    class_name "item"
    text "(1) If the Secretary has reason to believe, by thirty days prior to the expiration of two years after August 18, 1968, that a State has failed to develop or is not enforcing, with respect to all establishments within its jurisdiction (except those that would be exempted from Federal inspection under subparagraph (2) of this paragraph (c)) at which poultry are slaughtered, or poultry products are processed for use as human food, solely for distribution within such State, and the products of such establishments, requirements at least equal to those imposed under sections 451 to 453, 455 to 459, 461 to 467d of this title, he shall promptly notify the Governor of the State of this fact. If the Secretary determines, after consultation with the Governor of the State, or representative selected by him, that such requirements have not been developed and activated, he shall promptly after the expiration of such two-year period designate such State as one in which the provisions of said sections of this chapter shall apply to operations and transactions wholly within such State: Provided, That if the Secretary has reason to believe that the State will activate such requirements within one additional year, he may delay such designation for said period, and not designate the State, if he determines at the end of the year that the State then has such requirements in effective operation. The Secretary shall publish any such designation in the Federal Register and, upon the expiration of thirty days after such publication, the provisions of said sections of this chapter shall apply to operations and transactions and to persons engaged therein in the State to the same extent and in the same manner as if such operations and transactions were conducted in or for commerce. However, notwithstanding any other provision of this section, if the Secretary determines that any establishment within a State is producing adulterated poultry products for distribution within such State which would clearly endanger the public health he shall notify the Governor of the State and the appropriate advisory committee provided for by subparagraph (a)(4) of this section of such fact for effective action under State or local law. If the State does not take action to prevent such endangering of the public health within a reasonable time after such notice, as determined by the Secretary, in light of the risk to public health, the Secretary may forthwith designate any such establishment as subject to the provisions of said sections of this chapter, and thereupon the establishment and operator thereof shall be subject to such provisions as though engaged in commerce until such time as the Secretary determines that such State has developed and will enforce requirements at least equal to those imposed under said sections."
  ]
  node [
    id 2866
    label "section_454_subsection_c_item_4"
    class_name "item"
    text "(4) The Secretary shall promptly upon August 18, 1968, and periodically thereafter, but at least annually, review the requirements, including the enforcement thereof, of the several States not designated under this paragraph (c), with respect to the slaughter, and the processing, storage, handling, and distribution of poultry products, and inspection of such operations, and annually report thereon to the Committee on Agriculture of the House of Representatives and the Committee on Agriculture, Nutrition, and Forestry of the Senate in the report required in section 470 of this title."
  ]
  node [
    id 2867
    label "section_454_subsection_a_item_2"
    class_name "item"
    text "(2) The Secretary is further authorized, whenever he determines that it would effectuate the purposes of this chapter, to cooperate with appropriate State agencies in developing and administering State programs under State laws containing authorities at least equal to those provided in section 460 of this title; and to cooperate with other agencies of the United States in carrying out any provisions of this chapter. In carrying out the provisions of this chapter, the Secretary may conduct such examinations, investigations, and inspections as he determines practicable through any officer or employee of any State or Territory or the District of Columbia commissioned by the Secretary for such purpose."
  ]
  node [
    id 2868
    label "section_454_subsection_d"
    class_name "subsection"
    text "(d) &#8220;State&#8221; defined"
  ]
  node [
    id 2869
    label "section_454_subsection_a"
    class_name "subsection"
    text "(a) State laws; planning, technical and financial assistance; advisory committees"
  ]
  node [
    id 2870
    label "section_454_subsection_c"
    class_name "subsection"
    text "(c) Intrastate activities; designation of State for regulation; publication of designation; exempted operations; termination of designation; review of operations in nondesignated States; annual report"
  ]
  node [
    id 2871
    label "section_454_subsection_c_item_3"
    class_name "item"
    text "(3) Whenever the Secretary determines that any State designated under this paragraph (c) has developed and will enforce State poultry products inspection requirements at least equal to those imposed under the aforesaid sections of this chapter, with respect to the operations and transactions within such State which are regulated under subparagraph (1) of this paragraph (c), he shall terminate the designation of such State under this paragraph (c), but this shall not preclude the subsequent redesignation of the State at any time upon thirty days&#8217; notice to the Governor and publication in the Federal Register in accordance with this paragraph, and any State may be designated upon such notice and publication, at any time after the period specified in this paragraph whether or not the State has theretofore been designated, upon the Secretary determining that it is not effectively enforcing requirements at least equal to those imposed under said sections."
  ]
  node [
    id 2872
    label "section_454_subsection_c_item_2"
    class_name "item"
    text "(2) The provisions of this chapter requiring inspection of the slaughter of poultry and the processing of poultry products shall not apply to operations of types traditionally and usually conducted at retail stores and restaurants, when conducted at any retail store or restaurant or similar retail-type establishment for sale in normal retail quantities or service of such articles to consumers at such establishments if such establishment are subject to such inspection provisions only under this paragraph (c). For the purposes of this subparagraph, operations conducted at a restaurant central kitchen facility shall be considered as being conducted at a restaurant if the restaurant central kitchen prepares poultry products that are ready to eat when they leave such facility and are served in meals or as entrees only to customers at restaurants owned or operated by the same person owning or operating such facility: Provided, That such facility shall be subject to the provisions of section 460(b) of this title: Provided further, That the facility may be subject to the inspection requirements of this chapter for as long as the Secretary deems necessary, if the Secretary determines that the sanitary conditions or practices of the facility or the processing procedures or methods at the facility are such that any of its poultry products are rendered adulterated."
  ]
  node [
    id 2873
    label "section_454_subsection_b"
    class_name "subsection"
    text "(b) Appropriate State agency; performance of functions by subordinate governmental unit"
  ]
  node [
    id 2874
    label "section_455_subsection_c"
    class_name "subsection"
    text "(c) Condemnation; appeal; reprocessing"
  ]
  node [
    id 2875
    label "section_455_subsection_b"
    class_name "subsection"
    text "(b) Post mortem inspection; quarantine, segregation, and reinspection"
  ]
  node [
    id 2876
    label "section_455_subsection_a"
    class_name "subsection"
    text "(a) Ante mortem inspection"
  ]
  node [
    id 2877
    label "section_456_subsection_a"
    class_name "subsection"
    text "(a) Sanitary practices"
  ]
  node [
    id 2878
    label "section_456_subsection_b"
    class_name "subsection"
    text "(b) Refusal of inspection"
  ]
  node [
    id 2879
    label "section_457_subsection_b"
    class_name "subsection"
    text "(b) Labeling requirements; definitions and standards of identity or composition or articles and standards of fill of container; standards consistent with Federal Food, Drug, and Cosmetic Act; consistency between Federal and State standards"
  ]
  node [
    id 2880
    label "section_457_subsection_a"
    class_name "subsection"
    text "(a) Requirements for shipping containers and immediate containers; nonconsumer packaged carcasses"
  ]
  node [
    id 2881
    label "section_457_subsection_b_item_2"
    class_name "item"
    text "The Secretary, whenever he determines such action is necessary for the protection of the public, may prescribe: (1) the styles and sizes of type to be used with respect to material required to be incorporated in labeling to avoid false or misleading labeling in marketing and labeling any articles or poultry subject to this chapter; (2) definitions and standards of identity or composition or articles subject to this chapter and standards of fill of container for such articles not inconsistent with any such standards established under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], and there shall be consultation between the Secretary and the Secretary of Health and Human Services prior to the issuance of such standards under either Act relating to articles subject to this chapter to avoid inconsistency in such standards and possible impairment of the coordinated effective administration of this chapter and the Federal Food, Drug, and Cosmetic Act. There shall also be consultation between the Secretary and an appropriate advisory committee provided for in section 454 of this title, prior to the issuance of such standards under this chapter, to avoid, insofar as feasible, inconsistency between Federal and State standards."
  ]
  node [
    id 2882
    label "section_457_subsection_d"
    class_name "subsection"
    text "(d) Withholding use of false or misleading mark, label, or container size or form; modification; hearing; conclusiveness of determination; appeal"
  ]
  node [
    id 2883
    label "section_457_subsection_c"
    class_name "subsection"
    text "(c) Use of trade names; false or misleading marking or labeling; misleading form or size of container"
  ]
  node [
    id 2884
    label "section_457_subsection_b_item_1"
    class_name "item"
    text "The Secretary, whenever he determines such action is necessary for the protection of the public, may prescribe: (1) the styles and sizes of type to be used with respect to material required to be incorporated in labeling to avoid false or misleading labeling in marketing and labeling any articles or poultry subject to this chapter; (2) definitions and standards of identity or composition or articles subject to this chapter and standards of fill of container for such articles not inconsistent with any such standards established under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], and there shall be consultation between the Secretary and the Secretary of Health and Human Services prior to the issuance of such standards under either Act relating to articles subject to this chapter to avoid inconsistency in such standards and possible impairment of the coordinated effective administration of this chapter and the Federal Food, Drug, and Cosmetic Act. There shall also be consultation between the Secretary and an appropriate advisory committee provided for in section 454 of this title, prior to the issuance of such standards under this chapter, to avoid, insofar as feasible, inconsistency between Federal and State standards."
  ]
  node [
    id 2885
    label "section_458_subsection_a_item_2"
    class_name "item"
    text "(2) sell, transport, offer for sale or transportation, or receive for transportation, in commerce, (A) any poultry products which are capable of use as human food and are adulterated or misbranded at the time of such sale, transportation, offer for sale or transportation, or receipt for transportation; or (B) any poultry products required to be inspected under this chapter unless they have been so inspected and passed;"
  ]
  node [
    id 2886
    label "section_458_subsection_b"
    class_name "subsection"
    text "(b) No brand manufacturer, printer, or other person shall cast, print, lithograph, or otherwise make any device containing any official mark or simulation thereof, or any label bearing any such mark or simulation, or any form of official certificate or simulation thereof, except as authorized by the Secretary."
  ]
  node [
    id 2887
    label "section_458_subsection_a_item_4"
    class_name "item"
    text "(4) sell, transport, offer for sale or transportation, or receive for transportation, in commerce or from an official establishment, any slaughtered poultry from which the blood, feathers, feet, head, or viscera have not been removed in accordance with regulations promulgated by the Secretary, except as may be authorized by regulations of the Secretary;"
  ]
  node [
    id 2888
    label "section_458_subsection_a"
    class_name "subsection"
    text "(a) No person shall&#8212;"
  ]
  node [
    id 2889
    label "section_458_subsection_a_item_5"
    class_name "item"
    text "(5) use to his own advantage, or reveal other than to the authorized representatives of the United States Government or any State or other government in their official capacity, or as ordered by a court in any judicial proceedings, any information acquired under the authority of this chapter concerning any matter which is entitled to protection as a trade secret."
  ]
  node [
    id 2890
    label "section_458_subsection_c_item_5"
    class_name "item"
    text "(5) knowingly make any false statement in any shipper's certificate or other nonofficial or official certificate provided for in the regulations prescribed by the Secretary; or"
  ]
  node [
    id 2891
    label "section_458_subsection_c"
    class_name "subsection"
    text "(c) No person shall&#8212;"
  ]
  node [
    id 2892
    label "section_458_subsection_c_item_3"
    class_name "item"
    text "(3) contrary to the regulations prescribed by the Secretary, fail to use, or to detach, deface, or destroy any official device, mark, or certificate;"
  ]
  node [
    id 2893
    label "section_458_subsection_c_item_1"
    class_name "item"
    text "(1) forge any official device, mark, or certificate;"
  ]
  node [
    id 2894
    label "section_458_subsection_c_item_6"
    class_name "item"
    text "(6) knowingly represent that any article has been inspected and passed, or exempted, under this chapter when, in fact, it has respectively, not been so inspected and passed, or exempted."
  ]
  node [
    id 2895
    label "section_458_subsection_c_item_2"
    class_name "item"
    text "(2) without authorization from the Secretary use any official device, mark, or certificate, or simulation thereof, or alter, detach, deface, or destroy any official device, mark, or certificate;"
  ]
  node [
    id 2896
    label "section_458_subsection_a_item_1"
    class_name "item"
    text "(1) slaughter any poultry or process any poultry products which are capable of use as human food at any establishment processing any such articles for commerce, except in compliance with the requirements of this chapter;"
  ]
  node [
    id 2897
    label "section_458_subsection_c_item_4"
    class_name "item"
    text "(4) knowingly possess, without promptly notifying the Secretary or his representative, any official device or any counterfeit, simulated, forged, or improperly altered official certificate or any device or label or any carcass of any poultry, or part or product thereof, bearing any counterfeit, simulated, forged, or improperly altered official mark;"
  ]
  node [
    id 2898
    label "section_458_subsection_a_item_3"
    class_name "item"
    text "(3) do, with respect to any poultry products which are capable of use as human food, any act while they are being transported in commerce or held for sale after such transportation, which is intended to cause or has the effect of causing such products to be adulterated or misbranded;"
  ]
  node [
    id 2899
    label "section_460_subsection_e"
    class_name "subsection"
    text "(e) Federal provisions applicable to State or Territorial business transactions of a local nature and not subject to local authority"
  ]
  node [
    id 2900
    label "section_460_subsection_b_item_3"
    class_name "item"
    text "(3) Any person that engages in business, in or for commerce, as a renderer, or engages in the business of buying, selling, or transporting, in commerce, or importing, any dead, dying, disabled, or diseased poultry or parts of the carcasses of any poultry that died otherwise than by slaughter."
  ]
  node [
    id 2901
    label "section_460_subsection_a"
    class_name "subsection"
    text "(a) Prohibition of inspection of articles not intended for use as human food; denaturation or other identification prior to distribution in commerce; inedible articles"
  ]
  node [
    id 2902
    label "section_460_subsection_b"
    class_name "subsection"
    text "(b) Recordkeeping requirements; persons liable; scope of disclosure; access to places of business; examination of records, facilities, and inventories; copies; samples"
  ]
  node [
    id 2903
    label "section_460_subsection_c"
    class_name "subsection"
    text "(c) Registration of business, name of person, and trade names"
  ]
  node [
    id 2904
    label "section_460_subsection_b_item_1"
    class_name "item"
    text "(1) Any person that engages in the business of slaughtering any poultry or processing, freezing, packaging, or labeling any carcasses, or parts or products of carcasses, of any poultry, for commerce, for use as human food or animal food;"
  ]
  node [
    id 2905
    label "section_460_subsection_b_item_2"
    class_name "item"
    text "(2) Any person that engages in the business of buying or selling (as poultry products brokers, wholesalers or otherwise), or transporting, in commerce, or storing in or for commerce, or importing, any carcasses, or parts or products of carcasses, of any poultry;"
  ]
  node [
    id 2906
    label "section_460_subsection_d"
    class_name "subsection"
    text "(d) Regulation of transactions, transportation, or importation of dead, dying, disabled or diseased poultry or carcasses to prevent use as human food"
  ]
  node [
    id 2907
    label "section_461_subsection_c"
    class_name "subsection"
    text "(c) Assaulting, resisting, or impeding certain persons; murder; punishments"
  ]
  node [
    id 2908
    label "section_461_subsection_b"
    class_name "subsection"
    text "(b) Liability of carrier"
  ]
  node [
    id 2909
    label "section_461_subsection_a"
    class_name "subsection"
    text "(a) Violations; liability of agents, employees, and employers"
  ]
  node [
    id 2910
    label "section_461_subsection_a_item_8"
    class_name "item"
    text "Any person who violates the provisions of section 458, 459, 460, 463, or 466 of this title shall be fined not more than $1,000 or imprisoned not more than one year, or both; but if such violation involves intent to defraud, or any distribution or attempted distribution of an article that is adulterated (except as defined in section 453(g)(8) of this title), such person shall be fined not more than $10,000 or imprisoned not more than three years, or both. When construing or enforcing the provisions of said sections the act, omission, or failure of any person acting for or employed by any individual, partnership, corporation, or association within the scope of his employment or office shall in every case be deemed the act, omission, or failure of such individual, partnership, corporation, or association, as well as of such person."
  ]
  node [
    id 2911
    label "section_463_subsection_b"
    class_name "subsection"
    text "(b) Other necessary rules and regulations"
  ]
  node [
    id 2912
    label "section_463_subsection_c"
    class_name "subsection"
    text "(c) Oral presentation of views"
  ]
  node [
    id 2913
    label "section_463_subsection_a"
    class_name "subsection"
    text "(a) Storage and handling of poultry products; violation of regulations"
  ]
  node [
    id 2914
    label "section_464_subsection_c_item_4"
    class_name "item"
    text "(4) The provisions of this chapter shall not apply to poultry producers with respect to poultry of their own raising on their own farms if (i) such producers slaughter not more than 1,000 poultry during the calendar year for which this exemption is being determined; (ii) such poultry producers do not engage in buying or selling poultry products other than those produced from poultry raised on their own farms; and (iii) none of such poultry moves in commerce (as defined in section 453(a) of this title)."
  ]
  node [
    id 2915
    label "section_464_subsection_e"
    class_name "subsection"
    text "(e) Applicability of adulteration and misbranding provisions to articles exempted from inspection"
  ]
  node [
    id 2916
    label "section_464_subsection_c_item_3"
    class_name "item"
    text "(3) No exemption under subparagraph (1)(C) or (D) or subparagraph (2) shall apply to any poultry producer or other person who, in the current calendar year&#8212;"
  ]
  node [
    id 2917
    label "section_464_subsection_a_item_3"
    class_name "item"
    text "(3) persons slaughtering, processing, or otherwise handling poultry or poultry products which have been or are to be processed as required by recognized religious dietary laws, to the extent that the Secretary determines necessary to avoid conflict with such requirements while still effectuating the purposes of this chapter."
  ]
  node [
    id 2918
    label "section_464_subsection_c"
    class_name "subsection"
    text "(c) Personal slaughtering; custom slaughtering; name and address of the poultry producer or processor in lieu of other labeling requirements; small enterprises; slaughterers or processors of specified number of turkeys; poultry producers raising poultry on own farms"
  ]
  node [
    id 2919
    label "section_464_subsection_c_item_1_subitem_D"
    class_name "subitem"
    text "The exemptions provided for in clauses (C) and (D) above shall not apply if the poultry producer or other person engages in the current calendar year in the business of buying or selling any poultry or poultry products other than as specified in such clauses."
  ]
  node [
    id 2920
    label "section_464_subsection_a_item_2"
    class_name "item"
    text "(2) for such period of time as the Secretary determines that it would be impracticable to provide inspection and the exemption will aid in the effective administration of this chapter, any person engaged in the processing of poultry or poultry products for commerce and the poultry or poultry products processed by such person: Provided, however, That no such exemption shall continue in effect on and after January 1, 1970; and"
  ]
  node [
    id 2921
    label "section_464_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(A) the poultry product components of the pizzas have been prepared, inspected, and passed in a cured or cooked form as ready-to-eat in compliance with the requirements of this chapter; and"
  ]
  node [
    id 2922
    label "section_464_subsection_c_item_1"
    class_name "item"
    text "(1) The Secretary shall, by regulation and under such conditions, including sanitary standards, practices, and procedures, as he may prescribe, exempt from specific provisions of this chapter&#8212;"
  ]
  node [
    id 2923
    label "section_464_subsection_c_item_2"
    class_name "item"
    text "(2) In addition to the specific exemptions provided herein, the Secretary shall, when he determines that the protection of consumers from adulterated or misbranded poultry products will not be impaired by such action, provide by regulation, consistent with subparagraph (3), for the exemption of the operation and products of small enterprises (including poultry producers), not exempted under subparagraph (1), which are engaged in any State or Territory or the District of Columbia in slaughtering and/or cutting up poultry for distribution as carcasses or parts thereof solely for distribution within such jurisdiction, from such provisions of this chapter as he deems appropriate, while still protecting the public from adulterated or misbranded products, under such conditions, including sanitary requirements, as he shall prescribe to effectuate the purposes of this chapter."
  ]
  node [
    id 2924
    label "section_464_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) the custom slaughter by any person of poultry delivered by the owner thereof for such slaughter, and the processing by such slaughterer and transportation in commerce of the poultry products exclusively for use, in the household of such owner, by him and members of his household and his nonpaying guests and employees: Provided, That such custom slaughterer does not engage in the business of buying or selling any poultry products capable of use as human food;"
  ]
  node [
    id 2925
    label "section_464_subsection_d_item_1"
    class_name "item"
    text "(1) Under such terms and conditions as the Secretary shall prescribe through rules and regulations issued under this section that may be necessary to ensure food safety and protect public health such as special handling procedures, the Secretary shall exempt pizzas containing a poultry product from the inspection requirements of this chapter if&#8212;"
  ]
  node [
    id 2926
    label "section_464_subsection_d"
    class_name "subsection"
    text "(d) Pizzas containing poultry products"
  ]
  node [
    id 2927
    label "section_464_subsection_a"
    class_name "subsection"
    text "(a) Persons exempted"
  ]
  node [
    id 2928
    label "section_464_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "(A) slaughters or processes the products of more than 20,000 poultry; or"
  ]
  node [
    id 2929
    label "section_464_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) the pizzas are to be served in public or private nonprofit institutions."
  ]
  node [
    id 2930
    label "section_464_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) the slaughtering by any person of poultry of his own raising, and the processing by him and transportation in commerce of the poultry products exclusively for use by him and members of his household and his nonpaying guests and employees;"
  ]
  node [
    id 2931
    label "section_464_subsection_c_item_3_subitem_B"
    class_name "subitem"
    text "Notwithstanding clause (B), the Secretary may grant such exemption to any poultry producer or other person if the Secretary determines, upon application of such poultry producer or other person, that granting such exemption will not impair effectuating the purposes of this chapter."
  ]
  node [
    id 2932
    label "section_464_subsection_b"
    class_name "subsection"
    text "(b) Territorial exemption"
  ]
  node [
    id 2933
    label "section_464_subsection_c_item_1_subitem_C"
    class_name "subitem"
    text "The exemptions provided for in clauses (C) and (D) above shall not apply if the poultry producer or other person engages in the current calendar year in the business of buying or selling any poultry or poultry products other than as specified in such clauses."
  ]
  node [
    id 2934
    label "section_464_subsection_d_item_2"
    class_name "item"
    text "(2) The Secretary may withdraw or modify any exemption under this subsection whenever the Secretary determines such action is necessary to ensure food safety and to protect public health. The Secretary may reinstate or further modify any exemption withdrawn or modified under this subsection."
  ]
  node [
    id 2935
    label "section_464_subsection_a_item_1"
    class_name "item"
    text "(1) retail dealers with respect to poultry products sold directly to consumers in individual retail stores, if the only processing operation performed by such retail dealers is the cutting up of poultry products on the premises where such sales to consumers are made;"
  ]
  node [
    id 2936
    label "section_464_subsection_f"
    class_name "subsection"
    text "(f) Suspension or termination of exemption"
  ]
  node [
    id 2937
    label "section_466_subsection_d_item_2_subitem_B"
    class_name "subitem"
    text "(B) The Secretary may&#8212;"
  ]
  node [
    id 2938
    label "section_466_subsection_d_item_2"
    class_name "item"
    text "(2)(A) The Secretary may treat as equivalent to a United States standard a standard of an exporting country described in paragraph (1) if the exporting country provides the Secretary with scientific evidence or other information, in accordance with risk assessment methodologies determined appropriate by the Secretary, to demonstrate that the standard of the exporting country achieves the level of sanitary protection achieved under the United States standard. For the purposes of this subsection, the term &#8220;sanitary protection&#8221; means protection to safeguard public health."
  ]
  node [
    id 2939
    label "section_466_subsection_b"
    class_name "subsection"
    text "(b) Rules and regulations; destruction and exportation of refused imports"
  ]
  node [
    id 2940
    label "section_466_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) have been processed in facilities and under conditions that achieve a level of sanitary protection equivalent to that achieved under United States standards."
  ]
  node [
    id 2941
    label "section_466_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(A) be subject to inspection, sanitary, quality, species verification, and residue standards that achieve a level of sanitary protection equivalent to that achieved under United States standards; and"
  ]
  node [
    id 2942
    label "section_466_subsection_d_item_3"
    class_name "item"
    text "(3) Any such imported poultry article that does not meet such standards shall not be permitted entry into the United States."
  ]
  node [
    id 2943
    label "section_466_subsection_d_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) determine, on a scientific basis, that the standard of the exporting country does not achieve the level of protection that the Secretary considers appropriate; and"
  ]
  node [
    id 2944
    label "section_466_subsection_d_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) The Secretary may treat as equivalent to a United States standard a standard of an exporting country described in paragraph (1) if the exporting country provides the Secretary with scientific evidence or other information, in accordance with risk assessment methodologies determined appropriate by the Secretary, to demonstrate that the standard of the exporting country achieves the level of sanitary protection achieved under the United States standard. For the purposes of this subsection, the term &#8220;sanitary protection&#8221; means protection to safeguard public health."
  ]
  node [
    id 2945
    label "section_466_subsection_d"
    class_name "subsection"
    text "(d) Domestic standards and processing facilities applicable; enforcement"
  ]
  node [
    id 2946
    label "section_466_subsection_d_item_1"
    class_name "item"
    text "(1) Notwithstanding any other provision of law, all poultry, or parts or products of poultry, capable of use as human food offered for importation into the United States shall&#8212;"
  ]
  node [
    id 2947
    label "section_466_subsection_d_item_4"
    class_name "item"
    text "(4) The Secretary shall enforce this subsection through&#8212;"
  ]
  node [
    id 2948
    label "section_466_subsection_d_item_4_subitem_B"
    class_name "subitem"
    text "(B) random sampling and testing of internal organs and fat of carcasses for residues at the point of slaughter by the exporting country, in accordance with methods approved by the Secretary."
  ]
  node [
    id 2949
    label "section_466_subsection_a"
    class_name "subsection"
    text "(a) Compliance with standards and regulations; status after importation"
  ]
  node [
    id 2950
    label "section_466_subsection_d_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) provide the basis for the determination in writing to the exporting country on request."
  ]
  node [
    id 2951
    label "section_466_subsection_c"
    class_name "subsection"
    text "(c) Storage, cartage and labor charges for imports refused admission"
  ]
  node [
    id 2952
    label "section_466_subsection_d_item_4_subitem_A"
    class_name "subitem"
    text "(A) random inspections for such species verification and for residues; and"
  ]
  node [
    id 2953
    label "section_467_subsection_c"
    class_name "subsection"
    text "(c) Finality and conclusiveness of determination; judicial review; record"
  ]
  node [
    id 2954
    label "section_467_subsection_a_item_2"
    class_name "item"
    text "The Secretary may (for such period, or indefinitely, as he deems necessary to effectuate the purposes of this chapter) refuse to provide, or withdraw, inspection service under this chapter with respect to any establishment if he determines, after opportunity for a hearing is accorded to the applicant for, or recipient of, such service, that such applicant or recipient is unfit to engage in any business requiring inspection upon this chapter because the applicant or recipient or anyone responsibly connected with the applicant or recipient, has been convicted, in any Federal or State court, within the previous ten years of (1) any felony or more than one misdemeanor under any law based upon the acquiring, handling, or distributing of adulterated, mislabeled, or deceptively packaged food or fraud in connection with transactions in food; or (2) any felony, involving fraud, bribery, extortion, or any other act or circumstances indicating a lack of the integrity needed for the conduct of operations affecting the public health. For the purpose of this paragraph a person shall be deemed to be responsibly connected with the business if he was a partner, officer, director, holder, or owner of 10 per centum or more of its voting stock or employee in a managerial or executive capacity."
  ]
  node [
    id 2955
    label "section_467_subsection_a"
    class_name "subsection"
    text "(a) Refusal or withdrawal; hearing; business unfitness based upon certain convictions; persons responsibly connected with the business"
  ]
  node [
    id 2956
    label "section_467_subsection_a_item_1"
    class_name "item"
    text "The Secretary may (for such period, or indefinitely, as he deems necessary to effectuate the purposes of this chapter) refuse to provide, or withdraw, inspection service under this chapter with respect to any establishment if he determines, after opportunity for a hearing is accorded to the applicant for, or recipient of, such service, that such applicant or recipient is unfit to engage in any business requiring inspection upon this chapter because the applicant or recipient or anyone responsibly connected with the applicant or recipient, has been convicted, in any Federal or State court, within the previous ten years of (1) any felony or more than one misdemeanor under any law based upon the acquiring, handling, or distributing of adulterated, mislabeled, or deceptively packaged food or fraud in connection with transactions in food; or (2) any felony, involving fraud, bribery, extortion, or any other act or circumstances indicating a lack of the integrity needed for the conduct of operations affecting the public health. For the purpose of this paragraph a person shall be deemed to be responsibly connected with the business if he was a partner, officer, director, holder, or owner of 10 per centum or more of its voting stock or employee in a managerial or executive capacity."
  ]
  node [
    id 2957
    label "section_467_subsection_b"
    class_name "subsection"
    text "(b) Hearing to determine validity of withdrawal or refusal of inspection services; continuation of withdrawal or refusal"
  ]
  node [
    id 2958
    label "section_467b_subsection_a_item_5_subitem_A"
    class_name "subitem"
    text "(5)(A) An article that is condemned under paragraph (1) may as the court may direct, after entry of the decree, be distributed without charge to nonprofit, private entities or to Federal, State, or local government entities engaged in the distribution of food without charge to individuals, if such article&#8212;"
  ]
  node [
    id 2959
    label "section_467b_subsection_a_item_3"
    class_name "item"
    text "(3) When a decree of condemnation is entered against the article or poultry and it is released under bond, or destroyed, court costs and fees, and storage and other proper expenses shall be awarded against the person, if any, intervening as claimant of the article or poultry."
  ]
  node [
    id 2960
    label "section_467b_subsection_a_item_5_subitem_B"
    class_name "subitem"
    text "(B) The United States may not be held legally responsible for any article that is distributed under subparagraph (A) to a nonprofit, private entity or to a Federal, State, or local government entity, if such article&#8212;"
  ]
  node [
    id 2961
    label "section_467b_subsection_a_item_5_subitem_C"
    class_name "subitem"
    text "(C) The person from whom such article was seized and condemned may not be held legally responsible for such article, if such article&#8212;"
  ]
  node [
    id 2962
    label "section_467b_subsection_a_item_4"
    class_name "item"
    text "(4) The proceedings in such libel cases shall conform, as nearly as may be, to the proceedings in admiralty, except that either party may demand trial by jury of any issue of fact joined in any case, and all such proceedings shall be at the suit of and in the name of the United States."
  ]
  node [
    id 2963
    label "section_467b_subsection_a_item_5_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) has been inspected under this chapter and found to be wholesome and not to be adulterated within the meaning of paragraphs (1) through (7) of section 453(g) of this title and a determination is made at the time of the entry of the decree that such article is wholesome and not so adulterated; and"
  ]
  node [
    id 2964
    label "section_467b_subsection_a_item_5_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) is plainly marked &#8220;Not for Sale&#8221; on such article or its container."
  ]
  node [
    id 2965
    label "section_467b_subsection_a_item_2"
    class_name "item"
    text "(2) If the article or poultry is condemned it shall, after entry of the decree, (A) be distributed in accordance with paragraph (5), or (B) be disposed of by destruction or sale as the court may direct and the proceeds, if sold, less the court costs and fees, and storage and other proper expenses, shall be paid into the Treasury of the United States, but the article or poultry shall not be sold contrary to the provisions of this chapter, or the laws of the jurisdiction in which it is sold: Provided, That upon the execution and delivery of a good and sufficient bond conditioned that the article or poultry shall not be sold or otherwise disposed of contrary to the provisions of this chapter, or the laws of the jurisdiction in which disposal is made, the court may direct that such article or poultry be delivered to the owner thereof subject to such supervision by authorized representatives of the Secretary as is necessary to insure compliance with the applicable laws."
  ]
  node [
    id 2966
    label "section_467b_subsection_a_item_5"
    class_name "item"
    text "(5)(A) An article that is condemned under paragraph (1) may as the court may direct, after entry of the decree, be distributed without charge to nonprofit, private entities or to Federal, State, or local government entities engaged in the distribution of food without charge to individuals, if such article&#8212;"
  ]
  node [
    id 2967
    label "section_467b_subsection_a_item_5_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) was found after inspection under this chapter to be wholesome and not adulterated within the meaning of paragraphs (1) through (7) of section 453(g) of this title and a determination was made at the time of the entry of the decree that such article was wholesome and not so adulterated; and"
  ]
  node [
    id 2968
    label "section_467b_subsection_b"
    class_name "subsection"
    text "(b) Condemnation or seizure under other provisions unaffected"
  ]
  node [
    id 2969
    label "section_467b_subsection_a_item_5_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) was plainly marked &#8220;Not for Sale&#8221; on such article or its container."
  ]
  node [
    id 2970
    label "section_467b_subsection_a_item_5_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) was plainly marked &#8220;Not for Sale&#8221; on such article or its container."
  ]
  node [
    id 2971
    label "section_467b_subsection_a_item_5_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) is capable of use as a human food;"
  ]
  node [
    id 2972
    label "section_467b_subsection_a_item_1"
    class_name "item"
    text "(1) Any poultry product, or any dead, dying, disabled, or diseased poultry, that is being transported in commerce or otherwise subject to this chapter, or is held for sale in the United States after such transportation, and that (A) is or has been processed, sold, transported, or otherwise distributed or offered or received for distribution in violation of this chapter, or (B) is capable of use as human food and is adulterated or misbranded, or (C) in any other way is in violation of this chapter, shall be liable to be proceeded against and seized and condemned, at any time, on a libel of information in any United States district court or other proper court as provided in section 467c of this title within the jurisdiction of which the article or poultry is found."
  ]
  node [
    id 2973
    label "section_467b_subsection_a_item_5_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) was found after inspection under this chapter to be wholesome and not adulterated within the meaning of paragraphs (1) through (7) of section 453(g) of this title and a determination was made at the time of entry of the decree that such article was wholesome and not so adulterated; and"
  ]
  node [
    id 2974
    label "section_467b_subsection_a"
    class_name "subsection"
    text "(a) Proceedings in rem; libel of information; jurisdiction; disposal by destruction or sale; proceeds into the Treasury; sales restrictions; bonds; court costs and fees, storage, and other expenses against claimants; jury trial; United States as plaintiff"
  ]
  node [
    id 2975
    label "section_467f_subsection_b"
    class_name "subsection"
    text "(b) Enforcement proceedings; detainer authority of representatives of Secretary of Health and Human Services"
  ]
  node [
    id 2976
    label "section_467f_subsection_a"
    class_name "subsection"
    text "(a) Exemptions; authorities under food, drug, and cosmetic provisions unaffected"
  ]
  node [
    id 2977
    label "section_601_subsection_d"
    class_name "subsection"
    text "(d) The term &#8220;renderer&#8221; means any person, firm, or corporation engaged in the business of rendering carcasses or parts or products of the carcasses, of cattle, sheep, swine, goats, horses, mules, or other equines, except rendering conducted under inspection or exemption under this subchapter."
  ]
  node [
    id 2978
    label "section_601_subsection_m_item_3"
    class_name "item"
    text "(3) if it consists in whole or in part of any filthy, putrid, or decomposed substance or is for any other reason unsound, unhealthful, unwholesome, or otherwise unfit for human food;"
  ]
  node [
    id 2979
    label "section_601_subsection_m_item_4"
    class_name "item"
    text "(4) if it has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health;"
  ]
  node [
    id 2980
    label "section_601_subsection_n_item_6"
    class_name "item"
    text "(6) if any word, statement, or other information required by or under authority of this chapter to appear on the label or other labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use;"
  ]
  node [
    id 2981
    label "section_601_subsection_j"
    class_name "subsection"
    text "(j) The term &#8220;meat food product&#8221; means any product capable of use as human food which is made wholly or in part from any meat or other portion of the carcass of any cattle, sheep, swine, or goats, excepting products which contain meat or other portions of such carcasses only in a relatively small proportion or historically have not been considered by consumers as products of the meat food industry, and which are exempted from definition as a meat food product by the Secretary under such conditions as he may prescribe to assure that the meat or other portions of such carcasses contained in such product are not adulterated and that such products are not represented as meat food products. This term as applied to food products of equines shall have a meaning comparable to that provided in this paragraph with respect to cattle, sheep, swine, and goats."
  ]
  node [
    id 2982
    label "section_601_subsection_n_item_8"
    class_name "item"
    text "(8) if it purports to be or is represented as a food for which a standard or standards of fill of container have been prescribed by regulations of the Secretary under section 607 of this title, and it falls below the standard of fill of container applicable thereto, unless its label bears, in such manner and form as such regulations specify, a statement that it falls below such standard;"
  ]
  node [
    id 2983
    label "section_601_subsection_n_item_7"
    class_name "item"
    text "(7) if it purports to be or is represented as a food for which a definition and standard of identity or composition has been prescribed by regulations of the Secretary under section 607 of this title unless (A) it conforms to such definition and standard, and (B) its label bears the name of the food specified in the definition and standard and, insofar as may be required by such regulations, the common names of optional ingredients (other than spices, flavoring, and coloring) present in such food;"
  ]
  node [
    id 2984
    label "section_601_subsection_m_item_6"
    class_name "item"
    text "(6) if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health;"
  ]
  node [
    id 2985
    label "section_601_subsection_n_item_4"
    class_name "item"
    text "(4) if its container is so made, formed, or filled as to be misleading;"
  ]
  node [
    id 2986
    label "section_601_subsection_e"
    class_name "subsection"
    text "(e) The term &#8220;animal food manufacturer&#8221; means any person, firm, or corporation engaged in the business of manufacturing or processing animal food derived wholly or in part from carcasses, or parts of products of the carcasses, of cattle, sheep, swine, goats, horses, mules, or other equines."
  ]
  node [
    id 2987
    label "section_601_subsection_r"
    class_name "subsection"
    text "(r) The terms &#8220;pesticide chemical,&#8221; &#8220;food additive,&#8221; &#8220;color additive,&#8221; and &#8220;raw agricultural commodity&#8221; shall have the same meanings for purposes of this chapter as under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.]."
  ]
  node [
    id 2988
    label "section_601_subsection_t"
    class_name "subsection"
    text "(t) The term &#8220;official inspection legend&#8221; means any symbol prescribed by regulations of the Secretary showing that an article was inspected and passed in accordance with this chapter."
  ]
  node [
    id 2989
    label "section_601_subsection_u"
    class_name "subsection"
    text "(u) The term &#8220;official certificate&#8221; means any certificate prescribed by regulations of the Secretary for issuance by an inspector or other person performing official functions under this chapter."
  ]
  node [
    id 2990
    label "section_601_subsection_g"
    class_name "subsection"
    text "(g) The term &#8220;Territory&#8221; means Guam, the Virgin Islands of the United States, American Samoa, and any other territory or possession of the United States, excluding the Canal Zone."
  ]
  node [
    id 2991
    label "section_601_subsection_m_item_8"
    class_name "item"
    text "(8) if any valuable constituent has been in whole or in part omitted or abstracted therefrom; or if any substance has been substituted, wholly or in part therefor; or if damage or inferiority has been concealed in any manner; or if any substance has been added thereto or mixed or packed therewith so as to increase its bulk or weight, or reduce its quality or strength, or make it appear better or of greater value than it is; or"
  ]
  node [
    id 2992
    label "section_601_subsection_n_item_2"
    class_name "item"
    text "(2) if it is offered for sale under the name of another food;"
  ]
  node [
    id 2993
    label "section_601_subsection_f"
    class_name "subsection"
    text "(f) The term &#8220;State&#8221; means any State of the United States and the Commonwealth of Puerto Rico."
  ]
  node [
    id 2994
    label "section_601_subsection_s"
    class_name "subsection"
    text "(s) The term &#8220;official mark&#8221; means the official inspection legend or any other symbol prescribed by regulations of the Secretary to identify the status of any article or animal under this chapter."
  ]
  node [
    id 2995
    label "section_601_subsection_m_item_9"
    class_name "item"
    text "(9) if it is margarine containing animal fat and any of the raw material used therein consisted in whole or in part of any filthy, putrid, or decomposed substance."
  ]
  node [
    id 2996
    label "section_601_subsection_b"
    class_name "subsection"
    text "(b) The term &#8220;firm&#8221; means any partnership, association, or other unincorporated business organization."
  ]
  node [
    id 2997
    label "section_601_subsection_m_item_2_subitem_C"
    class_name "subitem"
    text "(C) if it bears or contains any food additive which is unsafe within the meaning of section 348 of this title,"
  ]
  node [
    id 2998
    label "section_601_subsection_c"
    class_name "subsection"
    text "(c) The term &#8220;meat broker&#8221; means any person, firm, or corporation engaged in the business of buying or selling carcasses, parts of carcasses, meat, or meat food products of cattle, sheep, swine, goats, horses, mules, or other equines on commission, or otherwise negotiating purchases or sales of such articles other than for his own account or as an employee of another person, firm, or corporation."
  ]
  node [
    id 2999
    label "section_601_subsection_n_item_12"
    class_name "item"
    text "(12) if it fails to bear, directly thereon or on its container, as the Secretary may by regulations prescribe, the inspection legend and, unrestricted by any of the foregoing, such other information as the Secretary may require in such regulations to assure that it will not have false or misleading labeling and that the public will be informed of the manner of handling required to maintain the article in a wholesome condition."
  ]
  node [
    id 3000
    label "section_601_subsection_n_item_10"
    class_name "item"
    text "(10) if it purports to be or is represented for special dietary uses, unless its label bears such information concerning its vitamin, mineral, and other dietary properties as the Secretary, after consultation with the Secretary of Health and Human Services, determines to be, and by regulations prescribes as, necessary in order fully to inform purchasers as to its value for such uses;"
  ]
  node [
    id 3001
    label "section_601_subsection_n"
    class_name "subsection"
    text "(n) The term &#8220;misbranded&#8221; shall apply to any carcass, part thereof, meat or meat food product under one or more of the following circumstances:"
  ]
  node [
    id 3002
    label "section_601_subsection_m_item_5"
    class_name "item"
    text "(5) if it is, in whole or in part, the product of an animal which has died otherwise than by slaughter;"
  ]
  node [
    id 3003
    label "section_601_subsection_m_item_2_subitem_B"
    class_name "subitem"
    text "(B) if it is, in whole or in part, a raw agricultural commodity and such commodity bears or contains a pesticide chemical which is unsafe within the meaning of section 346a of this title,"
  ]
  node [
    id 3004
    label "section_601_subsection_m_item_1"
    class_name "item"
    text "(1) if it bears or contains any poisonous or deleterious substance which may render it injurious to health; but in case the substance is not an added substance, such article shall not be considered adulterated under this clause if the quantity of such substance in or on such article does not ordinarily render it injurious to health;"
  ]
  node [
    id 3005
    label "section_601_subsection_m_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) if it bears or contains (by reason of administration of any substance to the live animal or otherwise) any added poisonous or added deleterious substance (other than one which is (i) a pesticide chemical in or on a raw agricultural commodity; (ii) a food additive; or (iii) a color additive) which may, in the judgment of the Secretary, make such article unfit for human food;"
  ]
  node [
    id 3006
    label "section_601_subsection_n_item_11"
    class_name "item"
    text "(11) if it bears or contains any artificial flavoring, artificial coloring, or chemical preservative, unless it bears labeling stating that fact: Provided, That, to the extent that compliance with the requirements of this subparagraph (11) is impracticable, exemptions shall be established by regulations promulgated by the Secretary; or"
  ]
  node [
    id 3007
    label "section_601_subsection_m_item_2"
    class_name "item"
    text "(2)(A) if it bears or contains (by reason of administration of any substance to the live animal or otherwise) any added poisonous or added deleterious substance (other than one which is (i) a pesticide chemical in or on a raw agricultural commodity; (ii) a food additive; or (iii) a color additive) which may, in the judgment of the Secretary, make such article unfit for human food;"
  ]
  node [
    id 3008
    label "section_601_subsection_v"
    class_name "subsection"
    text "(v) The term &#8220;official device&#8221; means any device prescribed or authorized by the Secretary for use in applying any official mark."
  ]
  node [
    id 3009
    label "section_601_subsection_a"
    class_name "subsection"
    text "(a) The term &#8220;Secretary&#8221; means the Secretary of Agriculture of the United States or his delegate."
  ]
  node [
    id 3010
    label "section_601_subsection_n_item_5"
    class_name "item"
    text "(5) if in a package or other container unless it bears a label showing (A) the name and place of business of the manufacturer, packer, or distributor; and (B) an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count: Provided, That under clause (B) of this subparagraph (5), reasonable variations may be permitted, and exemptions as to small packages may be established, by regulations prescribed by the Secretary;"
  ]
  node [
    id 3011
    label "section_601_subsection_o"
    class_name "subsection"
    text "(o) The term &#8220;label&#8221; means a display of written, printed, or graphic matter upon the immediate container (not including package liners) of any article."
  ]
  node [
    id 3012
    label "section_601_subsection_k"
    class_name "subsection"
    text "(k) The term &#8220;capable of use as human food&#8221; shall apply to any carcass, or part or product of a carcass, of any animal, unless it is denatured or otherwise identified as required by regulations prescribed by the Secretary to deter its use as human food, or it is naturally inedible by humans."
  ]
  node [
    id 3013
    label "section_601_subsection_n_item_1"
    class_name "item"
    text "(1) if its labeling is false or misleading in any particular;"
  ]
  node [
    id 3014
    label "section_601_subsection_m"
    class_name "subsection"
    text "(m) The term &#8220;adulterated&#8221; shall apply to any carcass, part thereof, meat or meat food product under one or more of the following circumstances:"
  ]
  node [
    id 3015
    label "section_601_subsection_p"
    class_name "subsection"
    text "(p) The term &#8220;labeling&#8221; means all labels and other written, printed, or graphic matter (1) upon any article or any of its containers or wrappers, or (2) accompanying such article."
  ]
  node [
    id 3016
    label "section_601_subsection_m_item_7"
    class_name "item"
    text "(7) if it has been intentionally subjected to radiation, unless the use of the radiation was in conformity with a regulation or exemption in effect pursuant to section 348 of this title;"
  ]
  node [
    id 3017
    label "section_601_subsection_n_item_3"
    class_name "item"
    text "(3) if it is an imitation of another food, unless its label bears, in type of uniform size and prominence, the word &#8220;imitation&#8221; and immediately thereafter, the name of the food imitated;"
  ]
  node [
    id 3018
    label "section_601_subsection_m_item_2_subitem_D"
    class_name "subitem"
    text "(D) if it bears or contains any color additive which is unsafe within the meaning of section 379e of this title: Provided, That an article which is not adulterated under clause (B), (C), or (D) shall nevertheless be deemed adulterated if use of the pesticide chemical, food additive, or color additive in or on such article is prohibited by regulations of the Secretary in establishments at which inspection is maintained under this subchapter;"
  ]
  node [
    id 3019
    label "section_601_subsection_i"
    class_name "subsection"
    text "(i) The term &#8220;United States&#8221; means the States, the District of Columbia, and the Territories of the United States."
  ]
  node [
    id 3020
    label "section_601_subsection_h"
    class_name "subsection"
    text "(h) The term &#8220;commerce&#8221; means commerce between any State, any Territory, or the District of Columbia, and any place outside thereof; or within any Territory not organized with a legislative body, or the District of Columbia."
  ]
  node [
    id 3021
    label "section_601_subsection_n_item_9"
    class_name "item"
    text "(9) if it is not subject to the provisions of subparagraph (7), unless its label bears (A) the common or usual name of the food, if any there be, and (B) in case it is fabricated from two or more ingredients, the common or usual name of each such ingredient; except that spices, flavorings, and colorings may, when authorized by the Secretary, be designated as spices, flavorings, and colorings without naming each: Provided, That to the extent that compliance with the requirements of clause (B) of this subparagraph (9) is impracticable, or results in deception or unfair competition, exemptions shall be established by regulations promulgated by the Secretary;"
  ]
  node [
    id 3022
    label "section_601_subsection_l"
    class_name "subsection"
    text "(l) The term &#8220;prepared&#8221; means slaughtered, canned, salted, rendered, boned, cut up, or otherwise manufactured or processed."
  ]
  node [
    id 3023
    label "section_601_subsection_q"
    class_name "subsection"
    text "(q) The term &#8220;Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.]&#8221; means the Act so entitled, approved June 25, 1938 (52 Stat. 1040), and Acts amendatory thereof or supplementary thereto."
  ]
  node [
    id 3024
    label "section_603_subsection_b"
    class_name "subsection"
    text "(b) Humane methods of slaughter"
  ]
  node [
    id 3025
    label "section_603_subsection_a"
    class_name "subsection"
    text "(a) Examination of animals before slaughtering; diseased animals slaughtered separately and carcasses examined"
  ]
  node [
    id 3026
    label "section_607_subsection_b"
    class_name "subsection"
    text "(b) Information on articles or containers; legible form"
  ]
  node [
    id 3027
    label "section_607_subsection_a"
    class_name "subsection"
    text "(a) Labeling receptacles or coverings of meat or meat food products inspected and passed; supervision by inspectors"
  ]
  node [
    id 3028
    label "section_607_subsection_c_item_2"
    class_name "item"
    text "The Secretary, whenever he determines such action is necessary for the protection of the public, may prescribe: (1) the styles and sizes of type to be used with respect to material required to be incorporated in labeling to avoid false or misleading labeling in marketing and labeling any articles or animals subject to this subchapter or subchapter II of this chapter; (2) definitions and standards of identity or composition for articles subject to this subchapter and standards of fill of container for such articles not inconsistent with any such standards established under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], and there shall be consultation between the Secretary and the Secretary of Health and Human Services prior to the issuance of such standards under either Act relating to articles subject to this chapter to avoid inconsistency in such standards and possible impairment of the coordinated effective administration of these Acts. There shall also be consultation between the Secretary and an appropriate advisory committee provided for in section 661 of this title, prior to the issuance of such standards under this chapter, to avoid, insofar as feasible, inconsistency between Federal and State standards."
  ]
  node [
    id 3029
    label "section_607_subsection_d"
    class_name "subsection"
    text "(d) Sales under false or misleading name, other marking or labeling or in containers of misleading form or size; trade names, and other marking, labeling, and containers approved by Secretary"
  ]
  node [
    id 3030
    label "section_607_subsection_c_item_1"
    class_name "item"
    text "The Secretary, whenever he determines such action is necessary for the protection of the public, may prescribe: (1) the styles and sizes of type to be used with respect to material required to be incorporated in labeling to avoid false or misleading labeling in marketing and labeling any articles or animals subject to this subchapter or subchapter II of this chapter; (2) definitions and standards of identity or composition for articles subject to this subchapter and standards of fill of container for such articles not inconsistent with any such standards established under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], and there shall be consultation between the Secretary and the Secretary of Health and Human Services prior to the issuance of such standards under either Act relating to articles subject to this chapter to avoid inconsistency in such standards and possible impairment of the coordinated effective administration of these Acts. There shall also be consultation between the Secretary and an appropriate advisory committee provided for in section 661 of this title, prior to the issuance of such standards under this chapter, to avoid, insofar as feasible, inconsistency between Federal and State standards."
  ]
  node [
    id 3031
    label "section_607_subsection_e"
    class_name "subsection"
    text "(e) Use withholding directive respecting false or misleading marking, labeling, or container; modification of false or misleading matter; hearing; withholding use pending proceedings; finality of Secretary's action; judicial review; application of section 194 of title 7"
  ]
  node [
    id 3032
    label "section_607_subsection_c"
    class_name "subsection"
    text "(c) Labeling: type styles and sizes; definitions and standards of identity or composition; standards of fill of container; consistency of Federal and Federal-State standards"
  ]
  node [
    id 3033
    label "section_610_subsection_d"
    class_name "subsection"
    text "(d) Adulteration or misbranding"
  ]
  node [
    id 3034
    label "section_610_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "sell, transport, offer for sale or transportation, or receive for transportation, in commerce, (1) any such articles which (A) are capable of use as human food and (B) are adulterated or misbranded at the time of such sale, transportation, offer for sale or transportation, or receipt for transportation; or (2) any articles required to be inspected under this subchapter unless they have been so inspected and passed;"
  ]
  node [
    id 3035
    label "section_610_subsection_b"
    class_name "subsection"
    text "(b) Humane methods of slaughter"
  ]
  node [
    id 3036
    label "section_610_subsection_c"
    class_name "subsection"
    text "(c) Sales, transportation, and other transactions"
  ]
  node [
    id 3037
    label "section_610_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "sell, transport, offer for sale or transportation, or receive for transportation, in commerce, (1) any such articles which (A) are capable of use as human food and (B) are adulterated or misbranded at the time of such sale, transportation, offer for sale or transportation, or receipt for transportation; or (2) any articles required to be inspected under this subchapter unless they have been so inspected and passed;"
  ]
  node [
    id 3038
    label "section_610_subsection_a"
    class_name "subsection"
    text "(a) Slaughtering animals or preparation of articles capable of use as human food"
  ]
  node [
    id 3039
    label "section_610_subsection_c_item_1"
    class_name "item"
    text "sell, transport, offer for sale or transportation, or receive for transportation, in commerce, (1) any such articles which (A) are capable of use as human food and (B) are adulterated or misbranded at the time of such sale, transportation, offer for sale or transportation, or receipt for transportation; or (2) any articles required to be inspected under this subchapter unless they have been so inspected and passed;"
  ]
  node [
    id 3040
    label "section_610_subsection_c_item_2"
    class_name "item"
    text "sell, transport, offer for sale or transportation, or receive for transportation, in commerce, (1) any such articles which (A) are capable of use as human food and (B) are adulterated or misbranded at the time of such sale, transportation, offer for sale or transportation, or receipt for transportation; or (2) any articles required to be inspected under this subchapter unless they have been so inspected and passed;"
  ]
  node [
    id 3041
    label "section_611_subsection_b_item_4"
    class_name "item"
    text "(4) knowingly possess, without promptly notifying the Secretary or his representative, any official device or any counterfeit, simulated, forged, or improperly altered official certificate or any device or label or any carcass of any animal, or part or product thereof, bearing any counterfeit, simulated, forged, or improperly altered official mark;"
  ]
  node [
    id 3042
    label "section_611_subsection_a"
    class_name "subsection"
    text "(a) Devices to be made under authorization of Secretary"
  ]
  node [
    id 3043
    label "section_611_subsection_b_item_1"
    class_name "item"
    text "(1) forge any official device, mark, or certificate;"
  ]
  node [
    id 3044
    label "section_611_subsection_b_item_5"
    class_name "item"
    text "(5) knowingly make any false statement in any shipper's certificate or other nonofficial or official certificate provided for in the regulations prescribed by the Secretary; or"
  ]
  node [
    id 3045
    label "section_611_subsection_b"
    class_name "subsection"
    text "(b) Other misconduct"
  ]
  node [
    id 3046
    label "section_611_subsection_b_item_6"
    class_name "item"
    text "(6) knowingly represent that any article has been inspected and passed, or exempted, under this chapter when, in fact, it has, respectively, not been so inspected and passed, or exempted."
  ]
  node [
    id 3047
    label "section_611_subsection_b_item_3"
    class_name "item"
    text "(3) contrary to the regulations prescribed by the Secretary, fail to use, or to detach, deface, or destroy any official device, mark, or certificate;"
  ]
  node [
    id 3048
    label "section_611_subsection_b_item_2"
    class_name "item"
    text "(2) without authorization from the Secretary use any official device, mark, or certificate, or simulation thereof, or alter, detach, deface, or destroy any official device, mark, or certificate;"
  ]
  node [
    id 3049
    label "section_620_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) A certification by the Secretary that foreign plants exporting carcasses or meat or meat products referred to in subsection (a) of this section have complied with requirements that achieve a level of sanitary protection equivalent to that achieved under United States requirements with regard to all inspection, building construction standards, and all other provisions of this chapter and regulations issued under this chapter."
  ]
  node [
    id 3050
    label "section_620_subsection_e_item_4"
    class_name "item"
    text "(4) The number of inspectors licensed by each country from which any imports subject to the provisions of this section were imported who were assigned, during the calendar year concerned, to inspect such imports and the facilities in which such imports were handled and the frequency and effectiveness of such inspections."
  ]
  node [
    id 3051
    label "section_620_subsection_e_item_6"
    class_name "item"
    text "(6) The name of each foreign country that applies standards for the importation of meat articles from the United States that are described in subsection (h)(2) of this section."
  ]
  node [
    id 3052
    label "section_620_subsection_e"
    class_name "subsection"
    text "(e) Reports to Congressional committees"
  ]
  node [
    id 3053
    label "section_620_subsection_e_item_3"
    class_name "item"
    text "(3) The number of inspectors employed by the Department of Agriculture in the calendar year concerned who were assigned to inspect plants referred to in paragraph (e)(2)&#160;1 hereof and the frequency with which each such plant was inspected by such inspectors."
  ]
  node [
    id 3054
    label "section_620_subsection_h_item_3"
    class_name "item"
    text "(3) If the Secretary determines that a foreign country applies standards described in paragraph (2)&#8212;"
  ]
  node [
    id 3055
    label "section_620_subsection_e_item_5"
    class_name "item"
    text "(5) The total volume of carcasses or meat or meat products referred to in subsection (a) of this section which was imported into the United States during the calendar year concerned from each country, including a separate itemization of the volume of each major category of such imports from each country during such year, and a detailed report of rejections of plants and products because of failure to meet appropriate standards prescribed by this chapter."
  ]
  node [
    id 3056
    label "section_620_subsection_b"
    class_name "subsection"
    text "(b) Terms and conditions for destruction"
  ]
  node [
    id 3057
    label "section_620_subsection_h_item_3_subitem_A"
    class_name "subitem"
    text "(A) the Secretary shall consult with the United States Trade Representative; and"
  ]
  node [
    id 3058
    label "section_620_subsection_e_item_1"
    class_name "item"
    text "(1)(A) A certification by the Secretary that foreign plants exporting carcasses or meat or meat products referred to in subsection (a) of this section have complied with requirements that achieve a level of sanitary protection equivalent to that achieved under United States requirements with regard to all inspection, building construction standards, and all other provisions of this chapter and regulations issued under this chapter."
  ]
  node [
    id 3059
    label "section_620_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) The Secretary may treat as equivalent to a United States requirement a requirement described in subparagraph (A) if the exporting country provides the Secretary with scientific evidence or other information, in accordance with risk assessment methodologies determined appropriate by the Secretary, to demonstrate that the requirement achieves the level of sanitary protection achieved under the United States requirement. For the purposes of this subsection, the term &#8220;sanitary protection&#8221; means protection to safeguard public health."
  ]
  node [
    id 3060
    label "section_620_subsection_f_item_2"
    class_name "item"
    text "Notwithstanding any other provision of law, all carcasses, parts of carcasses, meat, and meat food products of cattle, sheep, swine, goats, horses, mules, or other equines, capable of use as human food, offered for importation into the United States shall be subject to the inspection, sanitary, quality, species verification, and residue standards applied to products produced in the United States. Any such imported meat articles that do not meet such standards shall not be permitted entry in to the United States. The Secretary shall enforce this provision through (1) the imposition of random inspections for such species verification and for residues, and (2) random sampling and testing of internal organs and fat of the carcasses for residues at the point of slaughter by the exporting country in accordance with methods approved by the Secretary. Each foreign country from which such meat articles are offered for importation into the United States shall obtain a certification issued by the Secretary stating that the country maintains a program using reliable analytical methods to ensure compliance with the United States standards for residues in such meat articles. No such meat article shall be permitted entry into the United States from a country for which the Secretary has not issued such certification. The Secretary shall periodically review such certifications and shall revoke any certification if the Secretary determines that the country involved is not maintaining a program that uses reliable analytical methods to ensure compliance with United States standards for residues in such meat articles. The consideration of any application for a certification under this subsection and the review of any such certification, by the Secretary, shall include the inspection of individual establishments to ensure that the inspection program of the foreign country involved is meeting such United States standards."
  ]
  node [
    id 3061
    label "section_620_subsection_h_item_3_subitem_B"
    class_name "subitem"
    text "(B) within 30 days after the determination of the Secretary under paragraph (2), the Secretary and the United States Trade Representative shall recommend to the President whether action should be taken under paragraph (4)."
  ]
  node [
    id 3062
    label "section_620_subsection_f_item_1"
    class_name "item"
    text "Notwithstanding any other provision of law, all carcasses, parts of carcasses, meat, and meat food products of cattle, sheep, swine, goats, horses, mules, or other equines, capable of use as human food, offered for importation into the United States shall be subject to the inspection, sanitary, quality, species verification, and residue standards applied to products produced in the United States. Any such imported meat articles that do not meet such standards shall not be permitted entry in to the United States. The Secretary shall enforce this provision through (1) the imposition of random inspections for such species verification and for residues, and (2) random sampling and testing of internal organs and fat of the carcasses for residues at the point of slaughter by the exporting country in accordance with methods approved by the Secretary. Each foreign country from which such meat articles are offered for importation into the United States shall obtain a certification issued by the Secretary stating that the country maintains a program using reliable analytical methods to ensure compliance with the United States standards for residues in such meat articles. No such meat article shall be permitted entry into the United States from a country for which the Secretary has not issued such certification. The Secretary shall periodically review such certifications and shall revoke any certification if the Secretary determines that the country involved is not maintaining a program that uses reliable analytical methods to ensure compliance with United States standards for residues in such meat articles. The consideration of any application for a certification under this subsection and the review of any such certification, by the Secretary, shall include the inspection of individual establishments to ensure that the inspection program of the foreign country involved is meeting such United States standards."
  ]
  node [
    id 3063
    label "section_620_subsection_f"
    class_name "subsection"
    text "(f) Inspection and other standards; applicability, enforcement, etc.; certifications"
  ]
  node [
    id 3064
    label "section_620_subsection_d"
    class_name "subsection"
    text "(d) Prohibition"
  ]
  node [
    id 3065
    label "section_620_subsection_b_item_1"
    class_name "item"
    text "The Secretary may prescribe the terms and conditions for the destruction of all such articles which are imported contrary to this section, unless (1) they are exported by the consignee within the time fixed therefor by the Secretary, or (2) in the case of articles which are not in compliance with the chapter solely because of misbranding, such articles are brought into compliance with the chapter under supervision of authorized representatives of the Secretary."
  ]
  node [
    id 3066
    label "section_620_subsection_h_item_1"
    class_name "item"
    text "(1) As used in this subsection:"
  ]
  node [
    id 3067
    label "section_620_subsection_b_item_2"
    class_name "item"
    text "The Secretary may prescribe the terms and conditions for the destruction of all such articles which are imported contrary to this section, unless (1) they are exported by the consignee within the time fixed therefor by the Secretary, or (2) in the case of articles which are not in compliance with the chapter solely because of misbranding, such articles are brought into compliance with the chapter under supervision of authorized representatives of the Secretary."
  ]
  node [
    id 3068
    label "section_620_subsection_a"
    class_name "subsection"
    text "(a) Adulteration or misbranding prohibition; compliance with inspection, building construction standards, and other provisions; humane methods of slaughter; treatment as domestic articles subject to this chapter and food, drug, and cosmetic provisions; marking and labeling; personal consumption exemption"
  ]
  node [
    id 3069
    label "section_620_subsection_h_item_1_subitem_A"
    class_name "subitem"
    text "(A) The term &#8220;meat articles&#8221; means carcasses, meat and meat food products of cattle, sheep, swine, goats, horses, mules, or other equines, that are capable of use as human food."
  ]
  node [
    id 3070
    label "section_620_subsection_h_item_1_subitem_B"
    class_name "subitem"
    text "(B) The term &#8220;standards&#8221; means inspection, building construction, sanitary, quality, species verification, residue, and other standards that are applicable to meat articles."
  ]
  node [
    id 3071
    label "section_620_subsection_h"
    class_name "subsection"
    text "(h) Reciprocal meat inspection requirement"
  ]
  node [
    id 3072
    label "section_620_subsection_e_item_1_subitem_C"
    class_name "subitem"
    text "(C) The Secretary may&#8212;"
  ]
  node [
    id 3073
    label "section_620_subsection_h_item_4"
    class_name "item"
    text "(4) Within 30 days after receiving a recommendation for action under paragraph (3), the President shall, if and for such time as the President considers appropriate, prohibit imports into the United States of any meat articles produced in such foreign country unless it is determined that the meat articles produced in that country meet the standards applicable to meat articles in commerce within the United States."
  ]
  node [
    id 3074
    label "section_620_subsection_c"
    class_name "subsection"
    text "(c) Payment of storage, cartage, and labor charges by owner or consignee; liens"
  ]
  node [
    id 3075
    label "section_620_subsection_e_item_1_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) provide the basis for the determination to the exporting country in writing on request."
  ]
  node [
    id 3076
    label "section_620_subsection_e_item_2"
    class_name "item"
    text "(2) The names and locations of plants authorized or permitted to have imported into the United States therefrom carcasses or meat or meat products referred to in subsection (a) of this section."
  ]
  node [
    id 3077
    label "section_620_subsection_h_item_5"
    class_name "item"
    text "(5) The action authorized under paragraph (4) may be used instead of, or in addition to, any other action taken under any other law."
  ]
  node [
    id 3078
    label "section_620_subsection_e_item_1_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) determine, on a scientific basis, that a requirement of an exporting country does not achieve the level of protection that the Secretary considers appropriate; and"
  ]
  node [
    id 3079
    label "section_620_subsection_h_item_2"
    class_name "item"
    text "(2) On request of the Committee on Agriculture or the Committee on Ways and Means of the House of Representatives or the Committee on Agriculture, Nutrition, and Forestry or the Committee on Finance of the Senate, or at the initiative of the Secretary, the Secretary shall, as soon as practicable, determine whether a particular foreign country applies standards for the importation of meat articles from the United States that are not related to public health concerns about end-product quality that can be substantiated by reliable analytical methods."
  ]
  node [
    id 3080
    label "section_620_subsection_g"
    class_name "subsection"
    text "(g) Administration of animal drugs or antibiotics; terms and conditions; entry order violations"
  ]
  node [
    id 3081
    label "section_623_subsection_b"
    class_name "subsection"
    text "(b) Territorial exemption; refusal, withdrawal, or modification"
  ]
  node [
    id 3082
    label "section_623_subsection_c_item_2"
    class_name "item"
    text "(2) The Secretary may withdraw or modify any exemption under this subsection whenever the Secretary determines such action is necessary to ensure food safety and to protect public health. The Secretary may reinstate or further modify any exemption withdrawn or modified under this subsection."
  ]
  node [
    id 3083
    label "section_623_subsection_d"
    class_name "subsection"
    text "(d) Adulteration and misbranding provisions applicable to inspection-free articles"
  ]
  node [
    id 3084
    label "section_623_subsection_a"
    class_name "subsection"
    text "(a) Personal slaughtering and custom slaughtering for personal, household, guest, and employee uses"
  ]
  node [
    id 3085
    label "section_623_subsection_c"
    class_name "subsection"
    text "(c) Pizzas containing meat food products"
  ]
  node [
    id 3086
    label "section_623_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) the meat food product components of the pizzas have been prepared, inspected, and passed in a cured or cooked form as ready-to-eat in compliance with the requirements of this chapter; and"
  ]
  node [
    id 3087
    label "section_623_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) the pizzas are to be served in public or private nonprofit institutions."
  ]
  node [
    id 3088
    label "section_623_subsection_c_item_1"
    class_name "item"
    text "(1) Under such terms and conditions as the Secretary shall prescribe through rules and regulations issued under section 624 of this title that may be necessary to ensure food safety and protect public health such as special handling procedures, the Secretary shall exempt pizzas containing a meat food product from the inspection requirements of this chapter if&#8212;"
  ]
  node [
    id 3089
    label "section_642_subsection_a_item_2"
    class_name "item"
    text "(2) Any persons, firms, or corporations that engage in the business of buying or selling (as meat brokers, wholesalers or otherwise), or transporting in commerce, or storing in or for commerce, or importing, any carcasses, or parts or products of carcasses, of any such animals;"
  ]
  node [
    id 3090
    label "section_642_subsection_b"
    class_name "subsection"
    text "(b) Period of maintenance"
  ]
  node [
    id 3091
    label "section_642_subsection_a_item_3"
    class_name "item"
    text "(3) Any persons, firms, or corporations that engage in business, in or for commerce, as renderers, or engage in the business of buying, selling, or transporting, in commerce, or importing, any dead, dying, disabled, or diseased cattle, sheep, swine, goats, horses, mules, or other equines, or parts of the carcasses of any such animals that died otherwise than by slaughter."
  ]
  node [
    id 3092
    label "section_642_subsection_a"
    class_name "subsection"
    text "(a) Classes of persons bound; scope of disclosure; access to places of business; examination of records, facilities, and inventories; copies; samples"
  ]
  node [
    id 3093
    label "section_642_subsection_a_item_1"
    class_name "item"
    text "(1) Any persons, firms, or corporations that engage, for commerce, in the business of slaughtering any cattle, sheep, swine, goats, horses, mules, or other equines, or preparing, freezing, packaging, or labeling any carcasses, or parts or products of carcasses, of any such animals, for use as human food or animal food;"
  ]
  node [
    id 3094
    label "section_661_subsection_c_item_3"
    class_name "item"
    text "(3) Termination of designation of State upon development and enforcement of minimum requirements; redesignation; designation for nonenforcement of minimum requirements: notice and publication in Federal Register"
  ]
  node [
    id 3095
    label "section_661_subsection_a_item_1"
    class_name "item"
    text "(1) Development and administration of State meat inspection program equal to subchapter I ante and post mortem inspection, reinspection, and sanitation requirements"
  ]
  node [
    id 3096
    label "section_661_subsection_c_item_1"
    class_name "item"
    text "Whenever the Secretary determines that any State designated under this paragraph (c) has developed and will enforce State meat inspection requirements at least equal to those imposed under subchapters I and IV of this chapter with respect to the operations and transactions within such State which are regulated under paragraph (1), he shall terminate the designation of such State under this paragraph (c), but this shall not preclude the subsequent redesignation of the State at any time upon thirty days notice to the Governor and publication in the Federal Register in accordance with this paragraph, and any State may be designated upon such notice and publication at any time after the period specified in this paragraph whether or not the State has theretofore been designated upon the Secretary determining that it is not effectively enforcing requirements at least equal to those imposed under subchapters I and IV of this chapter."
  ]
  node [
    id 3097
    label "section_661_subsection_a_item_3"
    class_name "item"
    text "(3) Scope of cooperation: advisory assistance, technical and laboratory assistance and training, and financial and other aid; limitation on amount; equitable allocation of Federal funds; adequacy of State program to obtain Federal cooperation and payments"
  ]
  node [
    id 3098
    label "section_661_subsection_a"
    class_name "subsection"
    text "(a) Congressional statement of policy"
  ]
  node [
    id 3099
    label "section_661_subsection_a_item_4"
    class_name "item"
    text "(4) Advisory committees"
  ]
  node [
    id 3100
    label "section_661_subsection_b"
    class_name "subsection"
    text "(b) Single State agency; subordinate governmental unit as part of State agency"
  ]
  node [
    id 3101
    label "section_661_subsection_c"
    class_name "subsection"
    text "(c) State meat inspection requirements"
  ]
  node [
    id 3102
    label "section_661_subsection_a_item_2"
    class_name "item"
    text "(2) Development and administration of State program with authorities equal to subchapter II authorities; cooperation with Federal agencies"
  ]
  node [
    id 3103
    label "section_661_subsection_c_item_2"
    class_name "item"
    text "(2) Exemptions of retail stores, restaurants, and similar retail-type establishments; operations conducted at a restaurant central kitchen facility"
  ]
  node [
    id 3104
    label "section_661_subsection_a_item_3_subsubitem_ii"
    class_name "subsubitem"
    text "Cooperation with State agencies under this section may include furnishing to the appropriate State agency (i) advisory assistance in planning and otherwise developing an adequate State program under the State law; and (ii) technical and laboratory assistance and training (including necessary curricular and instructional materials and equipment), and financial and other aid for administration of such a program. The amount to be contributed to any State by the Secretary under this section from Federal funds for any year shall not exceed 50 per centum of the estimated total cost of the cooperative program; and the Federal funds shall be allocated among the States desiring to cooperate on an equitable basis. Such cooperation and payment shall be contingent at all times upon the administration of the State program in a manner which the Secretary, in consultation with the appropriate advisory committee appointed under paragraph (4), deems adequate to effectuate the purposes of this section."
  ]
  node [
    id 3105
    label "section_661_subsection_d"
    class_name "subsection"
    text "(d) &#8220;State&#8221; defined"
  ]
  node [
    id 3106
    label "section_661_subsection_c_item_4"
    class_name "item"
    text "(4) Periodic review; report to Congressional committees"
  ]
  node [
    id 3107
    label "section_661_subsection_a_item_3_subsubitem_i"
    class_name "subsubitem"
    text "Cooperation with State agencies under this section may include furnishing to the appropriate State agency (i) advisory assistance in planning and otherwise developing an adequate State program under the State law; and (ii) technical and laboratory assistance and training (including necessary curricular and instructional materials and equipment), and financial and other aid for administration of such a program. The amount to be contributed to any State by the Secretary under this section from Federal funds for any year shall not exceed 50 per centum of the estimated total cost of the cooperative program; and the Federal funds shall be allocated among the States desiring to cooperate on an equitable basis. Such cooperation and payment shall be contingent at all times upon the administration of the State program in a manner which the Secretary, in consultation with the appropriate advisory committee appointed under paragraph (4), deems adequate to effectuate the purposes of this section."
  ]
  node [
    id 3108
    label "section_671_item_2"
    class_name "item"
    text "The Secretary may (for such period, or indefinitely, as he deems necessary to effectuate the purposes of this chapter) refuse to provide, or withdraw, inspection service under subchapter I of this chapter with respect to any establishment if he determines, after opportunity for a hearing is accorded to the applicant for, or recipient of, such service, that such applicant or recipient is unfit to engage in any business requiring inspection under subchapter I because the applicant or recipient, or anyone responsibly connected with the applicant or recipient, has been convicted, in any Federal or State court, of (1) any felony, or (2) more than one violation of any law, other than a felony, based upon the acquiring, handling, or distributing of unwholesome, mislabeled, or deceptively packaged food or upon fraud in connection with transactions in food. This section shall not affect in any way other provisions of this chapter for withdrawal of inspection services under subchapter I from establishments failing to maintain sanitary conditions or to destroy condemned carcasses, parts, meat or meat food products."
  ]
  node [
    id 3109
    label "section_671_item_1"
    class_name "item"
    text "The Secretary may (for such period, or indefinitely, as he deems necessary to effectuate the purposes of this chapter) refuse to provide, or withdraw, inspection service under subchapter I of this chapter with respect to any establishment if he determines, after opportunity for a hearing is accorded to the applicant for, or recipient of, such service, that such applicant or recipient is unfit to engage in any business requiring inspection under subchapter I because the applicant or recipient, or anyone responsibly connected with the applicant or recipient, has been convicted, in any Federal or State court, of (1) any felony, or (2) more than one violation of any law, other than a felony, based upon the acquiring, handling, or distributing of unwholesome, mislabeled, or deceptively packaged food or upon fraud in connection with transactions in food. This section shall not affect in any way other provisions of this chapter for withdrawal of inspection services under subchapter I from establishments failing to maintain sanitary conditions or to destroy condemned carcasses, parts, meat or meat food products."
  ]
  node [
    id 3110
    label "section_673_subsection_a"
    class_name "subsection"
    text "(a) Proceedings in rem; libel of information; jurisdiction; disposal by destruction or sale; proceeds into the Treasury; sales restrictions; bond; court costs and fees, storage, and other expenses against claimants; proceedings in admiralty; jury trial; United States as plaintiff"
  ]
  node [
    id 3111
    label "section_673_subsection_a_item_5_subitem_A"
    class_name "subitem"
    text "(5)(A) An article that is condemned under paragraph (1) may as the court may direct, after entry of the decree, be distributed without charge to nonprofit, private entities or to Federal, State, or local government entities engaged in the distribution of food without charge to individuals, if such article&#8212;"
  ]
  node [
    id 3112
    label "section_673_subsection_a_item_2"
    class_name "item"
    text "(2) If the article or animal is condemned it shall, after entry of the decree, (A) be distributed in accordance with paragraph (5), or (B) be disposed of by destruction or sale as the court may direct and the proceeds, if sold, less the court costs and fees, and storage and other proper expenses, shall be paid into the Treasury of the United States, but the article or animal shall not be sold contrary to the provisions of this chapter, or the laws of the jurisdiction in which it is sold: Provided, That upon the execution and delivery of a good and sufficient bond conditioned that the article or animal shall not be sold or otherwise disposed of contrary to the provisions of this chapter, or the laws of the jurisdiction in which disposal is made, the court may direct that such article or animal be delivered to the owner thereof subject to such supervision by authorized representatives of the Secretary as is necessary to insure compliance with the applicable laws."
  ]
  node [
    id 3113
    label "section_673_subsection_b"
    class_name "subsection"
    text "(b) Condemnation or seizure under other provisions unaffected"
  ]
  node [
    id 3114
    label "section_673_subsection_a_item_5_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) has been inspected under this chapter and found to be wholesome and not to be adulterated within the meaning of paragraphs (1) through (7) and (9) of section 601(m) of this title and a determination is made at the time of the entry of the decree that such article is wholesome and not so adulterated; and"
  ]
  node [
    id 3115
    label "section_673_subsection_a_item_5_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) is plainly marked &#8220;Not for Sale&#8221; on such article or its container."
  ]
  node [
    id 3116
    label "section_673_subsection_a_item_5_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) was plainly marked &#8220;Not for Sale&#8221; on such article or its container."
  ]
  node [
    id 3117
    label "section_673_subsection_a_item_5_subitem_C"
    class_name "subitem"
    text "(C) The person from whom such article was seized and condemned may not be held legally responsible for such article, if such article&#8212;"
  ]
  node [
    id 3118
    label "section_673_subsection_a_item_5"
    class_name "item"
    text "(5)(A) An article that is condemned under paragraph (1) may as the court may direct, after entry of the decree, be distributed without charge to nonprofit, private entities or to Federal, State, or local government entities engaged in the distribution of food without charge to individuals, if such article&#8212;"
  ]
  node [
    id 3119
    label "section_673_subsection_a_item_4"
    class_name "item"
    text "(4) The proceedings in such libel cases shall conform, as nearly as may be, to the proceedings in admiralty, except that either party may demand trial by jury of any issue of fact joined in any case, and all such proceedings shall be at the suit of and in the name of the United States."
  ]
  node [
    id 3120
    label "section_673_subsection_a_item_5_subitem_B"
    class_name "subitem"
    text "(B) The United States may not be held legally responsible for any article that is distributed under subparagraph (A) to a nonprofit, private entity or to a Federal, State, or local government entity, if such article&#8212;"
  ]
  node [
    id 3121
    label "section_673_subsection_a_item_5_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) was found after inspection under this chapter to be wholesome and not adulterated within the meaning of paragraphs (1) through (7) and (9) of section 601(m) of this title and a determination was made at the time of the entry of the decree that such article was wholesome and not so adulterated; and"
  ]
  node [
    id 3122
    label "section_673_subsection_a_item_1"
    class_name "item"
    text "(1) Any carcass, part of a carcass, meat or meat food product of cattle, sheep, swine, goats, horses, mules or other equines, or any dead, dying, disabled, or diseased cattle, sheep, swine, goat, or equine, that is being transported in commerce or otherwise subject to subchapter I or II of this chapter, or is held for sale in the United States after such transportation, and that (A) is or has been prepared, sold, transported, or otherwise distributed or offered or received for distribution in violation of this chapter, or (B) is capable of use as human food and is adulterated or misbranded, or (C) in any other way is in violation of this chapter, shall be liable to be proceeded against and seized and condemned, at any time, on a libel of information in any United States district court or other proper court as provided in section 674 of this title within the jurisdiction of which the article or animal is found."
  ]
  node [
    id 3123
    label "section_673_subsection_a_item_3"
    class_name "item"
    text "(3) When a decree of condemnation is entered against the article or animal and it is released under bond, or destroyed, court costs and fees, and storage and other proper expenses shall be awarded against the person, if any, intervening as claimant of the article or animal."
  ]
  node [
    id 3124
    label "section_673_subsection_a_item_5_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) was plainly marked &#8220;Not for Sale&#8221; on such article or its container."
  ]
  node [
    id 3125
    label "section_673_subsection_a_item_5_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) was found after inspection under this chapter to be wholesome and not adulterated within the meaning of paragraphs (1) through (7) and (9) of section 601(m) of this title and a determination was made at the time of the entry of the decree that such article was wholesome and not so adulterated; and"
  ]
  node [
    id 3126
    label "section_676_subsection_a"
    class_name "subsection"
    text "(a) Misdemeanors; felonies: intent to defraud and distribution of adulterated articles; good faith"
  ]
  node [
    id 3127
    label "section_676_subsection_a_item_8"
    class_name "item"
    text "Any person, firm, or corporation who violates any provision of this chapter for which no other criminal penalty is provided by this chapter shall upon conviction be subject to imprisonment for not more than one year, or a fine of not more than $1,000, or both such imprisonment and fine; but if such violation involves intent to defraud, or any distribution or attempted distribution of an article that is adulterated (except as defined in section 601(m)(8) of this title), such person, firm, or corporation shall be subject to imprisonment for not more than three years or a fine of not more than $10,000, or both: Provided, That no person, firm, or corporation, shall be subject to penalties under this section for receiving for transportation any article or animal in violation of this chapter if such receipt was made in good faith, unless such person, firm, or corporation refuses to furnish on request of a representative of the Secretary the name and address of the person from whom he received such article or animal, and copies of all documents, if any there be, pertaining to the delivery of the article or animal to him."
  ]
  node [
    id 3128
    label "section_676_subsection_b"
    class_name "subsection"
    text "(b) Minor violations; written notice of warning of criminal and civil proceedings"
  ]
  node [
    id 3129
    label "section_679_subsection_a"
    class_name "subsection"
    text "(a) Authorities under food, drug, and cosmetic provisions unaffected"
  ]
  node [
    id 3130
    label "section_679_subsection_b"
    class_name "subsection"
    text "(b) Enforcement proceedings; detainer authority of representatives of Secretary of Health and Human Services"
  ]
  node [
    id 3131
    label "section_801_item_2"
    class_name "item"
    text "(2) The illegal importation, manufacture, distribution, and possession and improper use of controlled substances have a substantial and detrimental effect on the health and general welfare of the American people."
  ]
  node [
    id 3132
    label "section_801_item_5"
    class_name "item"
    text "(5) Controlled substances manufactured and distributed intrastate cannot be differentiated from controlled substances manufactured and distributed interstate. Thus, it is not feasible to distinguish, in terms of controls, between controlled substances manufactured and distributed interstate and controlled substances manufactured and distributed intrastate."
  ]
  node [
    id 3133
    label "section_801_item_3_subitem_C"
    class_name "subitem"
    text "(C) controlled substances possessed commonly flow through interstate commerce immediately prior to such possession."
  ]
  node [
    id 3134
    label "section_801_item_3_subitem_A"
    class_name "subitem"
    text "(A) after manufacture, many controlled substances are transported in interstate commerce,"
  ]
  node [
    id 3135
    label "section_801_item_1"
    class_name "item"
    text "(1) Many of the drugs included within this subchapter have a useful and legitimate medical purpose and are necessary to maintain the health and general welfare of the American people."
  ]
  node [
    id 3136
    label "section_801_item_7"
    class_name "item"
    text "(7) The United States is a party to the Single Convention on Narcotic Drugs, 1961, and other international conventions designed to establish effective control over international and domestic traffic in controlled substances."
  ]
  node [
    id 3137
    label "section_801_item_4"
    class_name "item"
    text "(4) Local distribution and possession of controlled substances contribute to swelling the interstate traffic in such substances."
  ]
  node [
    id 3138
    label "section_801_item_3_subitem_B"
    class_name "subitem"
    text "(B) controlled substances distributed locally usually have been transported in interstate commerce immediately before their distribution, and"
  ]
  node [
    id 3139
    label "section_801_item_6"
    class_name "item"
    text "(6) Federal control of the intrastate incidents of the traffic in controlled substances is essential to the effective control of the interstate incidents of such traffic."
  ]
  node [
    id 3140
    label "section_801_item_3"
    class_name "item"
    text "(3) A major portion of the traffic in controlled substances flows through interstate and foreign commerce. Incidents of the traffic which are not an integral part of the interstate or foreign flow, such as manufacture, local distribution, and possession, nonetheless have a substantial and direct effect upon interstate commerce because&#8212;"
  ]
  node [
    id 3141
    label "section_801a_item_3"
    class_name "item"
    text "(3) In implementing the Convention on Psychotropic Substances, the Congress intends that, consistent with the obligations of the United States under the Convention, control of psychotropic substances in the United States should be accomplished within the framework of the procedures and criteria for classification of substances provided in the Comprehensive Drug Abuse Prevention and Control Act of 1970 [21 U.S.C. 801 et seq.]. This will insure that (A) the availability of psychotropic substances to manufacturers, distributors, dispensers, and researchers for useful and legitimate medical and scientific purposes will not be unduly restricted; (B) nothing in the Convention will interfere with bona fide research activities; and (C) nothing in the Convention will interfere with ethical medical practice in this country as determined by the Secretary of Health and Human Services on the basis of a consensus of the views of the American medical and scientific community."
  ]
  node [
    id 3142
    label "section_801a_item_1"
    class_name "item"
    text "(1) The Congress has long recognized the danger involved in the manufacture, distribution, and use of certain psychotropic substances for nonscientific and nonmedical purposes, and has provided strong and effective legislation to control illicit trafficking and to regulate legitimate uses of psychotropic substances in this country. Abuse of psychotropic substances has become a phenomenon common to many countries, however, and is not confined to national borders. It is, therefore, essential that the United States cooperate with other nations in establishing effective controls over international traffic in such substances."
  ]
  node [
    id 3143
    label "section_801a_item_2"
    class_name "item"
    text "(2) The United States has joined with other countries in executing an international treaty, entitled the Convention on Psychotropic Substances and signed at Vienna, Austria, on February 21, 1971, which is designed to establish suitable controls over the manufacture, distribution, transfer, and use of certain psychotropic substances. The Convention is not self-executing, and the obligations of the United States thereunder may only be performed pursuant to appropriate legislation. It is the intent of the Congress that the amendments made by this Act, together with existing law, will enable the United States to meet all of its obligations under the Convention and that no further legislation will be necessary for that purpose."
  ]
  node [
    id 3144
    label "section_802_subsection_v_item_43"
    class_name "item"
    text "(43)&#160;3 The term &#8220;felony drug offense&#8221; means an offense that is punishable by imprisonment for more than one year under any law of the United States or of a State or foreign country that prohibits or restricts conduct relating to narcotic drugs, marihuana, or depressant or stimulant substances."
  ]
  node [
    id 3145
    label "section_802_item_2_subitem_B"
    class_name "subitem"
    text "(B) the patient or research subject at the direction and in the presence of the practitioner,"
  ]
  node [
    id 3146
    label "section_802_item_35_subitem_H"
    class_name "subitem"
    text "(H) Toluene."
  ]
  node [
    id 3147
    label "section_802_item_23_subitem_B"
    class_name "subitem"
    text "(B) which is an immediate chemical intermediary used or likely to be used in the manufacture of such controlled substance; and"
  ]
  node [
    id 3148
    label "section_802_item_34_subitem_B"
    class_name "subitem"
    text "(B) Benzyl cyanide."
  ]
  node [
    id 3149
    label "section_802_item_34_subitem_C"
    class_name "subitem"
    text "(C) Ephedrine, its salts, optical isomers, and salts of optical isomers."
  ]
  node [
    id 3150
    label "section_802_item_34_subitem_T"
    class_name "subitem"
    text "(T) N-methylpseudoephedrine."
  ]
  node [
    id 3151
    label "section_802_item_23_subitem_A"
    class_name "subitem"
    text "(A) which the Attorney General has found to be and by regulation designated as being the principal compound used, or produced primarily for use, in the manufacture of a controlled substance;"
  ]
  node [
    id 3152
    label "section_802_subsection_v_item_40"
    class_name "item"
    text "(40) The term &#8220;chemical mixture&#8221; means a combination of two or more chemical substances, at least one of which is not a list I chemical or a list II chemical, except that such term does not include any combination of a list I chemical or a list II chemical with another chemical that is present solely as an impurity."
  ]
  node [
    id 3153
    label "section_802_item_2"
    class_name "item"
    text "(2) The term &#8220;administer&#8221; refers to the direct application of a controlled substance to the body of a patient or research subject by&#8212;"
  ]
  node [
    id 3154
    label "section_802_item_30"
    class_name "item"
    text "(30) The term &#8220;detoxification treatment&#8221; means the dispensing, for a period not in excess of one hundred and eighty days, of a narcotic drug in decreasing doses to an individual in order to alleviate adverse physiological or psychological effects incident to withdrawal from the continuous or sustained use of a narcotic drug and as a method of bringing the individual to a narcotic drug-free state within such period."
  ]
  node [
    id 3155
    label "section_802_subsection_v_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(B)(i) Except as provided in clause (ii), such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for such administration."
  ]
  node [
    id 3156
    label "section_802_item_19"
    class_name "item"
    text "(19) The term &#8220;opium poppy&#8221; means the plant of the species Papaver somniferum L., except the seed thereof."
  ]
  node [
    id 3157
    label "section_802_subsection_v"
    class_name "subsection"
    text "(v) dihydrotestosterone,"
  ]
  node [
    id 3158
    label "section_802_subsection_v_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) If any person prescribes, dispenses, or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of subparagraph (A)."
  ]
  node [
    id 3159
    label "section_802_item_6"
    class_name "item"
    text "(6) The term &#8220;controlled substance&#8221; means a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V of part B of this subchapter. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are defined or used in subtitle E of the Internal Revenue Code of 1986."
  ]
  node [
    id 3160
    label "section_802_item_39_subitem_A_subsubitem_iv_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) the quantity of ephedrine or other listed chemical contained in the drug included in the transaction or multiple transactions equals or exceeds the threshold established for that chemical by the Attorney General; or"
  ]
  node [
    id 3161
    label "section_802_item_7"
    class_name "item"
    text "(7) The term &#8220;counterfeit substance&#8221; means a controlled substance which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, number, or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person or persons who in fact manufactured, distributed, or dispensed such substance and which thereby falsely purports or is represented to be the product of, or to have been distributed by, such other manufacturer, distributor, or dispenser."
  ]
  node [
    id 3162
    label "section_802_item_27"
    class_name "item"
    text "(27) The term &#8220;ultimate user&#8221; means a person who has lawfully obtained, and who possesses, a controlled substance for his own use or for the use of a member of his household or for an animal owned by him or by a member of his household."
  ]
  node [
    id 3163
    label "section_802_item_32_subitem_B"
    class_name "subitem"
    text "(B) Such term does not include&#8212;"
  ]
  node [
    id 3164
    label "section_802_item_34_subitem_J"
    class_name "subitem"
    text "(J) Piperidine and its salts."
  ]
  node [
    id 3165
    label "section_802_item_32_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) any substance for which there is an approved new drug application;"
  ]
  node [
    id 3166
    label "section_802_subsection_v_item_43_subitem_C"
    class_name "subitem"
    text "(C) bringing together a buyer and seller, a buyer and transporter, or a seller and transporter."
  ]
  node [
    id 3167
    label "section_802_item_34_subitem_W"
    class_name "subitem"
    text "(W) Nitroethane."
  ]
  node [
    id 3168
    label "section_802_item_32_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) with respect to a particular person, which such person represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in schedule I or II."
  ]
  node [
    id 3169
    label "section_802_item_34_subitem_H"
    class_name "subitem"
    text "(H) Phenylacetic acid, its esters, and its salts."
  ]
  node [
    id 3170
    label "section_802_item_39"
    class_name "item"
    text "(39) The term &#8220;regulated transaction&#8221; means&#8212;"
  ]
  node [
    id 3171
    label "section_802_subsection_v_item_43_subitem_A"
    class_name "subitem"
    text "(A) negotiating contracts;"
  ]
  node [
    id 3172
    label "section_802_item_17_subitem_A"
    class_name "subitem"
    text "(A) Opium, opiates, derivatives of opium and opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation. Such term does not include the isoquinoline alkaloids of opium."
  ]
  node [
    id 3173
    label "section_802_item_32"
    class_name "item"
    text "(32)(A) Except as provided in subparagraph (B), the term &#8220;controlled substance analogue&#8221; means a substance&#8212;"
  ]
  node [
    id 3174
    label "section_802_item_22"
    class_name "item"
    text "(22) The term &#8220;production&#8221; includes the manufacture, planting, cultivation, growing, or harvesting of a controlled substance."
  ]
  node [
    id 3175
    label "section_802_subsection_v_item_41_subitem_A"
    class_name "subitem"
    text "(41)(A) The term &#8220;anabolic steroid&#8221; means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes&#8212;"
  ]
  node [
    id 3176
    label "section_802_item_16"
    class_name "item"
    text "(16) The term &#8220;marihuana&#8221; means all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin. Such term does not include the mature stalks of such plant, fiber produced from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mixture, or preparation of such mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination."
  ]
  node [
    id 3177
    label "section_802_item_18"
    class_name "item"
    text "(18) The term &#8220;opiate&#8221; means any drug or other substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability."
  ]
  node [
    id 3178
    label "section_802_item_34_subitem_R"
    class_name "subitem"
    text "(R) Piperonal."
  ]
  node [
    id 3179
    label "section_802_item_17_subitem_C"
    class_name "subitem"
    text "(C) Coca leaves, except coca leaves and extracts of coca leaves from which cocaine, ecgonine, and derivatives of ecgonine or their salts have been removed."
  ]
  node [
    id 3180
    label "section_802_item_39_subitem_A_subsubitem_iv_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I)(aa) the drug contains ephedrine or its salts, optical isomers, or salts of optical isomers as the only active medicinal ingredient or contains ephedrine or its salts, optical isomers, or salts of optical isomers and therapeutically insignificant quantities of another active medicinal ingredient; or"
  ]
  node [
    id 3181
    label "section_802_item_9_subitem_C"
    class_name "subitem"
    text "(C) lysergic acid diethylamide; or"
  ]
  node [
    id 3182
    label "section_802_item_34_subitem_V"
    class_name "subitem"
    text "(V) Benzaldehyde."
  ]
  node [
    id 3183
    label "section_802_item_34_subitem_D"
    class_name "subitem"
    text "(D) Ergonovine and its salts."
  ]
  node [
    id 3184
    label "section_802_item_34_subitem_O"
    class_name "subitem"
    text "(O) Propionic anhydride."
  ]
  node [
    id 3185
    label "section_802_item_35_subitem_F"
    class_name "subitem"
    text "(F) Potassium permanganate."
  ]
  node [
    id 3186
    label "section_802_subsection_v_item_41_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) clostebol,"
  ]
  node [
    id 3187
    label "section_802_item_36"
    class_name "item"
    text "(36) The term &#8220;regular customer&#8221; means, with respect to a regulated person, a customer with whom the regulated person has an established business relationship that is reported to the Attorney General."
  ]
  node [
    id 3188
    label "section_802_item_31"
    class_name "item"
    text "(31) The term &#8220;Convention on Psychotropic Substances&#8221; means the Convention on Psychotropic Substances signed at Vienna, Austria, on February 21, 1971; and the term &#8220;Single Convention on Narcotic Drugs&#8221; means the Single Convention on Narcotic Drugs signed at New York, New York, on March 30, 1961."
  ]
  node [
    id 3189
    label "section_802_item_25_subitem_B"
    class_name "subitem"
    text "(B) protracted and obvious disfigurement; or"
  ]
  node [
    id 3190
    label "section_802_subsection_v_subitem_B"
    class_name "subitem"
    text "(B)(i) Except as provided in clause (ii), such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the Secretary of Health and Human Services for such administration."
  ]
  node [
    id 3191
    label "section_802_item_32_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) any substance to the extent not intended for human consumption before such an exemption takes effect with respect to that substance."
  ]
  node [
    id 3192
    label "section_802_item_9"
    class_name "item"
    text "(9) The term &#8220;depressant or stimulant substance&#8221; means&#8212;"
  ]
  node [
    id 3193
    label "section_802_item_34_subitem_K"
    class_name "subitem"
    text "(K) Pseudoephedrine, its salts, optical isomers, and salts of optical isomers."
  ]
  node [
    id 3194
    label "section_802_item_34"
    class_name "item"
    text "(34) The term &#8220;list I chemical&#8221; means a chemical specified by regulation of the Attorney General as a chemical that is used in manufacturing a controlled substance in violation of this subchapter and is important to the manufacture of the controlled substances, and such term includes (until otherwise specified by regulation of the Attorney General, as considered appropriate by the Attorney General or upon petition to the Attorney General by any person) the following:"
  ]
  node [
    id 3195
    label "section_802_subsection_v_item_43_subitem_B"
    class_name "subitem"
    text "(B) serving as an agent or intermediary; or"
  ]
  node [
    id 3196
    label "section_802_item_34_subitem_E"
    class_name "subitem"
    text "(E) Ergotamine and its salts."
  ]
  node [
    id 3197
    label "section_802_item_15"
    class_name "item"
    text "(15) The term &#8220;manufacture&#8221; means the production, preparation, propagation, compounding, or processing of a drug or other substance, either directly or indirectly or by extraction from substances of natural origin, or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis, and includes any packaging or repackaging of such substance or labeling or relabeling of its container; except that such term does not include the preparation, compounding, packaging, or labeling of a drug or other substance in conformity with applicable State or local law by a practitioner as an incident to his administration or dispensing of such drug or substance in the course of his professional practice. The term &#8220;manufacturer&#8221; means a person who manufactures a drug or other substance."
  ]
  node [
    id 3198
    label "section_802_subsection_v_item_42"
    class_name "item"
    text "(42) The term &#8220;international transaction&#8221; means a transaction involving the shipment of a listed chemical across an international border (other than a United States border) in which a broker or trader located in the United States participates."
  ]
  node [
    id 3199
    label "section_802_item_23_subitem_C"
    class_name "subitem"
    text "(C) the control of which is necessary to prevent, curtail, or limit the manufacture of such controlled substance."
  ]
  node [
    id 3200
    label "section_802_item_25_subitem_A"
    class_name "subitem"
    text "(A) a substantial risk of death;"
  ]
  node [
    id 3201
    label "section_802_item_35_subitem_B"
    class_name "subitem"
    text "(B) Acetone."
  ]
  node [
    id 3202
    label "section_802_item_20"
    class_name "item"
    text "(20) The term &#8220;poppy straw&#8221; means all parts, except the seeds, of the opium poppy, after mowing."
  ]
  node [
    id 3203
    label "section_802_item_1"
    class_name "item"
    text "(1) The term &#8220;addict&#8221; means any individual who habitually uses any narcotic drug so as to endanger the public morals, health, safety, or welfare, or who is so far addicted to the use of narcotic drugs as to have lost the power of self-control with reference to his addiction."
  ]
  node [
    id 3204
    label "section_802_item_26"
    class_name "item"
    text "(26) The term &#8220;State&#8221; means any State, territory, or possession of the United States, the District of Columbia, the Commonwealth of Puerto Rico, the Trust Territory of the Pacific Islands, and the Canal Zone."
  ]
  node [
    id 3205
    label "section_802_subsection_v_item_41_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) chlorotestosterone,"
  ]
  node [
    id 3206
    label "section_802_item_34_subitem_A"
    class_name "subitem"
    text "(A) Anthranilic acid, its esters, and its salts."
  ]
  node [
    id 3207
    label "section_802_item_39_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) a delivery of a listed chemical to or by a common or contract carrier for carriage in the lawful and usual course of the business of the common or contract carrier, or to or by a warehouseman for storage in the lawful and usual course of the business of the warehouseman, except that if the carriage or storage is in connection with the distribution, importation, or exportation of a listed chemical to a third person, this clause does not relieve a distributor, importer, or exporter from compliance with section 830 of this title;"
  ]
  node [
    id 3208
    label "section_802_item_5"
    class_name "item"
    text "(5) The term &#8220;control&#8221; means to add a drug or other substance, or immediate precursor, to a schedule under part B of this subchapter, whether by transfer from another schedule or otherwise."
  ]
  node [
    id 3209
    label "section_802_item_34_subitem_G"
    class_name "subitem"
    text "(G) Norpseudoephedrine, its salts, optical isomers, and salts of optical isomers."
  ]
  node [
    id 3210
    label "section_802_item_24"
    class_name "item"
    text "(24) The term &#8220;Secretary&#8221;, unless the context otherwise indicates, means the Secretary of Health and Human Services."
  ]
  node [
    id 3211
    label "section_802_item_37"
    class_name "item"
    text "(37) The term &#8220;regular importer&#8221; means, with respect to a listed chemical, a person that has an established record as an importer of that listed chemical that is reported to the Attorney General."
  ]
  node [
    id 3212
    label "section_802_item_17_subitem_E"
    class_name "subitem"
    text "(E) Ecgonine, its derivatives, their salts, isomers, and salts of isomers."
  ]
  node [
    id 3213
    label "section_802_item_17_subitem_B"
    class_name "subitem"
    text "(B) Poppy straw and concentrate of poppy straw."
  ]
  node [
    id 3214
    label "section_802_item_39_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) any transaction in a listed chemical that is contained in a drug that may be marketed or distributed lawfully in the United States under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) unless&#8212;"
  ]
  node [
    id 3215
    label "section_802_item_35"
    class_name "item"
    text "(35) The term &#8220;list II chemical&#8221; means a chemical (other than a list I chemical) specified by regulation of the Attorney General as a chemical that is used in manufacturing a controlled substance in violation of this subchapter, and such term includes (until otherwise specified by regulation of the Attorney General, as considered appropriate by the Attorney General or upon petition to the Attorney General by any person) the following chemicals:"
  ]
  node [
    id 3216
    label "section_802_item_11"
    class_name "item"
    text "(11) The term &#8220;distribute&#8221; means to deliver (other than by administering or dispensing) a controlled substance or a listed chemical. The term &#8220;distributor&#8221; means a person who so delivers a controlled substance or a listed chemical."
  ]
  node [
    id 3217
    label "section_802_item_2_subitem_A"
    class_name "subitem"
    text "(A) a practitioner (or, in his presence, by his authorized agent), or"
  ]
  node [
    id 3218
    label "section_802_item_21"
    class_name "item"
    text "(21) The term &#8220;practitioner&#8221; means a physician, dentist, veterinarian, scientific investigator, pharmacy, hospital, or other person licensed, registered, or otherwise permitted, by the United States or the jurisdiction in which he practices or does research, to distribute, dispense, conduct research with respect to, administer, or use in teaching or chemical analysis, a controlled substance in the course of professional practice or research."
  ]
  node [
    id 3219
    label "section_802_item_39_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) any category of transaction or any category of transaction for a specific listed chemical or chemicals specified by regulation of the Attorney General as excluded from this definition as unnecessary for enforcement of this subchapter or subchapter II of this chapter;"
  ]
  node [
    id 3220
    label "section_802_item_17"
    class_name "item"
    text "(17) The term &#8220;narcotic drug&#8221; means any of the following whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:"
  ]
  node [
    id 3221
    label "section_802_subsection_v_item_41_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) boldenone,"
  ]
  node [
    id 3222
    label "section_802_subsection_v_item_41_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) dehydrochlormethyltestosterone,"
  ]
  node [
    id 3223
    label "section_802_item_35_subitem_C"
    class_name "subitem"
    text "(C) Benzyl chloride."
  ]
  node [
    id 3224
    label "section_802_item_38"
    class_name "item"
    text "(38) The term &#8220;regulated person&#8221; means a person who manufactures, distributes, imports, or exports a listed chemical, a tableting machine, or an encapsulating machine or who acts as a broker or trader for an international transaction involving a listed chemical, a tableting machine, or an encapsulating machine."
  ]
  node [
    id 3225
    label "section_802_item_34_subitem_I"
    class_name "subitem"
    text "(I) Phenylpropanolamine, its salts, optical isomers, and salts of optical isomers."
  ]
  node [
    id 3226
    label "section_802_item_25"
    class_name "item"
    text "(25) The term &#8220;serious bodily injury&#8221; means bodily injury which involves&#8212;"
  ]
  node [
    id 3227
    label "section_802_item_12"
    class_name "item"
    text "(12) The term &#8220;drug&#8221; has the meaning given that term by section 321(g)(1) of this title."
  ]
  node [
    id 3228
    label "section_802_item_9_subitem_B"
    class_name "subitem"
    text "(B) a drug which contains any quantity of (i) amphetamine or any of its optical isomers; (ii) any salt of amphetamine or any salt of an optical isomer of amphetamine; or (iii) any substance which the Attorney General, after investigation, has found to be, and by regulation designated as, habit forming because of its stimulant effect on the central nervous systems; or"
  ]
  node [
    id 3229
    label "section_802_item_34_subitem_P"
    class_name "subitem"
    text "(P) Insosafrole."
  ]
  node [
    id 3230
    label "section_802_item_33"
    class_name "item"
    text "(33) The term &#8220;listed chemical&#8221; means any list I chemical or any list II chemical."
  ]
  node [
    id 3231
    label "section_802_item_39_subitem_A"
    class_name "subitem"
    text "(A) a distribution, receipt, sale, importation, or exportation of, or an international transaction involving shipment of, a listed chemical, or if the Attorney General establishes a threshold amount for a specific listed chemical, a threshold amount, including a cumulative threshold amount for multiple transactions (as determined by the Attorney General, in consultation with the chemical industry and taking into consideration the quantities normally used for lawful purposes), of a listed chemical, except that such term does not include&#8212;"
  ]
  node [
    id 3232
    label "section_802_item_8"
    class_name "item"
    text "(8) The terms &#8220;deliver&#8221; or &#8220;delivery&#8221; mean the actual, constructive, or attempted transfer of a controlled substance or a listed chemical, whether or not there exists an agency relationship."
  ]
  node [
    id 3233
    label "section_802_item_32_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) the chemical structure of which is substantially similar to the chemical structure of a controlled substance in schedule I or II;"
  ]
  node [
    id 3234
    label "section_802_item_39_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) a domestic lawful distribution in the usual course of business between agents or employees of a single regulated person;"
  ]
  node [
    id 3235
    label "section_802_item_9_subitem_D"
    class_name "subitem"
    text "(D) any drug which contains any quantity of a substance which the Attorney General, after investigation, has found to have, and by regulation designated as having, a potential for abuse because of its depressant or stimulant effect on the central nervous system or its hallucinogenic effect."
  ]
  node [
    id 3236
    label "section_802_item_34_subitem_S"
    class_name "subitem"
    text "(S) N-Methylepherdrine.1"
  ]
  node [
    id 3237
    label "section_802_item_17_subitem_F"
    class_name "subitem"
    text "(F) Any compound, mixture, or preparation which contains any quantity of any of the substances referred to in subparagraphs (A) through (E)."
  ]
  node [
    id 3238
    label "section_802_item_34_subitem_Q"
    class_name "subitem"
    text "(Q) Safrole."
  ]
  node [
    id 3239
    label "section_802_item_35_subitem_G"
    class_name "subitem"
    text "(G) 2-Butanone."
  ]
  node [
    id 3240
    label "section_802_item_29"
    class_name "item"
    text "(29) The term &#8220;maintenance treatment&#8221; means the dispensing, for a period in excess of twenty-one days, of a narcotic drug in the treatment of an individual for dependence upon heroin or other morphine-like drugs."
  ]
  node [
    id 3241
    label "section_802_item_25_subitem_C"
    class_name "subitem"
    text "(C) protracted loss or impairment of the function of a bodily member, organ, or mental faculty."
  ]
  node [
    id 3242
    label "section_802_item_17_subitem_D"
    class_name "subitem"
    text "(D) Cocaine, its salts, optical and geometric isomers, and salts of isomers."
  ]
  node [
    id 3243
    label "section_802_item_34_subitem_X"
    class_name "subitem"
    text "(X) Any salt, optical isomer, or salt of an optical isomer of the chemicals listed in subparagraphs (M) through (U) of this paragraph."
  ]
  node [
    id 3244
    label "section_802_subsection_v_item_41"
    class_name "item"
    text "(41)(A) The term &#8220;anabolic steroid&#8221; means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes&#8212;"
  ]
  node [
    id 3245
    label "section_802_item_32_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) with respect to a particular person any substance, if an exemption is in effect for investigational use, for that person, under section 355 of this title to the extent conduct with respect to such substance is pursuant to such exemption; or"
  ]
  node [
    id 3246
    label "section_802_item_13"
    class_name "item"
    text "(13) The term &#8220;felony&#8221; means any Federal or State offense classified by applicable Federal or State law as a felony."
  ]
  node [
    id 3247
    label "section_802_item_10"
    class_name "item"
    text "(10) The term &#8220;dispense&#8221; means to deliver a controlled substance to an ultimate user or research subject by, or pursuant to the lawful order of, a practitioner, including the prescribing and administering of a controlled substance and the packaging, labeling or compounding necessary to prepare the substance for such delivery. The term &#8220;dispenser&#8221; means a practitioner who so delivers a controlled substance to an ultimate user or research subject."
  ]
  node [
    id 3248
    label "section_802_subsection_v_subsubitem_x"
    class_name "subsubitem"
    text "(x) mesterolone,"
  ]
  node [
    id 3249
    label "section_802_item_23"
    class_name "item"
    text "(23) The term &#8220;immediate precursor&#8221; means a substance&#8212;"
  ]
  node [
    id 3250
    label "section_802_item_34_subitem_F"
    class_name "subitem"
    text "(F) N-Acetylanthranilic acid, its esters, and its salts."
  ]
  node [
    id 3251
    label "section_802_item_32_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) a controlled substance;"
  ]
  node [
    id 3252
    label "section_802_item_3"
    class_name "item"
    text "(3) The term &#8220;agent&#8221; means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser; except that such term does not include a common or contract carrier, public warehouseman, or employee of the carrier or warehouseman, when acting in the usual and lawful course of the carrier's or warehouseman's business."
  ]
  node [
    id 3253
    label "section_802_item_9_subitem_A"
    class_name "subitem"
    text "(A) a drug which contains any quantity of (i) barbituric acid or any of the salts of barbituric acid; or (ii) any derivative of barbituric acid which has been designated by the Secretary as habit forming under section 352(d) of this title; or"
  ]
  node [
    id 3254
    label "section_802_item_34_subitem_U"
    class_name "subitem"
    text "(U) Hydriotic&#160;2 acid."
  ]
  node [
    id 3255
    label "section_802_item_32_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) which has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in schedule I or II; or"
  ]
  node [
    id 3256
    label "section_802_item_34_subitem_M"
    class_name "subitem"
    text "(M) Methylamine."
  ]
  node [
    id 3257
    label "section_802_item_35_subitem_A"
    class_name "subitem"
    text "(A) Acetic anhydride."
  ]
  node [
    id 3258
    label "section_802_item_14"
    class_name "item"
    text "(14) The term &#8220;isomer&#8221; means the optical isomer, except as used in schedule I(c) and schedule II(a)(4). As used in schedule I(c), the term &#8220;isomer&#8221; means any optical, positional, or geometric isomer. As used in schedule II(a)(4), the term &#8220;isomer&#8221; means any optical or geometric isomer."
  ]
  node [
    id 3259
    label "section_802_item_34_subitem_L"
    class_name "subitem"
    text "(L) 3,4-Methylenedioxyphenyl-2-propanone."
  ]
  node [
    id 3260
    label "section_802_item_35_subitem_D"
    class_name "subitem"
    text "(D) Ethyl ether."
  ]
  node [
    id 3261
    label "section_802_item_4"
    class_name "item"
    text "(4) The term &#8220;Drug Enforcement Administration&#8221; means the Drug Enforcement Administration in the Department of Justice."
  ]
  node [
    id 3262
    label "section_802_item_32_subitem_A"
    class_name "subitem"
    text "(32)(A) Except as provided in subparagraph (B), the term &#8220;controlled substance analogue&#8221; means a substance&#8212;"
  ]
  node [
    id 3263
    label "section_802_item_28"
    class_name "item"
    text "(28) The term &#8220;United States&#8221;, when used in a geographic sense, means all places and waters, continental or insular, subject to the jurisdiction of the United States."
  ]
  node [
    id 3264
    label "section_802_item_34_subitem_N"
    class_name "subitem"
    text "(N) Ethylamine."
  ]
  node [
    id 3265
    label "section_802_subsection_v_subsubitem_xx"
    class_name "subsubitem"
    text "(xx) oxandrolone,"
  ]
  node [
    id 3266
    label "section_802_item_35_subitem_E"
    class_name "subitem"
    text "(E) Repealed. Pub. L. 101&#8211;647, title XXIII, &#167;2301(b), Nov. 29, 1990, 104 Stat. 4858."
  ]
  node [
    id 3267
    label "section_811_subsection_c_item_2"
    class_name "item"
    text "(2) Scientific evidence of its pharmacological effect, if known."
  ]
  node [
    id 3268
    label "section_811_subsection_c_item_7"
    class_name "item"
    text "(7) Its psychic or physiological dependence liability."
  ]
  node [
    id 3269
    label "section_811_subsection_g_item_2"
    class_name "item"
    text "(2) Dextromethorphan shall not be deemed to be included in any schedule by reason of enactment of this subchapter unless controlled after October 27, 1970 pursuant to the foregoing provisions of this section."
  ]
  node [
    id 3270
    label "section_811_subsection_h_item_5"
    class_name "item"
    text "(5) An order issued under paragraph (1) with respect to a substance shall be vacated upon the conclusion of a subsequent rulemaking proceeding initiated under subsection (a) of this section with respect to such substance."
  ]
  node [
    id 3271
    label "section_811_subsection_b_item_1"
    class_name "item"
    text "The Attorney General shall, before initiating proceedings under subsection (a) of this section to control a drug or other substance or to remove a drug or other substance entirely from the schedules, and after gathering the necessary data, request from the Secretary a scientific and medical evaluation, and his recommendations, as to whether such drug or other substance should be so controlled or removed as a controlled substance. In making such evaluation and recommendations, the Secretary shall consider the factors listed in paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and any scientific or medical considerations involved in paragraphs (1), (4), and (5) of such subsection. The recommendations of the Secretary shall include recommendations with respect to the appropriate schedule, if any, under which such drug or other substance should be listed. The evaluation and the recommendations of the Secretary shall be made in writing and submitted to the Attorney General within a reasonable time. The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance. If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal, as the case may be, under subsection (a) of this section."
  ]
  node [
    id 3272
    label "section_811_subsection_d_item_2"
    class_name "item"
    text "(2)(A) Whenever the Secretary of State receives notification from the Secretary-General of the United Nations that information has been transmitted by or to the World Health Organization, pursuant to article 2 of the Convention on Psychotropic Substances, which may justify adding a drug or other substance to one of the schedules of the Convention, transferring a drug or substance from one schedule to another, or deleting it from the schedules, the Secretary of State shall immediately transmit the notice to the Secretary of Health and Human Services who shall publish it in the Federal Register and provide opportunity to interested persons to submit to him comments respecting the scientific and medical evaluations which he is to prepare respecting such drug or substance. The Secretary of Health and Human Services shall prepare for transmission through the Secretary of State to the World Health Organization such medical and scientific evaluations as may be appropriate regarding the possible action that could be proposed by the World Health Organization respecting the drug or substance with respect to which a notice was transmitted under this subparagraph."
  ]
  node [
    id 3273
    label "section_811_subsection_d"
    class_name "subsection"
    text "(d) International treaties, conventions, and protocols requiring control; procedures respecting changes in drug schedules of Convention on Psychotropic Substances"
  ]
  node [
    id 3274
    label "section_811_subsection_b_item_6"
    class_name "item"
    text "The Attorney General shall, before initiating proceedings under subsection (a) of this section to control a drug or other substance or to remove a drug or other substance entirely from the schedules, and after gathering the necessary data, request from the Secretary a scientific and medical evaluation, and his recommendations, as to whether such drug or other substance should be so controlled or removed as a controlled substance. In making such evaluation and recommendations, the Secretary shall consider the factors listed in paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and any scientific or medical considerations involved in paragraphs (1), (4), and (5) of such subsection. The recommendations of the Secretary shall include recommendations with respect to the appropriate schedule, if any, under which such drug or other substance should be listed. The evaluation and the recommendations of the Secretary shall be made in writing and submitted to the Attorney General within a reasonable time. The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance. If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal, as the case may be, under subsection (a) of this section."
  ]
  node [
    id 3275
    label "section_811_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) makes with respect to such drug or other substance the findings prescribed by subsection (b) of section 812 of this title for the schedule in which such drug is to be placed; or"
  ]
  node [
    id 3276
    label "section_811_subsection_b_item_3"
    class_name "item"
    text "The Attorney General shall, before initiating proceedings under subsection (a) of this section to control a drug or other substance or to remove a drug or other substance entirely from the schedules, and after gathering the necessary data, request from the Secretary a scientific and medical evaluation, and his recommendations, as to whether such drug or other substance should be so controlled or removed as a controlled substance. In making such evaluation and recommendations, the Secretary shall consider the factors listed in paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and any scientific or medical considerations involved in paragraphs (1), (4), and (5) of such subsection. The recommendations of the Secretary shall include recommendations with respect to the appropriate schedule, if any, under which such drug or other substance should be listed. The evaluation and the recommendations of the Secretary shall be made in writing and submitted to the Attorney General within a reasonable time. The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance. If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal, as the case may be, under subsection (a) of this section."
  ]
  node [
    id 3277
    label "section_811_subsection_c_item_5"
    class_name "item"
    text "(5) The scope, duration, and significance of abuse."
  ]
  node [
    id 3278
    label "section_811_subsection_d_item_1"
    class_name "item"
    text "(1) If control is required by United States obligations under international treaties, conventions, or protocols in effect on October 27, 1970, the Attorney General shall issue an order controlling such drug under the schedule he deems most appropriate to carry out such obligations, without regard to the findings required by subsection (a) of this section or section 812(b) of this title and without regard to the procedures prescribed by subsections (a) and (b) of this section."
  ]
  node [
    id 3279
    label "section_811_subsection_d_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the drug or substance subject to such decision is not required to be controlled under schedule IV or V to carry out the minimum United States obligations under paragraph 7 of article 2 of the Convention,"
  ]
  node [
    id 3280
    label "section_811_subsection_a_item_1"
    class_name "item"
    text "Rules of the Attorney General under this subsection shall be made on the record after opportunity for a hearing pursuant to the rulemaking procedures prescribed by subchapter II of chapter 5 of title 5. Proceedings for the issuance, amendment, or repeal of such rules may be initiated by the Attorney General (1) on his own motion, (2) at the request of the Secretary, or (3) on the petition of any interested party."
  ]
  node [
    id 3281
    label "section_811_subsection_c_item_3"
    class_name "item"
    text "(3) The state of current scientific knowledge regarding the drug or other substance."
  ]
  node [
    id 3282
    label "section_811_subsection_d_item_3_subitem_C_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) in the case of a schedule notice, request the Secretary of State to take appropriate action under the Convention to initiate proceedings to remove the drug or substance from the schedules under the Convention or to transfer the drug or substance to a schedule under the Convention different from the one specified in the schedule notice."
  ]
  node [
    id 3283
    label "section_811_subsection_b_item_4"
    class_name "item"
    text "The Attorney General shall, before initiating proceedings under subsection (a) of this section to control a drug or other substance or to remove a drug or other substance entirely from the schedules, and after gathering the necessary data, request from the Secretary a scientific and medical evaluation, and his recommendations, as to whether such drug or other substance should be so controlled or removed as a controlled substance. In making such evaluation and recommendations, the Secretary shall consider the factors listed in paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and any scientific or medical considerations involved in paragraphs (1), (4), and (5) of such subsection. The recommendations of the Secretary shall include recommendations with respect to the appropriate schedule, if any, under which such drug or other substance should be listed. The evaluation and the recommendations of the Secretary shall be made in writing and submitted to the Attorney General within a reasonable time. The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance. If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal, as the case may be, under subsection (a) of this section."
  ]
  node [
    id 3284
    label "section_811_subsection_f"
    class_name "subsection"
    text "(f) Abuse potential"
  ]
  node [
    id 3285
    label "section_811_subsection_d_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Whenever the Secretary of State receives notification from the Secretary-General of the United Nations that information has been transmitted by or to the World Health Organization, pursuant to article 2 of the Convention on Psychotropic Substances, which may justify adding a drug or other substance to one of the schedules of the Convention, transferring a drug or substance from one schedule to another, or deleting it from the schedules, the Secretary of State shall immediately transmit the notice to the Secretary of Health and Human Services who shall publish it in the Federal Register and provide opportunity to interested persons to submit to him comments respecting the scientific and medical evaluations which he is to prepare respecting such drug or substance. The Secretary of Health and Human Services shall prepare for transmission through the Secretary of State to the World Health Organization such medical and scientific evaluations as may be appropriate regarding the possible action that could be proposed by the World Health Organization respecting the drug or substance with respect to which a notice was transmitted under this subparagraph."
  ]
  node [
    id 3286
    label "section_811_subsection_h_item_4"
    class_name "item"
    text "(4) The Attorney General shall transmit notice of an order proposed to be issued under paragraph (1) to the Secretary of Health and Human Services. In issuing an order under paragraph (1), the Attorney General shall take into consideration any comments submitted by the Secretary in response to a notice transmitted pursuant to this paragraph."
  ]
  node [
    id 3287
    label "section_811_subsection_a_item_3"
    class_name "item"
    text "Rules of the Attorney General under this subsection shall be made on the record after opportunity for a hearing pursuant to the rulemaking procedures prescribed by subchapter II of chapter 5 of title 5. Proceedings for the issuance, amendment, or repeal of such rules may be initiated by the Attorney General (1) on his own motion, (2) at the request of the Secretary, or (3) on the petition of any interested party."
  ]
  node [
    id 3288
    label "section_811_subsection_d_item_4_subitem_B"
    class_name "subitem"
    text "(B) After a notice of qualified acceptance of a scheduling decision with respect to a drug or other substance is transmitted to the Secretary-General of the United Nations in accordance with clause (ii) or (iii) of paragraph (3)(C) or after a request has been made under clause (iv) of such paragraph with respect to a drug or substance described in a schedule notice, the Attorney General, after consultation with the Secretary of Health and Human Services and after providing interested persons opportunity to submit comments respecting the requirements of the order to be issued under this sentence, shall issue an order controlling the drug or substance under schedule IV or V, whichever is most appropriate to carry out the minimum United States obligations under paragraph 7 of article 2 of the Convention in the case of a drug or substance for which a notice of qualified acceptance was transmitted or whichever the Attorney General determines is appropriate in the case of a drug or substance described in a schedule notice. As a part of such order, the Attorney General shall, after consultation with the Secretary, except such drug or substance from the application of any provision of part C of this subchapter which he finds is not required to carry out the United States obligations under paragraph 7 of article 2 of the Convention. If, as a result of a review under paragraph 8 of article 2 of the Convention of the scheduling decision with respect to which a notice of qualified acceptance was transmitted in accordance with clause (ii) or (iii) of paragraph (3)(C)&#8212;"
  ]
  node [
    id 3289
    label "section_811_subsection_b"
    class_name "subsection"
    text "(b) Evaluation of drugs and other substances"
  ]
  node [
    id 3290
    label "section_811_subsection_g_item_3"
    class_name "item"
    text "(3) The Attorney General may, by regulation, exempt any compound, mixture, or preparation containing a controlled substance from the application of all or any part of this subchapter if he finds such compound, mixture, or preparation meets the requirements of one of the following categories:"
  ]
  node [
    id 3291
    label "section_811_subsection_c_item_1"
    class_name "item"
    text "(1) Its actual or relative potential for abuse."
  ]
  node [
    id 3292
    label "section_811_subsection_b_item_2"
    class_name "item"
    text "The Attorney General shall, before initiating proceedings under subsection (a) of this section to control a drug or other substance or to remove a drug or other substance entirely from the schedules, and after gathering the necessary data, request from the Secretary a scientific and medical evaluation, and his recommendations, as to whether such drug or other substance should be so controlled or removed as a controlled substance. In making such evaluation and recommendations, the Secretary shall consider the factors listed in paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and any scientific or medical considerations involved in paragraphs (1), (4), and (5) of such subsection. The recommendations of the Secretary shall include recommendations with respect to the appropriate schedule, if any, under which such drug or other substance should be listed. The evaluation and the recommendations of the Secretary shall be made in writing and submitted to the Attorney General within a reasonable time. The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance. If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal, as the case may be, under subsection (a) of this section."
  ]
  node [
    id 3293
    label "section_811_subsection_d_item_3_subitem_A"
    class_name "subitem"
    text "(A) If such requirements are met by such existing controls but the Secretary of Health and Human Services nonetheless believes that more stringent controls should be applied to the drug or substance, the Secretary shall recommend to the Attorney General that he initiate proceedings for scheduling the drug or substance, pursuant to subsections (a) and (b) of this section, to apply to such controls."
  ]
  node [
    id 3294
    label "section_811_subsection_h_item_1"
    class_name "item"
    text "(1) If the Attorney General finds that the scheduling of a substance in schedule I on a temporary basis is necessary to avoid an imminent hazard to the public safety, he may, by order and without regard to the requirements of subsection (b) of this section relating to the Secretary of Health and Human Services, schedule such substance in schedule I if the substance is not listed in any other schedule in section 812 of this title or if no exemption or approval is in effect for the substance under section 505 of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 355]. Such an order may not be issued before the expiration of thirty days from&#8212;"
  ]
  node [
    id 3295
    label "section_811_subsection_d_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) If the Attorney General determines, after consultation with the Secretary of Health and Human Services, that proceedings initiated under recommendations made under paragraph&#160;1 (B) or (C)(i) of paragraph (3) will not be completed within the time period required by paragraph 7 of article 2 of the Convention, the Attorney General, after consultation with the Secretary and after providing interested persons opportunity to submit comments respecting the requirements of the temporary order to be issued under this sentence, shall issue a temporary order controlling the drug or substance under schedule IV or V, whichever is most appropriate to carry out the minimum United States obligations under paragraph 7 of article 2 of the Convention. As a part of such order, the Attorney General shall, after consultation with the Secretary, except such drug or substance from the application of any provision of part C of this subchapter which he finds is not required to carry out the United States obligations under paragraph 7 of article 2 of the Convention. In the case of proceedings initiated under subparagraph (B) of paragraph (3), the Attorney General, concurrently with the issuance of such order, shall request the Secretary of State to transmit a notice of qualified acceptance to the Secretary-General of the United Nations pursuant to paragraph 7 of article 2 of the Convention. A temporary order issued under this subparagraph controlling a drug or other substance subject to proceedings initiated under subsections (a) and (b) of this section shall expire upon the effective date of the application to the drug or substance of the controls resulting from such proceedings."
  ]
  node [
    id 3296
    label "section_811_subsection_h"
    class_name "subsection"
    text "(h) Temporary scheduling to avoid imminent hazards to public safety"
  ]
  node [
    id 3297
    label "section_811_subsection_d_item_3_subitem_C_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) request the Secretary of State to transmit a notice of qualified acceptance as prescribed in clause (ii) and request the Secretary of State to ask for a review by the Economic and Social Council of the United Nations, in accordance with paragraph 8 of article 2 of the Convention, of the scheduling decision; or"
  ]
  node [
    id 3298
    label "section_811_subsection_h_item_6"
    class_name "item"
    text "(6) An order issued under paragraph (1) is not subject to judicial review."
  ]
  node [
    id 3299
    label "section_811_subsection_c_item_6"
    class_name "item"
    text "(6) What, if any, risk there is to the public health."
  ]
  node [
    id 3300
    label "section_811_subsection_d_item_3_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) request the Secretary of State to transmit a notice of qualified acceptance, within the period specified in the Convention, pursuant to paragraph 7 of article 2 of the Convention, to the Secretary-General of the United Nations;"
  ]
  node [
    id 3301
    label "section_811_subsection_g_item_1"
    class_name "item"
    text "(1) The Attorney General shall by regulation exclude any non-narcotic substance from a schedule if such substance may, under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], be lawfully sold over the counter without a prescription."
  ]
  node [
    id 3302
    label "section_811_subsection_c"
    class_name "subsection"
    text "(c) Factors determinative of control or removal from schedules"
  ]
  node [
    id 3303
    label "section_811_subsection_g"
    class_name "subsection"
    text "(g) Exclusion of non-narcotic substances sold over the counter without a prescription; dextromethorphan; exemption of substances lacking abuse potential"
  ]
  node [
    id 3304
    label "section_811_subsection_c_item_8"
    class_name "item"
    text "(8) Whether the substance is an immediate precursor of a substance already controlled under this subchapter."
  ]
  node [
    id 3305
    label "section_811_subsection_g_item_3_subitem_B"
    class_name "subitem"
    text "(B) A compound, mixture, or preparation which contains any controlled substance, which is not for administration to a human being or animal, and which is packaged in such form or concentration, or with adulterants or denaturants, so that as packaged it does not present any significant potential for abuse."
  ]
  node [
    id 3306
    label "section_811_subsection_b_item_5"
    class_name "item"
    text "The Attorney General shall, before initiating proceedings under subsection (a) of this section to control a drug or other substance or to remove a drug or other substance entirely from the schedules, and after gathering the necessary data, request from the Secretary a scientific and medical evaluation, and his recommendations, as to whether such drug or other substance should be so controlled or removed as a controlled substance. In making such evaluation and recommendations, the Secretary shall consider the factors listed in paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and any scientific or medical considerations involved in paragraphs (1), (4), and (5) of such subsection. The recommendations of the Secretary shall include recommendations with respect to the appropriate schedule, if any, under which such drug or other substance should be listed. The evaluation and the recommendations of the Secretary shall be made in writing and submitted to the Attorney General within a reasonable time. The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance. If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal, as the case may be, under subsection (a) of this section."
  ]
  node [
    id 3307
    label "section_811_subsection_d_item_4"
    class_name "item"
    text "(4)(A) If the Attorney General determines, after consultation with the Secretary of Health and Human Services, that proceedings initiated under recommendations made under paragraph&#160;1 (B) or (C)(i) of paragraph (3) will not be completed within the time period required by paragraph 7 of article 2 of the Convention, the Attorney General, after consultation with the Secretary and after providing interested persons opportunity to submit comments respecting the requirements of the temporary order to be issued under this sentence, shall issue a temporary order controlling the drug or substance under schedule IV or V, whichever is most appropriate to carry out the minimum United States obligations under paragraph 7 of article 2 of the Convention. As a part of such order, the Attorney General shall, after consultation with the Secretary, except such drug or substance from the application of any provision of part C of this subchapter which he finds is not required to carry out the United States obligations under paragraph 7 of article 2 of the Convention. In the case of proceedings initiated under subparagraph (B) of paragraph (3), the Attorney General, concurrently with the issuance of such order, shall request the Secretary of State to transmit a notice of qualified acceptance to the Secretary-General of the United Nations pursuant to paragraph 7 of article 2 of the Convention. A temporary order issued under this subparagraph controlling a drug or other substance subject to proceedings initiated under subsections (a) and (b) of this section shall expire upon the effective date of the application to the drug or substance of the controls resulting from such proceedings."
  ]
  node [
    id 3308
    label "section_811_subsection_d_item_4_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "the order issued under this subparagraph with respect to such drug or substance shall expire upon receipt by the United States of the review decision. If, as a result of action taken pursuant to action initiated under a request transmitted under clause (iv) of paragraph (3)(C), the drug or substance with respect to which such action was taken is not required to be controlled under schedule IV or V, the order issued under this paragraph with respect to such drug or substance shall expire upon receipt by the United States of a notice of the action taken with respect to such drug or substance under the Convention."
  ]
  node [
    id 3309
    label "section_811_subsection_d_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the decision is reversed, and"
  ]
  node [
    id 3310
    label "section_811_subsection_a_item_2"
    class_name "item"
    text "Rules of the Attorney General under this subsection shall be made on the record after opportunity for a hearing pursuant to the rulemaking procedures prescribed by subchapter II of chapter 5 of title 5. Proceedings for the issuance, amendment, or repeal of such rules may be initiated by the Attorney General (1) on his own motion, (2) at the request of the Secretary, or (3) on the petition of any interested party."
  ]
  node [
    id 3311
    label "section_811_subsection_b_item_8"
    class_name "item"
    text "The Attorney General shall, before initiating proceedings under subsection (a) of this section to control a drug or other substance or to remove a drug or other substance entirely from the schedules, and after gathering the necessary data, request from the Secretary a scientific and medical evaluation, and his recommendations, as to whether such drug or other substance should be so controlled or removed as a controlled substance. In making such evaluation and recommendations, the Secretary shall consider the factors listed in paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and any scientific or medical considerations involved in paragraphs (1), (4), and (5) of such subsection. The recommendations of the Secretary shall include recommendations with respect to the appropriate schedule, if any, under which such drug or other substance should be listed. The evaluation and the recommendations of the Secretary shall be made in writing and submitted to the Attorney General within a reasonable time. The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance. If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal, as the case may be, under subsection (a) of this section."
  ]
  node [
    id 3312
    label "section_811_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) finds that such drug or other substance has a potential for abuse, and"
  ]
  node [
    id 3313
    label "section_811_subsection_d_item_2_subitem_B"
    class_name "subitem"
    text "(B) Whenever the Secretary of State receives information that the Commission on Narcotic Drugs of the United Nations proposes to decide whether to add a drug or other substance to one of the schedules of the Convention, transfer a drug or substance from one schedule to another, or delete it from the schedules, the Secretary of State shall transmit timely notice to the Secretary of Health and Human Services of such information who shall publish a summary of such information in the Federal Register and provide opportunity to interested persons to submit to him comments respecting the recommendation which he is to furnish, pursuant to this subparagraph, respecting such proposal. The Secretary of Health and Human Services shall evaluate the proposal and furnish a recommendation to the Secretary of State which shall be binding on the representative of the United States in discussions and negotiations relating to the proposal."
  ]
  node [
    id 3314
    label "section_811_subsection_g_item_3_subitem_A"
    class_name "subitem"
    text "(A) A mixture, or preparation containing a nonnarcotic controlled substance, which mixture or preparation is approved for prescription use, and which contains one or more other active ingredients which are not listed in any schedule and which are included therein in such combinations, quantity, proportion, or concentration as to vitiate the potential for abuse."
  ]
  node [
    id 3315
    label "section_811_subsection_a"
    class_name "subsection"
    text "(a) Rules and regulations of Attorney General; hearing"
  ]
  node [
    id 3316
    label "section_811_subsection_c_item_4"
    class_name "item"
    text "(4) Its history and current pattern of abuse."
  ]
  node [
    id 3317
    label "section_811_subsection_d_item_3_subitem_B"
    class_name "subitem"
    text "(B) If such requirements are not met by such existing controls and the Secretary of Health and Human Services concurs in the scheduling decision or schedule notice transmitted by the notification, the Secretary shall recommend to the Attorney General that he initiate proceedings for scheduling the drug or substance under the appropriate schedule pursuant to subsections (a) and (b) of this section."
  ]
  node [
    id 3318
    label "section_811_subsection_d_item_3_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) if he deems that additional controls are necessary to protect the public health and safety, recommend to the Attorney General that he initiate proceedings for scheduling the drug or substance pursuant to subsections (a) and (b) of this section, to apply such additional controls;"
  ]
  node [
    id 3319
    label "section_811_subsection_h_item_3"
    class_name "item"
    text "(3) When issuing an order under paragraph (1), the Attorney General shall be required to consider, with respect to the finding of an imminent hazard to the public safety, only those factors set forth in paragraphs (4), (5), and (6) of subsection (c) of this section, including actual abuse, diversion from legitimate channels, and clandestine importation, manufacture, or distribution."
  ]
  node [
    id 3320
    label "section_811_subsection_h_item_1_subitem_A"
    class_name "subitem"
    text "(A) the date of the publication by the Attorney General of a notice in the Federal Register of the intention to issue such order and the grounds upon which such order is to be issued, and"
  ]
  node [
    id 3321
    label "section_811_subsection_h_item_2"
    class_name "item"
    text "(2) The scheduling of a substance under this subsection shall expire at the end of one year from the date of the issuance of the order scheduling such substance, except that the Attorney General may, during the pendency of proceedings under subsection (a)(1) of this section with respect to the substance, extend the temporary scheduling for up to six months."
  ]
  node [
    id 3322
    label "section_811_subsection_e"
    class_name "subsection"
    text "(e) Immediate precursors"
  ]
  node [
    id 3323
    label "section_811_subsection_d_item_3"
    class_name "item"
    text "the order issued under this subparagraph with respect to such drug or substance shall expire upon receipt by the United States of the review decision. If, as a result of action taken pursuant to action initiated under a request transmitted under clause (iv) of paragraph (3)(C), the drug or substance with respect to which such action was taken is not required to be controlled under schedule IV or V, the order issued under this paragraph with respect to such drug or substance shall expire upon receipt by the United States of a notice of the action taken with respect to such drug or substance under the Convention."
  ]
  node [
    id 3324
    label "section_811_subsection_h_item_1_subitem_B"
    class_name "subitem"
    text "(B) the date the Attorney General has transmitted the notice required by paragraph (4)."
  ]
  node [
    id 3325
    label "section_811_subsection_d_item_5"
    class_name "item"
    text "(5) Nothing in the amendments made by the Psychotropic Substances Act of 1978 or the regulations or orders promulgated thereunder shall be construed to preclude requests by the Secretary of Health and Human Services or the Attorney General through the Secretary of State, pursuant to article 2 or other applicable provisions of the Convention, for review of scheduling decisions under such Convention, based on new or additional information."
  ]
  node [
    id 3326
    label "section_811_subsection_d_item_3_subitem_C"
    class_name "subitem"
    text "(C) An order issued under subparagraph (A) or (B) may be issued without regard to the findings required by subsection (a) of this section or by section 812(b) of this title and without regard to the procedures prescribed by subsection (a) or (b) of this section."
  ]
  node [
    id 3327
    label "section_811_subsection_b_item_7"
    class_name "item"
    text "The Attorney General shall, before initiating proceedings under subsection (a) of this section to control a drug or other substance or to remove a drug or other substance entirely from the schedules, and after gathering the necessary data, request from the Secretary a scientific and medical evaluation, and his recommendations, as to whether such drug or other substance should be so controlled or removed as a controlled substance. In making such evaluation and recommendations, the Secretary shall consider the factors listed in paragraphs (2), (3), (6), (7), and (8) of subsection (c) of this section and any scientific or medical considerations involved in paragraphs (1), (4), and (5) of such subsection. The recommendations of the Secretary shall include recommendations with respect to the appropriate schedule, if any, under which such drug or other substance should be listed. The evaluation and the recommendations of the Secretary shall be made in writing and submitted to the Attorney General within a reasonable time. The recommendations of the Secretary to the Attorney General shall be binding on the Attorney General as to such scientific and medical matters, and if the Secretary recommends that a drug or other substance not be controlled, the Attorney General shall not control the drug or other substance. If the Attorney General determines that these facts and all other relevant data constitute substantial evidence of potential for abuse such as to warrant control or substantial evidence that the drug or other substance should be removed entirely from the schedules, he shall initiate proceedings for control or removal, as the case may be, under subsection (a) of this section."
  ]
  node [
    id 3328
    label "section_812_subsection_a_item_29"
    class_name "item"
    text "(29) Morpheridine."
  ]
  node [
    id 3329
    label "section_812_subsection_a_item_4"
    class_name "item"
    text "(4) Methylphenidate."
  ]
  node [
    id 3330
    label "section_812_subsection_b_item_3_subitem_B"
    class_name "subitem"
    text "(B) The drug or other substance has a currently accepted medical use in treatment in the United States."
  ]
  node [
    id 3331
    label "section_812_subsection_a_item_7"
    class_name "item"
    text "(7) Betacetylmethadol."
  ]
  node [
    id 3332
    label "section_812_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) The drug or other substance has a high potential for abuse."
  ]
  node [
    id 3333
    label "section_812_subsection_a_item_13"
    class_name "item"
    text "(13) Dextrorphan."
  ]
  node [
    id 3334
    label "section_812_subsection_a_item_15"
    class_name "item"
    text "(15) Diethylthiambutene."
  ]
  node [
    id 3335
    label "section_812_subsection_b_item_12"
    class_name "item"
    text "(12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane."
  ]
  node [
    id 3336
    label "section_812_subsection_b_item_2"
    class_name "item"
    text "(2) Chorhexadol."
  ]
  node [
    id 3337
    label "section_812_subsection_b_item_3_subitem_C"
    class_name "subitem"
    text "(C) Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence."
  ]
  node [
    id 3338
    label "section_812_subsection_a_item_27"
    class_name "item"
    text "(27) Levomoramide."
  ]
  node [
    id 3339
    label "section_812_subsection_a_item_23"
    class_name "item"
    text "(23) Etoxeridine."
  ]
  node [
    id 3340
    label "section_812_subsection_e_item_10"
    class_name "item"
    text "(10) Petrichloral."
  ]
  node [
    id 3341
    label "section_812_subsection_a_item_30"
    class_name "item"
    text "(30) Noracymethadol."
  ]
  node [
    id 3342
    label "section_812_subsection_a_item_40"
    class_name "item"
    text "(40) Properidine."
  ]
  node [
    id 3343
    label "section_812_subsection_b_item_2_subitem_C"
    class_name "subitem"
    text "(C) Abuse of the drug or other substances may lead to severe psychological or physical dependence."
  ]
  node [
    id 3344
    label "section_812_subsection_a_item_3"
    class_name "item"
    text "(3) Any substance (except an injectable liquid) which contains any quantity of methamphetamine, including its salts, isomers, and salts of isomers."
  ]
  node [
    id 3345
    label "section_812_subsection_e_item_2"
    class_name "item"
    text "(2) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams."
  ]
  node [
    id 3346
    label "section_812_subsection_c_item_5"
    class_name "item"
    text "(5) Diethyltryptamine."
  ]
  node [
    id 3347
    label "section_812_subsection_a_item_31"
    class_name "item"
    text "(31) Norlevorphanol."
  ]
  node [
    id 3348
    label "section_812_subsection_e_item_4"
    class_name "item"
    text "(4) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit."
  ]
  node [
    id 3349
    label "section_812_subsection_a_item_19"
    class_name "item"
    text "(19) Dioxaphetyl butyrate."
  ]
  node [
    id 3350
    label "section_812_subsection_c_item_9"
    class_name "item"
    text "(9) Lysergic acid diethylamide."
  ]
  node [
    id 3351
    label "section_812_subsection_a_item_34"
    class_name "item"
    text "(34) Phenadoxone."
  ]
  node [
    id 3352
    label "section_812_subsection_d_item_2"
    class_name "item"
    text "(2) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts."
  ]
  node [
    id 3353
    label "section_812_subsection_c_item_10"
    class_name "item"
    text "(10) Marihuana."
  ]
  node [
    id 3354
    label "section_812_subsection_c_item_3"
    class_name "item"
    text "(3) 3,4,5-trimethoxy amphetamine."
  ]
  node [
    id 3355
    label "section_812_subsection_d_item_5"
    class_name "item"
    text "(5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts."
  ]
  node [
    id 3356
    label "section_812_subsection_a_item_25"
    class_name "item"
    text "(25) Hydroxypethidine."
  ]
  node [
    id 3357
    label "section_812_subsection_a_item_10"
    class_name "item"
    text "(10) Betaprodine."
  ]
  node [
    id 3358
    label "section_812_subsection_c_item_1"
    class_name "item"
    text "(1) 3,4-methylenedioxy amphetamine."
  ]
  node [
    id 3359
    label "section_812_subsection_a_item_16"
    class_name "item"
    text "(16) Dimenoxadol."
  ]
  node [
    id 3360
    label "section_812_subsection_e_item_7"
    class_name "item"
    text "(7) Meprobamate."
  ]
  node [
    id 3361
    label "section_812_subsection_a_item_14"
    class_name "item"
    text "(14) Diampromide."
  ]
  node [
    id 3362
    label "section_812_subsection_b_item_6"
    class_name "item"
    text "(6) Methyprylon."
  ]
  node [
    id 3363
    label "section_812_subsection_b_item_16"
    class_name "item"
    text "(16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate."
  ]
  node [
    id 3364
    label "section_812_subsection_a_item_33"
    class_name "item"
    text "(33) Norpipanone."
  ]
  node [
    id 3365
    label "section_812_subsection_b_item_1"
    class_name "item"
    text "(1) Any substance which contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid."
  ]
  node [
    id 3366
    label "section_812_subsection_b_item_13"
    class_name "item"
    text "(13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid."
  ]
  node [
    id 3367
    label "section_812_subsection_b_item_5_subitem_B"
    class_name "subitem"
    text "(B) The drug or other substance has a currently accepted medical use in treatment in the United States."
  ]
  node [
    id 3368
    label "section_812_subsection_a"
    class_name "subsection"
    text "(a) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:"
  ]
  node [
    id 3369
    label "section_812_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) The drug or other substance has no currently accepted medical use in treatment in the United States."
  ]
  node [
    id 3370
    label "section_812_subsection_d_item_1"
    class_name "item"
    text "(1) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium."
  ]
  node [
    id 3371
    label "section_812_subsection_b_item_10"
    class_name "item"
    text "(10) Sulfonmethane."
  ]
  node [
    id 3372
    label "section_812_subsection_b_item_4_subitem_B"
    class_name "subitem"
    text "(B) The drug or other substance has a currently accepted medical use in treatment in the United States."
  ]
  node [
    id 3373
    label "section_812_subsection_b_item_17"
    class_name "item"
    text "(17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid."
  ]
  node [
    id 3374
    label "section_812_subsection_e_item_5"
    class_name "item"
    text "(5) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams."
  ]
  node [
    id 3375
    label "section_812_subsection_b_item_3_subitem_A"
    class_name "subitem"
    text "(A) The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II."
  ]
  node [
    id 3376
    label "section_812_subsection_c_item_7"
    class_name "item"
    text "(7) 4-methyl-2,5-diamethoxyamphetamine."
  ]
  node [
    id 3377
    label "section_812_subsection_e_item_9"
    class_name "item"
    text "(9) Paraldehyde."
  ]
  node [
    id 3378
    label "section_812_subsection_a_item_18"
    class_name "item"
    text "(18) Dimethylthiambutene."
  ]
  node [
    id 3379
    label "section_812_subsection_b_item_18"
    class_name "item"
    text "(18) Phenazocine."
  ]
  node [
    id 3380
    label "section_812_subsection_c_item_6"
    class_name "item"
    text "(6) Dimethyltryptamine."
  ]
  node [
    id 3381
    label "section_812_subsection_b_item_20"
    class_name "item"
    text "(20) Racemethorphan."
  ]
  node [
    id 3382
    label "section_812_subsection_c_item_16"
    class_name "item"
    text "(16) Psilocyn."
  ]
  node [
    id 3383
    label "section_812_subsection_a_item_6"
    class_name "item"
    text "(6) Benzethidine."
  ]
  node [
    id 3384
    label "section_812_subsection_a_item_12"
    class_name "item"
    text "(12) Dextromoramide."
  ]
  node [
    id 3385
    label "section_812_subsection_a_item_26"
    class_name "item"
    text "(26) Ketobemidone."
  ]
  node [
    id 3386
    label "section_812_subsection_b_item_5"
    class_name "item"
    text "(5) Lysergic acid amide."
  ]
  node [
    id 3387
    label "section_812_subsection_c_item_14"
    class_name "item"
    text "(14) N-methyl-3-piperidyl benzilate."
  ]
  node [
    id 3388
    label "section_812_subsection_b_item_3"
    class_name "item"
    text "(3) Glutehimide."
  ]
  node [
    id 3389
    label "section_812_subsection_a_item_17"
    class_name "item"
    text "(17) Dimepheptanol."
  ]
  node [
    id 3390
    label "section_812_subsection_b_item_5_subitem_A"
    class_name "subitem"
    text "(A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV."
  ]
  node [
    id 3391
    label "section_812_subsection_a_item_37"
    class_name "item"
    text "(37) Phenoperidine."
  ]
  node [
    id 3392
    label "section_812_subsection_c_item_4"
    class_name "item"
    text "(4) Bufotenine."
  ]
  node [
    id 3393
    label "section_812_subsection_b_item_21"
    class_name "item"
    text "(21) Racemorphan."
  ]
  node [
    id 3394
    label "section_812_subsection_c_item_2"
    class_name "item"
    text "(2) 5-methoxy-3,4-methylenedioxy amphetamine."
  ]
  node [
    id 3395
    label "section_812_subsection_c_item_11"
    class_name "item"
    text "(11) Mescaline."
  ]
  node [
    id 3396
    label "section_812_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) There is a lack of accepted safety for use of the drug or other substance under medical supervision."
  ]
  node [
    id 3397
    label "section_812_subsection_d"
    class_name "subsection"
    text "(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:"
  ]
  node [
    id 3398
    label "section_812_subsection_a_item_2"
    class_name "item"
    text "(2) Phenmetrazine and its salts."
  ]
  node [
    id 3399
    label "section_812_subsection_b_item_4"
    class_name "item"
    text "(4) Lysergic acid."
  ]
  node [
    id 3400
    label "section_812_subsection_a_item_22"
    class_name "item"
    text "(22) Etonitazene."
  ]
  node [
    id 3401
    label "section_812_subsection_c_item_12"
    class_name "item"
    text "(12) Peyote."
  ]
  node [
    id 3402
    label "section_812_subsection_b_item_22"
    class_name "item"
    text "(22) Thebacon."
  ]
  node [
    id 3403
    label "section_812_subsection_a_item_38"
    class_name "item"
    text "(38) Piritramide."
  ]
  node [
    id 3404
    label "section_812_subsection_b_item_4_subitem_A"
    class_name "subitem"
    text "(A) The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III."
  ]
  node [
    id 3405
    label "section_812_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions."
  ]
  node [
    id 3406
    label "section_812_subsection_b"
    class_name "subsection"
    text "(b) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:"
  ]
  node [
    id 3407
    label "section_812_subsection_b_item_7"
    class_name "item"
    text "(7) Phencyclidine."
  ]
  node [
    id 3408
    label "section_812_subsection_a_item_20"
    class_name "item"
    text "(20) Dipipanone."
  ]
  node [
    id 3409
    label "section_812_subsection_c_item_8"
    class_name "item"
    text "(8) Ibogaine."
  ]
  node [
    id 3410
    label "section_812_subsection_a_item_5"
    class_name "item"
    text "(5) Alphamethadol."
  ]
  node [
    id 3411
    label "section_812_subsection_d_item_8"
    class_name "item"
    text "(8) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, nonnarcotic ingredients in recognized therapeutic amounts."
  ]
  node [
    id 3412
    label "section_812_subsection_c_item_13"
    class_name "item"
    text "(13) N-ethyl-3-piperidyl benzilate."
  ]
  node [
    id 3413
    label "section_812_subsection_b_item_5_subitem_C"
    class_name "subitem"
    text "(C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV."
  ]
  node [
    id 3414
    label "section_812_subsection_a_item_8"
    class_name "item"
    text "(8) Betameprodine."
  ]
  node [
    id 3415
    label "section_812_subsection_a_item_35"
    class_name "item"
    text "(35) Phenampromide."
  ]
  node [
    id 3416
    label "section_812_subsection_a_item_11"
    class_name "item"
    text "(11) Clonitazene."
  ]
  node [
    id 3417
    label "section_812_subsection_e_item_11"
    class_name "item"
    text "(11) Phenobarbital."
  ]
  node [
    id 3418
    label "section_812_subsection_a_item_24"
    class_name "item"
    text "(24) Furethidine."
  ]
  node [
    id 3419
    label "section_812_subsection_b_item_14"
    class_name "item"
    text "(14) Pethidine."
  ]
  node [
    id 3420
    label "section_812_subsection_b_item_9"
    class_name "item"
    text "(9) Sulfonethylmethane."
  ]
  node [
    id 3421
    label "section_812_subsection_c"
    class_name "subsection"
    text "(c) Nalorphine."
  ]
  node [
    id 3422
    label "section_812_subsection_d_item_3"
    class_name "item"
    text "(3) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium."
  ]
  node [
    id 3423
    label "section_812_subsection_b_item_19"
    class_name "item"
    text "(19) Piminodine."
  ]
  node [
    id 3424
    label "section_812_subsection_a_item_41"
    class_name "item"
    text "(41) Racemoramide."
  ]
  node [
    id 3425
    label "section_812_subsection_d_item_6"
    class_name "item"
    text "(6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts."
  ]
  node [
    id 3426
    label "section_812_subsection_a_item_9"
    class_name "item"
    text "(9) Betamethadol."
  ]
  node [
    id 3427
    label "section_812_subsection_a_item_39"
    class_name "item"
    text "(39) Propheptazine."
  ]
  node [
    id 3428
    label "section_812_subsection_a_item_36"
    class_name "item"
    text "(36) Phenomorphan."
  ]
  node [
    id 3429
    label "section_812_subsection_e_item_1"
    class_name "item"
    text "(1) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams."
  ]
  node [
    id 3430
    label "section_812_subsection_b_item_15"
    class_name "item"
    text "(15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine."
  ]
  node [
    id 3431
    label "section_812_subsection_c_item_15"
    class_name "item"
    text "(15) Psilocybin."
  ]
  node [
    id 3432
    label "section_812_subsection_b_item_4_subitem_C"
    class_name "subitem"
    text "(C) Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule III."
  ]
  node [
    id 3433
    label "section_812_subsection_a_item_42"
    class_name "item"
    text "(42) Trimeperidine."
  ]
  node [
    id 3434
    label "section_812_subsection_d_item_7"
    class_name "item"
    text "(7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts."
  ]
  node [
    id 3435
    label "section_812_subsection_e_item_8"
    class_name "item"
    text "(8) Methylphenobarbital."
  ]
  node [
    id 3436
    label "section_812_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) The drug or other substance has a high potential for abuse."
  ]
  node [
    id 3437
    label "section_812_subsection_a_item_32"
    class_name "item"
    text "(32) Normethadone."
  ]
  node [
    id 3438
    label "section_812_subsection_a_item_28"
    class_name "item"
    text "(28) Levophenacylmorphan."
  ]
  node [
    id 3439
    label "section_812_subsection_b_item_11"
    class_name "item"
    text "(11) Methadone."
  ]
  node [
    id 3440
    label "section_812_subsection_e_item_3"
    class_name "item"
    text "(3) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams."
  ]
  node [
    id 3441
    label "section_812_subsection_a_item_1"
    class_name "item"
    text "(1) Amphetamine, its salts, optical isomers, and salts of its optical isomers."
  ]
  node [
    id 3442
    label "section_812_subsection_e_item_6"
    class_name "item"
    text "(6) Methohexital."
  ]
  node [
    id 3443
    label "section_812_subsection_a_item_21"
    class_name "item"
    text "(21) Ethylmethylthiambutene."
  ]
  node [
    id 3444
    label "section_812_subsection_e"
    class_name "subsection"
    text "(e) Anabolic steroids."
  ]
  node [
    id 3445
    label "section_812_subsection_d_item_4"
    class_name "item"
    text "(4) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts."
  ]
  node [
    id 3446
    label "section_812_subsection_b_item_8"
    class_name "item"
    text "(8) Sulfondiethylmethane."
  ]
  node [
    id 3447
    label "section_812_subsection_c_item_17"
    class_name "item"
    text "(17) Tetrahydrocannabinols."
  ]
  node [
    id 3448
    label "section_814_subsection_a_item_39_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "The Attorney General shall by regulation remove from exemption under section 802(39)(A)(iv) of this title a drug or group of drugs that the Attorney General finds is being diverted to obtain a listed chemical for use in the illicit production of a controlled substance."
  ]
  node [
    id 3449
    label "section_814_subsection_d_item_3_subitem_A"
    class_name "subitem"
    text "(A) the Attorney General has evidence that, applying the factors described in subsection (b) of this section to the drug product, the drug product is being diverted; and"
  ]
  node [
    id 3450
    label "section_814_subsection_d_item_2"
    class_name "item"
    text "(2) Factors to be considered"
  ]
  node [
    id 3451
    label "section_814_subsection_c"
    class_name "subsection"
    text "(c) Specificity of designation"
  ]
  node [
    id 3452
    label "section_814_subsection_d"
    class_name "subsection"
    text "(d) Reinstatement of exemption with respect to particular drug products"
  ]
  node [
    id 3453
    label "section_814_subsection_a_item_39_subitem_A"
    class_name "subitem"
    text "The Attorney General shall by regulation remove from exemption under section 802(39)(A)(iv) of this title a drug or group of drugs that the Attorney General finds is being diverted to obtain a listed chemical for use in the illicit production of a controlled substance."
  ]
  node [
    id 3454
    label "section_814_subsection_d_item_3"
    class_name "item"
    text "(3) Status pending application for reinstatement"
  ]
  node [
    id 3455
    label "section_814_subsection_d_item_1"
    class_name "item"
    text "A regulation reinstating an exemption under paragraph (1) may be modified or revoked with respect to a particular drug product upon a finding that&#8212;"
  ]
  node [
    id 3456
    label "section_814_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(A) applying the factors described in subsection (b) of this section to the drug product, the drug product is being diverted; or"
  ]
  node [
    id 3457
    label "section_814_subsection_d_item_1_subitem_C"
    class_name "subitem"
    text "(C) evidence of diversion of the drug product;"
  ]
  node [
    id 3458
    label "section_814_subsection_d_item_3_subitem_B"
    class_name "subitem"
    text "(B) the Attorney General so notifies the applicant."
  ]
  node [
    id 3459
    label "section_814_subsection_b_item_2"
    class_name "item"
    text "(2) whether the drug or group of drugs is formulated in such a way that it cannot be easily used in the illicit production of a controlled substance; and"
  ]
  node [
    id 3460
    label "section_814_subsection_d_item_1_subitem_E"
    class_name "subitem"
    text "(E) such other factors as are relevant to and consistent with the public health and safety, including the factors described in subsection (b) of this section as applied to the drug product."
  ]
  node [
    id 3461
    label "section_814_subsection_b_item_1"
    class_name "item"
    text "(1) the scope, duration, and significance of the diversion;"
  ]
  node [
    id 3462
    label "section_814_subsection_a_item_39"
    class_name "item"
    text "The Attorney General shall by regulation remove from exemption under section 802(39)(A)(iv) of this title a drug or group of drugs that the Attorney General finds is being diverted to obtain a listed chemical for use in the illicit production of a controlled substance."
  ]
  node [
    id 3463
    label "section_814_subsection_b_item_3"
    class_name "item"
    text "(3) whether the listed chemical can be readily recovered from the drug or group of drugs."
  ]
  node [
    id 3464
    label "section_814_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) there is a significant change in the data that led to the issuance of the regulation."
  ]
  node [
    id 3465
    label "section_814_subsection_d_item_4"
    class_name "item"
    text "(4) Amendment and modification"
  ]
  node [
    id 3466
    label "section_814_subsection_d_item_1_subitem_D"
    class_name "subitem"
    text "(D) any actions taken by the manufacturer to prevent diversion of the drug product; and"
  ]
  node [
    id 3467
    label "section_814_subsection_b"
    class_name "subsection"
    text "(b) Factors to be considered"
  ]
  node [
    id 3468
    label "section_814_subsection_a"
    class_name "subsection"
    text "(a) Removal of exemption"
  ]
  node [
    id 3469
    label "section_822_subsection_c_item_2"
    class_name "item"
    text "(2) A common or contract carrier or warehouseman, or an employee thereof, whose possession of the controlled substance or list I chemical is in the usual course of his business or employment."
  ]
  node [
    id 3470
    label "section_822_subsection_d"
    class_name "subsection"
    text "(d) Waiver"
  ]
  node [
    id 3471
    label "section_822_subsection_c"
    class_name "subsection"
    text "(c) Exceptions"
  ]
  node [
    id 3472
    label "section_822_subsection_c_item_1"
    class_name "item"
    text "(1) An agent or employee of any registered manufacturer, distributor, or dispenser of any controlled substance or list I chemical if such agent or employee is acting in the usual course of his business or employment."
  ]
  node [
    id 3473
    label "section_822_subsection_a_item_1"
    class_name "item"
    text "(1) Every person who manufactures or distributes any controlled substance or list I chemical, or who proposes to engage in the manufacture or distribution of any controlled substance or list I chemical, shall obtain annually a registration issued by the Attorney General in accordance with the rules and regulations promulgated by him."
  ]
  node [
    id 3474
    label "section_822_subsection_b"
    class_name "subsection"
    text "(b) Authorized activities"
  ]
  node [
    id 3475
    label "section_822_subsection_a_item_2"
    class_name "item"
    text "(2) Every person who dispenses, or who proposes to dispense, any controlled substance, shall obtain from the Attorney General a registration issued in accordance with the rules and regulations promulgated by him. The Attorney General shall, by regulation, determine the period of such registrations. In no event, however, shall such registrations be issued for less than one year nor for more than three years."
  ]
  node [
    id 3476
    label "section_822_subsection_a"
    class_name "subsection"
    text "(a) Period of registration"
  ]
  node [
    id 3477
    label "section_822_subsection_f"
    class_name "subsection"
    text "(f) Inspection"
  ]
  node [
    id 3478
    label "section_822_subsection_c_item_3"
    class_name "item"
    text "(3) An ultimate user who possesses such substance for a purpose specified in section 802(25)&#160;1 of this title."
  ]
  node [
    id 3479
    label "section_822_subsection_e"
    class_name "subsection"
    text "(e) Separate registration"
  ]
  node [
    id 3480
    label "section_823_subsection_b_item_3"
    class_name "item"
    text "(3) prior conviction record of applicant under Federal or State laws relating to the manufacture, distribution, or dispensing of such substances;"
  ]
  node [
    id 3481
    label "section_823_subsection_f_item_2"
    class_name "item"
    text "(2) The applicant's experience in dispensing, or conducting research with respect to controlled substances."
  ]
  node [
    id 3482
    label "section_823_subsection_h_item_1"
    class_name "item"
    text "(1) maintenance by the applicant of effective controls against diversion of listed chemicals into other than legitimate channels;"
  ]
  node [
    id 3483
    label "section_823_subsection_h_item_39_subitem_A"
    class_name "subitem"
    text "The Attorney General shall register an applicant to distribute a list I chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest. Registration under this subsection shall not be required for the distribution of a drug product that is exempted under section 802(39)(A)(iv) of this title. In determining the public interest for the purposes of this subsection, the Attorney General shall consider&#8212;"
  ]
  node [
    id 3484
    label "section_823_subsection_c_item_1"
    class_name "item"
    text "Registration granted under subsections (a) and (b) of this section shall not entitle a registrant to (1) manufacture or distribute controlled substances in schedule I or II other than those specified in the registration, or (2) manufacture any quantity of those controlled substances in excess of the quota assigned pursuant to section 826 of this title."
  ]
  node [
    id 3485
    label "section_823_subsection_d"
    class_name "subsection"
    text "(d) Manufacturers of controlled substances in schedule III, IV, or V"
  ]
  node [
    id 3486
    label "section_823_subsection_f_item_1"
    class_name "item"
    text "(1) The recommendation of the appropriate State licensing board or professional disciplinary authority."
  ]
  node [
    id 3487
    label "section_823_subsection_a_item_2"
    class_name "item"
    text "(2) compliance with applicable State and local law;"
  ]
  node [
    id 3488
    label "section_823_subsection_e"
    class_name "subsection"
    text "(e) Distributors of controlled substances in schedule III, IV, or V"
  ]
  node [
    id 3489
    label "section_823_subsection_g_item_1"
    class_name "item"
    text "(1) if the applicant is a practitioner who is determined by the Secretary to be qualified (under standards established by the Secretary) to engage in the treatment with respect to which registration is sought;"
  ]
  node [
    id 3490
    label "section_823_subsection_e_item_4"
    class_name "item"
    text "(4) past experience in the distribution of controlled substances; and"
  ]
  node [
    id 3491
    label "section_823_subsection_h_item_5"
    class_name "item"
    text "(5) such other factors as are relevant to and consistent with the public health and safety."
  ]
  node [
    id 3492
    label "section_823_subsection_e_item_1"
    class_name "item"
    text "(1) maintenance of effective controls against diversion of particular controlled substances into other than legitimate medical, scientific, and industrial channels;"
  ]
  node [
    id 3493
    label "section_823_subsection_h_item_2"
    class_name "item"
    text "(2) compliance by the applicant with applicable Federal, State, and local law;"
  ]
  node [
    id 3494
    label "section_823_subsection_h_item_4"
    class_name "item"
    text "(4) any past experience of the applicant in the manufacture and distribution of chemicals; and"
  ]
  node [
    id 3495
    label "section_823_subsection_d_item_4"
    class_name "item"
    text "(4) prior conviction record of applicant under Federal or State laws relating to the manufacture, distribution, or dispensing of such substances;"
  ]
  node [
    id 3496
    label "section_823_subsection_f_item_4"
    class_name "item"
    text "(4) Compliance with applicable State, Federal, or local laws relating to controlled substances."
  ]
  node [
    id 3497
    label "section_823_subsection_g_item_2"
    class_name "item"
    text "(2) if the Attorney General determines that the applicant will comply with standards established by the Attorney General respecting (A) security of stocks of narcotic drugs for such treatment, and (B) the maintenance of records (in accordance with section 827 of this title) on such drugs; and"
  ]
  node [
    id 3498
    label "section_823_subsection_b"
    class_name "subsection"
    text "(b) Distributors of controlled substances in schedule I or II"
  ]
  node [
    id 3499
    label "section_823_subsection_b_item_4"
    class_name "item"
    text "(4) past experience in the distribution of controlled substances; and"
  ]
  node [
    id 3500
    label "section_823_subsection_b_item_5"
    class_name "item"
    text "(5) such other factors as may be relevant to and consistent with the public health and safety."
  ]
  node [
    id 3501
    label "section_823_subsection_c_item_2"
    class_name "item"
    text "Registration granted under subsections (a) and (b) of this section shall not entitle a registrant to (1) manufacture or distribute controlled substances in schedule I or II other than those specified in the registration, or (2) manufacture any quantity of those controlled substances in excess of the quota assigned pursuant to section 826 of this title."
  ]
  node [
    id 3502
    label "section_823_subsection_g_item_3"
    class_name "item"
    text "(3) if the Secretary determines that the applicant will comply with standards established by the Secretary (after consultation with the Attorney General) respecting the quantities of narcotic drugs which may be provided for unsupervised use by individuals in such treatment."
  ]
  node [
    id 3503
    label "section_823_subsection_d_item_3"
    class_name "item"
    text "(3) promotion of technical advances in the art of manufacturing these substances and the development of new substances;"
  ]
  node [
    id 3504
    label "section_823_subsection_c"
    class_name "subsection"
    text "(c) Limits of authorized activities"
  ]
  node [
    id 3505
    label "section_823_subsection_h"
    class_name "subsection"
    text "(h) Applicants for distribution of list I chemicals"
  ]
  node [
    id 3506
    label "section_823_subsection_h_item_39"
    class_name "item"
    text "The Attorney General shall register an applicant to distribute a list I chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest. Registration under this subsection shall not be required for the distribution of a drug product that is exempted under section 802(39)(A)(iv) of this title. In determining the public interest for the purposes of this subsection, the Attorney General shall consider&#8212;"
  ]
  node [
    id 3507
    label "section_823_subsection_a_item_5"
    class_name "item"
    text "(5) past experience in the manufacture of controlled substances, and the existence in the establishment of effective control against diversion; and"
  ]
  node [
    id 3508
    label "section_823_subsection_f"
    class_name "subsection"
    text "(f) Research by practitioners; pharmacies; research applications; construction of Article 7 of the Convention on Psychotropic Substances"
  ]
  node [
    id 3509
    label "section_823_subsection_b_item_2"
    class_name "item"
    text "(2) compliance with applicable State and local law;"
  ]
  node [
    id 3510
    label "section_823_subsection_d_item_6"
    class_name "item"
    text "(6) such other factors as may be relevant to and consistent with the public health and safety."
  ]
  node [
    id 3511
    label "section_823_subsection_e_item_2"
    class_name "item"
    text "(2) compliance with applicable State and local law;"
  ]
  node [
    id 3512
    label "section_823_subsection_d_item_2"
    class_name "item"
    text "(2) compliance with applicable State and local law;"
  ]
  node [
    id 3513
    label "section_823_subsection_h_item_39_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "The Attorney General shall register an applicant to distribute a list I chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest. Registration under this subsection shall not be required for the distribution of a drug product that is exempted under section 802(39)(A)(iv) of this title. In determining the public interest for the purposes of this subsection, the Attorney General shall consider&#8212;"
  ]
  node [
    id 3514
    label "section_823_subsection_a"
    class_name "subsection"
    text "(a) Manufacturers of controlled substances in schedule I or II"
  ]
  node [
    id 3515
    label "section_823_subsection_b_item_1"
    class_name "item"
    text "(1) maintenance of effective control against diversion of particular controlled substances into other than legitimate medical, scientific, and industrial channels;"
  ]
  node [
    id 3516
    label "section_823_subsection_f_item_5"
    class_name "item"
    text "(5) Such other conduct which may threaten the public health and safety."
  ]
  node [
    id 3517
    label "section_823_subsection_h_item_3"
    class_name "item"
    text "(3) any prior conviction record of the applicant under Federal or State laws relating to controlled substances or to chemicals controlled under Federal or State law;"
  ]
  node [
    id 3518
    label "section_823_subsection_f_item_3"
    class_name "item"
    text "(3) The applicant's conviction record under Federal or State laws relating to the manufacture, distribution, or dispensing of controlled substances."
  ]
  node [
    id 3519
    label "section_823_subsection_a_item_3"
    class_name "item"
    text "(3) promotion of technical advances in the art of manufacturing these substances and the development of new substances;"
  ]
  node [
    id 3520
    label "section_823_subsection_g"
    class_name "subsection"
    text "(g) Practitioners dispensing narcotic drugs for narcotic treatment; annual registration; separate registration; qualifications"
  ]
  node [
    id 3521
    label "section_823_subsection_a_item_4"
    class_name "item"
    text "(4) prior conviction record of applicant under Federal and State laws relating to the manufacture, distribution, or dispensing of such substances;"
  ]
  node [
    id 3522
    label "section_823_subsection_e_item_5"
    class_name "item"
    text "(5) such other factors as may be relevant to and consistent with the public health and safety."
  ]
  node [
    id 3523
    label "section_823_subsection_a_item_6"
    class_name "item"
    text "(6) such other factors as may be relevant to and consistent with the public health and safety."
  ]
  node [
    id 3524
    label "section_823_subsection_a_item_1"
    class_name "item"
    text "(1) maintenance of effective controls against diversion of particular controlled substances and any controlled substance in schedule I or II compounded therefrom into other than legitimate medical, scientific, research, or industrial channels, by limiting the importation and bulk manufacture of such controlled substances to a number of establishments which can produce an adequate and uninterrupted supply of these substances under adequately competitive conditions for legitimate medical, scientific, research, and industrial purposes;"
  ]
  node [
    id 3525
    label "section_823_subsection_d_item_5"
    class_name "item"
    text "(5) past experience in the manufacture, distribution, and dispensing of controlled substances, and the existence in the establishment of effective controls against diversion; and"
  ]
  node [
    id 3526
    label "section_823_subsection_e_item_3"
    class_name "item"
    text "(3) prior conviction record of applicant under Federal or State laws relating to the manufacture, distribution, or dispensing of such substances;"
  ]
  node [
    id 3527
    label "section_823_subsection_d_item_1"
    class_name "item"
    text "(1) maintenance of effective controls against diversion of particular controlled substances and any controlled substance in schedule III, IV, or V compounded therefrom into other than legitimate medical, scientific, or industrial channels;"
  ]
  node [
    id 3528
    label "section_824_subsection_e"
    class_name "subsection"
    text "(e) Suspension and revocation of quotas"
  ]
  node [
    id 3529
    label "section_824_subsection_a_item_4"
    class_name "item"
    text "(4) has committed such acts as would render his registration under section 823 of this title inconsistent with the public interest as determined under such section; or"
  ]
  node [
    id 3530
    label "section_824_subsection_a_item_1"
    class_name "item"
    text "(1) has materially falsified any application filed pursuant to or required by this subchapter or subchapter II of this chapter;"
  ]
  node [
    id 3531
    label "section_824_subsection_a_item_3"
    class_name "item"
    text "(3) has had his State license or registration suspended, revoked, or denied by competent State authority and is no longer authorized by State law to engage in the manufacturing, distribution, or dispensing of controlled substances or list I chemicals or has had the suspension, revocation, or denial of his registration recommended by competent State authority;"
  ]
  node [
    id 3532
    label "section_824_subsection_c"
    class_name "subsection"
    text "(c) Service of show cause order; proceedings"
  ]
  node [
    id 3533
    label "section_824_subsection_d"
    class_name "subsection"
    text "(d) Suspension of registration in cases of imminent danger"
  ]
  node [
    id 3534
    label "section_824_subsection_a"
    class_name "subsection"
    text "(a) Grounds"
  ]
  node [
    id 3535
    label "section_824_subsection_b"
    class_name "subsection"
    text "(b) Limits of revocation or suspension"
  ]
  node [
    id 3536
    label "section_824_subsection_a_item_5"
    class_name "item"
    text "(5) has been excluded (or directed to be excluded) from participation in a program pursuant to section 1320a&#8211;7(a) of title 42."
  ]
  node [
    id 3537
    label "section_824_subsection_a_item_2"
    class_name "item"
    text "(2) has been convicted of a felony under this subchapter or subchapter II of this chapter or any other law of the United States, or of any State, relating to any substance defined in this subchapter as a controlled substance or a list I chemical;"
  ]
  node [
    id 3538
    label "section_824_subsection_g"
    class_name "subsection"
    text "(g) Seizure or placement under seal of controlled substances or list I chemicals"
  ]
  node [
    id 3539
    label "section_824_subsection_f"
    class_name "subsection"
    text "(f) Disposition of controlled substances or list I chemicals"
  ]
  node [
    id 3540
    label "section_825_subsection_c"
    class_name "subsection"
    text "(c) Warning on label"
  ]
  node [
    id 3541
    label "section_825_subsection_a"
    class_name "subsection"
    text "(a) Symbol"
  ]
  node [
    id 3542
    label "section_825_subsection_b"
    class_name "subsection"
    text "(b) Unlawful distribution without identifying symbol"
  ]
  node [
    id 3543
    label "section_825_subsection_d"
    class_name "subsection"
    text "(d) Containers to be securely sealed"
  ]
  node [
    id 3544
    label "section_826_subsection_d"
    class_name "subsection"
    text "(d) Quotas for registrants who have not manufactured controlled substance during one or more preceding years"
  ]
  node [
    id 3545
    label "section_826_subsection_a"
    class_name "subsection"
    text "(a) Establishment of total annual needs"
  ]
  node [
    id 3546
    label "section_826_subsection_c"
    class_name "subsection"
    text "(c) Manufacturing quotas for registered manufacturers"
  ]
  node [
    id 3547
    label "section_826_subsection_e"
    class_name "subsection"
    text "(e) Quota increases"
  ]
  node [
    id 3548
    label "section_826_subsection_b"
    class_name "subsection"
    text "(b) Individual production quotas; revised quotas"
  ]
  node [
    id 3549
    label "section_826_subsection_f"
    class_name "subsection"
    text "(f) Incidental production exception"
  ]
  node [
    id 3550
    label "section_827_subsection_b_item_2"
    class_name "item"
    text "Every inventory or other record required under this section (1) shall be in accordance with, and contain such relevant information as may be required by, regulations of the Attorney General, (2) shall (A) be maintained separately from all other records of the registrant, or (B) alternatively, in the case of nonnarcotic controlled substances, be in such form that information required by the Attorney General is readily retrievable from the ordinary business records of the registrant, and (3) shall be kept and be available, for at least two years, for inspection and copying by officers or employees of the United States authorized by the Attorney General."
  ]
  node [
    id 3551
    label "section_827_subsection_c_item_2"
    class_name "item"
    text "Nothing in the Convention on Psychotropic Substances shall be construed as superseding or otherwise affecting the provisions of paragraph (1)(B), (2), or (3) of this subsection."
  ]
  node [
    id 3552
    label "section_827_subsection_c_item_1"
    class_name "item"
    text "Nothing in the Convention on Psychotropic Substances shall be construed as superseding or otherwise affecting the provisions of paragraph (1)(B), (2), or (3) of this subsection."
  ]
  node [
    id 3553
    label "section_827_subsection_b"
    class_name "subsection"
    text "(b) Availability of records"
  ]
  node [
    id 3554
    label "section_827_subsection_c"
    class_name "subsection"
    text "(c) Nonapplicability"
  ]
  node [
    id 3555
    label "section_827_subsection_a_item_2"
    class_name "item"
    text "(2) on the effective date of each regulation of the Attorney General controlling a substance that immediately prior to such date was not a controlled substance, each registrant under this subchapter manufacturing, distributing, or dispensing such substance shall make a complete and accurate record of all stocks thereof on hand; and"
  ]
  node [
    id 3556
    label "section_827_subsection_b_item_3"
    class_name "item"
    text "Every inventory or other record required under this section (1) shall be in accordance with, and contain such relevant information as may be required by, regulations of the Attorney General, (2) shall (A) be maintained separately from all other records of the registrant, or (B) alternatively, in the case of nonnarcotic controlled substances, be in such form that information required by the Attorney General is readily retrievable from the ordinary business records of the registrant, and (3) shall be kept and be available, for at least two years, for inspection and copying by officers or employees of the United States authorized by the Attorney General."
  ]
  node [
    id 3557
    label "section_827_subsection_f"
    class_name "subsection"
    text "(f) Investigational uses of drugs; procedures"
  ]
  node [
    id 3558
    label "section_827_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "Every inventory or other record required under this section (1) shall be in accordance with, and contain such relevant information as may be required by, regulations of the Attorney General, (2) shall (A) be maintained separately from all other records of the registrant, or (B) alternatively, in the case of nonnarcotic controlled substances, be in such form that information required by the Attorney General is readily retrievable from the ordinary business records of the registrant, and (3) shall be kept and be available, for at least two years, for inspection and copying by officers or employees of the United States authorized by the Attorney General."
  ]
  node [
    id 3559
    label "section_827_subsection_a"
    class_name "subsection"
    text "(a) Inventory"
  ]
  node [
    id 3560
    label "section_827_subsection_b_item_1"
    class_name "item"
    text "Every inventory or other record required under this section (1) shall be in accordance with, and contain such relevant information as may be required by, regulations of the Attorney General, (2) shall (A) be maintained separately from all other records of the registrant, or (B) alternatively, in the case of nonnarcotic controlled substances, be in such form that information required by the Attorney General is readily retrievable from the ordinary business records of the registrant, and (3) shall be kept and be available, for at least two years, for inspection and copying by officers or employees of the United States authorized by the Attorney General."
  ]
  node [
    id 3561
    label "section_827_subsection_a_item_1"
    class_name "item"
    text "(1) every registrant under this subchapter shall, on May 1, 1971, or as soon thereafter as such registrant first engages in the manufacture, distribution, or dispensing of controlled substances, and every second year thereafter, make a complete and accurate record of all stocks thereof on hand, except that the regulations prescribed under this section shall permit each such biennial inventory (following the initial inventory required by this paragraph) to be prepared on such registrant's regular general physical inventory date (if any) which is nearest to and does not vary by more than six months from the biennial date that would otherwise apply;"
  ]
  node [
    id 3562
    label "section_827_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) to the prescribing of controlled substances in schedule II, III, IV, or V by practitioners acting in the lawful course of their professional practice unless such substance is prescribed in the course of maintenance or detoxification treatment of an individual; or"
  ]
  node [
    id 3563
    label "section_827_subsection_g"
    class_name "subsection"
    text "(g) Change of address"
  ]
  node [
    id 3564
    label "section_827_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "Nothing in the Convention on Psychotropic Substances shall be construed as superseding or otherwise affecting the provisions of paragraph (1)(B), (2), or (3) of this subsection."
  ]
  node [
    id 3565
    label "section_827_subsection_e"
    class_name "subsection"
    text "(e) Reporting and recordkeeping requirements of drug conventions"
  ]
  node [
    id 3566
    label "section_827_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "Every inventory or other record required under this section (1) shall be in accordance with, and contain such relevant information as may be required by, regulations of the Attorney General, (2) shall (A) be maintained separately from all other records of the registrant, or (B) alternatively, in the case of nonnarcotic controlled substances, be in such form that information required by the Attorney General is readily retrievable from the ordinary business records of the registrant, and (3) shall be kept and be available, for at least two years, for inspection and copying by officers or employees of the United States authorized by the Attorney General."
  ]
  node [
    id 3567
    label "section_827_subsection_d"
    class_name "subsection"
    text "(d) Periodic reports to Attorney General"
  ]
  node [
    id 3568
    label "section_827_subsection_f_subsubitem_i"
    class_name "subsubitem"
    text "Regulations under sections 355(i) and 360(j) of this title, relating to investigational use of drugs, shall include such procedures as the Secretary, after consultation with the Attorney General, determines are necessary to insure the security and accountability of controlled substances used in research to which such regulations apply."
  ]
  node [
    id 3569
    label "section_827_subsection_a_item_3"
    class_name "item"
    text "(3) on and after May 1, 1971, every registrant under this subchapter manufacturing, distributing, or dispensing a controlled substance or substances shall maintain, on a current basis, a complete and accurate record of each such substance manufactured, received, sold, delivered, or otherwise disposed of by him, except that this paragraph shall not require the maintenance of a perpetual inventory."
  ]
  node [
    id 3570
    label "section_827_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) to the use of controlled substances, at establishments registered under this subchapter which keep records with respect to such substances, in research conducted in conformity with an exemption granted under section 355(i) or 360b(j) of this title;"
  ]
  node [
    id 3571
    label "section_827_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) to the use of controlled substances, at establishments registered under this subchapter which keep records with respect to such substances, in preclinical research or in teaching; or"
  ]
  node [
    id 3572
    label "section_827_subsection_c_item_3"
    class_name "item"
    text "Nothing in the Convention on Psychotropic Substances shall be construed as superseding or otherwise affecting the provisions of paragraph (1)(B), (2), or (3) of this subsection."
  ]
  node [
    id 3573
    label "section_828_subsection_c"
    class_name "subsection"
    text "(c) Preservation and availability"
  ]
  node [
    id 3574
    label "section_828_subsection_b"
    class_name "subsection"
    text "(b) Nonapplicability of provisions"
  ]
  node [
    id 3575
    label "section_828_subsection_b_item_1"
    class_name "item"
    text "(1) the exportation of such substances from the United States in conformity with subchapter II of this chapter;"
  ]
  node [
    id 3576
    label "section_828_subsection_b_item_2"
    class_name "item"
    text "(2) the delivery of such a substance to or by a common or contract carrier for carriage in the lawful and usual course of its business, or to or by a warehouseman for storage in the lawful and usual course of its business; but where such carriage or storage is in connection with the distribution by the owner of the substance to a third person, this paragraph shall not relieve the distributor from compliance with subsection (a) of this section."
  ]
  node [
    id 3577
    label "section_828_subsection_d_item_1"
    class_name "item"
    text "(1) The Attorney General shall issue forms pursuant to subsections (a) and (c)(2) of this section only to persons validly registered under section 823 of this title (or exempted from registration under section 822(d) of this title). Whenever any such form is issued to a person, the Attorney General shall, before delivery thereof, insert therein the name of such person, and it shall be unlawful for any other person (A) to use such form for the purpose of obtaining controlled substances or (B) to furnish such form to any person with intent thereby to procure the distribution of such substances."
  ]
  node [
    id 3578
    label "section_828_subsection_a"
    class_name "subsection"
    text "(a) Unlawful distribution of controlled substances"
  ]
  node [
    id 3579
    label "section_828_subsection_d_item_2"
    class_name "item"
    text "(2) The Attorney General may charge reasonable fees for the issuance of such forms in such amounts as he may prescribe for the purpose of covering the cost to the United States of issuing such forms, and other necessary activities in connection therewith."
  ]
  node [
    id 3580
    label "section_828_subsection_e"
    class_name "subsection"
    text "(e) Unlawful acts"
  ]
  node [
    id 3581
    label "section_828_subsection_c_item_2"
    class_name "item"
    text "(2) Every person who gives an order required under subsection (a) of this section shall, at or before the time of giving such order, make or cause to be made a duplicate thereof on a form to be issued by the Attorney General in blank in accordance with subsection (d) of this section and regulations prescribed by him pursuant to this section, and shall, if such order is accepted, preserve such duplicate for a period of two years and make it available for inspection and copying by the officers and employees mentioned in paragraph (1) of this subsection."
  ]
  node [
    id 3582
    label "section_828_subsection_d"
    class_name "subsection"
    text "(d) Issuance"
  ]
  node [
    id 3583
    label "section_828_subsection_c_item_1"
    class_name "item"
    text "(1) Every person who in pursuance of an order required under subsection (a) of this section distributes a controlled substance shall preserve such order for a period of two years, and shall make such order available for inspection and copying by officers and employees of the United States duly authorized for that purpose by the Attorney General, and by officers or employees of States or their political subdivisions who are charged with the enforcement of State or local laws regulating the production, or regulating the distribution or dispensing, of controlled substances and who are authorized under such laws to inspect such orders."
  ]
  node [
    id 3584
    label "section_829_subsection_c"
    class_name "subsection"
    text "(c) Schedule V substances"
  ]
  node [
    id 3585
    label "section_829_subsection_a"
    class_name "subsection"
    text "(a) Schedule II substances"
  ]
  node [
    id 3586
    label "section_829_subsection_d"
    class_name "subsection"
    text "(d) Non-prescription drugs with abuse potential"
  ]
  node [
    id 3587
    label "section_829_subsection_b"
    class_name "subsection"
    text "(b) Schedule III and IV substances"
  ]
  node [
    id 3588
    label "section_830_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(A) to an officer or employee of the United States engaged in carrying out this subchapter, subchapter II of this chapter, or the customs laws;"
  ]
  node [
    id 3589
    label "section_830_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "Each report under subparagraph (A) shall be made at the earliest practicable opportunity after the regulated person becomes aware of the circumstance involved. A regulated person may not complete a transaction with a person whose description or identifying characteristic is furnished to the regulated person under subparagraph (B) unless the transaction is approved by the Attorney General. The Attorney General shall make available to regulated persons guidance documents describing transactions and circumstances for which reports are required under subparagraph (A) and subparagraph (C)."
  ]
  node [
    id 3590
    label "section_830_subsection_c_item_5"
    class_name "item"
    text "(5) Notwithstanding paragraph (4), a civil action may not be brought under such paragraph against investigative or law enforcement personnel of the Drug Enforcement Administration."
  ]
  node [
    id 3591
    label "section_830_subsection_c_item_3_subitem_B"
    class_name "subitem"
    text "(B) issue guidelines that limit, to the maximum extent feasible, the disclosure of proprietary business information, including the names or identities of United States exporters of listed chemicals, to any person to whom such information is disclosed under paragraph (2)."
  ]
  node [
    id 3592
    label "section_830_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "Each report under subparagraph (A) shall be made at the earliest practicable opportunity after the regulated person becomes aware of the circumstance involved. A regulated person may not complete a transaction with a person whose description or identifying characteristic is furnished to the regulated person under subparagraph (B) unless the transaction is approved by the Attorney General. The Attorney General shall make available to regulated persons guidance documents describing transactions and circumstances for which reports are required under subparagraph (A) and subparagraph (C)."
  ]
  node [
    id 3593
    label "section_830_subsection_c_item_3"
    class_name "item"
    text "(3) The Attorney General shall&#8212;"
  ]
  node [
    id 3594
    label "section_830_subsection_b_item_1"
    class_name "item"
    text "(1) Each regulated person shall report to the Attorney General, in such form and manner as the Attorney General shall prescribe by regulation&#8212;"
  ]
  node [
    id 3595
    label "section_830_subsection_a"
    class_name "subsection"
    text "(a) Record of regulated transactions"
  ]
  node [
    id 3596
    label "section_830_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) for 2 years after the date of the transaction, if the listed chemical is a list II chemical."
  ]
  node [
    id 3597
    label "section_830_subsection_c_item_1"
    class_name "item"
    text "(1) Except as provided in paragraph (2), any information obtained by the Attorney General under this section which is exempt from disclosure under section 552(a) of title 5, by reason of section 552(b)(4) of such title, is confidential and may not be disclosed to any person."
  ]
  node [
    id 3598
    label "section_830_subsection_b"
    class_name "subsection"
    text "(b) Reports to Attorney General"
  ]
  node [
    id 3599
    label "section_830_subsection_a_item_3"
    class_name "item"
    text "(3) It is the duty of each regulated person who engages in a regulated transaction to identify each other party to the transaction. It is the duty of such other party to present proof of identity to the regulated person. The Attorney General shall specify by regulation the types of documents and other evidence that constitute proof of identity for purposes of this paragraph."
  ]
  node [
    id 3600
    label "section_830_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) for 4 years after the date of the transaction, if the listed chemical is a list I chemical or if the transaction involves a tableting machine or an encapsulating machine; and"
  ]
  node [
    id 3601
    label "section_830_subsection_a_item_1"
    class_name "item"
    text "(1) Each regulated person who engages in a regulated transaction involving a listed chemical, a tableting machine, or an encapsulating machine shall keep a record of the transaction&#8212;"
  ]
  node [
    id 3602
    label "section_830_subsection_b_item_1_subitem_D"
    class_name "subitem"
    text "(D) any regulated transaction in a tableting machine or an encapsulating machine."
  ]
  node [
    id 3603
    label "section_830_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "Each report under subparagraph (A) shall be made at the earliest practicable opportunity after the regulated person becomes aware of the circumstance involved. A regulated person may not complete a transaction with a person whose description or identifying characteristic is furnished to the regulated person under subparagraph (B) unless the transaction is approved by the Attorney General. The Attorney General shall make available to regulated persons guidance documents describing transactions and circumstances for which reports are required under subparagraph (A) and subparagraph (C)."
  ]
  node [
    id 3604
    label "section_830_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "(A) take such action as may be necessary to prevent unauthorized disclosure of information by any person to whom such information is disclosed under paragraph (2); and"
  ]
  node [
    id 3605
    label "section_830_subsection_c"
    class_name "subsection"
    text "(c) Confidentiality of information obtained by Attorney General; non-disclosure; exceptions"
  ]
  node [
    id 3606
    label "section_830_subsection_a_item_2"
    class_name "item"
    text "(2) A record under this subsection shall be retrievable and shall include the date of the regulated transaction, the identity of each party to the regulated transaction, a statement of the quantity and form of the listed chemical, a description of the tableting machine or encapsulating machine, and a description of the method of transfer. Such record shall be available for inspection and copying by the Attorney General."
  ]
  node [
    id 3607
    label "section_830_subsection_c_item_2_subitem_C"
    class_name "subitem"
    text "(C) when necessary to comply with an obligation of the United States under a treaty or other international agreement; or"
  ]
  node [
    id 3608
    label "section_830_subsection_c_item_4"
    class_name "item"
    text "(4) Any person who is aggrieved by a disclosure of information in violation of this section may bring a civil action against the violator for appropriate relief."
  ]
  node [
    id 3609
    label "section_830_subsection_b_item_2"
    class_name "item"
    text "(2) A regulated person that manufactures a listed chemical shall report annually to the Attorney General, in such form and manner and containing such specific data as the Attorney General shall prescribe by regulation, information concerning listed chemicals manufactured by the person. The requirement of the preceding sentence shall not apply to the manufacture of a drug product that is exempted under section 802(39)(A)(iv) of this title."
  ]
  node [
    id 3610
    label "section_830_subsection_c_item_2_subitem_D"
    class_name "subitem"
    text "(D) to a State or local official or employee in conjunction with the enforcement of controlled substances laws or chemical control laws."
  ]
  node [
    id 3611
    label "section_830_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) when relevant in any investigation or proceeding for the enforcement of this subchapter, subchapter II of this chapter, or the customs laws;"
  ]
  node [
    id 3612
    label "section_830_subsection_c_item_2"
    class_name "item"
    text "(2) Information referred to in paragraph (1) may be disclosed only&#8212;"
  ]
  node [
    id 3613
    label "section_841_subsection_b_item_1"
    class_name "item"
    text "(1)(A) In the case of a violation of subsection (a) of this section involving&#8212;"
  ]
  node [
    id 3614
    label "section_841_subsection_e_item_3"
    class_name "item"
    text "(3) For the purposes of this subsection, the term &#8220;boobytrap&#8221; means any concealed or camouflaged device designed to cause bodily injury when triggered by any action of any unsuspecting person making contact with the device. Such term includes guns, ammunition, or explosive devices attached to trip wires or other triggering mechanisms, sharpened stakes, and lines or wires with hooks attached."
  ]
  node [
    id 3615
    label "section_841_subsection_v_item_4"
    class_name "item"
    text "(4) Notwithstanding paragraph (1)(D) of this subsection, any person who violates subsection (a) of this section by distributing a small amount of marihuana for no remuneration shall be treated as provided in section 844 of this title and section 3607 of title 18."
  ]
  node [
    id 3616
    label "section_841_subsection_v_item_6_subitem_C"
    class_name "subitem"
    text "(C) pollutes an aquifer, spring, stream, river, or body of water,"
  ]
  node [
    id 3617
    label "section_841_subsection_v_item_5"
    class_name "item"
    text "(5) Any person who violates subsection (a) of this section by cultivating a controlled substance on Federal property shall be imprisoned as provided in this subsection and shall be fined any amount not to exceed&#8212;"
  ]
  node [
    id 3618
    label "section_841_subsection_b_item_1_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) 50 grams or more of a mixture or substance described in clause (ii) which contains cocaine base;"
  ]
  node [
    id 3619
    label "section_841_subsection_v_item_5_subitem_B"
    class_name "subitem"
    text "(B) the amount authorized in accordance with the provisions of title 18;"
  ]
  node [
    id 3620
    label "section_841_subsection_b_item_1_subitem_A_subsubitem_ii_subsubsubitem_IV"
    class_name "subsubsubitem"
    text "(IV) any compound, mixture, or preparation which contains any quantity of any of the substances referred to in subclauses (I) through (III);"
  ]
  node [
    id 3621
    label "section_841_subsection_v_item_6_subitem_B"
    class_name "subitem"
    text "(B) degrades or harms the environment or natural resources, or"
  ]
  node [
    id 3622
    label "section_841_subsection_b_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) 1 kilogram or more of a mixture or substance containing a detectable amount of heroin;"
  ]
  node [
    id 3623
    label "section_841_subsection_v_item_2"
    class_name "item"
    text "(2) In the case of a controlled substance in schedule IV, such person shall be sentenced to a term of imprisonment of not more than 3 years, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $250,000 if the defendant is an individual or $1,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after one or more prior convictions of him for an offense punishable under this paragraph, or for a felony under any other provision of this subchapter or subchapter II of this chapter or other law of a State, the United States, or a foreign country relating to narcotic drugs, marihuana, or depressant or stimulant substances, have become final, such person shall be sentenced to a term of imprisonment of not more than 6 years, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $500,000 if the defendant is an individual or $2,000,000 if the defendant is other than an individual, or both. Any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least one year in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 2 years in addition to such term of imprisonment."
  ]
  node [
    id 3624
    label "section_841_subsection_b_item_1_subitem_A_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) cocaine, its salts, optical and geometric isomers, and salts of isomers;"
  ]
  node [
    id 3625
    label "section_841_subsection_e"
    class_name "subsection"
    text "(e) Boobytraps on Federal property; penalties; &#8220;boobytrap&#8221; defined"
  ]
  node [
    id 3626
    label "section_841_subsection_g_item_2"
    class_name "item"
    text "(2) Whoever possesses any listed chemical, with knowledge that the recordkeeping or reporting requirements of section 830 of this title have not been adhered to, if, after such knowledge is acquired, such person does not take immediate steps to remedy the violation shall be fined under title 18 or imprisoned not more than one year, or both."
  ]
  node [
    id 3627
    label "section_841_subsection_v_subitem_C"
    class_name "subitem"
    text "(C) In the case of a controlled substance in schedule I or II except as provided in subparagraphs (A), (B), and (D), such person shall be sentenced to a term of imprisonment of not more than 20 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not less than twenty years or more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $1,000,000 if the defendant is an individual or $5,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 30 years and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $2,000,000 if the defendant is an individual or $10,000,000 if the defendant is other than an individual, or both. Any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 3 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 6 years in addition to such term of imprisonment. Notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under the provisions of this subparagraph which provide for a mandatory term of imprisonment if death or serious bodily injury results, nor shall a person so sentenced be eligible for parole during the term of such a sentence."
  ]
  node [
    id 3628
    label "section_841_subsection_v_item_5_subitem_A"
    class_name "subitem"
    text "(A) the amount authorized in accordance with this section;"
  ]
  node [
    id 3629
    label "section_841_subsection_a"
    class_name "subsection"
    text "(a) Unlawful acts"
  ]
  node [
    id 3630
    label "section_841_subsection_b_item_1_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) 100 grams or more of phencyclidine (PCP) or 1 kilogram or more of a mixture or substance containing a detectable amount of phencyclidine (PCP);"
  ]
  node [
    id 3631
    label "section_841_subsection_d_item_1"
    class_name "item"
    text "(1) possesses a listed chemical with intent to manufacture a controlled substance except as authorized by this subchapter;"
  ]
  node [
    id 3632
    label "section_841_subsection_a_item_2"
    class_name "item"
    text "(2) to create, distribute, or dispense, or possess with intent to distribute or dispense, a counterfeit substance."
  ]
  node [
    id 3633
    label "section_841_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(1)(A) In the case of a violation of subsection (a) of this section involving&#8212;"
  ]
  node [
    id 3634
    label "section_841_subsection_e_item_1"
    class_name "item"
    text "(1) Any person who assembles, maintains, places, or causes to be placed a boobytrap on Federal property where a controlled substance is being manufactured, distributed, or dispensed shall be sentenced to a term of imprisonment for not more than 10 years and shall be fined not more than $10,000."
  ]
  node [
    id 3635
    label "section_841_subsection_v_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) 100 grams or more of a mixture or substance containing a detectable amount of heroin;"
  ]
  node [
    id 3636
    label "section_841_subsection_f"
    class_name "subsection"
    text "(f) Ten-year injunction as additional penalty"
  ]
  node [
    id 3637
    label "section_841_subsection_v_subitem_B_subsubitem_ii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) ecgonine, its derivatives, their salts, isomers, and salts of isomers; or"
  ]
  node [
    id 3638
    label "section_841_subsection_v_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) 500 grams or more of a mixture or substance containing a detectable amount of&#8212;"
  ]
  node [
    id 3639
    label "section_841_subsection_g_item_1"
    class_name "item"
    text "(1) Whoever knowingly distributes a listed chemical in violation of this subchapter (other than in violation of a recordkeeping or reporting requirement of section 830 of this title) shall be fined under title 18 or imprisoned not more than 5 years, or both."
  ]
  node [
    id 3640
    label "section_841_subsection_v_item_3"
    class_name "item"
    text "(3) In the case of a controlled substance in schedule V, such person shall be sentenced to a term of imprisonment of not more than one year, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $100,000 if the defendant is an individual or $250,000 if the defendant is other than an individual, or both. If any person commits such a violation after one or more convictions of him for an offense punishable under this paragraph, or for a crime under any other provision of this subchapter or subchapter II of this chapter or other law of a State, the United States, or a foreign country relating to narcotic drugs, marihuana, or depressant or stimulant substances, have become final, such person shall be sentenced to a term of imprisonment of not more than 2 years, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $200,000 if the defendant is an individual or $500,000 if the defendant is other than an individual, or both."
  ]
  node [
    id 3641
    label "section_841_subsection_b"
    class_name "subsection"
    text "(b) Penalties"
  ]
  node [
    id 3642
    label "section_841_subsection_a_item_1"
    class_name "item"
    text "(1) to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance; or"
  ]
  node [
    id 3643
    label "section_841_subsection_v_subitem_B_subsubitem_ii_subsubsubitem_II"
    class_name "subsubsubitem"
    text "(II) cocaine, its salts, optical and geometric isomers, and salts of isomers;"
  ]
  node [
    id 3644
    label "section_841_subsection_d"
    class_name "subsection"
    text "(d) Offenses involving listed chemicals"
  ]
  node [
    id 3645
    label "section_841_subsection_v_item_6_subitem_A"
    class_name "subitem"
    text "(A) creates a serious hazard to humans, wildlife, or domestic animals,"
  ]
  node [
    id 3646
    label "section_841_subsection_v_subitem_D"
    class_name "subitem"
    text "(D) In the case of less than 50 kilograms of marihuana, except in the case of 50 or more marihuana plants regardless of weight, 10 kilograms of hashish, or one kilogram of hashish oil or in the case of any controlled substance in schedule III, such person shall, except as provided in paragraphs (4) and (5) of this subsection, be sentenced to a term of imprisonment of not more than 5 years, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $250,000 if the defendant is an individual or $1,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 10 years, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $500,000 if the defendant is an individual or $2,000,000 if the defendant is other than an individual, or both. Any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 2 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 4 years in addition to such term of imprisonment."
  ]
  node [
    id 3647
    label "section_841_subsection_b_item_1_subitem_A_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) coca leaves, except coca leaves and extracts of coca leaves from which cocaine, ecgonine, and derivatives of ecgonine or their salts have been removed;"
  ]
  node [
    id 3648
    label "section_841_subsection_v"
    class_name "subsection"
    text "(v) 1 gram or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);"
  ]
  node [
    id 3649
    label "section_841_subsection_v_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) 10 grams or more of phencyclidine (PCP) or 100 grams or more of a mixture or substance containing a detectable amount of phencyclidine (PCP);"
  ]
  node [
    id 3650
    label "section_841_subsection_v_item_5_subitem_D"
    class_name "subitem"
    text "(D) $1,000,000 if the defendant is other than an individual;"
  ]
  node [
    id 3651
    label "section_841_subsection_b_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) 5 kilograms or more of a mixture or substance containing a detectable amount of&#8212;"
  ]
  node [
    id 3652
    label "section_841_subsection_v_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) 5 grams or more of a mixture or substance described in clause (ii) which contains cocaine base;"
  ]
  node [
    id 3653
    label "section_841_subsection_v_item_5_subitem_C"
    class_name "subitem"
    text "(C) $500,000 if the defendant is an individual; or"
  ]
  node [
    id 3654
    label "section_841_subsection_b_item_1_subitem_A_subsubitem_ii_subsubsubitem_III"
    class_name "subsubsubitem"
    text "(III) ecgonine, its derivatives, their salts, isomers, and salts of isomers; or"
  ]
  node [
    id 3655
    label "section_841_subsection_v_subitem_B"
    class_name "subitem"
    text "(B) In the case of a violation of subsection (a) of this section involving&#8212;"
  ]
  node [
    id 3656
    label "section_841_subsection_v_subitem_B_subsubitem_ii_subsubsubitem_IV"
    class_name "subsubsubitem"
    text "(IV) any compound, mixture, or preparation which contains any quantity of any of the substances referred to in subclauses (I) through (III);"
  ]
  node [
    id 3657
    label "section_841_subsection_v_item_6"
    class_name "item"
    text "(6) Any person who violates subsection (a) of this section, or attempts to do so, and knowingly or intentionally uses a poison, chemical, or other hazardous substance on Federal land, and, by such use&#8212;"
  ]
  node [
    id 3658
    label "section_841_subsection_v_subitem_B_subsubitem_ii_subsubsubitem_I"
    class_name "subsubsubitem"
    text "(I) coca leaves, except coca leaves and extracts of coca leaves from which cocaine, ecgonine, and derivatives of ecgonine or their salts have been removed;"
  ]
  node [
    id 3659
    label "section_841_subsection_d_item_3"
    class_name "item"
    text "(3) with the intent of causing the evasion of the recordkeeping or reporting requirements of section 830 of this title, or the regulations issued under that section, receives or distributes a reportable amount of any listed chemical in units small enough so that the making of records or filing of reports under that section is not required;"
  ]
  node [
    id 3660
    label "section_841_subsection_d_item_2"
    class_name "item"
    text "(2) possesses or distributes a listed chemical knowing, or having reasonable cause to believe, that the listed chemical will be used to manufacture a controlled substance except as authorized by this subchapter; or"
  ]
  node [
    id 3661
    label "section_841_subsection_e_item_2"
    class_name "item"
    text "(2) If any person commits such a violation after 1 or more prior convictions for an offense punishable under this subsection, such person shall be sentenced to a term of imprisonment of not more than 20 years and shall be fined not more than $20,000."
  ]
  node [
    id 3662
    label "section_841_subsection_g"
    class_name "subsection"
    text "(g) Wrongful distribution or possession of listed chemicals"
  ]
  node [
    id 3663
    label "section_842_subsection_a_item_9"
    class_name "item"
    text "(9) who is a regulated person to engage in a regulated transaction without obtaining the identification required by 830(a)(3) of this title; or"
  ]
  node [
    id 3664
    label "section_842_subsection_c_item_1"
    class_name "item"
    text "(1) Except as provided in paragraph (2), any person who violates this section shall, with respect to any such violation, be subject to a civil penalty of not more than $25,000. The district courts of the United States (or, where there is no such court in the case of any territory or possession of the United States, then the court in such territory or possession having the jurisdiction of a district court of the United States in cases arising under the Constitution and laws of the United States) shall have jurisdiction in accordance with section 1355 of title 28 to enforce this paragraph."
  ]
  node [
    id 3665
    label "section_842_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) If a violation referred to in subparagraph (A) was committed after one or more prior convictions of the offender for an offense punishable under this paragraph (2), or for a crime under any other provision of this subchapter or subchapter II of this chapter or other law of the United States relating to narcotic drugs, marihuana, or depressant or stimulant substances, have become final, such person shall be sentenced to a term of imprisonment of not more than 2 years, a fine of $50,000, or both."
  ]
  node [
    id 3666
    label "section_842_subsection_a_item_7"
    class_name "item"
    text "(7) to remove, break, injure, or deface a seal placed upon controlled substances pursuant to section 824(f) or 881 of this title or to remove or dispose of substances so placed under seal;"
  ]
  node [
    id 3667
    label "section_842_subsection_a_item_5"
    class_name "item"
    text "(5) to refuse or fail to make, keep, or furnish any record, report, notification, declaration, order or order form, statement, invoice, or information required under this subchapter or subchapter II of this chapter;"
  ]
  node [
    id 3668
    label "section_842_subsection_a_item_1"
    class_name "item"
    text "(1) who is subject to the requirements of part C to distribute or dispense a controlled substance in violation of section 829 of this title;"
  ]
  node [
    id 3669
    label "section_842_subsection_a_item_10"
    class_name "item"
    text "(10) to fail to keep a record or make a report under section 830 of this title."
  ]
  node [
    id 3670
    label "section_842_subsection_a_item_2"
    class_name "item"
    text "(2) who is a registrant to distribute or dispense a controlled substance not authorized by his registration to another registrant or other authorized person or to manufacture a controlled substance not authorized by his registration;"
  ]
  node [
    id 3671
    label "section_842_subsection_b"
    class_name "subsection"
    text "(b) Manufacture"
  ]
  node [
    id 3672
    label "section_842_subsection_a_item_4"
    class_name "item"
    text "(4) to remove, alter, or obliterate a symbol or label required by section 825 of this title;"
  ]
  node [
    id 3673
    label "section_842_subsection_a"
    class_name "subsection"
    text "(a) Unlawful acts"
  ]
  node [
    id 3674
    label "section_842_subsection_a_item_8"
    class_name "item"
    text "(8) to use, to his own advantage, or to reveal, other than to duly authorized officers or employees of the United States, or to the courts when relevant in any judicial proceeding under this subchapter or subchapter II of this chapter, any information acquired in the course of an inspection authorized by this subchapter concerning any method or process which as a trade secret is entitled to protection, or to use to his own advantage or reveal (other than as authorized by section 830 of this title) any information that is confidential under such section;"
  ]
  node [
    id 3675
    label "section_842_subsection_b_item_1"
    class_name "item"
    text "(1) not expressly authorized by his registration and by a quota assigned to him pursuant to section 826 of this title; or"
  ]
  node [
    id 3676
    label "section_842_subsection_c_item_2"
    class_name "item"
    text "(2)(A) If a violation of this section is prosecuted by an information or indictment which alleges that the violation was committed knowingly and the trier of fact specifically finds that the violation was so committed, such person shall, except as otherwise provided in subparagraph (B) of this paragraph, be sentenced to imprisonment of not more than one year or a fine of not more than $25,000, or both."
  ]
  node [
    id 3677
    label "section_842_subsection_a_item_6"
    class_name "item"
    text "(6) to refuse any entry into any premises or inspection authorized by this subchapter or subchapter II of this chapter;"
  ]
  node [
    id 3678
    label "section_842_subsection_a_item_3"
    class_name "item"
    text "(3) who is a registrant to distribute a controlled substance in violation of section 825 of this title;"
  ]
  node [
    id 3679
    label "section_842_subsection_b_item_2"
    class_name "item"
    text "(2) in excess of a quota assigned to him pursuant to section 826 of this title."
  ]
  node [
    id 3680
    label "section_842_subsection_c_item_3"
    class_name "item"
    text "(3) Except under the conditions specified in paragraph (2) of this subsection, a violation of this section does not constitute a crime, and a judgment for the United States and imposition of a civil penalty pursuant to paragraph (1) shall not give rise to any disability or legal disadvantage based on conviction for a criminal offense."
  ]
  node [
    id 3681
    label "section_842_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) If a violation of this section is prosecuted by an information or indictment which alleges that the violation was committed knowingly and the trier of fact specifically finds that the violation was so committed, such person shall, except as otherwise provided in subparagraph (B) of this paragraph, be sentenced to imprisonment of not more than one year or a fine of not more than $25,000, or both."
  ]
  node [
    id 3682
    label "section_842_subsection_c"
    class_name "subsection"
    text "(c) Penalties"
  ]
  node [
    id 3683
    label "section_843_subsection_a_item_1"
    class_name "item"
    text "(1) who is a registrant to distribute a controlled substance classified in schedule I or II, in the course of his legitimate business, except pursuant to an order or an order form as required by section 828 of this title;"
  ]
  node [
    id 3684
    label "section_843_subsection_a_item_7"
    class_name "item"
    text "(7) to manufacture, distribute, export, or import any three-neck round-bottom flask, tableting machine, encapsulating machine, or gelatin capsule, or any equipment, chemical, product, or material which may be used to manufacture a controlled substance or listed chemical, knowing, intending, or having reasonable cause to believe, that it will be used to manufacture a controlled substance or listed chemical in violation of this subchapter or subchapter II of this chapter or, in the case of an exportation, in violation of this subchapter or subchapter II of this chapter or of the laws of the country to which it is exported;"
  ]
  node [
    id 3685
    label "section_843_subsection_a"
    class_name "subsection"
    text "(a) Unlawful acts"
  ]
  node [
    id 3686
    label "section_843_subsection_c"
    class_name "subsection"
    text "(c) Advertisement"
  ]
  node [
    id 3687
    label "section_843_subsection_b"
    class_name "subsection"
    text "(b) Communication facility"
  ]
  node [
    id 3688
    label "section_843_subsection_d"
    class_name "subsection"
    text "(d) Penalties"
  ]
  node [
    id 3689
    label "section_843_subsection_a_item_8"
    class_name "item"
    text "(8) to create a chemical mixture for the purpose of evading a requirement of section 830 of this title or to receive a chemical mixture created for that purpose; or"
  ]
  node [
    id 3690
    label "section_843_subsection_a_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) to furnish false or fraudulent material information in, or omit any material information from, any application, report, record, or other document required to be made, kept, or filed under this subchapter or subchapter II of this chapter, or (B) to present false or fraudulent identification where the person is receiving or purchasing a listed chemical and the person is required to present identification under section 830(a) of this title;"
  ]
  node [
    id 3691
    label "section_843_subsection_a_item_3"
    class_name "item"
    text "(3) to acquire or obtain possession of a controlled substance by misrepresentation, fraud, forgery, deception, or subterfuge;"
  ]
  node [
    id 3692
    label "section_843_subsection_e"
    class_name "subsection"
    text "(e) Additional penalties"
  ]
  node [
    id 3693
    label "section_843_subsection_a_item_4"
    class_name "item"
    text "(4)(A) to furnish false or fraudulent material information in, or omit any material information from, any application, report, record, or other document required to be made, kept, or filed under this subchapter or subchapter II of this chapter, or (B) to present false or fraudulent identification where the person is receiving or purchasing a listed chemical and the person is required to present identification under section 830(a) of this title;"
  ]
  node [
    id 3694
    label "section_843_subsection_a_item_9"
    class_name "item"
    text "(9) to distribute, import, or export a list I chemical without the registration required by this subchapter or subchapter II of this chapter."
  ]
  node [
    id 3695
    label "section_843_subsection_a_item_5"
    class_name "item"
    text "(5) to make, distribute, or possess any punch, die, plate, stone, or other thing designed to print, imprint, or reproduce the trademark, trade name, or other identifying mark, imprint, or device of another or any likeness of any of the foregoing upon any drug or container or labeling thereof so as to render such drug a counterfeit substance;"
  ]
  node [
    id 3696
    label "section_843_subsection_a_item_6"
    class_name "item"
    text "(6) to possess any three-neck round-bottom flask, tableting machine, encapsulating machine, or gelatin capsule, or any equipment, chemical, product, or material which may be used to manufacture a controlled substance or listed chemical, knowing, intending, or having reasonable cause to believe, that it will be used to manufacture a controlled substance or listed chemical in violation of this subchapter or subchapter II of this chapter;"
  ]
  node [
    id 3697
    label "section_843_subsection_a_item_2"
    class_name "item"
    text "(2) to use in the course of the manufacture, distribution, or dispensing of a controlled substance, or to use for the purpose of acquiring or obtaining a controlled substance, a registration number which is fictitious, revoked, suspended, expired, or issued to another person;"
  ]
  node [
    id 3698
    label "section_844_subsection_a"
    class_name "subsection"
    text "(a) Unlawful acts; penalties"
  ]
  node [
    id 3699
    label "section_844_subsection_c"
    class_name "subsection"
    text "(c) &#8220;Drug or narcotic offense&#8221; defined"
  ]
  node [
    id 3700
    label "section_844a_subsection_i"
    class_name "subsection"
    text "(i) Limitation"
  ]
  node [
    id 3701
    label "section_844a_subsection_c"
    class_name "subsection"
    text "(c) Prior conviction"
  ]
  node [
    id 3702
    label "section_844a_subsection_e"
    class_name "subsection"
    text "(e) Assessment"
  ]
  node [
    id 3703
    label "section_844a_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "Any individual who knowingly possesses a controlled substance that is listed in section 841(b)(1)(A) of this title in violation of section 844 of this title in an amount that, as specified by regulation of the Attorney General, is a personal use amount shall be liable to the United States for a civil penalty in an amount not to exceed $10,000 for each such violation."
  ]
  node [
    id 3704
    label "section_844a_subsection_j_item_1"
    class_name "item"
    text "(1) the individual has not previously been assessed a civil penalty under this section;"
  ]
  node [
    id 3705
    label "section_844a_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 3706
    label "section_844a_subsection_h"
    class_name "subsection"
    text "(h) Civil action"
  ]
  node [
    id 3707
    label "section_844a_subsection_f"
    class_name "subsection"
    text "(f) Compromise"
  ]
  node [
    id 3708
    label "section_844a_subsection_j"
    class_name "subsection"
    text "(j) Expungement procedures"
  ]
  node [
    id 3709
    label "section_844a_subsection_j_item_3"
    class_name "item"
    text "(3) the individual has complied with any conditions imposed by the Attorney General;"
  ]
  node [
    id 3710
    label "section_844a_subsection_a_item_1"
    class_name "item"
    text "Any individual who knowingly possesses a controlled substance that is listed in section 841(b)(1)(A) of this title in violation of section 844 of this title in an amount that, as specified by regulation of the Attorney General, is a personal use amount shall be liable to the United States for a civil penalty in an amount not to exceed $10,000 for each such violation."
  ]
  node [
    id 3711
    label "section_844a_subsection_j_item_5"
    class_name "item"
    text "(5) the individual agrees to submit to a drug test, and such test shows the individual to be drug free."
  ]
  node [
    id 3712
    label "section_844a_subsection_d"
    class_name "subsection"
    text "(d) Limitation on number of assessments"
  ]
  node [
    id 3713
    label "section_844a_subsection_j_item_2"
    class_name "item"
    text "(2) the individual has paid the assessment;"
  ]
  node [
    id 3714
    label "section_844a_subsection_g"
    class_name "subsection"
    text "(g) Judicial review"
  ]
  node [
    id 3715
    label "section_844a_subsection_b"
    class_name "subsection"
    text "(b) Income and net assets"
  ]
  node [
    id 3716
    label "section_844a_subsection_j_item_4"
    class_name "item"
    text "(4) the individual has not been convicted of a Federal or State offense relating to a controlled substance; and"
  ]
  node [
    id 3717
    label "section_848_subsection_c_item_1"
    class_name "item"
    text "(1) he violates any provision of this subchapter or subchapter II of this chapter the punishment for which is a felony, and"
  ]
  node [
    id 3718
    label "section_848_subsection_m_item_3"
    class_name "item"
    text "(3) The defendant is punishable as a principal (as defined in section 2 of title 18) in the offense, which was committed by another, but the defendant's participation was relatively minor, regardless of whether the participation was so minor as to constitute a defense to the charge."
  ]
  node [
    id 3719
    label "section_848_subsection_j"
    class_name "subsection"
    text "(j) Proof of aggravating and mitigating factors"
  ]
  node [
    id 3720
    label "section_848_subsection_k_item_1_subitem_B"
    class_name "subitem"
    text "The jury, or if there is no jury, the court, shall consider all the information received during the hearing. It shall return special findings identifying any aggravating factors set forth in subsection (n) of this section, found to exist. If one of the aggravating factors set forth in subsection (n)(1) of this section and another of the aggravating factors set forth in paragraphs (2) through (12) of subsection (n) of this section is found to exist, a special finding identifying any other aggravating factor for which notice has been provided under subsection (h)(1)(B) of this section, may be returned. A finding with respect to a mitigating factor may be made by one or more of the members of the jury, and any member of the jury who finds the existence of a mitigating factor may consider such a factor established for purposes of this subsection, regardless of the number of jurors who concur that the factor has been established. A finding with respect to any aggravating factor must be unanimous. If an aggravating factor set forth in subsection (n)(1) of this section is not found to exist or an aggravating factor set forth in subsection (n)(1) of this section is found to exist but no other aggravating factor set forth in subsection (n) of this section is found to exist, the court shall impose a sentence, other than death, authorized by law. If an aggravating factor set forth in subsection (n)(1) of this section and one or more of the other aggravating factors set forth in subsection (n) of this section are found to exist, the jury, or if there is no jury, the court, shall then consider whether the aggravating factors found to exist sufficiently outweigh any mitigating factor or factors found to exist, or in the absence of mitigating factors, whether the aggravating factors are themselves sufficient to justify a sentence of death. Based upon this consideration, the jury by unanimous vote, or if there is no jury, the court, shall recommend that a sentence of death shall be imposed rather than a sentence of life imprisonment without possibility of release or some other lesser sentence. The jury or the court, regardless of its findings with respect to aggravating and mitigating factors, is never required to impose a death sentence and the jury shall be so instructed."
  ]
  node [
    id 3721
    label "section_848_subsection_h_item_1_subitem_B"
    class_name "subitem"
    text "(B) setting forth the aggravating factors enumerated in subsection (n) of this section and any other aggravating factors which the Government will seek to prove as the basis for the death penalty."
  ]
  node [
    id 3722
    label "section_848_subsection_o_item_1"
    class_name "item"
    text "(1) In any hearing held before a jury under this section, the court shall instruct the jury that in its consideration of whether the sentence of death is justified it shall not consider the race, color, religious beliefs, national origin, or sex of the defendant or the victim, and that the jury is not to recommend a sentence of death unless it has concluded that it would recommend a sentence of death for the crime in question no matter what the race, color, religious beliefs, national origin, or sex of the defendant, or the victim, may be. The jury shall return to the court a certificate signed by each juror that consideration of the race, color, religious beliefs, national origin, or sex of the defendant or the victim was not involved in reaching his or her individual decision, and that the individual juror would have made the same recommendation regarding a sentence for the crime in question no matter what the race, color, religious beliefs, national origin, or sex of the defendant, or the victim, may be."
  ]
  node [
    id 3723
    label "section_848_subsection_h"
    class_name "subsection"
    text "(h) Notice by Government in death penalty cases"
  ]
  node [
    id 3724
    label "section_848_subsection_q_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) Notwithstanding any other provision of law to the contrary, in every criminal action in which a defendant is charged with a crime which may be punishable by death, a defendant who is or becomes financially unable to obtain adequate representation or investigative, expert, or other reasonably necessary services at any time either&#8212;"
  ]
  node [
    id 3725
    label "section_848_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(A) which are undertaken by such person in concert with five or more other persons with respect to whom such person occupies a position of organizer, a supervisory position, or any other position of management, and"
  ]
  node [
    id 3726
    label "section_848_subsection_e_item_2"
    class_name "item"
    text "(2) As used in paragraph (1)(b),1 the term &#8220;law enforcement officer&#8221; means a public servant authorized by law or by a Government agency or Congress to conduct or engage in the prevention, investigation, prosecution or adjudication of an offense, and includes those engaged in corrections, probation, or parole functions."
  ]
  node [
    id 3727
    label "section_848_subsection_n_item_1_subitem_D"
    class_name "subitem"
    text "(D) intentionally engaged in conduct which&#8212;"
  ]
  node [
    id 3728
    label "section_848_subsection_m"
    class_name "subsection"
    text "(m) Mitigating factors"
  ]
  node [
    id 3729
    label "section_848_subsection_n_item_11"
    class_name "item"
    text "(11) The violation of this subchapter in relation to which the conduct described in subsection (e) of this section occurred was a violation of section 859 of this title."
  ]
  node [
    id 3730
    label "section_848_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) any person, during the commission of, in furtherance of, or while attempting to avoid apprehension, prosecution or service of a prison sentence for, a felony violation of this subchapter or subchapter II of this chapter who intentionally kills or counsels, commands, induces, procures, or causes the intentional killing of any Federal, State, or local law enforcement officer engaged in, or on account of, the performance of such officer's official duties and such killing results, shall be sentenced to any term of imprisonment, which shall not be less than 20 years, and which may be up to life imprisonment, or may be sentenced to death."
  ]
  node [
    id 3731
    label "section_848_subsection_q_item_8"
    class_name "item"
    text "(8) Unless replaced by similarly qualified counsel upon the attorney's own motion or upon motion of the defendant, each attorney so appointed shall represent the defendant throughout every subsequent stage of available judicial proceedings, including pretrial proceedings, trial, sentencing, motions for new trial, appeals, applications for writ of certiorari to the Supreme Court of the United States, and all available post-conviction process, together with applications for stays of execution and other appropriate motions and procedures, and shall also represent the defendant in such competency proceedings and proceedings for executive or other clemency as may be available to the defendant."
  ]
  node [
    id 3732
    label "section_848_subsection_n_item_3"
    class_name "item"
    text "(3) The defendant has previously been convicted of two or more State or Federal offenses punishable by a term of imprisonment of more than one year, committed on different occasions, involving the infliction of, or attempted infliction of, serious bodily injury upon another person."
  ]
  node [
    id 3733
    label "section_848_subsection_c_item_2"
    class_name "item"
    text "(2) such violation is a part of a continuing series of violations of this subchapter or subchapter II of this chapter&#8212;"
  ]
  node [
    id 3734
    label "section_848_subsection_i_item_1_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) after initial imposition of a sentence under this section, redetermination of the sentence under this section is necessary; or"
  ]
  node [
    id 3735
    label "section_848_subsection_r"
    class_name "subsection"
    text "(r) Refusal to participate by State and Federal correctional employees"
  ]
  node [
    id 3736
    label "section_848_subsection_b_item_1"
    class_name "item"
    text "(1) such person is the principal administrator, organizer, or leader of the enterprise or is one of several such principal administrators, organizers, or leaders; and"
  ]
  node [
    id 3737
    label "section_848_subsection_q_item_7"
    class_name "item"
    text "(7) With respect to paragraphs (5) and (6), the court, for good cause, may appoint another attorney whose background, knowledge, or experience would otherwise enable him or her to properly represent the defendant, with due consideration to the seriousness of the possible penalty and to the unique and complex nature of the litigation."
  ]
  node [
    id 3738
    label "section_848_subsection_l_item_1"
    class_name "item"
    text "(1) cannot understand the nature of the pending proceedings, what such person was tried for, the reason for the punishment, or the nature of the punishment; or"
  ]
  node [
    id 3739
    label "section_848_subsection_n_item_2"
    class_name "item"
    text "(2) The defendant has been convicted of another Federal offense, or a State offense resulting in the death of a person, for which a sentence of life imprisonment or a sentence of death was authorized by statute."
  ]
  node [
    id 3740
    label "section_848_subsection_q_item_6"
    class_name "item"
    text "(6) If the appointment is made after judgment, at least one attorney so appointed must have been admitted to practice in the court of appeals for not less than five years, and must have had not less than three years experience in the handling of appeals in that court in felony cases."
  ]
  node [
    id 3741
    label "section_848_subsection_q_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) after the entry of a judgment imposing a sentence of death but before the execution of that judgment;"
  ]
  node [
    id 3742
    label "section_848_subsection_n_item_1_subitem_C"
    class_name "subitem"
    text "(C) intentionally engaged in conduct intending that the victim be killed or that lethal force be employed against the victim, which resulted in the death of the victim;"
  ]
  node [
    id 3743
    label "section_848_subsection_l"
    class_name "subsection"
    text "(l) Imposition of sentence"
  ]
  node [
    id 3744
    label "section_848_subsection_n"
    class_name "subsection"
    text "(n) Aggravating factors for homicide"
  ]
  node [
    id 3745
    label "section_848_subsection_g"
    class_name "subsection"
    text "(g)&#160;2 Hearing required with respect to death penalty"
  ]
  node [
    id 3746
    label "section_848_subsection_i_item_1_subitem_B"
    class_name "subitem"
    text "(B) before a jury impaneled for the purpose of the hearing if&#8212;"
  ]
  node [
    id 3747
    label "section_848_subsection_b_item_2"
    class_name "item"
    text "(2)(A) the violation referred to in subsection (c)(1) of this section involved at least 300 times the quantity of a substance described in subsection 841(b)(1)(B) of this title, or"
  ]
  node [
    id 3748
    label "section_848_subsection_o_item_2_subitem_A"
    class_name "subitem"
    text "(A) use ordinary methods of statistical analysis, including methods comparable to those ruled admissible by the courts in race discrimination cases under title VII of the Civil Rights Act of 1964 [42 U.S.C. 2000e et seq.];"
  ]
  node [
    id 3749
    label "section_848_subsection_k_item_1"
    class_name "item"
    text "The jury, or if there is no jury, the court, shall consider all the information received during the hearing. It shall return special findings identifying any aggravating factors set forth in subsection (n) of this section, found to exist. If one of the aggravating factors set forth in subsection (n)(1) of this section and another of the aggravating factors set forth in paragraphs (2) through (12) of subsection (n) of this section is found to exist, a special finding identifying any other aggravating factor for which notice has been provided under subsection (h)(1)(B) of this section, may be returned. A finding with respect to a mitigating factor may be made by one or more of the members of the jury, and any member of the jury who finds the existence of a mitigating factor may consider such a factor established for purposes of this subsection, regardless of the number of jurors who concur that the factor has been established. A finding with respect to any aggravating factor must be unanimous. If an aggravating factor set forth in subsection (n)(1) of this section is not found to exist or an aggravating factor set forth in subsection (n)(1) of this section is found to exist but no other aggravating factor set forth in subsection (n) of this section is found to exist, the court shall impose a sentence, other than death, authorized by law. If an aggravating factor set forth in subsection (n)(1) of this section and one or more of the other aggravating factors set forth in subsection (n) of this section are found to exist, the jury, or if there is no jury, the court, shall then consider whether the aggravating factors found to exist sufficiently outweigh any mitigating factor or factors found to exist, or in the absence of mitigating factors, whether the aggravating factors are themselves sufficient to justify a sentence of death. Based upon this consideration, the jury by unanimous vote, or if there is no jury, the court, shall recommend that a sentence of death shall be imposed rather than a sentence of life imprisonment without possibility of release or some other lesser sentence. The jury or the court, regardless of its findings with respect to aggravating and mitigating factors, is never required to impose a death sentence and the jury shall be so instructed."
  ]
  node [
    id 3750
    label "section_848_subsection_p"
    class_name "subsection"
    text "(p) Sentencing in capital cases in which death penalty is not sought or imposed"
  ]
  node [
    id 3751
    label "section_848_subsection_m_item_4"
    class_name "item"
    text "(4) The defendant could not reasonably have foreseen that the defendant's conduct in the course of the commission of murder, or other offense resulting in death for which the defendant was convicted, would cause, or would create a grave risk of causing, death to any person."
  ]
  node [
    id 3752
    label "section_848_subsection_q"
    class_name "subsection"
    text "(q) Appeal in capital cases; counsel for financially unable defendants"
  ]
  node [
    id 3753
    label "section_848_subsection_o"
    class_name "subsection"
    text "(o) Right of defendant to justice without discrimination"
  ]
  node [
    id 3754
    label "section_848_subsection_i_item_1_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the jury which determined the defendant's guilt has been discharged for good cause; or"
  ]
  node [
    id 3755
    label "section_848_subsection_q_item_3_subitem_A"
    class_name "subitem"
    text "(A) the sentence of death was not imposed under the influence of passion, prejudice, or any other arbitrary factor; and"
  ]
  node [
    id 3756
    label "section_848_subsection_k_item_12"
    class_name "item"
    text "The jury, or if there is no jury, the court, shall consider all the information received during the hearing. It shall return special findings identifying any aggravating factors set forth in subsection (n) of this section, found to exist. If one of the aggravating factors set forth in subsection (n)(1) of this section and another of the aggravating factors set forth in paragraphs (2) through (12) of subsection (n) of this section is found to exist, a special finding identifying any other aggravating factor for which notice has been provided under subsection (h)(1)(B) of this section, may be returned. A finding with respect to a mitigating factor may be made by one or more of the members of the jury, and any member of the jury who finds the existence of a mitigating factor may consider such a factor established for purposes of this subsection, regardless of the number of jurors who concur that the factor has been established. A finding with respect to any aggravating factor must be unanimous. If an aggravating factor set forth in subsection (n)(1) of this section is not found to exist or an aggravating factor set forth in subsection (n)(1) of this section is found to exist but no other aggravating factor set forth in subsection (n) of this section is found to exist, the court shall impose a sentence, other than death, authorized by law. If an aggravating factor set forth in subsection (n)(1) of this section and one or more of the other aggravating factors set forth in subsection (n) of this section are found to exist, the jury, or if there is no jury, the court, shall then consider whether the aggravating factors found to exist sufficiently outweigh any mitigating factor or factors found to exist, or in the absence of mitigating factors, whether the aggravating factors are themselves sufficient to justify a sentence of death. Based upon this consideration, the jury by unanimous vote, or if there is no jury, the court, shall recommend that a sentence of death shall be imposed rather than a sentence of life imprisonment without possibility of release or some other lesser sentence. The jury or the court, regardless of its findings with respect to aggravating and mitigating factors, is never required to impose a death sentence and the jury shall be so instructed."
  ]
  node [
    id 3757
    label "section_848_subsection_m_item_9"
    class_name "item"
    text "(9) The victim consented to the criminal conduct that resulted in the victim's death."
  ]
  node [
    id 3758
    label "section_848_subsection_o_item_2"
    class_name "item"
    text "(2) Not later than one year from November 18, 1988, the Comptroller General shall conduct a study of the various procedures used by the several States for determining whether or not to impose the death penalty in particular cases, and shall report to the Congress on whether or not any or all of the various procedures create a significant risk that the race of a defendant, or the race of a victim against whom a crime was committed, influence the likelihood that defendants in those States will be sentenced to death. In conducting the study required by this paragraph, the General Accounting Office shall&#8212;"
  ]
  node [
    id 3759
    label "section_848_subsection_q_item_4"
    class_name "item"
    text "(4)(A) Notwithstanding any other provision of law to the contrary, in every criminal action in which a defendant is charged with a crime which may be punishable by death, a defendant who is or becomes financially unable to obtain adequate representation or investigative, expert, or other reasonably necessary services at any time either&#8212;"
  ]
  node [
    id 3760
    label "section_848_subsection_e"
    class_name "subsection"
    text "(e) Death penalty"
  ]
  node [
    id 3761
    label "section_848_subsection_q_item_10"
    class_name "item"
    text "(10) Notwithstanding the rates and maximum limits generally applicable to criminal cases and any other provision of law to the contrary, the court shall fix the compensation to be paid to attorneys appointed under this subsection and the fees and expenses to be paid for investigative, expert, and other reasonably necessary services authorized under paragraph (9), at such rates or amounts as the court determines to be reasonably necessary to carry out the requirements of paragraphs (4) through (9)."
  ]
  node [
    id 3762
    label "section_848_subsection_n_item_1_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) resulted in the death of the victim."
  ]
  node [
    id 3763
    label "section_848_subsection_n_item_1_subitem_B"
    class_name "subitem"
    text "(B) intentionally inflicted serious bodily injury which resulted in the death of the victim;"
  ]
  node [
    id 3764
    label "section_848_subsection_o_item_2_subitem_B"
    class_name "subitem"
    text "(B) study only crimes occurring after January 1, 1976; and"
  ]
  node [
    id 3765
    label "section_848_subsection_n_item_12"
    class_name "item"
    text "(12) The defendant committed the offense in an especially heinous, cruel, or depraved manner in that it involved torture or serious physical abuse to the victim."
  ]
  node [
    id 3766
    label "section_848_subsection_i_item_1"
    class_name "item"
    text "(1) When the attorney for the Government has filed a notice as required under subsection (h) of this section and the defendant is found guilty of or pleads guilty to an offense under subsection (e) of this section, the judge who presided at the trial or before whom the guilty plea was entered, or any other judge if the judge who presided at the trial or before whom the guilty plea was entered is unavailable, shall conduct a separate sentencing hearing to determine the punishment to be imposed. The hearing shall be conducted&#8212;"
  ]
  node [
    id 3767
    label "section_848_subsection_i"
    class_name "subsection"
    text "(i) Hearing before court or jury"
  ]
  node [
    id 3768
    label "section_848_subsection_e_item_1"
    class_name "item"
    text "(1) In addition to the other penalties set forth in this section&#8212;"
  ]
  node [
    id 3769
    label "section_848_subsection_q_item_4_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) before judgment; or"
  ]
  node [
    id 3770
    label "section_848_subsection_n_item_10"
    class_name "item"
    text "(10) The defendant had previously been convicted of violating this subchapter or subchapter II of this chapter for which a sentence of five or more years may be imposed or had previously been convicted of engaging in a continuing criminal enterprise."
  ]
  node [
    id 3771
    label "section_848_subsection_h_item_2"
    class_name "item"
    text "(2) The court may permit the attorney for the Government to amend this notice for good cause shown."
  ]
  node [
    id 3772
    label "section_848_subsection_q_item_3"
    class_name "item"
    text "(3) The court shall affirm the sentence if it determines that&#8212;"
  ]
  node [
    id 3773
    label "section_848_subsection_o_item_2_subitem_C"
    class_name "subitem"
    text "(C) determine what, if any, other factors, including any relation between any aggravating or mitigating factors and the race of the victim or the defendant, may account for any evidence that the race of the defendant, or the race of the victim, influences the likelihood that defendants will be sentenced to death. In addition, the General Accounting Office shall examine separately and include in the report, death penalty cases involving crimes similar to those covered under this section."
  ]
  node [
    id 3774
    label "section_848_subsection_d"
    class_name "subsection"
    text "(d) Suspension of sentence and probation prohibited"
  ]
  node [
    id 3775
    label "section_848_subsection_k"
    class_name "subsection"
    text "(k) Return of findings"
  ]
  node [
    id 3776
    label "section_848_subsection_q_item_3_subitem_B"
    class_name "subitem"
    text "(B) the information supports the special finding of the existence of every aggravating factor upon which the sentence was based, together with, or the failure to find, any mitigating factors as set forth or allowed in this section."
  ]
  node [
    id 3777
    label "section_848_subsection_q_item_9"
    class_name "item"
    text "(9) Upon a finding in ex parte proceedings that investigative, expert or other services are reasonably necessary for the representation of the defendant, whether in connection with issues relating to guilt or sentence, the court shall authorize the defendant's attorneys to obtain such services on behalf of the defendant and shall order the payment of fees and expenses therefore, under paragraph (10). Upon a finding that timely procurement of such services could not practicably await prior authorization, the court may authorize the provision of and payment for such services nunc pro tunc."
  ]
  node [
    id 3778
    label "section_848_subsection_q_item_1"
    class_name "item"
    text "(1) In any case in which the sentence of death is imposed under this section, the sentence of death shall be subject to review by the court of appeals upon appeal by the defendant. Notice of appeal must be filed within the time prescribed for appeal of judgment in section 2107 of title 28. An appeal under this section may be consolidated with an appeal of the judgment of conviction. Such review shall have priority over all other cases."
  ]
  node [
    id 3779
    label "section_848_subsection_n_item_1"
    class_name "item"
    text "(1) The defendant&#8212;"
  ]
  node [
    id 3780
    label "section_848_subsection_m_item_2"
    class_name "item"
    text "(2) The defendant was under unusual and substantial duress, regardless of whether the duress was of such a degree as to constitute a defense to the charge."
  ]
  node [
    id 3781
    label "section_848_subsection_c"
    class_name "subsection"
    text "(c) &#8220;Continuing criminal enterprise&#8221; defined"
  ]
  node [
    id 3782
    label "section_848_subsection_i_item_1_subitem_A"
    class_name "subitem"
    text "(A) before the jury which determined the defendant's guilt;"
  ]
  node [
    id 3783
    label "section_848_subsection_m_item_1"
    class_name "item"
    text "(1) The defendant's capacity to appreciate the wrongfulness of the defendant's conduct or to conform conduct to the requirements of law was significantly impaired, regardless of whether the capacity was so impaired as to constitute a defense to the charge."
  ]
  node [
    id 3784
    label "section_848_subsection_n_item_1_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(i) the defendant knew would create a grave risk of death to a person, other than one of the participants in the offense; and"
  ]
  node [
    id 3785
    label "section_848_subsection_n_item_9"
    class_name "item"
    text "(9) The victim was particularly vulnerable due to old age, youth, or infirmity."
  ]
  node [
    id 3786
    label "section_848_subsection_j_item_1"
    class_name "item"
    text "Notwithstanding rule 32(c) of the Federal Rules of Criminal Procedure, when a defendant is found guilty of or pleads guilty to an offense under subsection (e) of this section, no presentence report shall be prepared. In the sentencing hearing, information may be presented as to matters relating to any of the aggravating or mitigating factors set forth in subsections (m) and (n) of this section, or any other mitigating factor or any other aggravating factor for which notice has been provided under subsection (h)(1)(B) of this section. Where information is presented relating to any of the aggravating factors set forth in subsection (n) of this section, information may be presented relating to any other aggravating factor for which notice has been provided under subsection (h)(1)(B) of this section. Information presented may include the trial transcript and exhibits if the hearing is held before a jury or judge not present during the trial, or at the trial judge's discretion. Any other information relevant to such mitigating or aggravating factors may be presented by either the Government or the defendant, regardless of its admissibility under the rules governing admission of evidence at criminal trials, except that information may be excluded if its probative value is substantially outweighed by the danger of unfair prejudice, confusion of the issues, or misleading the jury. The Government and the defendant shall be permitted to rebut any information received at the hearing and shall be given fair opportunity to present argument as to the adequacy of the information to establish the existence of any of the aggravating or mitigating factors and as to appropriateness in that case of imposing a sentence of death. The Government shall open the argument. The defendant shall be permitted to reply. The Government shall then be permitted to reply in rebuttal. The burden of establishing the existence of any aggravating factor is on the Government, and is not satisfied unless established beyond a reasonable doubt. The burden of establishing the existence of any mitigating factor is on the defendant, and is not satisfied unless established by a preponderance of the evidence."
  ]
  node [
    id 3787
    label "section_848_subsection_q_item_2"
    class_name "item"
    text "(2) On review of the sentence, the court of appeals shall consider the record, the evidence submitted during the trial, the information submitted during the sentencing hearing, the procedures employed in the sentencing hearing, and the special findings returned under this section."
  ]
  node [
    id 3788
    label "section_848_subsection_i_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the defendant was convicted after a trial before the court sitting without a jury;"
  ]
  node [
    id 3789
    label "section_848_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) the enterprise, or any other enterprise in which the defendant was the principal or one of several principal administrators, organizers, or leaders, received $10 million dollars in gross receipts during any twelve-month period of its existence for the manufacture, importation, or distribution of a substance described in section 841(b)(1)(B) of this title."
  ]
  node [
    id 3790
    label "section_848_subsection_m_item_6"
    class_name "item"
    text "(6) The defendant did not have a significant prior criminal record."
  ]
  node [
    id 3791
    label "section_848_subsection_m_item_7"
    class_name "item"
    text "(7) The defendant committed the offense under severe mental or emotional disturbance."
  ]
  node [
    id 3792
    label "section_848_subsection_m_item_8"
    class_name "item"
    text "(8) Another defendant or defendants, equally culpable in the crime, will not be punished by death."
  ]
  node [
    id 3793
    label "section_848_subsection_l_item_2"
    class_name "item"
    text "(2) lacks the capacity to recognize or understand facts which would make the punishment unjust or unlawful, or lacks the ability to convey such information to counsel or to the court."
  ]
  node [
    id 3794
    label "section_848_subsection_j_item_1_subitem_B"
    class_name "subitem"
    text "Notwithstanding rule 32(c) of the Federal Rules of Criminal Procedure, when a defendant is found guilty of or pleads guilty to an offense under subsection (e) of this section, no presentence report shall be prepared. In the sentencing hearing, information may be presented as to matters relating to any of the aggravating or mitigating factors set forth in subsections (m) and (n) of this section, or any other mitigating factor or any other aggravating factor for which notice has been provided under subsection (h)(1)(B) of this section. Where information is presented relating to any of the aggravating factors set forth in subsection (n) of this section, information may be presented relating to any other aggravating factor for which notice has been provided under subsection (h)(1)(B) of this section. Information presented may include the trial transcript and exhibits if the hearing is held before a jury or judge not present during the trial, or at the trial judge's discretion. Any other information relevant to such mitigating or aggravating factors may be presented by either the Government or the defendant, regardless of its admissibility under the rules governing admission of evidence at criminal trials, except that information may be excluded if its probative value is substantially outweighed by the danger of unfair prejudice, confusion of the issues, or misleading the jury. The Government and the defendant shall be permitted to rebut any information received at the hearing and shall be given fair opportunity to present argument as to the adequacy of the information to establish the existence of any of the aggravating or mitigating factors and as to appropriateness in that case of imposing a sentence of death. The Government shall open the argument. The defendant shall be permitted to reply. The Government shall then be permitted to reply in rebuttal. The burden of establishing the existence of any aggravating factor is on the Government, and is not satisfied unless established beyond a reasonable doubt. The burden of establishing the existence of any mitigating factor is on the defendant, and is not satisfied unless established by a preponderance of the evidence."
  ]
  node [
    id 3795
    label "section_848_subsection_n_item_1_subitem_A"
    class_name "subitem"
    text "(A) intentionally killed the victim;"
  ]
  node [
    id 3796
    label "section_848_subsection_i_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the defendant was convicted upon a plea of guilty;"
  ]
  node [
    id 3797
    label "section_848_subsection_n_item_4"
    class_name "item"
    text "(4) The defendant has previously been convicted of two or more State or Federal offenses punishable by a term of imprisonment of more than one year, committed on different occasions, involving the distribution of a controlled substance."
  ]
  node [
    id 3798
    label "section_848_subsection_b"
    class_name "subsection"
    text "(b) Life imprisonment for engaging in continuing criminal enterprise"
  ]
  node [
    id 3799
    label "section_848_subsection_k_item_2"
    class_name "item"
    text "The jury, or if there is no jury, the court, shall consider all the information received during the hearing. It shall return special findings identifying any aggravating factors set forth in subsection (n) of this section, found to exist. If one of the aggravating factors set forth in subsection (n)(1) of this section and another of the aggravating factors set forth in paragraphs (2) through (12) of subsection (n) of this section is found to exist, a special finding identifying any other aggravating factor for which notice has been provided under subsection (h)(1)(B) of this section, may be returned. A finding with respect to a mitigating factor may be made by one or more of the members of the jury, and any member of the jury who finds the existence of a mitigating factor may consider such a factor established for purposes of this subsection, regardless of the number of jurors who concur that the factor has been established. A finding with respect to any aggravating factor must be unanimous. If an aggravating factor set forth in subsection (n)(1) of this section is not found to exist or an aggravating factor set forth in subsection (n)(1) of this section is found to exist but no other aggravating factor set forth in subsection (n) of this section is found to exist, the court shall impose a sentence, other than death, authorized by law. If an aggravating factor set forth in subsection (n)(1) of this section and one or more of the other aggravating factors set forth in subsection (n) of this section are found to exist, the jury, or if there is no jury, the court, shall then consider whether the aggravating factors found to exist sufficiently outweigh any mitigating factor or factors found to exist, or in the absence of mitigating factors, whether the aggravating factors are themselves sufficient to justify a sentence of death. Based upon this consideration, the jury by unanimous vote, or if there is no jury, the court, shall recommend that a sentence of death shall be imposed rather than a sentence of life imprisonment without possibility of release or some other lesser sentence. The jury or the court, regardless of its findings with respect to aggravating and mitigating factors, is never required to impose a death sentence and the jury shall be so instructed."
  ]
  node [
    id 3800
    label "section_848_subsection_q_item_9_subitem_B"
    class_name "subitem"
    text "(B) In any post conviction proceeding under section 2254 or 2255 of title 28 seeking to vacate or set aside a death sentence, any defendant who is or becomes financially unable to obtain adequate representation or investigative, expert, or other reasonably necessary services shall be entitled to the appointment of one or more attorneys and the furnishing of such other services in accordance with paragraphs (5), (6), (7), (8), and (9)."
  ]
  node [
    id 3801
    label "section_848_subsection_h_item_1"
    class_name "item"
    text "(1) Whenever the Government intends to seek the death penalty for an offense under this section for which one of the sentences provided is death, the attorney for the Government, a reasonable time before trial or acceptance by the court of a plea of guilty, shall sign and file with the court, and serve upon the defendant, a notice&#8212;"
  ]
  node [
    id 3802
    label "section_848_subsection_n_item_8"
    class_name "item"
    text "(8) The defendant committed the offense after substantial planning and premeditation."
  ]
  node [
    id 3803
    label "section_848_subsection_h_item_1_subitem_A"
    class_name "subitem"
    text "(A) that the Government in the event of conviction will seek the sentence of death; and"
  ]
  node [
    id 3804
    label "section_848_subsection_n_item_5"
    class_name "item"
    text "(5) In the commission of the offense or in escaping apprehension for a violation of subsection (e) of this section, the defendant knowingly created a grave risk of death to one or more persons in addition to the victims of the offense."
  ]
  node [
    id 3805
    label "section_848_subsection_m_item_10"
    class_name "item"
    text "(10) That other factors in the defendant's background or character mitigate against imposition of the death sentence."
  ]
  node [
    id 3806
    label "section_848_subsection_n_item_6"
    class_name "item"
    text "(6) The defendant procured the commission of the offense by payment, or promise of payment, of anything of pecuniary value."
  ]
  node [
    id 3807
    label "section_848_subsection_a"
    class_name "subsection"
    text "(a) Penalties; forfeitures"
  ]
  node [
    id 3808
    label "section_848_subsection_n_item_7"
    class_name "item"
    text "(7) The defendant committed the offense as consideration for the receipt, or in the expectation of the receipt, of anything of pecuniary value."
  ]
  node [
    id 3809
    label "section_848_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) from which such person obtains substantial income or resources."
  ]
  node [
    id 3810
    label "section_848_subsection_i_item_1_subitem_C"
    class_name "subitem"
    text "(C) before the court alone, upon the motion of the defendant and with the approval of the Government."
  ]
  node [
    id 3811
    label "section_848_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) the violation referred to in subsection (c)(1) of this section involved at least 300 times the quantity of a substance described in subsection 841(b)(1)(B) of this title, or"
  ]
  node [
    id 3812
    label "section_848_subsection_i_item_2"
    class_name "item"
    text "(2) A jury impaneled under paragraph (1)(B) shall consist of 12 members, unless, at any time before the conclusion of the hearing, the parties stipulate with the approval of the court that it shall consist of any number less than 12."
  ]
  node [
    id 3813
    label "section_848_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(A) any person engaging in or working in furtherance of a continuing criminal enterprise, or any person engaging in an offense punishable under section 841(b)(1)(A) of this title or section 960(b)(1) of this title who intentionally kills or counsels, commands, induces, procures, or causes the intentional killing of an individual and such killing results, shall be sentenced to any term of imprisonment, which shall not be less than 20 years, and which may be up to life imprisonment, or may be sentenced to death; and"
  ]
  node [
    id 3814
    label "section_848_subsection_q_item_5"
    class_name "item"
    text "(5) If the appointment is made before judgment, at least one attorney so appointed must have been admitted to practice in the court in which the prosecution is to be tried for not less than five years, and must have had not less than three years experience in the actual trial of felony prosecutions in that court."
  ]
  node [
    id 3815
    label "section_848_subsection_m_item_5"
    class_name "item"
    text "(5) The defendant was youthful, although not under the age of 18."
  ]
  node [
    id 3816
    label "section_849_subsection_b_item_1"
    class_name "item"
    text "(1) twice the maximum punishment authorized by section 841(b) of this title; and"
  ]
  node [
    id 3817
    label "section_849_subsection_a"
    class_name "subsection"
    text "(a) Definitions"
  ]
  node [
    id 3818
    label "section_849_subsection_a_subitem_A"
    class_name "subitem"
    text "(A) has the capacity to provide fuel or service, or both, to any commercial motor vehicle (as defined in section 31301 of title 49), operating in commerce (as defined in that section); and"
  ]
  node [
    id 3819
    label "section_849_subsection_a_subitem_B"
    class_name "subitem"
    text "(B) is located within 2,500 feet of the National System of Interstate and Defense Highways or the Federal-Aid Primary System."
  ]
  node [
    id 3820
    label "section_849_subsection_b"
    class_name "subsection"
    text "(b) First offense"
  ]
  node [
    id 3821
    label "section_849_subsection_c_item_1"
    class_name "item"
    text "(1) 3 times the maximum punishment authorized by section 841(b) of this title; and"
  ]
  node [
    id 3822
    label "section_849_subsection_c"
    class_name "subsection"
    text "(c) Subsequent offense"
  ]
  node [
    id 3823
    label "section_849_subsection_c_item_2"
    class_name "item"
    text "(2) 3 times any term of supervised release authorized by section 841(b) of this title for a first offense."
  ]
  node [
    id 3824
    label "section_849_subsection_b_item_2"
    class_name "item"
    text "(2) twice any term of supervised release authorized by section 841(b) of this title for a first offense."
  ]
  node [
    id 3825
    label "section_851_subsection_e"
    class_name "subsection"
    text "(e) Statute of limitations"
  ]
  node [
    id 3826
    label "section_851_subsection_a_item_1"
    class_name "item"
    text "(1) No person who stands convicted of an offense under this part shall be sentenced to increased punishment by reason of one or more prior convictions, unless before trial, or before entry of a plea of guilty, the United States attorney files an information with the court (and serves a copy of such information on the person or counsel for the person) stating in writing the previous convictions to be relied upon. Upon a showing by the United States attorney that facts regarding prior convictions could not with due diligence be obtained prior to trial or before entry of a plea of guilty, the court may postpone the trial or the taking of the plea of guilty for a reasonable period for the purpose of obtaining such facts. Clerical mistakes in the information may be amended at any time prior to the pronouncement of sentence."
  ]
  node [
    id 3827
    label "section_851_subsection_d_item_2"
    class_name "item"
    text "(2) If the court determines that the person has not been convicted as alleged in the information, that a conviction alleged in the information is invalid, or that the person is otherwise not subject to an increased sentence as a matter of law, the court shall, at the request of the United States attorney, postpone sentence to allow an appeal from that determination. If no such request is made, the court shall impose sentence as provided by this part. The person may appeal from an order postponing sentence as if sentence had been pronounced and a final judgment of conviction entered."
  ]
  node [
    id 3828
    label "section_851_subsection_d"
    class_name "subsection"
    text "(d) Imposition of sentence"
  ]
  node [
    id 3829
    label "section_851_subsection_b"
    class_name "subsection"
    text "(b) Affirmation or denial of previous conviction"
  ]
  node [
    id 3830
    label "section_851_subsection_a_item_2"
    class_name "item"
    text "(2) An information may not be filed under this section if the increased punishment which may be imposed is imprisonment for a term in excess of three years unless the person either waived or was afforded prosecution by indictment for the offense for which such increased punishment may be imposed."
  ]
  node [
    id 3831
    label "section_851_subsection_c"
    class_name "subsection"
    text "(c) Denial; written response; hearing"
  ]
  node [
    id 3832
    label "section_851_subsection_c_item_2"
    class_name "item"
    text "(2) A person claiming that a conviction alleged in the information was obtained in violation of the Constitution of the United States shall set forth his claim, and the factual basis therefor, with particularity in his response to the information. The person shall have the burden of proof by a preponderance of the evidence on any issue of fact raised by the response. Any challenge to a prior conviction, not raised by response to the information before an increased sentence is imposed in reliance thereon, shall be waived unless good cause be shown for failure to make a timely challenge."
  ]
  node [
    id 3833
    label "section_851_subsection_d_item_1"
    class_name "item"
    text "(1) If the person files no response to the information, or if the court determines, after hearing, that the person is subject to increased punishment by reason of prior convictions, the court shall proceed to impose sentence upon him as provided by this part."
  ]
  node [
    id 3834
    label "section_851_subsection_a"
    class_name "subsection"
    text "(a) Information filed by United States Attorney"
  ]
  node [
    id 3835
    label "section_851_subsection_c_item_1"
    class_name "item"
    text "(1) If the person denies any allegation of the information of prior conviction, or claims that any conviction alleged is invalid, he shall file a written response to the information. A copy of the response shall be served upon the United States attorney. The court shall hold a hearing to determine any issues raised by the response which would except the person from increased punishment. The failure of the United States attorney to include in the information the complete criminal record of the person or any facts in addition to the convictions to be relied upon shall not constitute grounds for invalidating the notice given in the information required by subsection (a)(1) of this section. The hearing shall be before the court without a jury and either party may introduce evidence. Except as otherwise provided in paragraph (2) of this subsection, the United States attorney shall have the burden of proof beyond a reasonable doubt on any issue of fact. At the request of either party, the court shall enter findings of fact and conclusions of law."
  ]
  node [
    id 3836
    label "section_853_subsection_p_item_1"
    class_name "item"
    text "the court shall order the forfeiture of any other property of the defendant up to the value of any property described in paragraphs (1) through (5)."
  ]
  node [
    id 3837
    label "section_853_subsection_n_item_1"
    class_name "item"
    text "(1) Following the entry of an order of forfeiture under this section, the United States shall publish notice of the order and of its intent to dispose of the property in such manner as the Attorney General may direct. The Government may also, to the extent practicable, provide direct written notice to any person known to have alleged an interest in the property that is the subject of the order of forfeiture as a substitute for published notice as to those persons so notified."
  ]
  node [
    id 3838
    label "section_853_subsection_e_item_1"
    class_name "item"
    text "(1) Upon application of the United States, the court may enter a restraining order or injunction, require the execution of a satisfactory performance bond, or take any other action to preserve the availability of property described in subsection (a) of this section for forfeiture under this section&#8212;"
  ]
  node [
    id 3839
    label "section_853_subsection_e"
    class_name "subsection"
    text "(e) Protective orders"
  ]
  node [
    id 3840
    label "section_853_subsection_k"
    class_name "subsection"
    text "(k) Bar on intervention"
  ]
  node [
    id 3841
    label "section_853_subsection_d"
    class_name "subsection"
    text "(d) Rebuttable presumption"
  ]
  node [
    id 3842
    label "section_853_subsection_f"
    class_name "subsection"
    text "(f) Warrant of seizure"
  ]
  node [
    id 3843
    label "section_853_subsection_a"
    class_name "subsection"
    text "(a) Property subject to criminal forfeiture"
  ]
  node [
    id 3844
    label "section_853_subsection_e_item_2"
    class_name "item"
    text "(2) A temporary restraining order under this subsection may be entered upon application of the United States without notice or opportunity for a hearing when an information or indictment has not yet been filed with respect to the property, if the United States demonstrates that there is probable cause to believe that the property with respect to which the order is sought would, in the event of conviction, be subject to forfeiture under this section and that provision of notice will jeopardize the availability of the property for forfeiture. Such a temporary order shall expire not more than ten days after the date on which it is entered, unless extended for good cause shown or unless the party against whom it is entered consents to an extension for a longer period. A hearing requested concerning an order entered under this paragraph shall be held at the earliest possible time and prior to the expiration of the temporary order."
  ]
  node [
    id 3845
    label "section_853_subsection_b"
    class_name "subsection"
    text "(b) Meaning of term &#8220;property&#8221;"
  ]
  node [
    id 3846
    label "section_853_subsection_a_item_2"
    class_name "item"
    text "(2) any of the person's property used, or intended to be used, in any manner or part, to commit, or to facilitate the commission of, such violation; and"
  ]
  node [
    id 3847
    label "section_853_subsection_i_item_3"
    class_name "item"
    text "(3) award compensation to persons providing information resulting in a forfeiture under this section;"
  ]
  node [
    id 3848
    label "section_853_subsection_i_item_2"
    class_name "item"
    text "(2) compromise claims arising under this section;"
  ]
  node [
    id 3849
    label "section_853_subsection_n"
    class_name "subsection"
    text "(n) Third party interests"
  ]
  node [
    id 3850
    label "section_853_subsection_n_item_6_subitem_A"
    class_name "subitem"
    text "(A) the petitioner has a legal right, title, or interest in the property, and such right, title, or interest renders the order of forfeiture invalid in whole or in part because the right, title, or interest was vested in the petitioner rather than the defendant or was superior to any right, title, or interest of the defendant at the time of the commission of the acts which gave rise to the forfeiture of the property under this section; or"
  ]
  node [
    id 3851
    label "section_853_subsection_b_item_2"
    class_name "item"
    text "(2) tangible and intangible personal property, including rights, privileges, interests, claims, and securities."
  ]
  node [
    id 3852
    label "section_853_subsection_n_item_6"
    class_name "item"
    text "(6) If, after the hearing, the court determines that the petitioner has established by a preponderance of the evidence that&#8212;"
  ]
  node [
    id 3853
    label "section_853_subsection_p"
    class_name "subsection"
    text "(p) Forfeiture of substitute property"
  ]
  node [
    id 3854
    label "section_853_subsection_j"
    class_name "subsection"
    text "(j) Applicability of civil forfeiture provisions"
  ]
  node [
    id 3855
    label "section_853_subsection_p_item_2"
    class_name "item"
    text "(2) has been transferred or sold to, or deposited with, a third party;"
  ]
  node [
    id 3856
    label "section_853_subsection_g"
    class_name "subsection"
    text "(g) Execution"
  ]
  node [
    id 3857
    label "section_853_subsection_k_item_2"
    class_name "item"
    text "(2) commence an action at law or equity against the United States concerning the validity of his alleged interest in the property subsequent to the filing of an indictment or information alleging that the property is subject to forfeiture under this section."
  ]
  node [
    id 3858
    label "section_853_subsection_i_item_1"
    class_name "item"
    text "(1) grant petitions for mitigation or remission of forfeiture, restore forfeited property to victims of a violation of this subchapter, or take any other action to protect the rights of innocent persons which is in the interest of justice and which is not inconsistent with the provisions of this section;"
  ]
  node [
    id 3859
    label "section_853_subsection_e_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the need to preserve the availability of the property through the entry of the requested order outweighs the hardship on any party against whom the order is to be entered:"
  ]
  node [
    id 3860
    label "section_853_subsection_d_item_1"
    class_name "item"
    text "(1) such property was acquired by such person during the period of the violation of this subchapter or subchapter II of this chapter or within a reasonable time after such period; and"
  ]
  node [
    id 3861
    label "section_853_subsection_n_item_3"
    class_name "item"
    text "(3) The petition shall be signed by the petitioner under penalty of perjury and shall set forth the nature and extent of the petitioner's right, title, or interest in the property, the time and circumstances of the petitioner's acquisition of the right, title, or interest in the property, any additional facts supporting the petitioner's claim, and the relief sought."
  ]
  node [
    id 3862
    label "section_853_subsection_n_item_7"
    class_name "item"
    text "(7) Following the court's disposition of all petitions filed under this subsection, or if no such petitions are filed following the expiration of the period provided in paragraph (2) for the filing of such petitions, the United States shall have clear title to property that is the subject of the order of forfeiture and may warrant good title to any subsequent purchaser or transferee."
  ]
  node [
    id 3863
    label "section_853_subsection_m"
    class_name "subsection"
    text "(m) Depositions"
  ]
  node [
    id 3864
    label "section_853_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "Provided, however, That an order entered pursuant to subparagraph (B) shall be effective for not more than ninety days, unless extended by the court for good cause shown or unless an indictment or information described in subparagraph (A) has been filed."
  ]
  node [
    id 3865
    label "section_853_subsection_i_item_5"
    class_name "item"
    text "(5) take appropriate measures necessary to safeguard and maintain property ordered forfeited under this section pending its disposition."
  ]
  node [
    id 3866
    label "section_853_subsection_e_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) there is a substantial probability that the United States will prevail on the issue of forfeiture and that failure to enter the order will result in the property being destroyed, removed from the jurisdiction of the court, or otherwise made unavailable for forfeiture; and"
  ]
  node [
    id 3867
    label "section_853_subsection_p_item_3"
    class_name "item"
    text "(3) has been placed beyond the jurisdiction of the court;"
  ]
  node [
    id 3868
    label "section_853_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "Provided, however, That an order entered pursuant to subparagraph (B) shall be effective for not more than ninety days, unless extended by the court for good cause shown or unless an indictment or information described in subparagraph (A) has been filed."
  ]
  node [
    id 3869
    label "section_853_subsection_n_item_2"
    class_name "item"
    text "(2) Any person, other than the defendant, asserting a legal interest in property which has been ordered forfeited to the United States pursuant to this section may, within thirty days of the final publication of notice or his receipt of notice under paragraph (1), whichever is earlier, petition the court for a hearing to adjudicate the validity of his alleged interest in the property. The hearing shall be held before the court alone, without a jury."
  ]
  node [
    id 3870
    label "section_853_subsection_d_item_2"
    class_name "item"
    text "(2) there was no likely source for such property other than the violation of this subchapter or subchapter II of this chapter."
  ]
  node [
    id 3871
    label "section_853_subsection_n_item_5"
    class_name "item"
    text "(5) At the hearing, the petitioner may testify and present evidence and witnesses on his own behalf, and cross-examine witnesses who appear at the hearing. The United States may present evidence and witnesses in rebuttal and in defense of its claim to the property and cross-examine witnesses who appear at the hearing. In addition to testimony and evidence presented at the hearing, the court shall consider the relevant portions of the record of the criminal case which resulted in the order of forfeiture."
  ]
  node [
    id 3872
    label "section_853_subsection_c"
    class_name "subsection"
    text "(c) Third party transfers"
  ]
  node [
    id 3873
    label "section_853_subsection_a_item_1"
    class_name "item"
    text "(1) any property constituting, or derived from, any proceeds the person obtained, directly or indirectly, as the result of such violation;"
  ]
  node [
    id 3874
    label "section_853_subsection_p_item_5"
    class_name "item"
    text "the court shall order the forfeiture of any other property of the defendant up to the value of any property described in paragraphs (1) through (5)."
  ]
  node [
    id 3875
    label "section_853_subsection_l"
    class_name "subsection"
    text "(l) Jurisdiction to enter orders"
  ]
  node [
    id 3876
    label "section_853_subsection_o"
    class_name "subsection"
    text "(o) Construction"
  ]
  node [
    id 3877
    label "section_853_subsection_e_item_3"
    class_name "item"
    text "(3) The court may receive and consider, at a hearing held pursuant to this subsection, evidence and information that would be inadmissible under the Federal Rules of Evidence."
  ]
  node [
    id 3878
    label "section_853_subsection_p_item_4"
    class_name "item"
    text "(4) has been substantially diminished in value; or"
  ]
  node [
    id 3879
    label "section_853_subsection_a_item_3"
    class_name "item"
    text "(3) in the case of a person convicted of engaging in a continuing criminal enterprise in violation of section 848 of this title, the person shall forfeit, in addition to any property described in paragraph (1) or (2), any of his interest in, claims against, and property or contractual rights affording a source of control over, the continuing criminal enterprise."
  ]
  node [
    id 3880
    label "section_853_subsection_k_item_1"
    class_name "item"
    text "(1) intervene in a trial or appeal of a criminal case involving the forfeiture of such property under this section; or"
  ]
  node [
    id 3881
    label "section_853_subsection_b_item_1"
    class_name "item"
    text "(1) real property, including things growing on, affixed to, and found in land; and"
  ]
  node [
    id 3882
    label "section_853_subsection_h"
    class_name "subsection"
    text "(h) Disposition of property"
  ]
  node [
    id 3883
    label "section_853_subsection_i_item_4"
    class_name "item"
    text "(4) direct the disposition by the United States, in accordance with the provisions of section 881(e) of this title, of all property ordered forfeited under this section by public sale or any other commercially feasible means, making due provision for the rights of innocent persons; and"
  ]
  node [
    id 3884
    label "section_853_subsection_n_item_4"
    class_name "item"
    text "(4) The hearing on the petition shall, to the extent practicable and consistent with the interests of justice, be held within thirty days of the filing of the petition. The court may consolidate the hearing on the petition with a hearing on any other petition filed by a person other than the defendant under this subsection."
  ]
  node [
    id 3885
    label "section_853_subsection_i"
    class_name "subsection"
    text "(i) Authority of the Attorney General"
  ]
  node [
    id 3886
    label "section_853_subsection_n_item_6_subitem_B"
    class_name "subitem"
    text "(B) the petitioner is a bona fide purchaser for value of the right, title, or interest in the property and was at the time of purchase reasonably without cause to believe that the property was subject to forfeiture under this section;"
  ]
  node [
    id 3887
    label "section_853a_item_1"
    class_name "item"
    text "Section, Pub. L. 100&#8211;690, title V, &#167;5301, Nov. 18, 1988, 102 Stat. 4310, which related to denial of Federal benefits to drug traffickers and possessors, was renumbered section 421 of the Controlled Substances Act by Pub. L. 101&#8211;647, title X, &#167;1002(d)(1), Nov. 29, 1990, 104 Stat. 4827, and is classified to section 862 of this title."
  ]
  node [
    id 3888
    label "section_854_subsection_d"
    class_name "subsection"
    text "(d) Construction"
  ]
  node [
    id 3889
    label "section_854_subsection_b"
    class_name "subsection"
    text "(b) Penalty"
  ]
  node [
    id 3890
    label "section_854_subsection_c"
    class_name "subsection"
    text "(c) &#8220;Enterprise&#8221; defined"
  ]
  node [
    id 3891
    label "section_854_subsection_a"
    class_name "subsection"
    text "(a) Prohibition"
  ]
  node [
    id 3892
    label "section_856_subsection_b"
    class_name "subsection"
    text "(b) Any person who violates subsection (a) of this section shall be sentenced to a term of imprisonment of not more than 20 years or a fine of not more than $500,000, or both, or a fine of $2,000,000 for a person other than an individual."
  ]
  node [
    id 3893
    label "section_856_subsection_a"
    class_name "subsection"
    text "(a) Except as authorized by this subchapter, it shall be unlawful to&#8212;"
  ]
  node [
    id 3894
    label "section_856_subsection_a_item_2"
    class_name "item"
    text "(2) manage or control any building, room, or enclosure, either as an owner, lessee, agent, employee, or mortgagee, and knowingly and intentionally rent, lease, or make available for use, with or without compensation, the building, room, or enclosure for the purpose of unlawfully manufacturing, storing, distributing, or using a controlled substance."
  ]
  node [
    id 3895
    label "section_856_subsection_a_item_1"
    class_name "item"
    text "(1) knowingly open or maintain any place for the purpose of manufacturing, distributing, or using any controlled substance;"
  ]
  node [
    id 3896
    label "section_859_subsection_a"
    class_name "subsection"
    text "(a) First offense"
  ]
  node [
    id 3897
    label "section_859_subsection_a_item_2"
    class_name "item"
    text "Except as provided in section 860 of this title, any person at least eighteen years of age who violates section 841(a)(1) of this title by distributing a controlled substance to a person under twenty-one years of age is (except as provided in subsection (b) of this section) subject to (1) twice the maximum punishment authorized by section 841(b) of this title, and (2) at least twice any term of supervised release authorized by section 841(b) of this title, for a first offense involving the same controlled substance and schedule. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a term of imprisonment under this subsection shall be not less than one year. The mandatory minimum sentencing provisions of this subsection shall not apply to offenses involving 5 grams or less of marihuana."
  ]
  node [
    id 3898
    label "section_859_subsection_b"
    class_name "subsection"
    text "(b) Second offense"
  ]
  node [
    id 3899
    label "section_859_subsection_a_item_1"
    class_name "item"
    text "Except as provided in section 860 of this title, any person at least eighteen years of age who violates section 841(a)(1) of this title by distributing a controlled substance to a person under twenty-one years of age is (except as provided in subsection (b) of this section) subject to (1) twice the maximum punishment authorized by section 841(b) of this title, and (2) at least twice any term of supervised release authorized by section 841(b) of this title, for a first offense involving the same controlled substance and schedule. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a term of imprisonment under this subsection shall be not less than one year. The mandatory minimum sentencing provisions of this subsection shall not apply to offenses involving 5 grams or less of marihuana."
  ]
  node [
    id 3900
    label "section_859_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "Except as provided in section 860 of this title, any person at least eighteen years of age who violates section 841(a)(1) of this title by distributing a controlled substance to a person under twenty-one years of age after a prior conviction under subsection (a) of this section (or under section 333(b) of this title as in effect prior to May 1, 1971) has become final, is subject to (1) three times the maximum punishment authorized by section 841(b) of this title, and (2) at least three times any term of supervised release authorized by section 841(b) of this title, for a second or subsequent offense involving the same controlled substance and schedule. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a term of imprisonment under this subsection shall be not less than one year. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3901
    label "section_859_subsection_b_item_1"
    class_name "item"
    text "Except as provided in section 860 of this title, any person at least eighteen years of age who violates section 841(a)(1) of this title by distributing a controlled substance to a person under twenty-one years of age after a prior conviction under subsection (a) of this section (or under section 333(b) of this title as in effect prior to May 1, 1971) has become final, is subject to (1) three times the maximum punishment authorized by section 841(b) of this title, and (2) at least three times any term of supervised release authorized by section 841(b) of this title, for a second or subsequent offense involving the same controlled substance and schedule. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a term of imprisonment under this subsection shall be not less than one year. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3902
    label "section_859_subsection_b_item_2"
    class_name "item"
    text "Except as provided in section 860 of this title, any person at least eighteen years of age who violates section 841(a)(1) of this title by distributing a controlled substance to a person under twenty-one years of age after a prior conviction under subsection (a) of this section (or under section 333(b) of this title as in effect prior to May 1, 1971) has become final, is subject to (1) three times the maximum punishment authorized by section 841(b) of this title, and (2) at least three times any term of supervised release authorized by section 841(b) of this title, for a second or subsequent offense involving the same controlled substance and schedule. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a term of imprisonment under this subsection shall be not less than one year. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3903
    label "section_860_subsection_d"
    class_name "subsection"
    text "(d) Suspension of sentence; probation; parole"
  ]
  node [
    id 3904
    label "section_860_subsection_e_item_2"
    class_name "item"
    text "(2) The term &#8220;youth center&#8221; means any recreational facility and/or gymnasium (including any parking lot appurtenant thereto), intended primarily for use by persons under 18 years of age, which regularly provides athletic, civic, or cultural activities."
  ]
  node [
    id 3905
    label "section_860_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "Any person who violates section 841(a)(1) of this title or section 856 of this title by distributing, possessing with intent to distribute, or manufacturing a controlled substance in or on, or within one thousand feet of, the real property comprising a public or private elementary, vocational, or secondary school or a public or private college, junior college, or university, or a playground, or housing facility owned by a public housing authority, or within 100 feet of a public or private youth center, public swimming pool, or video arcade facility, after a prior conviction under subsection (a) of this section has become final is punishable (1) by the greater of (A) a term of imprisonment of not less than three years and not more than life imprisonment or (B) three times the maximum punishment authorized by section 841(b) of this title for a first offense, and (2) at least three times any term of supervised release authorized by section 841(b) of this title for a first offense. A fine up to three times that authorized by section 841(b) of this title may be imposed in addition to any term of imprisonment authorized by this subsection. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a person shall be sentenced under this subsection to a term of imprisonment of not less than three years. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3906
    label "section_860_subsection_e"
    class_name "subsection"
    text "(e) Definitions"
  ]
  node [
    id 3907
    label "section_860_subsection_b_item_1"
    class_name "item"
    text "Any person who violates section 841(a)(1) of this title or section 856 of this title by distributing, possessing with intent to distribute, or manufacturing a controlled substance in or on, or within one thousand feet of, the real property comprising a public or private elementary, vocational, or secondary school or a public or private college, junior college, or university, or a playground, or housing facility owned by a public housing authority, or within 100 feet of a public or private youth center, public swimming pool, or video arcade facility, after a prior conviction under subsection (a) of this section has become final is punishable (1) by the greater of (A) a term of imprisonment of not less than three years and not more than life imprisonment or (B) three times the maximum punishment authorized by section 841(b) of this title for a first offense, and (2) at least three times any term of supervised release authorized by section 841(b) of this title for a first offense. A fine up to three times that authorized by section 841(b) of this title may be imposed in addition to any term of imprisonment authorized by this subsection. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a person shall be sentenced under this subsection to a term of imprisonment of not less than three years. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3908
    label "section_860_subsection_e_item_4"
    class_name "item"
    text "(4) The term &#8220;swimming pool&#8221; includes any parking lot appurtenant thereto."
  ]
  node [
    id 3909
    label "section_860_subsection_a_item_2"
    class_name "item"
    text "Any person who violates section 841(a)(1) of this title or section 856 of this title by distributing, possessing with intent to distribute, or manufacturing a controlled substance in or on, or within one thousand feet of, the real property comprising a public or private elementary, vocational, or secondary school or a public or private college, junior college, or university, or a playground, or housing facility owned by a public housing authority, or within 100 feet of a public or private youth center, public swimming pool, or video arcade facility, is (except as provided in subsection (b) of this section) subject to (1) twice the maximum punishment authorized by section 841(b) of this title; and (2) at least twice any term of supervised release authorized by section 841(b) of this title for a first offense. A fine up to twice that authorized by section 841(b) of this title may be imposed in addition to any term of imprisonment authorized by this subsection. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a person shall be sentenced under this subsection to a term of imprisonment of not less than one year. The mandatory minimum sentencing provisions of this paragraph shall not apply to offenses involving 5 grams or less of marihuana."
  ]
  node [
    id 3910
    label "section_860_subsection_c_item_1"
    class_name "item"
    text "(1) employs, hires, uses, persuades, induces, entices, or coerces a person under 18 years of age to violate this section; or"
  ]
  node [
    id 3911
    label "section_860_subsection_a_item_1"
    class_name "item"
    text "Any person who violates section 841(a)(1) of this title or section 856 of this title by distributing, possessing with intent to distribute, or manufacturing a controlled substance in or on, or within one thousand feet of, the real property comprising a public or private elementary, vocational, or secondary school or a public or private college, junior college, or university, or a playground, or housing facility owned by a public housing authority, or within 100 feet of a public or private youth center, public swimming pool, or video arcade facility, is (except as provided in subsection (b) of this section) subject to (1) twice the maximum punishment authorized by section 841(b) of this title; and (2) at least twice any term of supervised release authorized by section 841(b) of this title for a first offense. A fine up to twice that authorized by section 841(b) of this title may be imposed in addition to any term of imprisonment authorized by this subsection. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a person shall be sentenced under this subsection to a term of imprisonment of not less than one year. The mandatory minimum sentencing provisions of this paragraph shall not apply to offenses involving 5 grams or less of marihuana."
  ]
  node [
    id 3912
    label "section_860_subsection_c_item_2"
    class_name "item"
    text "(2) employs, hires, uses, persuades, induces, entices, or coerces a person under 18 years of age to assist in avoiding detection or apprehension for any offense under this section by any Federal, State, or local law enforcement official,"
  ]
  node [
    id 3913
    label "section_860_subsection_b"
    class_name "subsection"
    text "(b) Second offenders"
  ]
  node [
    id 3914
    label "section_860_subsection_b_item_2"
    class_name "item"
    text "Any person who violates section 841(a)(1) of this title or section 856 of this title by distributing, possessing with intent to distribute, or manufacturing a controlled substance in or on, or within one thousand feet of, the real property comprising a public or private elementary, vocational, or secondary school or a public or private college, junior college, or university, or a playground, or housing facility owned by a public housing authority, or within 100 feet of a public or private youth center, public swimming pool, or video arcade facility, after a prior conviction under subsection (a) of this section has become final is punishable (1) by the greater of (A) a term of imprisonment of not less than three years and not more than life imprisonment or (B) three times the maximum punishment authorized by section 841(b) of this title for a first offense, and (2) at least three times any term of supervised release authorized by section 841(b) of this title for a first offense. A fine up to three times that authorized by section 841(b) of this title may be imposed in addition to any term of imprisonment authorized by this subsection. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a person shall be sentenced under this subsection to a term of imprisonment of not less than three years. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3915
    label "section_860_subsection_e_item_1"
    class_name "item"
    text "(1) The term &#8220;playground&#8221; means any outdoor facility (including any parking lot appurtenant thereto) intended for recreation, open to the public, and with any portion thereof containing three or more separate apparatus intended for the recreation of children including, but not limited to, sliding boards, swingsets, and teeterboards."
  ]
  node [
    id 3916
    label "section_860_subsection_a"
    class_name "subsection"
    text "(a) Penalty"
  ]
  node [
    id 3917
    label "section_860_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "Any person who violates section 841(a)(1) of this title or section 856 of this title by distributing, possessing with intent to distribute, or manufacturing a controlled substance in or on, or within one thousand feet of, the real property comprising a public or private elementary, vocational, or secondary school or a public or private college, junior college, or university, or a playground, or housing facility owned by a public housing authority, or within 100 feet of a public or private youth center, public swimming pool, or video arcade facility, after a prior conviction under subsection (a) of this section has become final is punishable (1) by the greater of (A) a term of imprisonment of not less than three years and not more than life imprisonment or (B) three times the maximum punishment authorized by section 841(b) of this title for a first offense, and (2) at least three times any term of supervised release authorized by section 841(b) of this title for a first offense. A fine up to three times that authorized by section 841(b) of this title may be imposed in addition to any term of imprisonment authorized by this subsection. Except to the extent a greater minimum sentence is otherwise provided by section 841(b) of this title, a person shall be sentenced under this subsection to a term of imprisonment of not less than three years. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3918
    label "section_860_subsection_e_item_3"
    class_name "item"
    text "(3) The term &#8220;video arcade facility&#8221; means any facility, legally accessible to persons under 18 years of age, intended primarily for the use of pinball and video machines for amusement containing a minimum of ten pinball and/or video machines."
  ]
  node [
    id 3919
    label "section_860_subsection_c"
    class_name "subsection"
    text "(c) Employing children to distribute drugs near schools or playgrounds"
  ]
  node [
    id 3920
    label "section_861_subsection_a_item_1"
    class_name "item"
    text "(1) employ, hire, use, persuade, induce, entice, or coerce, a person under eighteen years of age to violate any provision of this subchapter or subchapter II of this chapter;"
  ]
  node [
    id 3921
    label "section_861_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "Any person who violates subsection (a) of this section after a prior conviction under subsection (a) of this section has become final, is subject to three times the maximum punishment otherwise authorized and at least three times any term of supervised release otherwise authorized for a first offense. Except to the extent a greater minimum sentence is otherwise provided, a term of imprisonment under this subsection shall not be less than one year. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3922
    label "section_861_subsection_d"
    class_name "subsection"
    text "(d) Penalty for providing or distributing controlled substance to underage person"
  ]
  node [
    id 3923
    label "section_861_subsection_e"
    class_name "subsection"
    text "(e) Suspension of sentence; probation; parole"
  ]
  node [
    id 3924
    label "section_861_subsection_a"
    class_name "subsection"
    text "(a) Unlawful acts"
  ]
  node [
    id 3925
    label "section_861_subsection_a_item_2"
    class_name "item"
    text "(2) employ, hire, use, persuade, induce, entice, or coerce, a person under eighteen years of age to assist in avoiding detection or apprehension for any offense of this subchapter or subchapter II of this chapter by any Federal, State, or local law enforcement official; or"
  ]
  node [
    id 3926
    label "section_861_subsection_f"
    class_name "subsection"
    text "(f) Distribution of controlled substance to pregnant individual"
  ]
  node [
    id 3927
    label "section_861_subsection_a_item_3"
    class_name "item"
    text "(3) receive a controlled substance from a person under 18 years of age, other than an immediate family member, in violation of this subchapter or subchapter II of this chapter."
  ]
  node [
    id 3928
    label "section_861_subsection_c"
    class_name "subsection"
    text "(c) Penalty for subsequent offenses"
  ]
  node [
    id 3929
    label "section_861_subsection_d_item_2"
    class_name "item"
    text "(2) if the person employed, hired, or used is fourteen years of age or younger,"
  ]
  node [
    id 3930
    label "section_861_subsection_d_item_1"
    class_name "item"
    text "(1) by knowingly providing or distributing a controlled substance or a controlled substance analogue to any person under eighteen years of age; or"
  ]
  node [
    id 3931
    label "section_861_subsection_c_item_1"
    class_name "item"
    text "Any person who violates subsection (a) of this section after a prior conviction under subsection (a) of this section has become final, is subject to three times the maximum punishment otherwise authorized and at least three times any term of supervised release otherwise authorized for a first offense. Except to the extent a greater minimum sentence is otherwise provided, a term of imprisonment under this subsection shall not be less than one year. Penalties for third and subsequent convictions shall be governed by section 841(b)(1)(A) of this title."
  ]
  node [
    id 3932
    label "section_861_subsection_b"
    class_name "subsection"
    text "(b) Penalty for first offense"
  ]
  node [
    id 3933
    label "section_862_subsection_a_item_1_subitem_C"
    class_name "subitem"
    text "(C) upon a third or subsequent conviction for such an offense be permanently ineligible for all Federal benefits."
  ]
  node [
    id 3934
    label "section_862_subsection_d_item_1"
    class_name "item"
    text "(1) the term &#8220;Federal benefit&#8221;&#8212;"
  ]
  node [
    id 3935
    label "section_862_subsection_g_item_1"
    class_name "item"
    text "(1) On or before May 1, 1989, the President shall transmit to the Congress a report&#8212;"
  ]
  node [
    id 3936
    label "section_862_subsection_g_item_1_subitem_C"
    class_name "subitem"
    text "(C) detailing the means by which Federal and State agencies, courts, and law enforcement agencies will exchange and share the data and information necessary to implement and enforce the withholding of Federal benefits; and"
  ]
  node [
    id 3937
    label "section_862_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) at the discretion of the court, upon a second conviction for such an offense be ineligible for any or all Federal benefits for up to 10 years after such conviction; and"
  ]
  node [
    id 3938
    label "section_862_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) does not include any retirement, welfare, Social Security, health, disability, veterans benefit, public housing, or other similar benefit, or any other benefit for which payments or services are required for eligibility; and"
  ]
  node [
    id 3939
    label "section_862_subsection_c_subitem_B"
    class_name "subitem"
    text "(B) has otherwise been rehabilitated; or"
  ]
  node [
    id 3940
    label "section_862_subsection_a"
    class_name "subsection"
    text "(a) Drug traffickers"
  ]
  node [
    id 3941
    label "section_862_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "Nothing in this section shall be construed to affect the obligation of the United States to any Indian or Indian tribe arising out of any treaty, statute, Executive order, or the trust responsibility of the United States owing to such Indian or Indian tribe. Nothing in this subsection shall exempt any individual Indian from the sanctions provided for in this section, provided that no individual Indian shall be denied any benefit under Federal Indian programs comparable to those described in subsection (d)(1)(B) or (d)(2) of this section."
  ]
  node [
    id 3942
    label "section_862_subsection_g_item_2"
    class_name "item"
    text "(2) No later than September 1, 1989, the Congress shall consider the report of the President and enact such changes as it deems appropriate to further the goals of this section."
  ]
  node [
    id 3943
    label "section_862_subsection_g"
    class_name "subsection"
    text "(g) Presidential report"
  ]
  node [
    id 3944
    label "section_862_subsection_c"
    class_name "subsection"
    text "(c) Suspension of period of ineligibility"
  ]
  node [
    id 3945
    label "section_862_subsection_b_item_2"
    class_name "item"
    text "(2) The penalties and conditions which may be imposed under this subsection shall be waived in the case of a person who, if there is a reasonable body of evidence to substantiate such declaration, declares himself to be an addict and submits himself to a long-term treatment program for addiction, or is deemed to be rehabilitated pursuant to rules established by the Secretary of Health and Human Services."
  ]
  node [
    id 3946
    label "section_862_subsection_a_item_1"
    class_name "item"
    text "(1) Any individual who is convicted of any Federal or State offense consisting of the distribution of controlled substances shall&#8212;"
  ]
  node [
    id 3947
    label "section_862_subsection_h"
    class_name "subsection"
    text "(h) Effective date"
  ]
  node [
    id 3948
    label "section_862_subsection_f_item_1"
    class_name "item"
    text "Nothing in this section shall be construed to affect the obligation of the United States to any Indian or Indian tribe arising out of any treaty, statute, Executive order, or the trust responsibility of the United States owing to such Indian or Indian tribe. Nothing in this subsection shall exempt any individual Indian from the sanctions provided for in this section, provided that no individual Indian shall be denied any benefit under Federal Indian programs comparable to those described in subsection (d)(1)(B) or (d)(2) of this section."
  ]
  node [
    id 3949
    label "section_862_subsection_f_item_2"
    class_name "item"
    text "Nothing in this section shall be construed to affect the obligation of the United States to any Indian or Indian tribe arising out of any treaty, statute, Executive order, or the trust responsibility of the United States owing to such Indian or Indian tribe. Nothing in this subsection shall exempt any individual Indian from the sanctions provided for in this section, provided that no individual Indian shall be denied any benefit under Federal Indian programs comparable to those described in subsection (d)(1)(B) or (d)(2) of this section."
  ]
  node [
    id 3950
    label "section_862_subsection_b"
    class_name "subsection"
    text "(b) Drug possessors"
  ]
  node [
    id 3951
    label "section_862_subsection_f"
    class_name "subsection"
    text "(f) Indian provision"
  ]
  node [
    id 3952
    label "section_862_subsection_b_item_1_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) any combination of clause (i), (ii), or (iii); and"
  ]
  node [
    id 3953
    label "section_862_subsection_b_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) be ineligible for any or all Federal benefits for up to one year;"
  ]
  node [
    id 3954
    label "section_862_subsection_g_item_1_subitem_B"
    class_name "subitem"
    text "(B) describing the manner in which Federal agencies will implement and enforce the requirements of this section;"
  ]
  node [
    id 3955
    label "section_862_subsection_e"
    class_name "subsection"
    text "(e) Inapplicability of this section to Government witnesses"
  ]
  node [
    id 3956
    label "section_862_subsection_c_subitem_A"
    class_name "subitem"
    text "(A) completes a supervised drug rehabilitation program after becoming ineligible under this section;"
  ]
  node [
    id 3957
    label "section_862_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) at the discretion of the court, upon the first conviction for such an offense be ineligible for any or all Federal benefits for up to 5 years after such conviction;"
  ]
  node [
    id 3958
    label "section_862_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) upon a second or subsequent conviction for such an offense be ineligible for all Federal benefits for up to 5 years after such conviction as determined by the court. The court shall continue to have the discretion in subparagraph (A) above. In imposing penalties and conditions under subparagraph (A), the court may require that the completion of the conditions imposed by clause (ii) or (iii) be a requirement for the reinstatement of benefits under clause (i)."
  ]
  node [
    id 3959
    label "section_862_subsection_g_item_1_subitem_A"
    class_name "subitem"
    text "(A) delineating the role of State courts in implementing this section;"
  ]
  node [
    id 3960
    label "section_862_subsection_a_item_2"
    class_name "item"
    text "(2) The benefits which are denied under this subsection shall not include benefits relating to long-term drug treatment programs for addiction for any person who, if there is a reasonable body of evidence to substantiate such declaration, declares himself to be an addict and submits himself to a long-term treatment program for addiction, or is deemed to be rehabilitated pursuant to rules established by the Secretary of Health and Human Services."
  ]
  node [
    id 3961
    label "section_862_subsection_b_item_1"
    class_name "item"
    text "(1) Any individual who is convicted of any Federal or State offense involving the possession of a controlled substance (as such term is defined for purposes of this subchapter) shall&#8212;"
  ]
  node [
    id 3962
    label "section_862_subsection_g_item_1_subitem_D"
    class_name "subitem"
    text "(D) recommending any modifications to improve the administration of this section or otherwise achieve the goal of discouraging the trafficking and possession of controlled substances."
  ]
  node [
    id 3963
    label "section_862_subsection_b_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) be required to successfully complete an approved drug treatment program which includes periodic testing to insure that the individual remains drug free;"
  ]
  node [
    id 3964
    label "section_862_subsection_b_item_1_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) be required to perform appropriate community service; or"
  ]
  node [
    id 3965
    label "section_862_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(A) means the issuance of any grant, contract, loan, professional license, or commercial license provided by an agency of the United States or by appropriated funds of the United States; and"
  ]
  node [
    id 3966
    label "section_862_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) upon the first conviction for such an offense and at the discretion of the court&#8212;"
  ]
  node [
    id 3967
    label "section_862_subsection_c_subitem_C"
    class_name "subitem"
    text "(C) has made a good faith effort to gain admission to a supervised drug rehabilitation program, but is unable to do so because of inaccessibility or unavailability of such a program, or the inability of the individual to pay for such a program."
  ]
  node [
    id 3968
    label "section_862_subsection_d"
    class_name "subsection"
    text "(d) Definitions"
  ]
  node [
    id 3969
    label "section_862_subsection_d_item_2"
    class_name "item"
    text "(2) the term &#8220;veterans benefit&#8221; means all benefits provided to veterans, their families, or survivors by virtue of the service of a veteran in the Armed Forces of the United States."
  ]
  node [
    id 3970
    label "section_863_subsection_e_item_4"
    class_name "item"
    text "(4) the manner in which the item is displayed for sale;"
  ]
  node [
    id 3971
    label "section_863_subsection_d_item_2"
    class_name "item"
    text "(2) water pipes;"
  ]
  node [
    id 3972
    label "section_863_subsection_e_item_3"
    class_name "item"
    text "(3) national and local advertising concerning its use;"
  ]
  node [
    id 3973
    label "section_863_subsection_a_item_3"
    class_name "item"
    text "(3) to import or export drug paraphernalia."
  ]
  node [
    id 3974
    label "section_863_subsection_d_item_3"
    class_name "item"
    text "(3) carburetion tubes and devices;"
  ]
  node [
    id 3975
    label "section_863_subsection_d_item_13"
    class_name "item"
    text "(13) ice pipes or chillers;"
  ]
  node [
    id 3976
    label "section_863_subsection_e"
    class_name "subsection"
    text "(e) Matters considered in determination of what constitutes drug paraphernalia"
  ]
  node [
    id 3977
    label "section_863_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 3978
    label "section_863_subsection_c"
    class_name "subsection"
    text "(c) Seizure and forfeiture"
  ]
  node [
    id 3979
    label "section_863_subsection_d_item_5"
    class_name "item"
    text "(5) roach clips: meaning objects used to hold burning material, such as a marihuana cigarette, that has become too small or too short to be held in the hand;"
  ]
  node [
    id 3980
    label "section_863_subsection_f"
    class_name "subsection"
    text "(f) Exemptions"
  ]
  node [
    id 3981
    label "section_863_subsection_d_item_1"
    class_name "item"
    text "(1) metal, wooden, acrylic, glass, stone, plastic, or ceramic pipes with or without screens, permanent screens, hashish heads, or punctured metal bowls;"
  ]
  node [
    id 3982
    label "section_863_subsection_d_item_9"
    class_name "item"
    text "(9) electric pipes;"
  ]
  node [
    id 3983
    label "section_863_subsection_d_item_12"
    class_name "item"
    text "(12) bongs;"
  ]
  node [
    id 3984
    label "section_863_subsection_f_item_1"
    class_name "item"
    text "(1) any person authorized by local, State, or Federal law to manufacture, possess, or distribute such items; or"
  ]
  node [
    id 3985
    label "section_863_subsection_d_item_7"
    class_name "item"
    text "(7) chamber pipes;"
  ]
  node [
    id 3986
    label "section_863_subsection_d"
    class_name "subsection"
    text "(d) &#8220;Drug paraphernalia&#8221; defined"
  ]
  node [
    id 3987
    label "section_863_subsection_d_item_4"
    class_name "item"
    text "(4) smoking and carburetion masks;"
  ]
  node [
    id 3988
    label "section_863_subsection_d_item_6"
    class_name "item"
    text "(6) miniature spoons with level capacities of one-tenth cubic centimeter or less;"
  ]
  node [
    id 3989
    label "section_863_subsection_d_item_11"
    class_name "item"
    text "(11) chillums;"
  ]
  node [
    id 3990
    label "section_863_subsection_b"
    class_name "subsection"
    text "(b) Penalties"
  ]
  node [
    id 3991
    label "section_863_subsection_f_item_2"
    class_name "item"
    text "(2) any item that, in the normal lawful course of business, is imported, exported, transported, or sold through the mail or by any other means, and traditionally intended for use with tobacco products, including any pipe, paper, or accessory."
  ]
  node [
    id 3992
    label "section_863_subsection_e_item_7"
    class_name "item"
    text "(7) the existence and scope of legitimate uses of the item in the community; and"
  ]
  node [
    id 3993
    label "section_863_subsection_e_item_5"
    class_name "item"
    text "(5) whether the owner, or anyone in control of the item, is a legitimate supplier of like or related items to the community, such as a licensed distributor or dealer of tobacco products;"
  ]
  node [
    id 3994
    label "section_863_subsection_d_item_14"
    class_name "item"
    text "(14) wired cigarette papers; or"
  ]
  node [
    id 3995
    label "section_863_subsection_d_item_10"
    class_name "item"
    text "(10) air-driven pipes;"
  ]
  node [
    id 3996
    label "section_863_subsection_e_item_2"
    class_name "item"
    text "(2) descriptive materials accompanying the item which explain or depict its use;"
  ]
  node [
    id 3997
    label "section_863_subsection_a_item_1"
    class_name "item"
    text "(1) to sell or offer for sale drug paraphernalia;"
  ]
  node [
    id 3998
    label "section_863_subsection_d_item_8"
    class_name "item"
    text "(8) carburetor pipes;"
  ]
  node [
    id 3999
    label "section_863_subsection_e_item_6"
    class_name "item"
    text "(6) direct or circumstantial evidence of the ratio of sales of the item(s) to the total sales of the business enterprise;"
  ]
  node [
    id 4000
    label "section_863_subsection_e_item_1"
    class_name "item"
    text "(1) instructions, oral or written, provided with the item concerning its use;"
  ]
  node [
    id 4001
    label "section_863_subsection_a_item_2"
    class_name "item"
    text "(2) to use the mails or any other facility of interstate commerce to transport drug paraphernalia; or"
  ]
  node [
    id 4002
    label "section_863_subsection_d_item_15"
    class_name "item"
    text "(15) cocaine freebase kits."
  ]
  node [
    id 4003
    label "section_863_subsection_e_item_8"
    class_name "item"
    text "(8) expert testimony concerning its use."
  ]
  node [
    id 4004
    label "section_871_subsection_c"
    class_name "subsection"
    text "(c) Acceptance of devices, bequests, gifts, and donations"
  ]
  node [
    id 4005
    label "section_871_subsection_b"
    class_name "subsection"
    text "(b) Rules and regulations"
  ]
  node [
    id 4006
    label "section_871_subsection_a"
    class_name "subsection"
    text "(a) Delegation of functions"
  ]
  node [
    id 4007
    label "section_872_subsection_e"
    class_name "subsection"
    text "(e) Use of controlled substances in research"
  ]
  node [
    id 4008
    label "section_872_subsection_a_item_5"
    class_name "item"
    text "(5) studies or special projects to develop more effective methods to prevent diversion of controlled substances into illegal channels; and"
  ]
  node [
    id 4009
    label "section_872_subsection_a_item_1"
    class_name "item"
    text "(1) educational and training programs on drug abuse and controlled substances law enforcement for local, State, and Federal personnel;"
  ]
  node [
    id 4010
    label "section_872_subsection_f"
    class_name "subsection"
    text "(f) Program to curtail diversion of precursor and essential chemicals"
  ]
  node [
    id 4011
    label "section_872_subsection_d"
    class_name "subsection"
    text "(d) Affect of treaties and other international agreements on confidentiality"
  ]
  node [
    id 4012
    label "section_872_subsection_a"
    class_name "subsection"
    text "(a) Authorization"
  ]
  node [
    id 4013
    label "section_872_subsection_a_item_2"
    class_name "item"
    text "(2) studies or special projects designed to compare the deterrent effects of various enforcement strategies on drug use and abuse;"
  ]
  node [
    id 4014
    label "section_872_subsection_a_item_3"
    class_name "item"
    text "(3) studies or special projects designed to assess and detect accurately the presence in the human body of drugs or other substances which are or may be subject to control under this subchapter, including the development of rapid field identification methods which would enable agents to detect microquantities of such drugs or other substances;"
  ]
  node [
    id 4015
    label "section_872_subsection_a_item_4"
    class_name "item"
    text "(4) studies or special projects designed to evaluate the nature and sources of the supply of illegal drugs throughout the country;"
  ]
  node [
    id 4016
    label "section_872_subsection_c"
    class_name "subsection"
    text "(c) Identification of research populations; authorization to withhold"
  ]
  node [
    id 4017
    label "section_872_subsection_b"
    class_name "subsection"
    text "(b) Contracts"
  ]
  node [
    id 4018
    label "section_872_subsection_a_item_6"
    class_name "item"
    text "(6) studies or special projects to develop information necessary to carry out his functions under section 811 of this title."
  ]
  node [
    id 4019
    label "section_873_subsection_d_item_1_subitem_E"
    class_name "subitem"
    text "(E) preventing and detecting forged prescriptions, and"
  ]
  node [
    id 4020
    label "section_873_subsection_a_item_6_subitem_A"
    class_name "subitem"
    text "(A) making periodic assessments of the capabilities of State and local governments to adequately control the diversion of controlled substances;"
  ]
  node [
    id 4021
    label "section_873_subsection_d_item_1_subitem_F"
    class_name "subitem"
    text "(F) training law enforcement and regulatory personnel to improve the control of such diversions."
  ]
  node [
    id 4022
    label "section_873_subsection_a_item_3"
    class_name "item"
    text "(3) conduct training programs on controlled substance law enforcement for local, State, and Federal personnel;"
  ]
  node [
    id 4023
    label "section_873_subsection_a_item_6"
    class_name "item"
    text "(6) assist State and local governments in suppressing the diversion of controlled substances from legitimate medical, scientific, and commercial channels by&#8212;"
  ]
  node [
    id 4024
    label "section_873_subsection_d_item_1"
    class_name "item"
    text "(1) The Attorney General may make grants, in accordance with paragraph (2), to State and local governments to assist in meeting the costs of&#8212;"
  ]
  node [
    id 4025
    label "section_873_subsection_c"
    class_name "subsection"
    text "(c) Descriptive and analytic reports by Attorney General to State agencies of distribution patterns of schedule II substances having highest rates of abuse"
  ]
  node [
    id 4026
    label "section_873_subsection_a_item_6_subitem_B"
    class_name "subitem"
    text "(B) providing advice and counsel to State and local governments on the methods by which such governments may strengthen their controls against diversion; and"
  ]
  node [
    id 4027
    label "section_873_subsection_a_item_5"
    class_name "item"
    text "(5) conduct programs of eradication aimed at destroying wild or illicit growth of plant species from which controlled substances may be extracted;"
  ]
  node [
    id 4028
    label "section_873_subsection_c_item_2"
    class_name "item"
    text "The Attorney General shall annually (1) select the controlled substances (or controlled substances) contained in schedule II which, in the Attorney General's discretion, is determined to have the highest rate of abuse, and (2) prepare and make available to regulatory, licensing, and law enforcement agencies of States descriptive and analytic reports on the actual distribution patterns in such States of each such controlled substance."
  ]
  node [
    id 4029
    label "section_873_subsection_d_item_1_subitem_A"
    class_name "subitem"
    text "(A) collecting and analyzing data on the diversion of controlled substances,"
  ]
  node [
    id 4030
    label "section_873_subsection_a_item_4"
    class_name "item"
    text "(4) maintain in the Department of Justice a unit which will accept, catalog, file, and otherwise utilize all information and statistics, including records of controlled substance abusers and other controlled substance law offenders, which may be received from Federal, State, and local agencies, and make such information available for Federal, State, and local law enforcement purposes;"
  ]
  node [
    id 4031
    label "section_873_subsection_d_item_1_subitem_B"
    class_name "subitem"
    text "(B) conducting investigations and prosecutions of such diversions,"
  ]
  node [
    id 4032
    label "section_873_subsection_a_item_6_subitem_C"
    class_name "subitem"
    text "(C) establishing cooperative investigative efforts to control diversion; and"
  ]
  node [
    id 4033
    label "section_873_subsection_d_item_2"
    class_name "item"
    text "(2) No grant may be made under paragraph (1) unless an application therefor is submitted to the Attorney General in such form and manner as the Attorney General may prescribe. No grant may exceed 80 per centum of the costs for which the grant is made, and no grant may be made unless the recipient of the grant provides assurances satisfactory to the Attorney General that it will obligate funds to meet the remaining 20 per centum of such costs. The Attorney General shall review the activities carried out with grants under paragraph (1) and shall report annually to Congress on such activities."
  ]
  node [
    id 4034
    label "section_873_subsection_d_item_3"
    class_name "item"
    text "(3) To carry out this subsection there is authorized to be appropriated $6,000,000 for fiscal year 1985 and $6,000,000 for fiscal year 1986."
  ]
  node [
    id 4035
    label "section_873_subsection_d_item_1_subitem_D"
    class_name "subitem"
    text "(D) programs to prevent such diversions,"
  ]
  node [
    id 4036
    label "section_873_subsection_a_item_1"
    class_name "item"
    text "(1) arrange for the exchange of information between governmental officials concerning the use and abuse of controlled substances;"
  ]
  node [
    id 4037
    label "section_873_subsection_b"
    class_name "subsection"
    text "(b) Requests by Attorney General for assistance from Federal agencies or instrumentalities"
  ]
  node [
    id 4038
    label "section_873_subsection_a"
    class_name "subsection"
    text "(a) Cooperation of Attorney General with local, State, and Federal agencies"
  ]
  node [
    id 4039
    label "section_873_subsection_a_item_7"
    class_name "item"
    text "(7) notwithstanding any other provision of law, enter into contractual agreements with State and local law enforcement agencies to provide for cooperative enforcement and regulatory activities under this chapter.1"
  ]
  node [
    id 4040
    label "section_873_subsection_d_item_1_subitem_C"
    class_name "subitem"
    text "(C) improving regulatory controls and other authorities to control such diversions,"
  ]
  node [
    id 4041
    label "section_873_subsection_a_item_2"
    class_name "item"
    text "(2) cooperate in the institution and prosecution of cases in the courts of the United States and before the licensing boards and courts of the several States;"
  ]
  node [
    id 4042
    label "section_873_subsection_d"
    class_name "subsection"
    text "(d) Grants by Attorney General"
  ]
  node [
    id 4043
    label "section_873_subsection_c_item_1"
    class_name "item"
    text "The Attorney General shall annually (1) select the controlled substances (or controlled substances) contained in schedule II which, in the Attorney General's discretion, is determined to have the highest rate of abuse, and (2) prepare and make available to regulatory, licensing, and law enforcement agencies of States descriptive and analytic reports on the actual distribution patterns in such States of each such controlled substance."
  ]
  node [
    id 4044
    label "section_875_subsection_a"
    class_name "subsection"
    text "(a) Power of Attorney General"
  ]
  node [
    id 4045
    label "section_875_subsection_b"
    class_name "subsection"
    text "(b) Procedures applicable"
  ]
  node [
    id 4046
    label "section_876_subsection_b"
    class_name "subsection"
    text "(b) Service"
  ]
  node [
    id 4047
    label "section_876_subsection_a"
    class_name "subsection"
    text "(a) Authorization of use by Attorney General"
  ]
  node [
    id 4048
    label "section_876_subsection_c"
    class_name "subsection"
    text "(c) Enforcement"
  ]
  node [
    id 4049
    label "section_878_subsection_a"
    class_name "subsection"
    text "(a) Any officer or employee of the Drug Enforcement Administration or any State or local law enforcement officer designated by the Attorney General may&#8212;"
  ]
  node [
    id 4050
    label "section_878_subsection_b"
    class_name "subsection"
    text "(b) State and local law enforcement officers performing functions under this section shall not be deemed Federal employees and shall not be subject to provisions of law relating to Federal employees, except that such officers shall be subject to section 3374(c) of title 5."
  ]
  node [
    id 4051
    label "section_878_subsection_a_item_4"
    class_name "item"
    text "(4) make seizures of property pursuant to the provisions of this subchapter; and"
  ]
  node [
    id 4052
    label "section_878_subsection_a_item_3"
    class_name "item"
    text "(3) make arrests without warrant (A) for any offense against the United States committed in his presence, or (B) for any felony, cognizable under the laws of the United States, if he has probable cause to believe that the person to be arrested has committed or is committing a felony;"
  ]
  node [
    id 4053
    label "section_878_subsection_a_item_1"
    class_name "item"
    text "(1) carry firearms;"
  ]
  node [
    id 4054
    label "section_878_subsection_a_item_2"
    class_name "item"
    text "(2) execute and serve search warrants, arrest warrants, administrative inspection warrants, subpenas, and summonses issued under the authority of the United States;"
  ]
  node [
    id 4055
    label "section_878_subsection_a_item_5"
    class_name "item"
    text "(5) perform such other law enforcement duties as the Attorney General may designate."
  ]
  node [
    id 4056
    label "section_880_subsection_b_item_3"
    class_name "item"
    text "(3) Except as may otherwise be indicated in an applicable inspection warrant, the inspector shall have the right&#8212;"
  ]
  node [
    id 4057
    label "section_880_subsection_a_item_2"
    class_name "item"
    text "(2) places, including factories, warehouses, and other establishments, and conveyances, where persons registered under section 823 of this title (or exempt from registration under section 822(d) of this title or by regulation of the Attorney General) or regulated persons may lawfully hold, manufacture, distribute, dispense, administer, or otherwise dispose of controlled substances or listed chemicals or where records relating to those activities are maintained."
  ]
  node [
    id 4058
    label "section_880_subsection_b_item_4"
    class_name "item"
    text "(4) Except when the owner, operator, or agent in charge of the controlled premises so consents in writing, no inspection authorized by this section shall extend to&#8212;"
  ]
  node [
    id 4059
    label "section_880_subsection_a"
    class_name "subsection"
    text "(a) &#8220;Controlled premises&#8221; defined"
  ]
  node [
    id 4060
    label "section_880_subsection_d_item_2"
    class_name "item"
    text "(2) A warrant shall issue only upon an affidavit of an officer or employee having knowledge of the facts alleged, sworn to before the judge or magistrate judge and establishing the grounds for issuing the warrant. If the judge or magistrate judge is satisfied that grounds for the application exist or that there is probable cause to believe they exist, he shall issue a warrant identifying the area, premises, building, or conveyance to be inspected, the purpose of such inspection, and, where appropriate, the type of property to be inspected, if any. The warrant shall identify the items or types of property to be seized, if any. The warrant shall be directed to a person authorized under subsection (b)(2) of this section to execute it. The warrant shall state the grounds for its issuance and the name of the person or persons whose affidavit has been taken in support thereof. It shall command the person to whom it is directed to inspect the area, premises, building, or conveyance identified for the purpose specified, and, where appropriate, shall direct the seizure of the property specified. The warrant shall direct that it be served during normal business hours. It shall designate the judge or magistrate judge to whom it shall be returned."
  ]
  node [
    id 4061
    label "section_880_subsection_c_item_3"
    class_name "item"
    text "(3) in situations involving inspection of conveyances where there is reasonable cause to believe that the mobility of the conveyance makes it impracticable to obtain a warrant;"
  ]
  node [
    id 4062
    label "section_880_subsection_d_item_3"
    class_name "item"
    text "(3) A warrant issued pursuant to this section must be executed and returned within ten days of its date unless, upon a showing by the United States of a need therefor, the judge or magistrate judge allows additional time in the warrant. If property is seized pursuant to a warrant, the person executing the warrant shall give to the person from whom or from whose premises the property was taken a copy of the warrant and a receipt for the property taken or shall leave the copy and receipt at the place from which the property was taken. The return of the warrant shall be made promptly and shall be accompanied by a written inventory of any property taken. The inventory shall be made in the presence of the person executing the warrant and of the person from whose possession or premises the property was taken, if they are present, or in the presence of at least one credible person other than the person making such inventory, and shall be verified by the person executing the warrant. The judge or magistrate judge, upon request, shall deliver a copy of the inventory to the person from whom or from whose premises the property was taken and the applicant for the warrant."
  ]
  node [
    id 4063
    label "section_880_subsection_b_item_3_subitem_C"
    class_name "subitem"
    text "(C) to inventory any stock of any controlled substance or listed chemical therein and obtain samples of any such substance or chemical."
  ]
  node [
    id 4064
    label "section_880_subsection_d"
    class_name "subsection"
    text "(d) Administrative inspection warrants; issuance; execution; probable cause"
  ]
  node [
    id 4065
    label "section_880_subsection_b"
    class_name "subsection"
    text "(b) Grant of authority; scope of inspections"
  ]
  node [
    id 4066
    label "section_880_subsection_b_item_3_subitem_B"
    class_name "subitem"
    text "(B) to inspect, within reasonable limits and in a reasonable manner, controlled premises and all pertinent equipment, finished and unfinished drugs, listed chemicals, and other substances or materials, containers, and labeling found therein, and, except as provided in paragraph (4) of this subsection, all other things therein (including records, files, papers, processes, controls, and facilities) appropriate for verification of the records, reports, and documents referred to in clause (A) or otherwise bearing on the provisions of this subchapter; and"
  ]
  node [
    id 4067
    label "section_880_subsection_c_item_5"
    class_name "item"
    text "(5) in any other situations where a warrant is not constitutionally required."
  ]
  node [
    id 4068
    label "section_880_subsection_d_item_4"
    class_name "item"
    text "(4) The judge or magistrate judge who has issued a warrant under this section shall attach to the warrant a copy of the return and all papers filed in connection therewith and shall file them with the clerk of the district court of the United States for the judicial district in which the inspection was made."
  ]
  node [
    id 4069
    label "section_880_subsection_c_item_2"
    class_name "item"
    text "(2) in situations presenting imminent danger to health or safety;"
  ]
  node [
    id 4070
    label "section_880_subsection_c_item_4"
    class_name "item"
    text "(4) in any other exceptional or emergency circumstance where time or opportunity to apply for a warrant is lacking; or"
  ]
  node [
    id 4071
    label "section_880_subsection_d_item_1"
    class_name "item"
    text "(1) Any judge of the United States or of a State court of record, or any United States magistrate judge, may, within his territorial jurisdiction, and upon proper oath or affirmation showing probable cause, issue warrants for the purpose of conducting administrative inspections authorized by this subchapter or regulations thereunder, and seizures of property appropriate to such inspections. For the purposes of this section, the term &#8220;probable cause&#8221; means a valid public interest in the effective enforcement of this subchapter or regulations thereunder sufficient to justify administrative inspections of the area, premises, building, or conveyance, or contents thereof, in the circumstances specified in the application for the warrant."
  ]
  node [
    id 4072
    label "section_880_subsection_b_item_2"
    class_name "item"
    text "(2) Such entries and inspections shall be carried out through officers or employees (hereinafter referred to as &#8220;inspectors&#8221;) designated by the Attorney General. Any such inspector, upon stating his purpose and presenting to the owner, operator, or agent in charge of such premises (A) appropriate credentials and (B) a written notice of his inspection authority (which notice in the case of an inspection requiring, or in fact supported by, an administrative inspection warrant shall consist of such warrant), shall have the right to enter such premises and conduct such inspection at reasonable times."
  ]
  node [
    id 4073
    label "section_880_subsection_b_item_4_subitem_A"
    class_name "subitem"
    text "(A) financial data;"
  ]
  node [
    id 4074
    label "section_880_subsection_b_item_4_subitem_C"
    class_name "subitem"
    text "(C) pricing data."
  ]
  node [
    id 4075
    label "section_880_subsection_b_item_3_subitem_A"
    class_name "subitem"
    text "(A) to inspect and copy records, reports, and other documents required to be kept or made under this subchapter;"
  ]
  node [
    id 4076
    label "section_880_subsection_b_item_4_subitem_B"
    class_name "subitem"
    text "(B) sales data other than shipment data; or"
  ]
  node [
    id 4077
    label "section_880_subsection_c_item_1"
    class_name "item"
    text "(1) with the consent of the owner, operator, or agent in charge of the controlled premises;"
  ]
  node [
    id 4078
    label "section_880_subsection_a_item_1"
    class_name "item"
    text "(1) places where original or other records or documents required under this subchapter are kept or required to be kept, and"
  ]
  node [
    id 4079
    label "section_880_subsection_c"
    class_name "subsection"
    text "(c) Situations not requiring warrants"
  ]
  node [
    id 4080
    label "section_880_subsection_b_item_1"
    class_name "item"
    text "(1) For the purpose of inspecting, copying, and verifying the correctness of records, reports, or other documents required to be kept or made under this subchapter and otherwise facilitating the carrying out of his functions under this subchapter, the Attorney General is authorized, in accordance with this section, to enter controlled premises and to conduct administrative inspections thereof, and of the things specified in this section, relevant to those functions."
  ]
  node [
    id 4081
    label "section_881_subsection_a_item_6"
    class_name "item"
    text "(6) All moneys, negotiable instruments, securities, or other things of value furnished or intended to be furnished by any person in exchange for a controlled substance in violation of this subchapter, all proceeds traceable to such an exchange, and all moneys, negotiable instruments, and securities used or intended to be used to facilitate any violation of this subchapter, except that no property shall be forfeited under this paragraph, to the extent of the interest of an owner, by reason of any act or omission established by that owner to have been committed or omitted without the knowledge or consent of that owner."
  ]
  node [
    id 4082
    label "section_881_subsection_e_item_2_subitem_B"
    class_name "subitem"
    text "(B) The Attorney General shall forward to the Treasurer of the United States for deposit in accordance with section 524(c) of title 28, any amounts of such moneys and proceeds remaining after payment of the expenses provided in subparagraph (A), except that, with respect to forfeitures conducted by the Postal Service, the Postal Service shall deposit in the Postal Service Fund, under section 2003(b)(7) of title 39, such moneys and proceeds."
  ]
  node [
    id 4083
    label "section_881_subsection_e_item_4"
    class_name "item"
    text "(4)(A) With respect to real property described in subparagraph (B), if the chief executive officer of the State involved submits to the Attorney General a request for purposes of such subparagraph, the authority established in such subparagraph is in lieu of the authority established in paragraph (1)(B)."
  ]
  node [
    id 4084
    label "section_881_subsection_e_item_2"
    class_name "item"
    text "(2)(A) The proceeds from any sale under subparagraph (B) of paragraph (1) and any moneys forfeited under this subchapter shall be used to pay&#8212;"
  ]
  node [
    id 4085
    label "section_881_subsection_e_item_1_subitem_E_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) is made to a country which, if applicable, has been certified under section 2291j(b) of title 22."
  ]
  node [
    id 4086
    label "section_881_subsection_e_item_2_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) all property expenses of the proceedings for forfeiture and sale including expenses of seizure, maintenance of custody, advertising, and court costs; and"
  ]
  node [
    id 4087
    label "section_881_subsection_a_item_8"
    class_name "item"
    text "(8) All controlled substances which have been possessed in violation of this subchapter."
  ]
  node [
    id 4088
    label "section_881_subsection_a_item_7"
    class_name "item"
    text "(7) All real property, including any right, title, and interest (including any leasehold interest) in the whole of any lot or tract of land and any appurtenances or improvements, which is used, or intended to be used, in any manner or part, to commit, or to facilitate the commission of, a violation of this subchapter punishable by more than one year's imprisonment, except that no property shall be forfeited under this paragraph, to the extent of an interest of an owner, by reason of any act or omission established by that owner to have been committed or omitted without the knowledge or consent of that owner."
  ]
  node [
    id 4089
    label "section_881_subsection_g_item_1"
    class_name "item"
    text "(1) All species of plants from which controlled substances in schedules I and II may be derived which have been planted or cultivated in violation of this subchapter, or of which the owners or cultivators are unknown, or which are wild growths, may be seized and summarily forfeited to the United States."
  ]
  node [
    id 4090
    label "section_881_subsection_c"
    class_name "subsection"
    text "(c) Custody of Attorney General"
  ]
  node [
    id 4091
    label "section_881_subsection_e_item_3_subitem_B"
    class_name "subitem"
    text "(B) will serve to encourage further cooperation between the recipient State or local agency and Federal law enforcement agencies."
  ]
  node [
    id 4092
    label "section_881_subsection_a_item_10"
    class_name "item"
    text "(10) Any drug paraphernalia (as defined in section 1822 of the Mail Order Drug Paraphernalia Control Act).1"
  ]
  node [
    id 4093
    label "section_881_subsection_a_item_9"
    class_name "item"
    text "(9) All listed chemicals, all drug manufacturing equipment, all tableting machines, all encapsulating machines, and all gelatin capsules, which have been imported, exported, manufactured, possessed, distributed, or intended to be distributed, imported, or exported, in violation of a felony provision of this subchapter or subchapter II of this chapter."
  ]
  node [
    id 4094
    label "section_881_subsection_g"
    class_name "subsection"
    text "(g) Plants"
  ]
  node [
    id 4095
    label "section_881_subsection_b_item_3"
    class_name "item"
    text "In the event of seizure pursuant to paragraph (3) or (4) of this subsection, proceedings under subsection (d) of this section shall be instituted promptly."
  ]
  node [
    id 4096
    label "section_881_subsection_c_item_2"
    class_name "item"
    text "(2) remove the property to a place designated by him; or"
  ]
  node [
    id 4097
    label "section_881_subsection_a"
    class_name "subsection"
    text "(a) Subject property"
  ]
  node [
    id 4098
    label "section_881_subsection_d"
    class_name "subsection"
    text "(d) Other laws and proceedings applicable"
  ]
  node [
    id 4099
    label "section_881_subsection_a_item_1"
    class_name "item"
    text "(1) All controlled substances which have been manufactured, distributed, dispensed, or acquired in violation of this subchapter."
  ]
  node [
    id 4100
    label "section_881_subsection_e_item_3"
    class_name "item"
    text "(3) The Attorney General shall assure that any property transferred to a State or local law enforcement agency under paragraph (1)(A)&#8212;"
  ]
  node [
    id 4101
    label "section_881_subsection_b_item_2"
    class_name "item"
    text "(2) the property subject to seizure has been the subject of a prior judgment in favor of the United States in a criminal injunction or forfeiture proceeding under this subchapter;"
  ]
  node [
    id 4102
    label "section_881_subsection_a_item_4_subitem_A"
    class_name "subitem"
    text "(A) no conveyance used by any person as a common carrier in the transaction of business as a common carrier shall be forfeited under the provisions of this section unless it shall appear that the owner or other person in charge of such conveyance was a consenting party or privy to a violation of this subchapter or subchapter II of this chapter;"
  ]
  node [
    id 4103
    label "section_881_subsection_a_item_3"
    class_name "item"
    text "(3) All property which is used, or intended for use, as a container for property described in paragraph (1), (2), or (9)."
  ]
  node [
    id 4104
    label "section_881_subsection_f_item_1"
    class_name "item"
    text "(1) All controlled substances in schedule I or II that are possessed, transferred, sold, or offered for sale in violation of the provisions of this subchapter; all dangerous, toxic, or hazardous raw materials or products subject to forfeiture under subsection (a)(2) of this section; and any equipment or container subject to forfeiture under subsection (a)(2) or (3) of this section which cannot be separated safely from such raw materials or products shall be deemed contraband and seized and summarily forfeited to the United States. Similarly, all substances in schedule I or II, which are seized or come into the possession of the United States, the owners of which are unknown, shall be deemed contraband and summarily forfeited to the United States."
  ]
  node [
    id 4105
    label "section_881_subsection_g_item_2"
    class_name "item"
    text "(2) The failure, upon demand by the Attorney General or his duly authorized agent, of the person in occupancy or in control of land or premises upon which such species of plants are growing or being stored, to produce an appropriate registration, or proof that he is the holder thereof, shall constitute authority for the seizure and forfeiture."
  ]
  node [
    id 4106
    label "section_881_subsection_e_item_4_subitem_B"
    class_name "subitem"
    text "(B) In the case of property described in paragraph (1)(B) that is civilly or criminally forfeited under this subchapter, if the property is real property that is appropriate for use as a public area reserved for recreational or historic purposes or for the preservation of natural conditions, the Attorney General, upon the request of the chief executive officer of the State in which the property is located, may transfer title to the property to the State, either without charge or for a nominal charge, through a legal instrument providing that&#8212;"
  ]
  node [
    id 4107
    label "section_881_subsection_a_item_4_subitem_C"
    class_name "subitem"
    text "(C) no conveyance shall be forfeited under this paragraph to the extent of an interest of an owner, by reason of any act or omission established by that owner to have been committed or omitted without the knowledge, consent, or willful blindness of the owner."
  ]
  node [
    id 4108
    label "section_881_subsection_e_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) such use will be the principal use of the property; and"
  ]
  node [
    id 4109
    label "section_881_subsection_c_item_1"
    class_name "item"
    text "(1) place the property under seal;"
  ]
  node [
    id 4110
    label "section_881_subsection_b"
    class_name "subsection"
    text "(b) Seizure pursuant to Supplemental Rules for Certain Admiralty and Maritime Claims; issuance of warrant authorizing seizure"
  ]
  node [
    id 4111
    label "section_881_subsection_a_item_2"
    class_name "item"
    text "(2) All raw materials, products, and equipment of any kind which are used, or intended for use, in manufacturing, compounding, processing, delivering, importing, or exporting any controlled substance in violation of this subchapter."
  ]
  node [
    id 4112
    label "section_881_subsection_e_item_1_subitem_B"
    class_name "subitem"
    text "(B) except as provided in paragraph (4), sell, by public sale or any other commercially feasible means, any forfeited property which is not required to be destroyed by law and which is not harmful to the public;"
  ]
  node [
    id 4113
    label "section_881_subsection_e_item_3_subitem_A"
    class_name "subitem"
    text "(A) has a value that bears a reasonable relationship to the degree of direct participation of the State or local agency in the law enforcement effort resulting in the forfeiture, taking into account the total value of all property forfeited and the total law enforcement effort with respect to the violation of law on which the forfeiture is based; and"
  ]
  node [
    id 4114
    label "section_881_subsection_j"
    class_name "subsection"
    text "(j) Venue"
  ]
  node [
    id 4115
    label "section_881_subsection_h"
    class_name "subsection"
    text "(h) Vesting of title in United States"
  ]
  node [
    id 4116
    label "section_881_subsection_f"
    class_name "subsection"
    text "(f) Forfeiture and destruction of schedule I and II substances"
  ]
  node [
    id 4117
    label "section_881_subsection_e_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) With respect to real property described in subparagraph (B), if the chief executive officer of the State involved submits to the Attorney General a request for purposes of such subparagraph, the authority established in such subparagraph is in lieu of the authority established in paragraph (1)(B)."
  ]
  node [
    id 4118
    label "section_881_subsection_b_item_1"
    class_name "item"
    text "(1) the seizure is incident to an arrest or a search under a search warrant or an inspection under an administrative inspection warrant;"
  ]
  node [
    id 4119
    label "section_881_subsection_e_item_1"
    class_name "item"
    text "(1) Whenever property is civilly or criminally forfeited under this subchapter the Attorney General may&#8212;"
  ]
  node [
    id 4120
    label "section_881_subsection_g_item_3"
    class_name "item"
    text "(3) The Attorney General, or his duly authorized agent, shall have authority to enter upon any lands, or into any dwelling pursuant to a search warrant, to cut, harvest, carry off, or destroy such plants."
  ]
  node [
    id 4121
    label "section_881_subsection_a_item_11"
    class_name "item"
    text "(11) Any firearm (as defined in section 921 of title 18) used or intended to be used to facilitate the transportation, sale, receipt, possession, or concealment of property described in paragraph (1) or (2) and any proceeds traceable to such property."
  ]
  node [
    id 4122
    label "section_881_subsection_e_item_1_subitem_D"
    class_name "subitem"
    text "(D) forward it to the Bureau of Narcotics and Dangerous Drugs for disposition (including delivery for medical or scientific use to any Federal or State agency under regulations of the Attorney General); or"
  ]
  node [
    id 4123
    label "section_881_subsection_e_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) The proceeds from any sale under subparagraph (B) of paragraph (1) and any moneys forfeited under this subchapter shall be used to pay&#8212;"
  ]
  node [
    id 4124
    label "section_881_subsection_e_item_1_subitem_C"
    class_name "subitem"
    text "(C) require that the General Services Administration take custody of the property and dispose of it in accordance with law;"
  ]
  node [
    id 4125
    label "section_881_subsection_e_item_2_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "Any award paid for information concerning the killing or kidnapping of a Federal drug law enforcement agent, as provided in clause (ii), shall be paid at the discretion of the Attorney General."
  ]
  node [
    id 4126
    label "section_881_subsection_i"
    class_name "subsection"
    text "(i) Stay of civil forfeiture proceedings"
  ]
  node [
    id 4127
    label "section_881_subsection_l"
    class_name "subsection"
    text "(l)&#160;2 Agreement between Attorney General and Postal Service for performance of functions"
  ]
  node [
    id 4128
    label "section_881_subsection_b_item_4"
    class_name "item"
    text "In the event of seizure pursuant to paragraph (3) or (4) of this subsection, proceedings under subsection (d) of this section shall be instituted promptly."
  ]
  node [
    id 4129
    label "section_881_subsection_f_item_2"
    class_name "item"
    text "(2) The Attorney General may direct the destruction of all controlled substances in schedule I or II seized for violation of this subchapter; all dangerous, toxic, or hazardous raw materials or products subject to forfeiture under subsection (a)(2) of this section; and any equipment or container subject to forfeiture under subsection (a)(2) or (3) of this section which cannot be separated safely from such raw materials or products under such circumstances as the Attorney General may deem necessary."
  ]
  node [
    id 4130
    label "section_881_subsection_a_item_5"
    class_name "item"
    text "(5) All books, records, and research, including formulas, microfilm, tapes, and data which are used, or intended for use, in violation of this subchapter."
  ]
  node [
    id 4131
    label "section_881_subsection_a_item_4_subitem_B"
    class_name "subitem"
    text "(B) no conveyance shall be forfeited under the provisions of this section by reason of any act or omission established by the owner thereof to have been committed or omitted by any person other than such owner while such conveyance was unlawfully in the possession of a person other than the owner in violation of the criminal laws of the United States, or of any State; and"
  ]
  node [
    id 4132
    label "section_881_subsection_e"
    class_name "subsection"
    text "(e) Disposition of forfeited property"
  ]
  node [
    id 4133
    label "section_881_subsection_a_item_4"
    class_name "item"
    text "(4) All conveyances, including aircraft, vehicles, or vessels, which are used, or are intended for use, to transport, or in any manner to facilitate the transportation, sale, receipt, possession, or concealment of property described in paragraph (1), (2), or (9), except that&#8212;"
  ]
  node [
    id 4134
    label "section_881_subsection_e_item_1_subitem_E"
    class_name "subitem"
    text "(E) transfer the forfeited personal property or the proceeds of the sale of any forfeited personal or real property to any foreign country which participated directly or indirectly in the seizure or forfeiture of the property, if such a transfer&#8212;"
  ]
  node [
    id 4135
    label "section_881_subsection_e_item_1_subitem_E_subsubitem_i"
    class_name "subsubitem"
    text "(i) has been agreed to by the Secretary of State;"
  ]
  node [
    id 4136
    label "section_881_subsection_e_item_1_subitem_E_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) is authorized in an international agreement between the United States and the foreign country; and"
  ]
  node [
    id 4137
    label "section_881_subsection_e_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) title to the property reverts to the United States in the event that the property is used otherwise."
  ]
  node [
    id 4138
    label "section_881_subsection_c_item_3"
    class_name "item"
    text "(3) require that the General Services Administration take custody of the property and remove it, if practicable, to an appropriate location for disposition in accordance with law."
  ]
  node [
    id 4139
    label "section_881_subsection_e_item_1_subitem_A"
    class_name "subitem"
    text "(A) retain the property for official use or, in the manner provided with respect to transfers under section 1616a of title 19, transfer the property to any Federal agency or to any State or local law enforcement agency which participated directly in the seizure or forfeiture of the property;"
  ]
  node [
    id 4140
    label "section_882_subsection_b"
    class_name "subsection"
    text "(b) Jury trial"
  ]
  node [
    id 4141
    label "section_882_subsection_a"
    class_name "subsection"
    text "(a) Jurisdiction"
  ]
  node [
    id 4142
    label "section_884_subsection_c_item_2"
    class_name "item"
    text "(2) such individual has refused or is likely to refuse to testify or provide other information on the basis of his privilege against self-incrimination."
  ]
  node [
    id 4143
    label "section_884_subsection_c_item_1"
    class_name "item"
    text "(1) the testimony or other information from such individual may be necessary to the public interest; and"
  ]
  node [
    id 4144
    label "section_884_subsection_a"
    class_name "subsection"
    text "(a) Refusal to testify"
  ]
  node [
    id 4145
    label "section_884_subsection_b"
    class_name "subsection"
    text "(b) Order of United States district court"
  ]
  node [
    id 4146
    label "section_884_subsection_c"
    class_name "subsection"
    text "(c) Request by United States attorney"
  ]
  node [
    id 4147
    label "section_885_subsection_a_item_2"
    class_name "item"
    text "(2) In the case of a person charged under section 844(a) of this title with the possession of a controlled substance, any label identifying such substance for purposes of section 353(b)(2) of this title shall be admissible in evidence and shall be prima facie evidence that such substance was obtained pursuant to a valid prescription from a practitioner while acting in the course of his professional practice."
  ]
  node [
    id 4148
    label "section_885_subsection_a_item_1"
    class_name "item"
    text "(1) It shall not be necessary for the United States to negative any exemption or exception set forth in this subchapter in any complaint, information, indictment, or other pleading or in any trial, hearing, or other proceeding under this subchapter, and the burden of going forward with the evidence with respect to any such exemption or exception shall be upon the person claiming its benefit."
  ]
  node [
    id 4149
    label "section_885_subsection_c"
    class_name "subsection"
    text "(c) Use of vehicles, vessels, and aircraft"
  ]
  node [
    id 4150
    label "section_885_subsection_b"
    class_name "subsection"
    text "(b) Registration and order forms"
  ]
  node [
    id 4151
    label "section_885_subsection_d"
    class_name "subsection"
    text "(d) Immunity of Federal, State, local and other officials"
  ]
  node [
    id 4152
    label "section_885_subsection_a"
    class_name "subsection"
    text "(a) Exemptions and exceptions; presumption in simple possession offenses"
  ]
  node [
    id 4153
    label "section_886_subsection_a"
    class_name "subsection"
    text "(a) Payment to informers"
  ]
  node [
    id 4154
    label "section_886_subsection_b"
    class_name "subsection"
    text "(b) Reimbursement for purchase of controlled substances"
  ]
  node [
    id 4155
    label "section_886_subsection_d_item_1"
    class_name "item"
    text "(1) There is established in the Treasury a trust fund to be known as the &#8220;Drug Pollution Fund&#8221; (hereinafter referred to in this subsection as the &#8220;Fund&#8221;), consisting of amounts appropriated or credited to such Fund under section 841(b)(6) of this title."
  ]
  node [
    id 4156
    label "section_886_subsection_d_item_4_subitem_A"
    class_name "subitem"
    text "(4)(A) The Secretary of the Treasury, after consultation with the Attorney General, shall make payments under paragraph (3), in such amounts as the Secretary determines appropriate, to the heads of executive agencies or departments that meet the requirements of subparagraph (B)."
  ]
  node [
    id 4157
    label "section_886_subsection_d_item_4"
    class_name "item"
    text "(4)(A) The Secretary of the Treasury, after consultation with the Attorney General, shall make payments under paragraph (3), in such amounts as the Secretary determines appropriate, to the heads of executive agencies or departments that meet the requirements of subparagraph (B)."
  ]
  node [
    id 4158
    label "section_886_subsection_d_item_5"
    class_name "item"
    text "(5) For purposes of subchapter B of chapter 98 of title 26, the Fund established under this paragraph shall be treated in the same manner as a trust fund established under subchapter A of such chapter."
  ]
  node [
    id 4159
    label "section_886_subsection_c"
    class_name "subsection"
    text "(c) Advance of funds for enforcement purposes"
  ]
  node [
    id 4160
    label "section_886_subsection_d_item_2"
    class_name "item"
    text "(2) There are hereby appropriated to the Fund amounts equivalent to the fines imposed under section 841(b)(6) of this title."
  ]
  node [
    id 4161
    label "section_886_subsection_d"
    class_name "subsection"
    text "(d) Drug Pollution Fund"
  ]
  node [
    id 4162
    label "section_886_subsection_d_item_3"
    class_name "item"
    text "(3) Amounts in the Fund shall be available, as provided in appropriations Acts, for the purpose of making payments in accordance with paragraph (4) for the clean up of certain pollution resulting from the actions referred to in section 841(b)(6) of this title."
  ]
  node [
    id 4163
    label "section_886_subsection_d_item_4_subitem_B"
    class_name "subitem"
    text "(B) In order to receive a payment under paragraph (3), the head of an executive agency or department shall submit an application in such form and containing such information as the Secretary of the Treasury shall by regulation require. Such application shall contain a description of the fine imposed under section 841(b)(6) of this title, the circumstances surrounding the imposition of such fine, and the type and severity of pollution that resulted from the actions to which such fine applies."
  ]
  node [
    id 4164
    label "section_886a_item_5"
    class_name "item"
    text "(5) The Attorney General shall prepare and submit annually to the Congress, statements of financial condition of the account, including the beginning balance, receipts, refunds to appropriations, transfers to the general fund, and the ending balance."
  ]
  node [
    id 4165
    label "section_886a_item_3"
    class_name "item"
    text "(3) Fees charged by the Drug Enforcement Administration under its diversion control program shall be set at a level that ensures the recovery of the full costs of operating the various aspects of that program."
  ]
  node [
    id 4166
    label "section_886a_item_4"
    class_name "item"
    text "(4) The amount required to be refunded from the Diversion Control Fee Account for fiscal year 1994 and thereafter shall be refunded in accordance with estimates made in the budget request of the Attorney General for those fiscal years. Any proposed changes in the amounts designated in said budget requests shall only be made after notification to the Committees on Appropriations of the House of Representatives and the Senate fifteen days in advance."
  ]
  node [
    id 4167
    label "section_886a_item_1"
    class_name "item"
    text "(1) There shall be deposited as offsetting receipts into that account all fees collected by the Drug Enforcement Administration, in excess of $15,000,000, for the operation of its diversion control program."
  ]
  node [
    id 4168
    label "section_886a_item_2"
    class_name "item"
    text "(2) Such amounts as are deposited into the Diversion Control Fee Account shall remain available until expended and shall be refunded out of that account by the Secretary of the Treasury, at least on a quarterly basis, to reimburse the Drug Enforcement Administration for expenses incurred in the operation of the diversion control program."
  ]
  node [
    id 4169
    label "section_888_subsection_a_item_3"
    class_name "item"
    text "(3) Release of a conveyance under subsection (a)(1) or (a)(2)(C) of this section does not affect any forfeiture action with respect to the conveyance."
  ]
  node [
    id 4170
    label "section_888_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) grant the petition, move to dismiss the forfeiture action, if filed, and promptly release the conveyance to the owner; or"
  ]
  node [
    id 4171
    label "section_888_subsection_a_item_1"
    class_name "item"
    text "(1) The owner of a conveyance may petition the Attorney General for an expedited decision with respect to the conveyance, if the conveyance is seized for a drug-related offense and the owner has filed the requisite claim and cost bond in the manner provided in section 1608 of title 19. The Attorney General shall make a determination on a petition under this section expeditiously, including a determination of any rights or defenses available to the petitioner. If the Attorney General does not grant or deny a petition under this section within 20 days after the date on which the petition is filed, the conveyance shall be returned to the owner pending further forfeiture proceedings."
  ]
  node [
    id 4172
    label "section_888_subsection_a_item_2_subitem_C"
    class_name "subitem"
    text "(C) advise the petitioner that there is not adequate information available to determine the petition and promptly release the conveyance to the owner."
  ]
  node [
    id 4173
    label "section_888_subsection_b"
    class_name "subsection"
    text "(b) Written notice of procedures"
  ]
  node [
    id 4174
    label "section_888_subsection_c"
    class_name "subsection"
    text "(c) Complaint for forfeiture"
  ]
  node [
    id 4175
    label "section_888_subsection_d"
    class_name "subsection"
    text "(d) Bond for release of conveyance"
  ]
  node [
    id 4176
    label "section_888_subsection_a"
    class_name "subsection"
    text "(a) Petition for expedited decision; determination"
  ]
  node [
    id 4177
    label "section_888_subsection_a_item_2"
    class_name "item"
    text "(2) With respect to a petition under this section, the Attorney General may&#8212;"
  ]
  node [
    id 4178
    label "section_888_subsection_d_item_2"
    class_name "item"
    text "Any owner of a conveyance seized for a drug-related offense may obtain release of the conveyance by providing security in the form of a bond to the Attorney General in an amount equal to the value of the conveyance unless the Attorney General determines the conveyance should be retained (1) as contraband, (2) as evidence of a violation of law, or (3) because, by reason of design or other characteristic, the conveyance is particularly suited for use in illegal activities."
  ]
  node [
    id 4179
    label "section_888_subsection_d_item_1"
    class_name "item"
    text "Any owner of a conveyance seized for a drug-related offense may obtain release of the conveyance by providing security in the form of a bond to the Attorney General in an amount equal to the value of the conveyance unless the Attorney General determines the conveyance should be retained (1) as contraband, (2) as evidence of a violation of law, or (3) because, by reason of design or other characteristic, the conveyance is particularly suited for use in illegal activities."
  ]
  node [
    id 4180
    label "section_888_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) deny the petition and retain possession of the conveyance;"
  ]
  node [
    id 4181
    label "section_888_subsection_a_item_4"
    class_name "item"
    text "(4) The Attorney General shall prescribe regulations to carry out this section."
  ]
  node [
    id 4182
    label "section_888_subsection_d_item_3"
    class_name "item"
    text "Any owner of a conveyance seized for a drug-related offense may obtain release of the conveyance by providing security in the form of a bond to the Attorney General in an amount equal to the value of the conveyance unless the Attorney General determines the conveyance should be retained (1) as contraband, (2) as evidence of a violation of law, or (3) because, by reason of design or other characteristic, the conveyance is particularly suited for use in illegal activities."
  ]
  node [
    id 4183
    label "section_889_subsection_c_item_1"
    class_name "item"
    text "(1) define the term &#8220;person&#8221;;"
  ]
  node [
    id 4184
    label "section_889_subsection_b_item_1"
    class_name "item"
    text "(1) as to any commodity produced during that crop year, and the four succeeding crop years, by such person&#8212;"
  ]
  node [
    id 4185
    label "section_889_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) any price support or payment made available under the Agricultural Act of 1949 (7 U.S.C. 1421 et seq.), the Commodity Credit Corporation Charter Act (15 U.S.C. 714 et seq.), or any other Act;"
  ]
  node [
    id 4186
    label "section_889_subsection_c_item_3"
    class_name "item"
    text "(3) protect the interests of tenants and sharecroppers."
  ]
  node [
    id 4187
    label "section_889_subsection_a"
    class_name "subsection"
    text "(a) Definitions"
  ]
  node [
    id 4188
    label "section_889_subsection_a_item_3"
    class_name "item"
    text "(3) The term &#8220;State&#8221; means each of the fifty States, the District of Columbia, the Commonwealth of Puerto Rico, Guam, the Virgin Islands of the United States, American Samoa, the Commonwealth of the Northern Mariana Islands, or the Trust Territory of the Pacific Islands."
  ]
  node [
    id 4189
    label "section_889_subsection_b"
    class_name "subsection"
    text "(b) Persons ineligible for Federal agricultural program benefits"
  ]
  node [
    id 4190
    label "section_889_subsection_b_item_1_subitem_D"
    class_name "subitem"
    text "(D) a disaster payment made under the Agricultural Act of 1949 (7 U.S.C. 1421 et seq.); or"
  ]
  node [
    id 4191
    label "section_889_subsection_b_item_2"
    class_name "item"
    text "(2) a payment made under section 4 or 5 of the Commodity Credit Corporation Charter Act (15 U.S.C. 714b or 714c) for the storage of an agricultural commodity that is&#8212;"
  ]
  node [
    id 4192
    label "section_889_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) a farm storage facility loan made under section 4(h) of the Commodity Credit Corporation Charter Act (15 U.S.C. 714b(h));"
  ]
  node [
    id 4193
    label "section_889_subsection_c_item_2"
    class_name "item"
    text "(2) govern the determination of persons who shall be ineligible for program benefits under this section; and"
  ]
  node [
    id 4194
    label "section_889_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) produced during that crop year, or any of the four succeeding crop years, by such person; and"
  ]
  node [
    id 4195
    label "section_889_subsection_a_item_1"
    class_name "item"
    text "(1) The term &#8220;controlled substance&#8221; has the same meaning given such term in section 802(6) of this title."
  ]
  node [
    id 4196
    label "section_889_subsection_a_item_2"
    class_name "item"
    text "(2) The term &#8220;Secretary&#8221; means the Secretary of Agriculture."
  ]
  node [
    id 4197
    label "section_889_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) acquired by the Commodity Credit Corporation."
  ]
  node [
    id 4198
    label "section_889_subsection_c"
    class_name "subsection"
    text "(c) Regulations"
  ]
  node [
    id 4199
    label "section_889_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) crop insurance under the Federal Crop Insurance Act (7 U.S.C. 1501 et seq.);"
  ]
  node [
    id 4200
    label "section_889_subsection_b_item_1_subitem_E"
    class_name "subitem"
    text "(E) a loan made, insured or guaranteed under the Consolidated Farm and Rural Development Act (7 U.S.C. 1921 et seq.) or any other provision of law administered by the Farmers Home Administration; or"
  ]
  node [
    id 4201
    label "section_951_subsection_a"
    class_name "subsection"
    text "(a) For purposes of this subchapter&#8212;"
  ]
  node [
    id 4202
    label "section_951_subsection_a_item_1"
    class_name "item"
    text "(1) The term &#8220;import&#8221; means, with respect to any article, any bringing in or introduction of such article into any area (whether or not such bringing in or introduction constitutes an importation within the meaning of the tariff laws of the United States)."
  ]
  node [
    id 4203
    label "section_951_subsection_a_item_2"
    class_name "item"
    text "(2) The term &#8220;customs territory of the United States&#8221; has the meaning assigned to such term by general note 2 of the Harmonized Tariff Schedule of the United States."
  ]
  node [
    id 4204
    label "section_951_subsection_b"
    class_name "subsection"
    text "(b) Each term defined in section 802 of this title shall have the same meaning for purposes of this subchapter as such term has for purposes of subchapter I of this chapter."
  ]
  node [
    id 4205
    label "section_952_subsection_a_item_1"
    class_name "item"
    text "(1) such amounts of crude opium, poppy straw, concentrate of poppy straw, and coca leaves as the Attorney General finds to be necessary to provide for medical, scientific, or other legitimate purposes, and"
  ]
  node [
    id 4206
    label "section_952_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) during an emergency in which domestic supplies of such substance or drug are found by the Attorney General to be inadequate,"
  ]
  node [
    id 4207
    label "section_952_subsection_a_item_2"
    class_name "item"
    text "(2) such amounts of any controlled substance in schedule I or II or any narcotic drug in schedule III, IV, or V that the Attorney General finds to be necessary to provide for the medical, scientific, or other legitimate needs of the United States&#8212;"
  ]
  node [
    id 4208
    label "section_952_subsection_a"
    class_name "subsection"
    text "(a) Controlled substances in schedule I or II and narcotic drugs in schedule III, IV, or V; exceptions"
  ]
  node [
    id 4209
    label "section_952_subsection_b"
    class_name "subsection"
    text "(b) Nonnarcotic controlled substances in schedule III, IV, or V"
  ]
  node [
    id 4210
    label "section_952_subsection_a_item_2_subitem_C"
    class_name "subitem"
    text "(C) in any case in which the Attorney General finds that such controlled substance is in limited quantities exclusively for scientific, analytical, or research uses,"
  ]
  node [
    id 4211
    label "section_952_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) in any case in which the Attorney General finds that competition among domestic manufacturers of the controlled substance is inadequate and will not be rendered adequate by the registration of additional manufacturers under section 823 of this title, or"
  ]
  node [
    id 4212
    label "section_952_subsection_b_item_2"
    class_name "item"
    text "(2) is imported pursuant to such notification, or declaration, or in the case of any nonnarcotic controlled substance in schedule III, such import permit, notification, or declaration, as the Attorney General may by regulation prescribe, except that if a nonnarcotic controlled substance in schedule IV or V is also listed in schedule I or II of the Convention on Psychotropic Substances it shall be imported pursuant to such import permit requirements, prescribed by regulation of the Attorney General, as are required by the Convention."
  ]
  node [
    id 4213
    label "section_952_subsection_b_item_1"
    class_name "item"
    text "(1) is imported for medical, scientific, or other legitimate uses, and"
  ]
  node [
    id 4214
    label "section_952_subsection_c"
    class_name "subsection"
    text "(c) Coca leaves"
  ]
  node [
    id 4215
    label "section_953_subsection_c_item_2"
    class_name "item"
    text "(2) the controlled substance is consigned to a holder of such permits or licenses as may be required under the laws of the country of import;"
  ]
  node [
    id 4216
    label "section_953_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) the International Opium Convention of 1912 for the Suppression of the Abuses of Opium, Morphine, Cocaine, and Derivative Drugs, or to the International Opium Convention signed at Geneva on February 19, 1925; or"
  ]
  node [
    id 4217
    label "section_953_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) the Convention for Limiting the Manufacture and Regulating the Distribution of Narcotic Drugs concluded at Geneva, July 13, 1931, as amended by the protocol signed at Lake Success on December 11, 1946, and the protocol bringing under international control drugs outside the scope of the convention on July 13, 1931, for limiting the manufacture and regulating the distribution of narcotic drugs (as amended by the protocol signed at Lake Success on December 11, 1946), signed at Paris, November 19, 1948; or"
  ]
  node [
    id 4218
    label "section_953_subsection_a_item_2"
    class_name "item"
    text "(2) such country has instituted and maintains, in conformity with the conventions to which it is a party, a system for the control of imports of narcotic drugs which the Attorney General deems adequate;"
  ]
  node [
    id 4219
    label "section_953_subsection_c"
    class_name "subsection"
    text "(c) Nonnarcotic controlled substances in schedule I or II"
  ]
  node [
    id 4220
    label "section_953_subsection_c_item_4"
    class_name "item"
    text "(4) a permit to export the controlled substance in each instance has been issued by the Attorney General."
  ]
  node [
    id 4221
    label "section_953_subsection_a_item_1_subitem_C"
    class_name "subitem"
    text "(C) the Single Convention on Narcotic Drugs, 1961, signed at New York, March 30, 1961;"
  ]
  node [
    id 4222
    label "section_953_subsection_b"
    class_name "subsection"
    text "(b) Exception for exportation for special scientific purposes"
  ]
  node [
    id 4223
    label "section_953_subsection_a_item_1"
    class_name "item"
    text "(1) it is exported to a country which is a party to&#8212;"
  ]
  node [
    id 4224
    label "section_953_subsection_a_item_3"
    class_name "item"
    text "(3) the narcotic drug is consigned to a holder of such permits or licenses as may be required under the laws of the country of import, and a permit or license to import such drug has been issued by the country of import;"
  ]
  node [
    id 4225
    label "section_953_subsection_d"
    class_name "subsection"
    text "(d) Exception for exportation for special scientific purposes"
  ]
  node [
    id 4226
    label "section_953_subsection_a"
    class_name "subsection"
    text "(a) Narcotic drugs in schedule I, II, III, or IV"
  ]
  node [
    id 4227
    label "section_953_subsection_c_item_3"
    class_name "item"
    text "(3) substantial evidence is furnished to the Attorney General that (A) the controlled substance is to be applied exclusively to medical, scientific, or other legitimate uses within the country to which exported, (B) it will not be exported from such country, and (C) there is an actual need for the controlled substance for medical, scientific, or other legitimate uses within the country; and"
  ]
  node [
    id 4228
    label "section_953_subsection_a_item_5"
    class_name "item"
    text "(5) a permit to export the narcotic drug in each instance has been issued by the Attorney General."
  ]
  node [
    id 4229
    label "section_953_subsection_e_item_3"
    class_name "item"
    text "(3) in the case of a nonnarcotic controlled substance in schedule IV or V which is also listed in schedule I or II of the Convention on Psychotropic Substances, it is exported pursuant to such export permit requirements, prescribed by regulation of the Attorney General, as are required by the Convention."
  ]
  node [
    id 4230
    label "section_953_subsection_e"
    class_name "subsection"
    text "(e) Nonnarcotic controlled substances in schedule III or IV; controlled substances in schedule V"
  ]
  node [
    id 4231
    label "section_953_subsection_a_item_4"
    class_name "item"
    text "(4) substantial evidence is furnished to the Attorney General by the exporter that (A) the narcotic drug is to be applied exclusively to medical or scientific uses within the country of import, and (B) there is an actual need for the narcotic drug for medical or scientific uses within such country; and"
  ]
  node [
    id 4232
    label "section_953_subsection_c_item_1"
    class_name "item"
    text "(1) it is exported to a country which has instituted and maintains a system which the Attorney General deems adequate for the control of imports of such substances;"
  ]
  node [
    id 4233
    label "section_953_subsection_e_item_1"
    class_name "item"
    text "(1) there is furnished (before export) to the Attorney General documentary proof that importation is not contrary to the laws or regulations of the country of destination for consumption for medical, scientific, or other legitimate purposes;"
  ]
  node [
    id 4234
    label "section_953_subsection_e_item_2"
    class_name "item"
    text "(2) it is exported pursuant to such notification or declaration, or in the case of any nonnarcotic controlled substance in schedule III, such export permit, notification, or declaration as the Attorney General may by regulation prescribe; and"
  ]
  node [
    id 4235
    label "section_954_item_2"
    class_name "item"
    text "(2) A controlled substance in schedule II, III, or IV may be so imported, transferred, or transshipped if and only if advance notice is given to the Attorney General in accordance with regulations of the Attorney General."
  ]
  node [
    id 4236
    label "section_954_item_1_subitem_B"
    class_name "subitem"
    text "(B) be transferred or transshipped from one vessel, vehicle, or aircraft to another vessel, vehicle, or aircraft within the United States for immediate exportation,"
  ]
  node [
    id 4237
    label "section_954_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "if and only if it is so imported, transferred, or transshipped (i) for scientific, medical, or other legitimate purposes in the country of destination, and (ii) with the prior written approval of the Attorney General (which shall be granted or denied within 21 days of the request)."
  ]
  node [
    id 4238
    label "section_954_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "if and only if it is so imported, transferred, or transshipped (i) for scientific, medical, or other legitimate purposes in the country of destination, and (ii) with the prior written approval of the Attorney General (which shall be granted or denied within 21 days of the request)."
  ]
  node [
    id 4239
    label "section_954_item_1_subitem_A"
    class_name "subitem"
    text "(A) be imported into the United States for transshipment to another country, or"
  ]
  node [
    id 4240
    label "section_954_item_1"
    class_name "item"
    text "(1) A controlled substance in schedule I may&#8212;"
  ]
  node [
    id 4241
    label "section_956_subsection_a"
    class_name "subsection"
    text "(a) Individual possessing controlled substance"
  ]
  node [
    id 4242
    label "section_956_subsection_b"
    class_name "subsection"
    text "(b) Compound, mixture, or preparation"
  ]
  node [
    id 4243
    label "section_956_subsection_b_item_1"
    class_name "item"
    text "The Attorney General may by regulation except any compound, mixture, or preparation containing any depressant or stimulant substance listed in paragraph (a) or (b) of schedule III or in schedule IV or V from the application of all or any part of this subchapter if (1) the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant or stimulant effect on the central nervous system, and (2) such ingredients are included therein in such combinations, quantity, proportion, or concentration as to vitiate the potential for abuse of the substances which do have a depressant or stimulant effect on the central nervous system."
  ]
  node [
    id 4244
    label "section_956_subsection_b_item_2"
    class_name "item"
    text "The Attorney General may by regulation except any compound, mixture, or preparation containing any depressant or stimulant substance listed in paragraph (a) or (b) of schedule III or in schedule IV or V from the application of all or any part of this subchapter if (1) the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant or stimulant effect on the central nervous system, and (2) such ingredients are included therein in such combinations, quantity, proportion, or concentration as to vitiate the potential for abuse of the substances which do have a depressant or stimulant effect on the central nervous system."
  ]
  node [
    id 4245
    label "section_957_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) A common or contract carrier or warehouseman, or an employee thereof, whose possession of any controlled substance or list I chemical is in the usual course of his business or employment."
  ]
  node [
    id 4246
    label "section_957_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) An agent or an employee of any importer or exporter registered under section 958 of this title if such agent or employee is acting in the usual course of his business or employment."
  ]
  node [
    id 4247
    label "section_957_subsection_a"
    class_name "subsection"
    text "(a) Coverage"
  ]
  node [
    id 4248
    label "section_957_subsection_a_item_1"
    class_name "item"
    text "(1) import into the customs territory of the United States from any place outside thereof (but within the United States), or import into the United States from any place outside thereof, any controlled substance or list I chemical, or"
  ]
  node [
    id 4249
    label "section_957_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) An ultimate user who possesses such substance for a purpose specified in section 802(25)&#160;1 of this title and in conformity with an exemption granted under section 956(a) of this title."
  ]
  node [
    id 4250
    label "section_957_subsection_b_item_1"
    class_name "item"
    text "(1) The following persons shall not be required to register under the provisions of this section and may lawfully possess a controlled substance or list I chemical:"
  ]
  node [
    id 4251
    label "section_957_subsection_a_item_2"
    class_name "item"
    text "(2) export from the United States any controlled substance or list I chemical,"
  ]
  node [
    id 4252
    label "section_957_subsection_b"
    class_name "subsection"
    text "(b) Exemptions"
  ]
  node [
    id 4253
    label "section_957_subsection_b_item_2"
    class_name "item"
    text "(2) The Attorney General may, by regulation, waive the requirement for registration of certain importers and exporters if he finds it consistent with the public health and safety; and may authorize any such importer or exporter to possess controlled substances or list I chemicals for purposes of importation and exportation."
  ]
  node [
    id 4254
    label "section_958_subsection_c_item_1"
    class_name "item"
    text "(1) The Attorney General shall register an applicant to import a controlled substance in schedule III, IV, or V or to export a controlled substance in schedule III or IV, unless he determines that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the factors enumerated in paragraphs (1) through (6) of section 823(d) of this title shall be considered."
  ]
  node [
    id 4255
    label "section_958_subsection_h"
    class_name "subsection"
    text "(h) Separate registrations for each principal place of business"
  ]
  node [
    id 4256
    label "section_958_subsection_e"
    class_name "subsection"
    text "(e) Registration period"
  ]
  node [
    id 4257
    label "section_958_subsection_d_item_3"
    class_name "item"
    text "(3) The Attorney General may limit the revocation or suspension of a registration to the particular controlled substance, or substances, or list I chemical or chemicals, with respect to which grounds for revocation or suspension exist."
  ]
  node [
    id 4258
    label "section_958_subsection_c_item_2"
    class_name "item"
    text "(2)(A) The Attorney General shall register an applicant to import or export a list I chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest. Registration under this subsection shall not be required for the import or export of a drug product that is exempted under section 802(39)(A)(iv) of this title."
  ]
  node [
    id 4259
    label "section_958_subsection_c"
    class_name "subsection"
    text "(c) Applicants to import controlled substances in schedule III, IV, or V or to export controlled substances in schedule III or IV; applicants to import or export list I chemicals"
  ]
  node [
    id 4260
    label "section_958_subsection_i_item_2"
    class_name "item"
    text "Except in emergency situations as described in section 952(a)(2)(A) of this title, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under section 952(a) of this title authorizing the importation of such a substance, the Attorney General shall give manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing."
  ]
  node [
    id 4261
    label "section_958_subsection_d"
    class_name "subsection"
    text "(d) Denial of application"
  ]
  node [
    id 4262
    label "section_958_subsection_b"
    class_name "subsection"
    text "(b) Activity limited to specified substances"
  ]
  node [
    id 4263
    label "section_958_subsection_a_item_1"
    class_name "item"
    text "The Attorney General shall register an applicant to import or export a controlled substance in schedule I or II if he determines that such registration is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. In determining the public interest, the factors enumerated in paragraph (1) through (6) of section 823(a) of this title shall be considered."
  ]
  node [
    id 4264
    label "section_958_subsection_a"
    class_name "subsection"
    text "(a) Applicants to import or export controlled substances in schedule I or II"
  ]
  node [
    id 4265
    label "section_958_subsection_d_item_6"
    class_name "item"
    text "(6) In the event that the Attorney General suspends or revokes a registration granted under this section, all controlled substances or list I chemicals owned or possessed by the registrant pursuant to such registration at the time of suspension or the effective date of the revocation order, as the case may be, may, in the discretion of the Attorney General, be seized or placed under seal. No disposition may be made of any controlled substances or list I chemicals under seal until the time for taking an appeal has elapsed or until all appeals have been concluded, except that a court, upon application therefor, may at any time order the sale of perishable controlled substances or list I chemicals. Any such order shall require the deposit of the proceeds of the sale with the court. Upon a revocation order becoming final, all such controlled substances or list I chemicals (or proceeds of the sale thereof which have been deposited with the court) shall be forfeited to the United States; and the Attorney General shall dispose of such controlled substances or list I chemicals in accordance with section 881(e) of this title."
  ]
  node [
    id 4266
    label "section_958_subsection_d_item_1"
    class_name "item"
    text "(1) The Attorney General may deny an application for registration under subsection (a) of this section if he is unable to determine that such registration is consistent with the public interest (as defined in subsection (a) of this section) and with the United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971."
  ]
  node [
    id 4267
    label "section_958_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) In determining the public interest for the purposes of subparagraph (A), the Attorney General shall consider the factors specified in section 823(h) of this title."
  ]
  node [
    id 4268
    label "section_958_subsection_g"
    class_name "subsection"
    text "(g) Scope of authorized activity"
  ]
  node [
    id 4269
    label "section_958_subsection_f"
    class_name "subsection"
    text "(f) Rules and regulations"
  ]
  node [
    id 4270
    label "section_958_subsection_a_item_6"
    class_name "item"
    text "The Attorney General shall register an applicant to import or export a controlled substance in schedule I or II if he determines that such registration is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. In determining the public interest, the factors enumerated in paragraph (1) through (6) of section 823(a) of this title shall be considered."
  ]
  node [
    id 4271
    label "section_958_subsection_i"
    class_name "subsection"
    text "(i) Emergency situations"
  ]
  node [
    id 4272
    label "section_958_subsection_i_item_2_subitem_A"
    class_name "subitem"
    text "Except in emergency situations as described in section 952(a)(2)(A) of this title, prior to issuing a registration under this section to a bulk manufacturer of a controlled substance in schedule I or II, and prior to issuing a regulation under section 952(a) of this title authorizing the importation of such a substance, the Attorney General shall give manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing."
  ]
  node [
    id 4273
    label "section_958_subsection_d_item_5"
    class_name "item"
    text "(5) The Attorney General may, in his discretion, suspend any registration simultaneously with the institution of proceedings under this subsection, in cases where he finds that there is an imminent danger to the public health and safety. Such suspension shall continue in effect until the conclusion of such proceedings, including judicial review thereof, unless sooner withdrawn by the Attorney General or dissolved by a court of competent jurisdiction."
  ]
  node [
    id 4274
    label "section_958_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) The Attorney General shall register an applicant to import or export a list I chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest. Registration under this subsection shall not be required for the import or export of a drug product that is exempted under section 802(39)(A)(iv) of this title."
  ]
  node [
    id 4275
    label "section_958_subsection_d_item_2"
    class_name "item"
    text "(2) The Attorney General may deny an application for registration under subsection (c) of this section, or revoke or suspend a registration under subsection (a) or (c) of this section, if he determines that such registration is inconsistent with the public interest (as defined in subsection (a) or (c) of this section) or with the United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971."
  ]
  node [
    id 4276
    label "section_958_subsection_d_item_4"
    class_name "item"
    text "(4) Before taking action pursuant to this subsection, the Attorney General shall serve upon the applicant or registrant an order to show cause as to why the registration should not be denied, revoked, or suspended. The order to show cause shall contain a statement of the basis thereof and shall call upon the applicant or registrant to appear before the Attorney General, or his designee, at a time and place stated in the order, but in no event less than thirty days after the date of receipt of the order. Proceedings to deny, revoke, or suspend shall be conducted pursuant to this subsection in accordance with subchapter II of chapter 5 of title 5. Such proceedings shall be independent of, and not in lieu of, criminal prosecutions or other proceedings under this subchapter or any other law of the United States."
  ]
  node [
    id 4277
    label "section_959_subsection_a_item_1"
    class_name "item"
    text "(1) intending that such substance will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States; or"
  ]
  node [
    id 4278
    label "section_959_subsection_b"
    class_name "subsection"
    text "(b) Possession, manufacture, or distribution by person on board aircraft"
  ]
  node [
    id 4279
    label "section_959_subsection_c"
    class_name "subsection"
    text "(c) Acts committed outside territorial jurisdiction of United States; venue"
  ]
  node [
    id 4280
    label "section_959_subsection_a_item_2"
    class_name "item"
    text "(2) knowing that such substance will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States."
  ]
  node [
    id 4281
    label "section_959_subsection_b_item_1"
    class_name "item"
    text "(1) manufacture or distribute a controlled substance; or"
  ]
  node [
    id 4282
    label "section_959_subsection_b_item_2"
    class_name "item"
    text "(2) possess a controlled substance with intent to distribute."
  ]
  node [
    id 4283
    label "section_959_subsection_a"
    class_name "subsection"
    text "(a) Manufacture or distribution for purpose of unlawful importation"
  ]
  node [
    id 4284
    label "section_960_subsection_b_item_1_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) cocaine, its salts, optical and geometric isomers, and salts or isomers;"
  ]
  node [
    id 4285
    label "section_960_subsection_d_item_3"
    class_name "item"
    text "(3) imports or exports a listed chemical knowing, or having reasonable cause to believe, that the chemical will be used to manufacture a controlled substance in violation of this subchapter or subchapter I of this chapter;"
  ]
  node [
    id 4286
    label "section_960_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) 1 kilogram or more of a mixture or substance containing a detectable amount of heroin;"
  ]
  node [
    id 4287
    label "section_960_subsection_a"
    class_name "subsection"
    text "(a) Unlawful acts"
  ]
  node [
    id 4288
    label "section_960_subsection_d"
    class_name "subsection"
    text "(d) Penalty for importation or exportation"
  ]
  node [
    id 4289
    label "section_960_subsection_b_item_1_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) any compound, mixture, or preparation which contains any quantity of any of the substances referred to in clauses (i) through (iii);"
  ]
  node [
    id 4290
    label "section_960_subsection_b_item_2_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) ecgonine, its derivatives, their salts, isomers, and salts of isomers; or"
  ]
  node [
    id 4291
    label "section_960_subsection_b_item_2_subitem_H"
    class_name "subitem"
    text "(H) 10 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 100 grams or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers.2"
  ]
  node [
    id 4292
    label "section_960_subsection_b_item_2_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) coca leaves, except coca leaves and extracts of coca leaves from which cocaine, ecgonine, and derivatives of ecgonine or their salts have been removed;"
  ]
  node [
    id 4293
    label "section_960_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) 5 kilograms or more of a mixture or substance containing a detectable amount of&#8212;"
  ]
  node [
    id 4294
    label "section_960_subsection_a_item_1"
    class_name "item"
    text "(1) contrary to section 952, 953, or 957 of this title, knowingly or intentionally imports or exports a controlled substance,"
  ]
  node [
    id 4295
    label "section_960_subsection_b_item_1_subitem_E"
    class_name "subitem"
    text "(E) 10 grams or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);"
  ]
  node [
    id 4296
    label "section_960_subsection_b_item_2_subitem_E"
    class_name "subitem"
    text "(E) 1 gram or more of a mixture or substance containing a detectable amount of lysergic acid diethylamide (LSD);"
  ]
  node [
    id 4297
    label "section_960_subsection_b_item_2_subitem_F"
    class_name "subitem"
    text "(F) 40 grams or more of a mixture or substance containing a detectable amount of N-phenyl-N-&#160;[ 1-&#160;(&#160;2-phenylethyl&#160;)&#160;-4-piperidinyl ] propanamide or 10 grams or more of a mixture or substance containing a detectable amount of any analogue of N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide;"
  ]
  node [
    id 4298
    label "section_960_subsection_b_item_2_subitem_C"
    class_name "subitem"
    text "(C) 5 grams or more of a mixture or substance described in subparagraph (B) which contains cocaine base;"
  ]
  node [
    id 4299
    label "section_960_subsection_b_item_1_subitem_F"
    class_name "subitem"
    text "(F) 400 grams or more of a mixture or substance containing a detectable amount of N-phenyl-N-&#160;[ 1-&#160;(&#160;2-phenylethyl&#160;)&#160;-4-piperidinyl ] propanamide or 100 grams or more of a mixture or substance containing a detectable amount of any analogue of N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide;"
  ]
  node [
    id 4300
    label "section_960_subsection_d_item_4"
    class_name "item"
    text "(4) exports a listed chemical, or serves as a broker or trader for an international transaction involving a listed chemical, knowing, or having reasonable cause to believe, that the chemical will be used to manufacture a controlled substance in violation of the laws of the country to which the chemical is exported;"
  ]
  node [
    id 4301
    label "section_960_subsection_b_item_4"
    class_name "item"
    text "(4) In the case of a violation under subsection (a) of this section with respect to less than 50 kilograms of marihuana, except in the case of 100 or more marihuana plants regardless of weight, less than 10 kilograms of hashish, less than one kilogram of hashish oil, or any quantity of a controlled substance in schedule III, IV, or V, the person committing such violation shall be imprisoned not more than five years, or be fined not to exceed the greater of that authorized in accordance with the provisions of title 18 or $250,000 if the defendant is an individual or $1,000,000 if the defendant is other than an individual, or both. If a sentence under this paragraph provides for imprisonment, the sentence shall, in addition to such term of imprisonment, include (A) a term of supervised release of not less than two years if such controlled substance is in schedule I, II, III, or (B) a term of supervised release of not less than one year if such controlled substance is in schedule IV."
  ]
  node [
    id 4302
    label "section_960_subsection_d_item_2"
    class_name "item"
    text "(2) exports a listed chemical in violation of the laws of the country to which the chemical is exported or serves as a broker or trader for an international transaction involving a listed chemical, if the transaction is in violation of the laws of the country to which the chemical is exported;"
  ]
  node [
    id 4303
    label "section_960_subsection_b_item_1_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) coca leaves, except coca leaves and extracts of coca leaves from which cocaine, ecgonine, and derivatives of ecgonine or their salts have been removed;"
  ]
  node [
    id 4304
    label "section_960_subsection_b_item_1_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) ecgonine, its derivatives, their salts, isomers, and salts of isomers; or"
  ]
  node [
    id 4305
    label "section_960_subsection_b_item_2_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) cocaine, its salts, optical and geometric isomers, and salts or isomers;"
  ]
  node [
    id 4306
    label "section_960_subsection_b_item_1"
    class_name "item"
    text "(1) In the case of a violation of subsection (a) of this section involving&#8212;"
  ]
  node [
    id 4307
    label "section_960_subsection_b"
    class_name "subsection"
    text "(b) Penalties"
  ]
  node [
    id 4308
    label "section_960_subsection_a_item_3"
    class_name "item"
    text "(3) contrary to section 959 of this title, manufactures, possesses with intent to distribute, or distributes a controlled substance,"
  ]
  node [
    id 4309
    label "section_960_subsection_b_item_2"
    class_name "item"
    text "(2) In the case of a violation of subsection (a) of this section involving&#8212;"
  ]
  node [
    id 4310
    label "section_960_subsection_d_item_1"
    class_name "item"
    text "(1) imports or exports a listed chemical with intent to manufacture a controlled substance in violation of this subchapter or subchapter I of this chapter;"
  ]
  node [
    id 4311
    label "section_960_subsection_b_item_2_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) any compound, mixture, or preparation which contains any quantity of any of the substances referred to in clauses (i) through (iii);"
  ]
  node [
    id 4312
    label "section_960_subsection_b_item_3"
    class_name "item"
    text "(3) In the case of a violation under subsection (a) of this section involving a controlled substance in schedule I or II, the person committing such violation shall, except as provided in paragraphs (1), (2), and (4), be sentenced to a term of imprisonment of not more than 20 years and if death or serious bodily injury results from the use of such substance shall be sentenced to a term of imprisonment of not less than twenty years and not more than life, a fine not to exceed the greater of that authorized in accordance with the provisions of title 18 or $1,000,000 if the defendant is an individual or $5,000,000 if the defendant is other than an individual, or both. If any person commits such a violation after a prior conviction for a felony drug offense has become final, such person shall be sentenced to a term of imprisonment of not more than 30 years and if death or serious bodily injury results from the use of such substance shall be sentenced to life imprisonment, a fine not to exceed the greater of twice that authorized in accordance with the provisions of title 18 or $2,000,000 if the defendant is an individual or $10,000,000 if the defendant is other than an individual, or both. Any sentence imposing a term of imprisonment under this paragraph shall, in the absence of such a prior conviction, impose a term of supervised release of at least 3 years in addition to such term of imprisonment and shall, if there was such a prior conviction, impose a term of supervised release of at least 6 years in addition to such term of imprisonment. Notwithstanding the prior sentence, and notwithstanding any other provision of law, the court shall not place on probation or suspend the sentence of any person sentenced under the provisions of this paragraph which provide for a mandatory term of imprisonment if death or serious bodily injury results, nor shall a person so sentenced be eligible for parole during the term of such a sentence."
  ]
  node [
    id 4313
    label "section_960_subsection_b_item_2_subitem_G"
    class_name "subitem"
    text "(G) 100 kilograms or more of a mixture or substance containing a detectable amount of marihuana; or"
  ]
  node [
    id 4314
    label "section_960_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) 50 grams or more of a mixture or substance described in subparagraph (B) which contains cocaine base;"
  ]
  node [
    id 4315
    label "section_960_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) 100 grams or more of a mixture or substance containing a detectable amount of heroin;"
  ]
  node [
    id 4316
    label "section_960_subsection_b_item_1_subitem_G"
    class_name "subitem"
    text "(G) 1000 kilograms or more of a mixture or substance containing a detectable amount of marihuana; or"
  ]
  node [
    id 4317
    label "section_960_subsection_a_item_2"
    class_name "item"
    text "(2) contrary to section 955 of this title, knowingly or intentionally brings or possesses on board a vessel, aircraft, or vehicle a controlled substance, or"
  ]
  node [
    id 4318
    label "section_960_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) 500 grams or more of a mixture or substance containing a detectable amount of&#8212;"
  ]
  node [
    id 4319
    label "section_960_subsection_d_item_5"
    class_name "item"
    text "(5) imports or exports a listed chemical, with the intent to evade the reporting or recordkeeping requirements of section 971 of this title applicable to such importation or exportation by falsely representing to the Attorney General that the importation or exportation qualifies for a waiver of the 15-day notification requirement granted pursuant to section 971(e)(2) or (3) of this title by misrepresenting the actual country of final destination of the listed chemical or the actual listed chemical being imported or exported; or"
  ]
  node [
    id 4320
    label "section_960_subsection_b_item_1_subitem_H"
    class_name "subitem"
    text "(H) 100 grams or more of methamphetamine, its salts, isomers, and salts of its isomers or 1 kilogram or more of a mixture or substance containing a detectable amount of methamphetamine, its salts, isomers, or salts of its isomers.1"
  ]
  node [
    id 4321
    label "section_960_subsection_b_item_2_subitem_D"
    class_name "subitem"
    text "(D) 10 grams or more of phencyclidine (PCP) or 100 grams or more of a mixture or substance containing a detectable amount of phencyclidine (PCP);"
  ]
  node [
    id 4322
    label "section_960_subsection_d_item_6"
    class_name "item"
    text "(6) imports or exports a listed chemical in violation of section 957 or 971 of this title,"
  ]
  node [
    id 4323
    label "section_960_subsection_b_item_1_subitem_D"
    class_name "subitem"
    text "(D) 100 grams or more of phencyclidine (PCP) or 1 kilogram or more of a mixture or substance containing a detectable amount of phencyclidine (PCP);"
  ]
  node [
    id 4324
    label "section_961_item_2"
    class_name "item"
    text "(2) If such a violation is prosecuted by an information or indictment which alleges that the violation was committed knowingly or intentionally and the trier of fact specifically finds that the violation was so committed, such person shall be sentenced to imprisonment for not more than one year or a fine of not more than $25,000 or both."
  ]
  node [
    id 4325
    label "section_961_item_1"
    class_name "item"
    text "(1) Except as provided in paragraph (2), any such person shall, with respect to any such violation, be subject to a civil penalty of not more than $25,000. Sections 842(c)(1) and (c)(3) of this title shall apply to any civil penalty assessed under this paragraph."
  ]
  node [
    id 4326
    label "section_962_subsection_c"
    class_name "subsection"
    text "(c) Procedures applicable"
  ]
  node [
    id 4327
    label "section_962_subsection_a"
    class_name "subsection"
    text "(a) Term of imprisonment and fine"
  ]
  node [
    id 4328
    label "section_962_subsection_b"
    class_name "subsection"
    text "(b) Determination of status"
  ]
  node [
    id 4329
    label "section_965_item_2"
    class_name "item"
    text "Part E of subchapter I of this chapter shall apply with respect to functions of the Attorney General (and of officers and employees of the Bureau of Narcotics and Dangerous Drugs) under this subchapter, to administrative and judicial proceedings under this subchapter, and to violations of this subchapter, to the same extent that such part applies to functions of the Attorney General (and such officers and employees) under subchapter I of this chapter, to such proceedings under subchapter I of this chapter, and to violations of subchapter I of this chapter. For purposes of the application of this section to section 880 or 881 of this title, any reference in such section 880 or 881 of this title to &#8220;this subchapter&#8221; shall be deemed to be a reference to this subchapter, any reference to section 823 of this title shall be deemed to be a reference to section 958 of this title, and any reference to section 822(d) of this title shall be deemed to be a reference to section 957(b)(2) of this title."
  ]
  node [
    id 4330
    label "section_971_subsection_b_item_1"
    class_name "item"
    text "(1) The Attorney General shall provide by regulation for circumstances in which the requirement of subsection (a) of this section does not apply to a transaction between a regulated person and a regular customer or to an importation by a regular importer. At the time of any importation or exportation constituting a transaction referred to in the preceding sentence, the regulated person shall notify the Attorney General of the transaction."
  ]
  node [
    id 4331
    label "section_971_subsection_c"
    class_name "subsection"
    text "(c) Suspension of importation or exportation; disqualification of regular customers or importers; hearing"
  ]
  node [
    id 4332
    label "section_971_subsection_b_item_2"
    class_name "item"
    text "(2) The regulations under this subsection shall provide that the initial notification under subsection (a) of this section with respect to a customer of a regulated person or to an importer shall, upon the expiration of the 15-day period, qualify the customer as a regular customer or the importer as a regular importer, unless the Attorney General otherwise notifies the regulated person in writing."
  ]
  node [
    id 4333
    label "section_971_subsection_c_item_2"
    class_name "item"
    text "(2) Upon written request to the Attorney General, a regulated person to whom an order applies under paragraph (1) is entitled to an agency hearing on the record in accordance with subchapter II of chapter 5 of title 5. The hearing shall be held on an expedited basis and not later than 45 days after the request is made, except that the hearing may be held at a later time, if so requested by the regulated person."
  ]
  node [
    id 4334
    label "section_971_subsection_e_item_3"
    class_name "item"
    text "(3) The Attorney General may by regulation waive the 15-day notification requirement for the importation of a listed chemical if the Attorney General determines that such notification is not necessary for effective chemical diversion control. If the notification requirement is waived, importers of the listed chemical shall be required to submit to the Attorney General reports of individual importations or periodic reports of the importation of the listed chemical, at such time or times and containing such information as the Attorney General shall establish by regulation."
  ]
  node [
    id 4335
    label "section_971_subsection_a"
    class_name "subsection"
    text "(a) Notification prior to transaction"
  ]
  node [
    id 4336
    label "section_971_subsection_e_item_2"
    class_name "item"
    text "(2) The Attorney General may by regulation waive the 15-day notification requirement for exports of a listed chemical to a specified country if the Attorney General determines that such notification is not required for effective chemical diversion control. If the notification requirement is waived, exporters of the listed chemical shall be required to submit to the Attorney General reports of individual exportations or periodic reports of such exportation of the listed chemical, at such time or times and containing such information as the Attorney General shall establish by regulation."
  ]
  node [
    id 4337
    label "section_971_subsection_d"
    class_name "subsection"
    text "(d) Broker or trader for international transaction in listed chemical"
  ]
  node [
    id 4338
    label "section_971_subsection_c_item_1"
    class_name "item"
    text "(1) The Attorney General may order the suspension of any importation or exportation of a listed chemical (other than a regulated transaction to which the requirement of subsection (a) of this section does not apply by reason of subsection (b) of this section) or may disqualify any regular customer or regular importer on the ground that the chemical may be diverted to the clandestine manufacture of a controlled substance. From and after the time when the Attorney General provides written notice of the order (including a statement of the legal and factual basis for the order) to the regulated person, the regulated person may not carry out the transaction."
  ]
  node [
    id 4339
    label "section_971_subsection_b"
    class_name "subsection"
    text "(b) Regular customers or importers"
  ]
  node [
    id 4340
    label "section_971_subsection_e"
    class_name "subsection"
    text "(e) Application of notification requirement to exports of listed chemical; waiver"
  ]
  node [
    id 4341
    label "section_971_subsection_e_item_1"
    class_name "item"
    text "(1) The Attorney General may by regulation require that the 15-day notification requirement of subsection (a) of this section apply to all exports of a listed chemical to a specified country, regardless of the status of certain customers in such country as regular customers, if the Attorney General finds that such notification is necessary to support effective chemical diversion control programs or is required by treaty or other international agreement to which the United States is a party."
  ]
  node [
    id 4342
    label "section_1033_subsection_a_item_8"
    class_name "item"
    text "(8) if any valuable constituent has been in whole or in part omitted or abstracted therefrom; or if any substance has been substituted, wholly or in part therefor; or if damage or inferiority has been concealed in any manner; or if any substance has been added thereto or mixed or packed therewith so as to increase its bulk or weight, or reduce its quality or strength, or make it appear better or of greater value than it is."
  ]
  node [
    id 4343
    label "section_1033_subsection_g_item_3"
    class_name "item"
    text "(3) The term &#8220;dirty egg&#8221; means an egg that has a shell that is unbroken and has adhering dirt or foreign material."
  ]
  node [
    id 4344
    label "section_1033_subsection_a_item_5"
    class_name "item"
    text "(5) if it is an egg which has been subjected to incubation or the product of any egg which has been subjected to incubation;"
  ]
  node [
    id 4345
    label "section_1033_subsection_e"
    class_name "subsection"
    text "(e) The term &#8220;egg handler&#8221; means any person who engages in any business in commerce which involves buying or selling any eggs (as a poultry producer or otherwise), or processing any egg products, or otherwise using any eggs in the preparation of human food."
  ]
  node [
    id 4346
    label "section_1033_subsection_f"
    class_name "subsection"
    text "(f) The term &#8220;egg product&#8221; means any dried, frozen, or liquid eggs, with or without added ingredients, excepting products which contain eggs only in a relatively small proportion or historically have not been, in the judgment of the Secretary, considered by consumers as products of the egg food industry, and which may be exempted by the Secretary under such conditions as he may prescribe to assure that the egg ingredients are not adulterated and such products are not represented as egg products."
  ]
  node [
    id 4347
    label "section_1033_subsection_o"
    class_name "subsection"
    text "(o) The term &#8220;official inspection legend&#8221; means any symbol prescribed by regulations of the Secretary showing that egg products were inspected in accordance with this chapter."
  ]
  node [
    id 4348
    label "section_1033_subsection_m"
    class_name "subsection"
    text "(m) The term &#8220;official certificate&#8221; means any certificate prescribed by regulations of the Secretary for issuance by an inspector or other person performing official functions under this chapter."
  ]
  node [
    id 4349
    label "section_1033_subsection_g_item_2"
    class_name "item"
    text "(2) The term &#8220;clean and sound shell egg&#8221; means any egg whose shell is free of adhering dirt or foreign material and is not cracked or broken."
  ]
  node [
    id 4350
    label "section_1033_subsection_p"
    class_name "subsection"
    text "(p) The term &#8220;official mark&#8221; means the official inspection legend or any other symbol prescribed by regulations of the Secretary to identify the status of any article under this chapter."
  ]
  node [
    id 4351
    label "section_1033_subsection_g_item_4"
    class_name "item"
    text "(4) The term &#8220;incubator reject&#8221; means an egg that has been subjected to incubation and has been removed from incubation during the hatching operations as infertile or otherwise unhatchable."
  ]
  node [
    id 4352
    label "section_1033_subsection_a_item_2_subitem_D"
    class_name "subitem"
    text "(D) if it bears or contains any color additive which is unsafe within the meaning of section 379e of this title: Provided, That an article which is not otherwise deemed adulterated under clause (B), (C), or (D) shall nevertheless be deemed adulterated if use of the pesticide chemical, food additive, or color additive, in or on such article, is prohibited by regulations of the Secretary in official plants;"
  ]
  node [
    id 4353
    label "section_1033_subsection_j"
    class_name "subsection"
    text "(j) The term &#8220;inspection&#8221; means the application of such inspection methods and techniques as are deemed necessary by the responsible Secretary to carry out the provisions of this chapter."
  ]
  node [
    id 4354
    label "section_1033_subsection_d_item_1"
    class_name "item"
    text "(1) The term &#8220;immediate container&#8221; means any consumer package; or any other container in which egg products, not consumer packaged, are packed."
  ]
  node [
    id 4355
    label "section_1033_subsection_g"
    class_name "subsection"
    text "(g) The term &#8220;egg&#8221; means the shell egg of the domesticated chicken, turkey, duck, goose, or guinea."
  ]
  node [
    id 4356
    label "section_1033_subsection_a_item_3"
    class_name "item"
    text "(3) if it consists in whole or in part of any filthy, putrid, or decomposed substance, or if it is otherwise unfit for human food;"
  ]
  node [
    id 4357
    label "section_1033_subsection_g_item_5"
    class_name "item"
    text "(5) The term &#8220;inedible&#8221; means eggs of the following descriptions: black rots, yellow rots, white rots, mixed rots (addled eggs), sour eggs, eggs with green whites, eggs with stuck yolks, moldy eggs, musty eggs, eggs showing blood rings, and eggs containing embryo chicks (at or beyond the blood ring stage.)"
  ]
  node [
    id 4358
    label "section_1033_subsection_r"
    class_name "subsection"
    text "(r) The term &#8220;official standards&#8221; means the standards of quality, grades, and weight classes for eggs, in effect upon the effective date of this chapter, or as thereafter amended, under the Agricultural Marketing Act of 1946 (60 Stat. 1087, as amended; 7 U.S.C. 1621 et seq.)."
  ]
  node [
    id 4359
    label "section_1033_subsection_g_item_6"
    class_name "item"
    text "(6) The term &#8220;leaker&#8221; means an egg that has a crack or break in the shell and shell membranes to the extent that the egg contents are exposed or are exuding or free to exude through the shell."
  ]
  node [
    id 4360
    label "section_1033_subsection_k_item_2"
    class_name "item"
    text "(2) any employee or official of the government of any State or local jurisdiction authorized by the Secretary to inspect eggs or egg products under the authority of this chapter, under an agreement entered into between the Secretary and the appropriate State or other agency."
  ]
  node [
    id 4361
    label "section_1033_subsection_a"
    class_name "subsection"
    text "(a) The term &#8220;adulterated&#8221; applies to any egg or egg product under one or more of the following circumstances&#8212;"
  ]
  node [
    id 4362
    label "section_1033_subsection_g_item_1"
    class_name "item"
    text "(1) The term &#8220;check&#8221; means an egg that has a broken shell or crack in the shell but has its shell membranes intact and contents not leaking."
  ]
  node [
    id 4363
    label "section_1033_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) if it is, in whole or in part, a raw agricultural commodity and such commodity bears or contains a pesticide chemical which is unsafe within the meaning of section 346a of this title;"
  ]
  node [
    id 4364
    label "section_1033_subsection_u"
    class_name "subsection"
    text "(u) The terms &#8220;pesticide chemical,&#8221; &#8220;food additive,&#8221; &#8220;color additive,&#8221; and &#8220;raw agricultural commodity&#8221; shall have the same meaning for purposes of this chapter as under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.]."
  ]
  node [
    id 4365
    label "section_1033_subsection_v"
    class_name "subsection"
    text "(v) The term &#8220;plant&#8221; means any place of business where egg products are processed."
  ]
  node [
    id 4366
    label "section_1033_subsection_a_item_7"
    class_name "item"
    text "(7) if it has been intentionally subjected to radiation, unless the use of the radiation was in conformity with a regulation or exemption in effect pursuant to section 348 of this title; or"
  ]
  node [
    id 4367
    label "section_1033_subsection_y"
    class_name "subsection"
    text "(y) The term &#8220;State&#8221; means any State of the United States, the Commonwealth of Puerto Rico, the Virgin Islands of the United States, and the District of Columbia."
  ]
  node [
    id 4368
    label "section_1033_subsection_a_item_4"
    class_name "item"
    text "(4) if it has been prepared, packaged, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health;"
  ]
  node [
    id 4369
    label "section_1033_subsection_a_item_2_subitem_C"
    class_name "subitem"
    text "(C) if it bears or contains any food additive which is unsafe within the meaning of section 348 of this title;"
  ]
  node [
    id 4370
    label "section_1033_subsection_g_item_8"
    class_name "item"
    text "(8) The term &#8220;restricted egg&#8221; means any check, dirty egg, incubator reject, inedible, leaker, or loss."
  ]
  node [
    id 4371
    label "section_1033_subsection_z"
    class_name "subsection"
    text "(z) The term &#8220;United States&#8221; means the States."
  ]
  node [
    id 4372
    label "section_1033_subsection_a_item_6"
    class_name "item"
    text "(6) if its container is composed, in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health;"
  ]
  node [
    id 4373
    label "section_1033_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) if it bears or contains any added poisonous or added deleterious substance (other than one which is (i) a pesticide chemical in or on a raw agricultural commodity; (ii) a food additive; or (iii) a color additive) which may, in the judgment of the Secretary, make such article unfit for human food;"
  ]
  node [
    id 4374
    label "section_1033_subsection_q"
    class_name "subsection"
    text "(q) The term &#8220;official plant&#8221; means any plant, as determined by the Secretary, at which inspection of the processing of egg products is maintained by the Department of Agriculture under the authority of this chapter."
  ]
  node [
    id 4375
    label "section_1033_subsection_b"
    class_name "subsection"
    text "(b) The term &#8220;capable of use as human food&#8221; shall apply to any egg or egg product, unless it is denatured, or otherwise identified, as required by regulations prescribed by the Secretary to deter its use as human food."
  ]
  node [
    id 4376
    label "section_1033_subsection_k"
    class_name "subsection"
    text "(k) The term &#8220;inspector&#8221; means:"
  ]
  node [
    id 4377
    label "section_1033_subsection_t"
    class_name "subsection"
    text "(t) The term &#8220;person&#8221; means any individual, partnership, corporation, association, or other business unit."
  ]
  node [
    id 4378
    label "section_1033_subsection_d"
    class_name "subsection"
    text "(d) The term &#8220;container&#8221; or &#8220;package&#8221; includes any box, can, tin, plastic, or other receptacle, wrapper, or cover."
  ]
  node [
    id 4379
    label "section_1033_subsection_n"
    class_name "subsection"
    text "(n) The term &#8220;official device&#8221; means any device prescribed or authorized by the Secretary for use in applying any official mark."
  ]
  node [
    id 4380
    label "section_1033_subsection_x"
    class_name "subsection"
    text "(x) The term &#8220;Secretary&#8221; means the Secretary of Agriculture or his delegate."
  ]
  node [
    id 4381
    label "section_1033_subsection_d_item_2"
    class_name "item"
    text "(2) The term &#8220;shipping container&#8221; means any container used in packaging a product packed in an immediate container."
  ]
  node [
    id 4382
    label "section_1033_subsection_h"
    class_name "subsection"
    text "(h) The term &#8220;Fair Packaging and Labeling Act&#8221; [15 U.S.C. 1451 et seq.] means the Act so entitled, approved November 3, 1966, (80 Stat. 1296), and Acts amendatory thereof or supplementary thereto."
  ]
  node [
    id 4383
    label "section_1033_subsection_s"
    class_name "subsection"
    text "(s) The term &#8220;pasteurize&#8221; means the subjecting of each particle of egg products to heat or other treatments to destroy harmful viable micro-organisms by such processes as may be prescribed by regulations of the Secretary."
  ]
  node [
    id 4384
    label "section_1033_subsection_a_item_1"
    class_name "item"
    text "(1) if it bears or contains any poisonous or deleterious substance which may render it injurious to health; but in case the substance is not an added substance, such article shall not be considered adulterated under this clause if the quantity of such substance in or on such article does not ordinarily render it injurious to health;"
  ]
  node [
    id 4385
    label "section_1033_subsection_k_item_1"
    class_name "item"
    text "(1) any employee or official of the United States Government authorized to inspect eggs or egg products under the authority of this chapter; or"
  ]
  node [
    id 4386
    label "section_1033_subsection_i"
    class_name "subsection"
    text "(i) The term &#8220;Federal Food, Drug, and Cosmetic Act&#8221; [21 U.S.C. 301 et seq.] means the Act so entitled, approved June 25, 1938 (52 Stat. 1040), and Acts amendatory thereof or supplementary thereto."
  ]
  node [
    id 4387
    label "section_1033_subsection_w"
    class_name "subsection"
    text "(w) The term &#8220;processing&#8221; means manufacturing egg products, including breaking eggs or filtering, mixing, blending, pasteurizing, stabilizing, cooling, freezing, drying, or packaging egg products."
  ]
  node [
    id 4388
    label "section_1033_subsection_a_item_2"
    class_name "item"
    text "(2)(A) if it bears or contains any added poisonous or added deleterious substance (other than one which is (i) a pesticide chemical in or on a raw agricultural commodity; (ii) a food additive; or (iii) a color additive) which may, in the judgment of the Secretary, make such article unfit for human food;"
  ]
  node [
    id 4389
    label "section_1033_subsection_g_item_7"
    class_name "item"
    text "(7) The term &#8220;loss&#8221; means an egg that is unfit for human food because it is smashed or broken so that its contents are leaking; or overheated, frozen, or contaminated; or an incubator reject; or because it contains a bloody white, large meat spots, a large quantity of blood, or other foreign material."
  ]
  node [
    id 4390
    label "section_1033_subsection_l"
    class_name "subsection"
    text "(l) The term &#8220;misbranded&#8221; shall apply to egg products which are not labeled and packaged in accordance with the requirements prescribed by regulations of the Secretary under section 1036 of this title."
  ]
  node [
    id 4391
    label "section_1033_subsection_c"
    class_name "subsection"
    text "(c) The term &#8220;commerce&#8221; means interstate, foreign, or intrastate commerce."
  ]
  node [
    id 4392
    label "section_1034_subsection_b"
    class_name "subsection"
    text "(b) Authority of Secretary to retain, segregate, and reinspect eggs and egg products"
  ]
  node [
    id 4393
    label "section_1034_subsection_a"
    class_name "subsection"
    text "(a) Processing operations and establishments subject to coverage; rules and regulations"
  ]
  node [
    id 4394
    label "section_1034_subsection_a_item_1"
    class_name "item"
    text "For the purpose of preventing the entry into or flow or movement in commerce of, or the burdening of commerce by, any egg product which is capable of use as human food and is misbranded or adulterated, the Secretary shall, whenever processing operations are being conducted, cause continuous inspection to be made, in accordance with the regulations promulgated under this chapter, of the processing of egg products, in each plant processing egg products for commerce, unless exempted under section 1044 of this title. Without restricting the application of the preceding sentence to other kinds of establishments within its provisions, any food manufacturing establishment, institution, or restaurant which uses any eggs that do not meet the requirements of section 1044(a)(1) of this title in the preparation of any articles for human food shall be deemed to be a plant processing egg products, with respect to such operations."
  ]
  node [
    id 4395
    label "section_1034_subsection_d"
    class_name "subsection"
    text "(d) Inspection of business premises, facilities, inventory, operations, and records of egg handlers; inspection of records and inventory of others required to keep records; authority of Secretary of Health and Human Services to inspect food manufacturing establishments, institutions, and restaurants; access to places of business"
  ]
  node [
    id 4396
    label "section_1034_subsection_c"
    class_name "subsection"
    text "(c) Condemnation of adulterated products; destruction or reprocessing; procedure upon appeal from determination of adulteration"
  ]
  node [
    id 4397
    label "section_1035_subsection_b"
    class_name "subsection"
    text "(b) Refusal by Secretary to inspect nonconforming plants"
  ]
  node [
    id 4398
    label "section_1035_subsection_a"
    class_name "subsection"
    text "(a) Premises, facilities, and equipment"
  ]
  node [
    id 4399
    label "section_1036_subsection_b"
    class_name "subsection"
    text "(b) False or misleading or use of nonapproved labeling or containers; determination by Secretary; procedures applicable; appeal"
  ]
  node [
    id 4400
    label "section_1036_subsection_a"
    class_name "subsection"
    text "(a) Contents of label"
  ]
  node [
    id 4401
    label "section_1037_subsection_d_item_3"
    class_name "item"
    text "(3) without authorization from the Secretary, use any official device, mark, or certificate, or simulation thereof, or detach, deface, or destroy any official device or mark; or use any labeling or container ordered to be withheld from use under section 1036 of this title after final judicial affirmance of such order or expiration of the time for appeal if no appeal is taken under said section;"
  ]
  node [
    id 4402
    label "section_1037_subsection_e"
    class_name "subsection"
    text "(e) No person, while an official or employee of the United States Government or any State or local governmental agency, or thereafter, shall use to his own advantage, or reveal other than to the authorized representatives of the United States Government or any State or other government in their official capacity, or as ordered by a court in a judicial proceeding, any information acquired under the authority of this chapter concerning any matter which is entitled to protection as a trade secret."
  ]
  node [
    id 4403
    label "section_1037_subsection_d_item_4"
    class_name "item"
    text "(4) contrary to the regulations prescribed by the Secretary, fail to use, or to detach, deface, or destroy any official device, mark, or certificate;"
  ]
  node [
    id 4404
    label "section_1037_subsection_d_item_1"
    class_name "item"
    text "(1) manufacture, cast, print, lithograph, or otherwise make any device containing any official mark or simulation thereof, or any label bearing any such mark or simulation, or any form of official certificate or simulation thereof, except as authorized by the Secretary;"
  ]
  node [
    id 4405
    label "section_1037_subsection_d_item_2"
    class_name "item"
    text "(2) forge or alter any official device, mark, or certificate;"
  ]
  node [
    id 4406
    label "section_1037_subsection_d"
    class_name "subsection"
    text "(d) No person shall&#8212;"
  ]
  node [
    id 4407
    label "section_1037_subsection_b_item_1"
    class_name "item"
    text "(b)(1) No person shall process any egg products for commerce at any plant except in compliance with the requirements of this chapter."
  ]
  node [
    id 4408
    label "section_1037_subsection_a_item_2"
    class_name "item"
    text "(2) No egg handler shall possess with intent to use, or use, any restricted eggs in the preparation of human food for commerce except that such eggs may be so possessed and used when authorized by regulations of the Secretary under such conditions as he may prescribe to assure that only eggs fit for human food are used for such purpose."
  ]
  node [
    id 4409
    label "section_1037_subsection_b_item_3"
    class_name "item"
    text "(3) No operator of any official plant shall fail to comply with any requirements of section 1035(a) of this title or the regulations thereunder."
  ]
  node [
    id 4410
    label "section_1037_subsection_b_item_4"
    class_name "item"
    text "(4) No operator of any official plant shall allow any egg products to be moved from such plant if they are adulterated or misbranded and capable of use as human food."
  ]
  node [
    id 4411
    label "section_1037_subsection_d_item_7"
    class_name "item"
    text "(7) knowingly represent that any article has been inspected or exempted, under this chapter, when, in fact, it has, respectively, not been so inspected or exempted; and"
  ]
  node [
    id 4412
    label "section_1037_subsection_d_item_5"
    class_name "item"
    text "(5) knowingly possess, without promptly notifying the Secretary or his representative, any official device or any counterfeit, simulated, forged, or improperly altered official certificate or any device or label, or any eggs or egg products bearing any counterfeit, simulated, forged, or improperly altered official mark;"
  ]
  node [
    id 4413
    label "section_1037_subsection_d_item_6"
    class_name "item"
    text "(6) knowingly make any false statement in any shipper's certificate or other nonofficial or official certificate provided for in the regulations prescribed by the Secretary;"
  ]
  node [
    id 4414
    label "section_1037_subsection_d_item_8"
    class_name "item"
    text "(8) refuse access, at any reasonable time, to any representative of the Secretary of Agriculture or the Secretary of Health and Human Services, to any plant or other place of business subject to inspection under any provisions of this chapter."
  ]
  node [
    id 4415
    label "section_1037_subsection_b_item_2"
    class_name "item"
    text "(2) No person shall buy, sell, or transport, or offer to buy or sell, or offer or receive for transportation, in commerce any egg products required to be inspected under this chapter unless they have been so inspected and are labeled and packaged in accordance with the requirements of section 1036 of this title."
  ]
  node [
    id 4416
    label "section_1037_subsection_b"
    class_name "subsection"
    text "(b)(1) No person shall process any egg products for commerce at any plant except in compliance with the requirements of this chapter."
  ]
  node [
    id 4417
    label "section_1037_subsection_a"
    class_name "subsection"
    text "(a)(1) No person shall buy, sell, or transport, or offer to buy or sell, or offer or receive for transportation, in any business in commerce any restricted eggs, capable of use as human food, except as authorized by regulations of the Secretary under such conditions as he may prescribe to assure that only eggs fit for human food are used for such purpose."
  ]
  node [
    id 4418
    label "section_1037_subsection_a_item_1"
    class_name "item"
    text "(a)(1) No person shall buy, sell, or transport, or offer to buy or sell, or offer or receive for transportation, in any business in commerce any restricted eggs, capable of use as human food, except as authorized by regulations of the Secretary under such conditions as he may prescribe to assure that only eggs fit for human food are used for such purpose."
  ]
  node [
    id 4419
    label "section_1037_subsection_c"
    class_name "subsection"
    text "(c) No person shall violate any provision of section 1039, 1040 or 1046 of this title."
  ]
  node [
    id 4420
    label "section_1041_subsection_c"
    class_name "subsection"
    text "(c) Persons preventing enforcement of chapter; term of imprisonment and fine"
  ]
  node [
    id 4421
    label "section_1041_subsection_a_item_8"
    class_name "item"
    text "Any person who commits any offense prohibited by section 1037 of this title shall upon conviction be subject to imprisonment for not more than one year, or a fine of not more than $1,000, or both such imprisonment and fine, but if such violation involves intent to defraud, or any distribution or attempted distribution of any article that is known to be adulterated (except as defined in section 1033(a)(8) of this title), such person shall be subject to imprisonment for not more than three years or a fine of not more than $10,000, or both. When construing or enforcing the provisions of section 1037 of this title, the act, omission, or failure of any person acting for or employed by any individual, partnership, corporation, or association within the scope of his employment or office shall in every case be deemed the act, omission, or failure of such individual, partnership, corporation, or association, as well as of such person."
  ]
  node [
    id 4422
    label "section_1041_subsection_a"
    class_name "subsection"
    text "(a) Violations of section 1037; term of imprisonment and fine; scope of liability"
  ]
  node [
    id 4423
    label "section_1041_subsection_b"
    class_name "subsection"
    text "(b) Penalties applicable to carriers or warehousemen"
  ]
  node [
    id 4424
    label "section_1044_subsection_c"
    class_name "subsection"
    text "(c) Suspension or termination of exemptions"
  ]
  node [
    id 4425
    label "section_1044_subsection_a_item_7"
    class_name "item"
    text "(7) the sale of eggs by any egg producer with an annual egg production from a flock of three thousand or less hens."
  ]
  node [
    id 4426
    label "section_1044_subsection_a_item_2"
    class_name "item"
    text "(2) the processing of egg products at any plant where the facilities and operating procedures meet such sanitary standards as may be prescribed by the Secretary, and where the eggs received or used in the manufacture of egg products contain no more restricted eggs than are allowed by the official standards of United States consumer grades for shell eggs, and the egg products processed at such plant;"
  ]
  node [
    id 4427
    label "section_1044_subsection_b"
    class_name "subsection"
    text "(b) Plants located in noncontiguous areas of United States"
  ]
  node [
    id 4428
    label "section_1044_subsection_a"
    class_name "subsection"
    text "(a) Regulation for exemptions"
  ]
  node [
    id 4429
    label "section_1044_subsection_a_item_6"
    class_name "item"
    text "(6) for such period of time (not to exceed two years) during the initiation of operations under this chapter as the Secretary determines that it is impracticable to provide inspection, the processing of egg products at any class of plants and the egg products processed at such plants; and"
  ]
  node [
    id 4430
    label "section_1044_subsection_c_item_6"
    class_name "item"
    text "The Secretary may immediately suspend or terminate any exemption under subsection (a)(2) or (6) of this section at any time with respect to any person, if the conditions of exemption prescribed by this section or the regulations of the Secretary are not being met. The Secretary may modify or revoke any regulation granting exemption under this chapter whenever he deems such action appropriate to effectuate the purposes of this chapter."
  ]
  node [
    id 4431
    label "section_1044_subsection_a_item_5"
    class_name "item"
    text "(5) the sale of eggs by shell egg packers on his own premises directly to household consumers for use by such consumer and members of his household and his nonpaying guests and employees, and the transportation, possession, and use of such eggs in accordance with this paragraph;"
  ]
  node [
    id 4432
    label "section_1044_subsection_a_item_1"
    class_name "item"
    text "(1) the sale, transportation, possession, or use of eggs which contain no more restricted eggs than are allowed by the tolerance in the official standards of United States consumer grades for shell eggs;"
  ]
  node [
    id 4433
    label "section_1044_subsection_c_item_2"
    class_name "item"
    text "The Secretary may immediately suspend or terminate any exemption under subsection (a)(2) or (6) of this section at any time with respect to any person, if the conditions of exemption prescribed by this section or the regulations of the Secretary are not being met. The Secretary may modify or revoke any regulation granting exemption under this chapter whenever he deems such action appropriate to effectuate the purposes of this chapter."
  ]
  node [
    id 4434
    label "section_1044_subsection_a_item_3"
    class_name "item"
    text "(3) the sale of eggs by any poultry producer from his own flocks directly to a household consumer exclusively for use by such consumer and members of his household and his nonpaying guests and employees, and the transportation, possession, and use of such eggs in accordance with this paragraph;"
  ]
  node [
    id 4435
    label "section_1044_subsection_a_item_4"
    class_name "item"
    text "(4) the processing of egg products by any poultry producer from eggs of his own flocks&#8217; production for sale of such products directly to a household consumer exclusively for use by such consumer and members of his household and his nonpaying guests and employees, and the egg products so processed when handled in accordance with this paragraph;"
  ]
  node [
    id 4436
    label "section_1046_subsection_a"
    class_name "subsection"
    text "(a) Authorization for importation of restricted eggs; prerequisites for importation of egg products; treatment as domestic articles subject to this chapter; marking and labeling exemption for personal consumption"
  ]
  node [
    id 4437
    label "section_1046_subsection_d"
    class_name "subsection"
    text "(d) Prohibition"
  ]
  node [
    id 4438
    label "section_1046_subsection_b"
    class_name "subsection"
    text "(b) Terms and conditions for destruction"
  ]
  node [
    id 4439
    label "section_1046_subsection_b_item_2"
    class_name "item"
    text "The Secretary may prescribe the terms and conditions for the destruction of all such articles which are imported contrary to this section, unless (1) they are exported by the consignee within the time fixed therefor by the Secretary or (2) in the case of articles which are not in compliance solely because of misbranding, such articles are brought into compliance with this chapter under supervision of authorized representatives of the Secretary."
  ]
  node [
    id 4440
    label "section_1046_subsection_c"
    class_name "subsection"
    text "(c) Payment of storage, cartage, and labor charges by owner or consignee; liens"
  ]
  node [
    id 4441
    label "section_1046_subsection_b_item_1"
    class_name "item"
    text "The Secretary may prescribe the terms and conditions for the destruction of all such articles which are imported contrary to this section, unless (1) they are exported by the consignee within the time fixed therefor by the Secretary or (2) in the case of articles which are not in compliance solely because of misbranding, such articles are brought into compliance with this chapter under supervision of authorized representatives of the Secretary."
  ]
  node [
    id 4442
    label "section_1047_item_1"
    class_name "item"
    text "The Secretary (for such period, or indefinitely, as he deems necessary to effectuate the purposes of this chapter) may refuse to provide or may withdraw inspection service under this chapter with respect to any plant if he determines, after opportunity for a hearing is accorded to the applicant for, or recipient of, such service, that such applicant or recipient is unfit to engage in any business requiring inspection under this chapter because the applicant or recipient or anyone responsibly connected with the applicant or recipient has been convicted in any Federal or State court, within the previous ten years, of (1) any felony or more than one misdemeanor under any law based upon the acquiring, handling, or distributing of adulterated, mislabeled, or deceptively packaged food or fraud in connection with transactions in food, or (2) any felony, involving fraud, bribery, extortion, or any other act or circumstances indicating a lack of the integrity needed for the conduct of operations affecting the public health."
  ]
  node [
    id 4443
    label "section_1047_item_2"
    class_name "item"
    text "The Secretary (for such period, or indefinitely, as he deems necessary to effectuate the purposes of this chapter) may refuse to provide or may withdraw inspection service under this chapter with respect to any plant if he determines, after opportunity for a hearing is accorded to the applicant for, or recipient of, such service, that such applicant or recipient is unfit to engage in any business requiring inspection under this chapter because the applicant or recipient or anyone responsibly connected with the applicant or recipient has been convicted in any Federal or State court, within the previous ten years, of (1) any felony or more than one misdemeanor under any law based upon the acquiring, handling, or distributing of adulterated, mislabeled, or deceptively packaged food or fraud in connection with transactions in food, or (2) any felony, involving fraud, bribery, extortion, or any other act or circumstances indicating a lack of the integrity needed for the conduct of operations affecting the public health."
  ]
  node [
    id 4444
    label "section_1049_subsection_b"
    class_name "subsection"
    text "(b) Condemnation or seizure under other provisions unaffected"
  ]
  node [
    id 4445
    label "section_1049_subsection_a"
    class_name "subsection"
    text "(a) Jurisdiction; disposal of condemned articles; court costs and fees; conformity to supplemental rules for admiralty and maritime claims; jury trial; United States as plaintiff"
  ]
  node [
    id 4446
    label "section_1052_subsection_c"
    class_name "subsection"
    text "(c) Applicability of other Federal laws and authority of other Federal officials relating to eggs, egg products, or other food products unaffected; authority of Secretary of Agriculture to regulate official plants processing egg products"
  ]
  node [
    id 4447
    label "section_1052_subsection_a"
    class_name "subsection"
    text "(a) Prohibition against additional or different requirements than Federal requirements relating to premises, facilities, and operations at official plants; authority to impose recordkeeping and related requirements consistent with Federal requirements"
  ]
  node [
    id 4448
    label "section_1052_subsection_b_item_2"
    class_name "item"
    text "For eggs which have moved or are moving in interstate or foreign commerce, (1) no State or local jurisdiction may require the use of standards of quality, condition, weight, quantity, or grade which are in addition to or different from the official Federal standards, and (2) no State or local jurisdiction other than those in noncontiguous areas of the United States may require labeling to show the State or other geographical area of production or origin: Provided, however, That this shall not preclude a State from requiring that the name, address, and license number of the person processing or packaging eggs, be shown on each container. Labeling, packaging, or ingredient requirements, in addition to or different than those made under this chapter, the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] and the Fair Packaging and Labeling Act [15 U.S.C. 1451 et seq.], may not be imposed by any State or local jurisdiction, with respect to egg products processed at any official plant in accordance with the requirements under this chapter and such Acts. However, any State or local jurisdiction may exercise jurisdiction with respect to eggs and egg products for the purpose of preventing the distribution for human food purposes of any such articles which are outside of such a plant and are in violation of any of said Federal Acts or any State or local law consistent therewith. Otherwise the provisions of this chapter shall not invalidate any law or other provisions of any State or other jurisdiction in the absence of a conflict with this chapter."
  ]
  node [
    id 4449
    label "section_1052_subsection_b_item_1"
    class_name "item"
    text "For eggs which have moved or are moving in interstate or foreign commerce, (1) no State or local jurisdiction may require the use of standards of quality, condition, weight, quantity, or grade which are in addition to or different from the official Federal standards, and (2) no State or local jurisdiction other than those in noncontiguous areas of the United States may require labeling to show the State or other geographical area of production or origin: Provided, however, That this shall not preclude a State from requiring that the name, address, and license number of the person processing or packaging eggs, be shown on each container. Labeling, packaging, or ingredient requirements, in addition to or different than those made under this chapter, the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] and the Fair Packaging and Labeling Act [15 U.S.C. 1451 et seq.], may not be imposed by any State or local jurisdiction, with respect to egg products processed at any official plant in accordance with the requirements under this chapter and such Acts. However, any State or local jurisdiction may exercise jurisdiction with respect to eggs and egg products for the purpose of preventing the distribution for human food purposes of any such articles which are outside of such a plant and are in violation of any of said Federal Acts or any State or local law consistent therewith. Otherwise the provisions of this chapter shall not invalidate any law or other provisions of any State or other jurisdiction in the absence of a conflict with this chapter."
  ]
  node [
    id 4450
    label "section_1052_subsection_d"
    class_name "subsection"
    text "(d) Detainer authority"
  ]
  node [
    id 4451
    label "section_1052_subsection_b"
    class_name "subsection"
    text "(b) Prohibition against additional or different standards than Federal standards of quality, etc., or requiring labeling to show area of production or origin; authority to require name, address, and license number of processor or packer on containers; prohibition against additional or different requirements than Federal requirements relating to labeling, packaging or ingredients; authority to prevent distribution of violative articles; validity of nonconflicting laws"
  ]
  node [
    id 4452
    label "section_1053_subsection_a"
    class_name "subsection"
    text "(a) Overtime and holiday work costs; availability of funds"
  ]
  node [
    id 4453
    label "section_1053_subsection_b"
    class_name "subsection"
    text "(b) &#8220;Holiday&#8221; defined"
  ]
  node [
    id 4454
    label "section_1054_item_2"
    class_name "item"
    text "(2) the administration of section 1046 of this title (relating to imports) during the immediately preceding calendar year, including but not limited to&#8212;"
  ]
  node [
    id 4455
    label "section_1054_item_2_subitem_F"
    class_name "subitem"
    text "(F) recommendations for legislation to improve such program."
  ]
  node [
    id 4456
    label "section_1054_item_2_subitem_B"
    class_name "subitem"
    text "(B) the names and locations of plants authorized or permitted to export eggs or egg products to the United States;"
  ]
  node [
    id 4457
    label "section_1054_item_1"
    class_name "item"
    text "(1) the processing, storage, handling, and distribution of eggs and egg products subject to the provisions of this chapter; the inspection of establishments operated in connection therewith; the effectiveness of the operations of the inspection, including the effectiveness of the operations of State egg inspection programs; and recommendations for legislation to improve such program; and"
  ]
  node [
    id 4458
    label "section_1054_item_2_subitem_C"
    class_name "subitem"
    text "(C) the number of inspectors employed by the Department of Agriculture in the calendar year concerned who were assigned to inspect plants referred to in paragraph (B) hereof and the frequency with which each such plant was inspected by such inspectors;"
  ]
  node [
    id 4459
    label "section_1054_item_2_subitem_A"
    class_name "subitem"
    text "(A) a certification by the Secretary that foreign plants exporting eggs or egg products to the United States have complied with requirements of this chapter and regulations issued thereunder;"
  ]
  node [
    id 4460
    label "section_1054_item_2_subitem_D"
    class_name "subitem"
    text "(D) the number of inspectors that were licensed by each country from which any imports were received and that were assigned, during the calendar year concerned, to inspect such imports and the facilities in which such imports were handled; and the frequency and effectiveness of such inspections;"
  ]
  node [
    id 4461
    label "section_1054_item_2_subitem_E"
    class_name "subitem"
    text "(E) the total volume of eggs and egg products which was imported into the United States during the calendar year concerned from each country, including a separate itemization of the volume of each major category of such imports from each country during such year, and a detailed report of rejections of plants and products because of failure to meet appropriate standards prescribed by this chapter; and"
  ]
  node [
    id 4462
    label "section_1101_item_2"
    class_name "item"
    text "(2) Drug abuse seriously impairs individual, as well as societal, health and well-being."
  ]
  node [
    id 4463
    label "section_1101_item_9"
    class_name "item"
    text "(9) The increasing rate of drug abuse constitutes a serious and continuing threat to national health and welfare, requiring an immediate and effective response on the part of the Federal Government."
  ]
  node [
    id 4464
    label "section_1101_item_10"
    class_name "item"
    text "(10) Although the Congress observed a significant apparent reduction in the rate of increase of drug abuse during the three-year period subsequent to March 21, 1972, and in certain areas of the country apparent temporary reductions in its incidence, the increase and spread of heroin consumption since 1974, and the continuing abuse of other dangerous drugs, clearly indicate the need for effective, ongoing, and highly visible Federal leadership in the formation and execution of a comprehensive, coordinated drug abuse policy."
  ]
  node [
    id 4465
    label "section_1101_item_1"
    class_name "item"
    text "(1) Drug abuse is rapidly increasing in the United States and now afflicts urban, suburban, and rural areas of the Nation."
  ]
  node [
    id 4466
    label "section_1101_item_5"
    class_name "item"
    text "(5) Too little is known about drug abuse, especially the causes, and ways to treat and prevent drug abuse."
  ]
  node [
    id 4467
    label "section_1101_item_12"
    class_name "item"
    text "(12) The growing extent of drug abuse indicates an urgent need for prevention and intervention programs designed to reach the general population and members of high risk populations such as youth, women, and the elderly."
  ]
  node [
    id 4468
    label "section_1101_item_3"
    class_name "item"
    text "(3) Drug abuse, especially heroin addiction, substantially contributes to crime."
  ]
  node [
    id 4469
    label "section_1101_item_8"
    class_name "item"
    text "(8) Control of drug abuse requires the development of a comprehensive, coordinated long-term Federal strategy that encompasses both effective law enforcement against illegal drug traffic and effective health programs to rehabilitate victims of drug abuse."
  ]
  node [
    id 4470
    label "section_1101_item_13"
    class_name "item"
    text "(13) Effective control of drug abuse requires high-level coordination of Federal international and domestic activities relating to both supply of, and demand for, commonly abused drugs."
  ]
  node [
    id 4471
    label "section_1101_item_14"
    class_name "item"
    text "(14) Local governments with high concentrations of drug abuse should be actively involved in the planning and coordination of efforts to combat drug abuse."
  ]
  node [
    id 4472
    label "section_1101_item_7"
    class_name "item"
    text "(7) The effectiveness of efforts by State and local governments and by the Federal Government to control and treat drug abuse in the United States has been hampered by a lack of coordination among the States, between States and localities, among the Federal Government, States and localities, and throughout the Federal establishment."
  ]
  node [
    id 4473
    label "section_1101_item_6"
    class_name "item"
    text "(6) The success of Federal drug abuse programs and activities requires a recognition that education, treatment, rehabilitation, research, training, and law enforcement efforts are interrelated."
  ]
  node [
    id 4474
    label "section_1101_item_4"
    class_name "item"
    text "(4) The adverse impact of drug abuse inflicts increasing pain and hardship on individuals, families, and communities and undermines our institutions."
  ]
  node [
    id 4475
    label "section_1101_item_11"
    class_name "item"
    text "(11) Shifts in the usage of various drugs and in the Nation's demographic composition require a Federal strategy to adjust the focus of drug abuse programs to meet new needs and priorities on a cost-effective basis."
  ]
  node [
    id 4476
    label "section_1102_item_2"
    class_name "item"
    text "(2) the development and support of community-based prevention programs;"
  ]
  node [
    id 4477
    label "section_1102_item_3"
    class_name "item"
    text "(3) the development and encouragement of effective occupational prevention and treatment programs within the Government and in cooperation with the private sector; and"
  ]
  node [
    id 4478
    label "section_1102_item_1"
    class_name "item"
    text "(1) comprehensive Federal, State, and local planning for, and effective use of, Federal assistance to States and to community-based programs to meet the urgent needs of special populations, in coordination with all other governmental and nongovernmental sources of assistance;"
  ]
  node [
    id 4479
    label "section_1102_item_4"
    class_name "item"
    text "(4) increased Federal commitment to research into the behavioral and biomedical etiology of, the treatment of, and the mental and physical health and social and economic consequences of, drug abuse."
  ]
  node [
    id 4480
    label "section_1115_item_1"
    class_name "item"
    text "(1) a drug or other substance, which is not a controlled substance (as defined in section 802(6) of this title), has a potential for abuse, or"
  ]
  node [
    id 4481
    label "section_1115_item_2"
    class_name "item"
    text "(2) a controlled substance should be transferred or removed from a schedule under section 812 of this title,"
  ]
  node [
    id 4482
    label "section_1171_item_1"
    class_name "item"
    text "Any request for appropriations by a department or agency of the Government submitted after March 21, 1972, shall specify (1) on a line item basis, that part of the appropriations which the department or agency is requesting to carry out its drug abuse prevention functions, and (2) the authorization of the appropriations requested to carry out each of its drug abuse prevention functions."
  ]
  node [
    id 4483
    label "section_1171_item_2"
    class_name "item"
    text "Any request for appropriations by a department or agency of the Government submitted after March 21, 1972, shall specify (1) on a line item basis, that part of the appropriations which the department or agency is requesting to carry out its drug abuse prevention functions, and (2) the authorization of the appropriations requested to carry out each of its drug abuse prevention functions."
  ]
  node [
    id 4484
    label "section_1177_subsection_g"
    class_name "subsection"
    text "(g) Authorization by chief executive officer of State required; maximum amount and duration of grants"
  ]
  node [
    id 4485
    label "section_1177_subsection_e"
    class_name "subsection"
    text "(e) Payments; advances; reimbursement; installments"
  ]
  node [
    id 4486
    label "section_1177_subsection_c_item_3"
    class_name "item"
    text "(3) Approval of any application for a grant or contract under this section by the Secretary, including the earmarking of financial assistance for a program or project, may be granted only if the application substantially meets a set of criteria that&#8212;"
  ]
  node [
    id 4487
    label "section_1177_subsection_b"
    class_name "subsection"
    text "(b) Authorization of appropriations"
  ]
  node [
    id 4488
    label "section_1177_subsection_c_item_2"
    class_name "item"
    text "(2) Each applicant within a State, upon filing its application with the Secretary for a grant or contract under this section, shall submit a copy of its application for review by the State agency (if any) responsible for the administration of drug abuse prevention activities. Such State agency shall be given not more than thirty days from the date of receipt of the application to submit to the Secretary, in writing, an evaluation of the project set forth in the application. Such evaluation shall include comments on the relationship of the project to other projects pending and approved and to any State comprehensive plan for treatment and prevention of drug abuse. The State shall furnish the applicant a copy of any such evaluation. A State if it so desires may, in writing, waive its rights under this paragraph."
  ]
  node [
    id 4489
    label "section_1177_subsection_c_item_3_subitem_C"
    class_name "subitem"
    text "(C) provide for such fiscal control and fund accounting procedures as may be necessary to assure proper disbursement of and accounting for Federal funds paid to the applicant."
  ]
  node [
    id 4490
    label "section_1177_subsection_c_item_4"
    class_name "item"
    text "(4) Each applicant within a State, upon filing its application with the Secretary for a grant or contract to provide treatment or rehabilitation services shall provide a proposed performance standard or standards, to measure, or research protocol to determine, the effectiveness of such treatment or rehabilitation program or project."
  ]
  node [
    id 4491
    label "section_1177_subsection_f_item_3_subitem_B"
    class_name "subitem"
    text "Projects and programs for which grants and contracts are made or entered into under this section shall, in the case of prevention and treatment services, seek to (1) be responsive to special requirements of handicapped individuals in receiving such services; (2) whenever possible, be community based, insure care of good quality in general community care facilities and under health insurance plans, and be integrated with, and provide for the active participation of, a wide range of public and nongovernmental agencies, organizations, institutions, and individuals; (3) where a substantial number of the individuals in the population served by the project or program are of limited English-speaking ability (A) utilize the services of outreach workers fluent in the language spoken by a predominant number of such individuals and develop a plan and make arrangements responsive to the needs of such population for providing services to the extent practicable in the language and cultural context most appropriate to such individuals, and (B) identify an individual who is fluent both in that language and English and whose responsibilities shall include providing guidance to the individuals of limited English-speaking ability and to appropriate staff members with respect to cultural sensitivities and bridging linguistic and cultural differences; and (4) where appropriate, utilize existing community resources (including community mental health centers)."
  ]
  node [
    id 4492
    label "section_1177_subsection_c_item_1"
    class_name "item"
    text "(1) In carrying out this section, the Secretary shall require coordination of all applications for programs in a State and shall not give precedence to public agencies over private agencies, institutions, and organizations, or to State agencies over local agencies."
  ]
  node [
    id 4493
    label "section_1177_subsection_g_item_3_subitem_B"
    class_name "subitem"
    text "(B) For purposes of this paragraph, no grant or contract shall be considered to have been made under this section for a fiscal year ending before September 30, 1981."
  ]
  node [
    id 4494
    label "section_1177_subsection_f_item_1"
    class_name "item"
    text "Projects and programs for which grants and contracts are made or entered into under this section shall, in the case of prevention and treatment services, seek to (1) be responsive to special requirements of handicapped individuals in receiving such services; (2) whenever possible, be community based, insure care of good quality in general community care facilities and under health insurance plans, and be integrated with, and provide for the active participation of, a wide range of public and nongovernmental agencies, organizations, institutions, and individuals; (3) where a substantial number of the individuals in the population served by the project or program are of limited English-speaking ability (A) utilize the services of outreach workers fluent in the language spoken by a predominant number of such individuals and develop a plan and make arrangements responsive to the needs of such population for providing services to the extent practicable in the language and cultural context most appropriate to such individuals, and (B) identify an individual who is fluent both in that language and English and whose responsibilities shall include providing guidance to the individuals of limited English-speaking ability and to appropriate staff members with respect to cultural sensitivities and bridging linguistic and cultural differences; and (4) where appropriate, utilize existing community resources (including community mental health centers)."
  ]
  node [
    id 4495
    label "section_1177_subsection_g_item_1"
    class_name "item"
    text "(1) No grant may be made under this section to a State or to any entity within the government of a State unless the grant application has been duly authorized by the chief executive officer of such State."
  ]
  node [
    id 4496
    label "section_1177_subsection_a"
    class_name "subsection"
    text "(a) Scope of programs; priority"
  ]
  node [
    id 4497
    label "section_1177_subsection_g_item_3"
    class_name "item"
    text "(3)(A) The amount of any grant or contract under this section may not exceed 100 per centum of the cost of carrying out the grant or contract in the first fiscal year for which the grant or contract is made under this section, 80 per centum of such cost in the second fiscal year for which the grant or contract is made under this section, 70 per centum of such cost in the third fiscal year for which the grant or contract is made under this section, and 60 per centum of such cost in each of the fourth and fifth fiscal years for which the grant or contract is made under this section."
  ]
  node [
    id 4498
    label "section_1177_subsection_d"
    class_name "subsection"
    text "(d) Programs and projects aimed at underserved groups; encouragement and special consideration given to applications"
  ]
  node [
    id 4499
    label "section_1177_subsection_b_item_1"
    class_name "item"
    text "There are authorized to be appropriated $25,000,000 for the fiscal year ending June 30, 1972; $65,000,000 for the fiscal year ending June 30, 1973; $100,000,000 for the fiscal year ending June 30, 1974; $160,000,000 for each of the fiscal years ending June 30, 1975 and June 30, 1976; $40,000,000 for the period July 1, 1976, through September 30, 1976; and $160,000,000 for each of the fiscal years ending September 30, 1977, and September 30, 1978, to carry out this section. For the fiscal year ending September 30, 1979, there is authorized to be appropriated (1) $153,000,000 for grants and contracts under paragraphs (3) and (6) of subsection (a) of this section for drug abuse treatment programs, and (2) $24,000,000 for grants and contracts under such subsection for other programs and activities. For grants and contracts under paragraphs (3) and (6) of subsection (a) of this section for drug abuse treatment programs there is authorized to be appropriated $149,000,000 for the fiscal year ending September 30, 1980, and $155,000,000 for the fiscal year ending September 30, 1981; and for grants and contracts under such subsection for other programs and activities there is authorized to be appropriated $20,000,000 for the fiscal year ending September 30, 1980, and $30,000,000 for the fiscal year ending September 30, 1981. Of the funds appropriated under the preceding sentence for the fiscal year ending September 30, 1980, at least 7 percent of the funds shall be obligated for grants and contracts for primary prevention and intervention programs designed to discourage individuals, particularly those in high risk populations, from abusing drugs; and of the funds appropriated under the preceding sentence for the next fiscal year, at least 10 percent of the funds shall be obligated for such grants and contracts. For carrying out the purposes of this section, there are authorized to be appropriated $15,000,000 for the fiscal year ending September 30, 1982. Of the funds appropriated under the preceding sentence, at least 25 per centum of the funds shall be obligated for grants and contracts for primary prevention and intervention programs designed to discourage individuals, particularly individuals in high risk populations, from abusing drugs."
  ]
  node [
    id 4500
    label "section_1177_subsection_f_item_3"
    class_name "item"
    text "Projects and programs for which grants and contracts are made or entered into under this section shall, in the case of prevention and treatment services, seek to (1) be responsive to special requirements of handicapped individuals in receiving such services; (2) whenever possible, be community based, insure care of good quality in general community care facilities and under health insurance plans, and be integrated with, and provide for the active participation of, a wide range of public and nongovernmental agencies, organizations, institutions, and individuals; (3) where a substantial number of the individuals in the population served by the project or program are of limited English-speaking ability (A) utilize the services of outreach workers fluent in the language spoken by a predominant number of such individuals and develop a plan and make arrangements responsive to the needs of such population for providing services to the extent practicable in the language and cultural context most appropriate to such individuals, and (B) identify an individual who is fluent both in that language and English and whose responsibilities shall include providing guidance to the individuals of limited English-speaking ability and to appropriate staff members with respect to cultural sensitivities and bridging linguistic and cultural differences; and (4) where appropriate, utilize existing community resources (including community mental health centers)."
  ]
  node [
    id 4501
    label "section_1177_subsection_a_item_1"
    class_name "item"
    text "(1) to provide training seminars, educational programs, and technical assistance for the development, demonstration, and evaluation of drug abuse prevention, treatment, and rehabilitation programs; and"
  ]
  node [
    id 4502
    label "section_1177_subsection_f_item_4"
    class_name "item"
    text "Projects and programs for which grants and contracts are made or entered into under this section shall, in the case of prevention and treatment services, seek to (1) be responsive to special requirements of handicapped individuals in receiving such services; (2) whenever possible, be community based, insure care of good quality in general community care facilities and under health insurance plans, and be integrated with, and provide for the active participation of, a wide range of public and nongovernmental agencies, organizations, institutions, and individuals; (3) where a substantial number of the individuals in the population served by the project or program are of limited English-speaking ability (A) utilize the services of outreach workers fluent in the language spoken by a predominant number of such individuals and develop a plan and make arrangements responsive to the needs of such population for providing services to the extent practicable in the language and cultural context most appropriate to such individuals, and (B) identify an individual who is fluent both in that language and English and whose responsibilities shall include providing guidance to the individuals of limited English-speaking ability and to appropriate staff members with respect to cultural sensitivities and bridging linguistic and cultural differences; and (4) where appropriate, utilize existing community resources (including community mental health centers)."
  ]
  node [
    id 4503
    label "section_1177_subsection_b_item_6"
    class_name "item"
    text "There are authorized to be appropriated $25,000,000 for the fiscal year ending June 30, 1972; $65,000,000 for the fiscal year ending June 30, 1973; $100,000,000 for the fiscal year ending June 30, 1974; $160,000,000 for each of the fiscal years ending June 30, 1975 and June 30, 1976; $40,000,000 for the period July 1, 1976, through September 30, 1976; and $160,000,000 for each of the fiscal years ending September 30, 1977, and September 30, 1978, to carry out this section. For the fiscal year ending September 30, 1979, there is authorized to be appropriated (1) $153,000,000 for grants and contracts under paragraphs (3) and (6) of subsection (a) of this section for drug abuse treatment programs, and (2) $24,000,000 for grants and contracts under such subsection for other programs and activities. For grants and contracts under paragraphs (3) and (6) of subsection (a) of this section for drug abuse treatment programs there is authorized to be appropriated $149,000,000 for the fiscal year ending September 30, 1980, and $155,000,000 for the fiscal year ending September 30, 1981; and for grants and contracts under such subsection for other programs and activities there is authorized to be appropriated $20,000,000 for the fiscal year ending September 30, 1980, and $30,000,000 for the fiscal year ending September 30, 1981. Of the funds appropriated under the preceding sentence for the fiscal year ending September 30, 1980, at least 7 percent of the funds shall be obligated for grants and contracts for primary prevention and intervention programs designed to discourage individuals, particularly those in high risk populations, from abusing drugs; and of the funds appropriated under the preceding sentence for the next fiscal year, at least 10 percent of the funds shall be obligated for such grants and contracts. For carrying out the purposes of this section, there are authorized to be appropriated $15,000,000 for the fiscal year ending September 30, 1982. Of the funds appropriated under the preceding sentence, at least 25 per centum of the funds shall be obligated for grants and contracts for primary prevention and intervention programs designed to discourage individuals, particularly individuals in high risk populations, from abusing drugs."
  ]
  node [
    id 4504
    label "section_1177_subsection_f"
    class_name "subsection"
    text "(f) Prevention and treatment services"
  ]
  node [
    id 4505
    label "section_1177_subsection_b_item_3"
    class_name "item"
    text "There are authorized to be appropriated $25,000,000 for the fiscal year ending June 30, 1972; $65,000,000 for the fiscal year ending June 30, 1973; $100,000,000 for the fiscal year ending June 30, 1974; $160,000,000 for each of the fiscal years ending June 30, 1975 and June 30, 1976; $40,000,000 for the period July 1, 1976, through September 30, 1976; and $160,000,000 for each of the fiscal years ending September 30, 1977, and September 30, 1978, to carry out this section. For the fiscal year ending September 30, 1979, there is authorized to be appropriated (1) $153,000,000 for grants and contracts under paragraphs (3) and (6) of subsection (a) of this section for drug abuse treatment programs, and (2) $24,000,000 for grants and contracts under such subsection for other programs and activities. For grants and contracts under paragraphs (3) and (6) of subsection (a) of this section for drug abuse treatment programs there is authorized to be appropriated $149,000,000 for the fiscal year ending September 30, 1980, and $155,000,000 for the fiscal year ending September 30, 1981; and for grants and contracts under such subsection for other programs and activities there is authorized to be appropriated $20,000,000 for the fiscal year ending September 30, 1980, and $30,000,000 for the fiscal year ending September 30, 1981. Of the funds appropriated under the preceding sentence for the fiscal year ending September 30, 1980, at least 7 percent of the funds shall be obligated for grants and contracts for primary prevention and intervention programs designed to discourage individuals, particularly those in high risk populations, from abusing drugs; and of the funds appropriated under the preceding sentence for the next fiscal year, at least 10 percent of the funds shall be obligated for such grants and contracts. For carrying out the purposes of this section, there are authorized to be appropriated $15,000,000 for the fiscal year ending September 30, 1982. Of the funds appropriated under the preceding sentence, at least 25 per centum of the funds shall be obligated for grants and contracts for primary prevention and intervention programs designed to discourage individuals, particularly individuals in high risk populations, from abusing drugs."
  ]
  node [
    id 4506
    label "section_1177_subsection_f_item_3_subitem_A"
    class_name "subitem"
    text "Projects and programs for which grants and contracts are made or entered into under this section shall, in the case of prevention and treatment services, seek to (1) be responsive to special requirements of handicapped individuals in receiving such services; (2) whenever possible, be community based, insure care of good quality in general community care facilities and under health insurance plans, and be integrated with, and provide for the active participation of, a wide range of public and nongovernmental agencies, organizations, institutions, and individuals; (3) where a substantial number of the individuals in the population served by the project or program are of limited English-speaking ability (A) utilize the services of outreach workers fluent in the language spoken by a predominant number of such individuals and develop a plan and make arrangements responsive to the needs of such population for providing services to the extent practicable in the language and cultural context most appropriate to such individuals, and (B) identify an individual who is fluent both in that language and English and whose responsibilities shall include providing guidance to the individuals of limited English-speaking ability and to appropriate staff members with respect to cultural sensitivities and bridging linguistic and cultural differences; and (4) where appropriate, utilize existing community resources (including community mental health centers)."
  ]
  node [
    id 4507
    label "section_1177_subsection_g_item_2"
    class_name "item"
    text "(2) No grant or contract may be made under this section for a period in excess of five years."
  ]
  node [
    id 4508
    label "section_1177_subsection_b_item_2"
    class_name "item"
    text "There are authorized to be appropriated $25,000,000 for the fiscal year ending June 30, 1972; $65,000,000 for the fiscal year ending June 30, 1973; $100,000,000 for the fiscal year ending June 30, 1974; $160,000,000 for each of the fiscal years ending June 30, 1975 and June 30, 1976; $40,000,000 for the period July 1, 1976, through September 30, 1976; and $160,000,000 for each of the fiscal years ending September 30, 1977, and September 30, 1978, to carry out this section. For the fiscal year ending September 30, 1979, there is authorized to be appropriated (1) $153,000,000 for grants and contracts under paragraphs (3) and (6) of subsection (a) of this section for drug abuse treatment programs, and (2) $24,000,000 for grants and contracts under such subsection for other programs and activities. For grants and contracts under paragraphs (3) and (6) of subsection (a) of this section for drug abuse treatment programs there is authorized to be appropriated $149,000,000 for the fiscal year ending September 30, 1980, and $155,000,000 for the fiscal year ending September 30, 1981; and for grants and contracts under such subsection for other programs and activities there is authorized to be appropriated $20,000,000 for the fiscal year ending September 30, 1980, and $30,000,000 for the fiscal year ending September 30, 1981. Of the funds appropriated under the preceding sentence for the fiscal year ending September 30, 1980, at least 7 percent of the funds shall be obligated for grants and contracts for primary prevention and intervention programs designed to discourage individuals, particularly those in high risk populations, from abusing drugs; and of the funds appropriated under the preceding sentence for the next fiscal year, at least 10 percent of the funds shall be obligated for such grants and contracts. For carrying out the purposes of this section, there are authorized to be appropriated $15,000,000 for the fiscal year ending September 30, 1982. Of the funds appropriated under the preceding sentence, at least 25 per centum of the funds shall be obligated for grants and contracts for primary prevention and intervention programs designed to discourage individuals, particularly individuals in high risk populations, from abusing drugs."
  ]
  node [
    id 4509
    label "section_1177_subsection_a_item_2"
    class_name "item"
    text "(2) to conduct demonstration and evaluation projects, with a high priority on prevention and early intervention projects and on identifying new and more effective drug abuse prevention, treatment, and rehabilitation programs."
  ]
  node [
    id 4510
    label "section_1177_subsection_c"
    class_name "subsection"
    text "(c) Coordination of applications for programs in a State; precedence restriction; project evaluation; application approval; criteria; proposed performance standards or research protocol"
  ]
  node [
    id 4511
    label "section_1177_subsection_f_item_2"
    class_name "item"
    text "Projects and programs for which grants and contracts are made or entered into under this section shall, in the case of prevention and treatment services, seek to (1) be responsive to special requirements of handicapped individuals in receiving such services; (2) whenever possible, be community based, insure care of good quality in general community care facilities and under health insurance plans, and be integrated with, and provide for the active participation of, a wide range of public and nongovernmental agencies, organizations, institutions, and individuals; (3) where a substantial number of the individuals in the population served by the project or program are of limited English-speaking ability (A) utilize the services of outreach workers fluent in the language spoken by a predominant number of such individuals and develop a plan and make arrangements responsive to the needs of such population for providing services to the extent practicable in the language and cultural context most appropriate to such individuals, and (B) identify an individual who is fluent both in that language and English and whose responsibilities shall include providing guidance to the individuals of limited English-speaking ability and to appropriate staff members with respect to cultural sensitivities and bridging linguistic and cultural differences; and (4) where appropriate, utilize existing community resources (including community mental health centers)."
  ]
  node [
    id 4512
    label "section_1177_subsection_g_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) The amount of any grant or contract under this section may not exceed 100 per centum of the cost of carrying out the grant or contract in the first fiscal year for which the grant or contract is made under this section, 80 per centum of such cost in the second fiscal year for which the grant or contract is made under this section, 70 per centum of such cost in the third fiscal year for which the grant or contract is made under this section, and 60 per centum of such cost in each of the fourth and fifth fiscal years for which the grant or contract is made under this section."
  ]
  node [
    id 4513
    label "section_1177_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "(A) provide that the activities and services for which assistance under this section is sought will be substantially administered by or under the supervision of the applicant;"
  ]
  node [
    id 4514
    label "section_1177_subsection_c_item_3_subitem_B"
    class_name "subitem"
    text "(B) provide for such methods of administration as are necessary for the proper and efficient operation of such programs or projects; and"
  ]
  node [
    id 4515
    label "section_1178_subsection_b"
    class_name "subsection"
    text "(b) Access to pertinent information for audit and examination"
  ]
  node [
    id 4516
    label "section_1178_subsection_a"
    class_name "subsection"
    text "(a) Assistance records; contents"
  ]
  node [
    id 4517
    label "section_1179_subsection_d"
    class_name "subsection"
    text "(d) Authorization of appropriations; fiscal year availability"
  ]
  node [
    id 4518
    label "section_1179_subsection_c_item_3"
    class_name "item"
    text "The services and facilities of the Center shall, in accordance with regulations prescribed by the Director, be available to (1) Federal, State, and local governmental officials, and their respective staffs, (2) medical and paramedical personnel, and educators, and (3) other persons, including drug dependent persons, requiring training or education in drug abuse prevention."
  ]
  node [
    id 4519
    label "section_1179_subsection_d_item_2"
    class_name "item"
    text "(2) Sums appropriated under this subsection shall remain available for obligation or expenditure in the fiscal year for which appropriated and in the fiscal year next following."
  ]
  node [
    id 4520
    label "section_1179_subsection_b"
    class_name "subsection"
    text "(b) Activities and material"
  ]
  node [
    id 4521
    label "section_1179_subsection_d_item_1"
    class_name "item"
    text "(1) For the purpose of carrying out this section, there are authorized to be appropriated $1,000,000 for the fiscal year ending June 30, 1972, $3,000,000 for the fiscal year ending June 30, 1973, $5,000,000 for the fiscal year ending June 30, 1974, and $6,000,000 for the fiscal year ending June 30, 1975."
  ]
  node [
    id 4522
    label "section_1179_subsection_a"
    class_name "subsection"
    text "(a) Establishment; functions; general policies; transfer of supervision"
  ]
  node [
    id 4523
    label "section_1179_subsection_c_item_1"
    class_name "item"
    text "The services and facilities of the Center shall, in accordance with regulations prescribed by the Director, be available to (1) Federal, State, and local governmental officials, and their respective staffs, (2) medical and paramedical personnel, and educators, and (3) other persons, including drug dependent persons, requiring training or education in drug abuse prevention."
  ]
  node [
    id 4524
    label "section_1179_subsection_c_item_2"
    class_name "item"
    text "The services and facilities of the Center shall, in accordance with regulations prescribed by the Director, be available to (1) Federal, State, and local governmental officials, and their respective staffs, (2) medical and paramedical personnel, and educators, and (3) other persons, including drug dependent persons, requiring training or education in drug abuse prevention."
  ]
  node [
    id 4525
    label "section_1179_subsection_c"
    class_name "subsection"
    text "(c) Persons eligible for services and facilities"
  ]
  node [
    id 4526
    label "section_1180_item_16"
    class_name "item"
    text "Section, Pub. L. 92&#8211;255, title IV, &#167;413, Mar. 21, 1972, 86 Stat. 84; Pub. L. 96&#8211;181, &#167;8(a), (b)(1), Jan. 2, 1980, 93 Stat. 1313, 1314; Pub. L. 97&#8211;35, title IX, &#167;973(e), Aug. 13, 1981, 95 Stat. 598, which related to drug abuse among government and other employees, was redesignated section 525 of the Public Health Service Act by Pub. L. 98&#8211;24, &#167;2(b)(16)(A), Apr. 26, 1983, 97 Stat. 182, and is classified to section 290ee&#8211;1 of Title 42, The Public Health and Welfare."
  ]
  node [
    id 4527
    label "section_1180_item_1"
    class_name "item"
    text "Section, Pub. L. 92&#8211;255, title IV, &#167;413, Mar. 21, 1972, 86 Stat. 84; Pub. L. 96&#8211;181, &#167;8(a), (b)(1), Jan. 2, 1980, 93 Stat. 1313, 1314; Pub. L. 97&#8211;35, title IX, &#167;973(e), Aug. 13, 1981, 95 Stat. 598, which related to drug abuse among government and other employees, was redesignated section 525 of the Public Health Service Act by Pub. L. 98&#8211;24, &#167;2(b)(16)(A), Apr. 26, 1983, 97 Stat. 182, and is classified to section 290ee&#8211;1 of Title 42, The Public Health and Welfare."
  ]
  node [
    id 4528
    label "section_1180_item_16_subitem_A"
    class_name "subitem"
    text "Section, Pub. L. 92&#8211;255, title IV, &#167;413, Mar. 21, 1972, 86 Stat. 84; Pub. L. 96&#8211;181, &#167;8(a), (b)(1), Jan. 2, 1980, 93 Stat. 1313, 1314; Pub. L. 97&#8211;35, title IX, &#167;973(e), Aug. 13, 1981, 95 Stat. 598, which related to drug abuse among government and other employees, was redesignated section 525 of the Public Health Service Act by Pub. L. 98&#8211;24, &#167;2(b)(16)(A), Apr. 26, 1983, 97 Stat. 182, and is classified to section 290ee&#8211;1 of Title 42, The Public Health and Welfare."
  ]
  node [
    id 4529
    label "section_1302_item_3"
    class_name "item"
    text "(3) encourage media outlets throughout the country to provide information aimed at preventing alcohol and drug abuse, including public service announcements, documentary films, and advertisements; and"
  ]
  node [
    id 4530
    label "section_1302_item_1_subitem_A"
    class_name "subitem"
    text "(A) implemented through various segments of mass media; and"
  ]
  node [
    id 4531
    label "section_1302_item_2_subitem_D"
    class_name "subitem"
    text "(D) the business sector of the United States; and"
  ]
  node [
    id 4532
    label "section_1302_item_2_subitem_A"
    class_name "subitem"
    text "(A) television, radio, motion picture, cable communications, and print media;"
  ]
  node [
    id 4533
    label "section_1302_item_2_subitem_C"
    class_name "subitem"
    text "(C) the advertising industry;"
  ]
  node [
    id 4534
    label "section_1302_item_2_subitem_E"
    class_name "subitem"
    text "(E) professional sports organizations and associations;"
  ]
  node [
    id 4535
    label "section_1302_item_1_subitem_B"
    class_name "subitem"
    text "(B) intended to prevent alcohol and drug abuse;"
  ]
  node [
    id 4536
    label "section_1302_item_2"
    class_name "item"
    text "(2) act as an administrative and coordinating body for the voluntary donation of resources from&#8212;"
  ]
  node [
    id 4537
    label "section_1302_item_1"
    class_name "item"
    text "(1) examine public education programs in effect on October 27, 1986, which are&#8212;"
  ]
  node [
    id 4538
    label "section_1302_item_2_subitem_B"
    class_name "subitem"
    text "(B) the recording industry;"
  ]
  node [
    id 4539
    label "section_1302_item_4"
    class_name "item"
    text "(4) evaluate the effectiveness and assist in the update of programs and national strategies formulated with the assistance of the Commission."
  ]
  node [
    id 4540
    label "section_1303_subsection_b_item_3"
    class_name "item"
    text "(3) A member may serve after the expiration of his term until his successor has taken office."
  ]
  node [
    id 4541
    label "section_1303_subsection_a_item_4"
    class_name "item"
    text "(4) other segments of the business sector of the United States;"
  ]
  node [
    id 4542
    label "section_1303_subsection_a_item_2"
    class_name "item"
    text "(2) motion picture, television, radio, cable communications, and print media;"
  ]
  node [
    id 4543
    label "section_1303_subsection_c_item_2"
    class_name "item"
    text "(2) While away from their homes or regular places of business in the performance of services for the Commission, members shall be allowed travel expenses, including a per diem allowance in lieu of subsistence, in the same manner as persons serving intermittently in the Government service are allowed travel expenses under section 5703 of title 5."
  ]
  node [
    id 4544
    label "section_1303_subsection_a"
    class_name "subsection"
    text "(a) Number and appointment"
  ]
  node [
    id 4545
    label "section_1303_subsection_a_item_3"
    class_name "item"
    text "(3) the recording industry;"
  ]
  node [
    id 4546
    label "section_1303_subsection_c"
    class_name "subsection"
    text "(c) Basic pay and expenses"
  ]
  node [
    id 4547
    label "section_1303_subsection_a_item_1"
    class_name "item"
    text "(1) advertising agencies;"
  ]
  node [
    id 4548
    label "section_1303_subsection_b_item_2"
    class_name "item"
    text "(2) Any member appointed to fill a vacancy occurring before the expiration of the term for which his predecessor was appointed shall be appointed only for the remainder of such term."
  ]
  node [
    id 4549
    label "section_1303_subsection_a_item_6"
    class_name "item"
    text "(6) professional sports organizations and associations; and"
  ]
  node [
    id 4550
    label "section_1303_subsection_c_item_1"
    class_name "item"
    text "(1) Except as provided in paragraph (2), members of the Commission shall serve without pay."
  ]
  node [
    id 4551
    label "section_1303_subsection_b"
    class_name "subsection"
    text "(b) Terms"
  ]
  node [
    id 4552
    label "section_1303_subsection_a_item_5"
    class_name "item"
    text "(5) experts in the prevention of alcohol and drug abuse;"
  ]
  node [
    id 4553
    label "section_1303_subsection_b_item_1"
    class_name "item"
    text "(1) Except as provided in paragraphs (2) and (3), members shall be appointed for terms of 3 years."
  ]
  node [
    id 4554
    label "section_1303_subsection_a_item_7"
    class_name "item"
    text "(7) other Federal agencies, as designated by the President, including the Director of the Agency for Substance Abuse Prevention of the Department of Health and Human Services."
  ]
  node [
    id 4555
    label "section_1304_subsection_a_item_2"
    class_name "item"
    text "(2) The Moderator shall convene the 1st meeting of the Commission within 30 days after the date of the completion of appointments under section 1303(a) of this title."
  ]
  node [
    id 4556
    label "section_1304_subsection_d"
    class_name "subsection"
    text "(d) Voting"
  ]
  node [
    id 4557
    label "section_1304_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 4558
    label "section_1304_subsection_b"
    class_name "subsection"
    text "(b) Moderator"
  ]
  node [
    id 4559
    label "section_1304_subsection_a_item_1"
    class_name "item"
    text "(1) The Commission shall meet at the call of the Moderator."
  ]
  node [
    id 4560
    label "section_1304_subsection_c"
    class_name "subsection"
    text "(c) Quorum and procedure"
  ]
  node [
    id 4561
    label "section_1305_subsection_c"
    class_name "subsection"
    text "(c) Staff of Federal agencies"
  ]
  node [
    id 4562
    label "section_1305_subsection_a"
    class_name "subsection"
    text "(a) Director and staff"
  ]
  node [
    id 4563
    label "section_1305_subsection_b"
    class_name "subsection"
    text "(b) Experts and consultants"
  ]
  node [
    id 4564
    label "section_1305_subsection_a_item_1"
    class_name "item"
    text "(1) Subject to paragraph (2), the Moderator, with the approval of the Commission, may employ and set the rate of pay for a Director and such staff as the Moderator deems necessary."
  ]
  node [
    id 4565
    label "section_1305_subsection_a_item_2"
    class_name "item"
    text "(2) Rates of pay set under paragraph (1) shall be less than the rate of basic pay payable under section 5316 of title 5."
  ]
  node [
    id 4566
    label "section_1306_subsection_e"
    class_name "subsection"
    text "(e) Administrative support services"
  ]
  node [
    id 4567
    label "section_1306_subsection_c"
    class_name "subsection"
    text "(c) Gifts"
  ]
  node [
    id 4568
    label "section_1306_subsection_a"
    class_name "subsection"
    text "(a) Hearings and sessions"
  ]
  node [
    id 4569
    label "section_1306_subsection_b"
    class_name "subsection"
    text "(b) Obtaining official data"
  ]
  node [
    id 4570
    label "section_1306_subsection_d"
    class_name "subsection"
    text "(d) Mails"
  ]
  node [
    id 4571
    label "section_1401_subsection_c_item_1"
    class_name "item"
    text "The Food and Drug Administration shall use the computerized data management systems placed into effect under subsection (a)(1) of this section to summarize the volume of each type of food product subject to the requirements of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] which is imported into the United States and which has an entry value which exceeds an amount established by the Secretary of Health and Human Services. The summary shall be made by country of origin and district of entry. Information with respect to volumes of food products to be included in the summary shall, to the extent feasible, be obtained from data bases of other Federal agencies."
  ]
  node [
    id 4572
    label "section_1401_subsection_a"
    class_name "subsection"
    text "(a) Data management systems"
  ]
  node [
    id 4573
    label "section_1401_subsection_a_item_1_subitem_E"
    class_name "subitem"
    text "(E) prepare summaries of the information listed in subsection (b) of this section, and"
  ]
  node [
    id 4574
    label "section_1401_subsection_a_item_1_subitem_B"
    class_name "subitem"
    text "(B) identify gaps in its pesticide monitoring program in the monitoring of (i) pesticides, (ii) food products, and (iii) food from specific countries and from domestic sources,"
  ]
  node [
    id 4575
    label "section_1401_subsection_b_item_2"
    class_name "item"
    text "(2) information on&#8212;"
  ]
  node [
    id 4576
    label "section_1401_subsection_b_item_1"
    class_name "item"
    text "(1) information on&#8212;"
  ]
  node [
    id 4577
    label "section_1401_subsection_a_item_1_subitem_D"
    class_name "subitem"
    text "(D) focus its testing resources for monitoring pesticide residues in food on detecting those residues which pose a public health concern,"
  ]
  node [
    id 4578
    label "section_1401_subsection_c"
    class_name "subsection"
    text "(c) Volume data"
  ]
  node [
    id 4579
    label "section_1401_subsection_a_item_3_subitem_B"
    class_name "subitem"
    text "(B) In placing into effect the computerized data management systems under paragraph (1) and in carrying out paragraph (2), the Secretary shall comply with applicable regulations governing computer system design and procurement."
  ]
  node [
    id 4580
    label "section_1401_subsection_b_item_1_subitem_B"
    class_name "subitem"
    text "(B) the number of samples of each such food product analyzed for such compliance by country of origin,"
  ]
  node [
    id 4581
    label "section_1401_subsection_b_item_1_subitem_E"
    class_name "subitem"
    text "(E) the compliance status of each sample of such food tested and the violation rate for each country-product combination, and"
  ]
  node [
    id 4582
    label "section_1401_subsection_b_item_1_subitem_A"
    class_name "subitem"
    text "(A) the types of imported and domestically produced food products analyzed for compliance with the requirements of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] regarding the presence of pesticide residues,"
  ]
  node [
    id 4583
    label "section_1401_subsection_b_item_2_subitem_A"
    class_name "subitem"
    text "(A) the country of origin of each imported food product referred to in paragraph (1)(A), and"
  ]
  node [
    id 4584
    label "section_1401_subsection_b"
    class_name "subsection"
    text "(b) Information"
  ]
  node [
    id 4585
    label "section_1401_subsection_a_item_1"
    class_name "item"
    text "(1) Not later than 480 days after August 23, 1988, the Secretary of Health and Human Services shall place in effect computerized data management systems for the Food and Drug Administration under which the Administration will&#8212;"
  ]
  node [
    id 4586
    label "section_1401_subsection_a_item_1_subitem_C"
    class_name "subitem"
    text "(C) detect trends in the presence of pesticide residues in food products and identify public health problems emerging from the occurrence of pesticide residues in food products,"
  ]
  node [
    id 4587
    label "section_1401_subsection_b_item_1_subitem_D"
    class_name "subitem"
    text "(D) the pesticide residues in such food detected and the levels detected,"
  ]
  node [
    id 4588
    label "section_1401_subsection_a_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) develop additional data management systems,"
  ]
  node [
    id 4589
    label "section_1401_subsection_a_item_1_subitem_A"
    class_name "subitem"
    text "(A) record, summarize, and evaluate the results of its program for monitoring food products for pesticide residues,"
  ]
  node [
    id 4590
    label "section_1401_subsection_b_item_2_subitem_B"
    class_name "subitem"
    text "(B) the United States district of entry for each such imported food product."
  ]
  node [
    id 4591
    label "section_1401_subsection_a_item_3"
    class_name "item"
    text "(3)(A) Paragraph (1) does not limit the authority of the Food and Drug Administration to&#8212;"
  ]
  node [
    id 4592
    label "section_1401_subsection_b_item_1_subitem_C"
    class_name "subitem"
    text "(C) the pesticide residues which may be detected using the testing methods employed,"
  ]
  node [
    id 4593
    label "section_1401_subsection_a_item_1_subitem_F"
    class_name "subitem"
    text "(F) provide information to assist the Environmental Protection Agency in carrying out its responsibilities under the Federal Insecticide, Fungicide, and Rodenticide Act [7 U.S.C. 136 et seq.] and the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.]."
  ]
  node [
    id 4594
    label "section_1401_subsection_a_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) Paragraph (1) does not limit the authority of the Food and Drug Administration to&#8212;"
  ]
  node [
    id 4595
    label "section_1401_subsection_a_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) use the computerized data management systems placed in effect under paragraph (1), or"
  ]
  node [
    id 4596
    label "section_1401_subsection_a_item_2"
    class_name "item"
    text "(2) As soon as practicable, the Secretary of Health and Human Services shall develop a means to enable the computerized data management systems placed into effect under paragraph (1) to make the summary described in subsection (c) of this section."
  ]
  node [
    id 4597
    label "section_1401_subsection_d"
    class_name "subsection"
    text "(d) Compilation"
  ]
  node [
    id 4598
    label "section_1401_subsection_b_item_1_subitem_F"
    class_name "subitem"
    text "(F) the action taken with respect to each sample of such food found to be in violation of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] and its ultimate disposition, and"
  ]
  node [
    id 4599
    label "section_1402_subsection_b_item_2"
    class_name "item"
    text "(2) In the case of a foreign country with which the Secretary is unable to enter into an agreement under subsection (a) of this section or for which the information provided under paragraph (1) is insufficient to assure an effective pesticide monitoring program, the Secretary shall, to the extent practicable, obtain the information described in paragraph (1) with respect to such country from other Federal or international agencies or private sources."
  ]
  node [
    id 4600
    label "section_1402_subsection_b"
    class_name "subsection"
    text "(b) Information activities"
  ]
  node [
    id 4601
    label "section_1402_subsection_d"
    class_name "subsection"
    text "(d) Report"
  ]
  node [
    id 4602
    label "section_1402_subsection_b_item_3"
    class_name "item"
    text "(3) The Secretary of Health and Human Services shall assure that appropriate offices of the Food and Drug Administration which are engaged in the monitoring of imported food for pesticide residues receive the information obtained under paragraph (1) or (2)."
  ]
  node [
    id 4603
    label "section_1402_subsection_a"
    class_name "subsection"
    text "(a) Cooperative agreements"
  ]
  node [
    id 4604
    label "section_1402_subsection_b_item_4"
    class_name "item"
    text "(4) The Secretary of Health and Human Services shall make available any information obtained under paragraph (1) or (2) to State agencies engaged in the monitoring of imported food for pesticide residues other than information obtained from private sources the disclosure of which to such agencies is restricted."
  ]
  node [
    id 4605
    label "section_1402_subsection_c"
    class_name "subsection"
    text "(c) Coordination with other agencies"
  ]
  node [
    id 4606
    label "section_1402_subsection_c_item_2"
    class_name "item"
    text "(2) coordinate the activities of the Department of Health and Human Services with the activities of those departments and agencies, as appropriate, during the course of such negotiations."
  ]
  node [
    id 4607
    label "section_1402_subsection_b_item_1"
    class_name "item"
    text "(1) The cooperative agreements entered into under subsection (a) of this section with governments of foreign countries shall specify the action to be taken by the parties to the agreements to accomplish the purpose described in subsection (a) of this section, including the means by which the governments of the foreign countries will provide to the Secretary of Health and Human Services current information identifying each of the pesticides used in the production, transportation, and storage of food products imported from production regions of such countries into the United States."
  ]
  node [
    id 4608
    label "section_1402_subsection_c_item_1"
    class_name "item"
    text "(1) notify in writing the Department of Agriculture, the Environmental Protection Agency, and the Department of State at the initiation of negotiations with a foreign country to develop a cooperative agreement under subsection (a) of this section; and"
  ]
  node [
    id 4609
    label "section_1403_item_1_subitem_A"
    class_name "subitem"
    text "(A) new and improved analytical methods capable of detecting at one time the presence of multiple pesticide residues in food, and"
  ]
  node [
    id 4610
    label "section_1403_item_1"
    class_name "item"
    text "The Secretary shall report the plan developed under paragraph (1), the resources necessary to carry out the research described in such paragraph, recommendations for the implementation of such research, and the result of the review conducted under paragraph (2) not later than the expiration of 240 days after August 23, 1988, to the Committee on Agriculture, Nutrition, and Forestry and the Committee on Labor and Human Resources of the Senate and the House of Representatives."
  ]
  node [
    id 4611
    label "section_1403_item_2"
    class_name "item"
    text "The Secretary shall report the plan developed under paragraph (1), the resources necessary to carry out the research described in such paragraph, recommendations for the implementation of such research, and the result of the review conducted under paragraph (2) not later than the expiration of 240 days after August 23, 1988, to the Committee on Agriculture, Nutrition, and Forestry and the Committee on Labor and Human Resources of the Senate and the House of Representatives."
  ]
  node [
    id 4612
    label "section_1403_item_1_subitem_B"
    class_name "subitem"
    text "(B) rapid pesticide analytical methods, and"
  ]
  node [
    id 4613
    label "section_1501_subsection_b_item_2"
    class_name "item"
    text "(2) There shall be in the Office of National Drug Control Policy a Deputy Director for Demand Reduction and a Deputy Director for Supply Reduction."
  ]
  node [
    id 4614
    label "section_1501_subsection_c_item_1"
    class_name "item"
    text "(1) There is established in the Office of National Drug Control Policy a Bureau of State and Local Affairs."
  ]
  node [
    id 4615
    label "section_1501_subsection_b"
    class_name "subsection"
    text "(b) Director and Deputy Directors"
  ]
  node [
    id 4616
    label "section_1501_subsection_b_item_1"
    class_name "item"
    text "(1) There shall be at the head of the Office of National Drug Control Policy a Director of National Drug Control Policy."
  ]
  node [
    id 4617
    label "section_1501_subsection_d_item_2"
    class_name "item"
    text "(2) personnel of the Office of National Drug Control Policy."
  ]
  node [
    id 4618
    label "section_1501_subsection_a"
    class_name "subsection"
    text "(a) Establishment of Office"
  ]
  node [
    id 4619
    label "section_1501_subsection_d_item_1"
    class_name "item"
    text "(1) information, documents, and studies in the possession of, or conducted by or at the direction of the Director; or"
  ]
  node [
    id 4620
    label "section_1501_subsection_d"
    class_name "subsection"
    text "(d) Access by Congress"
  ]
  node [
    id 4621
    label "section_1501_subsection_b_item_3"
    class_name "item"
    text "(3) The Deputy Director for Demand Reduction and the Deputy Director for Supply Reduction shall assist the Director in carrying out the responsibilities of the Director under this Act."
  ]
  node [
    id 4622
    label "section_1501_subsection_c_item_2"
    class_name "item"
    text "(2) There shall be at the head of such bureau an Associate Director for National Drug Control Policy."
  ]
  node [
    id 4623
    label "section_1501_subsection_c"
    class_name "subsection"
    text "(c) Bureau of State and Local Affairs"
  ]
  node [
    id 4624
    label "section_1502_subsection_b_item_5"
    class_name "item"
    text "(5) consult with and assist State and local governments with respect to their relations with the National Drug Control Program agencies;"
  ]
  node [
    id 4625
    label "section_1502_subsection_e_item_2_subitem_C"
    class_name "subitem"
    text "(C) Any payment under this paragraph to an employee shall be in addition to the basic pay of such employee."
  ]
  node [
    id 4626
    label "section_1502_subsection_b_item_7"
    class_name "item"
    text "(7) notify any National Drug Control Program agency if its policies are not in compliance with the responsibilities of such agency under the National Drug Control Strategy and transmit a copy of each such notification to the President; and"
  ]
  node [
    id 4627
    label "section_1502_subsection_d_item_7_subitem_A"
    class_name "subitem"
    text "(A) conducting program and performance audits and evaluations; and"
  ]
  node [
    id 4628
    label "section_1502_subsection_a_item_1"
    class_name "item"
    text "(1) The Director, the Deputy Director for Demand Reduction, the Deputy Director for Supply Reduction, and the Associate Director for National Drug Control Policy shall each be appointed by the President, by and with the advice and consent of the Senate."
  ]
  node [
    id 4629
    label "section_1502_subsection_f_item_1"
    class_name "item"
    text "(1) A funds control notice may direct that all or part of an amount appropriated to the National Drug Control Program agency account be obligated by&#8212;"
  ]
  node [
    id 4630
    label "section_1502_subsection_c_item_3"
    class_name "item"
    text "(3) The Director shall&#8212;"
  ]
  node [
    id 4631
    label "section_1502_subsection_b_item_3"
    class_name "item"
    text "(3) coordinate and oversee the implementation by National Drug Control Program agencies of the policies, objectives, and priorities established under paragraph (1) and the fulfillment of the responsibilities of such agencies under the National Drug Control Strategy;"
  ]
  node [
    id 4632
    label "section_1502_subsection_d_item_3"
    class_name "item"
    text "(3) use for administrative purposes, on a reimbursable basis, the available services, equipment, personnel, and facilities of Federal, State, and local agencies;"
  ]
  node [
    id 4633
    label "section_1502_subsection_e_item_2"
    class_name "item"
    text "(2)(A) Notwithstanding any other provision of law, the Director may provide periodic bonus payments to any employee detailed to the Office of National Drug Control Policy."
  ]
  node [
    id 4634
    label "section_1502_subsection_b_item_4_subitem_B"
    class_name "subitem"
    text "(B) the allocation of personnel to and within such departments and agencies;"
  ]
  node [
    id 4635
    label "section_1502_subsection_b_item_1"
    class_name "item"
    text "to implement the policies, priorities, and objectives established under paragraph (1) and the National Drug Control Strategy;"
  ]
  node [
    id 4636
    label "section_1502_subsection_e_item_2_subitem_B"
    class_name "subitem"
    text "(B) An amount paid under this paragraph to an employee for any period shall not be greater than 20 percent of the basic pay paid or payable to such employee for such period."
  ]
  node [
    id 4637
    label "section_1502_subsection_c_item_5"
    class_name "item"
    text "(5) The Director shall request the head of a department or agency to include in the department's or agency's budget submission to the Office of Management and Budget funding requests for specific initiatives that are consistent with the President's priorities for the National Drug Control Strategy and certifications made pursuant to paragraph (3), and the head of the department or agency shall comply with such a request."
  ]
  node [
    id 4638
    label "section_1502_subsection_c_item_7"
    class_name "item"
    text "(7) The Director shall report to the Congress on a quarterly basis regarding the need for any reprogramming or transfer of appropriated funds for National Drug Control Program activities."
  ]
  node [
    id 4639
    label "section_1502_subsection_b_item_2"
    class_name "item"
    text "(2) annually promulgate the National Drug Control Strategy in accordance with section 1504 of this title;"
  ]
  node [
    id 4640
    label "section_1502_subsection_c_item_1"
    class_name "item"
    text "(1) The Director shall develop for each fiscal year, with the advice of the program managers of departments and agencies with responsibilities under the National Drug Control Program, a consolidated National Drug Control Program budget proposal to implement the National Drug Control Strategy, and shall transmit such budget proposal to the President and to the Congress."
  ]
  node [
    id 4641
    label "section_1502_subsection_e_item_1"
    class_name "item"
    text "(1) Notwithstanding any provision of chapter 43 of title 5, the Director shall perform the evaluation of the performance of any employee detailed to the Office of National Drug Control Policy for purposes of the applicable performance appraisal system established under such chapter for any rating period, or part thereof, that such employee is detailed to such office."
  ]
  node [
    id 4642
    label "section_1502_subsection_c_item_6"
    class_name "item"
    text "(6)(A) No National Drug Control Program agency shall submit to the Congress a reprogramming or transfer request with respect to any amount of appropriated funds greater than $5,000,000 which is included in the National Drug Control Program budget unless such request has been approved by the Director."
  ]
  node [
    id 4643
    label "section_1502_subsection_f_item_3"
    class_name "item"
    text "(3) In the case of a violation of paragraph (2) by an officer or employee of a National Drug Control Program agency, the head of the agency, upon the request of and in consultation with the Director, may subject the officer or employee to appropriate administrative discipline, including, when circumstances warrant, suspension from duty without pay or removal from office."
  ]
  node [
    id 4644
    label "section_1502_subsection_d"
    class_name "subsection"
    text "(d) Powers of Director"
  ]
  node [
    id 4645
    label "section_1502_subsection_d_item_1"
    class_name "item"
    text "(1) select, appoint, employ, and fix compensation of up to 75 and such additional officers and employees as may be necessary to carry out the functions of the Office of National Drug Control Policy under this title;&#160;1"
  ]
  node [
    id 4646
    label "section_1502_subsection_b"
    class_name "subsection"
    text "(b) Responsibilities"
  ]
  node [
    id 4647
    label "section_1502_subsection_d_item_2"
    class_name "item"
    text "(2) request the head of a department or agency or program to place department, agency, or program personnel who are engaged in drug control activities on temporary detail to another department or agency in order to implement the National Drug Control Strategy, and the head of the department or agency shall comply with such a request;"
  ]
  node [
    id 4648
    label "section_1502_subsection_d_item_8"
    class_name "item"
    text "(8) except to the extent that the Director's authority under this paragraph is limited in an annual appropriations Act, transfer funds appropriated to a National Drug Control Program agency account to a different National Drug Control Program agency account in an amount that does not exceed 2 percent of the amount appropriated to either account, upon advance approval of the Committees on Appropriations of each House of Congress; and"
  ]
  node [
    id 4649
    label "section_1502_subsection_c_item_2"
    class_name "item"
    text "(2) Each Federal Government program manager, agency head, and department head with responsibilities under the National Drug Control Strategy shall transmit the drug control budget request of the program, agency, or department to the Director at the same time as such request is submitted to their superiors (and before submission to the Office of Management and Budget) in the preparation of the budget of the President submitted to the Congress under section 1105(a) of title 31."
  ]
  node [
    id 4650
    label "section_1502_subsection_c_item_4"
    class_name "item"
    text "(4) The Director shall maintain records regarding certifications under paragraph (3)(B)."
  ]
  node [
    id 4651
    label "section_1502_subsection_f_item_1_subitem_B"
    class_name "subitem"
    text "(B) activities, functions, projects, or object classes."
  ]
  node [
    id 4652
    label "section_1502_subsection_b_item_8"
    class_name "item"
    text "(8) provide, by July 1 of each year, budget recommendations to the heads of departments and agencies with responsibilities under the National Drug Control Program, which recommendations shall apply to the second following fiscal year and address funding priorities developed in the annual National Drug Control Strategy."
  ]
  node [
    id 4653
    label "section_1502_subsection_e"
    class_name "subsection"
    text "(e) Personnel detailed to the Office"
  ]
  node [
    id 4654
    label "section_1502_subsection_c"
    class_name "subsection"
    text "(c) National Drug Control Program budget"
  ]
  node [
    id 4655
    label "section_1502_subsection_f_item_2"
    class_name "item"
    text "(2) An officer or employee of a National Drug Control Program agency shall not make or authorize an expenditure or obligation contrary to a funds control notice issued by the Director."
  ]
  node [
    id 4656
    label "section_1502_subsection_a_item_3"
    class_name "item"
    text "(3), (4) Omitted"
  ]
  node [
    id 4657
    label "section_1502_subsection_f_item_1_subitem_A"
    class_name "subitem"
    text "(A) months, fiscal year quarters, or other time periods; and"
  ]
  node [
    id 4658
    label "section_1502_subsection_c_item_3_subitem_C"
    class_name "subitem"
    text "(C) notify the program manager, agency head, or department head, as applicable, regarding the Director's certification under subparagraph (B)."
  ]
  node [
    id 4659
    label "section_1502_subsection_d_item_9"
    class_name "item"
    text "(9) in order to ensure compliance with the National Drug Control Program, issue to the head of a National Drug Control Program agency a funds control notice described in subsection (f)&#160;1 of this section."
  ]
  node [
    id 4660
    label "section_1502_subsection_c_item_3_subitem_B"
    class_name "subitem"
    text "(B) certify in writing as to the adequacy of such request in whole or in part to implement the objectives of the National Drug Control Strategy for the year for which the request is submitted and, with respect to a request that is not certified as adequate to implement the objectives of the National Drug Control Strategy, include in the certification an initiative or funding level that would make the request adequate; and"
  ]
  node [
    id 4661
    label "section_1502_subsection_d_item_7"
    class_name "item"
    text "(7) monitor implementation of the National Drug Control Program, including&#8212;"
  ]
  node [
    id 4662
    label "section_1502_subsection_c_item_6_subitem_A"
    class_name "subitem"
    text "(6)(A) No National Drug Control Program agency shall submit to the Congress a reprogramming or transfer request with respect to any amount of appropriated funds greater than $5,000,000 which is included in the National Drug Control Program budget unless such request has been approved by the Director."
  ]
  node [
    id 4663
    label "section_1502_subsection_a"
    class_name "subsection"
    text "(a) Appointment"
  ]
  node [
    id 4664
    label "section_1502_subsection_d_item_7_subitem_B"
    class_name "subitem"
    text "(B) requesting assistance from the Inspector General of the relevant agency in such audits and evaluations;"
  ]
  node [
    id 4665
    label "section_1502_subsection_d_item_6"
    class_name "item"
    text "(6) use the mails in the same manner as any other department or agency of the executive branch;"
  ]
  node [
    id 4666
    label "section_1502_subsection_a_item_2"
    class_name "item"
    text "(2) The Director, the Deputy Director for Demand Reduction, the Deputy Director for Supply Reduction, and the Associate Director for National Drug Control Policy shall each serve at the pleasure of the President. No person shall serve as Director, a Deputy Director, or Associate Director while serving in any other position in the Federal Government."
  ]
  node [
    id 4667
    label "section_1502_subsection_b_item_6"
    class_name "item"
    text "(6) appear before duly constituted committees and subcommittees of the House of Representatives and of the Senate to represent the drug policies of the executive branch;"
  ]
  node [
    id 4668
    label "section_1502_subsection_c_item_3_subitem_A"
    class_name "subitem"
    text "(A) review each drug control budget request transmitted to the Director under paragraph (2);"
  ]
  node [
    id 4669
    label "section_1502_subsection_c_item_6_subitem_B"
    class_name "subitem"
    text "(B) The head of any National Drug Control Program agency may appeal to the President any disapproval by the Director of a reprogramming or transfer request."
  ]
  node [
    id 4670
    label "section_1502_subsection_e_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) Notwithstanding any other provision of law, the Director may provide periodic bonus payments to any employee detailed to the Office of National Drug Control Policy."
  ]
  node [
    id 4671
    label "section_1502_subsection_c_item_8"
    class_name "item"
    text "(8) The head of each National Drug Control Program agency shall ensure timely development and submission to the Director of drug control budget requests transmitted pursuant to subsection (c)(2) of this section, in such format as may be designated by the Director with the concurrence of the Director of the Office of Management and Budget."
  ]
  node [
    id 4672
    label "section_1502_subsection_b_item_4"
    class_name "item"
    text "(4) make such recommendations to the President as the Director determines are appropriate regarding&#8212;"
  ]
  node [
    id 4673
    label "section_1502_subsection_f"
    class_name "subsection"
    text "(f)&#160;2 Prohibition on political campaigning"
  ]
  node [
    id 4674
    label "section_1502_subsection_d_item_5"
    class_name "item"
    text "(5) accept and use donations of property from Federal, State, and local government agencies;"
  ]
  node [
    id 4675
    label "section_1502_subsection_b_item_4_subitem_A"
    class_name "subitem"
    text "(A) changes in the organization, management, and budgets of Federal departments and agencies engaged in drug enforcement; and"
  ]
  node [
    id 4676
    label "section_1502_subsection_d_item_4"
    class_name "item"
    text "(4) procure the services of experts and consultants in accordance with section 3109 of title 5 relating to appointments in the Federal Service, at rates of compensation for individuals not to exceed the daily equivalent of the rate of pay payable for GS&#8211;18 of the General Schedule under section 5332 of title 5;"
  ]
  node [
    id 4677
    label "section_1502_subsection_e_item_2_subitem_D"
    class_name "subitem"
    text "(D) The aggregate amount paid during any fiscal year to an employee detailed to the Office of National Drug Control Policy as basic pay, awards, bonuses, and other compensation shall not exceed the annual rate payable at the end of such fiscal year for positions at level III of the Executive Schedule."
  ]
  node [
    id 4678
    label "section_1502a_item_3"
    class_name "item"
    text "Section, Pub. L. 100&#8211;690, title I, &#167;1003A, as added Pub. L. 101&#8211;510, div. A, title X, &#167;1011, Nov. 5, 1990, 104 Stat. 1633 and amended, which related to the Counter-Drug Technology Assessment Center, was renumbered section 1008 of Pub. L. 100&#8211;690 by Pub. L. 103&#8211;322, title IX, &#167;90204(c)(2), (3), Sept. 13, 1994, 108 Stat. 1994, and is classified to section 1505 of this title."
  ]
  node [
    id 4679
    label "section_1502a_item_2"
    class_name "item"
    text "Section, Pub. L. 100&#8211;690, title I, &#167;1003A, as added Pub. L. 101&#8211;510, div. A, title X, &#167;1011, Nov. 5, 1990, 104 Stat. 1633 and amended, which related to the Counter-Drug Technology Assessment Center, was renumbered section 1008 of Pub. L. 100&#8211;690 by Pub. L. 103&#8211;322, title IX, &#167;90204(c)(2), (3), Sept. 13, 1994, 108 Stat. 1994, and is classified to section 1505 of this title."
  ]
  node [
    id 4680
    label "section_1503_subsection_b_item_1"
    class_name "item"
    text "(1) The head of a National Drug Control Program agency shall, unless exigent circumstances require otherwise, notify the Director in writing regarding any proposed change in policies relating to the activities of such department or agency under the National Drug Control Program prior to implementation of such change. The Director shall promptly review such proposed change and certify to the department or agency head in writing whether such change is consistent with the National Drug Control Strategy."
  ]
  node [
    id 4681
    label "section_1503_subsection_a"
    class_name "subsection"
    text "(a) Access to information"
  ]
  node [
    id 4682
    label "section_1503_subsection_c"
    class_name "subsection"
    text "(c) General Services Administration"
  ]
  node [
    id 4683
    label "section_1503_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(2)(A) The authorities conferred on the Office of National Drug Control Policy and its Director by this Act shall be exercised in a manner consistent with provisions of the National Security Act of 1947. The Director of Central Intelligence shall prescribe such regulations as may be necessary to protect information provided pursuant to this Act regarding intelligence sources and methods."
  ]
  node [
    id 4684
    label "section_1503_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) The Director of Central Intelligence shall, to the fullest extent possible in accordance with subparagraph (A), render full assistance and support to the Office of National Drug Control Policy and its Director."
  ]
  node [
    id 4685
    label "section_1503_subsection_a_item_1"
    class_name "item"
    text "(1) Upon request of the Director, and subject to laws governing disclosure of information, the head of each National Drug Control Program agency shall provide to the Director such information as may be required for drug control."
  ]
  node [
    id 4686
    label "section_1503_subsection_b_item_2"
    class_name "item"
    text "(2) If prior notice of a proposed change under paragraph (1) is not possible, the department or agency head shall notify the Director as soon as practicable. The Director shall review such change and certify to the department or agency head in writing whether such change is consistent with the National Drug Control Program."
  ]
  node [
    id 4687
    label "section_1503_subsection_a_item_2"
    class_name "item"
    text "(2)(A) The authorities conferred on the Office of National Drug Control Policy and its Director by this Act shall be exercised in a manner consistent with provisions of the National Security Act of 1947. The Director of Central Intelligence shall prescribe such regulations as may be necessary to protect information provided pursuant to this Act regarding intelligence sources and methods."
  ]
  node [
    id 4688
    label "section_1503_subsection_b"
    class_name "subsection"
    text "(b) Certification of policy changes by Director"
  ]
  node [
    id 4689
    label "section_1504_subsection_a_item_3_subitem_A"
    class_name "subitem"
    text "(3)(A) In developing the National Drug Control Strategy, the Director shall consult with&#8212;"
  ]
  node [
    id 4690
    label "section_1504_subsection_v_item_4_subitem_B"
    class_name "subitem"
    text "(B) assessment of the reduction of drug availability, as measured by&#8212;"
  ]
  node [
    id 4691
    label "section_1504_subsection_v_subitem_C_subsubitem_i"
    class_name "subsubitem"
    text "(i) burdens drug users placed on hospital emergency rooms in the United States, such as the quantity of drug-related services provided;"
  ]
  node [
    id 4692
    label "section_1504_subsection_a"
    class_name "subsection"
    text "(a) Development and submission of National Drug Control Strategy"
  ]
  node [
    id 4693
    label "section_1504_subsection_c_item_2_subitem_D"
    class_name "subitem"
    text "(D) the extent to which a significant increase in allocation of Federal resources is necessary to respond adequately to drug-related activities in the area."
  ]
  node [
    id 4694
    label "section_1504_subsection_v_subitem_B"
    class_name "subitem"
    text "(B) At the time the President submits the National Drug Control Strategy to the Congress, the Director shall transmit a report to the Congress indicating the persons consulted under this paragraph."
  ]
  node [
    id 4695
    label "section_1504_subsection_c"
    class_name "subsection"
    text "(c) High intensity drug trafficking areas"
  ]
  node [
    id 4696
    label "section_1504_subsection_v_item_6"
    class_name "item"
    text "(6) Federal agencies responsible for the collection or estimation of drug-related information required by the Director shall cooperate with the Director, to the fullest extent possible, to enable the Director to satisfy the requirements of sections 4 and 5.1"
  ]
  node [
    id 4697
    label "section_1504_subsection_c_item_1_subitem_B"
    class_name "subitem"
    text "(B) take any other action authorized under section 1502 of this title to provide increased Federal assistance to such areas; and"
  ]
  node [
    id 4698
    label "section_1504_subsection_d_item_2_subitem_A"
    class_name "subitem"
    text "(A) notify such lead agency in writing of the activity; and"
  ]
  node [
    id 4699
    label "section_1504_subsection_v_item_4_subitem_B_subsubitem_i"
    class_name "subsubitem"
    text "(i) the quantities of cocaine, heroin, and marijuana available for consumption in the United States;"
  ]
  node [
    id 4700
    label "section_1504_subsection_v_item_4_subitem_B_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the amount of cocaine and heroin entering the United States;"
  ]
  node [
    id 4701
    label "section_1504_subsection_v_item_5_subitem_C"
    class_name "subitem"
    text "(C) an assessment of the actions the Director shall take to correct any deficiencies and limitations identified pursuant to subparagraphs (A) and (B); and"
  ]
  node [
    id 4702
    label "section_1504_subsection_c_item_2_subitem_B"
    class_name "subitem"
    text "(B) the extent to which State and local law enforcement agencies have committed resources to respond to the drug trafficking problem in the area, thereby indicating a determination to respond aggressively to the problem;"
  ]
  node [
    id 4703
    label "section_1504_subsection_v_item_4_subitem_A"
    class_name "subitem"
    text "(A) assessment of the reduction of drug use, including estimates of drug prevalence and frequency of use as measured by national, State, and local surveys of illicit drug use and by other special studies of&#8212;"
  ]
  node [
    id 4704
    label "section_1504_subsection_v_item_4_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) drug use in the workplace and the productivity lost by such use;"
  ]
  node [
    id 4705
    label "section_1504_subsection_a_item_2"
    class_name "item"
    text "(2) The National Drug Control Strategy submitted under paragraph (1) shall&#8212;"
  ]
  node [
    id 4706
    label "section_1504_subsection_v_item_5_subitem_B"
    class_name "subitem"
    text "(B) an assessment of the adequacy of the coverage of existing national drug use measurement instruments and techniques to measure the casual drug user population and groups at-risk for drug use;"
  ]
  node [
    id 4707
    label "section_1504_subsection_d_item_2"
    class_name "item"
    text "(2) The Director shall require that any National Drug Control Program agency that conducts a major supply reduction activity which is in the area of principal responsibility of a lead agency designated under paragraph (1) shall&#8212;"
  ]
  node [
    id 4708
    label "section_1504_subsection_b_item_6"
    class_name "item"
    text "(6) a plan for improving the compatibility of automated information and communication systems to provide Federal agencies with timely and accurate information for purposes of this subtitle."
  ]
  node [
    id 4709
    label "section_1504_subsection_v_item_7"
    class_name "item"
    text "(7) With each National Drug Control Strategy, the Director shall report to the President and the Congress on the Director's assessment of drug use and availability in the United States, including an estimate of the effectiveness of interdiction, treatment, prevention, law enforcement, and international programs under the National Drug Control Strategy in effect in the preceding year in reducing drug use and availability."
  ]
  node [
    id 4710
    label "section_1504_subsection_a_item_3_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) the heads of the National Drug Control Program agencies;"
  ]
  node [
    id 4711
    label "section_1504_subsection_d_item_2_subitem_B"
    class_name "subitem"
    text "(B) provide such notification prior to conducting such activity, unless exigent circumstances require otherwise."
  ]
  node [
    id 4712
    label "section_1504_subsection_d_item_3"
    class_name "item"
    text "(3) If a lead agency objects to the conduct of an activity described under paragraph (2), the lead agency and the agency planning to conduct such activity shall notify the Director in writing regarding such objection."
  ]
  node [
    id 4713
    label "section_1504_subsection_v_item_5_subitem_D"
    class_name "subitem"
    text "(D) identification of the specific factors that restrict the availability of treatment services to those seeking it and proposed administrative or legislative remedies to make treatment available to those individuals."
  ]
  node [
    id 4714
    label "section_1504_subsection_c_item_1_subitem_C"
    class_name "subitem"
    text "(C) coordinate actions under this paragraph with State and local officials."
  ]
  node [
    id 4715
    label "section_1504_subsection_a_item_3_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the Congress;"
  ]
  node [
    id 4716
    label "section_1504_subsection_d_item_1"
    class_name "item"
    text "(1) The President shall designate lead agencies with areas of principal responsibility for carrying out the National Drug Control Strategy."
  ]
  node [
    id 4717
    label "section_1504_subsection_v_subitem_C_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the contribution of drugs to the underground economy, as measured by the retail value of drugs sold in the United States; and"
  ]
  node [
    id 4718
    label "section_1504_subsection_v_subitem_C"
    class_name "subitem"
    text "(C) assessment of the reduction of the consequences of drug use and availability, which shall include estimation of&#8212;"
  ]
  node [
    id 4719
    label "section_1504_subsection_b_item_3"
    class_name "item"
    text "(3) 3-year projections for program and budget priorities and achievable projections for reductions of drug availability and usage;"
  ]
  node [
    id 4720
    label "section_1504_subsection_b_item_4"
    class_name "item"
    text "(4) a complete assessment of how the budget proposal transmitted under section 1502(c) of this title is intended to implement the strategy and whether the funding levels contained in such proposal are sufficient to implement such strategy;"
  ]
  node [
    id 4721
    label "section_1504_subsection_v_subitem_D_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the extent, within each State, to which treatment is available, on demand, to intravenous drug users and pregnant women;"
  ]
  node [
    id 4722
    label "section_1504_subsection_v"
    class_name "subsection"
    text "(v) the number of cocaine processing labs destroyed;"
  ]
  node [
    id 4723
    label "section_1504_subsection_c_item_3"
    class_name "item"
    text "(3) Before March 1, 1991, the Director shall submit a report to the House of Representatives and to the Senate concerning the effectiveness of and need for the designation of areas under this subsection as high intensity drug trafficking areas, along with any comments or recommendations for legislation."
  ]
  node [
    id 4724
    label "section_1504_subsection_v_item_5"
    class_name "item"
    text "(5) The Director shall include with the National Drug Control Strategy required to be submitted not later than February 1, 1995, and with every second such strategy submitted thereafter&#8212;"
  ]
  node [
    id 4725
    label "section_1504_subsection_b_item_5"
    class_name "item"
    text "(5) designation of areas of the United States as high intensity drug trafficking areas in accordance with subsection (c) of this section; and"
  ]
  node [
    id 4726
    label "section_1504_subsection_c_item_2"
    class_name "item"
    text "(2) When considering the designation of an area under this subsection as a high intensity drug trafficking area, the Director shall consider, along with other criteria the Director may deem appropriate&#8212;"
  ]
  node [
    id 4727
    label "section_1504_subsection_v_item_5_subitem_A"
    class_name "subitem"
    text "(A) an assessment of the quality of current drug use measurement instruments and techniques to measure supply reduction and demand reduction activities;"
  ]
  node [
    id 4728
    label "section_1504_subsection_a_item_3_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) State and local officials;"
  ]
  node [
    id 4729
    label "section_1504_subsection_v_subitem_C_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) the annual national health care costs of drug use, including costs associated with people becoming infected with the human immunodeficiency virus and other communicable diseases as a result of drug use;"
  ]
  node [
    id 4730
    label "section_1504_subsection_v_item_4_subitem_B_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the number of metric tons of heroin and cocaine seized;"
  ]
  node [
    id 4731
    label "section_1504_subsection_v_item_4"
    class_name "item"
    text "(4) The Director shall include with each National Drug Control Strategy an evaluation of the effectiveness of Federal drug control during the preceding year. The evaluation shall include an assessment of Federal drug control efforts, including&#8212;"
  ]
  node [
    id 4732
    label "section_1504_subsection_v_subitem_D_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the number of drug users the Director estimates could benefit from treatment; and"
  ]
  node [
    id 4733
    label "section_1504_subsection_d"
    class_name "subsection"
    text "(d) Lead agencies"
  ]
  node [
    id 4734
    label "section_1504_subsection_v_subitem_D_subsubitem_i"
    class_name "subsubitem"
    text "(i) public and private treatment capacity within each State, including information on the number of treatment slots available in relation to the number actually used, including data on intravenous drug users and pregnant women;"
  ]
  node [
    id 4735
    label "section_1504_subsection_c_item_2_subitem_C"
    class_name "subitem"
    text "(C) the extent to which drug-related activities in the area are having a harmful impact in other areas of the country; and"
  ]
  node [
    id 4736
    label "section_1504_subsection_a_item_3"
    class_name "item"
    text "(3)(A) In developing the National Drug Control Strategy, the Director shall consult with&#8212;"
  ]
  node [
    id 4737
    label "section_1504_subsection_v_subitem_D_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) the success of drug treatment programs, including an assessment of the effectiveness of the mechanisms in place federally, and within each State, to determine the relative quality of substance abuse treatment programs, the qualifications of treatment personnel, and the mechanism by which patients are admitted to the most appropriate and cost effective treatment setting."
  ]
  node [
    id 4738
    label "section_1504_subsection_v_item_4_subitem_B_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the number of hectares of poppy and coca cultivated and destroyed;"
  ]
  node [
    id 4739
    label "section_1504_subsection_v_subitem_C_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) the extent of drug-related crime and criminal activity; and"
  ]
  node [
    id 4740
    label "section_1504_subsection_v_subitem_D"
    class_name "subitem"
    text "(D) determination of the status of drug treatment in the United States, by assessing&#8212;"
  ]
  node [
    id 4741
    label "section_1504_subsection_a_item_2_subitem_A"
    class_name "subitem"
    text "(A) include comprehensive, research-based, long-range goals for reducing drug abuse and the consequences of drug abuse in the United States;"
  ]
  node [
    id 4742
    label "section_1504_subsection_c_item_1"
    class_name "item"
    text "(1) The Director, upon consultation with the Attorney General, heads of National Drug Control Program agencies, and the Governors of the several States, may designate any specified area of the United States as a high intensity drug trafficking area. After making such a designation and in order to provide Federal assistance to the area so designated, the Director may&#8212;"
  ]
  node [
    id 4743
    label "section_1504_subsection_a_item_2_subitem_B"
    class_name "subitem"
    text "(B) include short-term measurable objectives which the Director determines may be realistically achieved in the 2-year period beginning on the date of the submission of the strategy;"
  ]
  node [
    id 4744
    label "section_1504_subsection_v_item_4_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) high-risk populations, including school dropouts, the homeless and transient, arrestees, parolees, and probationers, and juvenile delinquents; and"
  ]
  node [
    id 4745
    label "section_1504_subsection_a_item_2_subitem_D"
    class_name "subitem"
    text "(D) review State and local drug control activities to ensure that the United States pursues well-coordinated and effective drug control at all levels of government."
  ]
  node [
    id 4746
    label "section_1504_subsection_c_item_2_subitem_A"
    class_name "subitem"
    text "(A) the extent to which the area is a center of illegal drug production, manufacturing, importation, or distribution;"
  ]
  node [
    id 4747
    label "section_1504_subsection_a_item_1"
    class_name "item"
    text "(1) Not later than 180 days after the first Director is confirmed by the Senate, and not later than February 1 of each year thereafter, the President shall submit to the Congress a National Drug Control Strategy. Any part of such strategy that involves information properly classified under criteria established by an Executive order shall be presented to the Congress separately."
  ]
  node [
    id 4748
    label "section_1504_subsection_b_item_1"
    class_name "item"
    text "(1) a complete list of goals, objectives, and priorities for supply reduction and for demand reduction;"
  ]
  node [
    id 4749
    label "section_1504_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) direct the temporary reassignment of Federal personnel to such area, subject to the approval of the Secretary of the department or head of the agency which employs such personnel;"
  ]
  node [
    id 4750
    label "section_1504_subsection_a_item_3_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) private citizens with experience and expertise in demand reduction; and"
  ]
  node [
    id 4751
    label "section_1504_subsection_a_item_2_subitem_C"
    class_name "subitem"
    text "(C) describe the balance between resources devoted to supply reduction and demand reduction; and"
  ]
  node [
    id 4752
    label "section_1504_subsection_b_item_2"
    class_name "item"
    text "(2) private sector initiatives and cooperative efforts between the Federal Government and State and local governments for drug control;"
  ]
  node [
    id 4753
    label "section_1504_subsection_b"
    class_name "subsection"
    text "(b) Goals, objectives, and priorities"
  ]
  node [
    id 4754
    label "section_1505_subsection_f"
    class_name "subsection"
    text "(f) Assistance and support to Office of National Drug Control Policy"
  ]
  node [
    id 4755
    label "section_1505_subsection_e"
    class_name "subsection"
    text "(e) Personnel"
  ]
  node [
    id 4756
    label "section_1505_subsection_c"
    class_name "subsection"
    text "(c) Additional responsibilities of Director"
  ]
  node [
    id 4757
    label "section_1505_subsection_v_subitem_C"
    class_name "subitem"
    text "(C) make a priority ranking of such needs according to fiscal and technological feasibility, as part of a National Counter-Drug Enforcement Research and Development Strategy;"
  ]
  node [
    id 4758
    label "section_1505_subsection_b"
    class_name "subsection"
    text "(b) Chief Scientist"
  ]
  node [
    id 4759
    label "section_1505_subsection_c_item_1_subitem_A_subsubitem_iii"
    class_name "subsubitem"
    text "(iii) communications;"
  ]
  node [
    id 4760
    label "section_1505_subsection_c_item_1_subitem_A_subsubitem_i"
    class_name "subsubitem"
    text "(i) advanced surveillance, tracking, and radar imaging;"
  ]
  node [
    id 4761
    label "section_1505_subsection_v_item_2"
    class_name "item"
    text "(2) The authority granted to the Director under this section shall not extend to the award of contracts, management of individual projects, or other operational activities."
  ]
  node [
    id 4762
    label "section_1505_subsection_d"
    class_name "subsection"
    text "(d) Counter-drug budget submission"
  ]
  node [
    id 4763
    label "section_1505_subsection_c_item_1"
    class_name "item"
    text "(1) The Director, acting through the Chief Scientist, shall&#8212;"
  ]
  node [
    id 4764
    label "section_1505_subsection_c_item_1_subitem_A_subsubitem_iv"
    class_name "subsubitem"
    text "(iv) data fusion, advanced computer systems and artificial intelligence; and"
  ]
  node [
    id 4765
    label "section_1505_subsection_v"
    class_name "subsection"
    text "(v) chemical, biological, radiological (including neutron, electron, and graviton) and other means of detection;"
  ]
  node [
    id 4766
    label "section_1505_subsection_a"
    class_name "subsection"
    text "(a) Establishment"
  ]
  node [
    id 4767
    label "section_1505_subsection_v_subitem_D"
    class_name "subitem"
    text "(D) oversee and coordinate counter-drug technology initiatives with related activities of other Federal civilian and military departments; and"
  ]
  node [
    id 4768
    label "section_1505_subsection_c_item_1_subitem_A"
    class_name "subitem"
    text "(A) identify and define the short, medium, and long-term scientific and technological needs of Federal, State, and local drug enforcement agencies, including&#8212;"
  ]
  node [
    id 4769
    label "section_1505_subsection_v_subitem_B"
    class_name "subitem"
    text "(B) in consultation with the National Institute on Drug Abuse, and through interagency agreements or grants, examine addiction and rehabilitation research and the application of technology to expanding the effectiveness or availability of drug treatment;"
  ]
  node [
    id 4770
    label "section_1505_subsection_c_item_1_subitem_A_subsubitem_ii"
    class_name "subsubitem"
    text "(ii) electronic support measures;"
  ]
  node [
    id 4771
    label "section_1505_subsection_v_subitem_E"
    class_name "subitem"
    text "(E) under the general authority of the Director of National Drug Control Policy, submit requests to Congress for the reprogramming or transfer of funds appropriated for counter-drug enforcement research and development."
  ]
  node [
    id 4772
    label "section_1507_item_4_subitem_E"
    class_name "subitem"
    text "(E) rehabilitation;"
  ]
  node [
    id 4773
    label "section_1507_item_3_subitem_D"
    class_name "subitem"
    text "(D) domestic drug law enforcement, including law enforcement directed at drug users;"
  ]
  node [
    id 4774
    label "section_1507_item_2"
    class_name "item"
    text "(2) the term &#8220;drug control&#8221; means any activity conducted by a National Drug Control Program agency involving supply reduction or demand reduction;"
  ]
  node [
    id 4775
    label "section_1507_item_6_subitem_A"
    class_name "subitem"
    text "(A) jointly by the Director and the head of the department or agency; or"
  ]
  node [
    id 4776
    label "section_1507_item_5"
    class_name "item"
    text "(5) the term &#8220;National Drug Control Program&#8221; means programs, policies, and activities undertaken by National Drug Control Program agencies pursuant to the responsibilities of such agencies under the National Drug Control Strategy;"
  ]
  node [
    id 4777
    label "section_1507_item_3_subitem_C"
    class_name "subitem"
    text "(C) interdiction; and"
  ]
  node [
    id 4778
    label "section_1507_item_8"
    class_name "item"
    text "(8) the term &#8220;National Drug Control Strategy&#8221; means a strategy developed and submitted to the Congress under section 1504 of this title."
  ]
  node [
    id 4779
    label "section_1507_item_3_subitem_A"
    class_name "subitem"
    text "(A) international drug control;"
  ]
  node [
    id 4780
    label "section_1507_item_7"
    class_name "item"
    text "(7) the term &#8220;Director&#8221; means the Director of National Drug Control Policy; and"
  ]
  node [
    id 4781
    label "section_1507_item_6_subitem_B"
    class_name "subitem"
    text "(B) by the President;"
  ]
  node [
    id 4782
    label "section_1507_item_3_subitem_B"
    class_name "subitem"
    text "(B) foreign and domestic drug enforcement intelligence;"
  ]
  node [
    id 4783
    label "section_1507_item_4_subitem_D"
    class_name "subitem"
    text "(D) research; and"
  ]
  node [
    id 4784
    label "section_1507_item_3"
    class_name "item"
    text "(3) the term &#8220;supply reduction&#8221; means any enforcement activity of a program conducted by a National Drug Control Program agency that is intended to reduce the supply or use of drugs in the United States and abroad, including&#8212;"
  ]
  node [
    id 4785
    label "section_1507_item_4_subitem_A"
    class_name "subitem"
    text "(A) drug abuse education;"
  ]
  node [
    id 4786
    label "section_1507_item_4_subitem_C"
    class_name "subitem"
    text "(C) treatment;"
  ]
  node [
    id 4787
    label "section_1507_item_4_subitem_B"
    class_name "subitem"
    text "(B) prevention;"
  ]
  node [
    id 4788
    label "section_1507_item_4"
    class_name "item"
    text "(4) the term &#8220;demand reduction&#8221; means any activity conducted by a National Drug Control Program agency, other than an enforcement activity, that is intended to reduce the demand for drugs, including&#8212;"
  ]
  node [
    id 4789
    label "section_1507_item_1"
    class_name "item"
    text "(1) the term &#8220;drug&#8221; has the same meaning as the term &#8220;controlled substance&#8221; has in section 802(6) of this title;"
  ]
  node [
    id 4790
    label "section_1507_item_6"
    class_name "item"
    text "(6) the term &#8220;National Drug Control Program agency&#8221; means any department or agency and all dedicated units thereof, with responsibilities under the National Drug Control Strategy, as designated&#8212;"
  ]
  node [
    id 4791
    label "section_1509_subsection_d"
    class_name "subsection"
    text "(d) Investment of Fund"
  ]
  node [
    id 4792
    label "section_1509_subsection_e"
    class_name "subsection"
    text "(e) President's budget"
  ]
  node [
    id 4793
    label "section_1509_subsection_g"
    class_name "subsection"
    text "(g) Annual report"
  ]
  node [
    id 4794
    label "section_1509_subsection_a"
    class_name "subsection"
    text "(a) In general"
  ]
  node [
    id 4795
    label "section_1509_subsection_b"
    class_name "subsection"
    text "(b) Deposits"
  ]
  node [
    id 4796
    label "section_1509_subsection_f"
    class_name "subsection"
    text "(f) Funds provided supplemental"
  ]
  node [
    id 4797
    label "section_1509_subsection_b_item_9"
    class_name "item"
    text "There shall be deposited into the Fund the amounts specified by section 524(c)(9) of title 28 and section 9307(g)&#160;1 of title 31 and any earnings on the investments authorized by subsection (d) of this section."
  ]
  node [
    id 4798
    label "section_1509_subsection_c_item_2"
    class_name "item"
    text "(2) A transfer may be made under paragraph (1) only with the advance written approval of the Committees on Appropriations of each House of Congress."
  ]
  node [
    id 4799
    label "section_1509_subsection_c"
    class_name "subsection"
    text "(c) Super surplus"
  ]
  node [
    id 4800
    label "section_1509_subsection_c_item_1"
    class_name "item"
    text "(1) Any unobligated balance up to $20,000,000 remaining in the Fund on September 30 of a fiscal year shall be available to the Director, subject to paragraph (2), to transfer to, and for obligation and expenditure in connection with drug control activities of, any Federal agency or State or local entity with responsibilities under the National Drug Control Strategy."
  ]
  edge [
    source 0
    target 1
  ]
  edge [
    source 0
    target 4
  ]
  edge [
    source 0
    target 5
  ]
  edge [
    source 0
    target 6
  ]
  edge [
    source 0
    target 11
  ]
  edge [
    source 0
    target 12
  ]
  edge [
    source 0
    target 13
  ]
  edge [
    source 0
    target 14
  ]
  edge [
    source 0
    target 15
  ]
  edge [
    source 0
    target 16
  ]
  edge [
    source 0
    target 26
  ]
  edge [
    source 0
    target 27
  ]
  edge [
    source 0
    target 28
  ]
  edge [
    source 0
    target 34
  ]
  edge [
    source 0
    target 37
  ]
  edge [
    source 0
    target 38
  ]
  edge [
    source 0
    target 39
  ]
  edge [
    source 0
    target 45
  ]
  edge [
    source 0
    target 46
  ]
  edge [
    source 0
    target 47
  ]
  edge [
    source 0
    target 48
  ]
  edge [
    source 1
    target 2
  ]
  edge [
    source 1
    target 3
  ]
  edge [
    source 2
    target 49
  ]
  edge [
    source 2
    target 50
  ]
  edge [
    source 3
    target 51
  ]
  edge [
    source 3
    target 52
  ]
  edge [
    source 3
    target 53
  ]
  edge [
    source 3
    target 54
  ]
  edge [
    source 3
    target 55
  ]
  edge [
    source 3
    target 56
  ]
  edge [
    source 3
    target 57
  ]
  edge [
    source 3
    target 58
  ]
  edge [
    source 4
    target 59
  ]
  edge [
    source 4
    target 60
  ]
  edge [
    source 4
    target 61
  ]
  edge [
    source 4
    target 62
  ]
  edge [
    source 4
    target 63
  ]
  edge [
    source 4
    target 64
  ]
  edge [
    source 4
    target 65
  ]
  edge [
    source 4
    target 66
  ]
  edge [
    source 4
    target 67
  ]
  edge [
    source 4
    target 68
  ]
  edge [
    source 4
    target 69
  ]
  edge [
    source 5
    target 70
  ]
  edge [
    source 5
    target 71
  ]
  edge [
    source 5
    target 72
  ]
  edge [
    source 5
    target 73
  ]
  edge [
    source 6
    target 7
  ]
  edge [
    source 6
    target 8
  ]
  edge [
    source 6
    target 9
  ]
  edge [
    source 6
    target 10
  ]
  edge [
    source 7
    target 74
  ]
  edge [
    source 8
    target 75
  ]
  edge [
    source 8
    target 76
  ]
  edge [
    source 8
    target 77
  ]
  edge [
    source 8
    target 78
  ]
  edge [
    source 8
    target 79
  ]
  edge [
    source 9
    target 80
  ]
  edge [
    source 9
    target 81
  ]
  edge [
    source 9
    target 82
  ]
  edge [
    source 9
    target 83
  ]
  edge [
    source 9
    target 84
  ]
  edge [
    source 9
    target 85
  ]
  edge [
    source 9
    target 86
  ]
  edge [
    source 9
    target 87
  ]
  edge [
    source 9
    target 88
  ]
  edge [
    source 9
    target 89
  ]
  edge [
    source 9
    target 90
  ]
  edge [
    source 9
    target 91
  ]
  edge [
    source 9
    target 92
  ]
  edge [
    source 9
    target 93
  ]
  edge [
    source 9
    target 94
  ]
  edge [
    source 9
    target 95
  ]
  edge [
    source 9
    target 96
  ]
  edge [
    source 9
    target 97
  ]
  edge [
    source 9
    target 98
  ]
  edge [
    source 9
    target 99
  ]
  edge [
    source 9
    target 100
  ]
  edge [
    source 9
    target 101
  ]
  edge [
    source 9
    target 102
  ]
  edge [
    source 9
    target 103
  ]
  edge [
    source 9
    target 104
  ]
  edge [
    source 9
    target 105
  ]
  edge [
    source 9
    target 106
  ]
  edge [
    source 9
    target 107
  ]
  edge [
    source 9
    target 108
  ]
  edge [
    source 9
    target 109
  ]
  edge [
    source 9
    target 110
  ]
  edge [
    source 9
    target 111
  ]
  edge [
    source 9
    target 112
  ]
  edge [
    source 9
    target 113
  ]
  edge [
    source 9
    target 114
  ]
  edge [
    source 9
    target 115
  ]
  edge [
    source 9
    target 116
  ]
  edge [
    source 9
    target 117
  ]
  edge [
    source 9
    target 118
  ]
  edge [
    source 9
    target 119
  ]
  edge [
    source 9
    target 120
  ]
  edge [
    source 9
    target 121
  ]
  edge [
    source 9
    target 122
  ]
  edge [
    source 9
    target 123
  ]
  edge [
    source 9
    target 124
  ]
  edge [
    source 9
    target 125
  ]
  edge [
    source 9
    target 126
  ]
  edge [
    source 9
    target 127
  ]
  edge [
    source 10
    target 128
  ]
  edge [
    source 10
    target 129
  ]
  edge [
    source 10
    target 130
  ]
  edge [
    source 10
    target 131
  ]
  edge [
    source 10
    target 132
  ]
  edge [
    source 10
    target 133
  ]
  edge [
    source 10
    target 134
  ]
  edge [
    source 10
    target 135
  ]
  edge [
    source 10
    target 136
  ]
  edge [
    source 11
    target 137
  ]
  edge [
    source 11
    target 138
  ]
  edge [
    source 11
    target 139
  ]
  edge [
    source 11
    target 140
  ]
  edge [
    source 11
    target 141
  ]
  edge [
    source 11
    target 142
  ]
  edge [
    source 11
    target 143
  ]
  edge [
    source 11
    target 144
  ]
  edge [
    source 11
    target 145
  ]
  edge [
    source 11
    target 146
  ]
  edge [
    source 14
    target 147
  ]
  edge [
    source 14
    target 148
  ]
  edge [
    source 14
    target 149
  ]
  edge [
    source 14
    target 150
  ]
  edge [
    source 14
    target 151
  ]
  edge [
    source 14
    target 152
  ]
  edge [
    source 14
    target 153
  ]
  edge [
    source 14
    target 154
  ]
  edge [
    source 14
    target 155
  ]
  edge [
    source 14
    target 156
  ]
  edge [
    source 14
    target 157
  ]
  edge [
    source 14
    target 158
  ]
  edge [
    source 14
    target 159
  ]
  edge [
    source 14
    target 160
  ]
  edge [
    source 14
    target 161
  ]
  edge [
    source 16
    target 17
  ]
  edge [
    source 16
    target 18
  ]
  edge [
    source 16
    target 19
  ]
  edge [
    source 16
    target 20
  ]
  edge [
    source 16
    target 21
  ]
  edge [
    source 16
    target 22
  ]
  edge [
    source 16
    target 23
  ]
  edge [
    source 16
    target 24
  ]
  edge [
    source 16
    target 25
  ]
  edge [
    source 17
    target 162
  ]
  edge [
    source 18
    target 163
  ]
  edge [
    source 18
    target 164
  ]
  edge [
    source 18
    target 165
  ]
  edge [
    source 18
    target 166
  ]
  edge [
    source 19
    target 167
  ]
  edge [
    source 19
    target 168
  ]
  edge [
    source 19
    target 169
  ]
  edge [
    source 19
    target 170
  ]
  edge [
    source 19
    target 171
  ]
  edge [
    source 19
    target 172
  ]
  edge [
    source 19
    target 173
  ]
  edge [
    source 19
    target 174
  ]
  edge [
    source 19
    target 175
  ]
  edge [
    source 19
    target 176
  ]
  edge [
    source 20
    target 177
  ]
  edge [
    source 20
    target 178
  ]
  edge [
    source 20
    target 179
  ]
  edge [
    source 20
    target 180
  ]
  edge [
    source 20
    target 181
  ]
  edge [
    source 20
    target 182
  ]
  edge [
    source 20
    target 183
  ]
  edge [
    source 20
    target 184
  ]
  edge [
    source 20
    target 185
  ]
  edge [
    source 20
    target 186
  ]
  edge [
    source 20
    target 187
  ]
  edge [
    source 20
    target 188
  ]
  edge [
    source 20
    target 189
  ]
  edge [
    source 20
    target 190
  ]
  edge [
    source 20
    target 191
  ]
  edge [
    source 20
    target 192
  ]
  edge [
    source 20
    target 193
  ]
  edge [
    source 20
    target 194
  ]
  edge [
    source 20
    target 195
  ]
  edge [
    source 21
    target 196
  ]
  edge [
    source 21
    target 197
  ]
  edge [
    source 21
    target 198
  ]
  edge [
    source 21
    target 199
  ]
  edge [
    source 21
    target 200
  ]
  edge [
    source 21
    target 201
  ]
  edge [
    source 21
    target 202
  ]
  edge [
    source 21
    target 203
  ]
  edge [
    source 21
    target 204
  ]
  edge [
    source 21
    target 205
  ]
  edge [
    source 21
    target 206
  ]
  edge [
    source 21
    target 207
  ]
  edge [
    source 21
    target 208
  ]
  edge [
    source 21
    target 209
  ]
  edge [
    source 21
    target 210
  ]
  edge [
    source 21
    target 211
  ]
  edge [
    source 21
    target 212
  ]
  edge [
    source 21
    target 213
  ]
  edge [
    source 21
    target 214
  ]
  edge [
    source 21
    target 215
  ]
  edge [
    source 22
    target 216
  ]
  edge [
    source 22
    target 217
  ]
  edge [
    source 22
    target 218
  ]
  edge [
    source 23
    target 219
  ]
  edge [
    source 23
    target 220
  ]
  edge [
    source 23
    target 221
  ]
  edge [
    source 23
    target 222
  ]
  edge [
    source 23
    target 223
  ]
  edge [
    source 23
    target 224
  ]
  edge [
    source 23
    target 225
  ]
  edge [
    source 23
    target 226
  ]
  edge [
    source 23
    target 227
  ]
  edge [
    source 23
    target 228
  ]
  edge [
    source 23
    target 229
  ]
  edge [
    source 23
    target 230
  ]
  edge [
    source 23
    target 231
  ]
  edge [
    source 23
    target 232
  ]
  edge [
    source 23
    target 233
  ]
  edge [
    source 23
    target 234
  ]
  edge [
    source 23
    target 235
  ]
  edge [
    source 23
    target 236
  ]
  edge [
    source 24
    target 237
  ]
  edge [
    source 24
    target 238
  ]
  edge [
    source 24
    target 239
  ]
  edge [
    source 25
    target 240
  ]
  edge [
    source 25
    target 241
  ]
  edge [
    source 25
    target 242
  ]
  edge [
    source 25
    target 243
  ]
  edge [
    source 25
    target 244
  ]
  edge [
    source 26
    target 245
  ]
  edge [
    source 26
    target 246
  ]
  edge [
    source 26
    target 247
  ]
  edge [
    source 26
    target 248
  ]
  edge [
    source 26
    target 249
  ]
  edge [
    source 26
    target 250
  ]
  edge [
    source 26
    target 251
  ]
  edge [
    source 26
    target 252
  ]
  edge [
    source 26
    target 253
  ]
  edge [
    source 26
    target 254
  ]
  edge [
    source 26
    target 255
  ]
  edge [
    source 26
    target 256
  ]
  edge [
    source 26
    target 257
  ]
  edge [
    source 26
    target 258
  ]
  edge [
    source 26
    target 259
  ]
  edge [
    source 26
    target 260
  ]
  edge [
    source 26
    target 261
  ]
  edge [
    source 26
    target 262
  ]
  edge [
    source 26
    target 263
  ]
  edge [
    source 26
    target 264
  ]
  edge [
    source 26
    target 265
  ]
  edge [
    source 26
    target 266
  ]
  edge [
    source 26
    target 267
  ]
  edge [
    source 26
    target 268
  ]
  edge [
    source 26
    target 269
  ]
  edge [
    source 26
    target 270
  ]
  edge [
    source 28
    target 29
  ]
  edge [
    source 28
    target 30
  ]
  edge [
    source 28
    target 31
  ]
  edge [
    source 28
    target 32
  ]
  edge [
    source 28
    target 33
  ]
  edge [
    source 29
    target 271
  ]
  edge [
    source 29
    target 272
  ]
  edge [
    source 29
    target 273
  ]
  edge [
    source 29
    target 274
  ]
  edge [
    source 29
    target 275
  ]
  edge [
    source 29
    target 276
  ]
  edge [
    source 29
    target 277
  ]
  edge [
    source 29
    target 278
  ]
  edge [
    source 29
    target 279
  ]
  edge [
    source 29
    target 280
  ]
  edge [
    source 29
    target 281
  ]
  edge [
    source 29
    target 282
  ]
  edge [
    source 29
    target 283
  ]
  edge [
    source 29
    target 284
  ]
  edge [
    source 29
    target 285
  ]
  edge [
    source 29
    target 286
  ]
  edge [
    source 29
    target 287
  ]
  edge [
    source 29
    target 288
  ]
  edge [
    source 29
    target 289
  ]
  edge [
    source 29
    target 290
  ]
  edge [
    source 29
    target 291
  ]
  edge [
    source 29
    target 292
  ]
  edge [
    source 29
    target 293
  ]
  edge [
    source 29
    target 294
  ]
  edge [
    source 30
    target 295
  ]
  edge [
    source 30
    target 296
  ]
  edge [
    source 30
    target 297
  ]
  edge [
    source 30
    target 298
  ]
  edge [
    source 30
    target 299
  ]
  edge [
    source 31
    target 300
  ]
  edge [
    source 32
    target 301
  ]
  edge [
    source 32
    target 302
  ]
  edge [
    source 32
    target 303
  ]
  edge [
    source 32
    target 304
  ]
  edge [
    source 32
    target 305
  ]
  edge [
    source 32
    target 306
  ]
  edge [
    source 32
    target 307
  ]
  edge [
    source 32
    target 308
  ]
  edge [
    source 32
    target 309
  ]
  edge [
    source 32
    target 310
  ]
  edge [
    source 33
    target 311
  ]
  edge [
    source 33
    target 312
  ]
  edge [
    source 33
    target 313
  ]
  edge [
    source 33
    target 314
  ]
  edge [
    source 33
    target 315
  ]
  edge [
    source 34
    target 35
  ]
  edge [
    source 34
    target 36
  ]
  edge [
    source 35
    target 316
  ]
  edge [
    source 35
    target 317
  ]
  edge [
    source 35
    target 318
  ]
  edge [
    source 35
    target 319
  ]
  edge [
    source 35
    target 320
  ]
  edge [
    source 35
    target 321
  ]
  edge [
    source 35
    target 322
  ]
  edge [
    source 35
    target 323
  ]
  edge [
    source 35
    target 324
  ]
  edge [
    source 35
    target 325
  ]
  edge [
    source 35
    target 326
  ]
  edge [
    source 35
    target 327
  ]
  edge [
    source 35
    target 328
  ]
  edge [
    source 35
    target 329
  ]
  edge [
    source 35
    target 330
  ]
  edge [
    source 35
    target 331
  ]
  edge [
    source 35
    target 332
  ]
  edge [
    source 35
    target 333
  ]
  edge [
    source 35
    target 334
  ]
  edge [
    source 35
    target 335
  ]
  edge [
    source 35
    target 336
  ]
  edge [
    source 35
    target 337
  ]
  edge [
    source 35
    target 338
  ]
  edge [
    source 35
    target 339
  ]
  edge [
    source 35
    target 340
  ]
  edge [
    source 35
    target 341
  ]
  edge [
    source 35
    target 342
  ]
  edge [
    source 35
    target 343
  ]
  edge [
    source 35
    target 344
  ]
  edge [
    source 35
    target 345
  ]
  edge [
    source 35
    target 346
  ]
  edge [
    source 35
    target 347
  ]
  edge [
    source 35
    target 348
  ]
  edge [
    source 35
    target 349
  ]
  edge [
    source 35
    target 350
  ]
  edge [
    source 35
    target 351
  ]
  edge [
    source 35
    target 352
  ]
  edge [
    source 35
    target 353
  ]
  edge [
    source 35
    target 354
  ]
  edge [
    source 35
    target 355
  ]
  edge [
    source 35
    target 356
  ]
  edge [
    source 35
    target 357
  ]
  edge [
    source 35
    target 358
  ]
  edge [
    source 35
    target 359
  ]
  edge [
    source 35
    target 360
  ]
  edge [
    source 35
    target 361
  ]
  edge [
    source 35
    target 362
  ]
  edge [
    source 35
    target 363
  ]
  edge [
    source 35
    target 364
  ]
  edge [
    source 35
    target 365
  ]
  edge [
    source 35
    target 366
  ]
  edge [
    source 35
    target 367
  ]
  edge [
    source 35
    target 368
  ]
  edge [
    source 35
    target 369
  ]
  edge [
    source 35
    target 370
  ]
  edge [
    source 35
    target 371
  ]
  edge [
    source 35
    target 372
  ]
  edge [
    source 35
    target 373
  ]
  edge [
    source 35
    target 374
  ]
  edge [
    source 35
    target 375
  ]
  edge [
    source 35
    target 376
  ]
  edge [
    source 35
    target 377
  ]
  edge [
    source 35
    target 378
  ]
  edge [
    source 35
    target 379
  ]
  edge [
    source 36
    target 380
  ]
  edge [
    source 36
    target 381
  ]
  edge [
    source 36
    target 382
  ]
  edge [
    source 36
    target 383
  ]
  edge [
    source 36
    target 384
  ]
  edge [
    source 36
    target 385
  ]
  edge [
    source 36
    target 386
  ]
  edge [
    source 36
    target 387
  ]
  edge [
    source 36
    target 388
  ]
  edge [
    source 36
    target 389
  ]
  edge [
    source 36
    target 390
  ]
  edge [
    source 36
    target 391
  ]
  edge [
    source 36
    target 392
  ]
  edge [
    source 36
    target 393
  ]
  edge [
    source 36
    target 394
  ]
  edge [
    source 36
    target 395
  ]
  edge [
    source 36
    target 396
  ]
  edge [
    source 36
    target 397
  ]
  edge [
    source 36
    target 398
  ]
  edge [
    source 36
    target 399
  ]
  edge [
    source 36
    target 400
  ]
  edge [
    source 38
    target 401
  ]
  edge [
    source 38
    target 402
  ]
  edge [
    source 38
    target 403
  ]
  edge [
    source 38
    target 404
  ]
  edge [
    source 38
    target 405
  ]
  edge [
    source 38
    target 406
  ]
  edge [
    source 38
    target 407
  ]
  edge [
    source 38
    target 408
  ]
  edge [
    source 38
    target 409
  ]
  edge [
    source 38
    target 410
  ]
  edge [
    source 38
    target 411
  ]
  edge [
    source 38
    target 412
  ]
  edge [
    source 38
    target 413
  ]
  edge [
    source 38
    target 414
  ]
  edge [
    source 38
    target 415
  ]
  edge [
    source 38
    target 416
  ]
  edge [
    source 38
    target 417
  ]
  edge [
    source 38
    target 418
  ]
  edge [
    source 38
    target 419
  ]
  edge [
    source 38
    target 420
  ]
  edge [
    source 38
    target 421
  ]
  edge [
    source 38
    target 422
  ]
  edge [
    source 38
    target 423
  ]
  edge [
    source 38
    target 424
  ]
  edge [
    source 38
    target 425
  ]
  edge [
    source 38
    target 426
  ]
  edge [
    source 39
    target 40
  ]
  edge [
    source 39
    target 41
  ]
  edge [
    source 39
    target 42
  ]
  edge [
    source 39
    target 43
  ]
  edge [
    source 39
    target 44
  ]
  edge [
    source 40
    target 427
  ]
  edge [
    source 40
    target 428
  ]
  edge [
    source 41
    target 429
  ]
  edge [
    source 43
    target 430
  ]
  edge [
    source 43
    target 431
  ]
  edge [
    source 43
    target 432
  ]
  edge [
    source 43
    target 433
  ]
  edge [
    source 43
    target 434
  ]
  edge [
    source 43
    target 435
  ]
  edge [
    source 46
    target 436
  ]
  edge [
    source 46
    target 437
  ]
  edge [
    source 46
    target 438
  ]
  edge [
    source 46
    target 439
  ]
  edge [
    source 46
    target 440
  ]
  edge [
    source 46
    target 441
  ]
  edge [
    source 46
    target 442
  ]
  edge [
    source 46
    target 443
  ]
  edge [
    source 47
    target 444
  ]
  edge [
    source 47
    target 445
  ]
  edge [
    source 47
    target 446
  ]
  edge [
    source 48
    target 447
  ]
  edge [
    source 48
    target 448
  ]
  edge [
    source 48
    target 449
  ]
  edge [
    source 48
    target 450
  ]
  edge [
    source 48
    target 451
  ]
  edge [
    source 48
    target 452
  ]
  edge [
    source 48
    target 453
  ]
  edge [
    source 48
    target 454
  ]
  edge [
    source 48
    target 455
  ]
  edge [
    source 48
    target 456
  ]
  edge [
    source 50
    target 457
  ]
  edge [
    source 65
    target 459
  ]
  edge [
    source 65
    target 458
  ]
  edge [
    source 70
    target 460
  ]
  edge [
    source 70
    target 462
  ]
  edge [
    source 70
    target 461
  ]
  edge [
    source 78
    target 466
  ]
  edge [
    source 78
    target 463
  ]
  edge [
    source 89
    target 469
  ]
  edge [
    source 89
    target 468
  ]
  edge [
    source 89
    target 471
  ]
  edge [
    source 93
    target 473
  ]
  edge [
    source 93
    target 472
  ]
  edge [
    source 94
    target 477
  ]
  edge [
    source 94
    target 474
  ]
  edge [
    source 94
    target 478
  ]
  edge [
    source 95
    target 479
  ]
  edge [
    source 95
    target 480
  ]
  edge [
    source 95
    target 482
  ]
  edge [
    source 95
    target 481
  ]
  edge [
    source 98
    target 483
  ]
  edge [
    source 98
    target 484
  ]
  edge [
    source 114
    target 488
  ]
  edge [
    source 114
    target 485
  ]
  edge [
    source 114
    target 486
  ]
  edge [
    source 114
    target 487
  ]
  edge [
    source 115
    target 492
  ]
  edge [
    source 115
    target 494
  ]
  edge [
    source 115
    target 491
  ]
  edge [
    source 115
    target 496
  ]
  edge [
    source 115
    target 495
  ]
  edge [
    source 118
    target 499
  ]
  edge [
    source 118
    target 497
  ]
  edge [
    source 118
    target 498
  ]
  edge [
    source 119
    target 501
  ]
  edge [
    source 119
    target 502
  ]
  edge [
    source 124
    target 504
  ]
  edge [
    source 124
    target 505
  ]
  edge [
    source 127
    target 511
  ]
  edge [
    source 127
    target 538
  ]
  edge [
    source 127
    target 523
  ]
  edge [
    source 127
    target 556
  ]
  edge [
    source 127
    target 510
  ]
  edge [
    source 127
    target 546
  ]
  edge [
    source 129
    target 558
  ]
  edge [
    source 129
    target 560
  ]
  edge [
    source 129
    target 559
  ]
  edge [
    source 129
    target 561
  ]
  edge [
    source 129
    target 562
  ]
  edge [
    source 136
    target 563
  ]
  edge [
    source 136
    target 564
  ]
  edge [
    source 138
    target 565
  ]
  edge [
    source 138
    target 566
  ]
  edge [
    source 141
    target 572
  ]
  edge [
    source 141
    target 567
  ]
  edge [
    source 141
    target 570
  ]
  edge [
    source 146
    target 576
  ]
  edge [
    source 146
    target 575
  ]
  edge [
    source 163
    target 644
  ]
  edge [
    source 163
    target 643
  ]
  edge [
    source 163
    target 586
  ]
  edge [
    source 163
    target 599
  ]
  edge [
    source 163
    target 614
  ]
  edge [
    source 163
    target 598
  ]
  edge [
    source 163
    target 629
  ]
  edge [
    source 163
    target 609
  ]
  edge [
    source 163
    target 580
  ]
  edge [
    source 163
    target 600
  ]
  edge [
    source 163
    target 590
  ]
  edge [
    source 163
    target 612
  ]
  edge [
    source 163
    target 595
  ]
  edge [
    source 163
    target 604
  ]
  edge [
    source 163
    target 632
  ]
  edge [
    source 163
    target 593
  ]
  edge [
    source 163
    target 640
  ]
  edge [
    source 163
    target 579
  ]
  edge [
    source 163
    target 633
  ]
  edge [
    source 163
    target 581
  ]
  edge [
    source 163
    target 601
  ]
  edge [
    source 163
    target 582
  ]
  edge [
    source 163
    target 588
  ]
  edge [
    source 163
    target 602
  ]
  edge [
    source 163
    target 634
  ]
  edge [
    source 163
    target 618
  ]
  edge [
    source 167
    target 660
  ]
  edge [
    source 167
    target 668
  ]
  edge [
    source 167
    target 671
  ]
  edge [
    source 167
    target 650
  ]
  edge [
    source 167
    target 658
  ]
  edge [
    source 167
    target 653
  ]
  edge [
    source 167
    target 667
  ]
  edge [
    source 167
    target 669
  ]
  edge [
    source 167
    target 664
  ]
  edge [
    source 167
    target 651
  ]
  edge [
    source 167
    target 655
  ]
  edge [
    source 167
    target 649
  ]
  edge [
    source 167
    target 670
  ]
  edge [
    source 167
    target 654
  ]
  edge [
    source 167
    target 652
  ]
  edge [
    source 167
    target 674
  ]
  edge [
    source 167
    target 662
  ]
  edge [
    source 167
    target 672
  ]
  edge [
    source 167
    target 659
  ]
  edge [
    source 167
    target 666
  ]
  edge [
    source 167
    target 656
  ]
  edge [
    source 168
    target 676
  ]
  edge [
    source 168
    target 677
  ]
  edge [
    source 169
    target 686
  ]
  edge [
    source 169
    target 714
  ]
  edge [
    source 169
    target 715
  ]
  edge [
    source 169
    target 720
  ]
  edge [
    source 169
    target 713
  ]
  edge [
    source 169
    target 706
  ]
  edge [
    source 170
    target 731
  ]
  edge [
    source 170
    target 760
  ]
  edge [
    source 170
    target 744
  ]
  edge [
    source 170
    target 751
  ]
  edge [
    source 170
    target 742
  ]
  edge [
    source 170
    target 729
  ]
  edge [
    source 170
    target 745
  ]
  edge [
    source 172
    target 769
  ]
  edge [
    source 172
    target 834
  ]
  edge [
    source 172
    target 780
  ]
  edge [
    source 172
    target 803
  ]
  edge [
    source 172
    target 869
  ]
  edge [
    source 172
    target 792
  ]
  edge [
    source 172
    target 774
  ]
  edge [
    source 172
    target 777
  ]
  edge [
    source 172
    target 879
  ]
  edge [
    source 172
    target 798
  ]
  edge [
    source 172
    target 860
  ]
  edge [
    source 172
    target 793
  ]
  edge [
    source 173
    target 900
  ]
  edge [
    source 173
    target 901
  ]
  edge [
    source 173
    target 893
  ]
  edge [
    source 173
    target 902
  ]
  edge [
    source 173
    target 905
  ]
  edge [
    source 174
    target 919
  ]
  edge [
    source 174
    target 916
  ]
  edge [
    source 174
    target 921
  ]
  edge [
    source 174
    target 920
  ]
  edge [
    source 176
    target 928
  ]
  edge [
    source 176
    target 923
  ]
  edge [
    source 178
    target 949
  ]
  edge [
    source 178
    target 935
  ]
  edge [
    source 178
    target 947
  ]
  edge [
    source 178
    target 942
  ]
  edge [
    source 178
    target 934
  ]
  edge [
    source 178
    target 939
  ]
  edge [
    source 178
    target 940
  ]
  edge [
    source 179
    target 1089
  ]
  edge [
    source 179
    target 1086
  ]
  edge [
    source 179
    target 993
  ]
  edge [
    source 179
    target 1069
  ]
  edge [
    source 179
    target 999
  ]
  edge [
    source 179
    target 1051
  ]
  edge [
    source 179
    target 1016
  ]
  edge [
    source 179
    target 996
  ]
  edge [
    source 179
    target 1027
  ]
  edge [
    source 179
    target 1070
  ]
  edge [
    source 179
    target 1088
  ]
  edge [
    source 179
    target 1026
  ]
  edge [
    source 179
    target 1063
  ]
  edge [
    source 179
    target 1025
  ]
  edge [
    source 179
    target 968
  ]
  edge [
    source 179
    target 964
  ]
  edge [
    source 179
    target 1082
  ]
  edge [
    source 179
    target 1104
  ]
  edge [
    source 179
    target 1057
  ]
  edge [
    source 179
    target 1100
  ]
  edge [
    source 180
    target 1113
  ]
  edge [
    source 180
    target 1114
  ]
  edge [
    source 181
    target 1126
  ]
  edge [
    source 181
    target 1127
  ]
  edge [
    source 181
    target 1123
  ]
  edge [
    source 182
    target 1129
  ]
  edge [
    source 182
    target 1128
  ]
  edge [
    source 183
    target 1133
  ]
  edge [
    source 183
    target 1134
  ]
  edge [
    source 183
    target 1132
  ]
  edge [
    source 184
    target 1136
  ]
  edge [
    source 184
    target 1135
  ]
  edge [
    source 185
    target 1139
  ]
  edge [
    source 185
    target 1137
  ]
  edge [
    source 186
    target 1181
  ]
  edge [
    source 186
    target 1145
  ]
  edge [
    source 186
    target 1163
  ]
  edge [
    source 186
    target 1177
  ]
  edge [
    source 186
    target 1161
  ]
  edge [
    source 186
    target 1147
  ]
  edge [
    source 186
    target 1162
  ]
  edge [
    source 186
    target 1159
  ]
  edge [
    source 186
    target 1167
  ]
  edge [
    source 186
    target 1188
  ]
  edge [
    source 186
    target 1143
  ]
  edge [
    source 186
    target 1170
  ]
  edge [
    source 186
    target 1171
  ]
  edge [
    source 186
    target 1164
  ]
  edge [
    source 186
    target 1149
  ]
  edge [
    source 187
    target 1197
  ]
  edge [
    source 188
    target 1199
  ]
  edge [
    source 188
    target 1203
  ]
  edge [
    source 188
    target 1206
  ]
  edge [
    source 188
    target 1207
  ]
  edge [
    source 188
    target 1201
  ]
  edge [
    source 191
    target 1216
  ]
  edge [
    source 191
    target 1245
  ]
  edge [
    source 191
    target 1235
  ]
  edge [
    source 191
    target 1214
  ]
  edge [
    source 191
    target 1232
  ]
  edge [
    source 191
    target 1241
  ]
  edge [
    source 191
    target 1218
  ]
  edge [
    source 191
    target 1242
  ]
  edge [
    source 191
    target 1252
  ]
  edge [
    source 193
    target 1268
  ]
  edge [
    source 193
    target 1257
  ]
  edge [
    source 193
    target 1263
  ]
  edge [
    source 194
    target 1331
  ]
  edge [
    source 194
    target 1300
  ]
  edge [
    source 194
    target 1318
  ]
  edge [
    source 194
    target 1332
  ]
  edge [
    source 194
    target 1335
  ]
  edge [
    source 194
    target 1278
  ]
  edge [
    source 194
    target 1343
  ]
  edge [
    source 194
    target 1309
  ]
  edge [
    source 194
    target 1291
  ]
  edge [
    source 194
    target 1279
  ]
  edge [
    source 195
    target 1349
  ]
  edge [
    source 195
    target 1348
  ]
  edge [
    source 195
    target 1352
  ]
  edge [
    source 196
    target 1353
  ]
  edge [
    source 196
    target 1379
  ]
  edge [
    source 196
    target 1376
  ]
  edge [
    source 196
    target 1370
  ]
  edge [
    source 196
    target 1377
  ]
  edge [
    source 196
    target 1367
  ]
  edge [
    source 196
    target 1381
  ]
  edge [
    source 196
    target 1356
  ]
  edge [
    source 196
    target 1364
  ]
  edge [
    source 197
    target 1411
  ]
  edge [
    source 197
    target 1400
  ]
  edge [
    source 197
    target 1403
  ]
  edge [
    source 197
    target 1424
  ]
  edge [
    source 197
    target 1392
  ]
  edge [
    source 197
    target 1395
  ]
  edge [
    source 197
    target 1426
  ]
  edge [
    source 197
    target 1417
  ]
  edge [
    source 197
    target 1416
  ]
  edge [
    source 197
    target 1390
  ]
  edge [
    source 197
    target 1402
  ]
  edge [
    source 197
    target 1383
  ]
  edge [
    source 197
    target 1401
  ]
  edge [
    source 197
    target 1404
  ]
  edge [
    source 197
    target 1393
  ]
  edge [
    source 197
    target 1382
  ]
  edge [
    source 197
    target 1418
  ]
  edge [
    source 197
    target 1413
  ]
  edge [
    source 197
    target 1410
  ]
  edge [
    source 197
    target 1409
  ]
  edge [
    source 198
    target 1506
  ]
  edge [
    source 198
    target 1457
  ]
  edge [
    source 198
    target 1514
  ]
  edge [
    source 198
    target 1453
  ]
  edge [
    source 198
    target 1480
  ]
  edge [
    source 198
    target 1445
  ]
  edge [
    source 198
    target 1494
  ]
  edge [
    source 198
    target 1435
  ]
  edge [
    source 198
    target 1449
  ]
  edge [
    source 199
    target 1616
  ]
  edge [
    source 199
    target 1621
  ]
  edge [
    source 199
    target 1601
  ]
  edge [
    source 199
    target 1635
  ]
  edge [
    source 199
    target 1592
  ]
  edge [
    source 199
    target 1638
  ]
  edge [
    source 199
    target 1566
  ]
  edge [
    source 199
    target 1571
  ]
  edge [
    source 199
    target 1569
  ]
  edge [
    source 199
    target 1608
  ]
  edge [
    source 199
    target 1542
  ]
  edge [
    source 199
    target 1581
  ]
  edge [
    source 199
    target 1530
  ]
  edge [
    source 199
    target 1672
  ]
  edge [
    source 200
    target 1680
  ]
  edge [
    source 200
    target 1677
  ]
  edge [
    source 200
    target 1674
  ]
  edge [
    source 201
    target 1694
  ]
  edge [
    source 201
    target 1695
  ]
  edge [
    source 201
    target 1692
  ]
  edge [
    source 201
    target 1682
  ]
  edge [
    source 201
    target 1684
  ]
  edge [
    source 201
    target 1685
  ]
  edge [
    source 201
    target 1687
  ]
  edge [
    source 201
    target 1700
  ]
  edge [
    source 202
    target 1704
  ]
  edge [
    source 202
    target 1711
  ]
  edge [
    source 202
    target 1710
  ]
  edge [
    source 202
    target 1709
  ]
  edge [
    source 202
    target 1707
  ]
  edge [
    source 204
    target 1733
  ]
  edge [
    source 204
    target 1731
  ]
  edge [
    source 204
    target 1713
  ]
  edge [
    source 204
    target 1734
  ]
  edge [
    source 204
    target 1712
  ]
  edge [
    source 204
    target 1740
  ]
  edge [
    source 204
    target 1727
  ]
  edge [
    source 204
    target 1732
  ]
  edge [
    source 204
    target 1726
  ]
  edge [
    source 204
    target 1728
  ]
  edge [
    source 204
    target 1719
  ]
  edge [
    source 205
    target 1828
  ]
  edge [
    source 205
    target 1762
  ]
  edge [
    source 205
    target 1812
  ]
  edge [
    source 205
    target 1870
  ]
  edge [
    source 205
    target 1895
  ]
  edge [
    source 205
    target 1866
  ]
  edge [
    source 205
    target 1768
  ]
  edge [
    source 205
    target 1917
  ]
  edge [
    source 205
    target 1787
  ]
  edge [
    source 205
    target 1945
  ]
  edge [
    source 205
    target 1798
  ]
  edge [
    source 205
    target 1882
  ]
  edge [
    source 205
    target 1770
  ]
  edge [
    source 205
    target 1941
  ]
  edge [
    source 205
    target 1760
  ]
  edge [
    source 205
    target 1816
  ]
  edge [
    source 205
    target 1849
  ]
  edge [
    source 205
    target 1809
  ]
  edge [
    source 206
    target 2012
  ]
  edge [
    source 206
    target 1979
  ]
  edge [
    source 206
    target 2018
  ]
  edge [
    source 206
    target 1971
  ]
  edge [
    source 206
    target 2005
  ]
  edge [
    source 206
    target 1961
  ]
  edge [
    source 206
    target 2004
  ]
  edge [
    source 206
    target 1966
  ]
  edge [
    source 206
    target 1998
  ]
  edge [
    source 207
    target 2042
  ]
  edge [
    source 207
    target 2049
  ]
  edge [
    source 207
    target 2053
  ]
  edge [
    source 208
    target 2137
  ]
  edge [
    source 208
    target 2154
  ]
  edge [
    source 208
    target 2096
  ]
  edge [
    source 208
    target 2067
  ]
  edge [
    source 208
    target 2061
  ]
  edge [
    source 208
    target 2144
  ]
  edge [
    source 208
    target 2134
  ]
  edge [
    source 208
    target 2087
  ]
  edge [
    source 208
    target 2139
  ]
  edge [
    source 208
    target 2128
  ]
  edge [
    source 209
    target 2161
  ]
  edge [
    source 209
    target 2166
  ]
  edge [
    source 210
    target 2178
  ]
  edge [
    source 210
    target 2168
  ]
  edge [
    source 210
    target 2170
  ]
  edge [
    source 210
    target 2180
  ]
  edge [
    source 210
    target 2173
  ]
  edge [
    source 210
    target 2184
  ]
  edge [
    source 211
    target 2207
  ]
  edge [
    source 211
    target 2213
  ]
  edge [
    source 211
    target 2197
  ]
  edge [
    source 211
    target 2202
  ]
  edge [
    source 211
    target 2191
  ]
  edge [
    source 211
    target 2192
  ]
  edge [
    source 212
    target 2233
  ]
  edge [
    source 212
    target 2264
  ]
  edge [
    source 212
    target 2236
  ]
  edge [
    source 212
    target 2245
  ]
  edge [
    source 212
    target 2247
  ]
  edge [
    source 212
    target 2266
  ]
  edge [
    source 213
    target 2308
  ]
  edge [
    source 213
    target 2368
  ]
  edge [
    source 213
    target 2406
  ]
  edge [
    source 213
    target 2287
  ]
  edge [
    source 213
    target 2294
  ]
  edge [
    source 213
    target 2345
  ]
  edge [
    source 213
    target 2303
  ]
  edge [
    source 213
    target 2354
  ]
  edge [
    source 213
    target 2306
  ]
  edge [
    source 213
    target 2331
  ]
  edge [
    source 213
    target 2290
  ]
  edge [
    source 213
    target 2372
  ]
  edge [
    source 213
    target 2286
  ]
  edge [
    source 214
    target 2410
  ]
  edge [
    source 214
    target 2413
  ]
  edge [
    source 215
    target 2423
  ]
  edge [
    source 215
    target 2422
  ]
  edge [
    source 216
    target 2430
  ]
  edge [
    source 216
    target 2429
  ]
  edge [
    source 216
    target 2431
  ]
  edge [
    source 216
    target 2428
  ]
  edge [
    source 216
    target 2427
  ]
  edge [
    source 217
    target 2432
  ]
  edge [
    source 217
    target 2436
  ]
  edge [
    source 217
    target 2437
  ]
  edge [
    source 217
    target 2434
  ]
  edge [
    source 217
    target 2435
  ]
  edge [
    source 217
    target 2433
  ]
  edge [
    source 219
    target 2453
  ]
  edge [
    source 219
    target 2447
  ]
  edge [
    source 219
    target 2445
  ]
  edge [
    source 219
    target 2448
  ]
  edge [
    source 219
    target 2440
  ]
  edge [
    source 219
    target 2444
  ]
  edge [
    source 219
    target 2439
  ]
  edge [
    source 220
    target 2462
  ]
  edge [
    source 220
    target 2457
  ]
  edge [
    source 220
    target 2456
  ]
  edge [
    source 220
    target 2455
  ]
  edge [
    source 220
    target 2461
  ]
  edge [
    source 221
    target 2464
  ]
  edge [
    source 223
    target 2470
  ]
  edge [
    source 223
    target 2477
  ]
  edge [
    source 223
    target 2475
  ]
  edge [
    source 223
    target 2468
  ]
  edge [
    source 223
    target 2473
  ]
  edge [
    source 224
    target 2482
  ]
  edge [
    source 224
    target 2481
  ]
  edge [
    source 227
    target 2486
  ]
  edge [
    source 227
    target 2496
  ]
  edge [
    source 227
    target 2491
  ]
  edge [
    source 227
    target 2483
  ]
  edge [
    source 228
    target 2502
  ]
  edge [
    source 230
    target 2503
  ]
  edge [
    source 230
    target 2505
  ]
  edge [
    source 230
    target 2506
  ]
  edge [
    source 230
    target 2504
  ]
  edge [
    source 231
    target 2507
  ]
  edge [
    source 232
    target 2509
  ]
  edge [
    source 232
    target 2508
  ]
  edge [
    source 233
    target 2534
  ]
  edge [
    source 233
    target 2547
  ]
  edge [
    source 233
    target 2532
  ]
  edge [
    source 233
    target 2542
  ]
  edge [
    source 233
    target 2524
  ]
  edge [
    source 233
    target 2510
  ]
  edge [
    source 234
    target 2556
  ]
  edge [
    source 234
    target 2559
  ]
  edge [
    source 234
    target 2562
  ]
  edge [
    source 235
    target 2582
  ]
  edge [
    source 235
    target 2566
  ]
  edge [
    source 235
    target 2576
  ]
  edge [
    source 235
    target 2572
  ]
  edge [
    source 235
    target 2581
  ]
  edge [
    source 235
    target 2563
  ]
  edge [
    source 235
    target 2577
  ]
  edge [
    source 235
    target 2564
  ]
  edge [
    source 236
    target 2625
  ]
  edge [
    source 236
    target 2634
  ]
  edge [
    source 236
    target 2628
  ]
  edge [
    source 236
    target 2644
  ]
  edge [
    source 236
    target 2596
  ]
  edge [
    source 236
    target 2646
  ]
  edge [
    source 236
    target 2592
  ]
  edge [
    source 236
    target 2593
  ]
  edge [
    source 236
    target 2622
  ]
  edge [
    source 237
    target 2662
  ]
  edge [
    source 237
    target 2666
  ]
  edge [
    source 237
    target 2649
  ]
  edge [
    source 237
    target 2659
  ]
  edge [
    source 237
    target 2657
  ]
  edge [
    source 238
    target 2714
  ]
  edge [
    source 238
    target 2670
  ]
  edge [
    source 238
    target 2734
  ]
  edge [
    source 238
    target 2772
  ]
  edge [
    source 238
    target 2716
  ]
  edge [
    source 238
    target 2749
  ]
  edge [
    source 238
    target 2762
  ]
  edge [
    source 238
    target 2784
  ]
  edge [
    source 238
    target 2690
  ]
  edge [
    source 239
    target 2789
  ]
  edge [
    source 239
    target 2787
  ]
  edge [
    source 241
    target 2791
  ]
  edge [
    source 241
    target 2792
  ]
  edge [
    source 242
    target 2802
  ]
  edge [
    source 242
    target 2800
  ]
  edge [
    source 242
    target 2793
  ]
  edge [
    source 243
    target 2804
  ]
  edge [
    source 243
    target 2803
  ]
  edge [
    source 244
    target 2805
  ]
  edge [
    source 244
    target 2811
  ]
  edge [
    source 244
    target 2806
  ]
  edge [
    source 247
    target 2845
  ]
  edge [
    source 247
    target 2857
  ]
  edge [
    source 247
    target 2838
  ]
  edge [
    source 247
    target 2816
  ]
  edge [
    source 247
    target 2858
  ]
  edge [
    source 247
    target 2825
  ]
  edge [
    source 247
    target 2812
  ]
  edge [
    source 247
    target 2819
  ]
  edge [
    source 247
    target 2830
  ]
  edge [
    source 247
    target 2848
  ]
  edge [
    source 247
    target 2822
  ]
  edge [
    source 247
    target 2831
  ]
  edge [
    source 247
    target 2821
  ]
  edge [
    source 247
    target 2826
  ]
  edge [
    source 247
    target 2854
  ]
  edge [
    source 247
    target 2842
  ]
  edge [
    source 247
    target 2813
  ]
  edge [
    source 247
    target 2843
  ]
  edge [
    source 247
    target 2844
  ]
  edge [
    source 247
    target 2846
  ]
  edge [
    source 247
    target 2849
  ]
  edge [
    source 247
    target 2856
  ]
  edge [
    source 247
    target 2833
  ]
  edge [
    source 247
    target 2827
  ]
  edge [
    source 247
    target 2814
  ]
  edge [
    source 247
    target 2832
  ]
  edge [
    source 248
    target 2869
  ]
  edge [
    source 248
    target 2873
  ]
  edge [
    source 248
    target 2870
  ]
  edge [
    source 248
    target 2868
  ]
  edge [
    source 249
    target 2876
  ]
  edge [
    source 249
    target 2875
  ]
  edge [
    source 249
    target 2874
  ]
  edge [
    source 250
    target 2877
  ]
  edge [
    source 250
    target 2878
  ]
  edge [
    source 251
    target 2880
  ]
  edge [
    source 251
    target 2879
  ]
  edge [
    source 251
    target 2883
  ]
  edge [
    source 251
    target 2882
  ]
  edge [
    source 252
    target 2888
  ]
  edge [
    source 252
    target 2886
  ]
  edge [
    source 252
    target 2891
  ]
  edge [
    source 254
    target 2901
  ]
  edge [
    source 254
    target 2902
  ]
  edge [
    source 254
    target 2903
  ]
  edge [
    source 254
    target 2906
  ]
  edge [
    source 254
    target 2899
  ]
  edge [
    source 255
    target 2909
  ]
  edge [
    source 255
    target 2908
  ]
  edge [
    source 255
    target 2907
  ]
  edge [
    source 257
    target 2913
  ]
  edge [
    source 257
    target 2911
  ]
  edge [
    source 257
    target 2912
  ]
  edge [
    source 258
    target 2927
  ]
  edge [
    source 258
    target 2932
  ]
  edge [
    source 258
    target 2918
  ]
  edge [
    source 258
    target 2926
  ]
  edge [
    source 258
    target 2915
  ]
  edge [
    source 258
    target 2936
  ]
  edge [
    source 260
    target 2949
  ]
  edge [
    source 260
    target 2939
  ]
  edge [
    source 260
    target 2951
  ]
  edge [
    source 260
    target 2945
  ]
  edge [
    source 261
    target 2955
  ]
  edge [
    source 261
    target 2957
  ]
  edge [
    source 261
    target 2953
  ]
  edge [
    source 263
    target 2974
  ]
  edge [
    source 263
    target 2968
  ]
  edge [
    source 267
    target 2976
  ]
  edge [
    source 267
    target 2975
  ]
  edge [
    source 271
    target 3009
  ]
  edge [
    source 271
    target 2996
  ]
  edge [
    source 271
    target 2998
  ]
  edge [
    source 271
    target 2977
  ]
  edge [
    source 271
    target 2986
  ]
  edge [
    source 271
    target 2993
  ]
  edge [
    source 271
    target 2990
  ]
  edge [
    source 271
    target 3020
  ]
  edge [
    source 271
    target 3019
  ]
  edge [
    source 271
    target 2981
  ]
  edge [
    source 271
    target 3012
  ]
  edge [
    source 271
    target 3022
  ]
  edge [
    source 271
    target 3014
  ]
  edge [
    source 271
    target 3001
  ]
  edge [
    source 271
    target 3011
  ]
  edge [
    source 271
    target 3015
  ]
  edge [
    source 271
    target 3023
  ]
  edge [
    source 271
    target 2987
  ]
  edge [
    source 271
    target 2994
  ]
  edge [
    source 271
    target 2988
  ]
  edge [
    source 271
    target 2989
  ]
  edge [
    source 271
    target 3008
  ]
  edge [
    source 273
    target 3025
  ]
  edge [
    source 273
    target 3024
  ]
  edge [
    source 277
    target 3027
  ]
  edge [
    source 277
    target 3026
  ]
  edge [
    source 277
    target 3032
  ]
  edge [
    source 277
    target 3029
  ]
  edge [
    source 277
    target 3031
  ]
  edge [
    source 280
    target 3038
  ]
  edge [
    source 280
    target 3035
  ]
  edge [
    source 280
    target 3036
  ]
  edge [
    source 280
    target 3033
  ]
  edge [
    source 281
    target 3042
  ]
  edge [
    source 281
    target 3045
  ]
  edge [
    source 290
    target 3068
  ]
  edge [
    source 290
    target 3056
  ]
  edge [
    source 290
    target 3074
  ]
  edge [
    source 290
    target 3064
  ]
  edge [
    source 290
    target 3052
  ]
  edge [
    source 290
    target 3063
  ]
  edge [
    source 290
    target 3080
  ]
  edge [
    source 290
    target 3071
  ]
  edge [
    source 293
    target 3084
  ]
  edge [
    source 293
    target 3081
  ]
  edge [
    source 293
    target 3085
  ]
  edge [
    source 293
    target 3083
  ]
  edge [
    source 296
    target 3092
  ]
  edge [
    source 296
    target 3090
  ]
  edge [
    source 300
    target 3098
  ]
  edge [
    source 300
    target 3100
  ]
  edge [
    source 300
    target 3101
  ]
  edge [
    source 300
    target 3105
  ]
  edge [
    source 301
    target 3109
  ]
  edge [
    source 301
    target 3108
  ]
  edge [
    source 303
    target 3110
  ]
  edge [
    source 303
    target 3113
  ]
  edge [
    source 306
    target 3126
  ]
  edge [
    source 306
    target 3128
  ]
  edge [
    source 309
    target 3129
  ]
  edge [
    source 309
    target 3130
  ]
  edge [
    source 316
    target 3135
  ]
  edge [
    source 316
    target 3131
  ]
  edge [
    source 316
    target 3140
  ]
  edge [
    source 316
    target 3137
  ]
  edge [
    source 316
    target 3132
  ]
  edge [
    source 316
    target 3139
  ]
  edge [
    source 316
    target 3136
  ]
  edge [
    source 317
    target 3142
  ]
  edge [
    source 317
    target 3143
  ]
  edge [
    source 317
    target 3141
  ]
  edge [
    source 318
    target 3203
  ]
  edge [
    source 318
    target 3153
  ]
  edge [
    source 318
    target 3252
  ]
  edge [
    source 318
    target 3261
  ]
  edge [
    source 318
    target 3208
  ]
  edge [
    source 318
    target 3159
  ]
  edge [
    source 318
    target 3161
  ]
  edge [
    source 318
    target 3232
  ]
  edge [
    source 318
    target 3192
  ]
  edge [
    source 318
    target 3247
  ]
  edge [
    source 318
    target 3216
  ]
  edge [
    source 318
    target 3227
  ]
  edge [
    source 318
    target 3246
  ]
  edge [
    source 318
    target 3258
  ]
  edge [
    source 318
    target 3197
  ]
  edge [
    source 318
    target 3176
  ]
  edge [
    source 318
    target 3220
  ]
  edge [
    source 318
    target 3177
  ]
  edge [
    source 318
    target 3156
  ]
  edge [
    source 318
    target 3202
  ]
  edge [
    source 318
    target 3218
  ]
  edge [
    source 318
    target 3174
  ]
  edge [
    source 318
    target 3249
  ]
  edge [
    source 318
    target 3210
  ]
  edge [
    source 318
    target 3226
  ]
  edge [
    source 318
    target 3204
  ]
  edge [
    source 318
    target 3162
  ]
  edge [
    source 318
    target 3263
  ]
  edge [
    source 318
    target 3240
  ]
  edge [
    source 318
    target 3154
  ]
  edge [
    source 318
    target 3188
  ]
  edge [
    source 318
    target 3173
  ]
  edge [
    source 318
    target 3230
  ]
  edge [
    source 318
    target 3194
  ]
  edge [
    source 318
    target 3215
  ]
  edge [
    source 318
    target 3187
  ]
  edge [
    source 318
    target 3211
  ]
  edge [
    source 318
    target 3224
  ]
  edge [
    source 318
    target 3170
  ]
  edge [
    source 318
    target 3157
  ]
  edge [
    source 319
    target 3315
  ]
  edge [
    source 319
    target 3289
  ]
  edge [
    source 319
    target 3302
  ]
  edge [
    source 319
    target 3273
  ]
  edge [
    source 319
    target 3322
  ]
  edge [
    source 319
    target 3284
  ]
  edge [
    source 319
    target 3303
  ]
  edge [
    source 319
    target 3296
  ]
  edge [
    source 320
    target 3368
  ]
  edge [
    source 320
    target 3406
  ]
  edge [
    source 320
    target 3421
  ]
  edge [
    source 320
    target 3397
  ]
  edge [
    source 320
    target 3444
  ]
  edge [
    source 322
    target 3468
  ]
  edge [
    source 322
    target 3467
  ]
  edge [
    source 322
    target 3451
  ]
  edge [
    source 322
    target 3452
  ]
  edge [
    source 324
    target 3476
  ]
  edge [
    source 324
    target 3474
  ]
  edge [
    source 324
    target 3471
  ]
  edge [
    source 324
    target 3470
  ]
  edge [
    source 324
    target 3479
  ]
  edge [
    source 324
    target 3477
  ]
  edge [
    source 325
    target 3514
  ]
  edge [
    source 325
    target 3498
  ]
  edge [
    source 325
    target 3504
  ]
  edge [
    source 325
    target 3485
  ]
  edge [
    source 325
    target 3488
  ]
  edge [
    source 325
    target 3508
  ]
  edge [
    source 325
    target 3520
  ]
  edge [
    source 325
    target 3505
  ]
  edge [
    source 326
    target 3534
  ]
  edge [
    source 326
    target 3535
  ]
  edge [
    source 326
    target 3532
  ]
  edge [
    source 326
    target 3533
  ]
  edge [
    source 326
    target 3528
  ]
  edge [
    source 326
    target 3539
  ]
  edge [
    source 326
    target 3538
  ]
  edge [
    source 327
    target 3541
  ]
  edge [
    source 327
    target 3542
  ]
  edge [
    source 327
    target 3540
  ]
  edge [
    source 327
    target 3543
  ]
  edge [
    source 328
    target 3545
  ]
  edge [
    source 328
    target 3548
  ]
  edge [
    source 328
    target 3546
  ]
  edge [
    source 328
    target 3544
  ]
  edge [
    source 328
    target 3547
  ]
  edge [
    source 328
    target 3549
  ]
  edge [
    source 329
    target 3559
  ]
  edge [
    source 329
    target 3553
  ]
  edge [
    source 329
    target 3554
  ]
  edge [
    source 329
    target 3567
  ]
  edge [
    source 329
    target 3565
  ]
  edge [
    source 329
    target 3557
  ]
  edge [
    source 329
    target 3563
  ]
  edge [
    source 330
    target 3578
  ]
  edge [
    source 330
    target 3574
  ]
  edge [
    source 330
    target 3573
  ]
  edge [
    source 330
    target 3582
  ]
  edge [
    source 330
    target 3580
  ]
  edge [
    source 331
    target 3585
  ]
  edge [
    source 331
    target 3587
  ]
  edge [
    source 331
    target 3584
  ]
  edge [
    source 331
    target 3586
  ]
  edge [
    source 332
    target 3595
  ]
  edge [
    source 332
    target 3598
  ]
  edge [
    source 332
    target 3605
  ]
  edge [
    source 333
    target 3629
  ]
  edge [
    source 333
    target 3641
  ]
  edge [
    source 333
    target 3648
  ]
  edge [
    source 333
    target 3644
  ]
  edge [
    source 333
    target 3625
  ]
  edge [
    source 333
    target 3636
  ]
  edge [
    source 333
    target 3662
  ]
  edge [
    source 334
    target 3673
  ]
  edge [
    source 334
    target 3671
  ]
  edge [
    source 334
    target 3682
  ]
  edge [
    source 335
    target 3685
  ]
  edge [
    source 335
    target 3687
  ]
  edge [
    source 335
    target 3686
  ]
  edge [
    source 335
    target 3688
  ]
  edge [
    source 335
    target 3692
  ]
  edge [
    source 336
    target 3698
  ]
  edge [
    source 336
    target 3699
  ]
  edge [
    source 337
    target 3705
  ]
  edge [
    source 337
    target 3715
  ]
  edge [
    source 337
    target 3701
  ]
  edge [
    source 337
    target 3712
  ]
  edge [
    source 337
    target 3702
  ]
  edge [
    source 337
    target 3707
  ]
  edge [
    source 337
    target 3714
  ]
  edge [
    source 337
    target 3706
  ]
  edge [
    source 337
    target 3700
  ]
  edge [
    source 337
    target 3708
  ]
  edge [
    source 340
    target 3807
  ]
  edge [
    source 340
    target 3798
  ]
  edge [
    source 340
    target 3781
  ]
  edge [
    source 340
    target 3774
  ]
  edge [
    source 340
    target 3760
  ]
  edge [
    source 340
    target 3745
  ]
  edge [
    source 340
    target 3723
  ]
  edge [
    source 340
    target 3767
  ]
  edge [
    source 340
    target 3719
  ]
  edge [
    source 340
    target 3775
  ]
  edge [
    source 340
    target 3743
  ]
  edge [
    source 340
    target 3728
  ]
  edge [
    source 340
    target 3744
  ]
  edge [
    source 340
    target 3753
  ]
  edge [
    source 340
    target 3750
  ]
  edge [
    source 340
    target 3752
  ]
  edge [
    source 340
    target 3735
  ]
  edge [
    source 341
    target 3817
  ]
  edge [
    source 341
    target 3820
  ]
  edge [
    source 341
    target 3822
  ]
  edge [
    source 343
    target 3834
  ]
  edge [
    source 343
    target 3829
  ]
  edge [
    source 343
    target 3831
  ]
  edge [
    source 343
    target 3828
  ]
  edge [
    source 343
    target 3825
  ]
  edge [
    source 345
    target 3843
  ]
  edge [
    source 345
    target 3845
  ]
  edge [
    source 345
    target 3872
  ]
  edge [
    source 345
    target 3841
  ]
  edge [
    source 345
    target 3839
  ]
  edge [
    source 345
    target 3842
  ]
  edge [
    source 345
    target 3856
  ]
  edge [
    source 345
    target 3882
  ]
  edge [
    source 345
    target 3885
  ]
  edge [
    source 345
    target 3854
  ]
  edge [
    source 345
    target 3840
  ]
  edge [
    source 345
    target 3875
  ]
  edge [
    source 345
    target 3863
  ]
  edge [
    source 345
    target 3849
  ]
  edge [
    source 345
    target 3876
  ]
  edge [
    source 345
    target 3853
  ]
  edge [
    source 346
    target 3887
  ]
  edge [
    source 347
    target 3891
  ]
  edge [
    source 347
    target 3889
  ]
  edge [
    source 347
    target 3890
  ]
  edge [
    source 347
    target 3888
  ]
  edge [
    source 349
    target 3893
  ]
  edge [
    source 349
    target 3892
  ]
  edge [
    source 351
    target 3896
  ]
  edge [
    source 351
    target 3898
  ]
  edge [
    source 352
    target 3916
  ]
  edge [
    source 352
    target 3913
  ]
  edge [
    source 352
    target 3919
  ]
  edge [
    source 352
    target 3903
  ]
  edge [
    source 352
    target 3906
  ]
  edge [
    source 353
    target 3924
  ]
  edge [
    source 353
    target 3932
  ]
  edge [
    source 353
    target 3928
  ]
  edge [
    source 353
    target 3922
  ]
  edge [
    source 353
    target 3923
  ]
  edge [
    source 353
    target 3926
  ]
  edge [
    source 354
    target 3940
  ]
  edge [
    source 354
    target 3950
  ]
  edge [
    source 354
    target 3944
  ]
  edge [
    source 354
    target 3968
  ]
  edge [
    source 354
    target 3955
  ]
  edge [
    source 354
    target 3951
  ]
  edge [
    source 354
    target 3943
  ]
  edge [
    source 354
    target 3947
  ]
  edge [
    source 355
    target 3977
  ]
  edge [
    source 355
    target 3990
  ]
  edge [
    source 355
    target 3978
  ]
  edge [
    source 355
    target 3986
  ]
  edge [
    source 355
    target 3976
  ]
  edge [
    source 355
    target 3980
  ]
  edge [
    source 356
    target 4006
  ]
  edge [
    source 356
    target 4005
  ]
  edge [
    source 356
    target 4004
  ]
  edge [
    source 357
    target 4012
  ]
  edge [
    source 357
    target 4017
  ]
  edge [
    source 357
    target 4016
  ]
  edge [
    source 357
    target 4011
  ]
  edge [
    source 357
    target 4007
  ]
  edge [
    source 357
    target 4010
  ]
  edge [
    source 358
    target 4038
  ]
  edge [
    source 358
    target 4037
  ]
  edge [
    source 358
    target 4025
  ]
  edge [
    source 358
    target 4042
  ]
  edge [
    source 360
    target 4044
  ]
  edge [
    source 360
    target 4045
  ]
  edge [
    source 361
    target 4047
  ]
  edge [
    source 361
    target 4046
  ]
  edge [
    source 361
    target 4048
  ]
  edge [
    source 363
    target 4049
  ]
  edge [
    source 363
    target 4050
  ]
  edge [
    source 365
    target 4059
  ]
  edge [
    source 365
    target 4065
  ]
  edge [
    source 365
    target 4079
  ]
  edge [
    source 365
    target 4064
  ]
  edge [
    source 366
    target 4097
  ]
  edge [
    source 366
    target 4110
  ]
  edge [
    source 366
    target 4090
  ]
  edge [
    source 366
    target 4098
  ]
  edge [
    source 366
    target 4132
  ]
  edge [
    source 366
    target 4116
  ]
  edge [
    source 366
    target 4094
  ]
  edge [
    source 366
    target 4115
  ]
  edge [
    source 366
    target 4126
  ]
  edge [
    source 366
    target 4114
  ]
  edge [
    source 366
    target 4127
  ]
  edge [
    source 367
    target 4141
  ]
  edge [
    source 367
    target 4140
  ]
  edge [
    source 369
    target 4144
  ]
  edge [
    source 369
    target 4145
  ]
  edge [
    source 369
    target 4146
  ]
  edge [
    source 370
    target 4152
  ]
  edge [
    source 370
    target 4150
  ]
  edge [
    source 370
    target 4149
  ]
  edge [
    source 370
    target 4151
  ]
  edge [
    source 371
    target 4153
  ]
  edge [
    source 371
    target 4154
  ]
  edge [
    source 371
    target 4159
  ]
  edge [
    source 371
    target 4161
  ]
  edge [
    source 372
    target 4167
  ]
  edge [
    source 372
    target 4168
  ]
  edge [
    source 372
    target 4165
  ]
  edge [
    source 372
    target 4166
  ]
  edge [
    source 372
    target 4164
  ]
  edge [
    source 374
    target 4176
  ]
  edge [
    source 374
    target 4173
  ]
  edge [
    source 374
    target 4174
  ]
  edge [
    source 374
    target 4175
  ]
  edge [
    source 375
    target 4187
  ]
  edge [
    source 375
    target 4189
  ]
  edge [
    source 375
    target 4198
  ]
  edge [
    source 380
    target 4201
  ]
  edge [
    source 380
    target 4204
  ]
  edge [
    source 381
    target 4208
  ]
  edge [
    source 381
    target 4209
  ]
  edge [
    source 381
    target 4214
  ]
  edge [
    source 382
    target 4226
  ]
  edge [
    source 382
    target 4222
  ]
  edge [
    source 382
    target 4219
  ]
  edge [
    source 382
    target 4225
  ]
  edge [
    source 382
    target 4230
  ]
  edge [
    source 383
    target 4240
  ]
  edge [
    source 383
    target 4235
  ]
  edge [
    source 385
    target 4241
  ]
  edge [
    source 385
    target 4242
  ]
  edge [
    source 386
    target 4247
  ]
  edge [
    source 386
    target 4252
  ]
  edge [
    source 387
    target 4264
  ]
  edge [
    source 387
    target 4262
  ]
  edge [
    source 387
    target 4259
  ]
  edge [
    source 387
    target 4261
  ]
  edge [
    source 387
    target 4256
  ]
  edge [
    source 387
    target 4269
  ]
  edge [
    source 387
    target 4268
  ]
  edge [
    source 387
    target 4255
  ]
  edge [
    source 387
    target 4271
  ]
  edge [
    source 388
    target 4283
  ]
  edge [
    source 388
    target 4278
  ]
  edge [
    source 388
    target 4279
  ]
  edge [
    source 389
    target 4287
  ]
  edge [
    source 389
    target 4307
  ]
  edge [
    source 389
    target 4288
  ]
  edge [
    source 390
    target 4325
  ]
  edge [
    source 390
    target 4324
  ]
  edge [
    source 391
    target 4327
  ]
  edge [
    source 391
    target 4328
  ]
  edge [
    source 391
    target 4326
  ]
  edge [
    source 394
    target 4329
  ]
  edge [
    source 400
    target 4335
  ]
  edge [
    source 400
    target 4339
  ]
  edge [
    source 400
    target 4331
  ]
  edge [
    source 400
    target 4337
  ]
  edge [
    source 400
    target 4340
  ]
  edge [
    source 403
    target 4361
  ]
  edge [
    source 403
    target 4375
  ]
  edge [
    source 403
    target 4391
  ]
  edge [
    source 403
    target 4378
  ]
  edge [
    source 403
    target 4345
  ]
  edge [
    source 403
    target 4346
  ]
  edge [
    source 403
    target 4355
  ]
  edge [
    source 403
    target 4382
  ]
  edge [
    source 403
    target 4386
  ]
  edge [
    source 403
    target 4353
  ]
  edge [
    source 403
    target 4376
  ]
  edge [
    source 403
    target 4390
  ]
  edge [
    source 403
    target 4348
  ]
  edge [
    source 403
    target 4379
  ]
  edge [
    source 403
    target 4347
  ]
  edge [
    source 403
    target 4350
  ]
  edge [
    source 403
    target 4374
  ]
  edge [
    source 403
    target 4358
  ]
  edge [
    source 403
    target 4383
  ]
  edge [
    source 403
    target 4377
  ]
  edge [
    source 403
    target 4364
  ]
  edge [
    source 403
    target 4365
  ]
  edge [
    source 403
    target 4387
  ]
  edge [
    source 403
    target 4380
  ]
  edge [
    source 403
    target 4367
  ]
  edge [
    source 403
    target 4371
  ]
  edge [
    source 404
    target 4393
  ]
  edge [
    source 404
    target 4392
  ]
  edge [
    source 404
    target 4396
  ]
  edge [
    source 404
    target 4395
  ]
  edge [
    source 405
    target 4398
  ]
  edge [
    source 405
    target 4397
  ]
  edge [
    source 406
    target 4400
  ]
  edge [
    source 406
    target 4399
  ]
  edge [
    source 407
    target 4417
  ]
  edge [
    source 407
    target 4416
  ]
  edge [
    source 407
    target 4419
  ]
  edge [
    source 407
    target 4406
  ]
  edge [
    source 407
    target 4402
  ]
  edge [
    source 411
    target 4422
  ]
  edge [
    source 411
    target 4423
  ]
  edge [
    source 411
    target 4420
  ]
  edge [
    source 414
    target 4428
  ]
  edge [
    source 414
    target 4427
  ]
  edge [
    source 414
    target 4424
  ]
  edge [
    source 416
    target 4436
  ]
  edge [
    source 416
    target 4438
  ]
  edge [
    source 416
    target 4440
  ]
  edge [
    source 416
    target 4437
  ]
  edge [
    source 417
    target 4442
  ]
  edge [
    source 417
    target 4443
  ]
  edge [
    source 419
    target 4445
  ]
  edge [
    source 419
    target 4444
  ]
  edge [
    source 422
    target 4447
  ]
  edge [
    source 422
    target 4451
  ]
  edge [
    source 422
    target 4446
  ]
  edge [
    source 422
    target 4450
  ]
  edge [
    source 423
    target 4452
  ]
  edge [
    source 423
    target 4453
  ]
  edge [
    source 424
    target 4457
  ]
  edge [
    source 424
    target 4454
  ]
  edge [
    source 427
    target 4465
  ]
  edge [
    source 427
    target 4462
  ]
  edge [
    source 427
    target 4468
  ]
  edge [
    source 427
    target 4474
  ]
  edge [
    source 427
    target 4466
  ]
  edge [
    source 427
    target 4473
  ]
  edge [
    source 427
    target 4472
  ]
  edge [
    source 427
    target 4469
  ]
  edge [
    source 427
    target 4463
  ]
  edge [
    source 427
    target 4464
  ]
  edge [
    source 427
    target 4475
  ]
  edge [
    source 427
    target 4467
  ]
  edge [
    source 427
    target 4470
  ]
  edge [
    source 427
    target 4471
  ]
  edge [
    source 428
    target 4478
  ]
  edge [
    source 428
    target 4476
  ]
  edge [
    source 428
    target 4477
  ]
  edge [
    source 428
    target 4479
  ]
  edge [
    source 429
    target 4480
  ]
  edge [
    source 429
    target 4481
  ]
  edge [
    source 430
    target 4482
  ]
  edge [
    source 430
    target 4483
  ]
  edge [
    source 431
    target 4496
  ]
  edge [
    source 431
    target 4487
  ]
  edge [
    source 431
    target 4510
  ]
  edge [
    source 431
    target 4498
  ]
  edge [
    source 431
    target 4485
  ]
  edge [
    source 431
    target 4504
  ]
  edge [
    source 431
    target 4484
  ]
  edge [
    source 432
    target 4516
  ]
  edge [
    source 432
    target 4515
  ]
  edge [
    source 433
    target 4522
  ]
  edge [
    source 433
    target 4520
  ]
  edge [
    source 433
    target 4525
  ]
  edge [
    source 433
    target 4517
  ]
  edge [
    source 434
    target 4527
  ]
  edge [
    source 434
    target 4526
  ]
  edge [
    source 437
    target 4537
  ]
  edge [
    source 437
    target 4536
  ]
  edge [
    source 437
    target 4529
  ]
  edge [
    source 437
    target 4539
  ]
  edge [
    source 438
    target 4544
  ]
  edge [
    source 438
    target 4551
  ]
  edge [
    source 438
    target 4546
  ]
  edge [
    source 439
    target 4557
  ]
  edge [
    source 439
    target 4558
  ]
  edge [
    source 439
    target 4560
  ]
  edge [
    source 439
    target 4556
  ]
  edge [
    source 440
    target 4562
  ]
  edge [
    source 440
    target 4563
  ]
  edge [
    source 440
    target 4561
  ]
  edge [
    source 441
    target 4568
  ]
  edge [
    source 441
    target 4569
  ]
  edge [
    source 441
    target 4567
  ]
  edge [
    source 441
    target 4570
  ]
  edge [
    source 441
    target 4566
  ]
  edge [
    source 444
    target 4572
  ]
  edge [
    source 444
    target 4584
  ]
  edge [
    source 444
    target 4578
  ]
  edge [
    source 444
    target 4597
  ]
  edge [
    source 445
    target 4603
  ]
  edge [
    source 445
    target 4600
  ]
  edge [
    source 445
    target 4605
  ]
  edge [
    source 445
    target 4601
  ]
  edge [
    source 446
    target 4610
  ]
  edge [
    source 446
    target 4611
  ]
  edge [
    source 447
    target 4618
  ]
  edge [
    source 447
    target 4615
  ]
  edge [
    source 447
    target 4623
  ]
  edge [
    source 447
    target 4620
  ]
  edge [
    source 448
    target 4663
  ]
  edge [
    source 448
    target 4646
  ]
  edge [
    source 448
    target 4654
  ]
  edge [
    source 448
    target 4644
  ]
  edge [
    source 448
    target 4653
  ]
  edge [
    source 448
    target 4673
  ]
  edge [
    source 449
    target 4679
  ]
  edge [
    source 449
    target 4678
  ]
  edge [
    source 450
    target 4681
  ]
  edge [
    source 450
    target 4688
  ]
  edge [
    source 450
    target 4682
  ]
  edge [
    source 451
    target 4692
  ]
  edge [
    source 451
    target 4722
  ]
  edge [
    source 451
    target 4753
  ]
  edge [
    source 451
    target 4695
  ]
  edge [
    source 451
    target 4733
  ]
  edge [
    source 452
    target 4766
  ]
  edge [
    source 452
    target 4758
  ]
  edge [
    source 452
    target 4756
  ]
  edge [
    source 452
    target 4765
  ]
  edge [
    source 452
    target 4762
  ]
  edge [
    source 452
    target 4755
  ]
  edge [
    source 452
    target 4754
  ]
  edge [
    source 454
    target 4789
  ]
  edge [
    source 454
    target 4774
  ]
  edge [
    source 454
    target 4784
  ]
  edge [
    source 454
    target 4788
  ]
  edge [
    source 454
    target 4776
  ]
  edge [
    source 454
    target 4790
  ]
  edge [
    source 454
    target 4780
  ]
  edge [
    source 454
    target 4778
  ]
  edge [
    source 456
    target 4794
  ]
  edge [
    source 456
    target 4795
  ]
  edge [
    source 456
    target 4799
  ]
  edge [
    source 456
    target 4791
  ]
  edge [
    source 456
    target 4792
  ]
  edge [
    source 456
    target 4796
  ]
  edge [
    source 456
    target 4793
  ]
  edge [
    source 463
    target 464
  ]
  edge [
    source 463
    target 465
  ]
  edge [
    source 471
    target 470
  ]
  edge [
    source 471
    target 467
  ]
  edge [
    source 477
    target 475
  ]
  edge [
    source 477
    target 476
  ]
  edge [
    source 492
    target 493
  ]
  edge [
    source 492
    target 489
  ]
  edge [
    source 492
    target 490
  ]
  edge [
    source 501
    target 503
  ]
  edge [
    source 501
    target 500
  ]
  edge [
    source 508
    target 557
  ]
  edge [
    source 508
    target 553
  ]
  edge [
    source 511
    target 550
  ]
  edge [
    source 511
    target 545
  ]
  edge [
    source 511
    target 524
  ]
  edge [
    source 522
    target 543
  ]
  edge [
    source 522
    target 530
  ]
  edge [
    source 522
    target 521
  ]
  edge [
    source 522
    target 536
  ]
  edge [
    source 522
    target 549
  ]
  edge [
    source 523
    target 515
  ]
  edge [
    source 523
    target 528
  ]
  edge [
    source 523
    target 512
  ]
  edge [
    source 523
    target 519
  ]
  edge [
    source 523
    target 535
  ]
  edge [
    source 524
    target 531
  ]
  edge [
    source 524
    target 522
  ]
  edge [
    source 527
    target 554
  ]
  edge [
    source 527
    target 537
  ]
  edge [
    source 527
    target 518
  ]
  edge [
    source 527
    target 534
  ]
  edge [
    source 527
    target 532
  ]
  edge [
    source 527
    target 514
  ]
  edge [
    source 527
    target 525
  ]
  edge [
    source 527
    target 544
  ]
  edge [
    source 527
    target 542
  ]
  edge [
    source 527
    target 526
  ]
  edge [
    source 527
    target 517
  ]
  edge [
    source 527
    target 552
  ]
  edge [
    source 527
    target 547
  ]
  edge [
    source 527
    target 520
  ]
  edge [
    source 527
    target 509
  ]
  edge [
    source 535
    target 541
  ]
  edge [
    source 535
    target 548
  ]
  edge [
    source 535
    target 508
  ]
  edge [
    source 538
    target 533
  ]
  edge [
    source 538
    target 529
  ]
  edge [
    source 546
    target 527
  ]
  edge [
    source 546
    target 539
  ]
  edge [
    source 546
    target 507
  ]
  edge [
    source 546
    target 506
  ]
  edge [
    source 546
    target 516
  ]
  edge [
    source 550
    target 540
  ]
  edge [
    source 550
    target 513
  ]
  edge [
    source 550
    target 555
  ]
  edge [
    source 550
    target 551
  ]
  edge [
    source 570
    target 568
  ]
  edge [
    source 570
    target 571
  ]
  edge [
    source 570
    target 574
  ]
  edge [
    source 570
    target 573
  ]
  edge [
    source 570
    target 569
  ]
  edge [
    source 581
    target 583
  ]
  edge [
    source 581
    target 626
  ]
  edge [
    source 581
    target 607
  ]
  edge [
    source 582
    target 623
  ]
  edge [
    source 582
    target 616
  ]
  edge [
    source 583
    target 630
  ]
  edge [
    source 583
    target 592
  ]
  edge [
    source 587
    target 648
  ]
  edge [
    source 587
    target 608
  ]
  edge [
    source 587
    target 613
  ]
  edge [
    source 587
    target 585
  ]
  edge [
    source 587
    target 635
  ]
  edge [
    source 587
    target 577
  ]
  edge [
    source 589
    target 636
  ]
  edge [
    source 589
    target 637
  ]
  edge [
    source 593
    target 606
  ]
  edge [
    source 593
    target 594
  ]
  edge [
    source 602
    target 620
  ]
  edge [
    source 602
    target 591
  ]
  edge [
    source 602
    target 617
  ]
  edge [
    source 602
    target 578
  ]
  edge [
    source 602
    target 611
  ]
  edge [
    source 602
    target 647
  ]
  edge [
    source 609
    target 621
  ]
  edge [
    source 609
    target 605
  ]
  edge [
    source 609
    target 645
  ]
  edge [
    source 618
    target 587
  ]
  edge [
    source 618
    target 619
  ]
  edge [
    source 618
    target 589
  ]
  edge [
    source 619
    target 646
  ]
  edge [
    source 619
    target 631
  ]
  edge [
    source 619
    target 596
  ]
  edge [
    source 629
    target 610
  ]
  edge [
    source 629
    target 625
  ]
  edge [
    source 633
    target 615
  ]
  edge [
    source 633
    target 642
  ]
  edge [
    source 633
    target 624
  ]
  edge [
    source 633
    target 622
  ]
  edge [
    source 633
    target 597
  ]
  edge [
    source 633
    target 628
  ]
  edge [
    source 637
    target 627
  ]
  edge [
    source 637
    target 639
  ]
  edge [
    source 644
    target 603
  ]
  edge [
    source 644
    target 641
  ]
  edge [
    source 646
    target 584
  ]
  edge [
    source 646
    target 638
  ]
  edge [
    source 662
    target 673
  ]
  edge [
    source 662
    target 657
  ]
  edge [
    source 664
    target 665
  ]
  edge [
    source 664
    target 663
  ]
  edge [
    source 664
    target 661
  ]
  edge [
    source 676
    target 675
  ]
  edge [
    source 679
    target 702
  ]
  edge [
    source 679
    target 724
  ]
  edge [
    source 679
    target 696
  ]
  edge [
    source 681
    target 678
  ]
  edge [
    source 686
    target 709
  ]
  edge [
    source 686
    target 710
  ]
  edge [
    source 692
    target 685
  ]
  edge [
    source 692
    target 718
  ]
  edge [
    source 694
    target 701
  ]
  edge [
    source 694
    target 721
  ]
  edge [
    source 694
    target 707
  ]
  edge [
    source 699
    target 723
  ]
  edge [
    source 699
    target 700
  ]
  edge [
    source 699
    target 704
  ]
  edge [
    source 699
    target 722
  ]
  edge [
    source 706
    target 712
  ]
  edge [
    source 706
    target 679
  ]
  edge [
    source 706
    target 689
  ]
  edge [
    source 706
    target 708
  ]
  edge [
    source 708
    target 690
  ]
  edge [
    source 708
    target 711
  ]
  edge [
    source 712
    target 688
  ]
  edge [
    source 712
    target 694
  ]
  edge [
    source 713
    target 703
  ]
  edge [
    source 713
    target 717
  ]
  edge [
    source 713
    target 726
  ]
  edge [
    source 713
    target 683
  ]
  edge [
    source 713
    target 725
  ]
  edge [
    source 714
    target 699
  ]
  edge [
    source 714
    target 728
  ]
  edge [
    source 714
    target 691
  ]
  edge [
    source 714
    target 692
  ]
  edge [
    source 714
    target 697
  ]
  edge [
    source 715
    target 716
  ]
  edge [
    source 715
    target 727
  ]
  edge [
    source 715
    target 705
  ]
  edge [
    source 715
    target 682
  ]
  edge [
    source 715
    target 681
  ]
  edge [
    source 718
    target 719
  ]
  edge [
    source 718
    target 695
  ]
  edge [
    source 720
    target 680
  ]
  edge [
    source 720
    target 693
  ]
  edge [
    source 727
    target 687
  ]
  edge [
    source 728
    target 698
  ]
  edge [
    source 728
    target 684
  ]
  edge [
    source 729
    target 739
  ]
  edge [
    source 729
    target 746
  ]
  edge [
    source 731
    target 737
  ]
  edge [
    source 731
    target 748
  ]
  edge [
    source 731
    target 743
  ]
  edge [
    source 735
    target 730
  ]
  edge [
    source 735
    target 750
  ]
  edge [
    source 736
    target 734
  ]
  edge [
    source 736
    target 732
  ]
  edge [
    source 743
    target 735
  ]
  edge [
    source 743
    target 755
  ]
  edge [
    source 743
    target 761
  ]
  edge [
    source 745
    target 759
  ]
  edge [
    source 745
    target 762
  ]
  edge [
    source 751
    target 752
  ]
  edge [
    source 751
    target 749
  ]
  edge [
    source 751
    target 757
  ]
  edge [
    source 758
    target 733
  ]
  edge [
    source 758
    target 740
  ]
  edge [
    source 760
    target 754
  ]
  edge [
    source 760
    target 753
  ]
  edge [
    source 761
    target 747
  ]
  edge [
    source 761
    target 756
  ]
  edge [
    source 761
    target 741
  ]
  edge [
    source 761
    target 738
  ]
  edge [
    source 762
    target 758
  ]
  edge [
    source 762
    target 736
  ]
  edge [
    source 765
    target 825
  ]
  edge [
    source 765
    target 858
  ]
  edge [
    source 765
    target 866
  ]
  edge [
    source 769
    target 845
  ]
  edge [
    source 769
    target 784
  ]
  edge [
    source 773
    target 807
  ]
  edge [
    source 774
    target 886
  ]
  edge [
    source 774
    target 844
  ]
  edge [
    source 774
    target 847
  ]
  edge [
    source 777
    target 830
  ]
  edge [
    source 777
    target 865
  ]
  edge [
    source 780
    target 801
  ]
  edge [
    source 780
    target 851
  ]
  edge [
    source 780
    target 837
  ]
  edge [
    source 780
    target 786
  ]
  edge [
    source 780
    target 854
  ]
  edge [
    source 780
    target 809
  ]
  edge [
    source 780
    target 823
  ]
  edge [
    source 780
    target 881
  ]
  edge [
    source 780
    target 765
  ]
  edge [
    source 780
    target 842
  ]
  edge [
    source 782
    target 813
  ]
  edge [
    source 782
    target 876
  ]
  edge [
    source 782
    target 785
  ]
  edge [
    source 784
    target 811
  ]
  edge [
    source 784
    target 791
  ]
  edge [
    source 787
    target 810
  ]
  edge [
    source 787
    target 885
  ]
  edge [
    source 793
    target 782
  ]
  edge [
    source 793
    target 840
  ]
  edge [
    source 794
    target 764
  ]
  edge [
    source 794
    target 767
  ]
  edge [
    source 797
    target 806
  ]
  edge [
    source 798
    target 878
  ]
  edge [
    source 798
    target 857
  ]
  edge [
    source 802
    target 838
  ]
  edge [
    source 802
    target 763
  ]
  edge [
    source 803
    target 814
  ]
  edge [
    source 803
    target 835
  ]
  edge [
    source 803
    target 828
  ]
  edge [
    source 804
    target 839
  ]
  edge [
    source 804
    target 873
  ]
  edge [
    source 805
    target 856
  ]
  edge [
    source 805
    target 849
  ]
  edge [
    source 805
    target 836
  ]
  edge [
    source 805
    target 817
  ]
  edge [
    source 809
    target 832
  ]
  edge [
    source 809
    target 871
  ]
  edge [
    source 809
    target 812
  ]
  edge [
    source 809
    target 779
  ]
  edge [
    source 814
    target 859
  ]
  edge [
    source 814
    target 795
  ]
  edge [
    source 814
    target 775
  ]
  edge [
    source 816
    target 826
  ]
  edge [
    source 816
    target 787
  ]
  edge [
    source 821
    target 766
  ]
  edge [
    source 821
    target 875
  ]
  edge [
    source 821
    target 772
  ]
  edge [
    source 823
    target 808
  ]
  edge [
    source 823
    target 862
  ]
  edge [
    source 828
    target 855
  ]
  edge [
    source 830
    target 843
  ]
  edge [
    source 830
    target 822
  ]
  edge [
    source 834
    target 773
  ]
  edge [
    source 834
    target 794
  ]
  edge [
    source 835
    target 821
  ]
  edge [
    source 835
    target 770
  ]
  edge [
    source 835
    target 887
  ]
  edge [
    source 835
    target 864
  ]
  edge [
    source 835
    target 790
  ]
  edge [
    source 835
    target 824
  ]
  edge [
    source 837
    target 841
  ]
  edge [
    source 837
    target 882
  ]
  edge [
    source 840
    target 852
  ]
  edge [
    source 840
    target 883
  ]
  edge [
    source 840
    target 818
  ]
  edge [
    source 840
    target 804
  ]
  edge [
    source 842
    target 778
  ]
  edge [
    source 843
    target 788
  ]
  edge [
    source 843
    target 853
  ]
  edge [
    source 847
    target 783
  ]
  edge [
    source 847
    target 850
  ]
  edge [
    source 847
    target 874
  ]
  edge [
    source 850
    target 833
  ]
  edge [
    source 850
    target 872
  ]
  edge [
    source 853
    target 888
  ]
  edge [
    source 853
    target 867
  ]
  edge [
    source 855
    target 815
  ]
  edge [
    source 857
    target 800
  ]
  edge [
    source 857
    target 796
  ]
  edge [
    source 857
    target 771
  ]
  edge [
    source 860
    target 820
  ]
  edge [
    source 860
    target 829
  ]
  edge [
    source 868
    target 877
  ]
  edge [
    source 869
    target 848
  ]
  edge [
    source 869
    target 789
  ]
  edge [
    source 869
    target 797
  ]
  edge [
    source 874
    target 870
  ]
  edge [
    source 874
    target 781
  ]
  edge [
    source 879
    target 816
  ]
  edge [
    source 879
    target 884
  ]
  edge [
    source 881
    target 868
  ]
  edge [
    source 881
    target 802
  ]
  edge [
    source 881
    target 880
  ]
  edge [
    source 881
    target 799
  ]
  edge [
    source 881
    target 819
  ]
  edge [
    source 881
    target 863
  ]
  edge [
    source 881
    target 805
  ]
  edge [
    source 881
    target 827
  ]
  edge [
    source 886
    target 768
  ]
  edge [
    source 886
    target 861
  ]
  edge [
    source 886
    target 846
  ]
  edge [
    source 886
    target 831
  ]
  edge [
    source 886
    target 776
  ]
  edge [
    source 893
    target 908
  ]
  edge [
    source 895
    target 906
  ]
  edge [
    source 895
    target 911
  ]
  edge [
    source 900
    target 894
  ]
  edge [
    source 900
    target 898
  ]
  edge [
    source 900
    target 904
  ]
  edge [
    source 900
    target 892
  ]
  edge [
    source 900
    target 896
  ]
  edge [
    source 900
    target 915
  ]
  edge [
    source 900
    target 903
  ]
  edge [
    source 901
    target 907
  ]
  edge [
    source 901
    target 914
  ]
  edge [
    source 901
    target 895
  ]
  edge [
    source 902
    target 910
  ]
  edge [
    source 905
    target 891
  ]
  edge [
    source 905
    target 889
  ]
  edge [
    source 907
    target 897
  ]
  edge [
    source 907
    target 909
  ]
  edge [
    source 908
    target 899
  ]
  edge [
    source 910
    target 913
  ]
  edge [
    source 915
    target 890
  ]
  edge [
    source 915
    target 912
  ]
  edge [
    source 919
    target 917
  ]
  edge [
    source 919
    target 918
  ]
  edge [
    source 923
    target 924
  ]
  edge [
    source 923
    target 926
  ]
  edge [
    source 926
    target 922
  ]
  edge [
    source 926
    target 925
  ]
  edge [
    source 926
    target 927
  ]
  edge [
    source 935
    target 945
  ]
  edge [
    source 937
    target 943
  ]
  edge [
    source 937
    target 930
  ]
  edge [
    source 937
    target 938
  ]
  edge [
    source 937
    target 950
  ]
  edge [
    source 939
    target 937
  ]
  edge [
    source 939
    target 944
  ]
  edge [
    source 940
    target 941
  ]
  edge [
    source 940
    target 933
  ]
  edge [
    source 942
    target 948
  ]
  edge [
    source 942
    target 936
  ]
  edge [
    source 942
    target 932
  ]
  edge [
    source 943
    target 946
  ]
  edge [
    source 943
    target 929
  ]
  edge [
    source 949
    target 931
  ]
  edge [
    source 956
    target 1064
  ]
  edge [
    source 956
    target 971
  ]
  edge [
    source 956
    target 1041
  ]
  edge [
    source 956
    target 1066
  ]
  edge [
    source 957
    target 1004
  ]
  edge [
    source 957
    target 1036
  ]
  edge [
    source 957
    target 1032
  ]
  edge [
    source 963
    target 1019
  ]
  edge [
    source 963
    target 984
  ]
  edge [
    source 963
    target 1005
  ]
  edge [
    source 964
    target 1061
  ]
  edge [
    source 964
    target 952
  ]
  edge [
    source 964
    target 1093
  ]
  edge [
    source 964
    target 997
  ]
  edge [
    source 968
    target 1096
  ]
  edge [
    source 968
    target 1031
  ]
  edge [
    source 969
    target 1058
  ]
  edge [
    source 969
    target 1054
  ]
  edge [
    source 969
    target 1085
  ]
  edge [
    source 969
    target 1033
  ]
  edge [
    source 970
    target 1024
  ]
  edge [
    source 970
    target 1042
  ]
  edge [
    source 971
    target 1044
  ]
  edge [
    source 971
    target 958
  ]
  edge [
    source 972
    target 1094
  ]
  edge [
    source 972
    target 1039
  ]
  edge [
    source 973
    target 994
  ]
  edge [
    source 973
    target 970
  ]
  edge [
    source 973
    target 1009
  ]
  edge [
    source 973
    target 982
  ]
  edge [
    source 973
    target 1107
  ]
  edge [
    source 973
    target 998
  ]
  edge [
    source 975
    target 1022
  ]
  edge [
    source 975
    target 1055
  ]
  edge [
    source 977
    target 992
  ]
  edge [
    source 977
    target 1102
  ]
  edge [
    source 977
    target 1035
  ]
  edge [
    source 977
    target 995
  ]
  edge [
    source 978
    target 1098
  ]
  edge [
    source 981
    target 1015
  ]
  edge [
    source 981
    target 957
  ]
  edge [
    source 981
    target 969
  ]
  edge [
    source 981
    target 1013
  ]
  edge [
    source 982
    target 1047
  ]
  edge [
    source 982
    target 1065
  ]
  edge [
    source 982
    target 955
  ]
  edge [
    source 989
    target 956
  ]
  edge [
    source 996
    target 1020
  ]
  edge [
    source 996
    target 951
  ]
  edge [
    source 999
    target 1071
  ]
  edge [
    source 999
    target 1079
  ]
  edge [
    source 1009
    target 1003
  ]
  edge [
    source 1009
    target 983
  ]
  edge [
    source 1010
    target 1012
  ]
  edge [
    source 1010
    target 986
  ]
  edge [
    source 1010
    target 1014
  ]
  edge [
    source 1011
    target 1056
  ]
  edge [
    source 1011
    target 1034
  ]
  edge [
    source 1012
    target 1109
  ]
  edge [
    source 1012
    target 1050
  ]
  edge [
    source 1015
    target 1002
  ]
  edge [
    source 1015
    target 1078
  ]
  edge [
    source 1015
    target 1072
  ]
  edge [
    source 1015
    target 980
  ]
  edge [
    source 1016
    target 960
  ]
  edge [
    source 1016
    target 991
  ]
  edge [
    source 1024
    target 988
  ]
  edge [
    source 1024
    target 1048
  ]
  edge [
    source 1027
    target 976
  ]
  edge [
    source 1027
    target 1006
  ]
  edge [
    source 1027
    target 1095
  ]
  edge [
    source 1027
    target 1017
  ]
  edge [
    source 1027
    target 966
  ]
  edge [
    source 1027
    target 1087
  ]
  edge [
    source 1027
    target 959
  ]
  edge [
    source 1028
    target 1037
  ]
  edge [
    source 1028
    target 1091
  ]
  edge [
    source 1028
    target 1106
  ]
  edge [
    source 1028
    target 1045
  ]
  edge [
    source 1040
    target 1080
  ]
  edge [
    source 1040
    target 1030
  ]
  edge [
    source 1040
    target 1101
  ]
  edge [
    source 1040
    target 985
  ]
  edge [
    source 1040
    target 1046
  ]
  edge [
    source 1041
    target 1103
  ]
  edge [
    source 1041
    target 967
  ]
  edge [
    source 1043
    target 1077
  ]
  edge [
    source 1043
    target 1011
  ]
  edge [
    source 1043
    target 1067
  ]
  edge [
    source 1049
    target 1076
  ]
  edge [
    source 1049
    target 1062
  ]
  edge [
    source 1052
    target 1053
  ]
  edge [
    source 1052
    target 1001
  ]
  edge [
    source 1052
    target 979
  ]
  edge [
    source 1052
    target 1021
  ]
  edge [
    source 1057
    target 975
  ]
  edge [
    source 1057
    target 989
  ]
  edge [
    source 1059
    target 1081
  ]
  edge [
    source 1059
    target 1043
  ]
  edge [
    source 1080
    target 1073
  ]
  edge [
    source 1080
    target 1007
  ]
  edge [
    source 1081
    target 961
  ]
  edge [
    source 1081
    target 990
  ]
  edge [
    source 1082
    target 1040
  ]
  edge [
    source 1082
    target 972
  ]
  edge [
    source 1082
    target 965
  ]
  edge [
    source 1082
    target 973
  ]
  edge [
    source 1082
    target 1090
  ]
  edge [
    source 1087
    target 1029
  ]
  edge [
    source 1087
    target 1092
  ]
  edge [
    source 1087
    target 1060
  ]
  edge [
    source 1088
    target 1008
  ]
  edge [
    source 1089
    target 962
  ]
  edge [
    source 1089
    target 1075
  ]
  edge [
    source 1090
    target 977
  ]
  edge [
    source 1095
    target 954
  ]
  edge [
    source 1095
    target 1018
  ]
  edge [
    source 1100
    target 1099
  ]
  edge [
    source 1100
    target 978
  ]
  edge [
    source 1101
    target 987
  ]
  edge [
    source 1101
    target 1084
  ]
  edge [
    source 1104
    target 1049
  ]
  edge [
    source 1104
    target 1038
  ]
  edge [
    source 1104
    target 1108
  ]
  edge [
    source 1104
    target 981
  ]
  edge [
    source 1104
    target 1000
  ]
  edge [
    source 1104
    target 1068
  ]
  edge [
    source 1104
    target 1083
  ]
  edge [
    source 1104
    target 953
  ]
  edge [
    source 1104
    target 963
  ]
  edge [
    source 1104
    target 1052
  ]
  edge [
    source 1104
    target 1097
  ]
  edge [
    source 1104
    target 1059
  ]
  edge [
    source 1104
    target 1010
  ]
  edge [
    source 1104
    target 1028
  ]
  edge [
    source 1104
    target 1105
  ]
  edge [
    source 1105
    target 974
  ]
  edge [
    source 1105
    target 1023
  ]
  edge [
    source 1105
    target 1074
  ]
  edge [
    source 1113
    target 1115
  ]
  edge [
    source 1113
    target 1116
  ]
  edge [
    source 1113
    target 1111
  ]
  edge [
    source 1113
    target 1118
  ]
  edge [
    source 1113
    target 1110
  ]
  edge [
    source 1114
    target 1112
  ]
  edge [
    source 1114
    target 1119
  ]
  edge [
    source 1114
    target 1117
  ]
  edge [
    source 1126
    target 1122
  ]
  edge [
    source 1126
    target 1124
  ]
  edge [
    source 1126
    target 1125
  ]
  edge [
    source 1126
    target 1121
  ]
  edge [
    source 1126
    target 1120
  ]
  edge [
    source 1128
    target 1130
  ]
  edge [
    source 1128
    target 1131
  ]
  edge [
    source 1139
    target 1138
  ]
  edge [
    source 1140
    target 1195
  ]
  edge [
    source 1144
    target 1183
  ]
  edge [
    source 1144
    target 1156
  ]
  edge [
    source 1145
    target 1151
  ]
  edge [
    source 1145
    target 1174
  ]
  edge [
    source 1145
    target 1191
  ]
  edge [
    source 1147
    target 1185
  ]
  edge [
    source 1147
    target 1180
  ]
  edge [
    source 1149
    target 1196
  ]
  edge [
    source 1149
    target 1148
  ]
  edge [
    source 1149
    target 1157
  ]
  edge [
    source 1149
    target 1160
  ]
  edge [
    source 1149
    target 1140
  ]
  edge [
    source 1155
    target 1187
  ]
  edge [
    source 1155
    target 1186
  ]
  edge [
    source 1155
    target 1173
  ]
  edge [
    source 1155
    target 1152
  ]
  edge [
    source 1155
    target 1141
  ]
  edge [
    source 1155
    target 1176
  ]
  edge [
    source 1155
    target 1184
  ]
  edge [
    source 1158
    target 1172
  ]
  edge [
    source 1161
    target 1150
  ]
  edge [
    source 1162
    target 1158
  ]
  edge [
    source 1166
    target 1179
  ]
  edge [
    source 1166
    target 1146
  ]
  edge [
    source 1166
    target 1169
  ]
  edge [
    source 1167
    target 1153
  ]
  edge [
    source 1167
    target 1154
  ]
  edge [
    source 1167
    target 1178
  ]
  edge [
    source 1167
    target 1192
  ]
  edge [
    source 1167
    target 1190
  ]
  edge [
    source 1170
    target 1168
  ]
  edge [
    source 1170
    target 1166
  ]
  edge [
    source 1177
    target 1155
  ]
  edge [
    source 1177
    target 1144
  ]
  edge [
    source 1177
    target 1182
  ]
  edge [
    source 1177
    target 1189
  ]
  edge [
    source 1177
    target 1175
  ]
  edge [
    source 1181
    target 1142
  ]
  edge [
    source 1181
    target 1194
  ]
  edge [
    source 1182
    target 1193
  ]
  edge [
    source 1182
    target 1165
  ]
  edge [
    source 1203
    target 1204
  ]
  edge [
    source 1203
    target 1202
  ]
  edge [
    source 1203
    target 1198
  ]
  edge [
    source 1203
    target 1200
  ]
  edge [
    source 1206
    target 1205
  ]
  edge [
    source 1206
    target 1208
  ]
  edge [
    source 1213
    target 1211
  ]
  edge [
    source 1213
    target 1209
  ]
  edge [
    source 1213
    target 1239
  ]
  edge [
    source 1216
    target 1236
  ]
  edge [
    source 1216
    target 1212
  ]
  edge [
    source 1218
    target 1229
  ]
  edge [
    source 1218
    target 1230
  ]
  edge [
    source 1218
    target 1247
  ]
  edge [
    source 1218
    target 1227
  ]
  edge [
    source 1218
    target 1237
  ]
  edge [
    source 1219
    target 1231
  ]
  edge [
    source 1219
    target 1215
  ]
  edge [
    source 1221
    target 1224
  ]
  edge [
    source 1221
    target 1248
  ]
  edge [
    source 1221
    target 1233
  ]
  edge [
    source 1221
    target 1238
  ]
  edge [
    source 1221
    target 1225
  ]
  edge [
    source 1235
    target 1219
  ]
  edge [
    source 1235
    target 1234
  ]
  edge [
    source 1235
    target 1250
  ]
  edge [
    source 1235
    target 1243
  ]
  edge [
    source 1235
    target 1213
  ]
  edge [
    source 1236
    target 1228
  ]
  edge [
    source 1241
    target 1226
  ]
  edge [
    source 1241
    target 1251
  ]
  edge [
    source 1241
    target 1217
  ]
  edge [
    source 1243
    target 1246
  ]
  edge [
    source 1243
    target 1222
  ]
  edge [
    source 1245
    target 1240
  ]
  edge [
    source 1245
    target 1221
  ]
  edge [
    source 1245
    target 1244
  ]
  edge [
    source 1245
    target 1223
  ]
  edge [
    source 1245
    target 1210
  ]
  edge [
    source 1250
    target 1220
  ]
  edge [
    source 1250
    target 1249
  ]
  edge [
    source 1257
    target 1266
  ]
  edge [
    source 1257
    target 1255
  ]
  edge [
    source 1259
    target 1270
  ]
  edge [
    source 1259
    target 1267
  ]
  edge [
    source 1259
    target 1261
  ]
  edge [
    source 1263
    target 1274
  ]
  edge [
    source 1263
    target 1272
  ]
  edge [
    source 1263
    target 1259
  ]
  edge [
    source 1268
    target 1273
  ]
  edge [
    source 1268
    target 1265
  ]
  edge [
    source 1269
    target 1271
  ]
  edge [
    source 1269
    target 1260
  ]
  edge [
    source 1269
    target 1254
  ]
  edge [
    source 1273
    target 1262
  ]
  edge [
    source 1273
    target 1264
  ]
  edge [
    source 1273
    target 1269
  ]
  edge [
    source 1274
    target 1258
  ]
  edge [
    source 1274
    target 1275
  ]
  edge [
    source 1275
    target 1256
  ]
  edge [
    source 1275
    target 1253
  ]
  edge [
    source 1278
    target 1313
  ]
  edge [
    source 1278
    target 1299
  ]
  edge [
    source 1279
    target 1304
  ]
  edge [
    source 1279
    target 1283
  ]
  edge [
    source 1283
    target 1324
  ]
  edge [
    source 1283
    target 1281
  ]
  edge [
    source 1287
    target 1308
  ]
  edge [
    source 1287
    target 1320
  ]
  edge [
    source 1290
    target 1340
  ]
  edge [
    source 1290
    target 1302
  ]
  edge [
    source 1291
    target 1334
  ]
  edge [
    source 1291
    target 1307
  ]
  edge [
    source 1300
    target 1297
  ]
  edge [
    source 1300
    target 1303
  ]
  edge [
    source 1300
    target 1344
  ]
  edge [
    source 1300
    target 1314
  ]
  edge [
    source 1301
    target 1285
  ]
  edge [
    source 1301
    target 1327
  ]
  edge [
    source 1301
    target 1337
  ]
  edge [
    source 1301
    target 1288
  ]
  edge [
    source 1303
    target 1284
  ]
  edge [
    source 1303
    target 1325
  ]
  edge [
    source 1309
    target 1338
  ]
  edge [
    source 1309
    target 1339
  ]
  edge [
    source 1310
    target 1311
  ]
  edge [
    source 1310
    target 1315
  ]
  edge [
    source 1310
    target 1286
  ]
  edge [
    source 1310
    target 1342
  ]
  edge [
    source 1313
    target 1322
  ]
  edge [
    source 1313
    target 1316
  ]
  edge [
    source 1314
    target 1310
  ]
  edge [
    source 1318
    target 1287
  ]
  edge [
    source 1325
    target 1321
  ]
  edge [
    source 1325
    target 1276
  ]
  edge [
    source 1325
    target 1305
  ]
  edge [
    source 1325
    target 1306
  ]
  edge [
    source 1329
    target 1341
  ]
  edge [
    source 1329
    target 1328
  ]
  edge [
    source 1330
    target 1346
  ]
  edge [
    source 1330
    target 1277
  ]
  edge [
    source 1331
    target 1293
  ]
  edge [
    source 1331
    target 1298
  ]
  edge [
    source 1331
    target 1292
  ]
  edge [
    source 1332
    target 1330
  ]
  edge [
    source 1332
    target 1290
  ]
  edge [
    source 1334
    target 1294
  ]
  edge [
    source 1334
    target 1289
  ]
  edge [
    source 1335
    target 1301
  ]
  edge [
    source 1335
    target 1317
  ]
  edge [
    source 1335
    target 1280
  ]
  edge [
    source 1342
    target 1333
  ]
  edge [
    source 1342
    target 1282
  ]
  edge [
    source 1343
    target 1329
  ]
  edge [
    source 1343
    target 1336
  ]
  edge [
    source 1343
    target 1319
  ]
  edge [
    source 1344
    target 1295
  ]
  edge [
    source 1344
    target 1296
  ]
  edge [
    source 1344
    target 1347
  ]
  edge [
    source 1344
    target 1326
  ]
  edge [
    source 1344
    target 1312
  ]
  edge [
    source 1347
    target 1323
  ]
  edge [
    source 1347
    target 1345
  ]
  edge [
    source 1349
    target 1351
  ]
  edge [
    source 1349
    target 1350
  ]
  edge [
    source 1353
    target 1371
  ]
  edge [
    source 1354
    target 1369
  ]
  edge [
    source 1354
    target 1378
  ]
  edge [
    source 1356
    target 1380
  ]
  edge [
    source 1356
    target 1373
  ]
  edge [
    source 1361
    target 1372
  ]
  edge [
    source 1361
    target 1360
  ]
  edge [
    source 1362
    target 1366
  ]
  edge [
    source 1362
    target 1361
  ]
  edge [
    source 1362
    target 1365
  ]
  edge [
    source 1362
    target 1368
  ]
  edge [
    source 1365
    target 1355
  ]
  edge [
    source 1365
    target 1357
  ]
  edge [
    source 1366
    target 1374
  ]
  edge [
    source 1367
    target 1362
  ]
  edge [
    source 1367
    target 1354
  ]
  edge [
    source 1370
    target 1358
  ]
  edge [
    source 1370
    target 1359
  ]
  edge [
    source 1378
    target 1363
  ]
  edge [
    source 1378
    target 1375
  ]
  edge [
    source 1383
    target 1406
  ]
  edge [
    source 1383
    target 1419
  ]
  edge [
    source 1392
    target 1423
  ]
  edge [
    source 1392
    target 1385
  ]
  edge [
    source 1392
    target 1384
  ]
  edge [
    source 1392
    target 1396
  ]
  edge [
    source 1395
    target 1422
  ]
  edge [
    source 1395
    target 1420
  ]
  edge [
    source 1400
    target 1412
  ]
  edge [
    source 1400
    target 1387
  ]
  edge [
    source 1402
    target 1399
  ]
  edge [
    source 1402
    target 1405
  ]
  edge [
    source 1404
    target 1415
  ]
  edge [
    source 1404
    target 1398
  ]
  edge [
    source 1404
    target 1414
  ]
  edge [
    source 1409
    target 1407
  ]
  edge [
    source 1409
    target 1389
  ]
  edge [
    source 1409
    target 1425
  ]
  edge [
    source 1413
    target 1388
  ]
  edge [
    source 1413
    target 1397
  ]
  edge [
    source 1414
    target 1421
  ]
  edge [
    source 1414
    target 1408
  ]
  edge [
    source 1416
    target 1394
  ]
  edge [
    source 1418
    target 1391
  ]
  edge [
    source 1418
    target 1386
  ]
  edge [
    source 1428
    target 1518
  ]
  edge [
    source 1428
    target 1438
  ]
  edge [
    source 1428
    target 1443
  ]
  edge [
    source 1432
    target 1475
  ]
  edge [
    source 1432
    target 1471
  ]
  edge [
    source 1435
    target 1465
  ]
  edge [
    source 1435
    target 1467
  ]
  edge [
    source 1435
    target 1509
  ]
  edge [
    source 1435
    target 1466
  ]
  edge [
    source 1436
    target 1511
  ]
  edge [
    source 1436
    target 1446
  ]
  edge [
    source 1436
    target 1485
  ]
  edge [
    source 1441
    target 1432
  ]
  edge [
    source 1441
    target 1501
  ]
  edge [
    source 1441
    target 1477
  ]
  edge [
    source 1441
    target 1476
  ]
  edge [
    source 1441
    target 1439
  ]
  edge [
    source 1441
    target 1460
  ]
  edge [
    source 1443
    target 1512
  ]
  edge [
    source 1443
    target 1430
  ]
  edge [
    source 1443
    target 1472
  ]
  edge [
    source 1445
    target 1508
  ]
  edge [
    source 1445
    target 1500
  ]
  edge [
    source 1445
    target 1441
  ]
  edge [
    source 1447
    target 1429
  ]
  edge [
    source 1447
    target 1515
  ]
  edge [
    source 1449
    target 1458
  ]
  edge [
    source 1449
    target 1452
  ]
  edge [
    source 1449
    target 1492
  ]
  edge [
    source 1449
    target 1481
  ]
  edge [
    source 1453
    target 1479
  ]
  edge [
    source 1453
    target 1478
  ]
  edge [
    source 1456
    target 1496
  ]
  edge [
    source 1456
    target 1448
  ]
  edge [
    source 1457
    target 1428
  ]
  edge [
    source 1457
    target 1470
  ]
  edge [
    source 1457
    target 1461
  ]
  edge [
    source 1457
    target 1442
  ]
  edge [
    source 1457
    target 1499
  ]
  edge [
    source 1458
    target 1474
  ]
  edge [
    source 1458
    target 1510
  ]
  edge [
    source 1458
    target 1486
  ]
  edge [
    source 1465
    target 1495
  ]
  edge [
    source 1465
    target 1504
  ]
  edge [
    source 1465
    target 1462
  ]
  edge [
    source 1467
    target 1454
  ]
  edge [
    source 1467
    target 1488
  ]
  edge [
    source 1469
    target 1437
  ]
  edge [
    source 1478
    target 1502
  ]
  edge [
    source 1478
    target 1489
  ]
  edge [
    source 1478
    target 1487
  ]
  edge [
    source 1478
    target 1490
  ]
  edge [
    source 1479
    target 1459
  ]
  edge [
    source 1479
    target 1482
  ]
  edge [
    source 1481
    target 1450
  ]
  edge [
    source 1481
    target 1436
  ]
  edge [
    source 1483
    target 1433
  ]
  edge [
    source 1483
    target 1473
  ]
  edge [
    source 1488
    target 1463
  ]
  edge [
    source 1488
    target 1427
  ]
  edge [
    source 1494
    target 1483
  ]
  edge [
    source 1494
    target 1447
  ]
  edge [
    source 1494
    target 1456
  ]
  edge [
    source 1495
    target 1503
  ]
  edge [
    source 1495
    target 1455
  ]
  edge [
    source 1500
    target 1505
  ]
  edge [
    source 1500
    target 1507
  ]
  edge [
    source 1500
    target 1434
  ]
  edge [
    source 1504
    target 1468
  ]
  edge [
    source 1504
    target 1464
  ]
  edge [
    source 1504
    target 1491
  ]
  edge [
    source 1505
    target 1497
  ]
  edge [
    source 1505
    target 1493
  ]
  edge [
    source 1507
    target 1431
  ]
  edge [
    source 1507
    target 1516
  ]
  edge [
    source 1507
    target 1444
  ]
  edge [
    source 1507
    target 1513
  ]
  edge [
    source 1508
    target 1484
  ]
  edge [
    source 1508
    target 1440
  ]
  edge [
    source 1508
    target 1517
  ]
  edge [
    source 1514
    target 1498
  ]
  edge [
    source 1514
    target 1451
  ]
  edge [
    source 1514
    target 1469
  ]
  edge [
    source 1523
    target 1586
  ]
  edge [
    source 1523
    target 1618
  ]
  edge [
    source 1523
    target 1560
  ]
  edge [
    source 1523
    target 1593
  ]
  edge [
    source 1525
    target 1572
  ]
  edge [
    source 1525
    target 1647
  ]
  edge [
    source 1525
    target 1526
  ]
  edge [
    source 1526
    target 1563
  ]
  edge [
    source 1526
    target 1590
  ]
  edge [
    source 1530
    target 1607
  ]
  edge [
    source 1530
    target 1594
  ]
  edge [
    source 1530
    target 1660
  ]
  edge [
    source 1530
    target 1548
  ]
  edge [
    source 1530
    target 1640
  ]
  edge [
    source 1531
    target 1670
  ]
  edge [
    source 1531
    target 1573
  ]
  edge [
    source 1531
    target 1662
  ]
  edge [
    source 1531
    target 1641
  ]
  edge [
    source 1538
    target 1543
  ]
  edge [
    source 1538
    target 1549
  ]
  edge [
    source 1538
    target 1565
  ]
  edge [
    source 1538
    target 1568
  ]
  edge [
    source 1542
    target 1574
  ]
  edge [
    source 1542
    target 1646
  ]
  edge [
    source 1551
    target 1519
  ]
  edge [
    source 1551
    target 1576
  ]
  edge [
    source 1551
    target 1643
  ]
  edge [
    source 1551
    target 1650
  ]
  edge [
    source 1552
    target 1597
  ]
  edge [
    source 1552
    target 1627
  ]
  edge [
    source 1552
    target 1587
  ]
  edge [
    source 1552
    target 1550
  ]
  edge [
    source 1552
    target 1657
  ]
  edge [
    source 1554
    target 1596
  ]
  edge [
    source 1554
    target 1537
  ]
  edge [
    source 1556
    target 1528
  ]
  edge [
    source 1556
    target 1614
  ]
  edge [
    source 1561
    target 1553
  ]
  edge [
    source 1561
    target 1520
  ]
  edge [
    source 1571
    target 1579
  ]
  edge [
    source 1571
    target 1603
  ]
  edge [
    source 1572
    target 1546
  ]
  edge [
    source 1572
    target 1547
  ]
  edge [
    source 1572
    target 1564
  ]
  edge [
    source 1572
    target 1636
  ]
  edge [
    source 1580
    target 1609
  ]
  edge [
    source 1580
    target 1628
  ]
  edge [
    source 1581
    target 1653
  ]
  edge [
    source 1581
    target 1535
  ]
  edge [
    source 1583
    target 1570
  ]
  edge [
    source 1583
    target 1652
  ]
  edge [
    source 1583
    target 1642
  ]
  edge [
    source 1588
    target 1655
  ]
  edge [
    source 1588
    target 1562
  ]
  edge [
    source 1588
    target 1659
  ]
  edge [
    source 1592
    target 1522
  ]
  edge [
    source 1592
    target 1567
  ]
  edge [
    source 1592
    target 1599
  ]
  edge [
    source 1592
    target 1582
  ]
  edge [
    source 1592
    target 1532
  ]
  edge [
    source 1592
    target 1632
  ]
  edge [
    source 1592
    target 1665
  ]
  edge [
    source 1600
    target 1580
  ]
  edge [
    source 1600
    target 1671
  ]
  edge [
    source 1600
    target 1527
  ]
  edge [
    source 1601
    target 1556
  ]
  edge [
    source 1601
    target 1667
  ]
  edge [
    source 1601
    target 1531
  ]
  edge [
    source 1605
    target 1551
  ]
  edge [
    source 1605
    target 1577
  ]
  edge [
    source 1608
    target 1639
  ]
  edge [
    source 1608
    target 1631
  ]
  edge [
    source 1608
    target 1611
  ]
  edge [
    source 1608
    target 1629
  ]
  edge [
    source 1613
    target 1545
  ]
  edge [
    source 1613
    target 1637
  ]
  edge [
    source 1621
    target 1539
  ]
  edge [
    source 1621
    target 1605
  ]
  edge [
    source 1621
    target 1600
  ]
  edge [
    source 1622
    target 1578
  ]
  edge [
    source 1622
    target 1554
  ]
  edge [
    source 1623
    target 1552
  ]
  edge [
    source 1623
    target 1558
  ]
  edge [
    source 1623
    target 1561
  ]
  edge [
    source 1629
    target 1620
  ]
  edge [
    source 1629
    target 1610
  ]
  edge [
    source 1629
    target 1544
  ]
  edge [
    source 1629
    target 1626
  ]
  edge [
    source 1629
    target 1559
  ]
  edge [
    source 1630
    target 1668
  ]
  edge [
    source 1630
    target 1666
  ]
  edge [
    source 1633
    target 1663
  ]
  edge [
    source 1633
    target 1588
  ]
  edge [
    source 1635
    target 1540
  ]
  edge [
    source 1635
    target 1533
  ]
  edge [
    source 1635
    target 1525
  ]
  edge [
    source 1635
    target 1656
  ]
  edge [
    source 1635
    target 1645
  ]
  edge [
    source 1635
    target 1633
  ]
  edge [
    source 1635
    target 1648
  ]
  edge [
    source 1635
    target 1623
  ]
  edge [
    source 1635
    target 1622
  ]
  edge [
    source 1635
    target 1538
  ]
  edge [
    source 1638
    target 1634
  ]
  edge [
    source 1638
    target 1585
  ]
  edge [
    source 1638
    target 1617
  ]
  edge [
    source 1638
    target 1624
  ]
  edge [
    source 1638
    target 1521
  ]
  edge [
    source 1641
    target 1541
  ]
  edge [
    source 1641
    target 1595
  ]
  edge [
    source 1641
    target 1589
  ]
  edge [
    source 1641
    target 1664
  ]
  edge [
    source 1642
    target 1644
  ]
  edge [
    source 1642
    target 1669
  ]
  edge [
    source 1645
    target 1536
  ]
  edge [
    source 1645
    target 1523
  ]
  edge [
    source 1645
    target 1604
  ]
  edge [
    source 1645
    target 1649
  ]
  edge [
    source 1645
    target 1661
  ]
  edge [
    source 1645
    target 1591
  ]
  edge [
    source 1645
    target 1612
  ]
  edge [
    source 1645
    target 1534
  ]
  edge [
    source 1645
    target 1529
  ]
  edge [
    source 1645
    target 1630
  ]
  edge [
    source 1646
    target 1606
  ]
  edge [
    source 1647
    target 1613
  ]
  edge [
    source 1647
    target 1602
  ]
  edge [
    source 1647
    target 1651
  ]
  edge [
    source 1648
    target 1673
  ]
  edge [
    source 1648
    target 1625
  ]
  edge [
    source 1656
    target 1619
  ]
  edge [
    source 1656
    target 1654
  ]
  edge [
    source 1656
    target 1583
  ]
  edge [
    source 1659
    target 1557
  ]
  edge [
    source 1659
    target 1598
  ]
  edge [
    source 1659
    target 1615
  ]
  edge [
    source 1662
    target 1658
  ]
  edge [
    source 1662
    target 1524
  ]
  edge [
    source 1662
    target 1555
  ]
  edge [
    source 1666
    target 1584
  ]
  edge [
    source 1666
    target 1575
  ]
  edge [
    source 1677
    target 1676
  ]
  edge [
    source 1677
    target 1675
  ]
  edge [
    source 1677
    target 1678
  ]
  edge [
    source 1677
    target 1681
  ]
  edge [
    source 1677
    target 1679
  ]
  edge [
    source 1682
    target 1703
  ]
  edge [
    source 1682
    target 1693
  ]
  edge [
    source 1682
    target 1701
  ]
  edge [
    source 1687
    target 1699
  ]
  edge [
    source 1687
    target 1698
  ]
  edge [
    source 1692
    target 1691
  ]
  edge [
    source 1692
    target 1702
  ]
  edge [
    source 1695
    target 1697
  ]
  edge [
    source 1695
    target 1688
  ]
  edge [
    source 1695
    target 1690
  ]
  edge [
    source 1695
    target 1696
  ]
  edge [
    source 1695
    target 1689
  ]
  edge [
    source 1700
    target 1686
  ]
  edge [
    source 1700
    target 1683
  ]
  edge [
    source 1710
    target 1708
  ]
  edge [
    source 1710
    target 1705
  ]
  edge [
    source 1710
    target 1706
  ]
  edge [
    source 1719
    target 1744
  ]
  edge [
    source 1719
    target 1745
  ]
  edge [
    source 1724
    target 1736
  ]
  edge [
    source 1724
    target 1746
  ]
  edge [
    source 1724
    target 1718
  ]
  edge [
    source 1724
    target 1714
  ]
  edge [
    source 1727
    target 1739
  ]
  edge [
    source 1727
    target 1716
  ]
  edge [
    source 1727
    target 1730
  ]
  edge [
    source 1727
    target 1722
  ]
  edge [
    source 1728
    target 1724
  ]
  edge [
    source 1728
    target 1738
  ]
  edge [
    source 1728
    target 1735
  ]
  edge [
    source 1733
    target 1720
  ]
  edge [
    source 1733
    target 1741
  ]
  edge [
    source 1738
    target 1717
  ]
  edge [
    source 1738
    target 1729
  ]
  edge [
    source 1738
    target 1723
  ]
  edge [
    source 1738
    target 1715
  ]
  edge [
    source 1740
    target 1743
  ]
  edge [
    source 1740
    target 1737
  ]
  edge [
    source 1740
    target 1742
  ]
  edge [
    source 1746
    target 1721
  ]
  edge [
    source 1746
    target 1725
  ]
  edge [
    source 1760
    target 1929
  ]
  edge [
    source 1760
    target 1794
  ]
  edge [
    source 1760
    target 1774
  ]
  edge [
    source 1760
    target 1771
  ]
  edge [
    source 1760
    target 1850
  ]
  edge [
    source 1761
    target 1813
  ]
  edge [
    source 1761
    target 1752
  ]
  edge [
    source 1762
    target 1930
  ]
  edge [
    source 1762
    target 1804
  ]
  edge [
    source 1763
    target 1853
  ]
  edge [
    source 1763
    target 1931
  ]
  edge [
    source 1763
    target 1864
  ]
  edge [
    source 1763
    target 1938
  ]
  edge [
    source 1763
    target 1755
  ]
  edge [
    source 1763
    target 1876
  ]
  edge [
    source 1763
    target 1939
  ]
  edge [
    source 1763
    target 1913
  ]
  edge [
    source 1763
    target 1867
  ]
  edge [
    source 1764
    target 1886
  ]
  edge [
    source 1764
    target 1926
  ]
  edge [
    source 1764
    target 1949
  ]
  edge [
    source 1765
    target 1925
  ]
  edge [
    source 1765
    target 1756
  ]
  edge [
    source 1766
    target 1889
  ]
  edge [
    source 1766
    target 1753
  ]
  edge [
    source 1766
    target 1922
  ]
  edge [
    source 1766
    target 1862
  ]
  edge [
    source 1768
    target 1901
  ]
  edge [
    source 1768
    target 1819
  ]
  edge [
    source 1768
    target 1860
  ]
  edge [
    source 1770
    target 1879
  ]
  edge [
    source 1770
    target 1919
  ]
  edge [
    source 1771
    target 1920
  ]
  edge [
    source 1771
    target 1841
  ]
  edge [
    source 1771
    target 1807
  ]
  edge [
    source 1772
    target 1765
  ]
  edge [
    source 1772
    target 1857
  ]
  edge [
    source 1772
    target 1801
  ]
  edge [
    source 1773
    target 1888
  ]
  edge [
    source 1773
    target 1872
  ]
  edge [
    source 1774
    target 1783
  ]
  edge [
    source 1779
    target 1861
  ]
  edge [
    source 1779
    target 1933
  ]
  edge [
    source 1779
    target 1881
  ]
  edge [
    source 1779
    target 1878
  ]
  edge [
    source 1784
    target 1891
  ]
  edge [
    source 1784
    target 1851
  ]
  edge [
    source 1786
    target 1834
  ]
  edge [
    source 1787
    target 1934
  ]
  edge [
    source 1787
    target 1823
  ]
  edge [
    source 1788
    target 1909
  ]
  edge [
    source 1788
    target 1831
  ]
  edge [
    source 1789
    target 1873
  ]
  edge [
    source 1789
    target 1749
  ]
  edge [
    source 1790
    target 1842
  ]
  edge [
    source 1790
    target 1778
  ]
  edge [
    source 1794
    target 1821
  ]
  edge [
    source 1794
    target 1908
  ]
  edge [
    source 1794
    target 1892
  ]
  edge [
    source 1794
    target 1786
  ]
  edge [
    source 1795
    target 1790
  ]
  edge [
    source 1795
    target 1773
  ]
  edge [
    source 1795
    target 1874
  ]
  edge [
    source 1795
    target 1855
  ]
  edge [
    source 1795
    target 1865
  ]
  edge [
    source 1795
    target 1893
  ]
  edge [
    source 1795
    target 1885
  ]
  edge [
    source 1795
    target 1766
  ]
  edge [
    source 1795
    target 1898
  ]
  edge [
    source 1798
    target 1918
  ]
  edge [
    source 1799
    target 1894
  ]
  edge [
    source 1799
    target 1924
  ]
  edge [
    source 1802
    target 1837
  ]
  edge [
    source 1802
    target 1792
  ]
  edge [
    source 1802
    target 1820
  ]
  edge [
    source 1802
    target 1833
  ]
  edge [
    source 1806
    target 1824
  ]
  edge [
    source 1806
    target 1754
  ]
  edge [
    source 1806
    target 1748
  ]
  edge [
    source 1808
    target 1796
  ]
  edge [
    source 1808
    target 1761
  ]
  edge [
    source 1808
    target 1900
  ]
  edge [
    source 1808
    target 1835
  ]
  edge [
    source 1808
    target 1847
  ]
  edge [
    source 1809
    target 1911
  ]
  edge [
    source 1809
    target 1814
  ]
  edge [
    source 1811
    target 1946
  ]
  edge [
    source 1811
    target 1863
  ]
  edge [
    source 1811
    target 1858
  ]
  edge [
    source 1812
    target 1875
  ]
  edge [
    source 1812
    target 1836
  ]
  edge [
    source 1814
    target 1856
  ]
  edge [
    source 1814
    target 1750
  ]
  edge [
    source 1815
    target 1789
  ]
  edge [
    source 1816
    target 1795
  ]
  edge [
    source 1816
    target 1772
  ]
  edge [
    source 1816
    target 1802
  ]
  edge [
    source 1816
    target 1923
  ]
  edge [
    source 1816
    target 1905
  ]
  edge [
    source 1819
    target 1844
  ]
  edge [
    source 1819
    target 1818
  ]
  edge [
    source 1819
    target 1822
  ]
  edge [
    source 1828
    target 1808
  ]
  edge [
    source 1828
    target 1811
  ]
  edge [
    source 1828
    target 1902
  ]
  edge [
    source 1828
    target 1832
  ]
  edge [
    source 1828
    target 1947
  ]
  edge [
    source 1832
    target 1840
  ]
  edge [
    source 1832
    target 1799
  ]
  edge [
    source 1836
    target 1852
  ]
  edge [
    source 1836
    target 1869
  ]
  edge [
    source 1840
    target 1896
  ]
  edge [
    source 1840
    target 1845
  ]
  edge [
    source 1841
    target 1899
  ]
  edge [
    source 1841
    target 1803
  ]
  edge [
    source 1841
    target 1940
  ]
  edge [
    source 1843
    target 1817
  ]
  edge [
    source 1843
    target 1785
  ]
  edge [
    source 1843
    target 1912
  ]
  edge [
    source 1846
    target 1839
  ]
  edge [
    source 1846
    target 1764
  ]
  edge [
    source 1850
    target 1780
  ]
  edge [
    source 1850
    target 1887
  ]
  edge [
    source 1852
    target 1944
  ]
  edge [
    source 1852
    target 1942
  ]
  edge [
    source 1852
    target 1825
  ]
  edge [
    source 1854
    target 1890
  ]
  edge [
    source 1866
    target 1763
  ]
  edge [
    source 1866
    target 1759
  ]
  edge [
    source 1866
    target 1910
  ]
  edge [
    source 1868
    target 1815
  ]
  edge [
    source 1868
    target 1757
  ]
  edge [
    source 1868
    target 1779
  ]
  edge [
    source 1869
    target 1782
  ]
  edge [
    source 1869
    target 1903
  ]
  edge [
    source 1870
    target 1806
  ]
  edge [
    source 1870
    target 1826
  ]
  edge [
    source 1870
    target 1907
  ]
  edge [
    source 1870
    target 1784
  ]
  edge [
    source 1870
    target 1846
  ]
  edge [
    source 1872
    target 1921
  ]
  edge [
    source 1872
    target 1916
  ]
  edge [
    source 1872
    target 1838
  ]
  edge [
    source 1874
    target 1859
  ]
  edge [
    source 1874
    target 1915
  ]
  edge [
    source 1884
    target 1928
  ]
  edge [
    source 1884
    target 1776
  ]
  edge [
    source 1895
    target 1793
  ]
  edge [
    source 1895
    target 1848
  ]
  edge [
    source 1895
    target 1843
  ]
  edge [
    source 1895
    target 1868
  ]
  edge [
    source 1901
    target 1948
  ]
  edge [
    source 1901
    target 1935
  ]
  edge [
    source 1901
    target 1943
  ]
  edge [
    source 1901
    target 1751
  ]
  edge [
    source 1901
    target 1791
  ]
  edge [
    source 1901
    target 1747
  ]
  edge [
    source 1905
    target 1767
  ]
  edge [
    source 1905
    target 1932
  ]
  edge [
    source 1907
    target 1937
  ]
  edge [
    source 1911
    target 1914
  ]
  edge [
    source 1911
    target 1805
  ]
  edge [
    source 1911
    target 1897
  ]
  edge [
    source 1911
    target 1800
  ]
  edge [
    source 1911
    target 1775
  ]
  edge [
    source 1912
    target 1883
  ]
  edge [
    source 1912
    target 1827
  ]
  edge [
    source 1912
    target 1871
  ]
  edge [
    source 1915
    target 1830
  ]
  edge [
    source 1915
    target 1877
  ]
  edge [
    source 1915
    target 1906
  ]
  edge [
    source 1920
    target 1829
  ]
  edge [
    source 1920
    target 1927
  ]
  edge [
    source 1923
    target 1884
  ]
  edge [
    source 1923
    target 1880
  ]
  edge [
    source 1923
    target 1788
  ]
  edge [
    source 1929
    target 1810
  ]
  edge [
    source 1929
    target 1854
  ]
  edge [
    source 1929
    target 1777
  ]
  edge [
    source 1929
    target 1936
  ]
  edge [
    source 1929
    target 1781
  ]
  edge [
    source 1941
    target 1904
  ]
  edge [
    source 1941
    target 1758
  ]
  edge [
    source 1947
    target 1797
  ]
  edge [
    source 1947
    target 1769
  ]
  edge [
    source 1950
    target 1963
  ]
  edge [
    source 1950
    target 1978
  ]
  edge [
    source 1951
    target 1969
  ]
  edge [
    source 1953
    target 1992
  ]
  edge [
    source 1953
    target 1972
  ]
  edge [
    source 1954
    target 1955
  ]
  edge [
    source 1954
    target 1996
  ]
  edge [
    source 1954
    target 2009
  ]
  edge [
    source 1961
    target 2013
  ]
  edge [
    source 1961
    target 2011
  ]
  edge [
    source 1963
    target 2017
  ]
  edge [
    source 1963
    target 2006
  ]
  edge [
    source 1964
    target 1980
  ]
  edge [
    source 1964
    target 1981
  ]
  edge [
    source 1964
    target 1986
  ]
  edge [
    source 1965
    target 1997
  ]
  edge [
    source 1965
    target 1982
  ]
  edge [
    source 1971
    target 2001
  ]
  edge [
    source 1971
    target 1954
  ]
  edge [
    source 1973
    target 2015
  ]
  edge [
    source 1973
    target 1991
  ]
  edge [
    source 1973
    target 1977
  ]
  edge [
    source 1975
    target 2021
  ]
  edge [
    source 1975
    target 1999
  ]
  edge [
    source 1975
    target 1976
  ]
  edge [
    source 1976
    target 2016
  ]
  edge [
    source 1976
    target 1989
  ]
  edge [
    source 1979
    target 1973
  ]
  edge [
    source 1979
    target 1985
  ]
  edge [
    source 1979
    target 1965
  ]
  edge [
    source 1979
    target 1951
  ]
  edge [
    source 1979
    target 1958
  ]
  edge [
    source 1980
    target 1952
  ]
  edge [
    source 1980
    target 2003
  ]
  edge [
    source 1982
    target 2002
  ]
  edge [
    source 1982
    target 1984
  ]
  edge [
    source 1985
    target 2020
  ]
  edge [
    source 1985
    target 2019
  ]
  edge [
    source 1985
    target 2010
  ]
  edge [
    source 1987
    target 1994
  ]
  edge [
    source 1987
    target 1957
  ]
  edge [
    source 1998
    target 1962
  ]
  edge [
    source 1998
    target 1974
  ]
  edge [
    source 1998
    target 1993
  ]
  edge [
    source 1999
    target 2000
  ]
  edge [
    source 1999
    target 1988
  ]
  edge [
    source 2003
    target 2022
  ]
  edge [
    source 2003
    target 2008
  ]
  edge [
    source 2004
    target 1950
  ]
  edge [
    source 2004
    target 1975
  ]
  edge [
    source 2004
    target 2014
  ]
  edge [
    source 2005
    target 1959
  ]
  edge [
    source 2005
    target 1987
  ]
  edge [
    source 2005
    target 1970
  ]
  edge [
    source 2011
    target 1967
  ]
  edge [
    source 2011
    target 1983
  ]
  edge [
    source 2012
    target 1964
  ]
  edge [
    source 2014
    target 1995
  ]
  edge [
    source 2014
    target 1960
  ]
  edge [
    source 2014
    target 1990
  ]
  edge [
    source 2018
    target 1953
  ]
  edge [
    source 2018
    target 1968
  ]
  edge [
    source 2018
    target 1956
  ]
  edge [
    source 2018
    target 2007
  ]
  edge [
    source 2027
    target 2046
  ]
  edge [
    source 2027
    target 2060
  ]
  edge [
    source 2027
    target 2050
  ]
  edge [
    source 2030
    target 2031
  ]
  edge [
    source 2030
    target 2058
  ]
  edge [
    source 2032
    target 2023
  ]
  edge [
    source 2032
    target 2034
  ]
  edge [
    source 2032
    target 2029
  ]
  edge [
    source 2032
    target 2047
  ]
  edge [
    source 2036
    target 2048
  ]
  edge [
    source 2036
    target 2039
  ]
  edge [
    source 2038
    target 2025
  ]
  edge [
    source 2038
    target 2059
  ]
  edge [
    source 2042
    target 2037
  ]
  edge [
    source 2042
    target 2054
  ]
  edge [
    source 2048
    target 2052
  ]
  edge [
    source 2048
    target 2044
  ]
  edge [
    source 2049
    target 2035
  ]
  edge [
    source 2049
    target 2040
  ]
  edge [
    source 2049
    target 2027
  ]
  edge [
    source 2053
    target 2056
  ]
  edge [
    source 2053
    target 2041
  ]
  edge [
    source 2053
    target 2030
  ]
  edge [
    source 2053
    target 2038
  ]
  edge [
    source 2053
    target 2036
  ]
  edge [
    source 2054
    target 2051
  ]
  edge [
    source 2054
    target 2057
  ]
  edge [
    source 2056
    target 2028
  ]
  edge [
    source 2056
    target 2032
  ]
  edge [
    source 2056
    target 2026
  ]
  edge [
    source 2056
    target 2043
  ]
  edge [
    source 2057
    target 2055
  ]
  edge [
    source 2057
    target 2033
  ]
  edge [
    source 2057
    target 2024
  ]
  edge [
    source 2057
    target 2045
  ]
  edge [
    source 2061
    target 2072
  ]
  edge [
    source 2061
    target 2112
  ]
  edge [
    source 2061
    target 2115
  ]
  edge [
    source 2063
    target 2132
  ]
  edge [
    source 2063
    target 2141
  ]
  edge [
    source 2064
    target 2090
  ]
  edge [
    source 2064
    target 2086
  ]
  edge [
    source 2064
    target 2126
  ]
  edge [
    source 2065
    target 2131
  ]
  edge [
    source 2065
    target 2146
  ]
  edge [
    source 2067
    target 2118
  ]
  edge [
    source 2067
    target 2114
  ]
  edge [
    source 2067
    target 2123
  ]
  edge [
    source 2069
    target 2109
  ]
  edge [
    source 2069
    target 2160
  ]
  edge [
    source 2069
    target 2156
  ]
  edge [
    source 2069
    target 2148
  ]
  edge [
    source 2071
    target 2159
  ]
  edge [
    source 2071
    target 2119
  ]
  edge [
    source 2072
    target 2085
  ]
  edge [
    source 2072
    target 2151
  ]
  edge [
    source 2072
    target 2125
  ]
  edge [
    source 2072
    target 2110
  ]
  edge [
    source 2072
    target 2081
  ]
  edge [
    source 2072
    target 2122
  ]
  edge [
    source 2072
    target 2121
  ]
  edge [
    source 2075
    target 2077
  ]
  edge [
    source 2075
    target 2104
  ]
  edge [
    source 2075
    target 2116
  ]
  edge [
    source 2087
    target 2071
  ]
  edge [
    source 2087
    target 2064
  ]
  edge [
    source 2088
    target 2069
  ]
  edge [
    source 2088
    target 2083
  ]
  edge [
    source 2090
    target 2157
  ]
  edge [
    source 2090
    target 2084
  ]
  edge [
    source 2094
    target 2130
  ]
  edge [
    source 2094
    target 2075
  ]
  edge [
    source 2094
    target 2093
  ]
  edge [
    source 2096
    target 2098
  ]
  edge [
    source 2096
    target 2133
  ]
  edge [
    source 2098
    target 2107
  ]
  edge [
    source 2098
    target 2099
  ]
  edge [
    source 2098
    target 2100
  ]
  edge [
    source 2098
    target 2127
  ]
  edge [
    source 2098
    target 2143
  ]
  edge [
    source 2098
    target 2089
  ]
  edge [
    source 2098
    target 2068
  ]
  edge [
    source 2102
    target 2074
  ]
  edge [
    source 2102
    target 2080
  ]
  edge [
    source 2103
    target 2113
  ]
  edge [
    source 2103
    target 2073
  ]
  edge [
    source 2106
    target 2145
  ]
  edge [
    source 2106
    target 2092
  ]
  edge [
    source 2106
    target 2150
  ]
  edge [
    source 2106
    target 2091
  ]
  edge [
    source 2108
    target 2149
  ]
  edge [
    source 2108
    target 2106
  ]
  edge [
    source 2114
    target 2111
  ]
  edge [
    source 2114
    target 2070
  ]
  edge [
    source 2114
    target 2135
  ]
  edge [
    source 2114
    target 2158
  ]
  edge [
    source 2114
    target 2078
  ]
  edge [
    source 2118
    target 2103
  ]
  edge [
    source 2118
    target 2065
  ]
  edge [
    source 2128
    target 2076
  ]
  edge [
    source 2128
    target 2102
  ]
  edge [
    source 2128
    target 2062
  ]
  edge [
    source 2130
    target 2129
  ]
  edge [
    source 2130
    target 2152
  ]
  edge [
    source 2130
    target 2101
  ]
  edge [
    source 2133
    target 2147
  ]
  edge [
    source 2133
    target 2142
  ]
  edge [
    source 2134
    target 2079
  ]
  edge [
    source 2134
    target 2063
  ]
  edge [
    source 2134
    target 2094
  ]
  edge [
    source 2134
    target 2140
  ]
  edge [
    source 2134
    target 2117
  ]
  edge [
    source 2137
    target 2120
  ]
  edge [
    source 2137
    target 2124
  ]
  edge [
    source 2138
    target 2105
  ]
  edge [
    source 2138
    target 2136
  ]
  edge [
    source 2139
    target 2097
  ]
  edge [
    source 2139
    target 2155
  ]
  edge [
    source 2144
    target 2082
  ]
  edge [
    source 2144
    target 2066
  ]
  edge [
    source 2144
    target 2108
  ]
  edge [
    source 2154
    target 2138
  ]
  edge [
    source 2154
    target 2088
  ]
  edge [
    source 2154
    target 2153
  ]
  edge [
    source 2154
    target 2095
  ]
  edge [
    source 2161
    target 2164
  ]
  edge [
    source 2161
    target 2165
  ]
  edge [
    source 2166
    target 2162
  ]
  edge [
    source 2166
    target 2163
  ]
  edge [
    source 2170
    target 2177
  ]
  edge [
    source 2170
    target 2175
  ]
  edge [
    source 2178
    target 2181
  ]
  edge [
    source 2178
    target 2176
  ]
  edge [
    source 2178
    target 2169
  ]
  edge [
    source 2178
    target 2174
  ]
  edge [
    source 2178
    target 2183
  ]
  edge [
    source 2178
    target 2171
  ]
  edge [
    source 2178
    target 2172
  ]
  edge [
    source 2178
    target 2179
  ]
  edge [
    source 2178
    target 2167
  ]
  edge [
    source 2178
    target 2182
  ]
  edge [
    source 2185
    target 2204
  ]
  edge [
    source 2185
    target 2200
  ]
  edge [
    source 2189
    target 2196
  ]
  edge [
    source 2190
    target 2215
  ]
  edge [
    source 2190
    target 2188
  ]
  edge [
    source 2190
    target 2201
  ]
  edge [
    source 2191
    target 2206
  ]
  edge [
    source 2191
    target 2185
  ]
  edge [
    source 2192
    target 2193
  ]
  edge [
    source 2192
    target 2194
  ]
  edge [
    source 2192
    target 2198
  ]
  edge [
    source 2192
    target 2203
  ]
  edge [
    source 2196
    target 2195
  ]
  edge [
    source 2196
    target 2205
  ]
  edge [
    source 2196
    target 2214
  ]
  edge [
    source 2196
    target 2187
  ]
  edge [
    source 2201
    target 2211
  ]
  edge [
    source 2201
    target 2186
  ]
  edge [
    source 2206
    target 2212
  ]
  edge [
    source 2206
    target 2209
  ]
  edge [
    source 2207
    target 2208
  ]
  edge [
    source 2207
    target 2199
  ]
  edge [
    source 2213
    target 2189
  ]
  edge [
    source 2213
    target 2190
  ]
  edge [
    source 2213
    target 2210
  ]
  edge [
    source 2216
    target 2250
  ]
  edge [
    source 2216
    target 2231
  ]
  edge [
    source 2220
    target 2244
  ]
  edge [
    source 2220
    target 2268
  ]
  edge [
    source 2220
    target 2217
  ]
  edge [
    source 2221
    target 2261
  ]
  edge [
    source 2221
    target 2256
  ]
  edge [
    source 2221
    target 2253
  ]
  edge [
    source 2222
    target 2218
  ]
  edge [
    source 2222
    target 2224
  ]
  edge [
    source 2225
    target 2267
  ]
  edge [
    source 2225
    target 2222
  ]
  edge [
    source 2226
    target 2249
  ]
  edge [
    source 2226
    target 2276
  ]
  edge [
    source 2226
    target 2252
  ]
  edge [
    source 2228
    target 2238
  ]
  edge [
    source 2228
    target 2277
  ]
  edge [
    source 2228
    target 2265
  ]
  edge [
    source 2228
    target 2240
  ]
  edge [
    source 2231
    target 2251
  ]
  edge [
    source 2231
    target 2230
  ]
  edge [
    source 2231
    target 2275
  ]
  edge [
    source 2233
    target 2241
  ]
  edge [
    source 2233
    target 2221
  ]
  edge [
    source 2233
    target 2239
  ]
  edge [
    source 2233
    target 2237
  ]
  edge [
    source 2233
    target 2223
  ]
  edge [
    source 2233
    target 2234
  ]
  edge [
    source 2233
    target 2262
  ]
  edge [
    source 2233
    target 2225
  ]
  edge [
    source 2233
    target 2229
  ]
  edge [
    source 2235
    target 2273
  ]
  edge [
    source 2235
    target 2242
  ]
  edge [
    source 2236
    target 2257
  ]
  edge [
    source 2236
    target 2269
  ]
  edge [
    source 2236
    target 2272
  ]
  edge [
    source 2241
    target 2248
  ]
  edge [
    source 2241
    target 2219
  ]
  edge [
    source 2245
    target 2270
  ]
  edge [
    source 2245
    target 2263
  ]
  edge [
    source 2247
    target 2260
  ]
  edge [
    source 2247
    target 2274
  ]
  edge [
    source 2264
    target 2228
  ]
  edge [
    source 2264
    target 2226
  ]
  edge [
    source 2264
    target 2220
  ]
  edge [
    source 2264
    target 2259
  ]
  edge [
    source 2264
    target 2216
  ]
  edge [
    source 2265
    target 2254
  ]
  edge [
    source 2265
    target 2232
  ]
  edge [
    source 2265
    target 2227
  ]
  edge [
    source 2265
    target 2243
  ]
  edge [
    source 2266
    target 2235
  ]
  edge [
    source 2266
    target 2246
  ]
  edge [
    source 2266
    target 2271
  ]
  edge [
    source 2277
    target 2258
  ]
  edge [
    source 2277
    target 2255
  ]
  edge [
    source 2280
    target 2322
  ]
  edge [
    source 2282
    target 2344
  ]
  edge [
    source 2282
    target 2321
  ]
  edge [
    source 2282
    target 2325
  ]
  edge [
    source 2282
    target 2360
  ]
  edge [
    source 2283
    target 2365
  ]
  edge [
    source 2283
    target 2289
  ]
  edge [
    source 2283
    target 2366
  ]
  edge [
    source 2283
    target 2359
  ]
  edge [
    source 2283
    target 2369
  ]
  edge [
    source 2283
    target 2403
  ]
  edge [
    source 2286
    target 2352
  ]
  edge [
    source 2286
    target 2310
  ]
  edge [
    source 2286
    target 2363
  ]
  edge [
    source 2286
    target 2329
  ]
  edge [
    source 2286
    target 2314
  ]
  edge [
    source 2286
    target 2339
  ]
  edge [
    source 2287
    target 2313
  ]
  edge [
    source 2287
    target 2361
  ]
  edge [
    source 2293
    target 2328
  ]
  edge [
    source 2293
    target 2399
  ]
  edge [
    source 2294
    target 2397
  ]
  edge [
    source 2294
    target 2400
  ]
  edge [
    source 2300
    target 2386
  ]
  edge [
    source 2300
    target 2396
  ]
  edge [
    source 2300
    target 2335
  ]
  edge [
    source 2300
    target 2387
  ]
  edge [
    source 2302
    target 2327
  ]
  edge [
    source 2302
    target 2405
  ]
  edge [
    source 2303
    target 2320
  ]
  edge [
    source 2303
    target 2357
  ]
  edge [
    source 2303
    target 2300
  ]
  edge [
    source 2303
    target 2323
  ]
  edge [
    source 2303
    target 2292
  ]
  edge [
    source 2305
    target 2382
  ]
  edge [
    source 2305
    target 2304
  ]
  edge [
    source 2306
    target 2280
  ]
  edge [
    source 2310
    target 2376
  ]
  edge [
    source 2310
    target 2398
  ]
  edge [
    source 2310
    target 2278
  ]
  edge [
    source 2311
    target 2340
  ]
  edge [
    source 2311
    target 2284
  ]
  edge [
    source 2321
    target 2312
  ]
  edge [
    source 2321
    target 2373
  ]
  edge [
    source 2323
    target 2391
  ]
  edge [
    source 2323
    target 2285
  ]
  edge [
    source 2324
    target 2279
  ]
  edge [
    source 2324
    target 2326
  ]
  edge [
    source 2324
    target 2342
  ]
  edge [
    source 2325
    target 2409
  ]
  edge [
    source 2325
    target 2297
  ]
  edge [
    source 2329
    target 2394
  ]
  edge [
    source 2329
    target 2395
  ]
  edge [
    source 2330
    target 2358
  ]
  edge [
    source 2330
    target 2336
  ]
  edge [
    source 2344
    target 2384
  ]
  edge [
    source 2344
    target 2316
  ]
  edge [
    source 2344
    target 2379
  ]
  edge [
    source 2345
    target 2389
  ]
  edge [
    source 2345
    target 2282
  ]
  edge [
    source 2345
    target 2349
  ]
  edge [
    source 2348
    target 2380
  ]
  edge [
    source 2348
    target 2293
  ]
  edge [
    source 2349
    target 2298
  ]
  edge [
    source 2349
    target 2281
  ]
  edge [
    source 2351
    target 2404
  ]
  edge [
    source 2351
    target 2318
  ]
  edge [
    source 2351
    target 2295
  ]
  edge [
    source 2354
    target 2355
  ]
  edge [
    source 2354
    target 2350
  ]
  edge [
    source 2354
    target 2385
  ]
  edge [
    source 2354
    target 2283
  ]
  edge [
    source 2355
    target 2343
  ]
  edge [
    source 2355
    target 2393
  ]
  edge [
    source 2355
    target 2375
  ]
  edge [
    source 2357
    target 2299
  ]
  edge [
    source 2357
    target 2351
  ]
  edge [
    source 2357
    target 2364
  ]
  edge [
    source 2359
    target 2311
  ]
  edge [
    source 2359
    target 2402
  ]
  edge [
    source 2367
    target 2291
  ]
  edge [
    source 2367
    target 2330
  ]
  edge [
    source 2368
    target 2333
  ]
  edge [
    source 2368
    target 2407
  ]
  edge [
    source 2369
    target 2378
  ]
  edge [
    source 2369
    target 2374
  ]
  edge [
    source 2370
    target 2388
  ]
  edge [
    source 2370
    target 2319
  ]
  edge [
    source 2372
    target 2381
  ]
  edge [
    source 2372
    target 2367
  ]
  edge [
    source 2372
    target 2392
  ]
  edge [
    source 2372
    target 2401
  ]
  edge [
    source 2372
    target 2324
  ]
  edge [
    source 2381
    target 2307
  ]
  edge [
    source 2381
    target 2408
  ]
  edge [
    source 2381
    target 2356
  ]
  edge [
    source 2381
    target 2337
  ]
  edge [
    source 2381
    target 2296
  ]
  edge [
    source 2381
    target 2346
  ]
  edge [
    source 2386
    target 2317
  ]
  edge [
    source 2386
    target 2390
  ]
  edge [
    source 2389
    target 2334
  ]
  edge [
    source 2389
    target 2370
  ]
  edge [
    source 2390
    target 2362
  ]
  edge [
    source 2390
    target 2309
  ]
  edge [
    source 2392
    target 2302
  ]
  edge [
    source 2392
    target 2338
  ]
  edge [
    source 2392
    target 2371
  ]
  edge [
    source 2392
    target 2348
  ]
  edge [
    source 2397
    target 2383
  ]
  edge [
    source 2397
    target 2288
  ]
  edge [
    source 2401
    target 2315
  ]
  edge [
    source 2401
    target 2332
  ]
  edge [
    source 2401
    target 2353
  ]
  edge [
    source 2406
    target 2347
  ]
  edge [
    source 2406
    target 2377
  ]
  edge [
    source 2406
    target 2301
  ]
  edge [
    source 2407
    target 2305
  ]
  edge [
    source 2407
    target 2341
  ]
  edge [
    source 2410
    target 2416
  ]
  edge [
    source 2410
    target 2417
  ]
  edge [
    source 2412
    target 2411
  ]
  edge [
    source 2412
    target 2415
  ]
  edge [
    source 2413
    target 2414
  ]
  edge [
    source 2413
    target 2412
  ]
  edge [
    source 2419
    target 2424
  ]
  edge [
    source 2419
    target 2420
  ]
  edge [
    source 2419
    target 2418
  ]
  edge [
    source 2422
    target 2425
  ]
  edge [
    source 2422
    target 2421
  ]
  edge [
    source 2423
    target 2419
  ]
  edge [
    source 2423
    target 2426
  ]
  edge [
    source 2440
    target 2449
  ]
  edge [
    source 2440
    target 2451
  ]
  edge [
    source 2440
    target 2452
  ]
  edge [
    source 2444
    target 2438
  ]
  edge [
    source 2444
    target 2443
  ]
  edge [
    source 2444
    target 2441
  ]
  edge [
    source 2444
    target 2446
  ]
  edge [
    source 2444
    target 2450
  ]
  edge [
    source 2444
    target 2442
  ]
  edge [
    source 2461
    target 2458
  ]
  edge [
    source 2461
    target 2459
  ]
  edge [
    source 2461
    target 2463
  ]
  edge [
    source 2461
    target 2460
  ]
  edge [
    source 2461
    target 2454
  ]
  edge [
    source 2467
    target 2480
  ]
  edge [
    source 2467
    target 2465
  ]
  edge [
    source 2469
    target 2478
  ]
  edge [
    source 2469
    target 2479
  ]
  edge [
    source 2469
    target 2474
  ]
  edge [
    source 2469
    target 2476
  ]
  edge [
    source 2470
    target 2471
  ]
  edge [
    source 2470
    target 2469
  ]
  edge [
    source 2470
    target 2467
  ]
  edge [
    source 2477
    target 2466
  ]
  edge [
    source 2477
    target 2472
  ]
  edge [
    source 2484
    target 2487
  ]
  edge [
    source 2484
    target 2490
  ]
  edge [
    source 2485
    target 2501
  ]
  edge [
    source 2485
    target 2493
  ]
  edge [
    source 2485
    target 2498
  ]
  edge [
    source 2485
    target 2500
  ]
  edge [
    source 2486
    target 2488
  ]
  edge [
    source 2486
    target 2484
  ]
  edge [
    source 2488
    target 2489
  ]
  edge [
    source 2488
    target 2495
  ]
  edge [
    source 2494
    target 2497
  ]
  edge [
    source 2494
    target 2499
  ]
  edge [
    source 2494
    target 2492
  ]
  edge [
    source 2496
    target 2485
  ]
  edge [
    source 2496
    target 2494
  ]
  edge [
    source 2517
    target 2513
  ]
  edge [
    source 2517
    target 2514
  ]
  edge [
    source 2520
    target 2527
  ]
  edge [
    source 2520
    target 2511
  ]
  edge [
    source 2520
    target 2533
  ]
  edge [
    source 2520
    target 2553
  ]
  edge [
    source 2526
    target 2529
  ]
  edge [
    source 2526
    target 2528
  ]
  edge [
    source 2527
    target 2541
  ]
  edge [
    source 2527
    target 2549
  ]
  edge [
    source 2527
    target 2537
  ]
  edge [
    source 2527
    target 2539
  ]
  edge [
    source 2532
    target 2535
  ]
  edge [
    source 2532
    target 2543
  ]
  edge [
    source 2532
    target 2545
  ]
  edge [
    source 2533
    target 2519
  ]
  edge [
    source 2533
    target 2531
  ]
  edge [
    source 2533
    target 2517
  ]
  edge [
    source 2534
    target 2530
  ]
  edge [
    source 2534
    target 2552
  ]
  edge [
    source 2534
    target 2518
  ]
  edge [
    source 2542
    target 2544
  ]
  edge [
    source 2542
    target 2551
  ]
  edge [
    source 2542
    target 2515
  ]
  edge [
    source 2542
    target 2525
  ]
  edge [
    source 2542
    target 2548
  ]
  edge [
    source 2542
    target 2512
  ]
  edge [
    source 2546
    target 2516
  ]
  edge [
    source 2546
    target 2523
  ]
  edge [
    source 2547
    target 2550
  ]
  edge [
    source 2547
    target 2526
  ]
  edge [
    source 2547
    target 2521
  ]
  edge [
    source 2547
    target 2538
  ]
  edge [
    source 2547
    target 2520
  ]
  edge [
    source 2547
    target 2522
  ]
  edge [
    source 2547
    target 2546
  ]
  edge [
    source 2547
    target 2536
  ]
  edge [
    source 2552
    target 2540
  ]
  edge [
    source 2556
    target 2554
  ]
  edge [
    source 2556
    target 2557
  ]
  edge [
    source 2556
    target 2555
  ]
  edge [
    source 2559
    target 2558
  ]
  edge [
    source 2560
    target 2561
  ]
  edge [
    source 2562
    target 2560
  ]
  edge [
    source 2563
    target 2578
  ]
  edge [
    source 2563
    target 2573
  ]
  edge [
    source 2563
    target 2587
  ]
  edge [
    source 2563
    target 2591
  ]
  edge [
    source 2563
    target 2585
  ]
  edge [
    source 2564
    target 2579
  ]
  edge [
    source 2564
    target 2569
  ]
  edge [
    source 2576
    target 2567
  ]
  edge [
    source 2576
    target 2583
  ]
  edge [
    source 2577
    target 2568
  ]
  edge [
    source 2577
    target 2565
  ]
  edge [
    source 2577
    target 2590
  ]
  edge [
    source 2577
    target 2586
  ]
  edge [
    source 2580
    target 2588
  ]
  edge [
    source 2580
    target 2570
  ]
  edge [
    source 2581
    target 2584
  ]
  edge [
    source 2581
    target 2574
  ]
  edge [
    source 2582
    target 2589
  ]
  edge [
    source 2582
    target 2580
  ]
  edge [
    source 2582
    target 2575
  ]
  edge [
    source 2582
    target 2571
  ]
  edge [
    source 2592
    target 2624
  ]
  edge [
    source 2592
    target 2607
  ]
  edge [
    source 2593
    target 2602
  ]
  edge [
    source 2593
    target 2598
  ]
  edge [
    source 2593
    target 2629
  ]
  edge [
    source 2594
    target 2595
  ]
  edge [
    source 2595
    target 2635
  ]
  edge [
    source 2595
    target 2641
  ]
  edge [
    source 2596
    target 2637
  ]
  edge [
    source 2596
    target 2600
  ]
  edge [
    source 2596
    target 2633
  ]
  edge [
    source 2596
    target 2627
  ]
  edge [
    source 2597
    target 2639
  ]
  edge [
    source 2597
    target 2605
  ]
  edge [
    source 2598
    target 2632
  ]
  edge [
    source 2598
    target 2599
  ]
  edge [
    source 2608
    target 2604
  ]
  edge [
    source 2612
    target 2620
  ]
  edge [
    source 2612
    target 2643
  ]
  edge [
    source 2616
    target 2642
  ]
  edge [
    source 2616
    target 2619
  ]
  edge [
    source 2618
    target 2597
  ]
  edge [
    source 2618
    target 2626
  ]
  edge [
    source 2619
    target 2614
  ]
  edge [
    source 2619
    target 2631
  ]
  edge [
    source 2623
    target 2613
  ]
  edge [
    source 2623
    target 2640
  ]
  edge [
    source 2623
    target 2611
  ]
  edge [
    source 2625
    target 2618
  ]
  edge [
    source 2628
    target 2594
  ]
  edge [
    source 2628
    target 2647
  ]
  edge [
    source 2629
    target 2630
  ]
  edge [
    source 2629
    target 2615
  ]
  edge [
    source 2629
    target 2636
  ]
  edge [
    source 2629
    target 2621
  ]
  edge [
    source 2629
    target 2645
  ]
  edge [
    source 2634
    target 2623
  ]
  edge [
    source 2634
    target 2603
  ]
  edge [
    source 2634
    target 2617
  ]
  edge [
    source 2634
    target 2608
  ]
  edge [
    source 2634
    target 2638
  ]
  edge [
    source 2634
    target 2616
  ]
  edge [
    source 2638
    target 2610
  ]
  edge [
    source 2638
    target 2601
  ]
  edge [
    source 2644
    target 2612
  ]
  edge [
    source 2644
    target 2609
  ]
  edge [
    source 2644
    target 2606
  ]
  edge [
    source 2657
    target 2665
  ]
  edge [
    source 2657
    target 2668
  ]
  edge [
    source 2659
    target 2653
  ]
  edge [
    source 2659
    target 2661
  ]
  edge [
    source 2662
    target 2663
  ]
  edge [
    source 2662
    target 2651
  ]
  edge [
    source 2662
    target 2664
  ]
  edge [
    source 2662
    target 2655
  ]
  edge [
    source 2665
    target 2654
  ]
  edge [
    source 2665
    target 2648
  ]
  edge [
    source 2665
    target 2650
  ]
  edge [
    source 2665
    target 2652
  ]
  edge [
    source 2666
    target 2658
  ]
  edge [
    source 2668
    target 2660
  ]
  edge [
    source 2668
    target 2656
  ]
  edge [
    source 2668
    target 2667
  ]
  edge [
    source 2670
    target 2740
  ]
  edge [
    source 2672
    target 2689
  ]
  edge [
    source 2672
    target 2710
  ]
  edge [
    source 2672
    target 2691
  ]
  edge [
    source 2672
    target 2775
  ]
  edge [
    source 2672
    target 2697
  ]
  edge [
    source 2676
    target 2699
  ]
  edge [
    source 2676
    target 2693
  ]
  edge [
    source 2676
    target 2686
  ]
  edge [
    source 2676
    target 2674
  ]
  edge [
    source 2688
    target 2745
  ]
  edge [
    source 2688
    target 2731
  ]
  edge [
    source 2690
    target 2679
  ]
  edge [
    source 2690
    target 2753
  ]
  edge [
    source 2694
    target 2675
  ]
  edge [
    source 2694
    target 2673
  ]
  edge [
    source 2695
    target 2733
  ]
  edge [
    source 2695
    target 2678
  ]
  edge [
    source 2695
    target 2676
  ]
  edge [
    source 2698
    target 2707
  ]
  edge [
    source 2698
    target 2684
  ]
  edge [
    source 2705
    target 2743
  ]
  edge [
    source 2705
    target 2770
  ]
  edge [
    source 2705
    target 2735
  ]
  edge [
    source 2705
    target 2706
  ]
  edge [
    source 2705
    target 2780
  ]
  edge [
    source 2707
    target 2685
  ]
  edge [
    source 2707
    target 2782
  ]
  edge [
    source 2707
    target 2680
  ]
  edge [
    source 2708
    target 2763
  ]
  edge [
    source 2708
    target 2742
  ]
  edge [
    source 2714
    target 2728
  ]
  edge [
    source 2714
    target 2724
  ]
  edge [
    source 2715
    target 2677
  ]
  edge [
    source 2715
    target 2759
  ]
  edge [
    source 2716
    target 2747
  ]
  edge [
    source 2716
    target 2738
  ]
  edge [
    source 2718
    target 2732
  ]
  edge [
    source 2718
    target 2758
  ]
  edge [
    source 2718
    target 2777
  ]
  edge [
    source 2718
    target 2726
  ]
  edge [
    source 2718
    target 2761
  ]
  edge [
    source 2721
    target 2757
  ]
  edge [
    source 2721
    target 2692
  ]
  edge [
    source 2721
    target 2718
  ]
  edge [
    source 2721
    target 2687
  ]
  edge [
    source 2728
    target 2717
  ]
  edge [
    source 2728
    target 2669
  ]
  edge [
    source 2730
    target 2776
  ]
  edge [
    source 2730
    target 2700
  ]
  edge [
    source 2733
    target 2671
  ]
  edge [
    source 2733
    target 2750
  ]
  edge [
    source 2734
    target 2786
  ]
  edge [
    source 2734
    target 2744
  ]
  edge [
    source 2734
    target 2688
  ]
  edge [
    source 2734
    target 2694
  ]
  edge [
    source 2734
    target 2708
  ]
  edge [
    source 2734
    target 2739
  ]
  edge [
    source 2734
    target 2767
  ]
  edge [
    source 2734
    target 2703
  ]
  edge [
    source 2734
    target 2736
  ]
  edge [
    source 2734
    target 2778
  ]
  edge [
    source 2734
    target 2779
  ]
  edge [
    source 2734
    target 2774
  ]
  edge [
    source 2734
    target 2781
  ]
  edge [
    source 2740
    target 2704
  ]
  edge [
    source 2747
    target 2711
  ]
  edge [
    source 2747
    target 2766
  ]
  edge [
    source 2747
    target 2764
  ]
  edge [
    source 2747
    target 2756
  ]
  edge [
    source 2748
    target 2752
  ]
  edge [
    source 2748
    target 2773
  ]
  edge [
    source 2748
    target 2727
  ]
  edge [
    source 2749
    target 2702
  ]
  edge [
    source 2749
    target 2712
  ]
  edge [
    source 2749
    target 2768
  ]
  edge [
    source 2749
    target 2760
  ]
  edge [
    source 2750
    target 2729
  ]
  edge [
    source 2750
    target 2713
  ]
  edge [
    source 2754
    target 2771
  ]
  edge [
    source 2754
    target 2683
  ]
  edge [
    source 2754
    target 2725
  ]
  edge [
    source 2754
    target 2769
  ]
  edge [
    source 2755
    target 2748
  ]
  edge [
    source 2755
    target 2785
  ]
  edge [
    source 2755
    target 2751
  ]
  edge [
    source 2755
    target 2720
  ]
  edge [
    source 2755
    target 2722
  ]
  edge [
    source 2762
    target 2715
  ]
  edge [
    source 2762
    target 2696
  ]
  edge [
    source 2762
    target 2698
  ]
  edge [
    source 2762
    target 2783
  ]
  edge [
    source 2762
    target 2681
  ]
  edge [
    source 2762
    target 2701
  ]
  edge [
    source 2772
    target 2695
  ]
  edge [
    source 2772
    target 2765
  ]
  edge [
    source 2772
    target 2741
  ]
  edge [
    source 2772
    target 2754
  ]
  edge [
    source 2781
    target 2682
  ]
  edge [
    source 2781
    target 2721
  ]
  edge [
    source 2783
    target 2737
  ]
  edge [
    source 2783
    target 2719
  ]
  edge [
    source 2784
    target 2705
  ]
  edge [
    source 2784
    target 2672
  ]
  edge [
    source 2784
    target 2730
  ]
  edge [
    source 2784
    target 2755
  ]
  edge [
    source 2785
    target 2746
  ]
  edge [
    source 2785
    target 2723
  ]
  edge [
    source 2785
    target 2709
  ]
  edge [
    source 2787
    target 2788
  ]
  edge [
    source 2787
    target 2790
  ]
  edge [
    source 2796
    target 2794
  ]
  edge [
    source 2796
    target 2798
  ]
  edge [
    source 2796
    target 2799
  ]
  edge [
    source 2796
    target 2797
  ]
  edge [
    source 2796
    target 2801
  ]
  edge [
    source 2800
    target 2795
  ]
  edge [
    source 2800
    target 2796
  ]
  edge [
    source 2805
    target 2809
  ]
  edge [
    source 2805
    target 2808
  ]
  edge [
    source 2809
    target 2807
  ]
  edge [
    source 2809
    target 2810
  ]
  edge [
    source 2812
    target 2835
  ]
  edge [
    source 2812
    target 2820
  ]
  edge [
    source 2812
    target 2824
  ]
  edge [
    source 2812
    target 2834
  ]
  edge [
    source 2812
    target 2839
  ]
  edge [
    source 2812
    target 2855
  ]
  edge [
    source 2812
    target 2837
  ]
  edge [
    source 2812
    target 2817
  ]
  edge [
    source 2819
    target 2815
  ]
  edge [
    source 2819
    target 2823
  ]
  edge [
    source 2819
    target 2847
  ]
  edge [
    source 2819
    target 2850
  ]
  edge [
    source 2819
    target 2860
  ]
  edge [
    source 2819
    target 2851
  ]
  edge [
    source 2819
    target 2818
  ]
  edge [
    source 2819
    target 2861
  ]
  edge [
    source 2819
    target 2829
  ]
  edge [
    source 2819
    target 2852
  ]
  edge [
    source 2819
    target 2853
  ]
  edge [
    source 2819
    target 2841
  ]
  edge [
    source 2820
    target 2840
  ]
  edge [
    source 2820
    target 2828
  ]
  edge [
    source 2820
    target 2859
  ]
  edge [
    source 2820
    target 2836
  ]
  edge [
    source 2869
    target 2862
  ]
  edge [
    source 2869
    target 2867
  ]
  edge [
    source 2869
    target 2863
  ]
  edge [
    source 2869
    target 2864
  ]
  edge [
    source 2870
    target 2865
  ]
  edge [
    source 2870
    target 2872
  ]
  edge [
    source 2870
    target 2871
  ]
  edge [
    source 2870
    target 2866
  ]
  edge [
    source 2879
    target 2884
  ]
  edge [
    source 2879
    target 2881
  ]
  edge [
    source 2888
    target 2896
  ]
  edge [
    source 2888
    target 2885
  ]
  edge [
    source 2888
    target 2898
  ]
  edge [
    source 2888
    target 2887
  ]
  edge [
    source 2888
    target 2889
  ]
  edge [
    source 2891
    target 2893
  ]
  edge [
    source 2891
    target 2895
  ]
  edge [
    source 2891
    target 2892
  ]
  edge [
    source 2891
    target 2897
  ]
  edge [
    source 2891
    target 2890
  ]
  edge [
    source 2891
    target 2894
  ]
  edge [
    source 2902
    target 2904
  ]
  edge [
    source 2902
    target 2905
  ]
  edge [
    source 2902
    target 2900
  ]
  edge [
    source 2909
    target 2910
  ]
  edge [
    source 2916
    target 2928
  ]
  edge [
    source 2916
    target 2931
  ]
  edge [
    source 2918
    target 2922
  ]
  edge [
    source 2918
    target 2923
  ]
  edge [
    source 2918
    target 2916
  ]
  edge [
    source 2918
    target 2914
  ]
  edge [
    source 2922
    target 2930
  ]
  edge [
    source 2922
    target 2924
  ]
  edge [
    source 2922
    target 2933
  ]
  edge [
    source 2922
    target 2919
  ]
  edge [
    source 2925
    target 2921
  ]
  edge [
    source 2925
    target 2929
  ]
  edge [
    source 2926
    target 2925
  ]
  edge [
    source 2926
    target 2934
  ]
  edge [
    source 2927
    target 2935
  ]
  edge [
    source 2927
    target 2920
  ]
  edge [
    source 2927
    target 2917
  ]
  edge [
    source 2937
    target 2943
  ]
  edge [
    source 2937
    target 2950
  ]
  edge [
    source 2938
    target 2944
  ]
  edge [
    source 2938
    target 2937
  ]
  edge [
    source 2945
    target 2946
  ]
  edge [
    source 2945
    target 2938
  ]
  edge [
    source 2945
    target 2942
  ]
  edge [
    source 2945
    target 2947
  ]
  edge [
    source 2946
    target 2941
  ]
  edge [
    source 2946
    target 2940
  ]
  edge [
    source 2947
    target 2952
  ]
  edge [
    source 2947
    target 2948
  ]
  edge [
    source 2955
    target 2956
  ]
  edge [
    source 2955
    target 2954
  ]
  edge [
    source 2958
    target 2971
  ]
  edge [
    source 2958
    target 2963
  ]
  edge [
    source 2958
    target 2964
  ]
  edge [
    source 2960
    target 2967
  ]
  edge [
    source 2960
    target 2969
  ]
  edge [
    source 2961
    target 2973
  ]
  edge [
    source 2961
    target 2970
  ]
  edge [
    source 2966
    target 2958
  ]
  edge [
    source 2966
    target 2960
  ]
  edge [
    source 2966
    target 2961
  ]
  edge [
    source 2974
    target 2972
  ]
  edge [
    source 2974
    target 2965
  ]
  edge [
    source 2974
    target 2959
  ]
  edge [
    source 2974
    target 2962
  ]
  edge [
    source 2974
    target 2966
  ]
  edge [
    source 3001
    target 3013
  ]
  edge [
    source 3001
    target 2992
  ]
  edge [
    source 3001
    target 3017
  ]
  edge [
    source 3001
    target 2985
  ]
  edge [
    source 3001
    target 3010
  ]
  edge [
    source 3001
    target 2980
  ]
  edge [
    source 3001
    target 2983
  ]
  edge [
    source 3001
    target 2982
  ]
  edge [
    source 3001
    target 3021
  ]
  edge [
    source 3001
    target 3000
  ]
  edge [
    source 3001
    target 3006
  ]
  edge [
    source 3001
    target 2999
  ]
  edge [
    source 3007
    target 3005
  ]
  edge [
    source 3007
    target 3003
  ]
  edge [
    source 3007
    target 2997
  ]
  edge [
    source 3007
    target 3018
  ]
  edge [
    source 3014
    target 3004
  ]
  edge [
    source 3014
    target 3007
  ]
  edge [
    source 3014
    target 2978
  ]
  edge [
    source 3014
    target 2979
  ]
  edge [
    source 3014
    target 3002
  ]
  edge [
    source 3014
    target 2984
  ]
  edge [
    source 3014
    target 3016
  ]
  edge [
    source 3014
    target 2991
  ]
  edge [
    source 3014
    target 2995
  ]
  edge [
    source 3032
    target 3030
  ]
  edge [
    source 3032
    target 3028
  ]
  edge [
    source 3036
    target 3039
  ]
  edge [
    source 3036
    target 3040
  ]
  edge [
    source 3039
    target 3037
  ]
  edge [
    source 3039
    target 3034
  ]
  edge [
    source 3045
    target 3043
  ]
  edge [
    source 3045
    target 3048
  ]
  edge [
    source 3045
    target 3047
  ]
  edge [
    source 3045
    target 3041
  ]
  edge [
    source 3045
    target 3044
  ]
  edge [
    source 3045
    target 3046
  ]
  edge [
    source 3052
    target 3058
  ]
  edge [
    source 3052
    target 3076
  ]
  edge [
    source 3052
    target 3053
  ]
  edge [
    source 3052
    target 3050
  ]
  edge [
    source 3052
    target 3055
  ]
  edge [
    source 3052
    target 3051
  ]
  edge [
    source 3054
    target 3057
  ]
  edge [
    source 3054
    target 3061
  ]
  edge [
    source 3056
    target 3065
  ]
  edge [
    source 3056
    target 3067
  ]
  edge [
    source 3058
    target 3049
  ]
  edge [
    source 3058
    target 3059
  ]
  edge [
    source 3058
    target 3072
  ]
  edge [
    source 3063
    target 3062
  ]
  edge [
    source 3063
    target 3060
  ]
  edge [
    source 3066
    target 3069
  ]
  edge [
    source 3066
    target 3070
  ]
  edge [
    source 3071
    target 3066
  ]
  edge [
    source 3071
    target 3079
  ]
  edge [
    source 3071
    target 3054
  ]
  edge [
    source 3071
    target 3073
  ]
  edge [
    source 3071
    target 3077
  ]
  edge [
    source 3072
    target 3078
  ]
  edge [
    source 3072
    target 3075
  ]
  edge [
    source 3085
    target 3088
  ]
  edge [
    source 3085
    target 3082
  ]
  edge [
    source 3088
    target 3086
  ]
  edge [
    source 3088
    target 3087
  ]
  edge [
    source 3092
    target 3093
  ]
  edge [
    source 3092
    target 3089
  ]
  edge [
    source 3092
    target 3091
  ]
  edge [
    source 3097
    target 3107
  ]
  edge [
    source 3097
    target 3104
  ]
  edge [
    source 3098
    target 3095
  ]
  edge [
    source 3098
    target 3102
  ]
  edge [
    source 3098
    target 3097
  ]
  edge [
    source 3098
    target 3099
  ]
  edge [
    source 3101
    target 3096
  ]
  edge [
    source 3101
    target 3103
  ]
  edge [
    source 3101
    target 3094
  ]
  edge [
    source 3101
    target 3106
  ]
  edge [
    source 3110
    target 3122
  ]
  edge [
    source 3110
    target 3112
  ]
  edge [
    source 3110
    target 3123
  ]
  edge [
    source 3110
    target 3119
  ]
  edge [
    source 3110
    target 3118
  ]
  edge [
    source 3111
    target 3114
  ]
  edge [
    source 3111
    target 3115
  ]
  edge [
    source 3117
    target 3121
  ]
  edge [
    source 3117
    target 3116
  ]
  edge [
    source 3118
    target 3111
  ]
  edge [
    source 3118
    target 3120
  ]
  edge [
    source 3118
    target 3117
  ]
  edge [
    source 3120
    target 3125
  ]
  edge [
    source 3120
    target 3124
  ]
  edge [
    source 3126
    target 3127
  ]
  edge [
    source 3140
    target 3134
  ]
  edge [
    source 3140
    target 3138
  ]
  edge [
    source 3140
    target 3133
  ]
  edge [
    source 3144
    target 3171
  ]
  edge [
    source 3144
    target 3195
  ]
  edge [
    source 3144
    target 3166
  ]
  edge [
    source 3153
    target 3217
  ]
  edge [
    source 3153
    target 3145
  ]
  edge [
    source 3157
    target 3190
  ]
  edge [
    source 3157
    target 3152
  ]
  edge [
    source 3157
    target 3244
  ]
  edge [
    source 3157
    target 3248
  ]
  edge [
    source 3157
    target 3265
  ]
  edge [
    source 3157
    target 3198
  ]
  edge [
    source 3157
    target 3144
  ]
  edge [
    source 3163
    target 3251
  ]
  edge [
    source 3163
    target 3165
  ]
  edge [
    source 3163
    target 3245
  ]
  edge [
    source 3163
    target 3191
  ]
  edge [
    source 3170
    target 3231
  ]
  edge [
    source 3173
    target 3262
  ]
  edge [
    source 3173
    target 3163
  ]
  edge [
    source 3175
    target 3221
  ]
  edge [
    source 3175
    target 3205
  ]
  edge [
    source 3175
    target 3186
  ]
  edge [
    source 3175
    target 3222
  ]
  edge [
    source 3190
    target 3155
  ]
  edge [
    source 3190
    target 3158
  ]
  edge [
    source 3192
    target 3253
  ]
  edge [
    source 3192
    target 3228
  ]
  edge [
    source 3192
    target 3181
  ]
  edge [
    source 3192
    target 3235
  ]
  edge [
    source 3194
    target 3206
  ]
  edge [
    source 3194
    target 3148
  ]
  edge [
    source 3194
    target 3149
  ]
  edge [
    source 3194
    target 3183
  ]
  edge [
    source 3194
    target 3196
  ]
  edge [
    source 3194
    target 3250
  ]
  edge [
    source 3194
    target 3209
  ]
  edge [
    source 3194
    target 3169
  ]
  edge [
    source 3194
    target 3225
  ]
  edge [
    source 3194
    target 3164
  ]
  edge [
    source 3194
    target 3193
  ]
  edge [
    source 3194
    target 3259
  ]
  edge [
    source 3194
    target 3256
  ]
  edge [
    source 3194
    target 3264
  ]
  edge [
    source 3194
    target 3184
  ]
  edge [
    source 3194
    target 3229
  ]
  edge [
    source 3194
    target 3238
  ]
  edge [
    source 3194
    target 3178
  ]
  edge [
    source 3194
    target 3236
  ]
  edge [
    source 3194
    target 3150
  ]
  edge [
    source 3194
    target 3254
  ]
  edge [
    source 3194
    target 3182
  ]
  edge [
    source 3194
    target 3167
  ]
  edge [
    source 3194
    target 3243
  ]
  edge [
    source 3214
    target 3180
  ]
  edge [
    source 3214
    target 3160
  ]
  edge [
    source 3215
    target 3257
  ]
  edge [
    source 3215
    target 3201
  ]
  edge [
    source 3215
    target 3223
  ]
  edge [
    source 3215
    target 3260
  ]
  edge [
    source 3215
    target 3266
  ]
  edge [
    source 3215
    target 3185
  ]
  edge [
    source 3215
    target 3239
  ]
  edge [
    source 3215
    target 3146
  ]
  edge [
    source 3220
    target 3172
  ]
  edge [
    source 3220
    target 3213
  ]
  edge [
    source 3220
    target 3179
  ]
  edge [
    source 3220
    target 3242
  ]
  edge [
    source 3220
    target 3212
  ]
  edge [
    source 3220
    target 3237
  ]
  edge [
    source 3226
    target 3200
  ]
  edge [
    source 3226
    target 3189
  ]
  edge [
    source 3226
    target 3241
  ]
  edge [
    source 3231
    target 3234
  ]
  edge [
    source 3231
    target 3207
  ]
  edge [
    source 3231
    target 3219
  ]
  edge [
    source 3231
    target 3214
  ]
  edge [
    source 3244
    target 3175
  ]
  edge [
    source 3249
    target 3151
  ]
  edge [
    source 3249
    target 3147
  ]
  edge [
    source 3249
    target 3199
  ]
  edge [
    source 3262
    target 3233
  ]
  edge [
    source 3262
    target 3255
  ]
  edge [
    source 3262
    target 3168
  ]
  edge [
    source 3272
    target 3285
  ]
  edge [
    source 3272
    target 3313
  ]
  edge [
    source 3273
    target 3278
  ]
  edge [
    source 3273
    target 3272
  ]
  edge [
    source 3273
    target 3323
  ]
  edge [
    source 3273
    target 3307
  ]
  edge [
    source 3273
    target 3325
  ]
  edge [
    source 3280
    target 3312
  ]
  edge [
    source 3280
    target 3275
  ]
  edge [
    source 3288
    target 3309
  ]
  edge [
    source 3288
    target 3279
  ]
  edge [
    source 3288
    target 3308
  ]
  edge [
    source 3289
    target 3292
  ]
  edge [
    source 3289
    target 3276
  ]
  edge [
    source 3289
    target 3274
  ]
  edge [
    source 3289
    target 3327
  ]
  edge [
    source 3289
    target 3311
  ]
  edge [
    source 3289
    target 3271
  ]
  edge [
    source 3289
    target 3283
  ]
  edge [
    source 3289
    target 3306
  ]
  edge [
    source 3290
    target 3314
  ]
  edge [
    source 3290
    target 3305
  ]
  edge [
    source 3294
    target 3320
  ]
  edge [
    source 3294
    target 3324
  ]
  edge [
    source 3296
    target 3294
  ]
  edge [
    source 3296
    target 3321
  ]
  edge [
    source 3296
    target 3319
  ]
  edge [
    source 3296
    target 3286
  ]
  edge [
    source 3296
    target 3270
  ]
  edge [
    source 3296
    target 3298
  ]
  edge [
    source 3302
    target 3291
  ]
  edge [
    source 3302
    target 3267
  ]
  edge [
    source 3302
    target 3281
  ]
  edge [
    source 3302
    target 3316
  ]
  edge [
    source 3302
    target 3277
  ]
  edge [
    source 3302
    target 3299
  ]
  edge [
    source 3302
    target 3268
  ]
  edge [
    source 3302
    target 3304
  ]
  edge [
    source 3303
    target 3301
  ]
  edge [
    source 3303
    target 3269
  ]
  edge [
    source 3303
    target 3290
  ]
  edge [
    source 3307
    target 3295
  ]
  edge [
    source 3307
    target 3288
  ]
  edge [
    source 3315
    target 3280
  ]
  edge [
    source 3315
    target 3310
  ]
  edge [
    source 3315
    target 3287
  ]
  edge [
    source 3323
    target 3293
  ]
  edge [
    source 3323
    target 3317
  ]
  edge [
    source 3323
    target 3326
  ]
  edge [
    source 3326
    target 3318
  ]
  edge [
    source 3326
    target 3300
  ]
  edge [
    source 3326
    target 3297
  ]
  edge [
    source 3326
    target 3282
  ]
  edge [
    source 3336
    target 3332
  ]
  edge [
    source 3336
    target 3405
  ]
  edge [
    source 3336
    target 3343
  ]
  edge [
    source 3365
    target 3436
  ]
  edge [
    source 3365
    target 3369
  ]
  edge [
    source 3365
    target 3396
  ]
  edge [
    source 3368
    target 3441
  ]
  edge [
    source 3368
    target 3398
  ]
  edge [
    source 3368
    target 3344
  ]
  edge [
    source 3368
    target 3329
  ]
  edge [
    source 3368
    target 3410
  ]
  edge [
    source 3368
    target 3383
  ]
  edge [
    source 3368
    target 3331
  ]
  edge [
    source 3368
    target 3414
  ]
  edge [
    source 3368
    target 3426
  ]
  edge [
    source 3368
    target 3357
  ]
  edge [
    source 3368
    target 3416
  ]
  edge [
    source 3368
    target 3384
  ]
  edge [
    source 3368
    target 3333
  ]
  edge [
    source 3368
    target 3361
  ]
  edge [
    source 3368
    target 3334
  ]
  edge [
    source 3368
    target 3359
  ]
  edge [
    source 3368
    target 3389
  ]
  edge [
    source 3368
    target 3378
  ]
  edge [
    source 3368
    target 3349
  ]
  edge [
    source 3368
    target 3408
  ]
  edge [
    source 3368
    target 3443
  ]
  edge [
    source 3368
    target 3400
  ]
  edge [
    source 3368
    target 3339
  ]
  edge [
    source 3368
    target 3418
  ]
  edge [
    source 3368
    target 3356
  ]
  edge [
    source 3368
    target 3385
  ]
  edge [
    source 3368
    target 3338
  ]
  edge [
    source 3368
    target 3438
  ]
  edge [
    source 3368
    target 3328
  ]
  edge [
    source 3368
    target 3341
  ]
  edge [
    source 3368
    target 3347
  ]
  edge [
    source 3368
    target 3437
  ]
  edge [
    source 3368
    target 3364
  ]
  edge [
    source 3368
    target 3351
  ]
  edge [
    source 3368
    target 3415
  ]
  edge [
    source 3368
    target 3428
  ]
  edge [
    source 3368
    target 3391
  ]
  edge [
    source 3368
    target 3403
  ]
  edge [
    source 3368
    target 3427
  ]
  edge [
    source 3368
    target 3342
  ]
  edge [
    source 3368
    target 3424
  ]
  edge [
    source 3368
    target 3433
  ]
  edge [
    source 3386
    target 3390
  ]
  edge [
    source 3386
    target 3367
  ]
  edge [
    source 3386
    target 3413
  ]
  edge [
    source 3388
    target 3375
  ]
  edge [
    source 3388
    target 3330
  ]
  edge [
    source 3388
    target 3337
  ]
  edge [
    source 3397
    target 3370
  ]
  edge [
    source 3397
    target 3352
  ]
  edge [
    source 3397
    target 3422
  ]
  edge [
    source 3397
    target 3445
  ]
  edge [
    source 3397
    target 3355
  ]
  edge [
    source 3397
    target 3425
  ]
  edge [
    source 3397
    target 3434
  ]
  edge [
    source 3397
    target 3411
  ]
  edge [
    source 3399
    target 3404
  ]
  edge [
    source 3399
    target 3372
  ]
  edge [
    source 3399
    target 3432
  ]
  edge [
    source 3406
    target 3365
  ]
  edge [
    source 3406
    target 3336
  ]
  edge [
    source 3406
    target 3388
  ]
  edge [
    source 3406
    target 3399
  ]
  edge [
    source 3406
    target 3386
  ]
  edge [
    source 3406
    target 3362
  ]
  edge [
    source 3406
    target 3407
  ]
  edge [
    source 3406
    target 3446
  ]
  edge [
    source 3406
    target 3420
  ]
  edge [
    source 3406
    target 3371
  ]
  edge [
    source 3406
    target 3439
  ]
  edge [
    source 3406
    target 3335
  ]
  edge [
    source 3406
    target 3366
  ]
  edge [
    source 3406
    target 3419
  ]
  edge [
    source 3406
    target 3430
  ]
  edge [
    source 3406
    target 3363
  ]
  edge [
    source 3406
    target 3373
  ]
  edge [
    source 3406
    target 3379
  ]
  edge [
    source 3406
    target 3423
  ]
  edge [
    source 3406
    target 3381
  ]
  edge [
    source 3406
    target 3393
  ]
  edge [
    source 3406
    target 3402
  ]
  edge [
    source 3421
    target 3358
  ]
  edge [
    source 3421
    target 3394
  ]
  edge [
    source 3421
    target 3354
  ]
  edge [
    source 3421
    target 3392
  ]
  edge [
    source 3421
    target 3346
  ]
  edge [
    source 3421
    target 3380
  ]
  edge [
    source 3421
    target 3376
  ]
  edge [
    source 3421
    target 3409
  ]
  edge [
    source 3421
    target 3350
  ]
  edge [
    source 3421
    target 3353
  ]
  edge [
    source 3421
    target 3395
  ]
  edge [
    source 3421
    target 3401
  ]
  edge [
    source 3421
    target 3412
  ]
  edge [
    source 3421
    target 3387
  ]
  edge [
    source 3421
    target 3431
  ]
  edge [
    source 3421
    target 3382
  ]
  edge [
    source 3421
    target 3447
  ]
  edge [
    source 3444
    target 3429
  ]
  edge [
    source 3444
    target 3345
  ]
  edge [
    source 3444
    target 3440
  ]
  edge [
    source 3444
    target 3348
  ]
  edge [
    source 3444
    target 3374
  ]
  edge [
    source 3444
    target 3442
  ]
  edge [
    source 3444
    target 3360
  ]
  edge [
    source 3444
    target 3435
  ]
  edge [
    source 3444
    target 3377
  ]
  edge [
    source 3444
    target 3340
  ]
  edge [
    source 3444
    target 3417
  ]
  edge [
    source 3452
    target 3455
  ]
  edge [
    source 3452
    target 3450
  ]
  edge [
    source 3452
    target 3454
  ]
  edge [
    source 3452
    target 3465
  ]
  edge [
    source 3453
    target 3448
  ]
  edge [
    source 3454
    target 3449
  ]
  edge [
    source 3454
    target 3458
  ]
  edge [
    source 3455
    target 3456
  ]
  edge [
    source 3455
    target 3464
  ]
  edge [
    source 3455
    target 3457
  ]
  edge [
    source 3455
    target 3466
  ]
  edge [
    source 3455
    target 3460
  ]
  edge [
    source 3462
    target 3453
  ]
  edge [
    source 3467
    target 3461
  ]
  edge [
    source 3467
    target 3459
  ]
  edge [
    source 3467
    target 3463
  ]
  edge [
    source 3468
    target 3462
  ]
  edge [
    source 3471
    target 3472
  ]
  edge [
    source 3471
    target 3469
  ]
  edge [
    source 3471
    target 3478
  ]
  edge [
    source 3476
    target 3473
  ]
  edge [
    source 3476
    target 3475
  ]
  edge [
    source 3483
    target 3513
  ]
  edge [
    source 3485
    target 3527
  ]
  edge [
    source 3485
    target 3512
  ]
  edge [
    source 3485
    target 3503
  ]
  edge [
    source 3485
    target 3495
  ]
  edge [
    source 3485
    target 3525
  ]
  edge [
    source 3485
    target 3510
  ]
  edge [
    source 3488
    target 3492
  ]
  edge [
    source 3488
    target 3511
  ]
  edge [
    source 3488
    target 3526
  ]
  edge [
    source 3488
    target 3490
  ]
  edge [
    source 3488
    target 3522
  ]
  edge [
    source 3498
    target 3515
  ]
  edge [
    source 3498
    target 3509
  ]
  edge [
    source 3498
    target 3480
  ]
  edge [
    source 3498
    target 3499
  ]
  edge [
    source 3498
    target 3500
  ]
  edge [
    source 3504
    target 3484
  ]
  edge [
    source 3504
    target 3501
  ]
  edge [
    source 3505
    target 3506
  ]
  edge [
    source 3505
    target 3482
  ]
  edge [
    source 3505
    target 3493
  ]
  edge [
    source 3505
    target 3517
  ]
  edge [
    source 3505
    target 3494
  ]
  edge [
    source 3505
    target 3491
  ]
  edge [
    source 3506
    target 3483
  ]
  edge [
    source 3508
    target 3486
  ]
  edge [
    source 3508
    target 3481
  ]
  edge [
    source 3508
    target 3518
  ]
  edge [
    source 3508
    target 3496
  ]
  edge [
    source 3508
    target 3516
  ]
  edge [
    source 3514
    target 3524
  ]
  edge [
    source 3514
    target 3487
  ]
  edge [
    source 3514
    target 3519
  ]
  edge [
    source 3514
    target 3521
  ]
  edge [
    source 3514
    target 3507
  ]
  edge [
    source 3514
    target 3523
  ]
  edge [
    source 3520
    target 3489
  ]
  edge [
    source 3520
    target 3497
  ]
  edge [
    source 3520
    target 3502
  ]
  edge [
    source 3534
    target 3530
  ]
  edge [
    source 3534
    target 3537
  ]
  edge [
    source 3534
    target 3531
  ]
  edge [
    source 3534
    target 3529
  ]
  edge [
    source 3534
    target 3536
  ]
  edge [
    source 3550
    target 3558
  ]
  edge [
    source 3550
    target 3566
  ]
  edge [
    source 3551
    target 3570
  ]
  edge [
    source 3551
    target 3571
  ]
  edge [
    source 3552
    target 3562
  ]
  edge [
    source 3552
    target 3564
  ]
  edge [
    source 3553
    target 3560
  ]
  edge [
    source 3553
    target 3550
  ]
  edge [
    source 3553
    target 3556
  ]
  edge [
    source 3554
    target 3552
  ]
  edge [
    source 3554
    target 3551
  ]
  edge [
    source 3554
    target 3572
  ]
  edge [
    source 3557
    target 3568
  ]
  edge [
    source 3559
    target 3561
  ]
  edge [
    source 3559
    target 3555
  ]
  edge [
    source 3559
    target 3569
  ]
  edge [
    source 3573
    target 3583
  ]
  edge [
    source 3573
    target 3581
  ]
  edge [
    source 3574
    target 3575
  ]
  edge [
    source 3574
    target 3576
  ]
  edge [
    source 3582
    target 3577
  ]
  edge [
    source 3582
    target 3579
  ]
  edge [
    source 3593
    target 3604
  ]
  edge [
    source 3593
    target 3591
  ]
  edge [
    source 3594
    target 3603
  ]
  edge [
    source 3594
    target 3589
  ]
  edge [
    source 3594
    target 3592
  ]
  edge [
    source 3594
    target 3602
  ]
  edge [
    source 3595
    target 3601
  ]
  edge [
    source 3595
    target 3606
  ]
  edge [
    source 3595
    target 3599
  ]
  edge [
    source 3598
    target 3594
  ]
  edge [
    source 3598
    target 3609
  ]
  edge [
    source 3601
    target 3600
  ]
  edge [
    source 3601
    target 3596
  ]
  edge [
    source 3605
    target 3597
  ]
  edge [
    source 3605
    target 3612
  ]
  edge [
    source 3605
    target 3593
  ]
  edge [
    source 3605
    target 3608
  ]
  edge [
    source 3605
    target 3590
  ]
  edge [
    source 3612
    target 3588
  ]
  edge [
    source 3612
    target 3611
  ]
  edge [
    source 3612
    target 3607
  ]
  edge [
    source 3612
    target 3610
  ]
  edge [
    source 3613
    target 3633
  ]
  edge [
    source 3617
    target 3628
  ]
  edge [
    source 3617
    target 3619
  ]
  edge [
    source 3617
    target 3653
  ]
  edge [
    source 3617
    target 3650
  ]
  edge [
    source 3625
    target 3634
  ]
  edge [
    source 3625
    target 3661
  ]
  edge [
    source 3625
    target 3614
  ]
  edge [
    source 3629
    target 3642
  ]
  edge [
    source 3629
    target 3632
  ]
  edge [
    source 3633
    target 3622
  ]
  edge [
    source 3633
    target 3651
  ]
  edge [
    source 3633
    target 3618
  ]
  edge [
    source 3633
    target 3630
  ]
  edge [
    source 3638
    target 3658
  ]
  edge [
    source 3638
    target 3643
  ]
  edge [
    source 3638
    target 3637
  ]
  edge [
    source 3638
    target 3656
  ]
  edge [
    source 3641
    target 3613
  ]
  edge [
    source 3644
    target 3631
  ]
  edge [
    source 3644
    target 3660
  ]
  edge [
    source 3644
    target 3659
  ]
  edge [
    source 3648
    target 3655
  ]
  edge [
    source 3648
    target 3627
  ]
  edge [
    source 3648
    target 3646
  ]
  edge [
    source 3648
    target 3623
  ]
  edge [
    source 3648
    target 3640
  ]
  edge [
    source 3648
    target 3615
  ]
  edge [
    source 3648
    target 3617
  ]
  edge [
    source 3648
    target 3657
  ]
  edge [
    source 3651
    target 3647
  ]
  edge [
    source 3651
    target 3624
  ]
  edge [
    source 3651
    target 3654
  ]
  edge [
    source 3651
    target 3620
  ]
  edge [
    source 3655
    target 3635
  ]
  edge [
    source 3655
    target 3638
  ]
  edge [
    source 3655
    target 3652
  ]
  edge [
    source 3655
    target 3649
  ]
  edge [
    source 3657
    target 3645
  ]
  edge [
    source 3657
    target 3621
  ]
  edge [
    source 3657
    target 3616
  ]
  edge [
    source 3662
    target 3639
  ]
  edge [
    source 3662
    target 3626
  ]
  edge [
    source 3671
    target 3675
  ]
  edge [
    source 3671
    target 3679
  ]
  edge [
    source 3673
    target 3668
  ]
  edge [
    source 3673
    target 3670
  ]
  edge [
    source 3673
    target 3678
  ]
  edge [
    source 3673
    target 3672
  ]
  edge [
    source 3673
    target 3667
  ]
  edge [
    source 3673
    target 3677
  ]
  edge [
    source 3673
    target 3666
  ]
  edge [
    source 3673
    target 3674
  ]
  edge [
    source 3673
    target 3663
  ]
  edge [
    source 3673
    target 3669
  ]
  edge [
    source 3676
    target 3681
  ]
  edge [
    source 3676
    target 3665
  ]
  edge [
    source 3682
    target 3664
  ]
  edge [
    source 3682
    target 3676
  ]
  edge [
    source 3682
    target 3680
  ]
  edge [
    source 3685
    target 3683
  ]
  edge [
    source 3685
    target 3697
  ]
  edge [
    source 3685
    target 3691
  ]
  edge [
    source 3685
    target 3693
  ]
  edge [
    source 3685
    target 3695
  ]
  edge [
    source 3685
    target 3696
  ]
  edge [
    source 3685
    target 3684
  ]
  edge [
    source 3685
    target 3689
  ]
  edge [
    source 3685
    target 3694
  ]
  edge [
    source 3693
    target 3690
  ]
  edge [
    source 3705
    target 3710
  ]
  edge [
    source 3708
    target 3704
  ]
  edge [
    source 3708
    target 3713
  ]
  edge [
    source 3708
    target 3709
  ]
  edge [
    source 3708
    target 3716
  ]
  edge [
    source 3708
    target 3711
  ]
  edge [
    source 3710
    target 3703
  ]
  edge [
    source 3719
    target 3786
  ]
  edge [
    source 3723
    target 3801
  ]
  edge [
    source 3723
    target 3771
  ]
  edge [
    source 3724
    target 3769
  ]
  edge [
    source 3724
    target 3741
  ]
  edge [
    source 3727
    target 3784
  ]
  edge [
    source 3727
    target 3762
  ]
  edge [
    source 3728
    target 3783
  ]
  edge [
    source 3728
    target 3780
  ]
  edge [
    source 3728
    target 3718
  ]
  edge [
    source 3728
    target 3751
  ]
  edge [
    source 3728
    target 3815
  ]
  edge [
    source 3728
    target 3790
  ]
  edge [
    source 3728
    target 3791
  ]
  edge [
    source 3728
    target 3792
  ]
  edge [
    source 3728
    target 3757
  ]
  edge [
    source 3728
    target 3805
  ]
  edge [
    source 3733
    target 3725
  ]
  edge [
    source 3733
    target 3809
  ]
  edge [
    source 3743
    target 3738
  ]
  edge [
    source 3743
    target 3793
  ]
  edge [
    source 3744
    target 3779
  ]
  edge [
    source 3744
    target 3739
  ]
  edge [
    source 3744
    target 3732
  ]
  edge [
    source 3744
    target 3797
  ]
  edge [
    source 3744
    target 3804
  ]
  edge [
    source 3744
    target 3806
  ]
  edge [
    source 3744
    target 3808
  ]
  edge [
    source 3744
    target 3802
  ]
  edge [
    source 3744
    target 3785
  ]
  edge [
    source 3744
    target 3770
  ]
  edge [
    source 3744
    target 3729
  ]
  edge [
    source 3744
    target 3765
  ]
  edge [
    source 3746
    target 3796
  ]
  edge [
    source 3746
    target 3788
  ]
  edge [
    source 3746
    target 3754
  ]
  edge [
    source 3746
    target 3734
  ]
  edge [
    source 3747
    target 3811
  ]
  edge [
    source 3747
    target 3789
  ]
  edge [
    source 3749
    target 3720
  ]
  edge [
    source 3752
    target 3778
  ]
  edge [
    source 3752
    target 3787
  ]
  edge [
    source 3752
    target 3772
  ]
  edge [
    source 3752
    target 3759
  ]
  edge [
    source 3752
    target 3814
  ]
  edge [
    source 3752
    target 3740
  ]
  edge [
    source 3752
    target 3737
  ]
  edge [
    source 3752
    target 3731
  ]
  edge [
    source 3752
    target 3777
  ]
  edge [
    source 3752
    target 3761
  ]
  edge [
    source 3753
    target 3722
  ]
  edge [
    source 3753
    target 3758
  ]
  edge [
    source 3758
    target 3748
  ]
  edge [
    source 3758
    target 3764
  ]
  edge [
    source 3758
    target 3773
  ]
  edge [
    source 3759
    target 3724
  ]
  edge [
    source 3760
    target 3768
  ]
  edge [
    source 3760
    target 3726
  ]
  edge [
    source 3766
    target 3782
  ]
  edge [
    source 3766
    target 3746
  ]
  edge [
    source 3766
    target 3810
  ]
  edge [
    source 3767
    target 3766
  ]
  edge [
    source 3767
    target 3812
  ]
  edge [
    source 3768
    target 3813
  ]
  edge [
    source 3768
    target 3730
  ]
  edge [
    source 3772
    target 3755
  ]
  edge [
    source 3772
    target 3776
  ]
  edge [
    source 3775
    target 3749
  ]
  edge [
    source 3775
    target 3799
  ]
  edge [
    source 3775
    target 3756
  ]
  edge [
    source 3777
    target 3800
  ]
  edge [
    source 3779
    target 3763
  ]
  edge [
    source 3779
    target 3795
  ]
  edge [
    source 3779
    target 3742
  ]
  edge [
    source 3779
    target 3727
  ]
  edge [
    source 3781
    target 3717
  ]
  edge [
    source 3781
    target 3733
  ]
  edge [
    source 3786
    target 3794
  ]
  edge [
    source 3798
    target 3736
  ]
  edge [
    source 3798
    target 3747
  ]
  edge [
    source 3801
    target 3803
  ]
  edge [
    source 3801
    target 3721
  ]
  edge [
    source 3817
    target 3818
  ]
  edge [
    source 3817
    target 3819
  ]
  edge [
    source 3820
    target 3816
  ]
  edge [
    source 3820
    target 3824
  ]
  edge [
    source 3822
    target 3821
  ]
  edge [
    source 3822
    target 3823
  ]
  edge [
    source 3828
    target 3833
  ]
  edge [
    source 3828
    target 3827
  ]
  edge [
    source 3831
    target 3835
  ]
  edge [
    source 3831
    target 3832
  ]
  edge [
    source 3834
    target 3826
  ]
  edge [
    source 3834
    target 3830
  ]
  edge [
    source 3838
    target 3868
  ]
  edge [
    source 3838
    target 3864
  ]
  edge [
    source 3839
    target 3838
  ]
  edge [
    source 3839
    target 3844
  ]
  edge [
    source 3839
    target 3877
  ]
  edge [
    source 3840
    target 3880
  ]
  edge [
    source 3840
    target 3857
  ]
  edge [
    source 3841
    target 3860
  ]
  edge [
    source 3841
    target 3870
  ]
  edge [
    source 3843
    target 3873
  ]
  edge [
    source 3843
    target 3846
  ]
  edge [
    source 3843
    target 3879
  ]
  edge [
    source 3845
    target 3881
  ]
  edge [
    source 3845
    target 3851
  ]
  edge [
    source 3849
    target 3837
  ]
  edge [
    source 3849
    target 3869
  ]
  edge [
    source 3849
    target 3861
  ]
  edge [
    source 3849
    target 3884
  ]
  edge [
    source 3849
    target 3871
  ]
  edge [
    source 3849
    target 3852
  ]
  edge [
    source 3849
    target 3862
  ]
  edge [
    source 3852
    target 3850
  ]
  edge [
    source 3852
    target 3886
  ]
  edge [
    source 3853
    target 3836
  ]
  edge [
    source 3853
    target 3855
  ]
  edge [
    source 3853
    target 3867
  ]
  edge [
    source 3853
    target 3878
  ]
  edge [
    source 3853
    target 3874
  ]
  edge [
    source 3864
    target 3866
  ]
  edge [
    source 3864
    target 3859
  ]
  edge [
    source 3885
    target 3858
  ]
  edge [
    source 3885
    target 3848
  ]
  edge [
    source 3885
    target 3847
  ]
  edge [
    source 3885
    target 3883
  ]
  edge [
    source 3885
    target 3865
  ]
  edge [
    source 3893
    target 3895
  ]
  edge [
    source 3893
    target 3894
  ]
  edge [
    source 3896
    target 3899
  ]
  edge [
    source 3896
    target 3897
  ]
  edge [
    source 3898
    target 3901
  ]
  edge [
    source 3898
    target 3902
  ]
  edge [
    source 3901
    target 3900
  ]
  edge [
    source 3906
    target 3915
  ]
  edge [
    source 3906
    target 3904
  ]
  edge [
    source 3906
    target 3918
  ]
  edge [
    source 3906
    target 3908
  ]
  edge [
    source 3907
    target 3917
  ]
  edge [
    source 3907
    target 3905
  ]
  edge [
    source 3913
    target 3907
  ]
  edge [
    source 3913
    target 3914
  ]
  edge [
    source 3916
    target 3911
  ]
  edge [
    source 3916
    target 3909
  ]
  edge [
    source 3919
    target 3910
  ]
  edge [
    source 3919
    target 3912
  ]
  edge [
    source 3922
    target 3930
  ]
  edge [
    source 3922
    target 3929
  ]
  edge [
    source 3924
    target 3920
  ]
  edge [
    source 3924
    target 3925
  ]
  edge [
    source 3924
    target 3927
  ]
  edge [
    source 3928
    target 3931
  ]
  edge [
    source 3931
    target 3921
  ]
  edge [
    source 3934
    target 3965
  ]
  edge [
    source 3934
    target 3938
  ]
  edge [
    source 3935
    target 3959
  ]
  edge [
    source 3935
    target 3954
  ]
  edge [
    source 3935
    target 3936
  ]
  edge [
    source 3935
    target 3962
  ]
  edge [
    source 3940
    target 3946
  ]
  edge [
    source 3940
    target 3960
  ]
  edge [
    source 3943
    target 3935
  ]
  edge [
    source 3943
    target 3942
  ]
  edge [
    source 3944
    target 3956
  ]
  edge [
    source 3944
    target 3939
  ]
  edge [
    source 3944
    target 3967
  ]
  edge [
    source 3946
    target 3957
  ]
  edge [
    source 3946
    target 3937
  ]
  edge [
    source 3946
    target 3933
  ]
  edge [
    source 3948
    target 3941
  ]
  edge [
    source 3950
    target 3961
  ]
  edge [
    source 3950
    target 3945
  ]
  edge [
    source 3951
    target 3948
  ]
  edge [
    source 3951
    target 3949
  ]
  edge [
    source 3961
    target 3966
  ]
  edge [
    source 3961
    target 3958
  ]
  edge [
    source 3966
    target 3953
  ]
  edge [
    source 3966
    target 3963
  ]
  edge [
    source 3966
    target 3964
  ]
  edge [
    source 3966
    target 3952
  ]
  edge [
    source 3968
    target 3934
  ]
  edge [
    source 3968
    target 3969
  ]
  edge [
    source 3976
    target 4000
  ]
  edge [
    source 3976
    target 3996
  ]
  edge [
    source 3976
    target 3972
  ]
  edge [
    source 3976
    target 3970
  ]
  edge [
    source 3976
    target 3993
  ]
  edge [
    source 3976
    target 3999
  ]
  edge [
    source 3976
    target 3992
  ]
  edge [
    source 3976
    target 4003
  ]
  edge [
    source 3977
    target 3997
  ]
  edge [
    source 3977
    target 4001
  ]
  edge [
    source 3977
    target 3973
  ]
  edge [
    source 3980
    target 3984
  ]
  edge [
    source 3980
    target 3991
  ]
  edge [
    source 3986
    target 3981
  ]
  edge [
    source 3986
    target 3971
  ]
  edge [
    source 3986
    target 3974
  ]
  edge [
    source 3986
    target 3987
  ]
  edge [
    source 3986
    target 3979
  ]
  edge [
    source 3986
    target 3988
  ]
  edge [
    source 3986
    target 3985
  ]
  edge [
    source 3986
    target 3998
  ]
  edge [
    source 3986
    target 3982
  ]
  edge [
    source 3986
    target 3995
  ]
  edge [
    source 3986
    target 3989
  ]
  edge [
    source 3986
    target 3983
  ]
  edge [
    source 3986
    target 3975
  ]
  edge [
    source 3986
    target 3994
  ]
  edge [
    source 3986
    target 4002
  ]
  edge [
    source 4012
    target 4009
  ]
  edge [
    source 4012
    target 4013
  ]
  edge [
    source 4012
    target 4014
  ]
  edge [
    source 4012
    target 4015
  ]
  edge [
    source 4012
    target 4008
  ]
  edge [
    source 4012
    target 4018
  ]
  edge [
    source 4023
    target 4020
  ]
  edge [
    source 4023
    target 4026
  ]
  edge [
    source 4023
    target 4032
  ]
  edge [
    source 4024
    target 4029
  ]
  edge [
    source 4024
    target 4031
  ]
  edge [
    source 4024
    target 4040
  ]
  edge [
    source 4024
    target 4035
  ]
  edge [
    source 4024
    target 4019
  ]
  edge [
    source 4024
    target 4021
  ]
  edge [
    source 4025
    target 4043
  ]
  edge [
    source 4025
    target 4028
  ]
  edge [
    source 4038
    target 4036
  ]
  edge [
    source 4038
    target 4041
  ]
  edge [
    source 4038
    target 4022
  ]
  edge [
    source 4038
    target 4030
  ]
  edge [
    source 4038
    target 4027
  ]
  edge [
    source 4038
    target 4023
  ]
  edge [
    source 4038
    target 4039
  ]
  edge [
    source 4042
    target 4024
  ]
  edge [
    source 4042
    target 4033
  ]
  edge [
    source 4042
    target 4034
  ]
  edge [
    source 4049
    target 4053
  ]
  edge [
    source 4049
    target 4054
  ]
  edge [
    source 4049
    target 4052
  ]
  edge [
    source 4049
    target 4051
  ]
  edge [
    source 4049
    target 4055
  ]
  edge [
    source 4056
    target 4075
  ]
  edge [
    source 4056
    target 4066
  ]
  edge [
    source 4056
    target 4063
  ]
  edge [
    source 4058
    target 4073
  ]
  edge [
    source 4058
    target 4076
  ]
  edge [
    source 4058
    target 4074
  ]
  edge [
    source 4059
    target 4078
  ]
  edge [
    source 4059
    target 4057
  ]
  edge [
    source 4064
    target 4071
  ]
  edge [
    source 4064
    target 4060
  ]
  edge [
    source 4064
    target 4062
  ]
  edge [
    source 4064
    target 4068
  ]
  edge [
    source 4065
    target 4080
  ]
  edge [
    source 4065
    target 4072
  ]
  edge [
    source 4065
    target 4056
  ]
  edge [
    source 4065
    target 4058
  ]
  edge [
    source 4079
    target 4077
  ]
  edge [
    source 4079
    target 4069
  ]
  edge [
    source 4079
    target 4061
  ]
  edge [
    source 4079
    target 4070
  ]
  edge [
    source 4079
    target 4067
  ]
  edge [
    source 4083
    target 4117
  ]
  edge [
    source 4083
    target 4106
  ]
  edge [
    source 4084
    target 4123
  ]
  edge [
    source 4084
    target 4082
  ]
  edge [
    source 4090
    target 4109
  ]
  edge [
    source 4090
    target 4096
  ]
  edge [
    source 4090
    target 4138
  ]
  edge [
    source 4094
    target 4089
  ]
  edge [
    source 4094
    target 4105
  ]
  edge [
    source 4094
    target 4120
  ]
  edge [
    source 4097
    target 4099
  ]
  edge [
    source 4097
    target 4111
  ]
  edge [
    source 4097
    target 4103
  ]
  edge [
    source 4097
    target 4133
  ]
  edge [
    source 4097
    target 4130
  ]
  edge [
    source 4097
    target 4081
  ]
  edge [
    source 4097
    target 4088
  ]
  edge [
    source 4097
    target 4087
  ]
  edge [
    source 4097
    target 4093
  ]
  edge [
    source 4097
    target 4092
  ]
  edge [
    source 4097
    target 4121
  ]
  edge [
    source 4100
    target 4113
  ]
  edge [
    source 4100
    target 4091
  ]
  edge [
    source 4106
    target 4108
  ]
  edge [
    source 4106
    target 4137
  ]
  edge [
    source 4110
    target 4118
  ]
  edge [
    source 4110
    target 4101
  ]
  edge [
    source 4110
    target 4095
  ]
  edge [
    source 4110
    target 4128
  ]
  edge [
    source 4116
    target 4104
  ]
  edge [
    source 4116
    target 4129
  ]
  edge [
    source 4119
    target 4139
  ]
  edge [
    source 4119
    target 4112
  ]
  edge [
    source 4119
    target 4124
  ]
  edge [
    source 4119
    target 4122
  ]
  edge [
    source 4119
    target 4134
  ]
  edge [
    source 4123
    target 4086
  ]
  edge [
    source 4123
    target 4125
  ]
  edge [
    source 4132
    target 4119
  ]
  edge [
    source 4132
    target 4084
  ]
  edge [
    source 4132
    target 4100
  ]
  edge [
    source 4132
    target 4083
  ]
  edge [
    source 4133
    target 4102
  ]
  edge [
    source 4133
    target 4131
  ]
  edge [
    source 4133
    target 4107
  ]
  edge [
    source 4134
    target 4135
  ]
  edge [
    source 4134
    target 4136
  ]
  edge [
    source 4134
    target 4085
  ]
  edge [
    source 4146
    target 4143
  ]
  edge [
    source 4146
    target 4142
  ]
  edge [
    source 4152
    target 4148
  ]
  edge [
    source 4152
    target 4147
  ]
  edge [
    source 4157
    target 4156
  ]
  edge [
    source 4157
    target 4163
  ]
  edge [
    source 4161
    target 4155
  ]
  edge [
    source 4161
    target 4160
  ]
  edge [
    source 4161
    target 4162
  ]
  edge [
    source 4161
    target 4157
  ]
  edge [
    source 4161
    target 4158
  ]
  edge [
    source 4175
    target 4179
  ]
  edge [
    source 4175
    target 4178
  ]
  edge [
    source 4175
    target 4182
  ]
  edge [
    source 4176
    target 4171
  ]
  edge [
    source 4176
    target 4177
  ]
  edge [
    source 4176
    target 4169
  ]
  edge [
    source 4176
    target 4181
  ]
  edge [
    source 4177
    target 4180
  ]
  edge [
    source 4177
    target 4170
  ]
  edge [
    source 4177
    target 4172
  ]
  edge [
    source 4184
    target 4185
  ]
  edge [
    source 4184
    target 4192
  ]
  edge [
    source 4184
    target 4199
  ]
  edge [
    source 4184
    target 4190
  ]
  edge [
    source 4184
    target 4200
  ]
  edge [
    source 4187
    target 4195
  ]
  edge [
    source 4187
    target 4196
  ]
  edge [
    source 4187
    target 4188
  ]
  edge [
    source 4189
    target 4184
  ]
  edge [
    source 4189
    target 4191
  ]
  edge [
    source 4191
    target 4194
  ]
  edge [
    source 4191
    target 4197
  ]
  edge [
    source 4198
    target 4183
  ]
  edge [
    source 4198
    target 4193
  ]
  edge [
    source 4198
    target 4186
  ]
  edge [
    source 4201
    target 4202
  ]
  edge [
    source 4201
    target 4203
  ]
  edge [
    source 4207
    target 4206
  ]
  edge [
    source 4207
    target 4211
  ]
  edge [
    source 4207
    target 4210
  ]
  edge [
    source 4208
    target 4205
  ]
  edge [
    source 4208
    target 4207
  ]
  edge [
    source 4209
    target 4213
  ]
  edge [
    source 4209
    target 4212
  ]
  edge [
    source 4219
    target 4232
  ]
  edge [
    source 4219
    target 4215
  ]
  edge [
    source 4219
    target 4227
  ]
  edge [
    source 4219
    target 4220
  ]
  edge [
    source 4223
    target 4216
  ]
  edge [
    source 4223
    target 4217
  ]
  edge [
    source 4223
    target 4221
  ]
  edge [
    source 4226
    target 4223
  ]
  edge [
    source 4226
    target 4218
  ]
  edge [
    source 4226
    target 4224
  ]
  edge [
    source 4226
    target 4231
  ]
  edge [
    source 4226
    target 4228
  ]
  edge [
    source 4230
    target 4233
  ]
  edge [
    source 4230
    target 4234
  ]
  edge [
    source 4230
    target 4229
  ]
  edge [
    source 4236
    target 4237
  ]
  edge [
    source 4236
    target 4238
  ]
  edge [
    source 4240
    target 4239
  ]
  edge [
    source 4240
    target 4236
  ]
  edge [
    source 4242
    target 4243
  ]
  edge [
    source 4242
    target 4244
  ]
  edge [
    source 4247
    target 4248
  ]
  edge [
    source 4247
    target 4251
  ]
  edge [
    source 4250
    target 4246
  ]
  edge [
    source 4250
    target 4245
  ]
  edge [
    source 4250
    target 4249
  ]
  edge [
    source 4252
    target 4250
  ]
  edge [
    source 4252
    target 4253
  ]
  edge [
    source 4258
    target 4274
  ]
  edge [
    source 4258
    target 4267
  ]
  edge [
    source 4259
    target 4254
  ]
  edge [
    source 4259
    target 4258
  ]
  edge [
    source 4260
    target 4272
  ]
  edge [
    source 4261
    target 4266
  ]
  edge [
    source 4261
    target 4275
  ]
  edge [
    source 4261
    target 4257
  ]
  edge [
    source 4261
    target 4276
  ]
  edge [
    source 4261
    target 4273
  ]
  edge [
    source 4261
    target 4265
  ]
  edge [
    source 4264
    target 4263
  ]
  edge [
    source 4264
    target 4270
  ]
  edge [
    source 4271
    target 4260
  ]
  edge [
    source 4278
    target 4281
  ]
  edge [
    source 4278
    target 4282
  ]
  edge [
    source 4283
    target 4277
  ]
  edge [
    source 4283
    target 4280
  ]
  edge [
    source 4287
    target 4294
  ]
  edge [
    source 4287
    target 4317
  ]
  edge [
    source 4287
    target 4308
  ]
  edge [
    source 4288
    target 4310
  ]
  edge [
    source 4288
    target 4302
  ]
  edge [
    source 4288
    target 4285
  ]
  edge [
    source 4288
    target 4300
  ]
  edge [
    source 4288
    target 4319
  ]
  edge [
    source 4288
    target 4322
  ]
  edge [
    source 4293
    target 4303
  ]
  edge [
    source 4293
    target 4284
  ]
  edge [
    source 4293
    target 4304
  ]
  edge [
    source 4293
    target 4289
  ]
  edge [
    source 4306
    target 4286
  ]
  edge [
    source 4306
    target 4293
  ]
  edge [
    source 4306
    target 4314
  ]
  edge [
    source 4306
    target 4323
  ]
  edge [
    source 4306
    target 4295
  ]
  edge [
    source 4306
    target 4299
  ]
  edge [
    source 4306
    target 4316
  ]
  edge [
    source 4306
    target 4320
  ]
  edge [
    source 4307
    target 4306
  ]
  edge [
    source 4307
    target 4309
  ]
  edge [
    source 4307
    target 4312
  ]
  edge [
    source 4307
    target 4301
  ]
  edge [
    source 4309
    target 4315
  ]
  edge [
    source 4309
    target 4318
  ]
  edge [
    source 4309
    target 4298
  ]
  edge [
    source 4309
    target 4321
  ]
  edge [
    source 4309
    target 4296
  ]
  edge [
    source 4309
    target 4297
  ]
  edge [
    source 4309
    target 4313
  ]
  edge [
    source 4309
    target 4291
  ]
  edge [
    source 4318
    target 4292
  ]
  edge [
    source 4318
    target 4305
  ]
  edge [
    source 4318
    target 4290
  ]
  edge [
    source 4318
    target 4311
  ]
  edge [
    source 4331
    target 4338
  ]
  edge [
    source 4331
    target 4333
  ]
  edge [
    source 4339
    target 4330
  ]
  edge [
    source 4339
    target 4332
  ]
  edge [
    source 4340
    target 4341
  ]
  edge [
    source 4340
    target 4336
  ]
  edge [
    source 4340
    target 4334
  ]
  edge [
    source 4355
    target 4362
  ]
  edge [
    source 4355
    target 4349
  ]
  edge [
    source 4355
    target 4343
  ]
  edge [
    source 4355
    target 4351
  ]
  edge [
    source 4355
    target 4357
  ]
  edge [
    source 4355
    target 4359
  ]
  edge [
    source 4355
    target 4389
  ]
  edge [
    source 4355
    target 4370
  ]
  edge [
    source 4361
    target 4384
  ]
  edge [
    source 4361
    target 4388
  ]
  edge [
    source 4361
    target 4356
  ]
  edge [
    source 4361
    target 4368
  ]
  edge [
    source 4361
    target 4344
  ]
  edge [
    source 4361
    target 4372
  ]
  edge [
    source 4361
    target 4366
  ]
  edge [
    source 4361
    target 4342
  ]
  edge [
    source 4376
    target 4385
  ]
  edge [
    source 4376
    target 4360
  ]
  edge [
    source 4378
    target 4354
  ]
  edge [
    source 4378
    target 4381
  ]
  edge [
    source 4388
    target 4373
  ]
  edge [
    source 4388
    target 4363
  ]
  edge [
    source 4388
    target 4369
  ]
  edge [
    source 4388
    target 4352
  ]
  edge [
    source 4393
    target 4394
  ]
  edge [
    source 4406
    target 4404
  ]
  edge [
    source 4406
    target 4405
  ]
  edge [
    source 4406
    target 4401
  ]
  edge [
    source 4406
    target 4403
  ]
  edge [
    source 4406
    target 4412
  ]
  edge [
    source 4406
    target 4413
  ]
  edge [
    source 4406
    target 4411
  ]
  edge [
    source 4406
    target 4414
  ]
  edge [
    source 4416
    target 4407
  ]
  edge [
    source 4416
    target 4415
  ]
  edge [
    source 4416
    target 4409
  ]
  edge [
    source 4416
    target 4410
  ]
  edge [
    source 4417
    target 4418
  ]
  edge [
    source 4417
    target 4408
  ]
  edge [
    source 4422
    target 4421
  ]
  edge [
    source 4424
    target 4433
  ]
  edge [
    source 4424
    target 4430
  ]
  edge [
    source 4428
    target 4432
  ]
  edge [
    source 4428
    target 4426
  ]
  edge [
    source 4428
    target 4434
  ]
  edge [
    source 4428
    target 4435
  ]
  edge [
    source 4428
    target 4431
  ]
  edge [
    source 4428
    target 4429
  ]
  edge [
    source 4428
    target 4425
  ]
  edge [
    source 4438
    target 4441
  ]
  edge [
    source 4438
    target 4439
  ]
  edge [
    source 4451
    target 4449
  ]
  edge [
    source 4451
    target 4448
  ]
  edge [
    source 4454
    target 4459
  ]
  edge [
    source 4454
    target 4456
  ]
  edge [
    source 4454
    target 4458
  ]
  edge [
    source 4454
    target 4460
  ]
  edge [
    source 4454
    target 4461
  ]
  edge [
    source 4454
    target 4455
  ]
  edge [
    source 4484
    target 4495
  ]
  edge [
    source 4484
    target 4507
  ]
  edge [
    source 4484
    target 4497
  ]
  edge [
    source 4486
    target 4513
  ]
  edge [
    source 4486
    target 4514
  ]
  edge [
    source 4486
    target 4489
  ]
  edge [
    source 4487
    target 4499
  ]
  edge [
    source 4487
    target 4505
  ]
  edge [
    source 4487
    target 4503
  ]
  edge [
    source 4487
    target 4508
  ]
  edge [
    source 4496
    target 4501
  ]
  edge [
    source 4496
    target 4509
  ]
  edge [
    source 4497
    target 4512
  ]
  edge [
    source 4497
    target 4493
  ]
  edge [
    source 4500
    target 4506
  ]
  edge [
    source 4500
    target 4491
  ]
  edge [
    source 4504
    target 4494
  ]
  edge [
    source 4504
    target 4511
  ]
  edge [
    source 4504
    target 4500
  ]
  edge [
    source 4504
    target 4502
  ]
  edge [
    source 4510
    target 4492
  ]
  edge [
    source 4510
    target 4488
  ]
  edge [
    source 4510
    target 4486
  ]
  edge [
    source 4510
    target 4490
  ]
  edge [
    source 4517
    target 4521
  ]
  edge [
    source 4517
    target 4519
  ]
  edge [
    source 4525
    target 4523
  ]
  edge [
    source 4525
    target 4524
  ]
  edge [
    source 4525
    target 4518
  ]
  edge [
    source 4526
    target 4528
  ]
  edge [
    source 4536
    target 4532
  ]
  edge [
    source 4536
    target 4538
  ]
  edge [
    source 4536
    target 4533
  ]
  edge [
    source 4536
    target 4531
  ]
  edge [
    source 4536
    target 4534
  ]
  edge [
    source 4537
    target 4530
  ]
  edge [
    source 4537
    target 4535
  ]
  edge [
    source 4544
    target 4547
  ]
  edge [
    source 4544
    target 4542
  ]
  edge [
    source 4544
    target 4545
  ]
  edge [
    source 4544
    target 4541
  ]
  edge [
    source 4544
    target 4552
  ]
  edge [
    source 4544
    target 4549
  ]
  edge [
    source 4544
    target 4554
  ]
  edge [
    source 4546
    target 4550
  ]
  edge [
    source 4546
    target 4543
  ]
  edge [
    source 4551
    target 4553
  ]
  edge [
    source 4551
    target 4548
  ]
  edge [
    source 4551
    target 4540
  ]
  edge [
    source 4557
    target 4559
  ]
  edge [
    source 4557
    target 4555
  ]
  edge [
    source 4562
    target 4564
  ]
  edge [
    source 4562
    target 4565
  ]
  edge [
    source 4572
    target 4585
  ]
  edge [
    source 4572
    target 4596
  ]
  edge [
    source 4572
    target 4591
  ]
  edge [
    source 4575
    target 4583
  ]
  edge [
    source 4575
    target 4590
  ]
  edge [
    source 4576
    target 4582
  ]
  edge [
    source 4576
    target 4580
  ]
  edge [
    source 4576
    target 4592
  ]
  edge [
    source 4576
    target 4587
  ]
  edge [
    source 4576
    target 4581
  ]
  edge [
    source 4576
    target 4598
  ]
  edge [
    source 4578
    target 4571
  ]
  edge [
    source 4584
    target 4576
  ]
  edge [
    source 4584
    target 4575
  ]
  edge [
    source 4585
    target 4589
  ]
  edge [
    source 4585
    target 4574
  ]
  edge [
    source 4585
    target 4586
  ]
  edge [
    source 4585
    target 4577
  ]
  edge [
    source 4585
    target 4573
  ]
  edge [
    source 4585
    target 4593
  ]
  edge [
    source 4591
    target 4594
  ]
  edge [
    source 4591
    target 4579
  ]
  edge [
    source 4594
    target 4595
  ]
  edge [
    source 4594
    target 4588
  ]
  edge [
    source 4600
    target 4607
  ]
  edge [
    source 4600
    target 4599
  ]
  edge [
    source 4600
    target 4602
  ]
  edge [
    source 4600
    target 4604
  ]
  edge [
    source 4605
    target 4608
  ]
  edge [
    source 4605
    target 4606
  ]
  edge [
    source 4610
    target 4609
  ]
  edge [
    source 4610
    target 4612
  ]
  edge [
    source 4615
    target 4616
  ]
  edge [
    source 4615
    target 4613
  ]
  edge [
    source 4615
    target 4621
  ]
  edge [
    source 4620
    target 4619
  ]
  edge [
    source 4620
    target 4617
  ]
  edge [
    source 4623
    target 4614
  ]
  edge [
    source 4623
    target 4622
  ]
  edge [
    source 4629
    target 4657
  ]
  edge [
    source 4629
    target 4651
  ]
  edge [
    source 4630
    target 4668
  ]
  edge [
    source 4630
    target 4660
  ]
  edge [
    source 4630
    target 4658
  ]
  edge [
    source 4633
    target 4670
  ]
  edge [
    source 4633
    target 4636
  ]
  edge [
    source 4633
    target 4625
  ]
  edge [
    source 4633
    target 4677
  ]
  edge [
    source 4642
    target 4662
  ]
  edge [
    source 4642
    target 4669
  ]
  edge [
    source 4644
    target 4645
  ]
  edge [
    source 4644
    target 4647
  ]
  edge [
    source 4644
    target 4632
  ]
  edge [
    source 4644
    target 4676
  ]
  edge [
    source 4644
    target 4674
  ]
  edge [
    source 4644
    target 4665
  ]
  edge [
    source 4644
    target 4661
  ]
  edge [
    source 4644
    target 4648
  ]
  edge [
    source 4644
    target 4659
  ]
  edge [
    source 4646
    target 4635
  ]
  edge [
    source 4646
    target 4639
  ]
  edge [
    source 4646
    target 4631
  ]
  edge [
    source 4646
    target 4672
  ]
  edge [
    source 4646
    target 4624
  ]
  edge [
    source 4646
    target 4667
  ]
  edge [
    source 4646
    target 4626
  ]
  edge [
    source 4646
    target 4652
  ]
  edge [
    source 4653
    target 4641
  ]
  edge [
    source 4653
    target 4633
  ]
  edge [
    source 4654
    target 4640
  ]
  edge [
    source 4654
    target 4649
  ]
  edge [
    source 4654
    target 4630
  ]
  edge [
    source 4654
    target 4650
  ]
  edge [
    source 4654
    target 4637
  ]
  edge [
    source 4654
    target 4642
  ]
  edge [
    source 4654
    target 4638
  ]
  edge [
    source 4654
    target 4671
  ]
  edge [
    source 4661
    target 4627
  ]
  edge [
    source 4661
    target 4664
  ]
  edge [
    source 4663
    target 4628
  ]
  edge [
    source 4663
    target 4666
  ]
  edge [
    source 4663
    target 4656
  ]
  edge [
    source 4672
    target 4675
  ]
  edge [
    source 4672
    target 4634
  ]
  edge [
    source 4673
    target 4629
  ]
  edge [
    source 4673
    target 4655
  ]
  edge [
    source 4673
    target 4643
  ]
  edge [
    source 4681
    target 4685
  ]
  edge [
    source 4681
    target 4687
  ]
  edge [
    source 4687
    target 4683
  ]
  edge [
    source 4687
    target 4684
  ]
  edge [
    source 4688
    target 4680
  ]
  edge [
    source 4688
    target 4686
  ]
  edge [
    source 4689
    target 4710
  ]
  edge [
    source 4689
    target 4715
  ]
  edge [
    source 4689
    target 4728
  ]
  edge [
    source 4689
    target 4750
  ]
  edge [
    source 4690
    target 4699
  ]
  edge [
    source 4690
    target 4700
  ]
  edge [
    source 4690
    target 4738
  ]
  edge [
    source 4690
    target 4730
  ]
  edge [
    source 4692
    target 4747
  ]
  edge [
    source 4692
    target 4705
  ]
  edge [
    source 4692
    target 4736
  ]
  edge [
    source 4695
    target 4742
  ]
  edge [
    source 4695
    target 4726
  ]
  edge [
    source 4695
    target 4723
  ]
  edge [
    source 4703
    target 4744
  ]
  edge [
    source 4703
    target 4704
  ]
  edge [
    source 4705
    target 4741
  ]
  edge [
    source 4705
    target 4743
  ]
  edge [
    source 4705
    target 4751
  ]
  edge [
    source 4705
    target 4745
  ]
  edge [
    source 4707
    target 4698
  ]
  edge [
    source 4707
    target 4711
  ]
  edge [
    source 4718
    target 4691
  ]
  edge [
    source 4718
    target 4729
  ]
  edge [
    source 4718
    target 4739
  ]
  edge [
    source 4718
    target 4717
  ]
  edge [
    source 4722
    target 4694
  ]
  edge [
    source 4722
    target 4731
  ]
  edge [
    source 4722
    target 4718
  ]
  edge [
    source 4722
    target 4740
  ]
  edge [
    source 4722
    target 4724
  ]
  edge [
    source 4722
    target 4696
  ]
  edge [
    source 4722
    target 4709
  ]
  edge [
    source 4724
    target 4727
  ]
  edge [
    source 4724
    target 4706
  ]
  edge [
    source 4724
    target 4701
  ]
  edge [
    source 4724
    target 4713
  ]
  edge [
    source 4726
    target 4746
  ]
  edge [
    source 4726
    target 4702
  ]
  edge [
    source 4726
    target 4735
  ]
  edge [
    source 4726
    target 4693
  ]
  edge [
    source 4731
    target 4703
  ]
  edge [
    source 4731
    target 4690
  ]
  edge [
    source 4733
    target 4716
  ]
  edge [
    source 4733
    target 4707
  ]
  edge [
    source 4733
    target 4712
  ]
  edge [
    source 4736
    target 4689
  ]
  edge [
    source 4740
    target 4734
  ]
  edge [
    source 4740
    target 4721
  ]
  edge [
    source 4740
    target 4732
  ]
  edge [
    source 4740
    target 4737
  ]
  edge [
    source 4742
    target 4749
  ]
  edge [
    source 4742
    target 4697
  ]
  edge [
    source 4742
    target 4714
  ]
  edge [
    source 4753
    target 4748
  ]
  edge [
    source 4753
    target 4752
  ]
  edge [
    source 4753
    target 4719
  ]
  edge [
    source 4753
    target 4720
  ]
  edge [
    source 4753
    target 4725
  ]
  edge [
    source 4753
    target 4708
  ]
  edge [
    source 4756
    target 4763
  ]
  edge [
    source 4763
    target 4768
  ]
  edge [
    source 4765
    target 4769
  ]
  edge [
    source 4765
    target 4757
  ]
  edge [
    source 4765
    target 4767
  ]
  edge [
    source 4765
    target 4771
  ]
  edge [
    source 4765
    target 4761
  ]
  edge [
    source 4768
    target 4760
  ]
  edge [
    source 4768
    target 4770
  ]
  edge [
    source 4768
    target 4759
  ]
  edge [
    source 4768
    target 4764
  ]
  edge [
    source 4784
    target 4779
  ]
  edge [
    source 4784
    target 4782
  ]
  edge [
    source 4784
    target 4777
  ]
  edge [
    source 4784
    target 4773
  ]
  edge [
    source 4788
    target 4785
  ]
  edge [
    source 4788
    target 4787
  ]
  edge [
    source 4788
    target 4786
  ]
  edge [
    source 4788
    target 4783
  ]
  edge [
    source 4788
    target 4772
  ]
  edge [
    source 4790
    target 4775
  ]
  edge [
    source 4790
    target 4781
  ]
  edge [
    source 4795
    target 4797
  ]
  edge [
    source 4799
    target 4800
  ]
  edge [
    source 4799
    target 4798
  ]
]
